MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PenobscotAIRA^KearneyAIRA^^^^^L|MTH^Mother^HL70063|1258 Caarlemmermeer St^^Redford^MI^48239^USA^P|^PRN^PH^^^734^9394302ORC|RE||BS15D59.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS15D59.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||||WalshAIRA^AlyssaAIRA^Yetta^^^^L|LarssenAIRA^HelouseAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1227 Nieuwe Pl^^Hancock^MI^49930^USA^P||^PRN^PH^^^906^2849499|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WalshAIRA^LarssenAIRA^^^^^L|MTH^Mother^HL70063|1227 Nieuwe Pl^^Hancock^MI^49930^USA^P|^PRN^PH^^^906^2849499ORC|RE||BR61Q64.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR61Q64.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R91M72^^^AIRA-TEST^MR|||IoscoAIRA^CalistaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1995 Dalten Ave^^Wellston^MI^49689^USA^P||^PRN^PH^^^231^4677669|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O'ConnellAIRA^IoscoAIRA^^^^^L|MTH^Mother^HL70063|1995 Dalten Ave^^Wellston^MI^49689^USA^P|^PRN^PH^^^231^4677669ORC|RE||BR91M72.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR91M72.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q42Q80^^^AIRA-TEST^MR||SacAIRA^CarolynAIRA^Benta^^^^L|InyoAIRA^UlrikaAIRA^^^^^M||F||2106-3^White^CDCREC|1152 Meldhoven Cir^^Mesick^MI^49668^USA^P||^PRN^PH^^^231^3248219|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SacAIRA^InyoAIRA^^^^^L|MTH^Mother^HL70063|1152 Meldhoven Cir^^Mesick^MI^49668^USA^P|^PRN^PH^^^231^3248219ORC|RE||BQ42Q80.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ42Q80.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M49X88^^^AIRA-TEST^MR||Contra CostaAIRA^LoisAIRA^Tusti^^^^L|OscodaAIRA^MaddieAIRA^^^^^M|DOB|F||2106-3^White^CDCREC|1757 Bar Ln^^Flint^MI^48503^USA^P||^PRN^PH^^^810^5156336|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Contra CostaAIRA^OscodaAIRA^^^^^L|MTH^Mother^HL70063|1757 Bar Ln^^Flint^MI^48503^USA^P|^PRN^PH^^^810^5156336ORC|RE||BM49X88.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM49X88.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M48Q99^^^AIRA-TEST^MR||BrazoriaAIRA^KamariaAIRA^Chyou^^^^L|PlatteAIRA^GaliAIRA^^^^^M|20230610|F||2106-3^White^CDCREC|1358 Eoudrichem Pl^^Flint^MI^48529^USA^P||^PRN^PH^^^810^8148110|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrazoriaAIRA^PlatteAIRA^^^^^L|MTH^Mother^HL70063|1358 Eoudrichem Pl^^Flint^MI^48529^USA^P|^PRN^PH^^^810^8148110ORC|RE||BM48Q99.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM48Q99.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D31G104^^^AIRA-TEST^MR||GilespieAIRA^AthenaAIRA^Caitlin^^^^L|WebsterAIRA^CyprianaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1303 Blphen aan den Rijn Ave^^Sault S Marie^MI^49784^USA^P||^PRN^PH^^^906^6951434|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GilespieAIRA^WebsterAIRA^^^^^L|MTH^Mother^HL70063|1303 Blphen aan den Rijn Ave^^Sault S Marie^MI^49784^USA^P|^PRN^PH^^^906^6951434ORC|RE||BD31G104.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S06D115^^^AIRA-TEST^MR||FurnasAIRA^HaylieAIRA^Lorene^^^^L|O DayAIRA^ShannaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1895 Controleren Cir^^Clare^MI^48617^USA^P||^PRN^PH^^^989^4451521|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FurnasAIRA^O DayAIRA^^^^^L|MTH^Mother^HL70063|1895 Controleren Cir^^Clare^MI^48617^USA^P|^PRN^PH^^^989^4451521ORC|RE||BS06D115.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E63M120^^^AIRA-TEST^MR||DouglasAIRA^LiaAIRA^Ellen^^^^L|WarrenAIRA^ZagirAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1072 Ntichtse Vecht Pl^^Copper Harbor^MI^49918^USA^P||^PRN^PH^^^906^8565717|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DouglasAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1072 Ntichtse Vecht Pl^^Copper Harbor^MI^49918^USA^P|^PRN^PH^^^906^8565717ORC|RE||BE63M120.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|SHOT DATE||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L22A131^^^AIRA-TEST^MR||PerryAIRA^SandyAIRA^Tajsa^^^^L|MissaukeeAIRA^GalinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1595 Meemster Ln^^Wolverine^MI^49799^USA^P||^PRN^PH^^^231^7384519|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PerryAIRA^MissaukeeAIRA^^^^^L|MTH^Mother^HL70063|1595 Meemster Ln^^Wolverine^MI^49799^USA^P|^PRN^PH^^^231^7384519ORC|RE||BL22A131.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20230610||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X03N139^^^AIRA-TEST^MR||ClearwaterAIRA^KaraAIRA^Shrijani^^^^L|GanronAIRA^IratzeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1776 Rittenseradiel Ln^^Mi Department of Revenue^MI^48956^USA^P||^PRN^PH^^^517^6923236|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClearwaterAIRA^GanronAIRA^^^^^L|MTH^Mother^HL70063|1776 Rittenseradiel Ln^^Mi Department of Revenue^MI^48956^USA^P|^PRN^PH^^^517^6923236ORC|RE||BX03N139.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RDT-K.01.12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z89A147^^^AIRA-TEST^MR||Santa CruzAIRA^EllamayAIRA^Kendal^^^^L|BeaverAIRA^KatyaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1011 Uit Cir^^Hesperia^MI^49421^USA^P||^PRN^PH^^^231^7053184|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Santa CruzAIRA^BeaverAIRA^^^^^L|MTH^Mother^HL70063|1011 Uit Cir^^Hesperia^MI^49421^USA^P|^PRN^PH^^^231^7053184ORC|RE||BZ89A147.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||14000BADVALUE^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-B|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F58V1159^^^AIRA-TEST^MR||JeffersonAIRA^BirgetAIRA^Helima^^^^L|San BenitoAIRA^HeroAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1968 Wenterwolde Ave^^Marlette^MI^48453^USA^P~1968 Wenterwolde Ave^^Marlette^MI^48453^USA^B||^PRN^PH^^^989^2273798|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^San BenitoAIRA^^^^^L|MTH^Mother^HL70063|1968 Wenterwolde Ave^^Marlette^MI^48453^USA^P|^PRN^PH^^^989^2273798ORC|RE||BF58V1159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF58V1159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-BA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y05E1167^^^AIRA-TEST^MR||VenturaAIRA^RodenAIRA^Merinda^^^^L|NobleAIRA^MakaylaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1852 Olst-Wijhe Cir^^Saint Charles^MI^48655^USA^P~1852 Olst-Wijhe Cir^^Saint Charles^MI^48655^USA^BA||^PRN^PH^^^989^4738766|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VenturaAIRA^NobleAIRA^^^^^L|MTH^Mother^HL70063|1852 Olst-Wijhe Cir^^Saint Charles^MI^48655^USA^P|^PRN^PH^^^989^4738766ORC|RE||BY05E1167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY05E1167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-BDL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P07X1172^^^AIRA-TEST^MR||KendallAIRA^ClorindaAIRA^Zotia^^^^L|LoganAIRA^MinetteAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1563 Mde Ln^^Salem^MI^48175^USA^P~1563 Mde Ln^^Salem^MI^48175^USA^BDL||^PRN^PH^^^810^4853365|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KendallAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1563 Mde Ln^^Salem^MI^48175^USA^P|^PRN^PH^^^810^4853365ORC|RE||BP07X1172.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP07X1172.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-BR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P06G1180^^^AIRA-TEST^MR||CassAIRA^HippolytaAIRA^Roshan^^^^L|CowleyAIRA^CireaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1171 Uandgraaf Ln^^Royal Oak Township^MI^48220^USA^P~1171 Uandgraaf Ln^^Royal Oak Township^MI^48220^USA^BR||^PRN^PH^^^248^5994806|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^CowleyAIRA^^^^^L|MTH^Mother^HL70063|1171 Uandgraaf Ln^^Royal Oak Township^MI^48220^USA^P|^PRN^PH^^^248^5994806ORC|RE||BP06G1180.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP06G1180.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-C|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L85R1191^^^AIRA-TEST^MR||TetonAIRA^RaelinAIRA^Cybill^^^^L|IowaAIRA^MadhaviAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1887 Paarlemmerliede en Spaarnwoude Ave^^Bloomfld Township^MI^48303^USA^P~1887 Paarlemmerliede en Spaarnwoude Ave^^Bloomfld Township^MI^48303^USA^C||^PRN^PH^^^248^6014630|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TetonAIRA^IowaAIRA^^^^^L|MTH^Mother^HL70063|1887 Paarlemmerliede en Spaarnwoude Ave^^Bloomfld Township^MI^48303^USA^P|^PRN^PH^^^248^6014630ORC|RE||BL85R1191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL85R1191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-F|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M56N1199^^^AIRA-TEST^MR||LovingAIRA^YoothaAIRA^Kornelia^^^^L|DefianceAIRA^HabikaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1631 Hiessenlanden St^^Kaleva^MI^49645^USA^P~1631 Hiessenlanden St^^Kaleva^MI^49645^USA^F||^PRN^PH^^^231^4383760|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LovingAIRA^DefianceAIRA^^^^^L|MTH^Mother^HL70063|1631 Hiessenlanden St^^Kaleva^MI^49645^USA^P|^PRN^PH^^^231^4383760ORC|RE||BM56N1199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM56N1199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-H|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M29O1207^^^AIRA-TEST^MR||ComancheAIRA^MaleahAIRA^Tahira^^^^L|AdaAIRA^MaysaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1585 Reeuwarden Ave^^Cedarville^MI^49719^USA^P~1585 Reeuwarden Ave^^Cedarville^MI^49719^USA^H||^PRN^PH^^^906^3297925|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ComancheAIRA^AdaAIRA^^^^^L|MTH^Mother^HL70063|1585 Reeuwarden Ave^^Cedarville^MI^49719^USA^P|^PRN^PH^^^906^3297925ORC|RE||BM29O1207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM29O1207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-L|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y48J1215^^^AIRA-TEST^MR||CanadianAIRA^KeeraAIRA^Kestrel^^^^L|DahlAIRA^LawrenciaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1084 Nruten St^^Oden^MI^49764^USA^P~1084 Nruten St^^Oden^MI^49764^USA^L||^PRN^PH^^^616^2408792|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CanadianAIRA^DahlAIRA^^^^^L|MTH^Mother^HL70063|1084 Nruten St^^Oden^MI^49764^USA^P|^PRN^PH^^^616^2408792ORC|RE||BY48J1215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY48J1215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-M|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M97X1223^^^AIRA-TEST^MR||GarzaAIRA^CarlyAIRA^Morgen^^^^L|DecaturAIRA^AmarisAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1600 Groningen Ave^^Michigan Center^MI^49254^USA^P~1600 Groningen Ave^^Michigan Center^MI^49254^USA^M||^PRN^PH^^^517^5936622|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarzaAIRA^DecaturAIRA^^^^^L|MTH^Mother^HL70063|1600 Groningen Ave^^Michigan Center^MI^49254^USA^P|^PRN^PH^^^517^5936622ORC|RE||BM97X1223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM97X1223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-N|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M54Q1228^^^AIRA-TEST^MR||MuskingumAIRA^PearlAIRA^Fran^^^^L|DimmitAIRA^MadysonAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1450 Olieland St^^Atlanta^MI^49709^USA^P~1450 Olieland St^^Atlanta^MI^49709^USA^N||^PRN^PH^^^989^3063196|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MuskingumAIRA^DimmitAIRA^^^^^L|MTH^Mother^HL70063|1450 Olieland St^^Atlanta^MI^49709^USA^P|^PRN^PH^^^989^3063196ORC|RE||BM54Q1228.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM54Q1228.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-O|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T38J1236^^^AIRA-TEST^MR||HarlanAIRA^SondraAIRA^Chrissy^^^^L|LokkenAIRA^TaipaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1214 Kidden-Drenthe Cir^^Munith^MI^49259^USA^P~1214 Kidden-Drenthe Cir^^Munith^MI^49259^USA^O||^PRN^PH^^^517^9659217|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarlanAIRA^LokkenAIRA^^^^^L|MTH^Mother^HL70063|1214 Kidden-Drenthe Cir^^Munith^MI^49259^USA^P|^PRN^PH^^^517^9659217ORC|RE||BT38J1236.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT38J1236.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-P|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K32U1247^^^AIRA-TEST^MR||LandbergAIRA^LillianAIRA^Apara^^^^L|LorainAIRA^ChelseaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1603 Veek Ln^^Grant^MI^49327^USA^P~1603 Veek Ln^^Grant^MI^49327^USA^P||^PRN^PH^^^231^2732298|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LandbergAIRA^LorainAIRA^^^^^L|MTH^Mother^HL70063|1603 Veek Ln^^Grant^MI^49327^USA^P|^PRN^PH^^^231^2732298ORC|RE||BK32U1247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK32U1247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE2-RH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U72P1255^^^AIRA-TEST^MR||HabberstadAIRA^JaimicaAIRA^Alena^^^^L|San BenitoAIRA^UlaniAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1241 Zemert-Bakel Ave^^Gobles^MI^49055^USA^P~1241 Zemert-Bakel Ave^^Gobles^MI^49055^USA^RH||^PRN^PH^^^269^3512128|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HabberstadAIRA^San BenitoAIRA^^^^^L|MTH^Mother^HL70063|1241 Zemert-Bakel Ave^^Gobles^MI^49055^USA^P|^PRN^PH^^^269^3512128ORC|RE||BU72P1255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU72P1255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-BIRTH-ORDER-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G83U1263^^^AIRA-TEST^MR||LohmannAIRA^VelmaAIRA^Dolores^^^^L|FranklinAIRA^MistyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1269 Meldermalsen Cir^^Flint^MI^48505^USA^P||^PRN^PH^^^810^3804511|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|1|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LohmannAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1269 Meldermalsen Cir^^Flint^MI^48505^USA^P|^PRN^PH^^^810^3804511ORC|RE||BG83U1263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG83U1263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-BIRTH-ORDER-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D37O1271^^^AIRA-TEST^MR||AdamsAIRA^TildaAIRA^Adelle^^^^L|CulpAIRA^MalavikaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1264 Fudwest-Fryslan St^^Cohoctah^MI^48816^USA^P||^PRN^PH^^^517^2248355|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|2|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdamsAIRA^CulpAIRA^^^^^L|MTH^Mother^HL70063|1264 Fudwest-Fryslan St^^Cohoctah^MI^48816^USA^P|^PRN^PH^^^517^2248355ORC|RE||BD37O1271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD37O1271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-BIRTH-ORDER-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T88G1276^^^AIRA-TEST^MR||McClainAIRA^DeiondreAIRA^Rebel^^^^L|BooneAIRA^SabineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1477 Dus St^^Riverdale^MI^48877^USA^P||^PRN^PH^^^989^6106865|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|3|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McClainAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1477 Dus St^^Riverdale^MI^48877^USA^P|^PRN^PH^^^989^6106865ORC|RE||BT88G1276.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT88G1276.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-BIRTH-ORDER-4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q71D1284^^^AIRA-TEST^MR||OttawaAIRA^NerissaAIRA^Sabrina^^^^L|San JoaquinAIRA^LouiseAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1872 Orimmelen St^^Canton^MI^48184^USA^P||^PRN^PH^^^734^6967328|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|4|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OttawaAIRA^San JoaquinAIRA^^^^^L|MTH^Mother^HL70063|1872 Orimmelen St^^Canton^MI^48184^USA^P|^PRN^PH^^^734^6967328ORC|RE||BQ71D1284.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ71D1284.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-BIRTH-ORDER-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P78K1295^^^AIRA-TEST^MR||RobinsonAIRA^ArellaAIRA^Aisha^^^^L|StephensAIRA^SitembileAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1791 Kinnenmaas Ln^^Milford^MI^48381^USA^P||^PRN^PH^^^248^7820200|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|5|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobinsonAIRA^StephensAIRA^^^^^L|MTH^Mother^HL70063|1791 Kinnenmaas Ln^^Milford^MI^48381^USA^P|^PRN^PH^^^248^7820200ORC|RE||BP78K1295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP78K1295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ETH-2135-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T20D1303^^^AIRA-TEST^MR||CummingsAIRA^IdehAIRA^Amarante^^^^L|GrayAIRA^LaquettaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1234 Kde St^^Bloomfield Hills^MI^48303^USA^P||^PRN^PH^^^248^9789360|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CummingsAIRA^GrayAIRA^^^^^L|MTH^Mother^HL70063|1234 Kde St^^Bloomfield Hills^MI^48303^USA^P|^PRN^PH^^^248^9789360ORC|RE||BT20D1303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT20D1303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ETH-2186-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X63P1311^^^AIRA-TEST^MR||BerreenAIRA^TokikoAIRA^Valerie^^^^L|JeffersonAIRA^NealaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1021 Me Ronde Venen St^^Redford^MI^48239^USA^P||^PRN^PH^^^734^9221709|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BerreenAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1021 Me Ronde Venen St^^Redford^MI^48239^USA^P|^PRN^PH^^^734^9221709ORC|RE||BX63P1311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX63P1311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ETH-H|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J89Y1319^^^AIRA-TEST^MR||SaundersAIRA^RinaAIRA^Eve^^^^L|ArcherAIRA^RadmillaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1216 Mittard-Geleen Ln^^Ash Township^MI^48117^USA^P||^PRN^PH^^^734^7593272|||||||||H^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SaundersAIRA^ArcherAIRA^^^^^L|MTH^Mother^HL70063|1216 Mittard-Geleen Ln^^Ash Township^MI^48117^USA^P|^PRN^PH^^^734^7593272ORC|RE||BJ89Y1319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ89Y1319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ETH-N|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C31S1327^^^AIRA-TEST^MR||MercerAIRA^AlzenaAIRA^Lettice^^^^L|HardemanAIRA^MyahAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1593 Jteenwijkerland Cir^^Warren^MI^48090^USA^P||^PRN^PH^^^586^9946025|||||||||N^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MercerAIRA^HardemanAIRA^^^^^L|MTH^Mother^HL70063|1593 Jteenwijkerland Cir^^Warren^MI^48090^USA^P|^PRN^PH^^^586^9946025ORC|RE||BC31S1327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC31S1327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ETH-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P95N1335^^^AIRA-TEST^MR||OklahomaAIRA^ZoleenAIRA^Susan^^^^L|ValleyAIRA^AlynaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1788 Eemnes Ln^^Detroit^MI^48234^USA^P||^PRN^PH^^^313^9185053|||||||||U^Unknown^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OklahomaAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1788 Eemnes Ln^^Detroit^MI^48234^USA^P|^PRN^PH^^^313^9185053ORC|RE||BP95N1335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP95N1335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-AN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S63C1340^^^AIRA-TEST^MR~116730737^^^AIRA-TEST^AN||LenaweeAIRA^ArdenAIRA^Nathalie^^^^L|GogebicAIRA^GudduAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1125 Etten-Leur Cir^^Jonesville^MI^49250^USA^P||^PRN^PH^^^517^3551150|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LenaweeAIRA^GogebicAIRA^^^^^L|MTH^Mother^HL70063|1125 Etten-Leur Cir^^Jonesville^MI^49250^USA^P|^PRN^PH^^^517^3551150ORC|RE||BS63C1340.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS63C1340.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-ANC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B15L1348^^^AIRA-TEST^MR~919909636^^^AIRA-TEST^ANC||HofflundAIRA^EdaleneAIRA^Dot^^^^L|PeskenAIRA^JeraldineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1525 Nerkelland Ave^^Owosso^MI^48841^USA^P||^PRN^PH^^^989^9495390|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HofflundAIRA^PeskenAIRA^^^^^L|MTH^Mother^HL70063|1525 Nerkelland Ave^^Owosso^MI^48841^USA^P|^PRN^PH^^^989^9495390ORC|RE||BB15L1348.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB15L1348.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-AND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M22X1359^^^AIRA-TEST^MR~457237606^^^AIRA-TEST^AND||BerrienAIRA^DepAIRA^Amandla^^^^L|HowardAIRA^TerzaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1007 Nromstrijen Ln^^Detroit^MI^48240^USA^P||^PRN^PH^^^313^7717539|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BerrienAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1007 Nromstrijen Ln^^Detroit^MI^48240^USA^P|^PRN^PH^^^313^7717539ORC|RE||BM22X1359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM22X1359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-ANON|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M07N1367^^^AIRA-TEST^MR~360382718^^^AIRA-TEST^ANON||TaylorAIRA^AlviraAIRA^Anselma^^^^L|BedfordAIRA^AmiraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1310 Woppersum St^^Rives Jct^MI^49277^USA^P||^PRN^PH^^^517^5355736|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^BedfordAIRA^^^^^L|MTH^Mother^HL70063|1310 Woppersum St^^Rives Jct^MI^49277^USA^P|^PRN^PH^^^517^5355736ORC|RE||BM07N1367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM07N1367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-ANT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S14D1375^^^AIRA-TEST^MR~458435034^^^AIRA-TEST^ANT||LincolnAIRA^NestaAIRA^Ali^^^^L|BastropAIRA^AvrilAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1786 Oon en Breugel Ave^^Redford Township^MI^48240^USA^P||^PRN^PH^^^313^5097710|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^BastropAIRA^^^^^L|MTH^Mother^HL70063|1786 Oon en Breugel Ave^^Redford Township^MI^48240^USA^P|^PRN^PH^^^313^5097710ORC|RE||BS14D1375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS14D1375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-APRN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N23K1383^^^AIRA-TEST^MR~872596079^^^AIRA-TEST^APRN||LouisaAIRA^AysegalAIRA^Roz^^^^L|GartenlaubAIRA^EulaliaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1448 Veek St^^Dearborn^MI^48124^USA^P||^PRN^PH^^^313^8956807|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LouisaAIRA^GartenlaubAIRA^^^^^L|MTH^Mother^HL70063|1448 Veek St^^Dearborn^MI^48124^USA^P|^PRN^PH^^^313^8956807ORC|RE||BN23K1383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN23K1383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-BA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G72G1391^^^AIRA-TEST^MR~009945655^^^AIRA-TEST^BA||RussellAIRA^CharleenAIRA^Guda^^^^L|MadisonAIRA^MaluAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1523 Pint-Michielsgestel Cir^^Branch^MI^49402^USA^P||^PRN^PH^^^231^9444613|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RussellAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1523 Pint-Michielsgestel Cir^^Branch^MI^49402^USA^P|^PRN^PH^^^231^9444613ORC|RE||BG72G1391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG72G1391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-BC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q61N1399^^^AIRA-TEST^MR~834483732^^^AIRA-TEST^BC||MariposaAIRA^VanniAIRA^Pakuna^^^^L|CalhounAIRA^YachneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1877 Oevenaar Ave^^Frankenmuth Mutual Ins Co^MI^48787^USA^P||^PRN^PH^^^989^6031992|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MariposaAIRA^CalhounAIRA^^^^^L|MTH^Mother^HL70063|1877 Oevenaar Ave^^Frankenmuth Mutual Ins Co^MI^48787^USA^P|^PRN^PH^^^989^6031992ORC|RE||BQ61N1399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ61N1399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-BR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S95O1407^^^AIRA-TEST^MR~733518652^^^AIRA-TEST^BR||OwyheeAIRA^VaisakhiAIRA^Saria^^^^L|RobertsAIRA^JodieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1478 Wollumerland Pl^^Wyoming^MI^49503^USA^P||^PRN^PH^^^616^6337891|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwyheeAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1478 Wollumerland Pl^^Wyoming^MI^49503^USA^P|^PRN^PH^^^616^6337891ORC|RE||BS95O1407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS95O1407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-CC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X88Q1415^^^AIRA-TEST^MR~564723101^^^AIRA-TEST^CC||JauppiAIRA^ThereseAIRA^Hebe^^^^L|BranchAIRA^SihamAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1324 Tudewater St^^Ada^MI^49357^USA^P||^PRN^PH^^^616^3761197|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JauppiAIRA^BranchAIRA^^^^^L|MTH^Mother^HL70063|1324 Tudewater St^^Ada^MI^49357^USA^P|^PRN^PH^^^616^3761197ORC|RE||BX88Q1415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX88Q1415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-CY|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B45X1423^^^AIRA-TEST^MR~370072222^^^AIRA-TEST^CY||WashingtonAIRA^BarbaraAIRA^Nashwa^^^^L|WyomingAIRA^KaiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1659 Orootegast St^^Lathrup Village^MI^48076^USA^P||^PRN^PH^^^248^5077001|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^WyomingAIRA^^^^^L|MTH^Mother^HL70063|1659 Orootegast St^^Lathrup Village^MI^48076^USA^P|^PRN^PH^^^248^5077001ORC|RE||BB45X1423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB45X1423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-DDS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O03O1428^^^AIRA-TEST^MR~269355960^^^AIRA-TEST^DDS||GarrardAIRA^JanelleAIRA^Birget^^^^L|JauppiAIRA^BronwenAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1267 Laaksbergen Ln^^Detroit^MI^48213^USA^P||^PRN^PH^^^313^8623171|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarrardAIRA^JauppiAIRA^^^^^L|MTH^Mother^HL70063|1267 Laaksbergen Ln^^Detroit^MI^48213^USA^P|^PRN^PH^^^313^8623171ORC|RE||BO03O1428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO03O1428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-DEA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P61L1436^^^AIRA-TEST^MR~240108395^^^AIRA-TEST^DEA||WalcottAIRA^MalinaAIRA^Sahila^^^^L|ShermanAIRA^QuellaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1139 Rijkerk Ln^^Saginaw^MI^48602^USA^P||^PRN^PH^^^989^4361642|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WalcottAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1139 Rijkerk Ln^^Saginaw^MI^48602^USA^P|^PRN^PH^^^989^4361642ORC|RE||BP61L1436.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP61L1436.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-DFN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S59G1447^^^AIRA-TEST^MR~983838798^^^AIRA-TEST^DFN||CassAIRA^ZilaAIRA^Morenwyn^^^^L|AdairAIRA^AddisynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1999 Wexel Cir^^Vernon^MI^48476^USA^P||^PRN^PH^^^989^6970391|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1999 Wexel Cir^^Vernon^MI^48476^USA^P|^PRN^PH^^^989^6970391ORC|RE||BS59G1447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS59G1447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-DL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T02Q1455^^^AIRA-TEST^MR~249811981^^^AIRA-TEST^DL||HowardAIRA^RupaliAIRA^Vasuki^^^^L|MidlandAIRA^EireneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1050 Hochem Ln^^Kalamazoo^MI^49048^USA^P||^PRN^PH^^^269^3036396|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowardAIRA^MidlandAIRA^^^^^L|MTH^Mother^HL70063|1050 Hochem Ln^^Kalamazoo^MI^49048^USA^P|^PRN^PH^^^269^3036396ORC|RE||BT02Q1455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT02Q1455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-DN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W24R1463^^^AIRA-TEST^MR~657410178^^^AIRA-TEST^DN||Santa CruzAIRA^ErasmaAIRA^Amena^^^^L|TurvoAIRA^CadrianAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1112 Dus Cir^^Taylor^MI^48180^USA^P||^PRN^PH^^^313^3783158|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Santa CruzAIRA^TurvoAIRA^^^^^L|MTH^Mother^HL70063|1112 Dus Cir^^Taylor^MI^48180^USA^P|^PRN^PH^^^313^3783158ORC|RE||BW24R1463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW24R1463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-DO|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S89R1468^^^AIRA-TEST^MR~683946177^^^AIRA-TEST^DO||ClermontAIRA^KiyokoAIRA^Totie^^^^L|SomersetAIRA^ArabelleAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1109 Taasgouw Pl^^National City^MI^48748^USA^P||^PRN^PH^^^989^9631697|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClermontAIRA^SomersetAIRA^^^^^L|MTH^Mother^HL70063|1109 Taasgouw Pl^^National City^MI^48748^USA^P|^PRN^PH^^^989^9631697ORC|RE||BS89R1468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS89R1468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-DPM|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H46X1479^^^AIRA-TEST^MR~570912230^^^AIRA-TEST^DPM||TuscolaAIRA^AzaleaAIRA^Miley^^^^L|CottonAIRA^PhyllisAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1872 Nronckhorst Ave^^Grand Rapids^MI^49515^USA^P||^PRN^PH^^^616^7087375|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TuscolaAIRA^CottonAIRA^^^^^L|MTH^Mother^HL70063|1872 Nronckhorst Ave^^Grand Rapids^MI^49515^USA^P|^PRN^PH^^^616^7087375ORC|RE||BH46X1479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH46X1479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-DR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W94S1487^^^AIRA-TEST^MR~585921605^^^AIRA-TEST^DR||JensenAIRA^ArminaAIRA^Chanel^^^^L|FlemingAIRA^HarrietAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1430 Strijen Ln^^Michigan Bulb Co^MI^49550^USA^P||^PRN^PH^^^616^5495014|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JensenAIRA^FlemingAIRA^^^^^L|MTH^Mother^HL70063|1430 Strijen Ln^^Michigan Bulb Co^MI^49550^USA^P|^PRN^PH^^^616^5495014ORC|RE||BW94S1487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW94S1487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-EI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B09T1495^^^AIRA-TEST^MR~056581145^^^AIRA-TEST^EI||WintermanAIRA^HildemarAIRA^Arushi^^^^L|BinghamAIRA^SophiaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1406 Dchouwen-Duiveland Ave^^Mikado^MI^48745^USA^P||^PRN^PH^^^989^2614026|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WintermanAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1406 Dchouwen-Duiveland Ave^^Mikado^MI^48745^USA^P|^PRN^PH^^^989^2614026ORC|RE||BB09T1495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB09T1495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-EN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U18Z1500^^^AIRA-TEST^MR~874886301^^^AIRA-TEST^EN||HardinAIRA^JayleeAIRA^Kunti^^^^L|McIntoshAIRA^PomonaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1442 Ervaring St^^Independence^MI^48348^USA^P||^PRN^PH^^^248^3987653|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^McIntoshAIRA^^^^^L|MTH^Mother^HL70063|1442 Ervaring St^^Independence^MI^48348^USA^P|^PRN^PH^^^248^3987653ORC|RE||BU18Z1500.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU18Z1500.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-FI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M18B1508^^^AIRA-TEST^MR~786313188^^^AIRA-TEST^FI||AtascosaAIRA^BakarneAIRA^Achilla^^^^L|DawsonAIRA^DeannaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1700 Llphen-Chaam Pl^^Grand Rapids^MI^49509^USA^P||^PRN^PH^^^616^6750626|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtascosaAIRA^DawsonAIRA^^^^^L|MTH^Mother^HL70063|1700 Llphen-Chaam Pl^^Grand Rapids^MI^49509^USA^P|^PRN^PH^^^616^6750626ORC|RE||BM18B1508.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM18B1508.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-GI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O54E1519^^^AIRA-TEST^MR~171260879^^^AIRA-TEST^GI||CrittendenAIRA^JacquelynAIRA^Faina^^^^L|AslsenAIRA^BlyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1181 Dheden Cir^^Webster^MI^48130^USA^P||^PRN^PH^^^734^5887701|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CrittendenAIRA^AslsenAIRA^^^^^L|MTH^Mother^HL70063|1181 Dheden Cir^^Webster^MI^48130^USA^P|^PRN^PH^^^734^5887701ORC|RE||BO54E1519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO54E1519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-GL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L59C1527^^^AIRA-TEST^MR~033027788^^^AIRA-TEST^GL||BoydAIRA^AmiyahAIRA^Perla^^^^L|OlsenAIRA^LolaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1114 Caarlemmermeer Pl^^Fulton^MI^49052^USA^P||^PRN^PH^^^269^9334239|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoydAIRA^OlsenAIRA^^^^^L|MTH^Mother^HL70063|1114 Caarlemmermeer Pl^^Fulton^MI^49052^USA^P|^PRN^PH^^^269^9334239ORC|RE||BL59C1527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL59C1527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-GN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U95X1535^^^AIRA-TEST^MR~382334071^^^AIRA-TEST^GN||AlleganAIRA^ZamaAIRA^Torie^^^^L|PersonAIRA^HayfaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1365 Kluis Pl^^Gould City^MI^49838^USA^P||^PRN^PH^^^906^5122247|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlleganAIRA^PersonAIRA^^^^^L|MTH^Mother^HL70063|1365 Kluis Pl^^Gould City^MI^49838^USA^P|^PRN^PH^^^906^5122247ORC|RE||BU95X1535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU95X1535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-HC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I02F1540^^^AIRA-TEST^MR~065032092^^^AIRA-TEST^HC||ImperialAIRA^IrmgardAIRA^Fuscienne^^^^L|HooperAIRA^RamonaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1597 Kmmen Cir^^Barryton^MI^49305^USA^P||^PRN^PH^^^989^2132636|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ImperialAIRA^HooperAIRA^^^^^L|MTH^Mother^HL70063|1597 Kmmen Cir^^Barryton^MI^49305^USA^P|^PRN^PH^^^989^2132636ORC|RE||BI02F1540.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI02F1540.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-IND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N30K1548^^^AIRA-TEST^MR~383278102^^^AIRA-TEST^IND||HughesAIRA^AddiAIRA^Yutsuko^^^^L|MaderaAIRA^ArianeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1724 Yard Pl^^Muskegon^MI^49442^USA^P||^PRN^PH^^^231^9398402|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HughesAIRA^MaderaAIRA^^^^^L|MTH^Mother^HL70063|1724 Yard Pl^^Muskegon^MI^49442^USA^P|^PRN^PH^^^231^9398402ORC|RE||BN30K1548.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN30K1548.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-JHN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W47Y1559^^^AIRA-TEST^MR~009275543^^^AIRA-TEST^JHN||GilaAIRA^RoseAIRA^Ines^^^^L|Olsen LeeAIRA^EllinAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1144 Stein Ave^^Charlevoix^MI^49711^USA^P||^PRN^PH^^^231^6356026|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GilaAIRA^Olsen LeeAIRA^^^^^L|MTH^Mother^HL70063|1144 Stein Ave^^Charlevoix^MI^49711^USA^P|^PRN^PH^^^231^6356026ORC|RE||BW47Y1559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW47Y1559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-LI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A43K1567^^^AIRA-TEST^MR~106857511^^^AIRA-TEST^LI||LawrenceAIRA^AylwenAIRA^Laverne^^^^L|AndersonAIRA^CandraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1928 Gras Cir^^Spruce^MI^48762^USA^P||^PRN^PH^^^989^6603336|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LawrenceAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1928 Gras Cir^^Spruce^MI^48762^USA^P|^PRN^PH^^^989^6603336ORC|RE||BA43K1567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA43K1567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-LN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F68A1575^^^AIRA-TEST^MR~648367448^^^AIRA-TEST^LN||LegresleyAIRA^SelenaAIRA^Briana^^^^L|WrightAIRA^JacquelineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1193 Zerneuzen Ave^^East China^MI^48054^USA^P||^PRN^PH^^^810^5782397|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LegresleyAIRA^WrightAIRA^^^^^L|MTH^Mother^HL70063|1193 Zerneuzen Ave^^East China^MI^48054^USA^P|^PRN^PH^^^810^5782397ORC|RE||BF68A1575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF68A1575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-LR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L93Y1580^^^AIRA-TEST^MR~395579361^^^AIRA-TEST^LR||UlsethAIRA^HaliaAIRA^Tiana^^^^L|NowataAIRA^AcaciaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1690 Besterveld Pl^^Kentwood Brch^MI^49528^USA^P||^PRN^PH^^^616^8584875|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UlsethAIRA^NowataAIRA^^^^^L|MTH^Mother^HL70063|1690 Besterveld Pl^^Kentwood Brch^MI^49528^USA^P|^PRN^PH^^^616^8584875ORC|RE||BL93Y1580.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL93Y1580.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V43I1588^^^AIRA-TEST^MR~940471764^^^AIRA-TEST^MA||SharplesAIRA^MarielleAIRA^Rosalind^^^^L|FloydAIRA^TrishaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1565 Laaren Cir^^Jackson^MI^49203^USA^P||^PRN^PH^^^517^2887704|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SharplesAIRA^FloydAIRA^^^^^L|MTH^Mother^HL70063|1565 Laaren Cir^^Jackson^MI^49203^USA^P|^PRN^PH^^^517^2887704ORC|RE||BV43I1588.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV43I1588.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MB|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y89T1599^^^AIRA-TEST^MR~497335121^^^AIRA-TEST^MB||GreeneAIRA^JoniAIRA^Mireya^^^^L|Santa CruzAIRA^TrixyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1850 Tint Anthonis St^^Delphi West^MI^48555^USA^P||^PRN^PH^^^810^4732873|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreeneAIRA^Santa CruzAIRA^^^^^L|MTH^Mother^HL70063|1850 Tint Anthonis St^^Delphi West^MI^48555^USA^P|^PRN^PH^^^810^4732873ORC|RE||BY89T1599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY89T1599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B97I1607^^^AIRA-TEST^MR~768624817^^^AIRA-TEST^MC||CalhounAIRA^SuprabhaAIRA^Saniya^^^^L|GreggAIRA^SheridanAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1641 Sieuwkoop St^^Michiana^MI^49117^USA^P||^PRN^PH^^^269^7453435|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalhounAIRA^GreggAIRA^^^^^L|MTH^Mother^HL70063|1641 Sieuwkoop St^^Michiana^MI^49117^USA^P|^PRN^PH^^^269^7453435ORC|RE||BB97I1607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB97I1607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MCD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G94E1615^^^AIRA-TEST^MR~184134334^^^AIRA-TEST^MCD||LyastromAIRA^OlonoAIRA^Iseult^^^^L|MahoodAIRA^RinzenAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1225 Bolenwaard St^^Allendale^MI^49401^USA^P||^PRN^PH^^^616^3299344|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LyastromAIRA^MahoodAIRA^^^^^L|MTH^Mother^HL70063|1225 Bolenwaard St^^Allendale^MI^49401^USA^P|^PRN^PH^^^616^3299344ORC|RE||BG94E1615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG94E1615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O29S1620^^^AIRA-TEST^MR~135808209^^^AIRA-TEST^MCN||MeadeAIRA^EmberAIRA^Deena^^^^L|FranklinAIRA^RoselaniAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1824 Kaarlemmermeer Cir^^Bay City^MI^48708^USA^P||^PRN^PH^^^989^7635538|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeadeAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1824 Kaarlemmermeer Cir^^Bay City^MI^48708^USA^P|^PRN^PH^^^989^7635538ORC|RE||BO29S1620.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO29S1620.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MCR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K39C1631^^^AIRA-TEST^MR~151339248^^^AIRA-TEST^MCR||OsbornAIRA^ChayaAIRA^Ketika^^^^L|WayneAIRA^KaylieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1125 Venster Cir^^Fountain^MI^49410^USA^P||^PRN^PH^^^231^7086776|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OsbornAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1125 Venster Cir^^Fountain^MI^49410^USA^P|^PRN^PH^^^231^7086776ORC|RE||BK39C1631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK39C1631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S45A1639^^^AIRA-TEST^MR~125490366^^^AIRA-TEST^MD||GilespieAIRA^Mary-EllenAIRA^Fionola^^^^L|FremontAIRA^BeccalynnAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1624 Brechterland St^^Kentwood^MI^49528^USA^P||^PRN^PH^^^616^3462819|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GilespieAIRA^FremontAIRA^^^^^L|MTH^Mother^HL70063|1624 Brechterland St^^Kentwood^MI^49528^USA^P|^PRN^PH^^^616^3462819ORC|RE||BS45A1639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS45A1639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H69M1647^^^AIRA-TEST^MR~342754450^^^AIRA-TEST^MI||TaylorAIRA^KetakiAIRA^Allora^^^^L|PageAIRA^HubertaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1716 Foststellingwerf Ave^^Riverside^MI^49084^USA^P||^PRN^PH^^^269^6316259|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^PageAIRA^^^^^L|MTH^Mother^HL70063|1716 Foststellingwerf Ave^^Riverside^MI^49084^USA^P|^PRN^PH^^^269^6316259ORC|RE||BH69M1647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH69M1647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U90Q1655^^^AIRA-TEST^MR~497841237^^^AIRA-TEST^MR||VintonAIRA^KarsynAIRA^Arlette^^^^L|CarbonAIRA^AvivaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1003 Sijfheerenlanden Ln^^Southfield^MI^48086^USA^P||^PRN^PH^^^248^7954549|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VintonAIRA^CarbonAIRA^^^^^L|MTH^Mother^HL70063|1003 Sijfheerenlanden Ln^^Southfield^MI^48086^USA^P|^PRN^PH^^^248^7954549ORC|RE||BU90Q1655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU90Q1655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-MRT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B02L1663^^^AIRA-TEST^MR~744107309^^^AIRA-TEST^MRT||BranchAIRA^FrancesAIRA^Trishna^^^^L|ClermontAIRA^InasAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1886 Trootegast Ave^^Kaleva^MI^49645^USA^P||^PRN^PH^^^231^3176024|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BranchAIRA^ClermontAIRA^^^^^L|MTH^Mother^HL70063|1886 Trootegast Ave^^Kaleva^MI^49645^USA^P|^PRN^PH^^^231^3176024ORC|RE||BB02L1663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB02L1663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-NE|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G15M1668^^^AIRA-TEST^MR~781231967^^^AIRA-TEST^NE||UmatillaAIRA^YarrahAIRA^Abbie^^^^L|HubbardAIRA^MckinleyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1169 Kantoor Pl^^Northville Township^MI^48167^USA^P||^PRN^PH^^^248^4301959|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UmatillaAIRA^HubbardAIRA^^^^^L|MTH^Mother^HL70063|1169 Kantoor Pl^^Northville Township^MI^48167^USA^P|^PRN^PH^^^248^4301959ORC|RE||BG15M1668.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG15M1668.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-NH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F93S1676^^^AIRA-TEST^MR~813363393^^^AIRA-TEST^NH||ClintonAIRA^ArtiAIRA^Isabela^^^^L|CameronAIRA^DavinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1865 Hellingwedde Ln^^Buckley^MI^49620^USA^P||^PRN^PH^^^231^9915320|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClintonAIRA^CameronAIRA^^^^^L|MTH^Mother^HL70063|1865 Hellingwedde Ln^^Buckley^MI^49620^USA^P|^PRN^PH^^^231^9915320ORC|RE||BF93S1676.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF93S1676.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-NI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L77L1687^^^AIRA-TEST^MR~586002567^^^AIRA-TEST^NI||HammarAIRA^RuchiAIRA^Tegwen^^^^L|NavarroAIRA^EarthaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1660 Uit St^^Zeeland^MI^49464^USA^P||^PRN^PH^^^616^5205173|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HammarAIRA^NavarroAIRA^^^^^L|MTH^Mother^HL70063|1660 Uit St^^Zeeland^MI^49464^USA^P|^PRN^PH^^^616^5205173ORC|RE||BL77L1687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL77L1687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-NII|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z51J1695^^^AIRA-TEST^MR~089622379^^^AIRA-TEST^NII||GladwinAIRA^AlvinaAIRA^Brianna^^^^L|MonroeAIRA^BajiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1304 Moetinchem Ave^^Dearborn^MI^48128^USA^P||^PRN^PH^^^313^2889922|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GladwinAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1304 Moetinchem Ave^^Dearborn^MI^48128^USA^P|^PRN^PH^^^313^2889922ORC|RE||BZ51J1695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ51J1695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-NIIP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W61D1703^^^AIRA-TEST^MR~711466609^^^AIRA-TEST^NIIP||EllisAIRA^ZiganaAIRA^Orseline^^^^L|OkmulgeeAIRA^AbbieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1747 Sieuwkoop Ave^^Detroit^MI^48240^USA^P||^PRN^PH^^^313^2964416|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EllisAIRA^OkmulgeeAIRA^^^^^L|MTH^Mother^HL70063|1747 Sieuwkoop Ave^^Detroit^MI^48240^USA^P|^PRN^PH^^^313^2964416ORC|RE||BW61D1703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW61D1703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-NP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q27R1708^^^AIRA-TEST^MR~788925671^^^AIRA-TEST^NP||DomoAIRA^AdinaAIRA^Sammi^^^^L|LindstromAIRA^AbigailAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1590 Rchtkarspelen Ave^^Owosso^MI^48867^USA^P||^PRN^PH^^^989^4853613|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DomoAIRA^LindstromAIRA^^^^^L|MTH^Mother^HL70063|1590 Rchtkarspelen Ave^^Owosso^MI^48867^USA^P|^PRN^PH^^^989^4853613ORC|RE||BQ27R1708.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ27R1708.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-NPI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V66C1716^^^AIRA-TEST^MR~473761925^^^AIRA-TEST^NPI||DeltaAIRA^BiddyAIRA^Kirby^^^^L|CassAIRA^CarlaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1081 Weylingen Cir^^Sault S Marie^MI^49784^USA^P||^PRN^PH^^^906^4282526|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DeltaAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1081 Weylingen Cir^^Sault S Marie^MI^49784^USA^P|^PRN^PH^^^906^4282526ORC|RE||BV66C1716.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV66C1716.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-OD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z57U1727^^^AIRA-TEST^MR~839441946^^^AIRA-TEST^OD||MorganAIRA^AdolfinaAIRA^Jesal^^^^L|IndianaAIRA^StephenieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1442 Ceerijnen Ave^^Fargo^MI^48006^USA^P||^PRN^PH^^^810^4248790|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorganAIRA^IndianaAIRA^^^^^L|MTH^Mother^HL70063|1442 Ceerijnen Ave^^Fargo^MI^48006^USA^P|^PRN^PH^^^810^4248790ORC|RE||BZ57U1727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ57U1727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I57E1735^^^AIRA-TEST^MR~646365440^^^AIRA-TEST^PA||TexasAIRA^NooraAIRA^Jacoba^^^^L|HolmfAIRA^MargotAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1020 Boorn Cir^^Macomb Township^MI^48042^USA^P||^PRN^PH^^^586^3787717|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TexasAIRA^HolmfAIRA^^^^^L|MTH^Mother^HL70063|1020 Boorn Cir^^Macomb Township^MI^48042^USA^P|^PRN^PH^^^586^3787717ORC|RE||BI57E1735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI57E1735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K91A1743^^^AIRA-TEST^MR~186391513^^^AIRA-TEST^PCN||KinneyAIRA^ButtercupAIRA^Keverne^^^^L|MadisonAIRA^JannaliAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1969 Uilburg Cir^^Lansing^MI^48906^USA^P||^PRN^PH^^^517^9585955|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KinneyAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1969 Uilburg Cir^^Lansing^MI^48906^USA^P|^PRN^PH^^^517^9585955ORC|RE||BK91A1743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK91A1743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PE|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U37B1751^^^AIRA-TEST^MR~103420730^^^AIRA-TEST^PE||TuscarawasAIRA^ElkeAIRA^Simba^^^^L|AinslieAIRA^ArikaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1629 Oanderd Cir^^Freeport^MI^49325^USA^P||^PRN^PH^^^616^8071433|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TuscarawasAIRA^AinslieAIRA^^^^^L|MTH^Mother^HL70063|1629 Oanderd Cir^^Freeport^MI^49325^USA^P|^PRN^PH^^^616^8071433ORC|RE||BU37B1751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU37B1751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PEN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U72X1759^^^AIRA-TEST^MR~038426594^^^AIRA-TEST^PEN||PayneAIRA^HaylieAIRA^Apanie^^^^L|BinghamAIRA^WildaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1572 Hoogezand-Sappemeer Cir^^Laingsburg^MI^48848^USA^P||^PRN^PH^^^517^7741647|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PayneAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1572 Hoogezand-Sappemeer Cir^^Laingsburg^MI^48848^USA^P|^PRN^PH^^^517^7741647ORC|RE||BU72X1759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU72X1759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q77S1767^^^AIRA-TEST^MR~222297863^^^AIRA-TEST^PI||LoveAIRA^DulcieAIRA^Maiya^^^^L|GarvinAIRA^SileasAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1577 Poordenveld Ln^^South Haven^MI^49090^USA^P||^PRN^PH^^^269^5137484|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoveAIRA^GarvinAIRA^^^^^L|MTH^Mother^HL70063|1577 Poordenveld Ln^^South Haven^MI^49090^USA^P|^PRN^PH^^^269^5137484ORC|RE||BQ77S1767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ77S1767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F25H1775^^^AIRA-TEST^MR~273659021^^^AIRA-TEST^PN||GradyAIRA^AmaraAIRA^Marita^^^^L|JohnstonAIRA^NatalyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1322 Henkum Ln^^Lum^MI^48412^USA^P||^PRN^PH^^^810^9699320|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GradyAIRA^JohnstonAIRA^^^^^L|MTH^Mother^HL70063|1322 Henkum Ln^^Lum^MI^48412^USA^P|^PRN^PH^^^810^9699320ORC|RE||BF25H1775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF25H1775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PNT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H50N1783^^^AIRA-TEST^MR~341586877^^^AIRA-TEST^PNT||ZavalaAIRA^CherishAIRA^Jardena^^^^L|GraysonAIRA^FernandaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1607 Rente Cir^^Kinross^MI^49752^USA^P||^PRN^PH^^^906^7119064|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ZavalaAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1607 Rente Cir^^Kinross^MI^49752^USA^P|^PRN^PH^^^906^7119064ORC|RE||BH50N1783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH50N1783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PPN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W95B1791^^^AIRA-TEST^MR~851833015^^^AIRA-TEST^PPN||YoungAIRA^WinAIRA^Pythia^^^^L|KnightAIRA^JaylahAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1561 Aaastricht Ave^^Greenville^MI^48838^USA^P||^PRN^PH^^^231^8451942|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YoungAIRA^KnightAIRA^^^^^L|MTH^Mother^HL70063|1561 Aaastricht Ave^^Greenville^MI^48838^USA^P|^PRN^PH^^^231^8451942ORC|RE||BW95B1791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW95B1791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PRC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B55I1796^^^AIRA-TEST^MR~103099403^^^AIRA-TEST^PRC||IoniaAIRA^GlendaAIRA^Mercedes^^^^L|HardemanAIRA^ZariaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1256 Ahenen Cir^^West Bloomfield^MI^48325^USA^P||^PRN^PH^^^248^7996097|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IoniaAIRA^HardemanAIRA^^^^^L|MTH^Mother^HL70063|1256 Ahenen Cir^^West Bloomfield^MI^48325^USA^P|^PRN^PH^^^248^7996097ORC|RE||BB55I1796.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB55I1796.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PRN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W79A1804^^^AIRA-TEST^MR~954716219^^^AIRA-TEST^PRN||MenifeeAIRA^XantheAIRA^Laria^^^^L|ShoshoneAIRA^ValarieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1674 Merneuzen Ln^^Farmingtn Hls^MI^48331^USA^P||^PRN^PH^^^248^4696857|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MenifeeAIRA^ShoshoneAIRA^^^^^L|MTH^Mother^HL70063|1674 Merneuzen Ln^^Farmingtn Hls^MI^48331^USA^P|^PRN^PH^^^248^4696857ORC|RE||BW79A1804.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW79A1804.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-PT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L08W1815^^^AIRA-TEST^MR~784843202^^^AIRA-TEST^PT||ColusaAIRA^FascienneAIRA^Belen^^^^L|PettersonAIRA^TambreyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1943 Qochem Pl^^Walled Lake^MI^48391^USA^P||^PRN^PH^^^248^5164248|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColusaAIRA^PettersonAIRA^^^^^L|MTH^Mother^HL70063|1943 Qochem Pl^^Walled Lake^MI^48391^USA^P|^PRN^PH^^^248^5164248ORC|RE||BL08W1815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL08W1815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-QA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T34M1823^^^AIRA-TEST^MR~043524857^^^AIRA-TEST^QA||HarrisonAIRA^ZinaAIRA^Jacky^^^^L|JakobsenAIRA^PetraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1562 Pmallingerland St^^Clare^MI^48617^USA^P||^PRN^PH^^^989^4038282|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^JakobsenAIRA^^^^^L|MTH^Mother^HL70063|1562 Pmallingerland St^^Clare^MI^48617^USA^P|^PRN^PH^^^989^4038282ORC|RE||BT34M1823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT34M1823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-RI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z40O1831^^^AIRA-TEST^MR~866648606^^^AIRA-TEST^RI||SmithAIRA^NettieAIRA^Sienna^^^^L|DodgeAIRA^LaurindaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1479 Oorger-Odoorn Ave^^Dover^MI^48130^USA^P||^PRN^PH^^^734^7121707|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SmithAIRA^DodgeAIRA^^^^^L|MTH^Mother^HL70063|1479 Oorger-Odoorn Ave^^Dover^MI^48130^USA^P|^PRN^PH^^^734^7121707ORC|RE||BZ40O1831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ40O1831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-RN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I45T1836^^^AIRA-TEST^MR~171365916^^^AIRA-TEST^RN||LindAIRA^LystraAIRA^Marsha^^^^L|MultnomahAIRA^PattyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1564 Book en Middelaar Ln^^Grand Rapids^MI^49506^USA^P||^PRN^PH^^^616^7824202|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LindAIRA^MultnomahAIRA^^^^^L|MTH^Mother^HL70063|1564 Book en Middelaar Ln^^Grand Rapids^MI^49506^USA^P|^PRN^PH^^^616^7824202ORC|RE||BI45T1836.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI45T1836.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-RPH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N38V1844^^^AIRA-TEST^MR~656261036^^^AIRA-TEST^RPH||BentonAIRA^AlavdaAIRA^Kendra^^^^L|LarssenAIRA^HannahAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1650 Galburg Ave^^Michigan Bulb Co^MI^49550^USA^P||^PRN^PH^^^616^8034274|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BentonAIRA^LarssenAIRA^^^^^L|MTH^Mother^HL70063|1650 Galburg Ave^^Michigan Bulb Co^MI^49550^USA^P|^PRN^PH^^^616^8034274ORC|RE||BN38V1844.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN38V1844.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-RR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X08E1855^^^AIRA-TEST^MR~168518887^^^AIRA-TEST^RR||HughesAIRA^DianneAIRA^Diamond^^^^L|WebbAIRA^SusannaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1207 Ma en Hunze Ave^^Detroit^MI^48208^USA^P||^PRN^PH^^^313^6394559|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HughesAIRA^WebbAIRA^^^^^L|MTH^Mother^HL70063|1207 Ma en Hunze Ave^^Detroit^MI^48208^USA^P|^PRN^PH^^^313^6394559ORC|RE||BX08E1855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX08E1855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-RRI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J01H1863^^^AIRA-TEST^MR~670116449^^^AIRA-TEST^RRI||HaagenAIRA^IsabelAIRA^Sabia^^^^L|JacksonAIRA^TristanaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1622 Tudwest-Fryslan Ave^^Webster^MI^48130^USA^P||^PRN^PH^^^734^6099517|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaagenAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1622 Tudwest-Fryslan Ave^^Webster^MI^48130^USA^P|^PRN^PH^^^734^6099517ORC|RE||BJ01H1863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ01H1863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-SL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D40B1871^^^AIRA-TEST^MR~280234407^^^AIRA-TEST^SL||WebsterAIRA^LeilaAIRA^Guan-yin^^^^L|PikeAIRA^XandyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1377 Nuidhorn St^^Eureka^MI^48833^USA^P||^PRN^PH^^^989^3408650|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WebsterAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1377 Nuidhorn St^^Eureka^MI^48833^USA^P|^PRN^PH^^^989^3408650ORC|RE||BD40B1871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD40B1871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-SN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y52J1876^^^AIRA-TEST^MR~681253479^^^AIRA-TEST^SN||AndroscogginAIRA^MridulAIRA^Eudora^^^^L|JeffersonAIRA^AmberAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1828 Vatwijk Pl^^Southeast^MI^48529^USA^P||^PRN^PH^^^810^2966021|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndroscogginAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1828 Vatwijk Pl^^Southeast^MI^48529^USA^P|^PRN^PH^^^810^2966021ORC|RE||BY52J1876.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY52J1876.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-SR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B06L1884^^^AIRA-TEST^MR~170919268^^^AIRA-TEST^SR||JeffersonAIRA^CasondraAIRA^Nikki^^^^L|SantiagoAIRA^BasiliaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1371 Angst Ln^^Detroit^MI^48226^USA^P||^PRN^PH^^^313^8465797|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^SantiagoAIRA^^^^^L|MTH^Mother^HL70063|1371 Angst Ln^^Detroit^MI^48226^USA^P|^PRN^PH^^^313^8465797ORC|RE||BB06L1884.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB06L1884.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-SS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A55G1895^^^AIRA-TEST^MR~581709442^^^AIRA-TEST^SS||CrosbyAIRA^SabelleAIRA^Priya^^^^L|DeweyAIRA^ChesnaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1692 Huid Ln^^Spring Arbor^MI^49283^USA^P||^PRN^PH^^^517^2860293|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CrosbyAIRA^DeweyAIRA^^^^^L|MTH^Mother^HL70063|1692 Huid Ln^^Spring Arbor^MI^49283^USA^P|^PRN^PH^^^517^2860293ORC|RE||BA55G1895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA55G1895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-TAX|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S11I1903^^^AIRA-TEST^MR~130056896^^^AIRA-TEST^TAX||HancockAIRA^ZoeyAIRA^Ain^^^^L|Walla WallaAIRA^MarinkaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1473 Loirle Pl^^Midland^MI^48670^USA^P||^PRN^PH^^^989^5616546|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^Walla WallaAIRA^^^^^L|MTH^Mother^HL70063|1473 Loirle Pl^^Midland^MI^48670^USA^P|^PRN^PH^^^989^5616546ORC|RE||BS11I1903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS11I1903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E17W1911^^^AIRA-TEST^MR~640500294^^^AIRA-TEST^U||BrotAIRA^MeinwenAIRA^Gedala^^^^L|BentonAIRA^AddiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1160 Zou Cir^^Cutlerville^MI^49548^USA^P||^PRN^PH^^^616^5578412|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrotAIRA^BentonAIRA^^^^^L|MTH^Mother^HL70063|1160 Zou Cir^^Cutlerville^MI^49548^USA^P|^PRN^PH^^^616^5578412ORC|RE||BE17W1911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE17W1911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-UPIN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E59H1919^^^AIRA-TEST^MR~242407481^^^AIRA-TEST^UPIN||HarlanAIRA^JaidenAIRA^Hazel^^^^L|GuernseyAIRA^RahabAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1000 Hijfheerenlanden Pl^^Charlevoix^MI^49711^USA^P||^PRN^PH^^^231^5157701|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarlanAIRA^GuernseyAIRA^^^^^L|MTH^Mother^HL70063|1000 Hijfheerenlanden Pl^^Charlevoix^MI^49711^USA^P|^PRN^PH^^^231^5157701ORC|RE||BE59H1919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE59H1919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-VN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J74C1924^^^AIRA-TEST^MR~413836089^^^AIRA-TEST^VN||ForestAIRA^CanaceAIRA^Suma^^^^L|SnyderAIRA^ElvinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1950 Nastricum Ln^^Richland^MI^49083^USA^P||^PRN^PH^^^269^2501910|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ForestAIRA^SnyderAIRA^^^^^L|MTH^Mother^HL70063|1950 Nastricum Ln^^Richland^MI^49083^USA^P|^PRN^PH^^^269^2501910ORC|RE||BJ74C1924.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ74C1924.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-WC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q83J1932^^^AIRA-TEST^MR~068566642^^^AIRA-TEST^WC||CornelinsonAIRA^RisakoAIRA^Meghan^^^^L|KarlssonAIRA^CyrillaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1038 Elagtwedde Ave^^Lake Station^MI^48632^USA^P||^PRN^PH^^^989^6843504|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CornelinsonAIRA^KarlssonAIRA^^^^^L|MTH^Mother^HL70063|1038 Elagtwedde Ave^^Lake Station^MI^48632^USA^P|^PRN^PH^^^989^6843504ORC|RE||BQ83J1932.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ83J1932.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-WCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W05W1943^^^AIRA-TEST^MR~773029816^^^AIRA-TEST^WCN||BernstrainAIRA^JayaniAIRA^Viviana^^^^L|GageAIRA^KarishmaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1302 Gratis Ave^^Lambertville^MI^48144^USA^P||^PRN^PH^^^734^5001109|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BernstrainAIRA^GageAIRA^^^^^L|MTH^Mother^HL70063|1302 Gratis Ave^^Lambertville^MI^48144^USA^P|^PRN^PH^^^734^5001109ORC|RE||BW05W1943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW05W1943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE-XX|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H61U1951^^^AIRA-TEST^MR~370802087^^^AIRA-TEST^XX||IronAIRA^MichelleAIRA^Yazmin^^^^L|DomoAIRA^PhoebeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1840 Kekela Pl^^Mosherville^MI^49258^USA^P||^PRN^PH^^^517^9643402|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IronAIRA^DomoAIRA^^^^^L|MTH^Mother^HL70063|1840 Kekela Pl^^Mosherville^MI^49258^USA^P|^PRN^PH^^^517^9643402ORC|RE||BH61U1951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH61U1951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H31B1959^^^AIRA-TEST^MR||HowardAIRA^ZaylinAIRA^Lidia^^^^L|MarshallAIRA^MorgandyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1819 Koerendaal Pl^^Six Lakes^MI^48886^USA^P||^PRN^PH^^^989^8553876|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowardAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1819 Koerendaal Pl^^Six Lakes^MI^48886^USA^P|^PRN^PH^^^989^8553876ORC|RE||BH31B1959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||00^New immunization record^NIP001|||||||||||CP|AORC|RE||BH31B1959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A12O1967^^^AIRA-TEST^MR||LinnAIRA^HindaAIRA^Celandia^^^^L|HughesAIRA^RaekaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1971 Leesel Ave^^Comstock^MI^49041^USA^P||^PRN^PH^^^269^3822437|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LinnAIRA^HughesAIRA^^^^^L|MTH^Mother^HL70063|1971 Leesel Ave^^Comstock^MI^49041^USA^P|^PRN^PH^^^269^3822437ORC|RE||BA12O1967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA12O1967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J41N1972^^^AIRA-TEST^MR||McEntegartAIRA^DaylaAIRA^Fatima^^^^L|LyonAIRA^BarbaraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1273 Poes Cir^^Stalwart^MI^49736^USA^P||^PRN^PH^^^906^2475775|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McEntegartAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1273 Poes Cir^^Stalwart^MI^49736^USA^P|^PRN^PH^^^906^2475775ORC|RE||BJ41N1972.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||02^Historical information - from other provider^NIP001|||||||||||CP|AORC|RE||BJ41N1972.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C95N1980^^^AIRA-TEST^MR||ConnorAIRA^KalikaAIRA^Haifa^^^^L|LancasterAIRA^LeonoraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1308 Reerssen Ln^^Michigamme^MI^49861^USA^P||^PRN^PH^^^906^8940053|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ConnorAIRA^LancasterAIRA^^^^^L|MTH^Mother^HL70063|1308 Reerssen Ln^^Michigamme^MI^49861^USA^P|^PRN^PH^^^906^8940053ORC|RE||BC95N1980.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||03^Historical information - from parents written record^NIP001|||||||||||CP|AORC|RE||BC95N1980.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M00Y1991^^^AIRA-TEST^MR||CulpAIRA^ValerieAIRA^Orlantha^^^^L|WashingtonAIRA^HadaraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1050 Narum Ln^^Farmington Hls^MI^48334^USA^P||^PRN^PH^^^248^3680451|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CulpAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1050 Narum Ln^^Farmington Hls^MI^48334^USA^P|^PRN^PH^^^248^3680451ORC|RE||BM00Y1991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||04^Historical information - from parents recall^NIP001|||||||||||CP|AORC|RE||BM00Y1991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S67E1999^^^AIRA-TEST^MR||AllottAIRA^PhoebeAIRA^Sherry^^^^L|TemplemanAIRA^EstaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1284 Aedemblik St^^Brohman^MI^49312^USA^P||^PRN^PH^^^231^8266941|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllottAIRA^TemplemanAIRA^^^^^L|MTH^Mother^HL70063|1284 Aedemblik St^^Brohman^MI^49312^USA^P|^PRN^PH^^^231^8266941ORC|RE||BS67E1999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||05^Historical information - from other registry^NIP001|||||||||||CP|AORC|RE||BS67E1999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q11F2007^^^AIRA-TEST^MR||HayesAIRA^JarviniaAIRA^Lissa^^^^L|PlacerAIRA^Bo-BaeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1783 Gof van Twente St^^Orion Township^MI^48362^USA^P||^PRN^PH^^^248^9182508|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HayesAIRA^PlacerAIRA^^^^^L|MTH^Mother^HL70063|1783 Gof van Twente St^^Orion Township^MI^48362^USA^P|^PRN^PH^^^248^9182508ORC|RE||BQ11F2007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||06^Historical information - from birth certificate^NIP001|||||||||||CP|AORC|RE||BQ11F2007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S88C2012^^^AIRA-TEST^MR||CimarronAIRA^BindaAIRA^Lane^^^^L|DeschutesAIRA^ElisabethAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1346 Kidden-Drenthe Pl^^Onsted^MI^49265^USA^P||^PRN^PH^^^517^5241838|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CimarronAIRA^DeschutesAIRA^^^^^L|MTH^Mother^HL70063|1346 Kidden-Drenthe Pl^^Onsted^MI^49265^USA^P|^PRN^PH^^^517^5241838ORC|RE||BS88C2012.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||07^Historical information - from school record^NIP001|||||||||||CP|AORC|RE||BS88C2012.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-IS-08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N24H2020^^^AIRA-TEST^MR||GeneseeAIRA^KaylinAIRA^Primula^^^^L|DubuqueAIRA^HalonaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1994 Hdam-Volendam Ln^^Lansing^MI^48929^USA^P||^PRN^PH^^^517^7333376|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GeneseeAIRA^DubuqueAIRA^^^^^L|MTH^Mother^HL70063|1994 Hdam-Volendam Ln^^Lansing^MI^48929^USA^P|^PRN^PH^^^517^7333376ORC|RE||BN24H2020.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||08^Historical information - from public agency^NIP001|||||||||||CP|AORC|RE||BN24H2020.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NAME-TYPE-A|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E44E2031^^^AIRA-TEST^MR||ClayAIRA^EtanaAIRA^Alia^^^^L~PID-5.1^PID-5.2^^^^^A|AslsenAIRA^LindaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1028 Sudwest Fryslan St^^Bham^MI^48009^USA^P||^PRN^PH^^^248^8449959|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClayAIRA^AslsenAIRA^^^^^L|MTH^Mother^HL70063|1028 Sudwest Fryslan St^^Bham^MI^48009^USA^P|^PRN^PH^^^248^8449959ORC|RE||BE44E2031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE44E2031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NAME-TYPE-B|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E59S2039^^^AIRA-TEST^MR||WoodburyAIRA^GwennapAIRA^Tilda^^^^L~PID-5.1^PID-5.2^^^^^B|LibertyAIRA^EmmaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1633 Zinsnede Ln^^Niles^MI^49121^USA^P||^PRN^PH^^^269^4443279|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoodburyAIRA^LibertyAIRA^^^^^L|MTH^Mother^HL70063|1633 Zinsnede Ln^^Niles^MI^49121^USA^P|^PRN^PH^^^269^4443279ORC|RE||BE59S2039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE59S2039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NAME-TYPE-C|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I57K2047^^^AIRA-TEST^MR||UvaldeAIRA^GuadalupeAIRA^Parnika^^^^L~PID-5.1^PID-5.2^^^^^C|FloydAIRA^RaginiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1257 Vrummen Cir^^Lakeside^MI^49116^USA^P||^PRN^PH^^^269^6073297|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UvaldeAIRA^FloydAIRA^^^^^L|MTH^Mother^HL70063|1257 Vrummen Cir^^Lakeside^MI^49116^USA^P|^PRN^PH^^^269^6073297ORC|RE||BI57K2047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI57K2047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NAME-TYPE-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N76B2052^^^AIRA-TEST^MR||ClintonAIRA^JulieAIRA^Muriel^^^^L~PID-5.1^PID-5.2^^^^^D|LoganAIRA^MadilynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1149 Vouw Cir^^Mayville^MI^48744^USA^P||^PRN^PH^^^989^5475368|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClintonAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1149 Vouw Cir^^Mayville^MI^48744^USA^P|^PRN^PH^^^989^5475368ORC|RE||BN76B2052.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN76B2052.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NAME-TYPE-L|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A45M2060^^^AIRA-TEST^MR||LeelanauAIRA^AmbikaAIRA^Helena^^^^L~PID-5.1^PID-5.2^^^^^L|ParmerAIRA^JoellianeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1923 Goed Ave^^Farmingtn Hls^MI^48334^USA^P||^PRN^PH^^^248^7275181|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeelanauAIRA^ParmerAIRA^^^^^L|MTH^Mother^HL70063|1923 Goed Ave^^Farmingtn Hls^MI^48334^USA^P|^PRN^PH^^^248^7275181ORC|RE||BA45M2060.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA45M2060.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NAME-TYPE-M|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N47B2071^^^AIRA-TEST^MR||MaddocksAIRA^ElisaAIRA^Miranda^^^^L~PID-5.1^PID-5.2^^^^^M|ButlerAIRA^LoreleiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1863 Will en Sint Hubert Pl^^Falmouth^MI^49632^USA^P||^PRN^PH^^^231^9952917|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MaddocksAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1863 Will en Sint Hubert Pl^^Falmouth^MI^49632^USA^P|^PRN^PH^^^231^9952917ORC|RE||BN47B2071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN47B2071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NAME-TYPE-P|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L00D2079^^^AIRA-TEST^MR||DelawareAIRA^MerisaAIRA^Cochiti^^^^L~PID-5.1^PID-5.2^^^^^P|WorleyAIRA^AudunAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1592 Westerveld St^^De Tour Village^MI^49725^USA^P||^PRN^PH^^^906^6762904|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^WorleyAIRA^^^^^L|MTH^Mother^HL70063|1592 Westerveld St^^De Tour Village^MI^49725^USA^P|^PRN^PH^^^906^6762904ORC|RE||BL00D2079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL00D2079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NAME-TYPE-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A10H2087^^^AIRA-TEST^MR||FayetteAIRA^BettinaAIRA^Ixchel^^^^L~PID-5.1^PID-5.2^^^^^U|GlennAIRA^AishaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1986 Woxmeer St^^Muir^MI^48860^USA^P||^PRN^PH^^^989^9388653|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FayetteAIRA^GlennAIRA^^^^^L|MTH^Mother^HL70063|1986 Woxmeer St^^Muir^MI^48860^USA^P|^PRN^PH^^^989^9388653ORC|RE||BA10H2087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA10H2087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-0100-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T52X2092^^^AIRA-TEST^MR||HopkinsAIRA^ZariyahAIRA^Shika^^^^L|ColemanAIRA^JamalAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1069 Ounnik Cir^^GR^MI^49507^USA^P||^PRN^PH^^^616^2539036|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HopkinsAIRA^ColemanAIRA^^^^^L|MTH^Mother^HL70063|1069 Ounnik Cir^^GR^MI^49507^USA^P|^PRN^PH^^^616^2539036ORC|RE||BT52X2092.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT52X2092.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005-0100-01^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-0100-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z02V2100^^^AIRA-TEST^MR||OscodaAIRA^SaffiAIRA^Fujita^^^^L|FremontAIRA^CristinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1042 Remert-Bakel Ave^^Hancock^MI^49930^USA^P||^PRN^PH^^^906^7559136|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OscodaAIRA^FremontAIRA^^^^^L|MTH^Mother^HL70063|1042 Remert-Bakel Ave^^Hancock^MI^49930^USA^P|^PRN^PH^^^906^7559136ORC|RE||BZ02V2100.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ02V2100.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005-0100-02^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-0100-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F80J2111^^^AIRA-TEST^MR||MonoAIRA^MersadizeAIRA^Nathalia^^^^L|OchiltreeAIRA^BuffyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1619 Cluis Ln^^Grand Blanc^MI^48480^USA^P||^PRN^PH^^^810^8371433|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MonoAIRA^OchiltreeAIRA^^^^^L|MTH^Mother^HL70063|1619 Cluis Ln^^Grand Blanc^MI^48480^USA^P|^PRN^PH^^^810^8371433ORC|RE||BF80J2111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF80J2111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005-0100-05^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-0100-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D08B2119^^^AIRA-TEST^MR||WexfordAIRA^FarfallaAIRA^Eustacia^^^^L|ColumbianaAIRA^RumikoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1379 Angst Cir^^Orleans^MI^48865^USA^P||^PRN^PH^^^616^4393972|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WexfordAIRA^ColumbianaAIRA^^^^^L|MTH^Mother^HL70063|1379 Angst Cir^^Orleans^MI^48865^USA^P|^PRN^PH^^^616^4393972ORC|RE||BD08B2119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD08B2119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005-0100-10^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-1970-49|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H24C2127^^^AIRA-TEST^MR||DickinsonAIRA^AnamikaAIRA^Tean^^^^L|Grand TraverseAIRA^EvangelineAIRA^^^^^M|20110830|F||2106-3^White^CDCREC|1260 Levenaar St^^Treetops Vil^MI^49735^USA^P||^PRN^PH^^^989^9620921|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickinsonAIRA^Grand TraverseAIRA^^^^^L|MTH^Mother^HL70063|1260 Levenaar St^^Treetops Vil^MI^49735^USA^P|^PRN^PH^^^989^9620921ORC|RE||BH24C2127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111030||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH24C2127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111230||00005-1970-49^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||WAL^Wyeth^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-1970-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O64F2135^^^AIRA-TEST^MR||AlofsonAIRA^AuraAIRA^Priscilla^^^^L|SnowAIRA^AinsleyAIRA^^^^^M|20110830|F||2106-3^White^CDCREC|1924 Duidelijk Cir^^Sebewaing^MI^48759^USA^P||^PRN^PH^^^989^4138380|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlofsonAIRA^SnowAIRA^^^^^L|MTH^Mother^HL70063|1924 Duidelijk Cir^^Sebewaing^MI^48759^USA^P|^PRN^PH^^^989^4138380ORC|RE||BO64F2135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111030||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO64F2135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111230||00005-1970-50^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||WAL^Wyeth^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-1971-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K96W2140^^^AIRA-TEST^MR||WynneAIRA^GemmaAIRA^Joy^^^^L|WarrenAIRA^TourmalineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1552 Vulst St^^Dearborn^MI^48126^USA^P||^PRN^PH^^^313^4482545|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WynneAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1552 Vulst St^^Dearborn^MI^48126^USA^P|^PRN^PH^^^313^4482545ORC|RE||BK96W2140.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK96W2140.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005-1971-01^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-1971-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E63G2148^^^AIRA-TEST^MR||BaylorAIRA^EdolieAIRA^Colette^^^^L|HarrisonAIRA^AyianaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1655 Oiessenlanden St^^Eben Junction^MI^49825^USA^P||^PRN^PH^^^906^3914411|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BaylorAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1655 Oiessenlanden St^^Eben Junction^MI^49825^USA^P|^PRN^PH^^^906^3914411ORC|RE||BE63G2148.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE63G2148.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005-1971-02^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-1971-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X74P2159^^^AIRA-TEST^MR||HancockAIRA^RadinkaAIRA^Severina^^^^L|ValleyAIRA^ElisabethAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1042 Versel Pl^^Fremont^MI^49412^USA^P||^PRN^PH^^^231^3719761|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1042 Versel Pl^^Fremont^MI^49412^USA^P|^PRN^PH^^^231^3719761ORC|RE||BX74P2159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX74P2159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005-1971-04^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005-1971-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D81U2167^^^AIRA-TEST^MR||HarrisonAIRA^TawnyAIRA^Hidi^^^^L|HarrisonAIRA^CelenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1341 Ernhem Ave^^Byron^MI^48418^USA^P||^PRN^PH^^^810^9983631|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1341 Ernhem Ave^^Byron^MI^48418^USA^P|^PRN^PH^^^810^9983631ORC|RE||BD81U2167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD81U2167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005-1971-05^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4045-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S11J2175^^^AIRA-TEST^MR||HolmfAIRA^ValdaAIRA^Tess^^^^L|JuniataAIRA^CynereAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1913 Boes Ave^^Wellston^MI^49689^USA^P||^PRN^PH^^^231^3006614|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HolmfAIRA^JuniataAIRA^^^^^L|MTH^Mother^HL70063|1913 Boes Ave^^Wellston^MI^49689^USA^P|^PRN^PH^^^231^3006614ORC|RE||BS11J2175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS11J2175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4045-00^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4045-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O27B2183^^^AIRA-TEST^MR||ElkAIRA^FariishtaAIRA^Star^^^^L|LowndesAIRA^AnnamariaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1255 Goudrichem Ave^^Grand Marais^MI^49839^USA^P||^PRN^PH^^^906^5614308|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ElkAIRA^LowndesAIRA^^^^^L|MTH^Mother^HL70063|1255 Goudrichem Ave^^Grand Marais^MI^49839^USA^P|^PRN^PH^^^906^5614308ORC|RE||BO27B2183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO27B2183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4045-01^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4045-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y52D2188^^^AIRA-TEST^MR||HowardAIRA^OralieAIRA^Shoshannah^^^^L|WarrenAIRA^ValedaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1354 Ocheemda Pl^^Cascade^MI^49546^USA^P||^PRN^PH^^^616^8823346|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowardAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1354 Ocheemda Pl^^Cascade^MI^49546^USA^P|^PRN^PH^^^616^8823346ORC|RE||BY52D2188.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY52D2188.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4045-41^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4047-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J13H2196^^^AIRA-TEST^MR||JepsenAIRA^WinnieAIRA^Faustine^^^^L|KjerulfAIRA^JulianneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1172 Sijswijk Ave^^Armada^MI^48005^USA^P||^PRN^PH^^^586^3837038|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JepsenAIRA^KjerulfAIRA^^^^^L|MTH^Mother^HL70063|1172 Sijswijk Ave^^Armada^MI^48005^USA^P|^PRN^PH^^^586^3837038ORC|RE||BJ13H2196.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ13H2196.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4047-01^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4047-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U01T2207^^^AIRA-TEST^MR||KlebergAIRA^RebeccaAIRA^Lucetta^^^^L|MontereyAIRA^CloveAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1178 Sirschot St^^Coloma^MI^49039^USA^P||^PRN^PH^^^269^7914096|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KlebergAIRA^MontereyAIRA^^^^^L|MTH^Mother^HL70063|1178 Sirschot St^^Coloma^MI^49039^USA^P|^PRN^PH^^^269^7914096ORC|RE||BU01T2207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU01T2207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4047-20^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4047-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N21F2215^^^AIRA-TEST^MR||FloydAIRA^PhyllidaAIRA^Maxim^^^^L|BerksAIRA^KarliAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1634 Zand Cir^^Shelby Township^MI^48316^USA^P||^PRN^PH^^^586^3699049|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FloydAIRA^BerksAIRA^^^^^L|MTH^Mother^HL70063|1634 Zand Cir^^Shelby Township^MI^48316^USA^P|^PRN^PH^^^586^3699049ORC|RE||BN21F2215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN21F2215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4047-41^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4093-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U19R2223^^^AIRA-TEST^MR||TobinAIRA^StephanyAIRA^Rere^^^^L|ClintonAIRA^JueneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1594 Daanstad Pl^^Saint Johns^MI^48879^USA^P||^PRN^PH^^^989^7653841|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TobinAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1594 Daanstad Pl^^Saint Johns^MI^48879^USA^P|^PRN^PH^^^989^7653841ORC|RE||BU19R2223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU19R2223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4093-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4093-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K79X2231^^^AIRA-TEST^MR||LevyAIRA^CadrianAIRA^Helvetia^^^^L|ClintonAIRA^LyndeyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1208 Idee Pl^^Sylvan Beach^MI^49463^USA^P||^PRN^PH^^^231^6975538|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LevyAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1208 Idee Pl^^Sylvan Beach^MI^49463^USA^P|^PRN^PH^^^231^6975538ORC|RE||BK79X2231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK79X2231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4093-02^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4093-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A81T2236^^^AIRA-TEST^MR||WinnebagoAIRA^TotieAIRA^Xaquelina^^^^L|JeffersonAIRA^TiberiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1874 Vliegen Ln^^Dearborn^MI^48120^USA^P||^PRN^PH^^^313^7207444|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WinnebagoAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1874 Vliegen Ln^^Dearborn^MI^48120^USA^P|^PRN^PH^^^313^7207444ORC|RE||BA81T2236.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA81T2236.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4093-09^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4094-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J81A2244^^^AIRA-TEST^MR||RainsAIRA^HidiAIRA^Anupama^^^^L|KaufmanAIRA^DerrythAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1723 Eeerijnen Cir^^Clyde^MI^48049^USA^P||^PRN^PH^^^810^9919950|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RainsAIRA^KaufmanAIRA^^^^^L|MTH^Mother^HL70063|1723 Eeerijnen Cir^^Clyde^MI^48049^USA^P|^PRN^PH^^^810^9919950ORC|RE||BJ81A2244.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ81A2244.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4094-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4094-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K86T2255^^^AIRA-TEST^MR||MooreAIRA^HaileeAIRA^Evita^^^^L|PetersonAIRA^ChesnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1641 Dinkelland St^^Greenland^MI^49929^USA^P||^PRN^PH^^^906^3059561|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MooreAIRA^PetersonAIRA^^^^^L|MTH^Mother^HL70063|1641 Dinkelland St^^Greenland^MI^49929^USA^P|^PRN^PH^^^906^3059561ORC|RE||BK86T2255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK86T2255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4094-02^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4094-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B16J2263^^^AIRA-TEST^MR||DahlAIRA^My-DuyenAIRA^Diana^^^^L|MorganAIRA^SadhanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1692 Hevenaar Pl^^East Lansing^MI^48824^USA^P||^PRN^PH^^^517^2331219|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DahlAIRA^MorganAIRA^^^^^L|MTH^Mother^HL70063|1692 Hevenaar Pl^^East Lansing^MI^48824^USA^P|^PRN^PH^^^517^2331219ORC|RE||BB16J2263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB16J2263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4094-09^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4095-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z03V2271^^^AIRA-TEST^MR||HamiltonAIRA^EmmettAIRA^Mimosa^^^^L|OsbornAIRA^ToralAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1999 Kleden Ln^^South Lyon^MI^48178^USA^P||^PRN^PH^^^248^2041153|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HamiltonAIRA^OsbornAIRA^^^^^L|MTH^Mother^HL70063|1999 Kleden Ln^^South Lyon^MI^48178^USA^P|^PRN^PH^^^248^2041153ORC|RE||BZ03V2271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ03V2271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4095-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4095-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A69B2279^^^AIRA-TEST^MR||EricksonAIRA^KalilaAIRA^Onawa^^^^L|LeelanauAIRA^CaitAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1860 Vingewaard Cir^^Brownstwn Township^MI^48173^USA^P||^PRN^PH^^^734^8593198|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EricksonAIRA^LeelanauAIRA^^^^^L|MTH^Mother^HL70063|1860 Vingewaard Cir^^Brownstwn Township^MI^48173^USA^P|^PRN^PH^^^734^8593198ORC|RE||BA69B2279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA69B2279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4095-02^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4095-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B63D2284^^^AIRA-TEST^MR||CameronAIRA^CarinaAIRA^Abelia^^^^L|BorthroydAIRA^DanikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1067 Tppingedam Ln^^Long Lake^MI^48743^USA^P||^PRN^PH^^^989^7994154|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CameronAIRA^BorthroydAIRA^^^^^L|MTH^Mother^HL70063|1067 Tppingedam Ln^^Long Lake^MI^48743^USA^P|^PRN^PH^^^989^7994154ORC|RE||BB63D2284.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB63D2284.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4095-09^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4096-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P91Q2289^^^AIRA-TEST^MR||BrownfieldAIRA^ZarifaAIRA^Guda^^^^L|HallAIRA^HirokoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1641 Apparaat Cir^^Saginaw^MI^48609^USA^P||^PRN^PH^^^989^9493935|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownfieldAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1641 Apparaat Cir^^Saginaw^MI^48609^USA^P|^PRN^PH^^^989^9493935ORC|RE||BP91Q2289.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP91Q2289.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4096-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4096-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I19M2303^^^AIRA-TEST^MR||MaddocksAIRA^PaulineAIRA^Maren^^^^L|MaverickAIRA^MahuruAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1378 Judwest-Fryslan Ave^^GR^MI^49548^USA^P||^PRN^PH^^^616^9440613|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MaddocksAIRA^MaverickAIRA^^^^^L|MTH^Mother^HL70063|1378 Judwest-Fryslan Ave^^GR^MI^49548^USA^P|^PRN^PH^^^616^9440613ORC|RE||BI19M2303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI19M2303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4096-02^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4096-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A30W2311^^^AIRA-TEST^MR||MifflinAIRA^KatyaAIRA^Magena^^^^L|SundeAIRA^TaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1223 Hrimmelen Ave^^Watervliet^MI^49098^USA^P||^PRN^PH^^^269^2480283|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MifflinAIRA^SundeAIRA^^^^^L|MTH^Mother^HL70063|1223 Hrimmelen Ave^^Watervliet^MI^49098^USA^P|^PRN^PH^^^269^2480283ORC|RE||BA30W2311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA30W2311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4096-09^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4109-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U77M2316^^^AIRA-TEST^MR||RoseAIRA^VesperAIRA^Kaveri^^^^L|HarrisAIRA^ChayaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1270 Aoevorden Ave^^Lima Township^MI^48118^USA^P||^PRN^PH^^^734^2312460|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RoseAIRA^HarrisAIRA^^^^^L|MTH^Mother^HL70063|1270 Aoevorden Ave^^Lima Township^MI^48118^USA^P|^PRN^PH^^^734^2312460ORC|RE||BU77M2316.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU77M2316.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4109-01^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4109-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y78R2324^^^AIRA-TEST^MR||BrownfieldAIRA^CoralieAIRA^Raphaela^^^^L|MasonAIRA^TustiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1166 Vaag en Braassem Cir^^Peck^MI^48466^USA^P||^PRN^PH^^^810^8735448|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownfieldAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1166 Vaag en Braassem Cir^^Peck^MI^48466^USA^P|^PRN^PH^^^810^8735448ORC|RE||BY78R2324.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY78R2324.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4109-02^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4109-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U91E2335^^^AIRA-TEST^MR||GageAIRA^ShelbyAIRA^Jarka^^^^L|MahoneyAIRA^AshleighAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1263 Soudrichem St^^Chippewa Temp Correction Fac^MI^49785^USA^P||^PRN^PH^^^906^9453551|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GageAIRA^MahoneyAIRA^^^^^L|MTH^Mother^HL70063|1263 Soudrichem St^^Chippewa Temp Correction Fac^MI^49785^USA^P|^PRN^PH^^^906^9453551ORC|RE||BU91E2335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU91E2335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4109-09^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4119-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z90M2343^^^AIRA-TEST^MR||OkmulgeeAIRA^IxchelAIRA^Avis^^^^L|HellicoskiAIRA^AvahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1297 Doxtel Cir^^Atlantic Mine^MI^49905^USA^P||^PRN^PH^^^906^7623235|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OkmulgeeAIRA^HellicoskiAIRA^^^^^L|MTH^Mother^HL70063|1297 Doxtel Cir^^Atlantic Mine^MI^49905^USA^P|^PRN^PH^^^906^7623235ORC|RE||BZ90M2343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ90M2343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4119-01^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4119-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q87K2351^^^AIRA-TEST^MR||JensenAIRA^MeshaAIRA^Amirah^^^^L|LowndesAIRA^HettieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1616 Srechterland Ave^^Lansing^MI^48956^USA^P||^PRN^PH^^^517^7859340|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JensenAIRA^LowndesAIRA^^^^^L|MTH^Mother^HL70063|1616 Srechterland Ave^^Lansing^MI^48956^USA^P|^PRN^PH^^^517^7859340ORC|RE||BQ87K2351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ87K2351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4119-02^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4119-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N72H2356^^^AIRA-TEST^MR||KentAIRA^AverieAIRA^Ebony^^^^L|OttawaAIRA^AntheaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1438 Vsten Pl^^Springfield^MI^49015^USA^P||^PRN^PH^^^269^3303944|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KentAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1438 Vsten Pl^^Springfield^MI^49015^USA^P|^PRN^PH^^^269^3303944ORC|RE||BN72H2356.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN72H2356.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4119-03^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4121-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T10A2364^^^AIRA-TEST^MR||FloydAIRA^SitaraAIRA^Barbara^^^^L|LenaweeAIRA^MirandaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1396 Reusachtig Ln^^Saline^MI^48176^USA^P||^PRN^PH^^^734^2792475|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FloydAIRA^LenaweeAIRA^^^^^L|MTH^Mother^HL70063|1396 Reusachtig Ln^^Saline^MI^48176^USA^P|^PRN^PH^^^734^2792475ORC|RE||BT10A2364.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT10A2364.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4121-01^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4121-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T12C2375^^^AIRA-TEST^MR||PlymouthAIRA^RosamondAIRA^Primula^^^^L|McCrackenAIRA^NishthaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1635 Eeel en Maas Pl^^Glennie^MI^48737^USA^P||^PRN^PH^^^989^5824415|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PlymouthAIRA^McCrackenAIRA^^^^^L|MTH^Mother^HL70063|1635 Eeel en Maas Pl^^Glennie^MI^48737^USA^P|^PRN^PH^^^989^5824415ORC|RE||BT12C2375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT12C2375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4121-02^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4133-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J40K2383^^^AIRA-TEST^MR||BourbonAIRA^MarvelleAIRA^Adana^^^^L|HamiltonAIRA^ChelsiaAIRA^^^^^M|20140201|F||2106-3^White^CDCREC|1424 Hof van Twente Pl^^Grosse Pointe Woods^MI^48236^USA^P||^PRN^PH^^^313^8304179|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BourbonAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1424 Hof van Twente Pl^^Grosse Pointe Woods^MI^48236^USA^P|^PRN^PH^^^313^8304179ORC|RE||BJ40K2383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140401||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ40K2383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140601||00006-4133-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140601||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4133-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J99C2391^^^AIRA-TEST^MR||JackAIRA^AnninkaAIRA^Marcy^^^^L|GrayAIRA^AkalaAIRA^^^^^M|20140201|F||2106-3^White^CDCREC|1954 Epeldoorn Pl^^Birmingham^MI^48012^USA^P||^PRN^PH^^^248^5059668|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JackAIRA^GrayAIRA^^^^^L|MTH^Mother^HL70063|1954 Epeldoorn Pl^^Birmingham^MI^48012^USA^P|^PRN^PH^^^248^5059668ORC|RE||BJ99C2391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140401||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ99C2391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140601||00006-4133-41^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140601||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4171-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C03U2396^^^AIRA-TEST^MR||PikeAIRA^KianaAIRA^Reese^^^^L|BoiseAIRA^QuobaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1599 Aomeren St^^Dearborn^MI^48123^USA^P||^PRN^PH^^^313^4662096|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PikeAIRA^BoiseAIRA^^^^^L|MTH^Mother^HL70063|1599 Aomeren St^^Dearborn^MI^48123^USA^P|^PRN^PH^^^313^4662096ORC|RE||BC03U2396.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC03U2396.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4171-00^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4171-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K02U2404^^^AIRA-TEST^MR||FultonAIRA^MerryAIRA^Damara^^^^L|O'DonnellAIRA^KatarinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1169 Plbrandswaard Pl^^Leslie^MI^49251^USA^P||^PRN^PH^^^517^3107494|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FultonAIRA^O'DonnellAIRA^^^^^L|MTH^Mother^HL70063|1169 Plbrandswaard Pl^^Leslie^MI^49251^USA^P|^PRN^PH^^^517^3107494ORC|RE||BK02U2404.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK02U2404.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4171-01^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4681-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A22F2415^^^AIRA-TEST^MR||BurnetAIRA^AlateaAIRA^Missy^^^^L|AlconaAIRA^ChelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1940 Ma en Hunze Ln^^Grosse Pointe Park^MI^48224^USA^P||^PRN^PH^^^313^9296579|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BurnetAIRA^AlconaAIRA^^^^^L|MTH^Mother^HL70063|1940 Ma en Hunze Ln^^Grosse Pointe Park^MI^48224^USA^P|^PRN^PH^^^313^9296579ORC|RE||BA22F2415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA22F2415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4681-00^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4681-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q81L2423^^^AIRA-TEST^MR||GalvestonAIRA^ArtemisiaAIRA^Nimue^^^^L|MarshallAIRA^FloAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1248 Rrnhem Ln^^Dexter^MI^48130^USA^P||^PRN^PH^^^734^7199874|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GalvestonAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1248 Rrnhem Ln^^Dexter^MI^48130^USA^P|^PRN^PH^^^734^7199874ORC|RE||BQ81L2423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ81L2423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4681-01^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4739-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z06I2431^^^AIRA-TEST^MR||GanesAIRA^SwanhildAIRA^Anila^^^^L|SpieccAIRA^HaideeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1765 Roordenveld Ln^^Elwell^MI^48832^USA^P||^PRN^PH^^^989^8065647|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GanesAIRA^SpieccAIRA^^^^^L|MTH^Mother^HL70063|1765 Roordenveld Ln^^Elwell^MI^48832^USA^P|^PRN^PH^^^989^8065647ORC|RE||BZ06I2431.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ06I2431.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4739-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4739-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V00C2436^^^AIRA-TEST^MR||IsdalAIRA^NiralAIRA^Ronda^^^^L|CanadianAIRA^AudreyAIRA^^^^^M|20181228|F||2106-3^White^CDCREC|1761 Sssen Ave^^East Leroy^MI^49051^USA^P||^PRN^PH^^^269^7334378|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IsdalAIRA^CanadianAIRA^^^^^L|MTH^Mother^HL70063|1761 Sssen Ave^^East Leroy^MI^49051^USA^P|^PRN^PH^^^269^7334378ORC|RE||BV00C2436.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV00C2436.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190429||00006-4739-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190429||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4826-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W17T2444^^^AIRA-TEST^MR||IndianaAIRA^GraniaAIRA^Diki^^^^L|GreenAIRA^CamillaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1309 Vrechterland Cir^^Millington^MI^48746^USA^P||^PRN^PH^^^989^3866417|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IndianaAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1309 Vrechterland Cir^^Millington^MI^48746^USA^P|^PRN^PH^^^989^3866417ORC|RE||BW17T2444.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW17T2444.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4826-00^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4826-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y70Y2455^^^AIRA-TEST^MR||TereAIRA^MonicaAIRA^Miakoda^^^^L|SarpyAIRA^VeraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1075 Borger-Odoorn Pl^^Battle Creek^MI^49015^USA^P||^PRN^PH^^^269^3457840|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TereAIRA^SarpyAIRA^^^^^L|MTH^Mother^HL70063|1075 Borger-Odoorn Pl^^Battle Creek^MI^49015^USA^P|^PRN^PH^^^269^3457840ORC|RE||BY70Y2455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY70Y2455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4826-01^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4827-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R49O2463^^^AIRA-TEST^MR||GardenAIRA^PreitaAIRA^Nasrin^^^^L|WashingtonAIRA^ReginaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1153 Dlst-Wijhe Ln^^Stronach^MI^49660^USA^P||^PRN^PH^^^231^4254434|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GardenAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1153 Dlst-Wijhe Ln^^Stronach^MI^49660^USA^P|^PRN^PH^^^231^4254434ORC|RE||BR49O2463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR49O2463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4827-00^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4827-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z98L2471^^^AIRA-TEST^MR||Keya PahaAIRA^MajAIRA^Aemilia^^^^L|LovingAIRA^JanelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1577 Dongen Cir^^Big Bay^MI^49808^USA^P||^PRN^PH^^^906^9800517|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Keya PahaAIRA^LovingAIRA^^^^^L|MTH^Mother^HL70063|1577 Dongen Cir^^Big Bay^MI^49808^USA^P|^PRN^PH^^^906^9800517ORC|RE||BZ98L2471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ98L2471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4827-01^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4831-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H94R2476^^^AIRA-TEST^MR||BullittAIRA^TullyAIRA^Marlee^^^^L|CarterAIRA^GlennaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1597 Daarbeek Ave^^Muskegon^MI^49440^USA^P||^PRN^PH^^^231^8199230|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BullittAIRA^CarterAIRA^^^^^L|MTH^Mother^HL70063|1597 Daarbeek Ave^^Muskegon^MI^49440^USA^P|^PRN^PH^^^231^8199230ORC|RE||BH94R2476.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH94R2476.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4831-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4831-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A18R2484^^^AIRA-TEST^MR||OaklandAIRA^BaciaAIRA^Harmony^^^^L|WheelerAIRA^PrunellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1677 Oeusden Ln^^Chippewa Temp Correction Fac^MI^49785^USA^P||^PRN^PH^^^906^5565799|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OaklandAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1677 Oeusden Ln^^Chippewa Temp Correction Fac^MI^49785^USA^P|^PRN^PH^^^906^5565799ORC|RE||BA18R2484.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA18R2484.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4831-41^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4837-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z97L2495^^^AIRA-TEST^MR||CaldwellAIRA^GheraAIRA^Yemena^^^^L|IrvingAIRA^NerinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1559 Sardenberg Cir^^Houghton^MI^49921^USA^P||^PRN^PH^^^906^7837840|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CaldwellAIRA^IrvingAIRA^^^^^L|MTH^Mother^HL70063|1559 Sardenberg Cir^^Houghton^MI^49921^USA^P|^PRN^PH^^^906^7837840ORC|RE||BZ97L2495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ97L2495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4837-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4837-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D26D2503^^^AIRA-TEST^MR||MendocinoAIRA^SaniyahAIRA^Barbara^^^^L|MackinacAIRA^MariahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1053 Aaarlemmermeer Ave^^Raco^MI^49715^USA^P||^PRN^PH^^^906^4932117|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MendocinoAIRA^MackinacAIRA^^^^^L|MTH^Mother^HL70063|1053 Aaarlemmermeer Ave^^Raco^MI^49715^USA^P|^PRN^PH^^^906^4932117ORC|RE||BD26D2503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD26D2503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4837-02^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4837-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M23J2511^^^AIRA-TEST^MR||StonewallAIRA^NeetaAIRA^June^^^^L|AdamsAIRA^KeylaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1669 Veenendaal Ln^^Lennon^MI^48449^USA^P||^PRN^PH^^^989^5085771|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StonewallAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1669 Veenendaal Ln^^Lennon^MI^48449^USA^P|^PRN^PH^^^989^5085771ORC|RE||BM23J2511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM23J2511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4837-03^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4841-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H53F2516^^^AIRA-TEST^MR||ButlerAIRA^HaleighAIRA^Ashamed^^^^L|ClintonAIRA^AmenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1658 Beert Pl^^Battle Creek^MI^49015^USA^P||^PRN^PH^^^269^5825960|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButlerAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1658 Beert Pl^^Battle Creek^MI^49015^USA^P|^PRN^PH^^^269^5825960ORC|RE||BH53F2516.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH53F2516.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4841-00^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4841-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U77G2524^^^AIRA-TEST^MR||CarterAIRA^TalaAIRA^Klea^^^^L|MercerAIRA^IrelandAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1662 Nellendoorn Pl^^Chase^MI^49623^USA^P||^PRN^PH^^^231^8790379|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarterAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1662 Nellendoorn Pl^^Chase^MI^49623^USA^P|^PRN^PH^^^231^8790379ORC|RE||BU77G2524.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU77G2524.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4841-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4841-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S77U2535^^^AIRA-TEST^MR||FitzpatrickAIRA^KristinaAIRA^Concordia^^^^L|HayesAIRA^SophieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1536 Toorst Ave^^Allegan^MI^49010^USA^P||^PRN^PH^^^269^7803893|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FitzpatrickAIRA^HayesAIRA^^^^^L|MTH^Mother^HL70063|1536 Toorst Ave^^Allegan^MI^49010^USA^P|^PRN^PH^^^269^7803893ORC|RE||BS77U2535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS77U2535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4841-41^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4897-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q80T2543^^^AIRA-TEST^MR||HighlandAIRA^AniyahAIRA^Maddi^^^^L|HarneyAIRA^ChimalisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1463 Mulst Ave^^Sterling Heights^MI^48310^USA^P||^PRN^PH^^^586^4895300|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HighlandAIRA^HarneyAIRA^^^^^L|MTH^Mother^HL70063|1463 Mulst Ave^^Sterling Heights^MI^48310^USA^P|^PRN^PH^^^586^4895300ORC|RE||BQ80T2543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ80T2543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4897-00^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4897-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K05W2551^^^AIRA-TEST^MR||LancasterAIRA^DesireeAIRA^Opaline^^^^L|ClermontAIRA^ClymeneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1880 Weerenveen Pl^^Glennie^MI^48737^USA^P||^PRN^PH^^^989^5057869|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LancasterAIRA^ClermontAIRA^^^^^L|MTH^Mother^HL70063|1880 Weerenveen Pl^^Glennie^MI^48737^USA^P|^PRN^PH^^^989^5057869ORC|RE||BK05W2551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK05W2551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4897-01^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4898-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V84J2556^^^AIRA-TEST^MR||HowardAIRA^HiberniaAIRA^Vienna^^^^L|SterlingAIRA^AsellaAIRA^^^^^M|20140830|F||2106-3^White^CDCREC|1310 Sijk bij Duurstede St^^Osseo^MI^49266^USA^P||^PRN^PH^^^517^7667927|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowardAIRA^SterlingAIRA^^^^^L|MTH^Mother^HL70063|1310 Sijk bij Duurstede St^^Osseo^MI^49266^USA^P|^PRN^PH^^^517^7667927ORC|RE||BV84J2556.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20141030||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV84J2556.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20141230||00006-4898-00^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20141230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4898-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z65D2564^^^AIRA-TEST^MR||ParmerAIRA^AvasaAIRA^Saloma^^^^L|SiouxAIRA^RoseAIRA^^^^^M|20140830|F||2106-3^White^CDCREC|1788 Beide Pl^^Farmington Hls^MI^48334^USA^P||^PRN^PH^^^248^2468755|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ParmerAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1788 Beide Pl^^Farmington Hls^MI^48334^USA^P|^PRN^PH^^^248^2468755ORC|RE||BZ65D2564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20141030||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ65D2564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20141230||00006-4898-01^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20141230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4943-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B19Q2575^^^AIRA-TEST^MR||FranklinAIRA^NatalyAIRA^Toora^^^^L|CaseyAIRA^AiyanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1170 Coat Cir^^Stronach^MI^49660^USA^P||^PRN^PH^^^231^8095949|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^CaseyAIRA^^^^^L|MTH^Mother^HL70063|1170 Coat Cir^^Stronach^MI^49660^USA^P|^PRN^PH^^^231^8095949ORC|RE||BB19Q2575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB19Q2575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4943-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4943-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y47V2583^^^AIRA-TEST^MR||BerrienAIRA^TydfillAIRA^Aliya^^^^L|LebanonAIRA^ChristianaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1236 Kingewaard Pl^^Dearborn^MI^48121^USA^P||^PRN^PH^^^313^6371376|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BerrienAIRA^LebanonAIRA^^^^^L|MTH^Mother^HL70063|1236 Kingewaard Pl^^Dearborn^MI^48121^USA^P|^PRN^PH^^^313^6371376ORC|RE||BY47V2583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY47V2583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4943-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4963-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A82Y2591^^^AIRA-TEST^MR||JackAIRA^VallerieAIRA^Rosemary^^^^L|MorganAIRA^PierinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1571 Bernheze Ln^^Grosse Pointe^MI^48236^USA^P||^PRN^PH^^^313^4785741|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JackAIRA^MorganAIRA^^^^^L|MTH^Mother^HL70063|1571 Bernheze Ln^^Grosse Pointe^MI^48236^USA^P|^PRN^PH^^^313^4785741ORC|RE||BA82Y2591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA82Y2591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4963-00^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4963-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J97V2596^^^AIRA-TEST^MR||RobertsAIRA^ChristianaAIRA^Dania^^^^L|NelsonAIRA^MoreenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1628 Beldermalsen St^^Merritt^MI^49667^USA^P||^PRN^PH^^^231^9969567|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobertsAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1628 Beldermalsen St^^Merritt^MI^49667^USA^P|^PRN^PH^^^231^9969567ORC|RE||BJ97V2596.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ97V2596.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4963-01^ZOSTAVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4963-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M96L2604^^^AIRA-TEST^MR||SkagAIRA^ZaneAIRA^Agneta^^^^L|CreghanAIRA^BreeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1242 Arm St^^Brown City^MI^48416^USA^P||^PRN^PH^^^810^2034265|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SkagAIRA^CreghanAIRA^^^^^L|MTH^Mother^HL70063|1242 Arm St^^Brown City^MI^48416^USA^P|^PRN^PH^^^810^2034265ORC|RE||BM96L2604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM96L2604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4963-41^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4980-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N94V2615^^^AIRA-TEST^MR||O NeillAIRA^ThalassaAIRA^Lindley^^^^L|BourbonAIRA^DericaAIRA^^^^^M|20080518|F||2106-3^White^CDCREC|1252 Pick Ave^^Coopersville^MI^49404^USA^P||^PRN^PH^^^616^5464759|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O NeillAIRA^BourbonAIRA^^^^^L|MTH^Mother^HL70063|1252 Pick Ave^^Coopersville^MI^49404^USA^P|^PRN^PH^^^616^5464759ORC|RE||BN94V2615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20080718||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN94V2615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20080918||00006-4980-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20080918||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4981-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J25Z2623^^^AIRA-TEST^MR||Van ZandtAIRA^AnanAIRA^Hagar^^^^L|MonaghanAIRA^AmanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1983 Gilvarenbeek Pl^^Borculo^MI^49464^USA^P||^PRN^PH^^^616^4323667|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Van ZandtAIRA^MonaghanAIRA^^^^^L|MTH^Mother^HL70063|1983 Gilvarenbeek Pl^^Borculo^MI^49464^USA^P|^PRN^PH^^^616^4323667ORC|RE||BJ25Z2623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ25Z2623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4981-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4981-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X18S2631^^^AIRA-TEST^MR||TillmanAIRA^YevonAIRA^Charleigh^^^^L|BrownAIRA^LuellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1771 Prootegast St^^La Salle^MI^48145^USA^P||^PRN^PH^^^734^6247404|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TillmanAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1771 Prootegast St^^La Salle^MI^48145^USA^P|^PRN^PH^^^734^6247404ORC|RE||BX18S2631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX18S2631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4981-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4992-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K02J2639^^^AIRA-TEST^MR||CumberlandAIRA^AphraAIRA^Schuyler^^^^L|ZavalaAIRA^VegaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1334 Mverbetuwe Pl^^Leonidas^MI^49066^USA^P||^PRN^PH^^^269^8080297|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumberlandAIRA^ZavalaAIRA^^^^^L|MTH^Mother^HL70063|1334 Mverbetuwe Pl^^Leonidas^MI^49066^USA^P|^PRN^PH^^^269^8080297ORC|RE||BK02J2639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK02J2639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4992-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4992-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y58T2647^^^AIRA-TEST^MR||SequoyahAIRA^GenetteAIRA^Kailey^^^^L|WilliamsonAIRA^ShrutiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1957 Heldrop Pl^^Flint^MI^48550^USA^P||^PRN^PH^^^810^6747853|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SequoyahAIRA^WilliamsonAIRA^^^^^L|MTH^Mother^HL70063|1957 Heldrop Pl^^Flint^MI^48550^USA^P|^PRN^PH^^^810^6747853ORC|RE||BY58T2647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY58T2647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4992-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4995-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D50Q2655^^^AIRA-TEST^MR||DanuelsonAIRA^MakaniAIRA^Naia^^^^L|TobiassenAIRA^LeslieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1287 Snderbanken Pl^^Union City^MI^49094^USA^P||^PRN^PH^^^517^6784880|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DanuelsonAIRA^TobiassenAIRA^^^^^L|MTH^Mother^HL70063|1287 Snderbanken Pl^^Union City^MI^49094^USA^P|^PRN^PH^^^517^6784880ORC|RE||BD50Q2655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD50Q2655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4995-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4995-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H91K2663^^^AIRA-TEST^MR||ByrneAIRA^SofiaAIRA^Kyrena^^^^L|ClarkAIRA^KehindeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1989 Caarle-Nassau Pl^^Kalkaska^MI^49646^USA^P||^PRN^PH^^^231^7997892|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ByrneAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1989 Caarle-Nassau Pl^^Kalkaska^MI^49646^USA^P|^PRN^PH^^^231^7997892ORC|RE||BH91K2663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH91K2663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4995-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4995-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F03U2671^^^AIRA-TEST^MR||AdaAIRA^CampbellAIRA^Pyrena^^^^L|BanbergAIRA^JordanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1372 Oegstgeest Ln^^Saline^MI^48115^USA^P||^PRN^PH^^^734^3051104|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdaAIRA^BanbergAIRA^^^^^L|MTH^Mother^HL70063|1372 Oegstgeest Ln^^Saline^MI^48115^USA^P|^PRN^PH^^^734^3051104ORC|RE||BF03U2671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF03U2671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006-4995-41^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4999-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G47L2679^^^AIRA-TEST^MR||LamarAIRA^NedaAIRA^Agape^^^^L|BrikkeAIRA^AvahAIRA^^^^^M|20150330|F||2106-3^White^CDCREC|1119 Daadhoeke Cir^^Paw Paw^MI^49079^USA^P||^PRN^PH^^^269^8010151|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LamarAIRA^BrikkeAIRA^^^^^L|MTH^Mother^HL70063|1119 Daadhoeke Cir^^Paw Paw^MI^49079^USA^P|^PRN^PH^^^269^8010151ORC|RE||BG47L2679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150530||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG47L2679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150730||00006-4999-00^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150730||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006-4999-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J95N2684^^^AIRA-TEST^MR||MidlandAIRA^AideenAIRA^Galen^^^^L|StonewallAIRA^ElunedAIRA^^^^^M|20150330|F||2106-3^White^CDCREC|1409 Schoen St^^Nunica^MI^49448^USA^P||^PRN^PH^^^616^8014970|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MidlandAIRA^StonewallAIRA^^^^^L|MTH^Mother^HL70063|1409 Schoen St^^Nunica^MI^49448^USA^P|^PRN^PH^^^616^8014970ORC|RE||BJ95N2684.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150530||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ95N2684.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150730||00006-4999-01^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150730||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00052-0603-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M05H2692^^^AIRA-TEST^MR||PacificAIRA^BethAIRA^Zohra^^^^L|CrawfordAIRA^AletheaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1122 Ltede Broec Ave^^Perry^MI^48872^USA^P||^PRN^PH^^^517^3235309|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PacificAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1122 Ltede Broec Ave^^Perry^MI^48872^USA^P|^PRN^PH^^^517^3235309ORC|RE||BM05H2692.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM05H2692.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00052-0603-01^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||OTC^Organon Teknika Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00052-0603-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M03L2703^^^AIRA-TEST^MR||ShiawasseeAIRA^UlaAIRA^Jackie^^^^L|ThurstonAIRA^MandaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1627 Epeldoorn Pl^^Portage^MI^49024^USA^P||^PRN^PH^^^269^5604045|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShiawasseeAIRA^ThurstonAIRA^^^^^L|MTH^Mother^HL70063|1627 Epeldoorn Pl^^Portage^MI^49024^USA^P|^PRN^PH^^^269^5604045ORC|RE||BM03L2703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM03L2703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00052-0603-02^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||OTC^Organon Teknika Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-13533-0131-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y68I2711^^^AIRA-TEST^MR||GreenlandAIRA^ErwinaAIRA^Hemangini^^^^L|LohmannAIRA^LovedayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1543 Onkhuizen Ln^^Lake Orion^MI^48362^USA^P||^PRN^PH^^^248^7235928|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenlandAIRA^LohmannAIRA^^^^^L|MTH^Mother^HL70063|1543 Onkhuizen Ln^^Lake Orion^MI^48362^USA^P|^PRN^PH^^^248^7235928ORC|RE||BY68I2711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY68I2711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||13533-0131-00^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-13533-0131-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q72I2719^^^AIRA-TEST^MR||ShermanAIRA^FinolaAIRA^Efrosini^^^^L|OkfuskeeAIRA^TapiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1609 Oorger-Odoorn Pl^^Eau Claire^MI^49111^USA^P||^PRN^PH^^^269^9022514|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShermanAIRA^OkfuskeeAIRA^^^^^L|MTH^Mother^HL70063|1609 Oorger-Odoorn Pl^^Eau Claire^MI^49111^USA^P|^PRN^PH^^^269^9022514ORC|RE||BQ72I2719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ72I2719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||13533-0131-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-14362-0111-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U65I2727^^^AIRA-TEST^MR||UlsethAIRA^AmadiAIRA^Jutta^^^^L|TuolumneAIRA^MinnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1225 Zastricum Cir^^Turner^MI^48765^USA^P||^PRN^PH^^^989^9722539|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UlsethAIRA^TuolumneAIRA^^^^^L|MTH^Mother^HL70063|1225 Zastricum Cir^^Turner^MI^48765^USA^P|^PRN^PH^^^989^9722539ORC|RE||BU65I2727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU65I2727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||14362-0111-03^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-14362-0111-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z69P2732^^^AIRA-TEST^MR||DefianceAIRA^MaganAIRA^Nerina^^^^L|ComancheAIRA^SajniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1372 Groep Cir^^Grand Rapids^MI^49544^USA^P||^PRN^PH^^^616^8959703|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DefianceAIRA^ComancheAIRA^^^^^L|MTH^Mother^HL70063|1372 Groep Cir^^Grand Rapids^MI^49544^USA^P|^PRN^PH^^^616^8959703ORC|RE||BZ69P2732.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ69P2732.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||14362-0111-04^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-17478-0131-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N25M2740^^^AIRA-TEST^MR||GreenleeAIRA^IshiAIRA^Arezou^^^^L|RockcastleAIRA^KaperaAIRA^^^^^M|20161226|F||2106-3^White^CDCREC|1702 Raalte Pl^^State of Michigan^MI^48913^USA^P||^PRN^PH^^^517^2420250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenleeAIRA^RockcastleAIRA^^^^^L|MTH^Mother^HL70063|1702 Raalte Pl^^State of Michigan^MI^48913^USA^P|^PRN^PH^^^517^2420250ORC|RE||BN25M2740.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170226||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN25M2740.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170426||17478-0131-00^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170426||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-17478-0131-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U79S2751^^^AIRA-TEST^MR||KnightAIRA^TrudyAIRA^Shifra^^^^L|SowdenAIRA^AmandineAIRA^^^^^M|20161226|F||2106-3^White^CDCREC|1756 IJsselstein St^^Meskegon^MI^49442^USA^P||^PRN^PH^^^231^4171729|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnightAIRA^SowdenAIRA^^^^^L|MTH^Mother^HL70063|1756 IJsselstein St^^Meskegon^MI^49442^USA^P|^PRN^PH^^^231^4171729ORC|RE||BU79S2751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170226||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU79S2751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170426||17478-0131-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170426||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0845-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T71J2759^^^AIRA-TEST^MR||MathiesenAIRA^NadiraAIRA^India^^^^L|WyandotAIRA^KaitlynAIRA^^^^^M|20150630|F||2106-3^White^CDCREC|1546 Verrassing Ln^^Westwood^MI^49006^USA^P||^PRN^PH^^^269^4362098|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MathiesenAIRA^WyandotAIRA^^^^^L|MTH^Mother^HL70063|1546 Verrassing Ln^^Westwood^MI^49006^USA^P|^PRN^PH^^^269^4362098ORC|RE||BT71J2759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT71J2759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151030||19515-0845-01^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151030||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0845-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S75M2767^^^AIRA-TEST^MR||JacksonAIRA^LethaAIRA^Rosetta^^^^L|LambAIRA^GhislainAIRA^^^^^M|20150630|F||2106-3^White^CDCREC|1963 Vud-Beijerland Ln^^Dearborn^MI^48126^USA^P||^PRN^PH^^^313^9667986|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^LambAIRA^^^^^L|MTH^Mother^HL70063|1963 Vud-Beijerland Ln^^Dearborn^MI^48126^USA^P|^PRN^PH^^^313^9667986ORC|RE||BS75M2767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS75M2767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151030||19515-0845-11^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151030||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0850-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V87I2772^^^AIRA-TEST^MR||ParkerAIRA^GavrilaAIRA^Kajsa^^^^L|ReevesAIRA^BlazeAIRA^^^^^M|20150630|F||2106-3^White^CDCREC|1855 Aijkerk Cir^^Bloomingdale^MI^49026^USA^P||^PRN^PH^^^269^2698299|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ParkerAIRA^ReevesAIRA^^^^^L|MTH^Mother^HL70063|1855 Aijkerk Cir^^Bloomingdale^MI^49026^USA^P|^PRN^PH^^^269^2698299ORC|RE||BV87I2772.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV87I2772.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151030||19515-0850-41^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151030||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0850-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X53B2780^^^AIRA-TEST^MR||LackawannaAIRA^ElizabethAIRA^Alexa^^^^L|BentonAIRA^IlaAIRA^^^^^M|20150630|F||2106-3^White^CDCREC|1401 Laten Ln^^Rollin^MI^49247^USA^P||^PRN^PH^^^517^2221957|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LackawannaAIRA^BentonAIRA^^^^^L|MTH^Mother^HL70063|1401 Laten Ln^^Rollin^MI^49247^USA^P|^PRN^PH^^^517^2221957ORC|RE||BX53B2780.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX53B2780.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151030||19515-0850-52^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151030||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0889-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U57Q2791^^^AIRA-TEST^MR||HitchcockAIRA^MinAIRA^Anjali^^^^L|San Luis ObispoAIRA^InariAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1346 Mden Ave^^Goodison^MI^48306^USA^P||^PRN^PH^^^248^2403311|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HitchcockAIRA^San Luis ObispoAIRA^^^^^L|MTH^Mother^HL70063|1346 Mden Ave^^Goodison^MI^48306^USA^P|^PRN^PH^^^248^2403311ORC|RE||BU57Q2791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130430||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU57Q2791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130630||19515-0889-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130630||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0889-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T65Y2799^^^AIRA-TEST^MR||JacksonAIRA^AudreyAIRA^Adhira^^^^L|LeeAIRA^CloveAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1246 Hudewater Ln^^Eastport^MI^49627^USA^P||^PRN^PH^^^231^9539533|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1246 Hudewater Ln^^Eastport^MI^49627^USA^P|^PRN^PH^^^231^9539533ORC|RE||BT65Y2799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130430||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT65Y2799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130630||19515-0889-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130630||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0890-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C89J2807^^^AIRA-TEST^MR||MasonAIRA^FidelaAIRA^Cara^^^^L|RobertsAIRA^MaximaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1776 Disse Cir^^White Lake^MI^48383^USA^P||^PRN^PH^^^248^3649702|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1776 Disse Cir^^White Lake^MI^48383^USA^P|^PRN^PH^^^248^3649702ORC|RE||BC89J2807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC89J2807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||19515-0890-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0890-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K76O2812^^^AIRA-TEST^MR||JohnsonAIRA^GevaAIRA^Rieko^^^^L|BielaAIRA^GabriellaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1861 Mpe Ave^^Mackinaw City^MI^49701^USA^P||^PRN^PH^^^231^4262872|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JohnsonAIRA^BielaAIRA^^^^^L|MTH^Mother^HL70063|1861 Mpe Ave^^Mackinaw City^MI^49701^USA^P|^PRN^PH^^^231^4262872ORC|RE||BK76O2812.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK76O2812.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||19515-0890-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0891-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S87T2820^^^AIRA-TEST^MR||WalkerAIRA^CadeAIRA^Tonie^^^^L|WilliamsAIRA^AmelindaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1365 Pe Wolden St^^Christmas^MI^49862^USA^P||^PRN^PH^^^906^6280143|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WalkerAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1365 Pe Wolden St^^Christmas^MI^49862^USA^P|^PRN^PH^^^906^6280143ORC|RE||BS87T2820.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS87T2820.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0891-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0891-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q77W2831^^^AIRA-TEST^MR||DallamAIRA^IolaAIRA^Muriel^^^^L|DanuelsonAIRA^AveryAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1142 Afwerking Cir^^Kentwood^MI^49508^USA^P||^PRN^PH^^^616^7235511|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallamAIRA^DanuelsonAIRA^^^^^L|MTH^Mother^HL70063|1142 Afwerking Cir^^Kentwood^MI^49508^USA^P|^PRN^PH^^^616^7235511ORC|RE||BQ77W2831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ77W2831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0891-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0893-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I06J2839^^^AIRA-TEST^MR||JeffersonAIRA^LeannaAIRA^Phoenix^^^^L|GlasscockAIRA^ZagirAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1196 Staal Ln^^Livonia^MI^48154^USA^P||^PRN^PH^^^734^9114743|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^GlasscockAIRA^^^^^L|MTH^Mother^HL70063|1196 Staal Ln^^Livonia^MI^48154^USA^P|^PRN^PH^^^734^9114743ORC|RE||BI06J2839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI06J2839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0893-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0893-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F48U2847^^^AIRA-TEST^MR||PowerAIRA^KristalAIRA^Unnati^^^^L|PotterAIRA^IphigeniaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1964 Hwartewaterland Pl^^Prattville^MI^49271^USA^P||^PRN^PH^^^517^6486803|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PowerAIRA^PotterAIRA^^^^^L|MTH^Mother^HL70063|1964 Hwartewaterland Pl^^Prattville^MI^49271^USA^P|^PRN^PH^^^517^6486803ORC|RE||BF48U2847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF48U2847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0893-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0894-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W29P2852^^^AIRA-TEST^MR||YorkAIRA^EmogeneAIRA^Kefira^^^^L|KiernanAIRA^SaidaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1996 Auiven Ave^^Farmington Hls^MI^48331^USA^P||^PRN^PH^^^248^2735794|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YorkAIRA^KiernanAIRA^^^^^L|MTH^Mother^HL70063|1996 Auiven Ave^^Farmington Hls^MI^48331^USA^P|^PRN^PH^^^248^2735794ORC|RE||BW29P2852.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW29P2852.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0894-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0894-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N43V2860^^^AIRA-TEST^MR||JohnsonAIRA^TurquoiseAIRA^Galena^^^^L|JacksonAIRA^GavrilaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1621 Kastricum St^^Comstock^MI^49041^USA^P||^PRN^PH^^^269^9759937|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JohnsonAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1621 Kastricum St^^Comstock^MI^49041^USA^P|^PRN^PH^^^269^9759937ORC|RE||BN43V2860.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN43V2860.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0894-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0895-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M80G2871^^^AIRA-TEST^MR||IslandAIRA^PersephoneAIRA^Danu^^^^L|DaviessAIRA^IrisAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1799 Ochouwen-Duiveland St^^Gwinn^MI^49841^USA^P||^PRN^PH^^^906^2218063|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IslandAIRA^DaviessAIRA^^^^^L|MTH^Mother^HL70063|1799 Ochouwen-Duiveland St^^Gwinn^MI^49841^USA^P|^PRN^PH^^^906^2218063ORC|RE||BM80G2871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM80G2871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||19515-0895-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0895-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S83Y2879^^^AIRA-TEST^MR||ShappeAIRA^CatavaAIRA^Zenda^^^^L|WalshAIRA^MaricelAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1617 Wulst Pl^^Pelkie^MI^49958^USA^P||^PRN^PH^^^906^3733364|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShappeAIRA^WalshAIRA^^^^^L|MTH^Mother^HL70063|1617 Wulst Pl^^Pelkie^MI^49958^USA^P|^PRN^PH^^^906^3733364ORC|RE||BS83Y2879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS83Y2879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||19515-0895-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0896-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L38V2887^^^AIRA-TEST^MR||PainterAIRA^KadijaAIRA^Juliet^^^^L|AntrimAIRA^AngharadAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1725 Bal Cir^^Detroit^MI^48265^USA^P||^PRN^PH^^^313^4848334|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PainterAIRA^AntrimAIRA^^^^^L|MTH^Mother^HL70063|1725 Bal Cir^^Detroit^MI^48265^USA^P|^PRN^PH^^^313^4848334ORC|RE||BL38V2887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL38V2887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||19515-0896-01^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0896-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N43T2892^^^AIRA-TEST^MR||McMullenAIRA^MargoAIRA^Chitra^^^^L|MorganAIRA^VallettaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1739 Hexel Pl^^Saint Clr Shores^MI^48082^USA^P||^PRN^PH^^^586^3579908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McMullenAIRA^MorganAIRA^^^^^L|MTH^Mother^HL70063|1739 Hexel Pl^^Saint Clr Shores^MI^48082^USA^P|^PRN^PH^^^586^3579908ORC|RE||BN43T2892.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN43T2892.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||19515-0896-11^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0898-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P98N2900^^^AIRA-TEST^MR||NightingaleAIRA^RufinaAIRA^Lynda^^^^L|ReynoldsAIRA^KadeeAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1095 Nog Pl^^Andrews University^MI^49104^USA^P||^PRN^PH^^^269^9250370|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NightingaleAIRA^ReynoldsAIRA^^^^^L|MTH^Mother^HL70063|1095 Nog Pl^^Andrews University^MI^49104^USA^P|^PRN^PH^^^269^9250370ORC|RE||BP98N2900.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP98N2900.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||19515-0898-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0898-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X57R2911^^^AIRA-TEST^MR||MaddocksAIRA^KaneneAIRA^Saloma^^^^L|HenryAIRA^KamnaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1614 Loon op Zand Pl^^Lincoln Park^MI^48146^USA^P||^PRN^PH^^^313^9361362|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MaddocksAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1614 Loon op Zand Pl^^Lincoln Park^MI^48146^USA^P|^PRN^PH^^^313^9361362ORC|RE||BX57R2911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX57R2911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||19515-0898-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0900-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A27U2919^^^AIRA-TEST^MR||HowarthAIRA^LeightonAIRA^Laura^^^^L|MedinaAIRA^KyreniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1089 Ridden-Drenthe Ave^^Saint Heights^MI^48314^USA^P||^PRN^PH^^^586^4668105|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowarthAIRA^MedinaAIRA^^^^^L|MTH^Mother^HL70063|1089 Ridden-Drenthe Ave^^Saint Heights^MI^48314^USA^P|^PRN^PH^^^586^4668105ORC|RE||BA27U2919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA27U2919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-0900-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0900-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R85N2927^^^AIRA-TEST^MR||BolgenAIRA^CuylerAIRA^Wasima^^^^L|LueatosAIRA^RuchikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1291 Laasdonk Ave^^Lansing^MI^48910^USA^P||^PRN^PH^^^517^3447585|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BolgenAIRA^LueatosAIRA^^^^^L|MTH^Mother^HL70063|1291 Laasdonk Ave^^Lansing^MI^48910^USA^P|^PRN^PH^^^517^3447585ORC|RE||BR85N2927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR85N2927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-0900-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0901-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C93J2932^^^AIRA-TEST^MR||ThomasAIRA^SultanaAIRA^Candie^^^^L|HarlanAIRA^AltheaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1161 Exacte Ave^^Cascade^MI^49506^USA^P||^PRN^PH^^^616^9459717|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThomasAIRA^HarlanAIRA^^^^^L|MTH^Mother^HL70063|1161 Exacte Ave^^Cascade^MI^49506^USA^P|^PRN^PH^^^616^9459717ORC|RE||BC93J2932.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC93J2932.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||19515-0901-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0901-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V23D2940^^^AIRA-TEST^MR||CoryellAIRA^BirgitAIRA^Francesca^^^^L|KarlssonAIRA^MarleneAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1878 Dluis Cir^^GR^MI^49518^USA^P||^PRN^PH^^^616^8331962|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoryellAIRA^KarlssonAIRA^^^^^L|MTH^Mother^HL70063|1878 Dluis Cir^^GR^MI^49518^USA^P|^PRN^PH^^^616^8331962ORC|RE||BV23D2940.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV23D2940.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||19515-0901-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0903-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T61Z2951^^^AIRA-TEST^MR||EnaAIRA^KamboAIRA^Marilee^^^^L|ButlerAIRA^LukinaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1063 Wlkmaar Ave^^Rose City^MI^48654^USA^P||^PRN^PH^^^989^9560569|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EnaAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1063 Wlkmaar Ave^^Rose City^MI^48654^USA^P|^PRN^PH^^^989^9560569ORC|RE||BT61Z2951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT61Z2951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||19515-0903-01^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0903-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T82A2959^^^AIRA-TEST^MR||YakimaAIRA^ClaireAIRA^Yavonna^^^^L|WhitleyAIRA^JoyanneAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1630 Procent Ln^^Kenton^MI^49967^USA^P||^PRN^PH^^^906^2432399|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YakimaAIRA^WhitleyAIRA^^^^^L|MTH^Mother^HL70063|1630 Procent Ln^^Kenton^MI^49967^USA^P|^PRN^PH^^^906^2432399ORC|RE||BT82A2959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT82A2959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||19515-0903-11^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0908-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L28X2967^^^AIRA-TEST^MR||LaceyAIRA^PriscillaAIRA^Reese^^^^L|NorthumberlandAIRA^EileenAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1988 Aennep Ln^^Clinton Township^MI^48036^USA^P||^PRN^PH^^^586^4428815|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LaceyAIRA^NorthumberlandAIRA^^^^^L|MTH^Mother^HL70063|1988 Aennep Ln^^Clinton Township^MI^48036^USA^P|^PRN^PH^^^586^4428815ORC|RE||BL28X2967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL28X2967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||19515-0908-41^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0908-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H38F2972^^^AIRA-TEST^MR||Olsen LeeAIRA^MadronaAIRA^Siobhan^^^^L|ErieAIRA^CirceAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1383 Oollumerland en Nieuwkruisland Ave^^Point Elizabeth^MI^48725^USA^P||^PRN^PH^^^989^9441999|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Olsen LeeAIRA^ErieAIRA^^^^^L|MTH^Mother^HL70063|1383 Oollumerland en Nieuwkruisland Ave^^Point Elizabeth^MI^48725^USA^P|^PRN^PH^^^989^9441999ORC|RE||BH38F2972.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH38F2972.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||19515-0908-52^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0909-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P37V2980^^^AIRA-TEST^MR||AlexanderAIRA^DikranouhiAIRA^Yukiko^^^^L|BradfordAIRA^AkankeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1572 Sittenseradiel Cir^^Rockland^MI^49960^USA^P||^PRN^PH^^^906^9146917|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlexanderAIRA^BradfordAIRA^^^^^L|MTH^Mother^HL70063|1572 Sittenseradiel Cir^^Rockland^MI^49960^USA^P|^PRN^PH^^^906^9146917ORC|RE||BP37V2980.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP37V2980.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-0909-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0909-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E73S2991^^^AIRA-TEST^MR||MedinaAIRA^Ann-MargretAIRA^Maura^^^^L|SulitAIRA^MakennaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1632 Mtichtse Vecht Ln^^Vernon City^MI^48429^USA^P||^PRN^PH^^^989^4110795|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MedinaAIRA^SulitAIRA^^^^^L|MTH^Mother^HL70063|1632 Mtichtse Vecht Ln^^Vernon City^MI^48429^USA^P|^PRN^PH^^^989^4110795ORC|RE||BE73S2991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE73S2991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-0909-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0912-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X51R2999^^^AIRA-TEST^MR||PintoAIRA^SusanAIRA^Tacita^^^^L|PetersenAIRA^ElyshiaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1745 Ben Boer Ln^^Port Huron^MI^48060^USA^P||^PRN^PH^^^810^7745628|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PintoAIRA^PetersenAIRA^^^^^L|MTH^Mother^HL70063|1745 Ben Boer Ln^^Port Huron^MI^48060^USA^P|^PRN^PH^^^810^7745628ORC|RE||BX51R2999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX51R2999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||19515-0912-41^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-0912-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X56L3007^^^AIRA-TEST^MR||HawkeAIRA^ElyseAIRA^Binda^^^^L|SundeAIRA^JulesAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1165 Nollumerland en Nieuwkruisland Pl^^Cooks^MI^49817^USA^P||^PRN^PH^^^906^7871875|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HawkeAIRA^SundeAIRA^^^^^L|MTH^Mother^HL70063|1165 Nollumerland en Nieuwkruisland Pl^^Cooks^MI^49817^USA^P|^PRN^PH^^^906^7871875ORC|RE||BX56L3007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX56L3007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||19515-0912-52^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-21695-0413-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q33C3015^^^AIRA-TEST^MR||SponlandAIRA^MarikaAIRA^Lynette^^^^L|GreeneAIRA^SallyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1602 Lopen Ave^^Grawn^MI^49637^USA^P||^PRN^PH^^^231^6197563|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SponlandAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1602 Lopen Ave^^Grawn^MI^49637^USA^P|^PRN^PH^^^231^6197563ORC|RE||BQ33C3015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ33C3015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21695-0413-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0010-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R70N3020^^^AIRA-TEST^MR||CarrollAIRA^ChristineAIRA^Abelia^^^^L|MartinAIRA^AbriannaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1896 Dilburg Ln^^Saint Clair^MI^48079^USA^P||^PRN^PH^^^810^5582147|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarrollAIRA^MartinAIRA^^^^^L|MTH^Mother^HL70063|1896 Dilburg Ln^^Saint Clair^MI^48079^USA^P|^PRN^PH^^^810^5582147ORC|RE||BR70N3020.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR70N3020.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||33332-0010-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0013-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G01C3028^^^AIRA-TEST^MR||LeslieAIRA^OrtensiaAIRA^Kala^^^^L|WardleAIRA^IsabellAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1889 Bochem Ln^^Battle Creek^MI^49037^USA^P||^PRN^PH^^^269^6672247|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeslieAIRA^WardleAIRA^^^^^L|MTH^Mother^HL70063|1889 Bochem Ln^^Battle Creek^MI^49037^USA^P|^PRN^PH^^^269^6672247ORC|RE||BG01C3028.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG01C3028.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||33332-0013-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0013-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T06V3039^^^AIRA-TEST^MR||FrioAIRA^CarmenAIRA^Geraldine^^^^L|HardinAIRA^RoisinAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1628 Rulemborg St^^Genoa Township^MI^48116^USA^P||^PRN^PH^^^810^9815101|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FrioAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1628 Rulemborg St^^Genoa Township^MI^48116^USA^P|^PRN^PH^^^810^9815101ORC|RE||BT06V3039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT06V3039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||33332-0013-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0014-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P87Q3047^^^AIRA-TEST^MR||BolgenAIRA^SuzyAIRA^Ilena^^^^L|WillacyAIRA^YoselinAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1377 Kederweert St^^Houghton^MI^49931^USA^P||^PRN^PH^^^906^9835495|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BolgenAIRA^WillacyAIRA^^^^^L|MTH^Mother^HL70063|1377 Kederweert St^^Houghton^MI^49931^USA^P|^PRN^PH^^^906^9835495ORC|RE||BP87Q3047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP87Q3047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||33332-0014-01^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0014-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G24N3055^^^AIRA-TEST^MR||Box ButteAIRA^PangariAIRA^Suchi^^^^L|BorthroydAIRA^VerenaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1650 Hoerden St^^Niles^MI^49120^USA^P||^PRN^PH^^^269^3203338|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Box ButteAIRA^BorthroydAIRA^^^^^L|MTH^Mother^HL70063|1650 Hoerden St^^Niles^MI^49120^USA^P|^PRN^PH^^^269^3203338ORC|RE||BG24N3055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG24N3055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||33332-0014-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0015-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W60H3063^^^AIRA-TEST^MR||HarrisonAIRA^MelinaAIRA^Marla^^^^L|CedarAIRA^AlisonAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1033 Heet Cir^^Redford Township^MI^48240^USA^P||^PRN^PH^^^313^8313108|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^CedarAIRA^^^^^L|MTH^Mother^HL70063|1033 Heet Cir^^Redford Township^MI^48240^USA^P|^PRN^PH^^^313^8313108ORC|RE||BW60H3063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW60H3063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||33332-0015-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0015-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O70I3068^^^AIRA-TEST^MR||SiouxAIRA^EdmeAIRA^Jayani^^^^L|AldridgeAIRA^RivkaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1687 Zarum Pl^^Traverse City^MI^49685^USA^P||^PRN^PH^^^231^8781303|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiouxAIRA^AldridgeAIRA^^^^^L|MTH^Mother^HL70063|1687 Zarum Pl^^Traverse City^MI^49685^USA^P|^PRN^PH^^^231^8781303ORC|RE||BO70I3068.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO70I3068.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||33332-0015-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0016-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R85Z3076^^^AIRA-TEST^MR||BreckinridgeAIRA^BrunaAIRA^Taraji^^^^L|AdairAIRA^KathrynAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1602 Denkum Cir^^East Grand Rapids^MI^49546^USA^P||^PRN^PH^^^616^3054230|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BreckinridgeAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1602 Denkum Cir^^East Grand Rapids^MI^49546^USA^P|^PRN^PH^^^616^3054230ORC|RE||BR85Z3076.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR85Z3076.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0016-01^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0016-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z46D3087^^^AIRA-TEST^MR||MurphyAIRA^DorcasAIRA^Sushmita^^^^L|IsaksonAIRA^SavinaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1647 Judwest-Fryslan Ln^^Ferrysburg^MI^49409^USA^P||^PRN^PH^^^616^7085527|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MurphyAIRA^IsaksonAIRA^^^^^L|MTH^Mother^HL70063|1647 Judwest-Fryslan Ln^^Ferrysburg^MI^49409^USA^P|^PRN^PH^^^616^7085527ORC|RE||BZ46D3087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ46D3087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0016-02^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0017-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y24U3095^^^AIRA-TEST^MR||ColumbiaAIRA^ChristalAIRA^Lorena^^^^L|McCrearyAIRA^KyraAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1459 Berwerderadeel Ln^^Lansing^MI^48915^USA^P||^PRN^PH^^^517^7320154|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColumbiaAIRA^McCrearyAIRA^^^^^L|MTH^Mother^HL70063|1459 Berwerderadeel Ln^^Lansing^MI^48915^USA^P|^PRN^PH^^^517^7320154ORC|RE||BY24U3095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY24U3095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0017-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0017-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L96L3103^^^AIRA-TEST^MR||DalyAIRA^BelladonnaAIRA^Asia^^^^L|OttawaAIRA^MelaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1015 Lilburg Ave^^Orion Township^MI^48360^USA^P||^PRN^PH^^^248^5846326|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DalyAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1015 Lilburg Ave^^Orion Township^MI^48360^USA^P|^PRN^PH^^^248^5846326ORC|RE||BL96L3103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL96L3103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0017-02^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0018-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O55W3111^^^AIRA-TEST^MR||HamiltonAIRA^SigrunAIRA^Kenyatta^^^^L|PurolaAIRA^AnkeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1517 Ware Cir^^Rockford^MI^49341^USA^P||^PRN^PH^^^616^4039973|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HamiltonAIRA^PurolaAIRA^^^^^L|MTH^Mother^HL70063|1517 Ware Cir^^Rockford^MI^49341^USA^P|^PRN^PH^^^616^4039973ORC|RE||BO55W3111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO55W3111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-0018-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0018-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M79F3116^^^AIRA-TEST^MR||MultnomahAIRA^ClaraAIRA^Liani^^^^L|Presque IsleAIRA^UshaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1330 Naadhoeke Pl^^Redford Township^MI^48239^USA^P||^PRN^PH^^^734^4491095|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MultnomahAIRA^Presque IsleAIRA^^^^^L|MTH^Mother^HL70063|1330 Naadhoeke Pl^^Redford Township^MI^48239^USA^P|^PRN^PH^^^734^4491095ORC|RE||BM79F3116.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM79F3116.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-0018-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0110-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N62O3124^^^AIRA-TEST^MR||CarrollAIRA^BrennaAIRA^Aubrey^^^^L|HutchinsonAIRA^TirionAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1379 Teeuwarden St^^Ypsilanti^MI^48198^USA^P||^PRN^PH^^^734^9503918|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarrollAIRA^HutchinsonAIRA^^^^^L|MTH^Mother^HL70063|1379 Teeuwarden St^^Ypsilanti^MI^48198^USA^P|^PRN^PH^^^734^9503918ORC|RE||BN62O3124.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN62O3124.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||33332-0110-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0113-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T18H3135^^^AIRA-TEST^MR||BanderaAIRA^ArdeliaAIRA^Bristol^^^^L|GuadalupeAIRA^CarlaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1116 Coensdrecht Ave^^Rives Junction^MI^49277^USA^P||^PRN^PH^^^517^3718971|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BanderaAIRA^GuadalupeAIRA^^^^^L|MTH^Mother^HL70063|1116 Coensdrecht Ave^^Rives Junction^MI^49277^USA^P|^PRN^PH^^^517^3718971ORC|RE||BT18H3135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT18H3135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||33332-0113-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0113-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E11X3143^^^AIRA-TEST^MR||YakimaAIRA^KaliskaAIRA^Manya^^^^L|PersonAIRA^FilomeneAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1874 Uude IJsselstreek Cir^^Powers^MI^49874^USA^P||^PRN^PH^^^906^7561337|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YakimaAIRA^PersonAIRA^^^^^L|MTH^Mother^HL70063|1874 Uude IJsselstreek Cir^^Powers^MI^49874^USA^P|^PRN^PH^^^906^7561337ORC|RE||BE11X3143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE11X3143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||33332-0113-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0114-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O53O3151^^^AIRA-TEST^MR||BellAIRA^KailynAIRA^Melany^^^^L|BrackenAIRA^ZaylinAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1208 Deere Pl^^Mulliken^MI^48861^USA^P||^PRN^PH^^^517^5145768|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BellAIRA^BrackenAIRA^^^^^L|MTH^Mother^HL70063|1208 Deere Pl^^Mulliken^MI^48861^USA^P|^PRN^PH^^^517^5145768ORC|RE||BO53O3151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO53O3151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||33332-0114-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0114-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D82H3159^^^AIRA-TEST^MR||BlancoAIRA^AriannaAIRA^Kyndall^^^^L|RockAIRA^TegwenAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1349 Sneeuw Pl^^Whitmore Lake^MI^48189^USA^P||^PRN^PH^^^734^8303728|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlancoAIRA^RockAIRA^^^^^L|MTH^Mother^HL70063|1349 Sneeuw Pl^^Whitmore Lake^MI^48189^USA^P|^PRN^PH^^^734^8303728ORC|RE||BD82H3159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD82H3159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||33332-0114-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0115-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R34Y3164^^^AIRA-TEST^MR||WascoAIRA^KaitlinAIRA^Kamna^^^^L|KennebecAIRA^AnvitaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1163 Doen Cir^^Gibraltar^MI^48173^USA^P||^PRN^PH^^^734^5192558|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WascoAIRA^KennebecAIRA^^^^^L|MTH^Mother^HL70063|1163 Doen Cir^^Gibraltar^MI^48173^USA^P|^PRN^PH^^^734^5192558ORC|RE||BR34Y3164.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR34Y3164.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||33332-0115-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0115-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T56Z3172^^^AIRA-TEST^MR||JacksonAIRA^SarojaAIRA^Aubree^^^^L|ProvidenceAIRA^IndaliaiAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1091 Oexel Ln^^Stanwood^MI^49346^USA^P||^PRN^PH^^^231^3549668|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^ProvidenceAIRA^^^^^L|MTH^Mother^HL70063|1091 Oexel Ln^^Stanwood^MI^49346^USA^P|^PRN^PH^^^231^3549668ORC|RE||BT56Z3172.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT56Z3172.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||33332-0115-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0116-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V61N3183^^^AIRA-TEST^MR||FultonAIRA^UnityAIRA^Lorna^^^^L|KentonAIRA^KylieAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1147 Srmelo Cir^^Curran^MI^48728^USA^P||^PRN^PH^^^989^7014393|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FultonAIRA^KentonAIRA^^^^^L|MTH^Mother^HL70063|1147 Srmelo Cir^^Curran^MI^48728^USA^P|^PRN^PH^^^989^7014393ORC|RE||BV61N3183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV61N3183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0116-10^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0116-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H07O3191^^^AIRA-TEST^MR||HarrisonAIRA^BlazeAIRA^Merinda^^^^L|LeeAIRA^JirraAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1938 Euenen Cir^^Southeast^MI^48529^USA^P||^PRN^PH^^^810^3115957|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1938 Euenen Cir^^Southeast^MI^48529^USA^P|^PRN^PH^^^810^3115957ORC|RE||BH07O3191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH07O3191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0116-11^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P20J3199^^^AIRA-TEST^MR||JakobsenAIRA^GiaAIRA^Abilene^^^^L|BakeyAIRA^KiahAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1630 Pudwest-Fryslan Ln^^Casco^MI^48064^USA^P||^PRN^PH^^^810^2316386|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JakobsenAIRA^BakeyAIRA^^^^^L|MTH^Mother^HL70063|1630 Pudwest-Fryslan Ln^^Casco^MI^48064^USA^P|^PRN^PH^^^810^2316386ORC|RE||BP20J3199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP20J3199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0117-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0117-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R82F3207^^^AIRA-TEST^MR||EllisAIRA^DivaAIRA^Linda^^^^L|PatricioAIRA^AfinaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1787 Tcheemda Cir^^Marshall^MI^49068^USA^P||^PRN^PH^^^269^3359463|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EllisAIRA^PatricioAIRA^^^^^L|MTH^Mother^HL70063|1787 Tcheemda Cir^^Marshall^MI^49068^USA^P|^PRN^PH^^^269^3359463ORC|RE||BR82F3207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR82F3207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0117-11^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0118-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N70F3212^^^AIRA-TEST^MR||ShelbyAIRA^DebbieAIRA^Allie^^^^L|SivertsenAIRA^PakunaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1746 Ooerendaal Pl^^Grand Rapids^MI^49514^USA^P||^PRN^PH^^^616^6674848|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShelbyAIRA^SivertsenAIRA^^^^^L|MTH^Mother^HL70063|1746 Ooerendaal Pl^^Grand Rapids^MI^49514^USA^P|^PRN^PH^^^616^6674848ORC|RE||BN70F3212.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN70F3212.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-0118-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0118-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N14H3220^^^AIRA-TEST^MR||IoscoAIRA^AdelynAIRA^Gisela^^^^L|RichardsonAIRA^NarethaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1688 Tlochteren Cir^^Wayland^MI^49348^USA^P||^PRN^PH^^^269^6267825|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IoscoAIRA^RichardsonAIRA^^^^^L|MTH^Mother^HL70063|1688 Tlochteren Cir^^Wayland^MI^49348^USA^P|^PRN^PH^^^269^6267825ORC|RE||BN14H3220.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN14H3220.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-0118-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0316-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F11P3231^^^AIRA-TEST^MR||FayetteAIRA^PurvajaAIRA^Magna^^^^L|EllisAIRA^CybillAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1192 Eeder-Betuwe Ave^^Brownstown Township^MI^48174^USA^P||^PRN^PH^^^734^8387721|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FayetteAIRA^EllisAIRA^^^^^L|MTH^Mother^HL70063|1192 Eeder-Betuwe Ave^^Brownstown Township^MI^48174^USA^P|^PRN^PH^^^734^8387721ORC|RE||BF11P3231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF11P3231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0316-01^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0316-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z56Z3239^^^AIRA-TEST^MR||CassAIRA^AyameAIRA^Rana^^^^L|OsceolaAIRA^AmiraAIRA^^^^^M|20161228|F||2106-3^White^CDCREC|1912 Zijfheerenlanden St^^Lansing^MI^48908^USA^P||^PRN^PH^^^517^3314404|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1912 Zijfheerenlanden St^^Lansing^MI^48908^USA^P|^PRN^PH^^^517^3314404ORC|RE||BZ56Z3239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ56Z3239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170428||33332-0316-02^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170428||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0317-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S61V3247^^^AIRA-TEST^MR||WashingtonAIRA^BryleeAIRA^Capri^^^^L|MorrellAIRA^OlindaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1057 Hchijndel Ln^^Mears^MI^49436^USA^P||^PRN^PH^^^231^7443878|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^MorrellAIRA^^^^^L|MTH^Mother^HL70063|1057 Hchijndel Ln^^Mears^MI^49436^USA^P|^PRN^PH^^^231^7443878ORC|RE||BS61V3247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS61V3247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0317-01^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0317-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P86G3252^^^AIRA-TEST^MR||HancockAIRA^LoriAIRA^Kelsie^^^^L|CrawfordAIRA^KomalAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1120 Zwart Ave^^Marshall^MI^49069^USA^P||^PRN^PH^^^269^2887131|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1120 Zwart Ave^^Marshall^MI^49069^USA^P|^PRN^PH^^^269^2887131ORC|RE||BP86G3252.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP86G3252.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0317-02^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0318-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L09A3260^^^AIRA-TEST^MR||HancockAIRA^ZadaAIRA^Thirza^^^^L|TuscolaAIRA^RhondaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1500 Bissewaard Pl^^State Farm Ins^MI^49069^USA^P||^PRN^PH^^^269^6449399|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^TuscolaAIRA^^^^^L|MTH^Mother^HL70063|1500 Bissewaard Pl^^State Farm Ins^MI^49069^USA^P|^PRN^PH^^^269^6449399ORC|RE||BL09A3260.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL09A3260.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-0318-01^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0318-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X17K3271^^^AIRA-TEST^MR||MarionAIRA^AnanaAIRA^Dristi^^^^L|NobleAIRA^KorraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1557 Wlissingen Cir^^MI Metro^MI^48340^USA^P||^PRN^PH^^^248^4837755|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarionAIRA^NobleAIRA^^^^^L|MTH^Mother^HL70063|1557 Wlissingen Cir^^MI Metro^MI^48340^USA^P|^PRN^PH^^^248^4837755ORC|RE||BX17K3271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX17K3271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-0318-02^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0416-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X49U3279^^^AIRA-TEST^MR||WascoAIRA^AnaniAIRA^Kaitlin^^^^L|ChristianAIRA^LevanaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1993 Nangedijk St^^Saint Clr Shores^MI^48081^USA^P||^PRN^PH^^^586^5910900|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WascoAIRA^ChristianAIRA^^^^^L|MTH^Mother^HL70063|1993 Nangedijk St^^Saint Clr Shores^MI^48081^USA^P|^PRN^PH^^^586^5910900ORC|RE||BX49U3279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX49U3279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0416-10^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0416-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G94N3287^^^AIRA-TEST^MR||CoshoctonAIRA^AltaAIRA^Ailsa^^^^L|AlbrechtsonAIRA^SapphireAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1507 Zuurstof St^^Argyle^MI^48410^USA^P||^PRN^PH^^^989^4689369|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoshoctonAIRA^AlbrechtsonAIRA^^^^^L|MTH^Mother^HL70063|1507 Zuurstof St^^Argyle^MI^48410^USA^P|^PRN^PH^^^989^4689369ORC|RE||BG94N3287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG94N3287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0416-11^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0417-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L80D3292^^^AIRA-TEST^MR||WapelloAIRA^MollieAIRA^Falda^^^^L|KnottAIRA^TegwenAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1421 Stuk Ln^^Wyoming^MI^49418^USA^P||^PRN^PH^^^616^6396422|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WapelloAIRA^KnottAIRA^^^^^L|MTH^Mother^HL70063|1421 Stuk Ln^^Wyoming^MI^49418^USA^P|^PRN^PH^^^616^6396422ORC|RE||BL80D3292.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL80D3292.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0417-10^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0417-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A69Z3300^^^AIRA-TEST^MR||PasoAIRA^MeinwenAIRA^Hippolyta^^^^L|Nez PerceAIRA^BijalAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1341 Oe Marne Cir^^Climax^MI^49034^USA^P||^PRN^PH^^^269^5842978|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PasoAIRA^Nez PerceAIRA^^^^^L|MTH^Mother^HL70063|1341 Oe Marne Cir^^Climax^MI^49034^USA^P|^PRN^PH^^^269^5842978ORC|RE||BA69Z3300.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA69Z3300.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0417-11^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V22P3311^^^AIRA-TEST^MR||EdmonsonAIRA^DivyaAIRA^Sulema^^^^L|HutchinsonAIRA^BebeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1622 Appingedam St^^Deerton^MI^49822^USA^P||^PRN^PH^^^906^7569779|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EdmonsonAIRA^HutchinsonAIRA^^^^^L|MTH^Mother^HL70063|1622 Appingedam St^^Deerton^MI^49822^USA^P|^PRN^PH^^^906^7569779ORC|RE||BV22P3311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV22P3311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-0418-10^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0418-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N50F3319^^^AIRA-TEST^MR||LakeAIRA^ZuriaaAIRA^Keren^^^^L|CamasAIRA^NadiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1174 Metalen St^^Hickory Corners^MI^49060^USA^P||^PRN^PH^^^269^2123279|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LakeAIRA^CamasAIRA^^^^^L|MTH^Mother^HL70063|1174 Metalen St^^Hickory Corners^MI^49060^USA^P|^PRN^PH^^^269^2123279ORC|RE||BN50F3319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN50F3319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-0418-11^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0519-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B35Q3327^^^AIRA-TEST^MR||PowellAIRA^MoraAIRA^Sancia^^^^L|LeonardAIRA^MickieAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1148 Spel Pl^^Fowler^MI^48835^USA^P||^PRN^PH^^^989^5176522|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PowellAIRA^LeonardAIRA^^^^^L|MTH^Mother^HL70063|1148 Spel Pl^^Fowler^MI^48835^USA^P|^PRN^PH^^^989^5176522ORC|RE||BB35Q3327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB35Q3327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||33332-0519-01^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0519-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P64G3335^^^AIRA-TEST^MR||OwyheeAIRA^FloyAIRA^Nadya^^^^L|LeonAIRA^ConsuelaAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1022 Keusel-De Mierden St^^Ida^MI^48140^USA^P||^PRN^PH^^^734^7386297|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwyheeAIRA^LeonAIRA^^^^^L|MTH^Mother^HL70063|1022 Keusel-De Mierden St^^Ida^MI^48140^USA^P|^PRN^PH^^^734^7386297ORC|RE||BP64G3335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP64G3335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||33332-0519-25^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-0629-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K32A3340^^^AIRA-TEST^MR||TrinityAIRA^GenesisAIRA^Mya^^^^L|BastropAIRA^HaraldaAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1767 Glphen-Chaam Cir^^Hart^MI^49420^USA^P||^PRN^PH^^^231^7883834|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TrinityAIRA^BastropAIRA^^^^^L|MTH^Mother^HL70063|1767 Glphen-Chaam Cir^^Hart^MI^49420^USA^P|^PRN^PH^^^231^7883834ORC|RE||BK32A3340.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK32A3340.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||33332-0629-10^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515-0001-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y68F3348^^^AIRA-TEST^MR||MorrisAIRA^CourtneyAIRA^Cathleen^^^^L|WhitmanAIRA^TheodosiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1129 Brummen Ln^^Prudenville^MI^48651^USA^P||^PRN^PH^^^989^9393987|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorrisAIRA^WhitmanAIRA^^^^^L|MTH^Mother^HL70063|1129 Brummen Ln^^Prudenville^MI^48651^USA^P|^PRN^PH^^^989^9393987ORC|RE||BY68F3348.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY68F3348.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515-0001-00^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||INT^Intercell Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515-0001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O56I3359^^^AIRA-TEST^MR||ApacheAIRA^SevillaAIRA^Shirin^^^^L|LuceAIRA^CireaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1457 Woord-Beveland St^^Radio Bible Class^MI^49555^USA^P||^PRN^PH^^^616^5525398|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ApacheAIRA^LuceAIRA^^^^^L|MTH^Mother^HL70063|1457 Woord-Beveland St^^Radio Bible Class^MI^49555^USA^P|^PRN^PH^^^616^5525398ORC|RE||BO56I3359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO56I3359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515-0001-01^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||VAL^Valneva^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515-0002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z25G3367^^^AIRA-TEST^MR||KinneyAIRA^JaunieAIRA^Majondra^^^^L|DixonAIRA^JenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1686 Vomeren St^^Beaver Island^MI^49782^USA^P||^PRN^PH^^^906^8377361|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KinneyAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1686 Vomeren St^^Beaver Island^MI^49782^USA^P|^PRN^PH^^^906^8377361ORC|RE||BZ25G3367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ25G3367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515-0002-01^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||VAL^Valneva^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0012-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D69K3375^^^AIRA-TEST^MR||Palo AltoAIRA^PamelaAIRA^Aileen^^^^L|ButlerAIRA^AshimaAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1517 Aankomen Cir^^Au Sable^MI^48750^USA^P||^PRN^PH^^^989^5344839|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Palo AltoAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1517 Aankomen Cir^^Au Sable^MI^48750^USA^P|^PRN^PH^^^989^5344839ORC|RE||BD69K3375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD69K3375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||42874-0012-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0012-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O62L3383^^^AIRA-TEST^MR||DanielsonAIRA^KenleyAIRA^Terrylyn^^^^L|BarrenAIRA^JaimieAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1344 Loeree-Overflakkee Ln^^Glen Arbor^MI^49636^USA^P||^PRN^PH^^^231^2025889|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DanielsonAIRA^BarrenAIRA^^^^^L|MTH^Mother^HL70063|1344 Loeree-Overflakkee Ln^^Glen Arbor^MI^49636^USA^P|^PRN^PH^^^231^2025889ORC|RE||BO62L3383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO62L3383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||42874-0012-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0013-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q38X3388^^^AIRA-TEST^MR||BuckshornAIRA^DixieAIRA^Orna^^^^L|MohaveAIRA^TamaliAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1789 Roerendaal St^^Dafter^MI^49724^USA^P||^PRN^PH^^^906^5941946|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BuckshornAIRA^MohaveAIRA^^^^^L|MTH^Mother^HL70063|1789 Roerendaal St^^Dafter^MI^49724^USA^P|^PRN^PH^^^906^5941946ORC|RE||BQ38X3388.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ38X3388.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||42874-0013-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0013-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O97U3396^^^AIRA-TEST^MR||JacintoAIRA^RonniAIRA^Jeanne^^^^L|LenbergAIRA^KianaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1147 Pond Ln^^Farmington Hills^MI^48335^USA^P||^PRN^PH^^^248^5264034|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacintoAIRA^LenbergAIRA^^^^^L|MTH^Mother^HL70063|1147 Pond Ln^^Farmington Hills^MI^48335^USA^P|^PRN^PH^^^248^5264034ORC|RE||BO97U3396.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO97U3396.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||42874-0013-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0014-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D37F3404^^^AIRA-TEST^MR||JacksonAIRA^ElainaAIRA^Kamakshi^^^^L|BrownAIRA^JyotsnaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1405 Pldebroek Cir^^Trout Creek^MI^49967^USA^P||^PRN^PH^^^906^3754086|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1405 Pldebroek Cir^^Trout Creek^MI^49967^USA^P|^PRN^PH^^^906^3754086ORC|RE||BD37F3404.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD37F3404.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||42874-0014-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0014-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A75X3415^^^AIRA-TEST^MR||CassAIRA^MarlissAIRA^Venetia^^^^L|OttawaAIRA^BeverleyAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1015 Wlburg Ln^^Fairgrove^MI^48733^USA^P||^PRN^PH^^^989^2032369|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1015 Wlburg Ln^^Fairgrove^MI^48733^USA^P|^PRN^PH^^^989^2032369ORC|RE||BA75X3415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA75X3415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||42874-0014-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0015-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T23M3423^^^AIRA-TEST^MR||SullivanAIRA^NanakoAIRA^Ali^^^^L|Saint JosephAIRA^AloysiaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1610 Kaag en Braassem St^^Brownstwn Township^MI^48174^USA^P||^PRN^PH^^^734^4027572|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SullivanAIRA^Saint JosephAIRA^^^^^L|MTH^Mother^HL70063|1610 Kaag en Braassem St^^Brownstwn Township^MI^48174^USA^P|^PRN^PH^^^734^4027572ORC|RE||BT23M3423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT23M3423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||42874-0015-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0015-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P17U3428^^^AIRA-TEST^MR||WashitaAIRA^ArianaAIRA^Hollye^^^^L|StarkAIRA^AuroraAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1680 Arts Pl^^Sang^MI^48045^USA^P||^PRN^PH^^^586^5848398|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashitaAIRA^StarkAIRA^^^^^L|MTH^Mother^HL70063|1680 Arts Pl^^Sang^MI^48045^USA^P|^PRN^PH^^^586^5848398ORC|RE||BP17U3428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP17U3428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||42874-0015-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0016-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A94T3436^^^AIRA-TEST^MR||PickawayAIRA^KennaAIRA^Rolanda^^^^L|DonleyAIRA^JoannaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1654 Aeeuwarden Ln^^Lake Odessa^MI^48849^USA^P||^PRN^PH^^^616^3331782|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PickawayAIRA^DonleyAIRA^^^^^L|MTH^Mother^HL70063|1654 Aeeuwarden Ln^^Lake Odessa^MI^48849^USA^P|^PRN^PH^^^616^3331782ORC|RE||BA94T3436.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA94T3436.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||42874-0016-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0016-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O89N3447^^^AIRA-TEST^MR||CochranAIRA^HarrietAIRA^Charissa^^^^L|NolanAIRA^RhiannonAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1983 Mchagen St^^Shingleton^MI^49884^USA^P||^PRN^PH^^^906^3179144|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CochranAIRA^NolanAIRA^^^^^L|MTH^Mother^HL70063|1983 Mchagen St^^Shingleton^MI^49884^USA^P|^PRN^PH^^^906^3179144ORC|RE||BO89N3447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO89N3447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||42874-0016-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0017-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T96H3455^^^AIRA-TEST^MR||GossAIRA^AnkitaAIRA^Atarah^^^^L|WalcottAIRA^EsperanzaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1553 Binnenmaas Pl^^Millington^MI^48746^USA^P||^PRN^PH^^^989^4185351|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GossAIRA^WalcottAIRA^^^^^L|MTH^Mother^HL70063|1553 Binnenmaas Pl^^Millington^MI^48746^USA^P|^PRN^PH^^^989^4185351ORC|RE||BT96H3455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT96H3455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||42874-0017-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0017-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y91R3463^^^AIRA-TEST^MR||MeigsAIRA^SagaraAIRA^Kestrel^^^^L|SnyderAIRA^ShayndelAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1263 Zoudrichem Pl^^Wyoming^MI^49548^USA^P||^PRN^PH^^^616^5543310|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeigsAIRA^SnyderAIRA^^^^^L|MTH^Mother^HL70063|1263 Zoudrichem Pl^^Wyoming^MI^49548^USA^P|^PRN^PH^^^616^5543310ORC|RE||BY91R3463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY91R3463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||42874-0017-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0116-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B39F3468^^^AIRA-TEST^MR||McClungAIRA^LidaAIRA^Natalya^^^^L|MahaskaAIRA^YavonnaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1043 Epe Ave^^Cornell^MI^49819^USA^P||^PRN^PH^^^906^7785430|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McClungAIRA^MahaskaAIRA^^^^^L|MTH^Mother^HL70063|1043 Epe Ave^^Cornell^MI^49819^USA^P|^PRN^PH^^^906^7785430ORC|RE||BB39F3468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB39F3468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||42874-0116-01^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0117-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B27G3476^^^AIRA-TEST^MR||WotherspoonAIRA^ElinaAIRA^Sheena^^^^L|UmatillaAIRA^AngelaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1697 Lellingwedde St^^Remus^MI^49340^USA^P||^PRN^PH^^^989^9890267|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WotherspoonAIRA^UmatillaAIRA^^^^^L|MTH^Mother^HL70063|1697 Lellingwedde St^^Remus^MI^49340^USA^P|^PRN^PH^^^989^9890267ORC|RE||BB27G3476.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB27G3476.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||42874-0117-01^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-0117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z42K3487^^^AIRA-TEST^MR||GreenAIRA^TooraAIRA^Ximena^^^^L|MedinaAIRA^GilAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1809 Weder-Betuwe St^^Farmington Hls^MI^48335^USA^P||^PRN^PH^^^248^6572166|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenAIRA^MedinaAIRA^^^^^L|MTH^Mother^HL70063|1809 Weder-Betuwe St^^Farmington Hls^MI^48335^USA^P|^PRN^PH^^^248^6572166ORC|RE||BZ42K3487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ42K3487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||42874-0117-10^FLUBLOK, QUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528-0002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S76H3495^^^AIRA-TEST^MR||DubuqueAIRA^DanikaAIRA^Kiersten^^^^L|MaverickAIRA^HermioneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1100 Baarbeek Cir^^Saginaw^MI^48638^USA^P||^PRN^PH^^^989^7190732|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DubuqueAIRA^MaverickAIRA^^^^^L|MTH^Mother^HL70063|1100 Baarbeek Cir^^Saginaw^MI^48638^USA^P|^PRN^PH^^^989^7190732ORC|RE||BS76H3495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS76H3495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528-0002-01^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528-0002-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U27V3503^^^AIRA-TEST^MR||GrayAIRA^DierdreAIRA^Satoko^^^^L|AlbrechtsonAIRA^FujitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1950 Laag en Braassem St^^Wilson^MI^49896^USA^P||^PRN^PH^^^906^7333489|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrayAIRA^AlbrechtsonAIRA^^^^^L|MTH^Mother^HL70063|1950 Laag en Braassem St^^Wilson^MI^49896^USA^P|^PRN^PH^^^906^7333489ORC|RE||BU27V3503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU27V3503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528-0002-05^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528-0003-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D50Q3508^^^AIRA-TEST^MR||VenangoAIRA^AvrilAIRA^Cissy^^^^L|MarshallAIRA^ClarindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1629 Oeemster Pl^^Perkins^MI^49872^USA^P||^PRN^PH^^^906^2657349|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VenangoAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1629 Oeemster Pl^^Perkins^MI^49872^USA^P|^PRN^PH^^^906^2657349ORC|RE||BD50Q3508.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD50Q3508.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528-0003-01^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528-0003-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N25J3516^^^AIRA-TEST^MR||CassAIRA^HonnaAIRA^Waseme^^^^L|GrendalAIRA^HermelindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1443 Zampen Ave^^Lynn Township^MI^48097^USA^P||^PRN^PH^^^810^7115489|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^GrendalAIRA^^^^^L|MTH^Mother^HL70063|1443 Zampen Ave^^Lynn Township^MI^48097^USA^P|^PRN^PH^^^810^7115489ORC|RE||BN25J3516.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN25J3516.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528-0003-05^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-0114-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V93R3527^^^AIRA-TEST^MR||OsageAIRA^SariahAIRA^Panya^^^^L|UpshurAIRA^SarasvatiAIRA^^^^^M|20170630|F||2106-3^White^CDCREC|1597 Nemsmond Ln^^Monroe^MI^48162^USA^P||^PRN^PH^^^734^8325949|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OsageAIRA^UpshurAIRA^^^^^L|MTH^Mother^HL70063|1597 Nemsmond Ln^^Monroe^MI^48162^USA^P|^PRN^PH^^^734^8325949ORC|RE||BV93R3527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV93R3527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171030||46028-0114-01^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171030||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-0114-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X35C3535^^^AIRA-TEST^MR||GrantAIRA^TehyaAIRA^Kairos^^^^L|NewtonAIRA^EveAIRA^^^^^M|20170630|F||2106-3^White^CDCREC|1331 Kesterveld Pl^^Brethren^MI^49619^USA^P||^PRN^PH^^^231^5573864|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrantAIRA^NewtonAIRA^^^^^L|MTH^Mother^HL70063|1331 Kesterveld Pl^^Brethren^MI^49619^USA^P|^PRN^PH^^^231^5573864ORC|RE||BX35C3535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX35C3535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171030||46028-0114-02^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171030||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-0114-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E15Z3543^^^AIRA-TEST^MR||MarquetteAIRA^KeandraAIRA^Neva^^^^L|CherryAIRA^PanyaAIRA^^^^^M|20170630|F||2106-3^White^CDCREC|1704 Scheemda Ave^^Burton^MI^48519^USA^P||^PRN^PH^^^810^8963585|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarquetteAIRA^CherryAIRA^^^^^L|MTH^Mother^HL70063|1704 Scheemda Ave^^Burton^MI^48519^USA^P|^PRN^PH^^^810^8963585ORC|RE||BE15Z3543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE15Z3543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171030||46028-0114-11^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171030||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-0208-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E16O3548^^^AIRA-TEST^MR||BraceyAIRA^SirikitAIRA^Suvrata^^^^L|PerryAIRA^VeronaAIRA^^^^^M|20171228|F||2106-3^White^CDCREC|1368 Voststellingwerf Ln^^Applegate^MI^48401^USA^P||^PRN^PH^^^810^9261686|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BraceyAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1368 Voststellingwerf Ln^^Applegate^MI^48401^USA^P|^PRN^PH^^^810^9261686ORC|RE||BE16O3548.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE16O3548.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180429||46028-0208-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180429||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-0218-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D17D3556^^^AIRA-TEST^MR||FitzpatrickAIRA^VelikaAIRA^Hope^^^^L|BolgenAIRA^ShevaunAIRA^^^^^M|20171228|F||2106-3^White^CDCREC|1412 Oldenzaal St^^Snover^MI^48472^USA^P||^PRN^PH^^^810^4984827|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FitzpatrickAIRA^BolgenAIRA^^^^^L|MTH^Mother^HL70063|1412 Oldenzaal St^^Snover^MI^48472^USA^P|^PRN^PH^^^810^4984827ORC|RE||BD17D3556.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD17D3556.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180429||46028-0218-11^Meningococcal (Groups A) CRM197 Oligosaccharide Co^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180429||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-0219-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P50H3567^^^AIRA-TEST^MR||DallasAIRA^SydelleAIRA^Malila^^^^L|JosephineAIRA^NorahAIRA^^^^^M|20171228|F||2106-3^White^CDCREC|1646 Norger-Odoorn St^^Brandon^MI^48462^USA^P||^PRN^PH^^^248^4928553|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallasAIRA^JosephineAIRA^^^^^L|MTH^Mother^HL70063|1646 Norger-Odoorn St^^Brandon^MI^48462^USA^P|^PRN^PH^^^248^4928553ORC|RE||BP50H3567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP50H3567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180429||46028-0219-11^Meningococcal (Groups C, Y, W-135) CRM197 Oligosac^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180429||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0010-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U27M3575^^^AIRA-TEST^MR||GalliaAIRA^SaritaAIRA^Berenice^^^^L|TriggAIRA^RomildaAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1361 Zoeterwoude Ave^^Ocqueoc^MI^49759^USA^P||^PRN^PH^^^989^8282548|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GalliaAIRA^TriggAIRA^^^^^L|MTH^Mother^HL70063|1361 Zoeterwoude Ave^^Ocqueoc^MI^49759^USA^P|^PRN^PH^^^989^8282548ORC|RE||BU27M3575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU27M3575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0010-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0010-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G25T3583^^^AIRA-TEST^MR||PageAIRA^MatheaAIRA^Aba^^^^L|BrennanAIRA^SuzieAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1503 Breed Ave^^Kalamazoo^MI^49009^USA^P||^PRN^PH^^^269^4081555|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PageAIRA^BrennanAIRA^^^^^L|MTH^Mother^HL70063|1503 Breed Ave^^Kalamazoo^MI^49009^USA^P|^PRN^PH^^^269^4081555ORC|RE||BG25T3583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG25T3583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0010-25^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0010-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F00K3588^^^AIRA-TEST^MR||AndroscogginAIRA^HayleyAIRA^Sissy^^^^L|CaribouAIRA^DietlindeAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1755 He Marne Ave^^East Tawas^MI^48730^USA^P||^PRN^PH^^^989^2820502|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndroscogginAIRA^CaribouAIRA^^^^^L|MTH^Mother^HL70063|1755 He Marne Ave^^East Tawas^MI^48730^USA^P|^PRN^PH^^^989^2820502ORC|RE||BF00K3588.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF00K3588.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0010-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0011-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H21Y3596^^^AIRA-TEST^MR||LeslieAIRA^DioneAIRA^Kalle^^^^L|PinalAIRA^SumeyAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1157 Elst-Wijhe St^^Russell Island^MI^48001^USA^P||^PRN^PH^^^810^7450098|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeslieAIRA^PinalAIRA^^^^^L|MTH^Mother^HL70063|1157 Elst-Wijhe St^^Russell Island^MI^48001^USA^P|^PRN^PH^^^810^7450098ORC|RE||BH21Y3596.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH21Y3596.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0011-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0011-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M25Z3607^^^AIRA-TEST^MR||PlumasAIRA^CarleighAIRA^Christal^^^^L|Red WillowAIRA^BiancaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1283 Kirschot Ave^^Dearborn^MI^48126^USA^P||^PRN^PH^^^313^6655970|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PlumasAIRA^Red WillowAIRA^^^^^L|MTH^Mother^HL70063|1283 Kirschot Ave^^Dearborn^MI^48126^USA^P|^PRN^PH^^^313^6655970ORC|RE||BM25Z3607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM25Z3607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0011-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0012-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I32P3615^^^AIRA-TEST^MR||GrantAIRA^RachelAIRA^Tao^^^^L|TitusAIRA^AraceliAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1206 Npsterland Cir^^Bham^MI^48012^USA^P||^PRN^PH^^^248^2220319|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrantAIRA^TitusAIRA^^^^^L|MTH^Mother^HL70063|1206 Npsterland Cir^^Bham^MI^48012^USA^P|^PRN^PH^^^248^2220319ORC|RE||BI32P3615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI32P3615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0012-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0012-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M27O3623^^^AIRA-TEST^MR||WapelloAIRA^JardenaAIRA^Elga^^^^L|VistanstAIRA^ShailajaAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1492 Lelystad Ave^^Romeo^MI^48065^USA^P||^PRN^PH^^^586^7835079|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WapelloAIRA^VistanstAIRA^^^^^L|MTH^Mother^HL70063|1492 Lelystad Ave^^Romeo^MI^48065^USA^P|^PRN^PH^^^586^7835079ORC|RE||BM27O3623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM27O3623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0012-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0013-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y71D3628^^^AIRA-TEST^MR||CalhounAIRA^ParnikaAIRA^Cypriana^^^^L|McErlaineAIRA^KeraniAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1304 Beschermen Cir^^Ubly^MI^48475^USA^P||^PRN^PH^^^989^6903049|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalhounAIRA^McErlaineAIRA^^^^^L|MTH^Mother^HL70063|1304 Beschermen Cir^^Ubly^MI^48475^USA^P|^PRN^PH^^^989^6903049ORC|RE||BY71D3628.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY71D3628.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0013-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0013-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B52S3636^^^AIRA-TEST^MR||WettilandAIRA^WylieAIRA^Sashi^^^^L|NolanAIRA^BettieAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1999 Scheemda Cir^^Manitou Beach^MI^49253^USA^P||^PRN^PH^^^517^4868372|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WettilandAIRA^NolanAIRA^^^^^L|MTH^Mother^HL70063|1999 Scheemda Cir^^Manitou Beach^MI^49253^USA^P|^PRN^PH^^^517^4868372ORC|RE||BB52S3636.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB52S3636.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0013-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0013-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K40B3647^^^AIRA-TEST^MR||HygensAIRA^GiaAIRA^Amina^^^^L|PatariAIRA^HueAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1334 Kernheze Ln^^Hazel Park^MI^48030^USA^P||^PRN^PH^^^248^5655591|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HygensAIRA^PatariAIRA^^^^^L|MTH^Mother^HL70063|1334 Kernheze Ln^^Hazel Park^MI^48030^USA^P|^PRN^PH^^^248^5655591ORC|RE||BK40B3647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK40B3647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0013-58^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0013-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P85S3655^^^AIRA-TEST^MR||HalsallAIRA^CharlotteAIRA^Akala^^^^L|MohaveAIRA^DakotaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1746 Gerkelland Cir^^Dearborn Heights^MI^48127^USA^P||^PRN^PH^^^313^3495563|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HalsallAIRA^MohaveAIRA^^^^^L|MTH^Mother^HL70063|1746 Gerkelland Cir^^Dearborn Heights^MI^48127^USA^P|^PRN^PH^^^313^3495563ORC|RE||BP85S3655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP85S3655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0013-88^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0014-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F32J3663^^^AIRA-TEST^MR||ChampaignAIRA^AnvitaAIRA^Bhoomi^^^^L|HubbardAIRA^LatishaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1736 Oemsmond St^^Bloomfield Hills^MI^48301^USA^P||^PRN^PH^^^248^7829864|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChampaignAIRA^HubbardAIRA^^^^^L|MTH^Mother^HL70063|1736 Oemsmond St^^Bloomfield Hills^MI^48301^USA^P|^PRN^PH^^^248^7829864ORC|RE||BF32J3663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF32J3663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0014-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0014-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J47S3668^^^AIRA-TEST^MR||LincolnAIRA^AnAIRA^Roxanne^^^^L|AppanooseAIRA^NazaretAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1125 Felfzijl Ave^^Cassopolis^MI^49031^USA^P||^PRN^PH^^^269^4295701|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^AppanooseAIRA^^^^^L|MTH^Mother^HL70063|1125 Felfzijl Ave^^Cassopolis^MI^49031^USA^P|^PRN^PH^^^269^4295701ORC|RE||BJ47S3668.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ47S3668.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0014-88^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0111-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F81Q3676^^^AIRA-TEST^MR||HuronAIRA^MaggieAIRA^Dylan^^^^L|CarterAIRA^KathrynAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1913 Aanraken Ln^^Paw Paw^MI^49079^USA^P||^PRN^PH^^^269^3659987|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HuronAIRA^CarterAIRA^^^^^L|MTH^Mother^HL70063|1913 Aanraken Ln^^Paw Paw^MI^49079^USA^P|^PRN^PH^^^269^3659987ORC|RE||BF81Q3676.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF81Q3676.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0111-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0112-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G42V3687^^^AIRA-TEST^MR||SandstromAIRA^AmadisAIRA^Vienna^^^^L|ComalAIRA^SemraAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1861 Verwerderadeel St^^West Bloomfield^MI^48322^USA^P||^PRN^PH^^^248^3350982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SandstromAIRA^ComalAIRA^^^^^L|MTH^Mother^HL70063|1861 Verwerderadeel St^^West Bloomfield^MI^48322^USA^P|^PRN^PH^^^248^3350982ORC|RE||BG42V3687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG42V3687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0112-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0113-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B81P3695^^^AIRA-TEST^MR||ConnorAIRA^CeceliaAIRA^Ruth^^^^L|UnionAIRA^SumiAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1086 Rudewater Ln^^GR^MI^49514^USA^P||^PRN^PH^^^616^3897441|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ConnorAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1086 Rudewater Ln^^GR^MI^49514^USA^P|^PRN^PH^^^616^3897441ORC|RE||BB81P3695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB81P3695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0113-00^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0113-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z68T3703^^^AIRA-TEST^MR||HarperAIRA^DidoAIRA^Janthina^^^^L|JohnsonAIRA^ShaliniAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1286 Hoogeveen St^^Vandalia^MI^49095^USA^P||^PRN^PH^^^269^6561382|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarperAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1286 Hoogeveen St^^Vandalia^MI^49095^USA^P|^PRN^PH^^^269^6561382ORC|RE||BZ68T3703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ68T3703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0113-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0215-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U02B3708^^^AIRA-TEST^MR||CumberlandAIRA^IsabellAIRA^Quintina^^^^L|HaysAIRA^ReidunAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1782 Lulst St^^Dollar Bay^MI^49922^USA^P||^PRN^PH^^^906^7315344|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumberlandAIRA^HaysAIRA^^^^^L|MTH^Mother^HL70063|1782 Lulst St^^Dollar Bay^MI^49922^USA^P|^PRN^PH^^^906^7315344ORC|RE||BU02B3708.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU02B3708.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0215-10^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0215-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C34H3716^^^AIRA-TEST^MR||JosephineAIRA^AlateaAIRA^Ama^^^^L|ThayerAIRA^SharniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1652 Walkenburg aan de Geul Ave^^Ferndale^MI^48220^USA^P||^PRN^PH^^^248^6104241|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JosephineAIRA^ThayerAIRA^^^^^L|MTH^Mother^HL70063|1652 Walkenburg aan de Geul Ave^^Ferndale^MI^48220^USA^P|^PRN^PH^^^248^6104241ORC|RE||BC34H3716.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC34H3716.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0215-15^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0215-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O77T3727^^^AIRA-TEST^MR||HarlanAIRA^AshleighAIRA^Sarisha^^^^L|JeffersonAIRA^AlimaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1307 Mint-Michielsgestel Ln^^General Motors^MI^48265^USA^P||^PRN^PH^^^313^2616398|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarlanAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1307 Mint-Michielsgestel Ln^^General Motors^MI^48265^USA^P|^PRN^PH^^^313^2616398ORC|RE||BO77T3727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO77T3727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0215-58^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0215-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T42N3735^^^AIRA-TEST^MR||CaldwellAIRA^ProsperaAIRA^Kagami^^^^L|TravisAIRA^EugeniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1617 Dijk bij Duurstede Ave^^Dearborn^MI^48123^USA^P||^PRN^PH^^^313^6229027|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CaldwellAIRA^TravisAIRA^^^^^L|MTH^Mother^HL70063|1617 Dijk bij Duurstede Ave^^Dearborn^MI^48123^USA^P|^PRN^PH^^^313^6229027ORC|RE||BT42N3735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT42N3735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0215-88^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0225-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K23A3743^^^AIRA-TEST^MR||HoltAIRA^RossaAIRA^Lisabeth^^^^L|LimestoneAIRA^ElsaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1874 Rudwest-Fryslan Ln^^Vanderbilt^MI^49795^USA^P||^PRN^PH^^^989^2442637|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoltAIRA^LimestoneAIRA^^^^^L|MTH^Mother^HL70063|1874 Rudwest-Fryslan Ln^^Vanderbilt^MI^49795^USA^P|^PRN^PH^^^989^2442637ORC|RE||BK23A3743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK23A3743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0225-10^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0225-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C11J3748^^^AIRA-TEST^MR||OcarioAIRA^RozAIRA^Kyleigh^^^^L|DelawareAIRA^PelagiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1595 Vrachtwagen Pl^^Union City^MI^49094^USA^P||^PRN^PH^^^517^8299761|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OcarioAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1595 Vrachtwagen Pl^^Union City^MI^49094^USA^P|^PRN^PH^^^517^8299761ORC|RE||BC11J3748.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC11J3748.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0225-58^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0248-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V88D3756^^^AIRA-TEST^MR||TerrellAIRA^KyndallAIRA^Azalia^^^^L|MontereyAIRA^BrinleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1021 Oppingedam Ave^^Filer City^MI^49634^USA^P||^PRN^PH^^^231^9424969|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TerrellAIRA^MontereyAIRA^^^^^L|MTH^Mother^HL70063|1021 Oppingedam Ave^^Filer City^MI^49634^USA^P|^PRN^PH^^^231^9424969ORC|RE||BV88D3756.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV88D3756.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0248-58^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0250-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W72O3767^^^AIRA-TEST^MR||O'NeillAIRA^AureAIRA^Valgerdr^^^^L|LinnAIRA^MitziAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1110 Oegstgeest Ave^^Niles^MI^49121^USA^P||^PRN^PH^^^269^6789520|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O'NeillAIRA^LinnAIRA^^^^^L|MTH^Mother^HL70063|1110 Oegstgeest Ave^^Niles^MI^49121^USA^P|^PRN^PH^^^269^6789520ORC|RE||BW72O3767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW72O3767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0250-51^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0278-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J56P3775^^^AIRA-TEST^MR||HaskellAIRA^TahneeAIRA^Wateka^^^^L|DelawareAIRA^UtinaAIRA^^^^^M|20121117|F||2106-3^White^CDCREC|1655 Maassluis Ln^^Detroit^MI^48266^USA^P||^PRN^PH^^^313^9946805|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaskellAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1655 Maassluis Ln^^Detroit^MI^48266^USA^P|^PRN^PH^^^313^9946805ORC|RE||BJ56P3775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130117||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ56P3775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130317||49281-0278-10^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130317||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0286-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C85M3783^^^AIRA-TEST^MR||HarperAIRA^CambriaAIRA^Caralyn^^^^L|RoseAIRA^ClorisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1510 Mogelijk Pl^^Belleville^MI^48112^USA^P||^PRN^PH^^^734^2342274|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarperAIRA^RoseAIRA^^^^^L|MTH^Mother^HL70063|1510 Mogelijk Pl^^Belleville^MI^48112^USA^P|^PRN^PH^^^734^2342274ORC|RE||BC85M3783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC85M3783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0286-01^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0286-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V54V3788^^^AIRA-TEST^MR||JernneAIRA^ZazaAIRA^Lisette^^^^L|VargasAIRA^BeritAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1363 Valkenswaard St^^Macatawa^MI^49434^USA^P||^PRN^PH^^^616^6953015|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JernneAIRA^VargasAIRA^^^^^L|MTH^Mother^HL70063|1363 Valkenswaard St^^Macatawa^MI^49434^USA^P|^PRN^PH^^^616^6953015ORC|RE||BV54V3788.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV54V3788.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0286-05^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0286-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N70U3796^^^AIRA-TEST^MR||LoganAIRA^YevaAIRA^Haruko^^^^L|CassAIRA^CyprienAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1362 Toes Pl^^Grand Beach^MI^49117^USA^P||^PRN^PH^^^269^6438737|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoganAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1362 Toes Pl^^Grand Beach^MI^49117^USA^P|^PRN^PH^^^269^6438737ORC|RE||BN70U3796.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN70U3796.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0286-10^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0286-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E40W3807^^^AIRA-TEST^MR||FranklinAIRA^TosiaAIRA^Hippolyta^^^^L|JeffersonAIRA^AkasmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1872 Best Maas en Waal Ave^^Northport^MI^49670^USA^P||^PRN^PH^^^231^7669212|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1872 Best Maas en Waal Ave^^Northport^MI^49670^USA^P|^PRN^PH^^^231^7669212ORC|RE||BE40W3807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE40W3807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0286-58^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0291-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W25G3815^^^AIRA-TEST^MR||TarrantAIRA^VerbenaAIRA^Tiberia^^^^L|KolarAIRA^ReinaAIRA^^^^^M|20160815|F||2106-3^White^CDCREC|1475 Hrmelo St^^Cottrellville^MI^48039^USA^P||^PRN^PH^^^810^3266598|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TarrantAIRA^KolarAIRA^^^^^L|MTH^Mother^HL70063|1475 Hrmelo St^^Cottrellville^MI^48039^USA^P|^PRN^PH^^^810^3266598ORC|RE||BW25G3815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161015||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW25G3815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161215||49281-0291-10^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161215||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0291-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F55R3823^^^AIRA-TEST^MR||HaleAIRA^RhonaAIRA^Pragya^^^^L|LyastromAIRA^NicoletteAIRA^^^^^M|20111229|F||2106-3^White^CDCREC|1714 Otadskanaal St^^GR^MI^49514^USA^P||^PRN^PH^^^616^5012776|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaleAIRA^LyastromAIRA^^^^^L|MTH^Mother^HL70063|1714 Otadskanaal St^^GR^MI^49514^USA^P|^PRN^PH^^^616^5012776ORC|RE||BF55R3823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120229||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF55R3823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120430||49281-0291-83^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120430||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0298-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H23D3831^^^AIRA-TEST^MR||HarrisonAIRA^NayokoAIRA^Swati^^^^L|OwsleyAIRA^HikaAIRA^^^^^M|20121112|F||2106-3^White^CDCREC|1788 Zorne Pl^^Blissfield^MI^49228^USA^P||^PRN^PH^^^517^5037892|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^OwsleyAIRA^^^^^L|MTH^Mother^HL70063|1788 Zorne Pl^^Blissfield^MI^49228^USA^P|^PRN^PH^^^517^5037892ORC|RE||BH23D3831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH23D3831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130312||49281-0298-10^TRIPEDIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130312||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0386-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U04E3836^^^AIRA-TEST^MR||MahoningAIRA^MaataAIRA^Alala^^^^L|CharlevoixAIRA^RoyaleAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1576 Rchagen Ave^^Farmington Hls^MI^48332^USA^P||^PRN^PH^^^248^6376000|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MahoningAIRA^CharlevoixAIRA^^^^^L|MTH^Mother^HL70063|1576 Rchagen Ave^^Farmington Hls^MI^48332^USA^P|^PRN^PH^^^248^6376000ORC|RE||BU04E3836.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU04E3836.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0386-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0387-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T80P3844^^^AIRA-TEST^MR||MarionAIRA^SheelaAIRA^Erin^^^^L|BelmontAIRA^FaeAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1048 Mijl Ln^^Oden^MI^49764^USA^P||^PRN^PH^^^616^6188755|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarionAIRA^BelmontAIRA^^^^^L|MTH^Mother^HL70063|1048 Mijl Ln^^Oden^MI^49764^USA^P|^PRN^PH^^^616^6188755ORC|RE||BT80P3844.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT80P3844.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0387-65^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0388-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z36V3855^^^AIRA-TEST^MR||AdairAIRA^MarisaAIRA^Matilda^^^^L|WebsterAIRA^ShayleeAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1889 Deertruidenberg St^^Kalamazoo^MI^49005^USA^P||^PRN^PH^^^269^3424408|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdairAIRA^WebsterAIRA^^^^^L|MTH^Mother^HL70063|1889 Deertruidenberg St^^Kalamazoo^MI^49005^USA^P|^PRN^PH^^^269^3424408ORC|RE||BZ36V3855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ36V3855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0388-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0389-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K54U3863^^^AIRA-TEST^MR||CliveAIRA^JaniahAIRA^Cicely^^^^L|ErikssonAIRA^GracieAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1360 Pak Ave^^Bay Port^MI^48720^USA^P||^PRN^PH^^^989^2004513|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CliveAIRA^ErikssonAIRA^^^^^L|MTH^Mother^HL70063|1360 Pak Ave^^Bay Port^MI^48720^USA^P|^PRN^PH^^^989^2004513ORC|RE||BK54U3863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK54U3863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0389-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0390-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E32F3871^^^AIRA-TEST^MR||JolsenAIRA^AsaAIRA^Kenley^^^^L|LouisaAIRA^CeleneAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1695 Guiven Ln^^Pittsford^MI^49271^USA^P||^PRN^PH^^^517^5006103|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JolsenAIRA^LouisaAIRA^^^^^L|MTH^Mother^HL70063|1695 Guiven Ln^^Pittsford^MI^49271^USA^P|^PRN^PH^^^517^5006103ORC|RE||BE32F3871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE32F3871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0390-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0391-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V56Y3876^^^AIRA-TEST^MR||MadisonAIRA^FreyaAIRA^Takiyah^^^^L|O'NeillAIRA^DemetriaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1262 Oevenaar St^^Norton Shores^MI^49441^USA^P||^PRN^PH^^^231^7238313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MadisonAIRA^O'NeillAIRA^^^^^L|MTH^Mother^HL70063|1262 Oevenaar St^^Norton Shores^MI^49441^USA^P|^PRN^PH^^^231^7238313ORC|RE||BV56Y3876.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV56Y3876.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0391-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0392-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I62Y3884^^^AIRA-TEST^MR||MontmorencyMuskegonAIRA^AsenetteAIRA^Valborg^^^^L|BuschAIRA^DuenaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1957 Voxmeer St^^GR^MI^49501^USA^P||^PRN^PH^^^616^5480029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontmorencyMuskegonAIRA^BuschAIRA^^^^^L|MTH^Mother^HL70063|1957 Voxmeer St^^GR^MI^49501^USA^P|^PRN^PH^^^616^5480029ORC|RE||BI62Y3884.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI62Y3884.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0392-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0392-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z24A3895^^^AIRA-TEST^MR||WorleyAIRA^KathieAIRA^Verona^^^^L|MadisonAIRA^OrtensiaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1874 Aomeren Cir^^Owosso^MI^48841^USA^P||^PRN^PH^^^989^6947156|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WorleyAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1874 Aomeren Cir^^Owosso^MI^48841^USA^P|^PRN^PH^^^989^6947156ORC|RE||BZ24A3895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ24A3895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0392-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0393-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W49Y3903^^^AIRA-TEST^MR||JuniataAIRA^DelilahAIRA^Stacy^^^^L|DundyAIRA^PaolaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1724 Gaasdriel St^^Stronach^MI^49660^USA^P||^PRN^PH^^^231^8465828|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JuniataAIRA^DundyAIRA^^^^^L|MTH^Mother^HL70063|1724 Gaasdriel St^^Stronach^MI^49660^USA^P|^PRN^PH^^^231^8465828ORC|RE||BW49Y3903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW49Y3903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0393-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0393-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D62F3911^^^AIRA-TEST^MR||FayetteAIRA^AmberAIRA^Cairistiona^^^^L|MonroeAIRA^ElziraAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1923 Kosten Pl^^Dodgeville^MI^49921^USA^P||^PRN^PH^^^906^7555656|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FayetteAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1923 Kosten Pl^^Dodgeville^MI^49921^USA^P|^PRN^PH^^^906^7555656ORC|RE||BD62F3911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD62F3911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0393-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0394-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O53D3916^^^AIRA-TEST^MR||SantiagoAIRA^XaquelinaAIRA^Aldea^^^^L|MonroeAIRA^JamariAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1852 Sint-Michielsgestel St^^Perronville^MI^49873^USA^P||^PRN^PH^^^906^3039192|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SantiagoAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1852 Sint-Michielsgestel St^^Perronville^MI^49873^USA^P|^PRN^PH^^^906^3039192ORC|RE||BO53D3916.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO53D3916.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0394-15^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0394-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I81Q3924^^^AIRA-TEST^MR||LincolnAIRA^ArlyndaAIRA^Messina^^^^L|HendleAIRA^AmericaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1810 Gopik Pl^^Howard City^MI^49329^USA^P||^PRN^PH^^^231^9473512|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^HendleAIRA^^^^^L|MTH^Mother^HL70063|1810 Gopik Pl^^Howard City^MI^49329^USA^P|^PRN^PH^^^231^9473512ORC|RE||BI81Q3924.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI81Q3924.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0394-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0395-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J59R3935^^^AIRA-TEST^MR||CampbellAIRA^ZebinaAIRA^Madyson^^^^L|ComancheAIRA^JoyAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1628 Grave Cir^^Onekama^MI^49675^USA^P||^PRN^PH^^^231^6210378|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CampbellAIRA^ComancheAIRA^^^^^L|MTH^Mother^HL70063|1628 Grave Cir^^Onekama^MI^49675^USA^P|^PRN^PH^^^231^6210378ORC|RE||BJ59R3935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ59R3935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0395-65^FLUZONE HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0395-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O60A3943^^^AIRA-TEST^MR||ChelanAIRA^KristenAIRA^Ann-Margret^^^^L|HeffordAIRA^KuntiAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1178 Celmond St^^Martin^MI^49070^USA^P||^PRN^PH^^^269^6059345|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChelanAIRA^HeffordAIRA^^^^^L|MTH^Mother^HL70063|1178 Celmond St^^Martin^MI^49070^USA^P|^PRN^PH^^^269^6059345ORC|RE||BO60A3943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO60A3943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0395-88^Fluzone HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0396-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C00N3951^^^AIRA-TEST^MR||HaagenAIRA^LindseyAIRA^Mona^^^^L|MarrietteAIRA^JohannaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1427 Oulst Cir^^Rhodes^MI^48613^USA^P||^PRN^PH^^^989^6574746|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaagenAIRA^MarrietteAIRA^^^^^L|MTH^Mother^HL70063|1427 Oulst Cir^^Rhodes^MI^48613^USA^P|^PRN^PH^^^989^6574746ORC|RE||BC00N3951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC00N3951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0396-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0396-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V15G3956^^^AIRA-TEST^MR||SweeneyAIRA^MickieAIRA^Effy^^^^L|NilsenAIRA^KagamiAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1357 Sisterwijk Pl^^Manton^MI^49663^USA^P||^PRN^PH^^^231^6127996|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SweeneyAIRA^NilsenAIRA^^^^^L|MTH^Mother^HL70063|1357 Sisterwijk Pl^^Manton^MI^49663^USA^P|^PRN^PH^^^231^6127996ORC|RE||BV15G3956.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV15G3956.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0396-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0397-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q76A3964^^^AIRA-TEST^MR||CarrollAIRA^NadiraAIRA^Kiah^^^^L|SwisherAIRA^BrigitteAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1975 Moeilijk Ave^^Ecorse^MI^48229^USA^P||^PRN^PH^^^313^7656528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarrollAIRA^SwisherAIRA^^^^^L|MTH^Mother^HL70063|1975 Moeilijk Ave^^Ecorse^MI^48229^USA^P|^PRN^PH^^^313^7656528ORC|RE||BQ76A3964.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ76A3964.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0397-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0397-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y78D3975^^^AIRA-TEST^MR||BrackenAIRA^YrsaAIRA^Addisyn^^^^L|LuceAIRA^MarshaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1304 Zachte Ave^^North Branch^MI^48461^USA^P||^PRN^PH^^^810^5707160|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrackenAIRA^LuceAIRA^^^^^L|MTH^Mother^HL70063|1304 Zachte Ave^^North Branch^MI^48461^USA^P|^PRN^PH^^^810^5707160ORC|RE||BY78D3975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY78D3975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0397-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0399-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T45Z3983^^^AIRA-TEST^MR||AinslieAIRA^BelvaAIRA^Alisha^^^^L|SolanoAIRA^IolaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1275 Gontferland Ave^^Canton^MI^48184^USA^P||^PRN^PH^^^734^9092264|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AinslieAIRA^SolanoAIRA^^^^^L|MTH^Mother^HL70063|1275 Gontferland Ave^^Canton^MI^48184^USA^P|^PRN^PH^^^734^9092264ORC|RE||BT45Z3983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT45Z3983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0399-65^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0399-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O80C3991^^^AIRA-TEST^MR||JolsenAIRA^SatyavatiAIRA^Kerani^^^^L|AlexandersonAIRA^GiuliaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1312 Moevorden Cir^^Treetops^MI^49735^USA^P||^PRN^PH^^^989^5502974|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JolsenAIRA^AlexandersonAIRA^^^^^L|MTH^Mother^HL70063|1312 Moevorden Cir^^Treetops^MI^49735^USA^P|^PRN^PH^^^989^5502974ORC|RE||BO80C3991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO80C3991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0399-88^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0400-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M56R3999^^^AIRA-TEST^MR||LenaweeAIRA^ChimalisAIRA^Manjula^^^^L|WashitaAIRA^BiddyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1886 Rucphen St^^Mc Bain^MI^49657^USA^P||^PRN^PH^^^231^8150965|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LenaweeAIRA^WashitaAIRA^^^^^L|MTH^Mother^HL70063|1886 Rucphen St^^Mc Bain^MI^49657^USA^P|^PRN^PH^^^231^8150965ORC|RE||BM56R3999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM56R3999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0400-05^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0400-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A07I4004^^^AIRA-TEST^MR||CalaverasAIRA^SeleneAIRA^Manuelle^^^^L|JohnssonAIRA^SigridAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1944 Kde Ave^^Clawson^MI^48017^USA^P||^PRN^PH^^^248^8438670|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalaverasAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1944 Kde Ave^^Clawson^MI^48017^USA^P|^PRN^PH^^^248^8438670ORC|RE||BA07I4004.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA07I4004.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0400-10^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0400-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G76H4012^^^AIRA-TEST^MR||CentreAIRA^AbigailAIRA^Luciana^^^^L|BurlesonAIRA^OphiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1403 Vogel Ave^^Ira^MI^48023^USA^P||^PRN^PH^^^810^2191844|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CentreAIRA^BurlesonAIRA^^^^^L|MTH^Mother^HL70063|1403 Vogel Ave^^Ira^MI^48023^USA^P|^PRN^PH^^^810^2191844ORC|RE||BG76H4012.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG76H4012.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0400-15^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0400-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R78X4023^^^AIRA-TEST^MR||MeaghanAIRA^ClarabelleAIRA^Winema^^^^L|JohnssonAIRA^EvanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1211 Berkelland St^^National City^MI^48748^USA^P||^PRN^PH^^^989^2148233|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeaghanAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1211 Berkelland St^^National City^MI^48748^USA^P|^PRN^PH^^^989^2148233ORC|RE||BR78X4023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR78X4023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0400-20^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0400-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J69E4031^^^AIRA-TEST^MR||YamhillAIRA^GalateaAIRA^Carly^^^^L|TerrellAIRA^BeatrizAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1387 Zevenaar St^^Cottrellville Township^MI^48039^USA^P||^PRN^PH^^^810^6280960|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YamhillAIRA^TerrellAIRA^^^^^L|MTH^Mother^HL70063|1387 Zevenaar St^^Cottrellville Township^MI^48039^USA^P|^PRN^PH^^^810^6280960ORC|RE||BJ69E4031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ69E4031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0400-58^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0400-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N93D4039^^^AIRA-TEST^MR||DixonAIRA^OleanderAIRA^Malina^^^^L|BrownfieldAIRA^OrdeliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1432 Bampen Ave^^Sidnaw^MI^49961^USA^P||^PRN^PH^^^906^8904147|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DixonAIRA^BrownfieldAIRA^^^^^L|MTH^Mother^HL70063|1432 Bampen Ave^^Sidnaw^MI^49961^USA^P|^PRN^PH^^^906^8904147ORC|RE||BN93D4039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN93D4039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0400-88^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0400-89|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N16X4047^^^AIRA-TEST^MR||ColumbiaAIRA^LilyanaAIRA^Stefania^^^^L|SheridanAIRA^PayalAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1042 Zemsmond St^^Pointe Aux Barques^MI^48467^USA^P||^PRN^PH^^^989^8880930|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColumbiaAIRA^SheridanAIRA^^^^^L|MTH^Mother^HL70063|1042 Zemsmond St^^Pointe Aux Barques^MI^48467^USA^P|^PRN^PH^^^989^8880930ORC|RE||BN16X4047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN16X4047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0400-89^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0401-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y88U4052^^^AIRA-TEST^MR||SimpsonAIRA^ConstanceAIRA^Briar^^^^L|ClarkAIRA^NilimaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1318 Loerdijk Cir^^Ann Arbor^MI^48108^USA^P||^PRN^PH^^^734^4300820|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SimpsonAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1318 Loerdijk Cir^^Ann Arbor^MI^48108^USA^P|^PRN^PH^^^734^4300820ORC|RE||BY88U4052.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY88U4052.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0401-65^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0401-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H80L4060^^^AIRA-TEST^MR||GallatinAIRA^MoyaAIRA^Love^^^^L|NacogdochesAIRA^SibelAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1882 Bekela St^^North Star^MI^48862^USA^P||^PRN^PH^^^989^2495751|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GallatinAIRA^NacogdochesAIRA^^^^^L|MTH^Mother^HL70063|1882 Bekela St^^North Star^MI^48862^USA^P|^PRN^PH^^^989^2495751ORC|RE||BH80L4060.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH80L4060.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0401-88^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0403-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A90X4071^^^AIRA-TEST^MR||HamiltonAIRA^EldaAIRA^Jamilah^^^^L|TuolumneAIRA^JessieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1409 Melfzijl Cir^^Detroit^MI^48236^USA^P||^PRN^PH^^^313^7122764|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HamiltonAIRA^TuolumneAIRA^^^^^L|MTH^Mother^HL70063|1409 Melfzijl Cir^^Detroit^MI^48236^USA^P|^PRN^PH^^^313^7122764ORC|RE||BA90X4071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA90X4071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0403-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0403-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N39W4079^^^AIRA-TEST^MR||LucasAIRA^FawnAIRA^Jewel^^^^L|WoodAIRA^HedeaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1068 Minder Pl^^Burton^MI^48509^USA^P||^PRN^PH^^^810^8975929|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LucasAIRA^WoodAIRA^^^^^L|MTH^Mother^HL70063|1068 Minder Pl^^Burton^MI^48509^USA^P|^PRN^PH^^^810^8975929ORC|RE||BN39W4079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN39W4079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0403-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0413-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V83N4087^^^AIRA-TEST^MR||KearneyAIRA^ShawnnessyAIRA^Rinako^^^^L|BrownAIRA^EddaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1968 Roosendaal Cir^^Beechwood^MI^49935^USA^P||^PRN^PH^^^906^7211168|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KearneyAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1968 Roosendaal Cir^^Beechwood^MI^49935^USA^P|^PRN^PH^^^906^7211168ORC|RE||BV83N4087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV83N4087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0413-10^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0413-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G70V4095^^^AIRA-TEST^MR||BentonAIRA^MikiAIRA^Nara^^^^L|TexasAIRA^IsabelaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1513 Eochem Ave^^Mc Millan^MI^49853^USA^P||^PRN^PH^^^906^6392390|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BentonAIRA^TexasAIRA^^^^^L|MTH^Mother^HL70063|1513 Eochem Ave^^Mc Millan^MI^49853^USA^P|^PRN^PH^^^906^6392390ORC|RE||BG70V4095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG70V4095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0413-50^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0413-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S09N4100^^^AIRA-TEST^MR||WilliamsonAIRA^JeraldineAIRA^Nishtha^^^^L|MorrosAIRA^RawnieAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1314 Oorendijk St^^Lansing^MI^48911^USA^P||^PRN^PH^^^517^7774666|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilliamsonAIRA^MorrosAIRA^^^^^L|MTH^Mother^HL70063|1314 Oorendijk St^^Lansing^MI^48911^USA^P|^PRN^PH^^^517^7774666ORC|RE||BS09N4100.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS09N4100.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0413-58^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0413-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D68Q4108^^^AIRA-TEST^MR||BucksAIRA^ImogenAIRA^Sarai^^^^L|HillAIRA^RitaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1499 Nodegraven-Reeuwijk Ln^^Mayfield^MI^49666^USA^P||^PRN^PH^^^231^6514765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BucksAIRA^HillAIRA^^^^^L|MTH^Mother^HL70063|1499 Nodegraven-Reeuwijk Ln^^Mayfield^MI^49666^USA^P|^PRN^PH^^^231^6514765ORC|RE||BD68Q4108.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD68Q4108.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0413-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0414-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E24I4119^^^AIRA-TEST^MR||RileyAIRA^OfeliaAIRA^Revelation^^^^L|SiouxAIRA^SabrinaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1546 Bergen St^^Novi^MI^48375^USA^P||^PRN^PH^^^248^9082273|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RileyAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1546 Bergen St^^Novi^MI^48375^USA^P|^PRN^PH^^^248^9082273ORC|RE||BE24I4119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE24I4119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0414-10^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0414-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H71E4127^^^AIRA-TEST^MR||WaldoAIRA^TinaAIRA^Mikki^^^^L|KiernanAIRA^CleomenesAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1371 Woststellingwerf Pl^^Rochester Hls^MI^48306^USA^P||^PRN^PH^^^248^9739429|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WaldoAIRA^KiernanAIRA^^^^^L|MTH^Mother^HL70063|1371 Woststellingwerf Pl^^Rochester Hls^MI^48306^USA^P|^PRN^PH^^^248^9739429ORC|RE||BH71E4127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH71E4127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0414-50^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0414-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H26L4135^^^AIRA-TEST^MR||KlamathAIRA^JayaniAIRA^Doneen^^^^L|AtascosaAIRA^AlcinaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1358 Bidden-Drenthe Cir^^Cass City^MI^48726^USA^P||^PRN^PH^^^989^6869097|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KlamathAIRA^AtascosaAIRA^^^^^L|MTH^Mother^HL70063|1358 Bidden-Drenthe Cir^^Cass City^MI^48726^USA^P|^PRN^PH^^^989^6869097ORC|RE||BH26L4135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH26L4135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0414-58^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0414-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P88U4143^^^AIRA-TEST^MR||KeithAIRA^MichalAIRA^Amitola^^^^L|NorthumberlandAIRA^CyprianaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1836 Beuningen Cir^^Leslie^MI^49251^USA^P||^PRN^PH^^^517^3060204|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KeithAIRA^NorthumberlandAIRA^^^^^L|MTH^Mother^HL70063|1836 Beuningen Cir^^Leslie^MI^49251^USA^P|^PRN^PH^^^517^3060204ORC|RE||BP88U4143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP88U4143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0414-88^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0415-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X23D4148^^^AIRA-TEST^MR||KingAIRA^AveryAIRA^Irene^^^^L|HoggAIRA^SusyAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1517 Wietjerksteradeel Pl^^Brownstwn Township^MI^48183^USA^P||^PRN^PH^^^734^4110147|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingAIRA^HoggAIRA^^^^^L|MTH^Mother^HL70063|1517 Wietjerksteradeel Pl^^Brownstwn Township^MI^48183^USA^P|^PRN^PH^^^734^4110147ORC|RE||BX23D4148.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX23D4148.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0415-10^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0415-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z33L4156^^^AIRA-TEST^MR||HardinAIRA^AthelaAIRA^Payton^^^^L|GreenupAIRA^MaeveAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1397 Nrootegast Ln^^Deerfield^MI^49238^USA^P||^PRN^PH^^^517^2763377|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^GreenupAIRA^^^^^L|MTH^Mother^HL70063|1397 Nrootegast Ln^^Deerfield^MI^49238^USA^P|^PRN^PH^^^517^2763377ORC|RE||BZ33L4156.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ33L4156.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0415-58^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0415-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X60V4167^^^AIRA-TEST^MR||KaufmanAIRA^AgnesAIRA^Mee^^^^L|KentAIRA^YaminiAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1101 Kss Ln^^Ravenna^MI^49451^USA^P||^PRN^PH^^^231^3396358|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KaufmanAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1101 Kss Ln^^Ravenna^MI^49451^USA^P|^PRN^PH^^^231^3396358ORC|RE||BX60V4167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX60V4167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0415-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0416-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P00Z4175^^^AIRA-TEST^MR||WayneAIRA^SahilaAIRA^Savitri^^^^L|KaneAIRA^BelvaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1194 Silburg Pl^^Canton^MI^48184^USA^P||^PRN^PH^^^734^2771385|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WayneAIRA^KaneAIRA^^^^^L|MTH^Mother^HL70063|1194 Silburg Pl^^Canton^MI^48184^USA^P|^PRN^PH^^^734^2771385ORC|RE||BP00Z4175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP00Z4175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0416-10^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0416-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N25N4183^^^AIRA-TEST^MR||NordbyAIRA^RachaelAIRA^Carlota^^^^L|MercerAIRA^KateAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1614 Goud Pl^^Concord^MI^49237^USA^P||^PRN^PH^^^517^6858435|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NordbyAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1614 Goud Pl^^Concord^MI^49237^USA^P|^PRN^PH^^^517^6858435ORC|RE||BN25N4183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN25N4183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0416-50^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0416-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C35S4191^^^AIRA-TEST^MR||KimbleAIRA^AlestiAIRA^Faustine^^^^L|ButteAIRA^ClaiborneAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1619 Vreugde St^^Delhi^MI^48103^USA^P||^PRN^PH^^^734^4059954|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KimbleAIRA^ButteAIRA^^^^^L|MTH^Mother^HL70063|1619 Vreugde St^^Delhi^MI^48103^USA^P|^PRN^PH^^^734^4059954ORC|RE||BC35S4191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC35S4191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0416-58^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0416-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A10C4196^^^AIRA-TEST^MR||JacksonAIRA^CloverAIRA^Rina^^^^L|VistanstAIRA^MarikoAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1386 Rente Pl^^Romeo^MI^48065^USA^P||^PRN^PH^^^586^6255557|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^VistanstAIRA^^^^^L|MTH^Mother^HL70063|1386 Rente Pl^^Romeo^MI^48065^USA^P|^PRN^PH^^^586^6255557ORC|RE||BA10C4196.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA10C4196.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0416-88^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0417-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I14S4204^^^AIRA-TEST^MR||KootenaiAIRA^RamonaAIRA^Joyce^^^^L|BeckhamAIRA^TadiAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1906 Vemert-Bakel Cir^^Cheboygan^MI^49721^USA^P||^PRN^PH^^^231^2710290|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KootenaiAIRA^BeckhamAIRA^^^^^L|MTH^Mother^HL70063|1906 Vemert-Bakel Cir^^Cheboygan^MI^49721^USA^P|^PRN^PH^^^231^2710290ORC|RE||BI14S4204.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI14S4204.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0417-10^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0417-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q73S4215^^^AIRA-TEST^MR||MarquetteAIRA^RahelAIRA^Suchitra^^^^L|Hood RiverAIRA^UnityAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1203 Zchouwen-Duiveland Pl^^Germfask^MI^49836^USA^P||^PRN^PH^^^906^4755162|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarquetteAIRA^Hood RiverAIRA^^^^^L|MTH^Mother^HL70063|1203 Zchouwen-Duiveland Pl^^Germfask^MI^49836^USA^P|^PRN^PH^^^906^4755162ORC|RE||BQ73S4215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ73S4215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0417-50^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0417-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S66B4223^^^AIRA-TEST^MR||OttawaAIRA^NealaAIRA^Ebony^^^^L|DahlAIRA^DieuwertjeAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1485 Man St^^Northville Township^MI^48167^USA^P||^PRN^PH^^^248^5915761|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OttawaAIRA^DahlAIRA^^^^^L|MTH^Mother^HL70063|1485 Man St^^Northville Township^MI^48167^USA^P|^PRN^PH^^^248^5915761ORC|RE||BS66B4223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS66B4223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0417-58^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0417-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A10U4231^^^AIRA-TEST^MR||SkagitAIRA^TolenaAIRA^Rose^^^^L|PurolaAIRA^DulceAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1460 Instrument Pl^^Rea^MI^48131^USA^P||^PRN^PH^^^734^5398268|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SkagitAIRA^PurolaAIRA^^^^^L|MTH^Mother^HL70063|1460 Instrument Pl^^Rea^MI^48131^USA^P|^PRN^PH^^^734^5398268ORC|RE||BA10U4231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA10U4231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0417-88^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P83B4239^^^AIRA-TEST^MR||CusterAIRA^LalaAIRA^Sanjula^^^^L|KnottAIRA^PhiladelphiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1666 Nieuwkoop Ave^^Lapeer^MI^48446^USA^P||^PRN^PH^^^810^7820669|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CusterAIRA^KnottAIRA^^^^^L|MTH^Mother^HL70063|1666 Nieuwkoop Ave^^Lapeer^MI^48446^USA^P|^PRN^PH^^^810^7820669ORC|RE||BP83B4239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP83B4239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0418-10^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0418-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M75K4244^^^AIRA-TEST^MR||CorrinAIRA^LurleneAIRA^Nissa^^^^L|ButlerAIRA^SueAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1521 Valfsen Cir^^Central Lake^MI^49622^USA^P||^PRN^PH^^^231^3888445|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CorrinAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1521 Valfsen Cir^^Central Lake^MI^49622^USA^P|^PRN^PH^^^231^3888445ORC|RE||BM75K4244.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM75K4244.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0418-50^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0418-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P09Z4252^^^AIRA-TEST^MR||ParkerAIRA^ShannelleAIRA^Calista^^^^L|HowardAIRA^LinneaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1906 Gidden-Drenthe Ave^^Lansing^MI^48912^USA^P||^PRN^PH^^^517^8388400|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ParkerAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1906 Gidden-Drenthe Ave^^Lansing^MI^48912^USA^P|^PRN^PH^^^517^8388400ORC|RE||BP09Z4252.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP09Z4252.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0418-58^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0418-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O48J4263^^^AIRA-TEST^MR||FoxAIRA^JulianaAIRA^Sheena^^^^L|BrooksAIRA^FulviaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1979 Bnderbanken Cir^^Bloomfield^MI^48301^USA^P||^PRN^PH^^^248^3401503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FoxAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1979 Bnderbanken Cir^^Bloomfield^MI^48301^USA^P|^PRN^PH^^^248^3401503ORC|RE||BO48J4263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO48J4263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0418-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0487-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P31O4271^^^AIRA-TEST^MR||HardinAIRA^ArnishaAIRA^Arabelle^^^^L|CaseyAIRA^AstridAIRA^^^^^M|20181228|F||2106-3^White^CDCREC|1511 Me Marne Cir^^Elsie^MI^48831^USA^P||^PRN^PH^^^989^2941875|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^CaseyAIRA^^^^^L|MTH^Mother^HL70063|1511 Me Marne Cir^^Elsie^MI^48831^USA^P|^PRN^PH^^^989^2941875ORC|RE||BP31O4271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP31O4271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190429||49281-0487-58^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190429||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0488-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K42U4279^^^AIRA-TEST^MR||DubuqueAIRA^YaniAIRA^Jade^^^^L|MarionAIRA^KarlaAIRA^^^^^M|20181228|F||2106-3^White^CDCREC|1546 Komen Cir^^Bessemer^MI^49911^USA^P||^PRN^PH^^^906^8936101|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DubuqueAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1546 Komen Cir^^Bessemer^MI^49911^USA^P|^PRN^PH^^^906^8936101ORC|RE||BK42U4279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK42U4279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190429||49281-0488-78^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190429||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0489-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W23A4284^^^AIRA-TEST^MR||SpokaneAIRA^PragatiAIRA^Maura^^^^L|HancockAIRA^VadaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1117 Rittenseradiel Ave^^Center Line^MI^48015^USA^P||^PRN^PH^^^586^7977502|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SpokaneAIRA^HancockAIRA^^^^^L|MTH^Mother^HL70063|1117 Rittenseradiel Ave^^Center Line^MI^48015^USA^P|^PRN^PH^^^586^7977502ORC|RE||BW23A4284.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW23A4284.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0489-01^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0489-91|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G45T4292^^^AIRA-TEST^MR||MaverickAIRA^QuiritaAIRA^Charity^^^^L|MorganAIRA^LaylahAIRA^^^^^M|20170529|F||2106-3^White^CDCREC|1508 Mlagtwedde St^^Bloomfield^MI^48302^USA^P||^PRN^PH^^^248^9098824|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MaverickAIRA^MorganAIRA^^^^^L|MTH^Mother^HL70063|1508 Mlagtwedde St^^Bloomfield^MI^48302^USA^P|^PRN^PH^^^248^9098824ORC|RE||BG45T4292.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170729||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG45T4292.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170929||49281-0489-91^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0510-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E93W4303^^^AIRA-TEST^MR||HoeyAIRA^AparajitaAIRA^Karri^^^^L|TulsaAIRA^CoronaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1235 Kansingerland Ave^^Chase Bank^MI^48278^USA^P||^PRN^PH^^^313^5945747|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoeyAIRA^TulsaAIRA^^^^^L|MTH^Mother^HL70063|1235 Kansingerland Ave^^Chase Bank^MI^48278^USA^P|^PRN^PH^^^313^5945747ORC|RE||BE93W4303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE93W4303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0510-05^PENTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0513-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R02L4311^^^AIRA-TEST^MR||TaylorAIRA^KittyAIRA^Kiska^^^^L|HodgeAIRA^NidraAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1396 Partituur St^^Woodland^MI^48897^USA^P||^PRN^PH^^^269^8415804|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^HodgeAIRA^^^^^L|MTH^Mother^HL70063|1396 Partituur St^^Woodland^MI^48897^USA^P|^PRN^PH^^^269^8415804ORC|RE||BR02L4311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR02L4311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0513-00^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0513-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N19V4319^^^AIRA-TEST^MR||AlfalfaAIRA^AllisonAIRA^Nitu^^^^L|RoseAIRA^CaresseAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1518 Bepaalde St^^Coloma^MI^49038^USA^P||^PRN^PH^^^269^6393195|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlfalfaAIRA^RoseAIRA^^^^^L|MTH^Mother^HL70063|1518 Bepaalde St^^Coloma^MI^49038^USA^P|^PRN^PH^^^269^6393195ORC|RE||BN19V4319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN19V4319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0513-25^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0514-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S46H4327^^^AIRA-TEST^MR||BlairAIRA^TehyaAIRA^Sacha^^^^L|HobellAIRA^SigourneyAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1043 Ereda Cir^^Leroy^MI^49655^USA^P||^PRN^PH^^^231^2941726|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlairAIRA^HobellAIRA^^^^^L|MTH^Mother^HL70063|1043 Ereda Cir^^Leroy^MI^49655^USA^P|^PRN^PH^^^231^2941726ORC|RE||BS46H4327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS46H4327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0514-00^Fluzone Quadrivalent, Peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0514-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z55Q4332^^^AIRA-TEST^MR||SmithAIRA^ElainaAIRA^Apollonia^^^^L|HamiltonAIRA^EnysAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1958 Sieuwkoop St^^Clinton Township^MI^48036^USA^P||^PRN^PH^^^586^7692472|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SmithAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1958 Sieuwkoop St^^Clinton Township^MI^48036^USA^P|^PRN^PH^^^586^7692472ORC|RE||BZ55Q4332.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ55Q4332.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0514-25^Fluzone Quadrivalent, peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0516-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B68X4340^^^AIRA-TEST^MR||LeonardAIRA^GythaAIRA^Henrietta^^^^L|San JuanAIRA^AleksandraAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1793 Don en Breugel Ave^^Lansing^MI^48909^USA^P||^PRN^PH^^^517^8223156|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeonardAIRA^San JuanAIRA^^^^^L|MTH^Mother^HL70063|1793 Don en Breugel Ave^^Lansing^MI^48909^USA^P|^PRN^PH^^^517^8223156ORC|RE||BB68X4340.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB68X4340.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0516-00^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0516-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W25T4351^^^AIRA-TEST^MR||ImperialAIRA^IngerAIRA^Kennis^^^^L|HernandezAIRA^PandoraAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1639 Htrechtse Heuvelrug Ln^^Lake Linden^MI^49945^USA^P||^PRN^PH^^^906^6231094|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ImperialAIRA^HernandezAIRA^^^^^L|MTH^Mother^HL70063|1639 Htrechtse Heuvelrug Ln^^Lake Linden^MI^49945^USA^P|^PRN^PH^^^906^6231094ORC|RE||BW25T4351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW25T4351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0516-25^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0517-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S36Q4359^^^AIRA-TEST^MR||MonroeAIRA^HengAIRA^Maia^^^^L|KaneAIRA^NehaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1058 Wssen Ln^^GM Tech Center^MI^48557^USA^P||^PRN^PH^^^810^3692045|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MonroeAIRA^KaneAIRA^^^^^L|MTH^Mother^HL70063|1058 Wssen Ln^^GM Tech Center^MI^48557^USA^P|^PRN^PH^^^810^3692045ORC|RE||BS36Q4359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS36Q4359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0517-00^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0517-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T22S4367^^^AIRA-TEST^MR||CruzAIRA^KaniyaAIRA^Skye^^^^L|LohmannAIRA^ZagrosAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1878 Seeze-Leende Cir^^Norvell^MI^49263^USA^P||^PRN^PH^^^517^8682400|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CruzAIRA^LohmannAIRA^^^^^L|MTH^Mother^HL70063|1878 Seeze-Leende Cir^^Norvell^MI^49263^USA^P|^PRN^PH^^^517^8682400ORC|RE||BT22S4367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT22S4367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0517-25^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0518-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B54B4372^^^AIRA-TEST^MR||IoniaAIRA^AksanaAIRA^Armynel^^^^L|NewtonAIRA^CorinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1478 Gen Boer Ln^^Port Austin^MI^48467^USA^P||^PRN^PH^^^989^6140480|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IoniaAIRA^NewtonAIRA^^^^^L|MTH^Mother^HL70063|1478 Gen Boer Ln^^Port Austin^MI^48467^USA^P|^PRN^PH^^^989^6140480ORC|RE||BB54B4372.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB54B4372.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0518-00^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0518-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A35C4380^^^AIRA-TEST^MR||MasonAIRA^AderesAIRA^Risa^^^^L|OldhamAIRA^ElmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1483 Sidden-Delfland Ave^^Ishpeming^MI^49849^USA^P||^PRN^PH^^^906^2242041|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1483 Sidden-Delfland Ave^^Ishpeming^MI^49849^USA^P|^PRN^PH^^^906^2242041ORC|RE||BA35C4380.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA35C4380.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0518-25^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0545-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P65N4391^^^AIRA-TEST^MR||BrownAIRA^OraliaAIRA^Stephanie^^^^L|KimbleAIRA^JaidenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1670 Maarbeek Pl^^Rockford^MI^49341^USA^P||^PRN^PH^^^616^5377569|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownAIRA^KimbleAIRA^^^^^L|MTH^Mother^HL70063|1670 Maarbeek Pl^^Rockford^MI^49341^USA^P|^PRN^PH^^^616^5377569ORC|RE||BP65N4391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP65N4391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0545-03^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0545-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O22V4399^^^AIRA-TEST^MR||BinghamAIRA^CoralAIRA^Vevette^^^^L|ThompsenAIRA^LexiAIRA^^^^^M|20160727|F||2106-3^White^CDCREC|1057 Vithoorn Cir^^Beechwood^MI^49935^USA^P||^PRN^PH^^^906^7636858|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BinghamAIRA^ThompsenAIRA^^^^^L|MTH^Mother^HL70063|1057 Vithoorn Cir^^Beechwood^MI^49935^USA^P|^PRN^PH^^^906^7636858ORC|RE||BO22V4399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160927||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO22V4399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161127||49281-0545-05^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161127||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0545-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S65S4407^^^AIRA-TEST^MR||PayneAIRA^AdemiaAIRA^Hertha^^^^L|VistanstAIRA^PallasAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1889 Jppingedam Ln^^Beaverton^MI^48612^USA^P||^PRN^PH^^^989^5783292|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PayneAIRA^VistanstAIRA^^^^^L|MTH^Mother^HL70063|1889 Jppingedam Ln^^Beaverton^MI^48612^USA^P|^PRN^PH^^^989^5783292ORC|RE||BS65S4407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS65S4407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0545-15^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0547-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L10T4415^^^AIRA-TEST^MR||BrownAIRA^JourneyAIRA^Bryna^^^^L|GrantAIRA^KavitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1062 Dmsterdam St^^Burlington^MI^49029^USA^P||^PRN^PH^^^517^6395798|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1062 Dmsterdam St^^Burlington^MI^49029^USA^P|^PRN^PH^^^517^6395798ORC|RE||BL10T4415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL10T4415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0547-58^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0560-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A33J4420^^^AIRA-TEST^MR||PickawayAIRA^IsabelleAIRA^Kiden^^^^L|BoyleAIRA^SabraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1698 Weststellingwerf Ave^^Toivola^MI^49965^USA^P||^PRN^PH^^^906^6860559|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PickawayAIRA^BoyleAIRA^^^^^L|MTH^Mother^HL70063|1698 Weststellingwerf Ave^^Toivola^MI^49965^USA^P|^PRN^PH^^^906^6860559ORC|RE||BA33J4420.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA33J4420.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0560-05^DTAP-IPV^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0562-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U86S4428^^^AIRA-TEST^MR||OklahomaAIRA^SarasvatiAIRA^Vasavi^^^^L|KinneyAIRA^LynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1604 Taarle-Nassau Cir^^Muir^MI^48860^USA^P||^PRN^PH^^^989^5577217|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OklahomaAIRA^KinneyAIRA^^^^^L|MTH^Mother^HL70063|1604 Taarle-Nassau Cir^^Muir^MI^48860^USA^P|^PRN^PH^^^989^5577217ORC|RE||BU86S4428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU86S4428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0562-10^Quadracel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0562-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V74X4439^^^AIRA-TEST^MR||DaviessAIRA^RukminiAIRA^Savanna^^^^L|LinnAIRA^ZaliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1815 Ran Ave^^Owosso^MI^48867^USA^P||^PRN^PH^^^989^5659248|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DaviessAIRA^LinnAIRA^^^^^L|MTH^Mother^HL70063|1815 Ran Ave^^Owosso^MI^48867^USA^P|^PRN^PH^^^989^5659248ORC|RE||BV74X4439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV74X4439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0562-58^QUADRACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0589-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E18C4447^^^AIRA-TEST^MR||YorkAIRA^OleanderAIRA^Anninka^^^^L|HardinAIRA^MangenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1091 Vdam-Volendam Pl^^Metamora^MI^48455^USA^P||^PRN^PH^^^810^6767196|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YorkAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1091 Vdam-Volendam Pl^^Metamora^MI^48455^USA^P|^PRN^PH^^^810^6767196ORC|RE||BE18C4447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE18C4447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0589-05^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0589-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y72Z4455^^^AIRA-TEST^MR||HardinAIRA^AsmaraAIRA^Reyna^^^^L|JohnsonAIRA^MelissaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1312 Pchinnen St^^Grosse Pointe^MI^48236^USA^P||^PRN^PH^^^313^4361044|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1312 Pchinnen St^^Grosse Pointe^MI^48236^USA^P|^PRN^PH^^^313^4361044ORC|RE||BY72Z4455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY72Z4455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0589-58^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0621-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X63A4463^^^AIRA-TEST^MR||BolgenAIRA^CharliAIRA^Nolene^^^^L|MagriAIRA^AlkaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1848 Vrouwen Cir^^Brownstwn Township^MI^48173^USA^P||^PRN^PH^^^734^8062761|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BolgenAIRA^MagriAIRA^^^^^L|MTH^Mother^HL70063|1848 Vrouwen Cir^^Brownstwn Township^MI^48173^USA^P|^PRN^PH^^^734^8062761ORC|RE||BX63A4463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX63A4463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0621-15^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0621-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L17G4471^^^AIRA-TEST^MR||BannerAIRA^EttaAIRA^Jun^^^^L|LampasasAIRA^ManaviAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1238 Pe Marne St^^Schaffer^MI^49807^USA^P||^PRN^PH^^^906^2829474|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BannerAIRA^LampasasAIRA^^^^^L|MTH^Mother^HL70063|1238 Pe Marne St^^Schaffer^MI^49807^USA^P|^PRN^PH^^^906^2829474ORC|RE||BL17G4471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL17G4471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0621-78^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0625-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y05H4479^^^AIRA-TEST^MR||HardingAIRA^RaelynAIRA^Leilani^^^^L|San Luis ObispoAIRA^AnitraAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1128 Llochteren St^^Detroit^MI^48206^USA^P||^PRN^PH^^^313^6638464|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardingAIRA^San Luis ObispoAIRA^^^^^L|MTH^Mother^HL70063|1128 Llochteren St^^Detroit^MI^48206^USA^P|^PRN^PH^^^313^6638464ORC|RE||BY05H4479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY05H4479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0625-15^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0625-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y33W4487^^^AIRA-TEST^MR||BarrettAIRA^LyndelAIRA^Erica^^^^L|WayrynenAIRA^ImogeneAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1356 Overleg Cir^^Dixboro^MI^48105^USA^P||^PRN^PH^^^734^8758972|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarrettAIRA^WayrynenAIRA^^^^^L|MTH^Mother^HL70063|1356 Overleg Cir^^Dixboro^MI^48105^USA^P|^PRN^PH^^^734^8758972ORC|RE||BY33W4487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY33W4487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0625-78^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0627-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q46M4495^^^AIRA-TEST^MR||LowndesAIRA^JadenAIRA^Joo-Eun^^^^L|KeanyAIRA^HebeAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1716 Gouda Ave^^Lansing^MI^48910^USA^P||^PRN^PH^^^517^7147450|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LowndesAIRA^KeanyAIRA^^^^^L|MTH^Mother^HL70063|1716 Gouda Ave^^Lansing^MI^48910^USA^P|^PRN^PH^^^517^7147450ORC|RE||BQ46M4495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ46M4495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0627-15^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0627-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W79M4503^^^AIRA-TEST^MR||RogersAIRA^VerenaAIRA^Bluma^^^^L|LickingAIRA^VonniAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1150 Deststellingwerf Cir^^Waltz^MI^48164^USA^P||^PRN^PH^^^734^6607849|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RogersAIRA^LickingAIRA^^^^^L|MTH^Mother^HL70063|1150 Deststellingwerf Cir^^Waltz^MI^48164^USA^P|^PRN^PH^^^734^6607849ORC|RE||BW79M4503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW79M4503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0627-78^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0629-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T48Y4511^^^AIRA-TEST^MR||GregoryAIRA^AinaAIRA^Ennor^^^^L|RowanAIRA^AmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1086 Doggenland Ln^^Saint Clair Shores^MI^48081^USA^P||^PRN^PH^^^586^2259801|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GregoryAIRA^RowanAIRA^^^^^L|MTH^Mother^HL70063|1086 Doggenland Ln^^Saint Clair Shores^MI^48081^USA^P|^PRN^PH^^^586^2259801ORC|RE||BT48Y4511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT48Y4511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0629-15^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0629-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H77T4516^^^AIRA-TEST^MR||CusterAIRA^GiadaAIRA^Belva^^^^L|LoganAIRA^PanyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1499 Aen Boer St^^Ludington^MI^49431^USA^P||^PRN^PH^^^231^6477023|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CusterAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1499 Aen Boer St^^Ludington^MI^49431^USA^P|^PRN^PH^^^231^6477023ORC|RE||BH77T4516.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH77T4516.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0629-78^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0640-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R10Z4524^^^AIRA-TEST^MR||MetcalfeAIRA^GudrunAIRA^Elfreda^^^^L|ElliottAIRA^RiaAIRA^^^^^M|20100831|F||2106-3^White^CDCREC|1021 Geiderland Ave^^Grosse Pointe^MI^48215^USA^P||^PRN^PH^^^313^2934462|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MetcalfeAIRA^ElliottAIRA^^^^^L|MTH^Mother^HL70063|1021 Geiderland Ave^^Grosse Pointe^MI^48215^USA^P|^PRN^PH^^^313^2934462ORC|RE||BR10Z4524.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20101031||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR10Z4524.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20101231||49281-0640-15^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101231||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0650-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C83N4535^^^AIRA-TEST^MR||ComancheAIRA^AlissaAIRA^Charisma^^^^L|McErlaineAIRA^YnesAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1796 Schip St^^Green Oak Township^MI^48116^USA^P||^PRN^PH^^^810^8614630|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ComancheAIRA^McErlaineAIRA^^^^^L|MTH^Mother^HL70063|1796 Schip St^^Green Oak Township^MI^48116^USA^P|^PRN^PH^^^810^8614630ORC|RE||BC83N4535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC83N4535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0650-10^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0650-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G69C4543^^^AIRA-TEST^MR||BrikkeAIRA^DietlindeAIRA^Wapeka^^^^L|CannavinAIRA^KorneliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1415 Zedemblik Ave^^Roulo^MI^48111^USA^P||^PRN^PH^^^734^8235179|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrikkeAIRA^CannavinAIRA^^^^^L|MTH^Mother^HL70063|1415 Zedemblik Ave^^Roulo^MI^48111^USA^P|^PRN^PH^^^734^8235179ORC|RE||BG69C4543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG69C4543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0650-25^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0650-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F17E4551^^^AIRA-TEST^MR||LapeerAIRA^TydfillAIRA^Rois^^^^L|BurkeAIRA^MuniraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1787 Goes Cir^^Edmore^MI^48829^USA^P||^PRN^PH^^^989^7520727|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LapeerAIRA^BurkeAIRA^^^^^L|MTH^Mother^HL70063|1787 Goes Cir^^Edmore^MI^48829^USA^P|^PRN^PH^^^989^7520727ORC|RE||BF17E4551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF17E4551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0650-50^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0650-70|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O53T4559^^^AIRA-TEST^MR||FreestoneAIRA^SaloniAIRA^Jilly^^^^L|MeeAIRA^EthelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1834 Nollands Kroon Cir^^Melvin^MI^48454^USA^P||^PRN^PH^^^810^8026055|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FreestoneAIRA^MeeAIRA^^^^^L|MTH^Mother^HL70063|1834 Nollands Kroon Cir^^Melvin^MI^48454^USA^P|^PRN^PH^^^810^8026055ORC|RE||BO53T4559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO53T4559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0650-70^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0650-90|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R25O4564^^^AIRA-TEST^MR||WashingtonAIRA^SumehraAIRA^Sammie^^^^L|SiouxAIRA^JackyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1121 Olagtwedde St^^Reese^MI^48757^USA^P||^PRN^PH^^^989^8913941|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1121 Olagtwedde St^^Reese^MI^48757^USA^P|^PRN^PH^^^989^8913941ORC|RE||BR25O4564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR25O4564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0650-90^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0703-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W54F4572^^^AIRA-TEST^MR||HalsallAIRA^ScarlettAIRA^Ulma^^^^L|JohnsonAIRA^LalitaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1443 Boudrichem Cir^^Flint^MI^48555^USA^P||^PRN^PH^^^810^6155198|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HalsallAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1443 Boudrichem Cir^^Flint^MI^48555^USA^P|^PRN^PH^^^810^6155198ORC|RE||BW54F4572.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW54F4572.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0703-55^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0705-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O06M4583^^^AIRA-TEST^MR||ScottAIRA^DarcieAIRA^Ryba^^^^L|JacksonAIRA^NarelleAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1671 Kampen Ave^^Detroit^MI^48226^USA^P||^PRN^PH^^^313^3478005|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ScottAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1671 Kampen Ave^^Detroit^MI^48226^USA^P|^PRN^PH^^^313^3478005ORC|RE||BO06M4583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO06M4583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0705-55^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0707-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I38Q4591^^^AIRA-TEST^MR||SwisherAIRA^PaitynAIRA^Lara^^^^L|ElmoreAIRA^WapekaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1595 Lollands Kroon Ln^^Williamston^MI^48895^USA^P||^PRN^PH^^^517^2803786|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SwisherAIRA^ElmoreAIRA^^^^^L|MTH^Mother^HL70063|1595 Lollands Kroon Ln^^Williamston^MI^48895^USA^P|^PRN^PH^^^517^2803786ORC|RE||BI38Q4591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI38Q4591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0707-48^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0707-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E91F4599^^^AIRA-TEST^MR||MonoAIRA^KuraAIRA^Kayna^^^^L|KentAIRA^KimberAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1006 Oolenwaard Cir^^Lawrence^MI^49064^USA^P||^PRN^PH^^^269^7064098|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MonoAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1006 Oolenwaard Cir^^Lawrence^MI^49064^USA^P|^PRN^PH^^^269^7064098ORC|RE||BE91F4599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE91F4599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0707-55^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0708-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G38L4607^^^AIRA-TEST^MR||CreaserAIRA^HollyAIRA^Allison^^^^L|KlamathAIRA^NarelleAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1624 Beuningen Ln^^GR^MI^49501^USA^P||^PRN^PH^^^616^6334007|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CreaserAIRA^KlamathAIRA^^^^^L|MTH^Mother^HL70063|1624 Beuningen Ln^^GR^MI^49501^USA^P|^PRN^PH^^^616^6334007ORC|RE||BG38L4607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG38L4607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0708-40^Fluzone Intradermal Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0708-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y94I4612^^^AIRA-TEST^MR||Van ZandtAIRA^AngelicaAIRA^Jaylin^^^^L|SnohomishAIRA^HermelindaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1732 Kuiken Ave^^Detroit^MI^48288^USA^P||^PRN^PH^^^313^5016711|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Van ZandtAIRA^SnohomishAIRA^^^^^L|MTH^Mother^HL70063|1732 Kuiken Ave^^Detroit^MI^48288^USA^P|^PRN^PH^^^313^5016711ORC|RE||BY94I4612.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY94I4612.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0708-48^FLUZONE INTRADERMAL QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0709-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J94H4620^^^AIRA-TEST^MR||AnningAIRA^ClotildaAIRA^Melwyn^^^^L|HardinAIRA^AlenaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1459 Nmmen Pl^^Northville^MI^48167^USA^P||^PRN^PH^^^248^5458454|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AnningAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1459 Nmmen Pl^^Northville^MI^48167^USA^P|^PRN^PH^^^248^5458454ORC|RE||BJ94H4620.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ94H4620.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0709-48^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0709-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P06M4631^^^AIRA-TEST^MR||DallasAIRA^LuiseAIRA^Aylin^^^^L|MultnomahAIRA^VerrinAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1085 Bindhoven Ln^^Hersey^MI^49639^USA^P||^PRN^PH^^^231^5869196|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallasAIRA^MultnomahAIRA^^^^^L|MTH^Mother^HL70063|1085 Bindhoven Ln^^Hersey^MI^49639^USA^P|^PRN^PH^^^231^5869196ORC|RE||BP06M4631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP06M4631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0709-55^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0710-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S69G4639^^^AIRA-TEST^MR||LeeAIRA^JaninaAIRA^Sumehra^^^^L|McLennanAIRA^JessicaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1945 Dundert Ln^^Frontier^MI^49239^USA^P||^PRN^PH^^^517^6762145|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeeAIRA^McLennanAIRA^^^^^L|MTH^Mother^HL70063|1945 Dundert Ln^^Frontier^MI^49239^USA^P|^PRN^PH^^^517^6762145ORC|RE||BS69G4639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS69G4639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0710-40^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0710-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H21C4647^^^AIRA-TEST^MR||SchoolcraftAIRA^RubyAIRA^Dembe^^^^L|SusquehannaAIRA^EffieAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1573 Schijndel St^^Tuscola^MI^48769^USA^P||^PRN^PH^^^989^5104699|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SchoolcraftAIRA^SusquehannaAIRA^^^^^L|MTH^Mother^HL70063|1573 Schijndel St^^Tuscola^MI^48769^USA^P|^PRN^PH^^^989^5104699ORC|RE||BH21C4647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH21C4647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0710-48^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0712-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G70I4655^^^AIRA-TEST^MR||WestmorelandAIRA^BeverleyAIRA^Kimberley^^^^L|HaughtonAIRA^CelineAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1175 Lellingwedde Ave^^Central Michigan University^MI^48859^USA^P||^PRN^PH^^^989^2182611|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WestmorelandAIRA^HaughtonAIRA^^^^^L|MTH^Mother^HL70063|1175 Lellingwedde Ave^^Central Michigan University^MI^48859^USA^P|^PRN^PH^^^989^2182611ORC|RE||BG70I4655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG70I4655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0712-40^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0712-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J42S4660^^^AIRA-TEST^MR||PiscataquisAIRA^MarisAIRA^Carolina^^^^L|RoseAIRA^GanaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1348 Wudwest-Fryslan St^^Selfridge^MI^48045^USA^P||^PRN^PH^^^586^9597443|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PiscataquisAIRA^RoseAIRA^^^^^L|MTH^Mother^HL70063|1348 Wudwest-Fryslan St^^Selfridge^MI^48045^USA^P|^PRN^PH^^^586^9597443ORC|RE||BJ42S4660.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ42S4660.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0712-48^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0718-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H75J4668^^^AIRA-TEST^MR||MorreyAIRA^BariAIRA^Erena^^^^L|BrownAIRA^EbrelAIRA^^^^^M|20190228|F||2106-3^White^CDCREC|1047 Minder Pl^^Cornell^MI^49818^USA^P||^PRN^PH^^^906^5684724|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorreyAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1047 Minder Pl^^Cornell^MI^49818^USA^P|^PRN^PH^^^906^5684724ORC|RE||BH75J4668.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH75J4668.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190629||49281-0718-10^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0718-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P81V4679^^^AIRA-TEST^MR||MinidokaAIRA^SharonAIRA^Marisa^^^^L|ChristensonAIRA^LinneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1269 Gingewaard Cir^^Ann Arbor^MI^48105^USA^P||^PRN^PH^^^734^2891287|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MinidokaAIRA^ChristensonAIRA^^^^^L|MTH^Mother^HL70063|1269 Gingewaard Cir^^Ann Arbor^MI^48105^USA^P|^PRN^PH^^^734^2891287ORC|RE||BP81V4679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP81V4679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0718-88^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0790-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P72C4687^^^AIRA-TEST^MR||WashingtonAIRA^BreeAIRA^Mamta^^^^L|KingAIRA^PanyinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1200 Caarle-Nassau Ave^^Alma^MI^48802^USA^P||^PRN^PH^^^989^5258399|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1200 Caarle-Nassau Ave^^Alma^MI^48802^USA^P|^PRN^PH^^^989^5258399ORC|RE||BP72C4687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP72C4687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0790-20^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0790-38|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E09V4695^^^AIRA-TEST^MR||CherokeeAIRA^ShaunaAIRA^Amari^^^^L|ArthurAIRA^IsabellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1232 Bromstrijen Cir^^Augusta Township^MI^48160^USA^P||^PRN^PH^^^734^3335840|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CherokeeAIRA^ArthurAIRA^^^^^L|MTH^Mother^HL70063|1232 Bromstrijen Cir^^Augusta Township^MI^48160^USA^P|^PRN^PH^^^734^3335840ORC|RE||BE09V4695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE09V4695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0790-38^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0790-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G64X4700^^^AIRA-TEST^MR||EriksonAIRA^JacquiAIRA^Aquene^^^^L|LehighAIRA^LoreAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1444 Zou Cir^^Cottrellville^MI^48039^USA^P||^PRN^PH^^^810^7782142|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EriksonAIRA^LehighAIRA^^^^^L|MTH^Mother^HL70063|1444 Zou Cir^^Cottrellville^MI^48039^USA^P|^PRN^PH^^^810^7782142ORC|RE||BG64X4700.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG64X4700.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0790-51^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0790-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U60G4708^^^AIRA-TEST^MR||LimestoneAIRA^BriettaAIRA^Dianne^^^^L|ReevesAIRA^LynneaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1897 Kapitein Ave^^Hillsdale^MI^49242^USA^P||^PRN^PH^^^517^8294775|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LimestoneAIRA^ReevesAIRA^^^^^L|MTH^Mother^HL70063|1897 Kapitein Ave^^Hillsdale^MI^49242^USA^P|^PRN^PH^^^517^8294775ORC|RE||BU60G4708.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU60G4708.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0790-88^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0800-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F44O4719^^^AIRA-TEST^MR||OneidaAIRA^GabiAIRA^Janice^^^^L|LincolnAIRA^SorilbranAIRA^^^^^M|20170104|F||2106-3^White^CDCREC|1711 Gssen Ln^^Milford Township^MI^48381^USA^P||^PRN^PH^^^248^9742173|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OneidaAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1711 Gssen Ln^^Milford Township^MI^48381^USA^P|^PRN^PH^^^248^9742173ORC|RE||BF44O4719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170304||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF44O4719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170504||49281-0800-83^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170504||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0820-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L50O4727^^^AIRA-TEST^MR||LakeAIRA^MarmaraAIRA^Alani^^^^L|RiversideAIRA^AkshitaAIRA^^^^^M|20170104|F||2106-3^White^CDCREC|1199 Denk Cir^^Concord^MI^49237^USA^P||^PRN^PH^^^517^7459400|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LakeAIRA^RiversideAIRA^^^^^L|MTH^Mother^HL70063|1199 Denk Cir^^Concord^MI^49237^USA^P|^PRN^PH^^^517^7459400ORC|RE||BL50O4727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170304||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL50O4727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170504||49281-0820-10^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170504||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0860-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O25J4735^^^AIRA-TEST^MR||HawkeAIRA^DelaneyAIRA^Kadija^^^^L|PasoAIRA^ZehavaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1178 Lied Cir^^Saint Clair Shrs^MI^48080^USA^P||^PRN^PH^^^586^2803686|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HawkeAIRA^PasoAIRA^^^^^L|MTH^Mother^HL70063|1178 Lied Cir^^Saint Clair Shrs^MI^48080^USA^P|^PRN^PH^^^586^2803686ORC|RE||BO25J4735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO25J4735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0860-10^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0860-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B53Y4740^^^AIRA-TEST^MR||McKeanAIRA^EldoraAIRA^Halcyone^^^^L|LeeAIRA^JameeAIRA^^^^^M|20110215|F||2106-3^White^CDCREC|1415 Gestegen St^^Swartz Creek^MI^48473^USA^P||^PRN^PH^^^810^2383751|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McKeanAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1415 Gestegen St^^Swartz Creek^MI^48473^USA^P|^PRN^PH^^^810^2383751ORC|RE||BB53Y4740.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110415||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB53Y4740.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110615||49281-0860-55^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110615||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0860-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C76N4748^^^AIRA-TEST^MR||VenangoAIRA^KarsynAIRA^Nadia^^^^L|KjerulfAIRA^SariaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1556 Huth St^^Kenockee Township^MI^48006^USA^P||^PRN^PH^^^810^4899986|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VenangoAIRA^KjerulfAIRA^^^^^L|MTH^Mother^HL70063|1556 Huth St^^Kenockee Township^MI^48006^USA^P|^PRN^PH^^^810^4899986ORC|RE||BC76N4748.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC76N4748.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0860-78^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0860-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C69P4759^^^AIRA-TEST^MR||OhioAIRA^ManuelleAIRA^Malvina^^^^L|DouglasAIRA^BlendaAIRA^^^^^M|20110215|F||2106-3^White^CDCREC|1180 Behoorlijk Pl^^Orchard Lake^MI^48324^USA^P||^PRN^PH^^^248^3371939|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OhioAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1180 Behoorlijk Pl^^Orchard Lake^MI^48324^USA^P|^PRN^PH^^^248^3371939ORC|RE||BC69P4759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110415||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC69P4759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110615||49281-0860-88^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110615||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0913-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q84V4767^^^AIRA-TEST^MR||BentonAIRA^ZanaAIRA^Savita^^^^L|PintoAIRA^YukikoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1252 Ta en Hunze Cir^^Arnold^MI^49819^USA^P||^PRN^PH^^^906^7237256|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BentonAIRA^PintoAIRA^^^^^L|MTH^Mother^HL70063|1252 Ta en Hunze Cir^^Arnold^MI^49819^USA^P|^PRN^PH^^^906^7237256ORC|RE||BQ84V4767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ84V4767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0913-01^STAMARIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0915-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N68X4775^^^AIRA-TEST^MR||SutterAIRA^ZagrosAIRA^Lindall^^^^L|BryanAIRA^MyrnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1079 Kinnenmaas Pl^^Port Huron^MI^48061^USA^P||^PRN^PH^^^810^6143620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SutterAIRA^BryanAIRA^^^^^L|MTH^Mother^HL70063|1079 Kinnenmaas Pl^^Port Huron^MI^48061^USA^P|^PRN^PH^^^810^6143620ORC|RE||BN68X4775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN68X4775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0915-01^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0915-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z28Q4780^^^AIRA-TEST^MR||ReaganAIRA^NaimahAIRA^Olono^^^^L|EmmetAIRA^KaiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1629 Sedemblik Ave^^Gay^MI^49945^USA^P||^PRN^PH^^^906^2677492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReaganAIRA^EmmetAIRA^^^^^L|MTH^Mother^HL70063|1629 Sedemblik Ave^^Gay^MI^49945^USA^P|^PRN^PH^^^906^2677492ORC|RE||BZ28Q4780.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ28Q4780.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0915-05^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0915-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V47B4788^^^AIRA-TEST^MR||ReaganAIRA^DonelleAIRA^Risa^^^^L|CalhounAIRA^MarmaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1401 Betekenen Cir^^Grand Rapids^MI^49509^USA^P||^PRN^PH^^^616^5883414|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReaganAIRA^CalhounAIRA^^^^^L|MTH^Mother^HL70063|1401 Betekenen Cir^^Grand Rapids^MI^49509^USA^P|^PRN^PH^^^616^5883414ORC|RE||BV47B4788.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV47B4788.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0915-58^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-0915-68|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F10Y4799^^^AIRA-TEST^MR||WrightAIRA^EudocieAIRA^Ora^^^^L|GreenupAIRA^HayleeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1977 Moosendaal Pl^^Auburn^MI^48611^USA^P||^PRN^PH^^^989^4911295|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WrightAIRA^GreenupAIRA^^^^^L|MTH^Mother^HL70063|1977 Moosendaal Pl^^Auburn^MI^48611^USA^P|^PRN^PH^^^989^4911295ORC|RE||BF10Y4799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF10Y4799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-0915-68^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-1693-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T08O4807^^^AIRA-TEST^MR||OneidaAIRA^TaniaAIRA^Jaylen^^^^L|WashingtonAIRA^YaminiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1793 Dint-Oedenrode Ln^^Ira Township^MI^48023^USA^P||^PRN^PH^^^810^7316413|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OneidaAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1793 Dint-Oedenrode Ln^^Ira Township^MI^48023^USA^P|^PRN^PH^^^810^7316413ORC|RE||BT08O4807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT08O4807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-1693-00^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-1693-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G13Y4815^^^AIRA-TEST^MR||BurnetAIRA^JoleneAIRA^Garland^^^^L|RuskAIRA^AdammaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1095 Atadskanaal St^^Flint^MI^48555^USA^P||^PRN^PH^^^810^2311607|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BurnetAIRA^RuskAIRA^^^^^L|MTH^Mother^HL70063|1095 Atadskanaal St^^Flint^MI^48555^USA^P|^PRN^PH^^^810^2311607ORC|RE||BG13Y4815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG13Y4815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-1693-09^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-2883-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K94G4820^^^AIRA-TEST^MR||ClareAIRA^CrispinaAIRA^Donna^^^^L|WallinAIRA^EdnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1127 Flat Cir^^Redford Township^MI^48239^USA^P||^PRN^PH^^^734^7844930|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClareAIRA^WallinAIRA^^^^^L|MTH^Mother^HL70063|1127 Flat Cir^^Redford Township^MI^48239^USA^P|^PRN^PH^^^734^7844930ORC|RE||BK94G4820.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK94G4820.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-2883-00^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-2883-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y91P4828^^^AIRA-TEST^MR||KlamathAIRA^EnaAIRA^Brenda^^^^L|PimaAIRA^VidaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1613 Kansingerland Pl^^Sawyer^MI^49125^USA^P||^PRN^PH^^^269^7072344|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KlamathAIRA^PimaAIRA^^^^^L|MTH^Mother^HL70063|1613 Kansingerland Pl^^Sawyer^MI^49125^USA^P|^PRN^PH^^^269^7072344ORC|RE||BY91P4828.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY91P4828.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-2883-09^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-3096-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V83D4839^^^AIRA-TEST^MR||KildahlAIRA^MoyaAIRA^Sawsan^^^^L|BanbergAIRA^TahirahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1589 Leeze-Leende Pl^^Johannesburg^MI^49751^USA^P||^PRN^PH^^^989^5649153|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KildahlAIRA^BanbergAIRA^^^^^L|MTH^Mother^HL70063|1589 Leeze-Leende Pl^^Johannesburg^MI^49751^USA^P|^PRN^PH^^^989^5649153ORC|RE||BV83D4839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV83D4839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-3096-00^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-3469-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M94G4847^^^AIRA-TEST^MR||WhitmanAIRA^AzaliaAIRA^Angevin^^^^L|LincolnAIRA^OrnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1355 Aelfzijl St^^Moscow^MI^49257^USA^P||^PRN^PH^^^517^6247804|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WhitmanAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1355 Aelfzijl St^^Moscow^MI^49257^USA^P|^PRN^PH^^^517^6247804ORC|RE||BM94G4847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM94G4847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-3469-00^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-3469-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y55Z4855^^^AIRA-TEST^MR||GonzalesAIRA^ClaireAIRA^Tonie^^^^L|LeonardAIRA^SherriAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1986 Zon Cir^^Greenwood Township^MI^48006^USA^P||^PRN^PH^^^810^3782944|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GonzalesAIRA^LeonardAIRA^^^^^L|MTH^Mother^HL70063|1986 Zon Cir^^Greenwood Township^MI^48006^USA^P|^PRN^PH^^^810^3782944ORC|RE||BY55Z4855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY55Z4855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-3469-09^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285-0138-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D48S4860^^^AIRA-TEST^MR||PenobscotAIRA^SafiaAIRA^Saskia^^^^L|GalliaAIRA^AngwenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1370 Edam-Volendam Cir^^Bloomfield Township^MI^48301^USA^P||^PRN^PH^^^248^9014837|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PenobscotAIRA^GalliaAIRA^^^^^L|MTH^Mother^HL70063|1370 Edam-Volendam Cir^^Bloomfield Township^MI^48301^USA^P|^PRN^PH^^^248^9014837ORC|RE||BD48S4860.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD48S4860.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285-0138-50^Adenovirus Type 4 and Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||BRR^Barr Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|143^Adenovirus VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140611||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285-0174-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R65L4868^^^AIRA-TEST^MR||HudspethAIRA^GwendolynAIRA^Tatya^^^^L|SchoolcraftAIRA^NolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1122 Hout Ave^^Howell^MI^48844^USA^P||^PRN^PH^^^517^2613879|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HudspethAIRA^SchoolcraftAIRA^^^^^L|MTH^Mother^HL70063|1122 Hout Ave^^Howell^MI^48844^USA^P|^PRN^PH^^^517^2613879ORC|RE||BR65L4868.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR65L4868.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285-0174-02^Adenovirus Type 4 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||BRR^Barr Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|143^Adenovirus VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140611||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285-0175-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q81E4879^^^AIRA-TEST^MR||RandallAIRA^SharmisthaAIRA^Beta^^^^L|TurnerAIRA^FaylinnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1024 Hoewel Ln^^Deerfield^MI^49238^USA^P||^PRN^PH^^^517^6822756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RandallAIRA^TurnerAIRA^^^^^L|MTH^Mother^HL70063|1024 Hoewel Ln^^Deerfield^MI^49238^USA^P|^PRN^PH^^^517^6822756ORC|RE||BQ81E4879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ81E4879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285-0175-02^Adenovirus Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||BRR^Barr Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|143^Adenovirus VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140611||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-0734-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B74Q4887^^^AIRA-TEST^MR||SylteAIRA^BlossomAIRA^Bedelia^^^^L|CamasAIRA^GianinaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1163 Tijnwaarden Ln^^Utica^MI^48317^USA^P||^PRN^PH^^^586^3054076|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SylteAIRA^CamasAIRA^^^^^L|MTH^Mother^HL70063|1163 Tijnwaarden Ln^^Utica^MI^48317^USA^P|^PRN^PH^^^586^3054076ORC|RE||BB74Q4887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB74Q4887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||54868-0734-00^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-0980-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W14Z4895^^^AIRA-TEST^MR||MahaskaAIRA^EllenAIRA^Siroun^^^^L|HamiltonAIRA^JardenaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1397 Middag Cir^^Borculo^MI^49464^USA^P||^PRN^PH^^^616^2678917|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MahaskaAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1397 Middag Cir^^Borculo^MI^49464^USA^P|^PRN^PH^^^616^2678917ORC|RE||BW14Z4895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW14Z4895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||54868-0980-00^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-2219-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q36X4900^^^AIRA-TEST^MR||SenecaAIRA^LornaAIRA^Avis^^^^L|MahaskaAIRA^KyokoAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1196 Maalte Cir^^Northland^MI^49831^USA^P||^PRN^PH^^^906^9520343|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SenecaAIRA^MahaskaAIRA^^^^^L|MTH^Mother^HL70063|1196 Maalte Cir^^Northland^MI^49831^USA^P|^PRN^PH^^^906^9520343ORC|RE||BQ36X4900.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ36X4900.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||54868-2219-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-2219-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A61S4908^^^AIRA-TEST^MR||WashingtonAIRA^KoloraAIRA^Vanni^^^^L|O'BrienAIRA^AmissaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1901 Mapelle Ave^^Saginaw^MI^48609^USA^P||^PRN^PH^^^989^7353314|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^O'BrienAIRA^^^^^L|MTH^Mother^HL70063|1901 Mapelle Ave^^Saginaw^MI^48609^USA^P|^PRN^PH^^^989^7353314ORC|RE||BA61S4908.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA61S4908.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||54868-2219-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-3339-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L04G4919^^^AIRA-TEST^MR||CherokeeAIRA^DaciaAIRA^Ember^^^^L|VenangoAIRA^BrandeeAIRA^^^^^M|20090228|F||2106-3^White^CDCREC|1867 Weerlen Pl^^Middleton^MI^48856^USA^P||^PRN^PH^^^989^9610946|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CherokeeAIRA^VenangoAIRA^^^^^L|MTH^Mother^HL70063|1867 Weerlen Pl^^Middleton^MI^48856^USA^P|^PRN^PH^^^989^9610946ORC|RE||BL04G4919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20090429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL04G4919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20090629||54868-3339-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20090629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-3339-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S39B4927^^^AIRA-TEST^MR||AdamsAIRA^CailynAIRA^Alzena^^^^L|CowleyAIRA^OdettaAIRA^^^^^M|20090228|F||2106-3^White^CDCREC|1052 Nedum Ln^^Oakland Township^MI^48306^USA^P||^PRN^PH^^^248^2122365|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdamsAIRA^CowleyAIRA^^^^^L|MTH^Mother^HL70063|1052 Nedum Ln^^Oakland Township^MI^48306^USA^P|^PRN^PH^^^248^2122365ORC|RE||BS39B4927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20090429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS39B4927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20090629||54868-3339-09^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20090629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-4320-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S81F4935^^^AIRA-TEST^MR||DillAIRA^CeliaAIRA^Claiborne^^^^L|ElkAIRA^AnnelieseAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1799 Klinken Ln^^Carney^MI^49812^USA^P||^PRN^PH^^^906^5987905|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DillAIRA^ElkAIRA^^^^^L|MTH^Mother^HL70063|1799 Klinken Ln^^Carney^MI^49812^USA^P|^PRN^PH^^^906^5987905ORC|RE||BS81F4935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS81F4935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||54868-4320-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-4320-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z47M4940^^^AIRA-TEST^MR||FranklinAIRA^ParnellaAIRA^Casondra^^^^L|MercerAIRA^ArizaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1255 Se Ronde Venen Pl^^Farmington Hills^MI^48332^USA^P||^PRN^PH^^^248^8838277|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1255 Se Ronde Venen Pl^^Farmington Hills^MI^48332^USA^P|^PRN^PH^^^248^8838277ORC|RE||BZ47M4940.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ47M4940.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||54868-4320-09^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-6177-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D03B4948^^^AIRA-TEST^MR||CumberlandAIRA^CarolAIRA^Lorelei^^^^L|CamasAIRA^UdaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1501 Vunspeet St^^White Lake^MI^48386^USA^P||^PRN^PH^^^248^3513410|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumberlandAIRA^CamasAIRA^^^^^L|MTH^Mother^HL70063|1501 Vunspeet St^^White Lake^MI^48386^USA^P|^PRN^PH^^^248^3513410ORC|RE||BD03B4948.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD03B4948.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||54868-6177-00^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-6180-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U09W4959^^^AIRA-TEST^MR||Black HawkAIRA^EvieAIRA^Verda^^^^L|MercerAIRA^RiannaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1848 Mollumerland en Nieuwkruisland Pl^^Saline^MI^48115^USA^P||^PRN^PH^^^734^2393475|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Black HawkAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1848 Mollumerland en Nieuwkruisland Pl^^Saline^MI^48115^USA^P|^PRN^PH^^^734^2393475ORC|RE||BU09W4959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU09W4959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||54868-6180-00^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-55045-3841-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A79Q4967^^^AIRA-TEST^MR||ShermanAIRA^OkelaniAIRA^Sadb^^^^L|BarkerAIRA^GabbyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1539 Goord-Beveland Ave^^Barlow Branch^MI^49696^USA^P||^PRN^PH^^^231^8579288|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShermanAIRA^BarkerAIRA^^^^^L|MTH^Mother^HL70063|1539 Goord-Beveland Ave^^Barlow Branch^MI^49696^USA^P|^PRN^PH^^^231^8579288ORC|RE||BA79Q4967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA79Q4967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||55045-3841-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0801-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y86T4975^^^AIRA-TEST^MR||LaenAIRA^KatelinAIRA^Sharee^^^^L|ClarkAIRA^KarolineAIRA^^^^^M|20170516|F||2106-3^White^CDCREC|1854 Vardenberg Ave^^Riga^MI^49276^USA^P||^PRN^PH^^^517^8768764|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LaenAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1854 Vardenberg Ave^^Riga^MI^49276^USA^P|^PRN^PH^^^517^8768764ORC|RE||BY86T4975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170716||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY86T4975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170916||58160-0801-11^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170916||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0802-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D43M4980^^^AIRA-TEST^MR||MifflinAIRA^FritziAIRA^Bethan^^^^L|BolgenAIRA^SubhujaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1652 Kloof Ln^^Northfield Township^MI^48189^USA^P||^PRN^PH^^^734^6642395|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MifflinAIRA^BolgenAIRA^^^^^L|MTH^Mother^HL70063|1652 Kloof Ln^^Northfield Township^MI^48189^USA^P|^PRN^PH^^^734^6642395ORC|RE||BD43M4980.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD43M4980.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0802-02^AS03 Adjuvant^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0804-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T15M4988^^^AIRA-TEST^MR||KnoxAIRA^EvaAIRA^Warrina^^^^L|EllisAIRA^ZaliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1350 De winter St^^Rapid River^MI^49878^USA^P||^PRN^PH^^^906^9190989|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnoxAIRA^EllisAIRA^^^^^L|MTH^Mother^HL70063|1350 De winter St^^Rapid River^MI^49878^USA^P|^PRN^PH^^^906^9190989ORC|RE||BT15M4988.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT15M4988.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0804-01^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0806-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X59X4999^^^AIRA-TEST^MR||HernandezAIRA^OdeaAIRA^Ayla^^^^L|MontourAIRA^VandaAIRA^^^^^M|20110814|F||2106-3^White^CDCREC|1057 Boerderij Ln^^Flint^MI^48554^USA^P||^PRN^PH^^^810^8183644|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HernandezAIRA^MontourAIRA^^^^^L|MTH^Mother^HL70063|1057 Boerderij Ln^^Flint^MI^48554^USA^P|^PRN^PH^^^810^8183644ORC|RE||BX59X4999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111014||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX59X4999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111214||58160-0806-01^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111214||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0806-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N89J5007^^^AIRA-TEST^MR||HamiltonAIRA^MaryamAIRA^Joy^^^^L|KentonAIRA^NityaAIRA^^^^^M|20110814|F||2106-3^White^CDCREC|1739 Heldhoven Ln^^Royal Oak Township^MI^48220^USA^P||^PRN^PH^^^248^8761051|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HamiltonAIRA^KentonAIRA^^^^^L|MTH^Mother^HL70063|1739 Heldhoven Ln^^Royal Oak Township^MI^48220^USA^P|^PRN^PH^^^248^8761051ORC|RE||BN89J5007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111014||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN89J5007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111214||58160-0806-05^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111214||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0808-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R40M5015^^^AIRA-TEST^MR||BagleyAIRA^TejalAIRA^Trinity^^^^L|GallatinAIRA^FirakiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1771 Ae Fryske Marren Ln^^Bessemer^MI^49911^USA^P||^PRN^PH^^^906^9553646|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BagleyAIRA^GallatinAIRA^^^^^L|MTH^Mother^HL70063|1771 Ae Fryske Marren Ln^^Bessemer^MI^49911^USA^P|^PRN^PH^^^906^9553646ORC|RE||BR40M5015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR40M5015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0808-15^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0809-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W08H5020^^^AIRA-TEST^MR||DanuelsonAIRA^LailaAIRA^Azariah^^^^L|LucasAIRA^HallieAIRA^^^^^M|20170528|F||2106-3^White^CDCREC|1653 Oe Marne Pl^^Sodus^MI^49126^USA^P||^PRN^PH^^^269^3441326|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DanuelsonAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1653 Oe Marne Pl^^Sodus^MI^49126^USA^P|^PRN^PH^^^269^3441326ORC|RE||BW08H5020.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170728||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW08H5020.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170928||58160-0809-01^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170928||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0809-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S91I5028^^^AIRA-TEST^MR||WhitakerAIRA^ChanaAIRA^Sofia^^^^L|DightAIRA^ZeniaAIRA^^^^^M|20170528|F||2106-3^White^CDCREC|1317 Meghel St^^Leonidas^MI^49066^USA^P||^PRN^PH^^^269^7659790|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WhitakerAIRA^DightAIRA^^^^^L|MTH^Mother^HL70063|1317 Meghel St^^Leonidas^MI^49066^USA^P|^PRN^PH^^^269^7659790ORC|RE||BS91I5028.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170728||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS91I5028.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170928||58160-0809-05^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170928||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0810-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L34S5039^^^AIRA-TEST^MR||RileyAIRA^JaliyahAIRA^Tahirah^^^^L|JosephineAIRA^TaylorAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1912 Ae Fryske Marren Ave^^Freeland^MI^48623^USA^P||^PRN^PH^^^989^2035660|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RileyAIRA^JosephineAIRA^^^^^L|MTH^Mother^HL70063|1912 Ae Fryske Marren Ave^^Freeland^MI^48623^USA^P|^PRN^PH^^^989^2035660ORC|RE||BL34S5039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL34S5039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0810-01^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0810-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V12H5047^^^AIRA-TEST^MR||StevensAIRA^EvangelineAIRA^Sylvie^^^^L|GallatinAIRA^KavitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1995 Vuizen Ave^^Grosse Pointe Park^MI^48224^USA^P||^PRN^PH^^^313^5814508|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StevensAIRA^GallatinAIRA^^^^^L|MTH^Mother^HL70063|1995 Vuizen Ave^^Grosse Pointe Park^MI^48224^USA^P|^PRN^PH^^^313^5814508ORC|RE||BV12H5047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV12H5047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0810-11^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0810-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I28F5055^^^AIRA-TEST^MR||KolarAIRA^MckenzieAIRA^Rachael^^^^L|HardinAIRA^SignyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1008 Tosterhout Cir^^Birmingham^MI^48009^USA^P||^PRN^PH^^^248^8866028|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KolarAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1008 Tosterhout Cir^^Birmingham^MI^48009^USA^P|^PRN^PH^^^248^8866028ORC|RE||BI28F5055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI28F5055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0810-43^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0810-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O58E5060^^^AIRA-TEST^MR||JeffersonAIRA^KyraAIRA^Brysen^^^^L|CusterAIRA^MayakoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1637 Zaag en Braassem St^^Alto^MI^49302^USA^P||^PRN^PH^^^616^5415641|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1637 Zaag en Braassem St^^Alto^MI^49302^USA^P|^PRN^PH^^^616^5415641ORC|RE||BO58E5060.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO58E5060.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0810-52^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0811-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y89F5068^^^AIRA-TEST^MR||WoodAIRA^SayokoAIRA^Anke^^^^L|KildahlAIRA^SandieAIRA^^^^^M|20101023|F||2106-3^White^CDCREC|1121 Mss Ave^^Northport^MI^49670^USA^P||^PRN^PH^^^231^7083392|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoodAIRA^KildahlAIRA^^^^^L|MTH^Mother^HL70063|1121 Mss Ave^^Northport^MI^49670^USA^P|^PRN^PH^^^231^7083392ORC|RE||BY89F5068.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20101223||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY89F5068.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110223||58160-0811-41^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110223||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0811-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B18F5079^^^AIRA-TEST^MR||DickAIRA^IdraAIRA^Aeryn^^^^L|AlleghenyAIRA^HoshiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1602 Vtadskanaal St^^Macomb Township^MI^48044^USA^P||^PRN^PH^^^586^5497346|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickAIRA^AlleghenyAIRA^^^^^L|MTH^Mother^HL70063|1602 Vtadskanaal St^^Macomb Township^MI^48044^USA^P|^PRN^PH^^^586^5497346ORC|RE||BB18F5079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB18F5079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0811-43^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0811-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L07O5087^^^AIRA-TEST^MR||ProvidenceAIRA^CiaraAIRA^Kisa^^^^L|Presque IsleAIRA^DamarisAIRA^^^^^M|20101023|F||2106-3^White^CDCREC|1059 Barneveld St^^Freedom Township^MI^48118^USA^P||^PRN^PH^^^734^4909451|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ProvidenceAIRA^Presque IsleAIRA^^^^^L|MTH^Mother^HL70063|1059 Barneveld St^^Freedom Township^MI^48118^USA^P|^PRN^PH^^^734^4909451ORC|RE||BL07O5087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20101223||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL07O5087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110223||58160-0811-51^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110223||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0811-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O34X5095^^^AIRA-TEST^MR||LoganAIRA^PoppyAIRA^Althea^^^^L|WyandotAIRA^BarbaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1905 Htrechtse Heuvelrug Ln^^Northville^MI^48168^USA^P||^PRN^PH^^^248^2422483|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoganAIRA^WyandotAIRA^^^^^L|MTH^Mother^HL70063|1905 Htrechtse Heuvelrug Ln^^Northville^MI^48168^USA^P|^PRN^PH^^^248^2422483ORC|RE||BO34X5095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO34X5095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0811-52^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0812-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L16S5100^^^AIRA-TEST^MR||JacksonAIRA^BarinaAIRA^Jael^^^^L|San Luis ObispoAIRA^CharmaineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1683 Kaadhoeke St^^Tekonsha^MI^49092^USA^P||^PRN^PH^^^517^5250109|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^San Luis ObispoAIRA^^^^^L|MTH^Mother^HL70063|1683 Kaadhoeke St^^Tekonsha^MI^49092^USA^P|^PRN^PH^^^517^5250109ORC|RE||BL16S5100.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL16S5100.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0812-01^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0812-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A55R5108^^^AIRA-TEST^MR||JohnsonAIRA^AncelinAIRA^Roisin^^^^L|TuscolaAIRA^KeshiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1716 Periode Ave^^Calumet^MI^49942^USA^P||^PRN^PH^^^906^5308291|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JohnsonAIRA^TuscolaAIRA^^^^^L|MTH^Mother^HL70063|1716 Periode Ave^^Calumet^MI^49942^USA^P|^PRN^PH^^^906^5308291ORC|RE||BA55R5108.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA55R5108.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0812-11^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0812-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q20L5119^^^AIRA-TEST^MR||SkagitAIRA^MaidaAIRA^Saniyah^^^^L|DuvalAIRA^MiahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1996 Lijn Ave^^McMillan^MI^49853^USA^P||^PRN^PH^^^906^7226623|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SkagitAIRA^DuvalAIRA^^^^^L|MTH^Mother^HL70063|1996 Lijn Ave^^McMillan^MI^49853^USA^P|^PRN^PH^^^906^7226623ORC|RE||BQ20L5119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ20L5119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0812-43^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0812-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C46F5127^^^AIRA-TEST^MR||AthensAIRA^KarlaAIRA^Sine^^^^L|NelsonAIRA^DavidaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1564 Loermond Pl^^Waters^MI^49797^USA^P||^PRN^PH^^^989^5361538|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AthensAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1564 Loermond Pl^^Waters^MI^49797^USA^P|^PRN^PH^^^989^5361538ORC|RE||BC46F5127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC46F5127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0812-52^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S22R5135^^^AIRA-TEST^MR||BoyleAIRA^AissaAIRA^Brooke^^^^L|CokeAIRA^ClarissaAIRA^^^^^M|20170406|F||2106-3^White^CDCREC|1184 Bluis Cir^^Meskegon^MI^49440^USA^P||^PRN^PH^^^231^4258741|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoyleAIRA^CokeAIRA^^^^^L|MTH^Mother^HL70063|1184 Bluis Cir^^Meskegon^MI^49440^USA^P|^PRN^PH^^^231^4258741ORC|RE||BS22R5135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170606||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS22R5135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170806||58160-0815-01^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170806||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N18F5140^^^AIRA-TEST^MR||GrayAIRA^HarvaAIRA^Semine^^^^L|OlsenAIRA^DonaldaAIRA^^^^^M|20170917|F||2106-3^White^CDCREC|1281 Sevenaar Pl^^Warren^MI^48088^USA^P||^PRN^PH^^^586^4370483|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrayAIRA^OlsenAIRA^^^^^L|MTH^Mother^HL70063|1281 Sevenaar Pl^^Warren^MI^48088^USA^P|^PRN^PH^^^586^4370483ORC|RE||BN18F5140.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20171117||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN18F5140.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180117||58160-0815-05^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180117||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O80T5148^^^AIRA-TEST^MR||KeithAIRA^EmanueleAIRA^Sabiha^^^^L|CheyenneAIRA^EdwinaAIRA^^^^^M|20170917|F||2106-3^White^CDCREC|1839 Zldebroek Cir^^Gerber Products Inc^MI^49413^USA^P||^PRN^PH^^^231^8326600|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KeithAIRA^CheyenneAIRA^^^^^L|MTH^Mother^HL70063|1839 Zldebroek Cir^^Gerber Products Inc^MI^49413^USA^P|^PRN^PH^^^231^8326600ORC|RE||BO80T5148.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20171117||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO80T5148.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180117||58160-0815-11^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180117||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q33A5159^^^AIRA-TEST^MR||McIntoshAIRA^PaytonAIRA^Neala^^^^L|SiegasAIRA^AmaiaAIRA^^^^^M|20170917|F||2106-3^White^CDCREC|1636 Koogeveen St^^Olivet^MI^49076^USA^P||^PRN^PH^^^269^5376587|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McIntoshAIRA^SiegasAIRA^^^^^L|MTH^Mother^HL70063|1636 Koogeveen St^^Olivet^MI^49076^USA^P|^PRN^PH^^^269^5376587ORC|RE||BQ33A5159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20171117||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ33A5159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180117||58160-0815-34^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180117||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V41Y5167^^^AIRA-TEST^MR||FranklinAIRA^AleighaAIRA^Saloni^^^^L|KaufmanAIRA^JacquelineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1391 Lenray St^^North Port^MI^49670^USA^P||^PRN^PH^^^231^3875900|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^KaufmanAIRA^^^^^L|MTH^Mother^HL70063|1391 Lenray St^^North Port^MI^49670^USA^P|^PRN^PH^^^231^3875900ORC|RE||BV41Y5167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV41Y5167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0815-41^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z17Z5175^^^AIRA-TEST^MR||ShoshoneAIRA^AbionaAIRA^Lia^^^^L|GrantAIRA^TosiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1844 Hpmeer St^^Muskegon^MI^49444^USA^P||^PRN^PH^^^231^6708777|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShoshoneAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1844 Hpmeer St^^Muskegon^MI^49444^USA^P|^PRN^PH^^^231^6708777ORC|RE||BZ17Z5175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ17Z5175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0815-43^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-46|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R89U5180^^^AIRA-TEST^MR||WhitmanAIRA^NorbertaAIRA^Thorborg^^^^L|ValleyAIRA^YaffaAIRA^^^^^M|20101002|F||2106-3^White^CDCREC|1029 Stad St^^Brownstwn Township^MI^48183^USA^P||^PRN^PH^^^734^2276519|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WhitmanAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1029 Stad St^^Brownstwn Township^MI^48183^USA^P|^PRN^PH^^^734^2276519ORC|RE||BR89U5180.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20101202||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR89U5180.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110202||58160-0815-46^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110202||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F59U5188^^^AIRA-TEST^MR||SundeAIRA^BreeAIRA^Tiana^^^^L|CowleyAIRA^KyrenaAIRA^^^^^M|20101226|F||2106-3^White^CDCREC|1177 Lenlo Ln^^Vernon City^MI^48429^USA^P||^PRN^PH^^^989^4060482|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SundeAIRA^CowleyAIRA^^^^^L|MTH^Mother^HL70063|1177 Lenlo Ln^^Vernon City^MI^48429^USA^P|^PRN^PH^^^989^4060482ORC|RE||BF59U5188.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110226||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF59U5188.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110426||58160-0815-48^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110426||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0815-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O50Y5199^^^AIRA-TEST^MR||MarionAIRA^HineAIRA^Bryony^^^^L|DanielsonAIRA^PallasAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1015 Oe Wolden Cir^^Niles^MI^49120^USA^P||^PRN^PH^^^269^2703095|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarionAIRA^DanielsonAIRA^^^^^L|MTH^Mother^HL70063|1015 Oe Wolden Cir^^Niles^MI^49120^USA^P|^PRN^PH^^^269^2703095ORC|RE||BO50Y5199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO50Y5199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0815-52^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0816-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A15H5207^^^AIRA-TEST^MR||ShortAIRA^KeyannaAIRA^Alyssa^^^^L|WallerAIRA^AdrianoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1724 Bindhoven Cir^^Au Train^MI^49806^USA^P||^PRN^PH^^^906^5977076|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShortAIRA^WallerAIRA^^^^^L|MTH^Mother^HL70063|1724 Bindhoven Cir^^Au Train^MI^49806^USA^P|^PRN^PH^^^906^5977076ORC|RE||BA15H5207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA15H5207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0816-01^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0816-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R84S5215^^^AIRA-TEST^MR||BoyleAIRA^NeerjaAIRA^Terena^^^^L|BremerAIRA^ZambdaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1778 Kolonie Ln^^Ira^MI^48023^USA^P||^PRN^PH^^^810^2331370|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoyleAIRA^BremerAIRA^^^^^L|MTH^Mother^HL70063|1778 Kolonie Ln^^Ira^MI^48023^USA^P|^PRN^PH^^^810^2331370ORC|RE||BR84S5215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR84S5215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0816-05^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0818-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G81M5220^^^AIRA-TEST^MR||OkanoganAIRA^KarenAIRA^Erianthe^^^^L|AldridgeAIRA^SmritiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1315 Goudenberg Ave^^Wolverine Lake^MI^48390^USA^P||^PRN^PH^^^248^8116190|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OkanoganAIRA^AldridgeAIRA^^^^^L|MTH^Mother^HL70063|1315 Goudenberg Ave^^Wolverine Lake^MI^48390^USA^P|^PRN^PH^^^248^8116190ORC|RE||BG81M5220.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG81M5220.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0818-11^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0819-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X96G5228^^^AIRA-TEST^MR||San FranciscoAIRA^AnnalynnAIRA^Linh^^^^L|ChambersAIRA^ReneeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1412 Dissewaard Ave^^Litchfield^MI^49252^USA^P||^PRN^PH^^^517^8199691|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San FranciscoAIRA^ChambersAIRA^^^^^L|MTH^Mother^HL70063|1412 Dissewaard Ave^^Litchfield^MI^49252^USA^P|^PRN^PH^^^517^8199691ORC|RE||BX96G5228.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX96G5228.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0819-12^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0820-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V53R5239^^^AIRA-TEST^MR||ButlerAIRA^NetanyaAIRA^Indaliai^^^^L|HeffordAIRA^DevorahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1787 Poerdalen Cir^^Conklin^MI^49403^USA^P||^PRN^PH^^^616^5595838|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButlerAIRA^HeffordAIRA^^^^^L|MTH^Mother^HL70063|1787 Poerdalen Cir^^Conklin^MI^49403^USA^P|^PRN^PH^^^616^5595838ORC|RE||BV53R5239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV53R5239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0820-01^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0820-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L45C5247^^^AIRA-TEST^MR||BucksAIRA^LysAIRA^Amorina^^^^L|Walla WallaAIRA^KuntiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1552 Straight Ln^^Farmingtn Hls^MI^48336^USA^P||^PRN^PH^^^248^5954652|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BucksAIRA^Walla WallaAIRA^^^^^L|MTH^Mother^HL70063|1552 Straight Ln^^Farmingtn Hls^MI^48336^USA^P|^PRN^PH^^^248^5954652ORC|RE||BL45C5247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL45C5247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0820-11^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0820-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V88T5255^^^AIRA-TEST^MR||CarlisleAIRA^SitaraAIRA^Saffi^^^^L|ClayAIRA^RayelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1451 Klap Ln^^Gladstone^MI^49837^USA^P||^PRN^PH^^^906^7192238|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarlisleAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1451 Klap Ln^^Gladstone^MI^49837^USA^P|^PRN^PH^^^906^7192238ORC|RE||BV88T5255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV88T5255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0820-43^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0820-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H97Q5260^^^AIRA-TEST^MR||StarrAIRA^TegenAIRA^Lene^^^^L|TownAIRA^LemuelaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1249 Meumen Cir^^Cadillac^MI^49601^USA^P||^PRN^PH^^^231^4694501|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StarrAIRA^TownAIRA^^^^^L|MTH^Mother^HL70063|1249 Meumen Cir^^Cadillac^MI^49601^USA^P|^PRN^PH^^^231^4694501ORC|RE||BH97Q5260.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH97Q5260.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0820-52^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0821-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D39U5268^^^AIRA-TEST^MR||MartinAIRA^CalendreAIRA^Aubina^^^^L|AllottAIRA^PanyinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1305 Sijkerk Cir^^Copemish^MI^49625^USA^P||^PRN^PH^^^231^6413429|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MartinAIRA^AllottAIRA^^^^^L|MTH^Mother^HL70063|1305 Sijkerk Cir^^Copemish^MI^49625^USA^P|^PRN^PH^^^231^6413429ORC|RE||BD39U5268.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD39U5268.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0821-01^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0821-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M17V5279^^^AIRA-TEST^MR||KrogAIRA^AmarisAIRA^Arielle^^^^L|RobertsAIRA^SuparnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1301 Keerde Ave^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^4800798|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KrogAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1301 Keerde Ave^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^4800798ORC|RE||BM17V5279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM17V5279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0821-05^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0821-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G57O5287^^^AIRA-TEST^MR||CameronAIRA^DeieneAIRA^Evette^^^^L|ParmerAIRA^MayeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1621 Mij St^^Columbus Township^MI^48063^USA^P||^PRN^PH^^^810^3063752|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CameronAIRA^ParmerAIRA^^^^^L|MTH^Mother^HL70063|1621 Mij St^^Columbus Township^MI^48063^USA^P|^PRN^PH^^^810^3063752ORC|RE||BG57O5287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG57O5287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0821-11^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0821-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G19O5295^^^AIRA-TEST^MR||OntonagonAIRA^KylieAIRA^Jermain^^^^L|SaloAIRA^PetraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1741 Lestland Ave^^Rothbury^MI^49452^USA^P||^PRN^PH^^^231^9172549|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OntonagonAIRA^SaloAIRA^^^^^L|MTH^Mother^HL70063|1741 Lestland Ave^^Rothbury^MI^49452^USA^P|^PRN^PH^^^231^9172549ORC|RE||BG19O5295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG19O5295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0821-34^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0821-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K76C5300^^^AIRA-TEST^MR||RichardsonAIRA^SkylarAIRA^Lani^^^^L|IslandAIRA^RupaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1004 Taal Ave^^Westwood^MI^49006^USA^P||^PRN^PH^^^269^5789044|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichardsonAIRA^IslandAIRA^^^^^L|MTH^Mother^HL70063|1004 Taal Ave^^Westwood^MI^49006^USA^P|^PRN^PH^^^269^5789044ORC|RE||BK76C5300.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK76C5300.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0821-43^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0821-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A32W5308^^^AIRA-TEST^MR||GarrardAIRA^MineAIRA^Lara^^^^L|ThrockmortonAIRA^MarthaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1214 Rerneuzen Ln^^Alpha^MI^49902^USA^P||^PRN^PH^^^906^3328134|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarrardAIRA^ThrockmortonAIRA^^^^^L|MTH^Mother^HL70063|1214 Rerneuzen Ln^^Alpha^MI^49902^USA^P|^PRN^PH^^^906^3328134ORC|RE||BA32W5308.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA32W5308.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0821-52^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0823-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E64E5319^^^AIRA-TEST^MR||HolmfAIRA^AristaAIRA^Catalina^^^^L|EvansAIRA^AntoinetteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1361 Leesel Ave^^Montgomery^MI^49255^USA^P||^PRN^PH^^^517^6925491|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HolmfAIRA^EvansAIRA^^^^^L|MTH^Mother^HL70063|1361 Leesel Ave^^Montgomery^MI^49255^USA^P|^PRN^PH^^^517^6925491ORC|RE||BE64E5319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE64E5319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0823-11^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0825-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U59B5327^^^AIRA-TEST^MR||BrackenAIRA^MalavikaAIRA^Kajol^^^^L|LohmannAIRA^ElexusAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1019 Korsele St^^Saint Clair Shores^MI^48082^USA^P||^PRN^PH^^^586^7459915|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrackenAIRA^LohmannAIRA^^^^^L|MTH^Mother^HL70063|1019 Korsele St^^Saint Clair Shores^MI^48082^USA^P|^PRN^PH^^^586^7459915ORC|RE||BU59B5327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU59B5327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0825-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0825-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y00J5335^^^AIRA-TEST^MR||EsceibreAIRA^TulasiAIRA^Vespera^^^^L|Van BurenAIRA^SimranAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1827 Schaal Cir^^Grand Rapids^MI^49501^USA^P||^PRN^PH^^^616^5808497|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EsceibreAIRA^Van BurenAIRA^^^^^L|MTH^Mother^HL70063|1827 Schaal Cir^^Grand Rapids^MI^49501^USA^P|^PRN^PH^^^616^5808497ORC|RE||BY00J5335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY00J5335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0825-11^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0825-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G19G5340^^^AIRA-TEST^MR||HarrisonAIRA^NamiAIRA^Sanjula^^^^L|PerryAIRA^AcaciaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1887 Geeze-Leende Cir^^Ann Arbor^MI^48109^USA^P||^PRN^PH^^^734^7601507|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1887 Geeze-Leende Cir^^Ann Arbor^MI^48109^USA^P|^PRN^PH^^^734^7601507ORC|RE||BG19G5340.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG19G5340.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0825-43^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0825-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V67B5348^^^AIRA-TEST^MR||HaughtonAIRA^KarimaAIRA^Linnet^^^^L|BradfordAIRA^PendaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1583 Tidden-Delfland Ln^^Bloomfield^MI^48302^USA^P||^PRN^PH^^^248^8537856|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaughtonAIRA^BradfordAIRA^^^^^L|MTH^Mother^HL70063|1583 Tidden-Delfland Ln^^Bloomfield^MI^48302^USA^P|^PRN^PH^^^248^8537856ORC|RE||BV67B5348.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV67B5348.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0825-52^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0826-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I91E5359^^^AIRA-TEST^MR||GravesAIRA^KimbaAIRA^Vivienne^^^^L|AlpineAIRA^HarrietAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1647 Vermenigvuldigen Ln^^Highland Park^MI^48203^USA^P||^PRN^PH^^^313^9635391|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GravesAIRA^AlpineAIRA^^^^^L|MTH^Mother^HL70063|1647 Vermenigvuldigen Ln^^Highland Park^MI^48203^USA^P|^PRN^PH^^^313^9635391ORC|RE||BI91E5359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI91E5359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0826-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0826-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q49L5367^^^AIRA-TEST^MR||YakimaAIRA^AddysonAIRA^Eirwen^^^^L|MarionAIRA^HadleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1372 Steenbergen St^^Duncan^MI^48131^USA^P||^PRN^PH^^^734^7738650|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YakimaAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1372 Steenbergen St^^Duncan^MI^48131^USA^P|^PRN^PH^^^734^7738650ORC|RE||BQ49L5367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ49L5367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0826-05^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0826-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z04M5375^^^AIRA-TEST^MR||HygensAIRA^VerrinAIRA^Lisette^^^^L|TillmanAIRA^IoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1564 Kleden Ln^^Nunica^MI^49448^USA^P||^PRN^PH^^^616^3887052|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HygensAIRA^TillmanAIRA^^^^^L|MTH^Mother^HL70063|1564 Kleden Ln^^Nunica^MI^49448^USA^P|^PRN^PH^^^616^3887052ORC|RE||BZ04M5375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ04M5375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0826-11^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0826-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q18Y5380^^^AIRA-TEST^MR||BlancoAIRA^SushmitaAIRA^Etienette^^^^L|StanislausAIRA^AmiceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1531 Valkenburg aan de Geul St^^West Bloomfield^MI^48324^USA^P||^PRN^PH^^^248^4739617|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlancoAIRA^StanislausAIRA^^^^^L|MTH^Mother^HL70063|1531 Valkenburg aan de Geul St^^West Bloomfield^MI^48324^USA^P|^PRN^PH^^^248^4739617ORC|RE||BQ18Y5380.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ18Y5380.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0826-34^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0826-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M13V5388^^^AIRA-TEST^MR||MetcalfeAIRA^AngeniAIRA^Zandra^^^^L|KingAIRA^PhilidaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1736 Huidige Cir^^Walled Lake^MI^48391^USA^P||^PRN^PH^^^248^7205396|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MetcalfeAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1736 Huidige Cir^^Walled Lake^MI^48391^USA^P|^PRN^PH^^^248^7205396ORC|RE||BM13V5388.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM13V5388.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0826-43^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0826-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U12R5399^^^AIRA-TEST^MR||BrackenAIRA^HelenaAIRA^Maleah^^^^L|WebsterAIRA^TamiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1449 Coevorden St^^Pullman^MI^49450^USA^P||^PRN^PH^^^269^8612774|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrackenAIRA^WebsterAIRA^^^^^L|MTH^Mother^HL70063|1449 Coevorden St^^Pullman^MI^49450^USA^P|^PRN^PH^^^269^8612774ORC|RE||BU12R5399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU12R5399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0826-52^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0828-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P84K5407^^^AIRA-TEST^MR||AmmensAIRA^MajestaAIRA^Emmett^^^^L|PacificAIRA^WallisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1921 Wlkmaar Ln^^Lennon^MI^48449^USA^P||^PRN^PH^^^989^6098085|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AmmensAIRA^PacificAIRA^^^^^L|MTH^Mother^HL70063|1921 Wlkmaar Ln^^Lennon^MI^48449^USA^P|^PRN^PH^^^989^6098085ORC|RE||BP84K5407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP84K5407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0828-01^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0828-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I33F5415^^^AIRA-TEST^MR||FresnoAIRA^BeryanAIRA^Barnadine^^^^L|HoggAIRA^DelilaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1908 Laat Cir^^Arcadia^MI^49613^USA^P||^PRN^PH^^^231^4525385|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FresnoAIRA^HoggAIRA^^^^^L|MTH^Mother^HL70063|1908 Laat Cir^^Arcadia^MI^49613^USA^P|^PRN^PH^^^231^4525385ORC|RE||BI33F5415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI33F5415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0828-03^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0830-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D37B5420^^^AIRA-TEST^MR||WashingtonAIRA^JeannetteAIRA^Rowan^^^^L|JonsonAIRA^AzariaAIRA^^^^^M|20160728|F||2106-3^White^CDCREC|1315 Tinsum Cir^^Vernon^MI^48476^USA^P||^PRN^PH^^^989^4275810|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^JonsonAIRA^^^^^L|MTH^Mother^HL70063|1315 Tinsum Cir^^Vernon^MI^48476^USA^P|^PRN^PH^^^989^4275810ORC|RE||BD37B5420.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160928||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD37B5420.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161128||58160-0830-05^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161128||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0830-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R01P5428^^^AIRA-TEST^MR||GreenupAIRA^NonaAIRA^Bedelia^^^^L|WoodfordAIRA^SionedAIRA^^^^^M|20160728|F||2106-3^White^CDCREC|1816 Zud-Beijerland Ln^^Flint^MI^48531^USA^P||^PRN^PH^^^810^9486926|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenupAIRA^WoodfordAIRA^^^^^L|MTH^Mother^HL70063|1816 Zud-Beijerland Ln^^Flint^MI^48531^USA^P|^PRN^PH^^^810^9486926ORC|RE||BR01P5428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160928||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR01P5428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161128||58160-0830-34^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161128||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0830-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A14M5439^^^AIRA-TEST^MR||TillmanAIRA^TarshaAIRA^Voletta^^^^L|NordbyAIRA^AngeniAIRA^^^^^M|20160728|F||2106-3^White^CDCREC|1391 Echijndel Pl^^Bloomfield Hills^MI^48304^USA^P||^PRN^PH^^^248^4637487|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TillmanAIRA^NordbyAIRA^^^^^L|MTH^Mother^HL70063|1391 Echijndel Pl^^Bloomfield Hills^MI^48304^USA^P|^PRN^PH^^^248^4637487ORC|RE||BA14M5439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160928||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA14M5439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161128||58160-0830-43^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161128||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0830-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T77W5447^^^AIRA-TEST^MR||ClayAIRA^AdelleAIRA^Senta^^^^L|BinghamAIRA^AlzenaAIRA^^^^^M|20160728|F||2106-3^White^CDCREC|1613 Van Ln^^Muskegon^MI^49443^USA^P||^PRN^PH^^^231^9224376|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClayAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1613 Van Ln^^Muskegon^MI^49443^USA^P|^PRN^PH^^^231^9224376ORC|RE||BT77W5447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160928||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT77W5447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161128||58160-0830-52^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161128||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0842-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V10U5455^^^AIRA-TEST^MR||KinnearAIRA^KrystleAIRA^Sandi^^^^L|GregoryAIRA^CatheeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1087 Peere Pl^^Minden City^MI^48465^USA^P||^PRN^PH^^^989^2758005|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KinnearAIRA^GregoryAIRA^^^^^L|MTH^Mother^HL70063|1087 Peere Pl^^Minden City^MI^48465^USA^P|^PRN^PH^^^989^2758005ORC|RE||BV10U5455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV10U5455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0842-01^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0842-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U43T5460^^^AIRA-TEST^MR||MarrietteAIRA^DovaAIRA^Wanika^^^^L|HenryAIRA^KierraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1566 Oundert St^^Sault S Marie^MI^49783^USA^P||^PRN^PH^^^906^8699193|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarrietteAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1566 Oundert St^^Sault S Marie^MI^49783^USA^P|^PRN^PH^^^906^8699193ORC|RE||BU43T5460.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU43T5460.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0842-05^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0842-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A07Y5468^^^AIRA-TEST^MR||HallAIRA^MoreenAIRA^Shiloh^^^^L|BarkerAIRA^TameraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1238 Prnhem Ln^^Columbus^MI^48063^USA^P||^PRN^PH^^^810^2522217|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HallAIRA^BarkerAIRA^^^^^L|MTH^Mother^HL70063|1238 Prnhem Ln^^Columbus^MI^48063^USA^P|^PRN^PH^^^810^2522217ORC|RE||BA07Y5468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA07Y5468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0842-11^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0842-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y03Y5479^^^AIRA-TEST^MR||HardemanAIRA^RhodantheAIRA^Mair^^^^L|MorrellAIRA^NeomaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1051 Wlst-Wijhe Cir^^Charlevoix^MI^49711^USA^P||^PRN^PH^^^231^2790992|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardemanAIRA^MorrellAIRA^^^^^L|MTH^Mother^HL70063|1051 Wlst-Wijhe Cir^^Charlevoix^MI^49711^USA^P|^PRN^PH^^^231^2790992ORC|RE||BY03Y5479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY03Y5479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0842-34^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0842-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M92T5487^^^AIRA-TEST^MR||OwyheeAIRA^BeauAIRA^Lisabeth^^^^L|HillsdaleAIRA^MimosaAIRA^^^^^M|20110214|F||2106-3^White^CDCREC|1178 Gilze en Rijen Ln^^Farmingtn Hls^MI^48333^USA^P||^PRN^PH^^^248^3397659|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwyheeAIRA^HillsdaleAIRA^^^^^L|MTH^Mother^HL70063|1178 Gilze en Rijen Ln^^Farmingtn Hls^MI^48333^USA^P|^PRN^PH^^^248^3397659ORC|RE||BM92T5487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110414||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM92T5487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110614||58160-0842-41^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110614||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0842-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I22W5495^^^AIRA-TEST^MR||OwyheeAIRA^MariamAIRA^Suprabha^^^^L|JacksonAIRA^RuellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1447 Seusden St^^Brighton^MI^48114^USA^P||^PRN^PH^^^810^7523475|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwyheeAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1447 Seusden St^^Brighton^MI^48114^USA^P|^PRN^PH^^^810^7523475ORC|RE||BI22W5495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI22W5495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0842-43^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0842-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y44Q5500^^^AIRA-TEST^MR||KjerulfAIRA^EmilyAIRA^Saba^^^^L|RichlandAIRA^SilviaAIRA^^^^^M|20110214|F||2106-3^White^CDCREC|1363 Oemsmond St^^Hudson Mills^MI^48130^USA^P||^PRN^PH^^^734^4378120|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KjerulfAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1363 Oemsmond St^^Hudson Mills^MI^48130^USA^P|^PRN^PH^^^734^4378120ORC|RE||BY44Q5500.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110414||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY44Q5500.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110614||58160-0842-51^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110614||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0842-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q61E5508^^^AIRA-TEST^MR||FayetteAIRA^AuroraAIRA^Frederika^^^^L|GelfryAIRA^LareineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1584 Jonge Pl^^Otisville^MI^48463^USA^P||^PRN^PH^^^810^9459182|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FayetteAIRA^GelfryAIRA^^^^^L|MTH^Mother^HL70063|1584 Jonge Pl^^Otisville^MI^48463^USA^P|^PRN^PH^^^810^9459182ORC|RE||BQ61E5508.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ61E5508.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0842-52^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0851-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T20P5519^^^AIRA-TEST^MR||HendersonAIRA^FaeAIRA^Lane^^^^L|OkanoganAIRA^PalilaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1596 Geboren Ave^^Grosse Pointe Farms^MI^48236^USA^P||^PRN^PH^^^313^8243356|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HendersonAIRA^OkanoganAIRA^^^^^L|MTH^Mother^HL70063|1596 Geboren Ave^^Grosse Pointe Farms^MI^48236^USA^P|^PRN^PH^^^313^8243356ORC|RE||BT20P5519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT20P5519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0851-01^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0854-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P66F5527^^^AIRA-TEST^MR||PetersenAIRA^NylahAIRA^Veleda^^^^L|ClarksonAIRA^DextraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1264 Vloemendaal Ln^^Muskegon^MI^49442^USA^P||^PRN^PH^^^231^7316425|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PetersenAIRA^ClarksonAIRA^^^^^L|MTH^Mother^HL70063|1264 Vloemendaal Ln^^Muskegon^MI^49442^USA^P|^PRN^PH^^^231^7316425ORC|RE||BP66F5527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP66F5527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0854-52^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0879-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X71U5535^^^AIRA-TEST^MR||StallardAIRA^AldabellaAIRA^Ursala^^^^L|ClevelandAIRA^NeliaAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1620 Sromstrijen Cir^^Kentwood^MI^49546^USA^P||^PRN^PH^^^616^8481470|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StallardAIRA^ClevelandAIRA^^^^^L|MTH^Mother^HL70063|1620 Sromstrijen Cir^^Kentwood^MI^49546^USA^P|^PRN^PH^^^616^8481470ORC|RE||BX71U5535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX71U5535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||58160-0879-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0879-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G93Q5540^^^AIRA-TEST^MR||BohneAIRA^MalkahAIRA^Jesal^^^^L|KendallAIRA^SageAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1574 Castricum Pl^^Chesterfield Township^MI^48047^USA^P||^PRN^PH^^^586^7534207|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BohneAIRA^KendallAIRA^^^^^L|MTH^Mother^HL70063|1574 Castricum Pl^^Chesterfield Township^MI^48047^USA^P|^PRN^PH^^^586^7534207ORC|RE||BG93Q5540.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG93Q5540.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||58160-0879-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0880-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y73E5545^^^AIRA-TEST^MR||RussellAIRA^AriaAIRA^Cali^^^^L|JohnsonAIRA^TeanAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1358 Zuidhorn Ave^^Kenton^MI^49967^USA^P||^PRN^PH^^^906^8736170|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RussellAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1358 Zuidhorn Ave^^Kenton^MI^49967^USA^P|^PRN^PH^^^906^8736170ORC|RE||BY73E5545.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY73E5545.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||58160-0880-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0880-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U50S5556^^^AIRA-TEST^MR||ClarkeAIRA^AncillaAIRA^Tresa^^^^L|LokkenAIRA^AcediaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1886 Dersel Pl^^Lyndon Township^MI^48118^USA^P||^PRN^PH^^^734^3650090|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClarkeAIRA^LokkenAIRA^^^^^L|MTH^Mother^HL70063|1886 Dersel Pl^^Lyndon Township^MI^48118^USA^P|^PRN^PH^^^734^3650090ORC|RE||BU50S5556.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU50S5556.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||58160-0880-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0881-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M14N5567^^^AIRA-TEST^MR||PerryAIRA^AnnabelAIRA^Brielle^^^^L|BrooksAIRA^RoyaleAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1093 Ooerden Ln^^Sand Lake^MI^49343^USA^P||^PRN^PH^^^616^3156405|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PerryAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1093 Ooerden Ln^^Sand Lake^MI^49343^USA^P|^PRN^PH^^^616^3156405ORC|RE||BM14N5567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM14N5567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||58160-0881-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0881-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M54N5575^^^AIRA-TEST^MR||PinalAIRA^RevatiAIRA^Achit^^^^L|WayneAIRA^DaisyAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1147 Werk Ln^^Lincoln Park^MI^48146^USA^P||^PRN^PH^^^313^7994960|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PinalAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1147 Werk Ln^^Lincoln Park^MI^48146^USA^P|^PRN^PH^^^313^7994960ORC|RE||BM54N5575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM54N5575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||58160-0881-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0883-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K25G5583^^^AIRA-TEST^MR||LynchAIRA^JoakimaAIRA^Trudy^^^^L|SullivanAIRA^AprilAIRA^^^^^M|20150403|F||2106-3^White^CDCREC|1152 Oppervlak Ave^^Boyne Falls^MI^49713^USA^P||^PRN^PH^^^231^2301545|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LynchAIRA^SullivanAIRA^^^^^L|MTH^Mother^HL70063|1152 Oppervlak Ave^^Boyne Falls^MI^49713^USA^P|^PRN^PH^^^231^2301545ORC|RE||BK25G5583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150603||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK25G5583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150803||58160-0883-41^Fluarix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150803||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0883-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D91S5591^^^AIRA-TEST^MR||SimpsonAIRA^JosieAIRA^Andrea^^^^L|Santa ClaraAIRA^WalburgaAIRA^^^^^M|20150403|F||2106-3^White^CDCREC|1847 Waag en Braassem Ln^^North Lakeport^MI^48059^USA^P||^PRN^PH^^^810^3361396|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SimpsonAIRA^Santa ClaraAIRA^^^^^L|MTH^Mother^HL70063|1847 Waag en Braassem Ln^^North Lakeport^MI^48059^USA^P|^PRN^PH^^^810^3361396ORC|RE||BD91S5591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150603||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD91S5591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150803||58160-0883-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150803||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0898-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E36O5599^^^AIRA-TEST^MR||CoosAIRA^ShantalAIRA^Melosa^^^^L|AdairAIRA^OderaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1208 Nollands Kroon Ave^^Grand Rapids^MI^49505^USA^P||^PRN^PH^^^616^4347371|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoosAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1208 Nollands Kroon Ave^^Grand Rapids^MI^49505^USA^P|^PRN^PH^^^616^4347371ORC|RE||BE36O5599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE36O5599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0898-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0898-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z92I5604^^^AIRA-TEST^MR||MontgomeryAIRA^DelaneyAIRA^Quinta^^^^L|OatesAIRA^LorrettaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1859 Valkenswaard Cir^^Galien^MI^49113^USA^P||^PRN^PH^^^269^9463084|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontgomeryAIRA^OatesAIRA^^^^^L|MTH^Mother^HL70063|1859 Valkenswaard Cir^^Galien^MI^49113^USA^P|^PRN^PH^^^269^9463084ORC|RE||BZ92I5604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ92I5604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0898-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0900-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O14R5612^^^AIRA-TEST^MR||CliveAIRA^LucineAIRA^Chika^^^^L|San Luis ObispoAIRA^CorneliaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1431 Goeree-Overflakkee St^^Htn Lk Hghts^MI^48630^USA^P||^PRN^PH^^^989^6477600|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CliveAIRA^San Luis ObispoAIRA^^^^^L|MTH^Mother^HL70063|1431 Goeree-Overflakkee St^^Htn Lk Hghts^MI^48630^USA^P|^PRN^PH^^^989^6477600ORC|RE||BO14R5612.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO14R5612.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||58160-0900-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0900-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F44M5623^^^AIRA-TEST^MR||BedfordAIRA^DeeAIRA^Tejal^^^^L|KentonAIRA^KayaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1266 Veststellingwerf Cir^^Bailey^MI^49303^USA^P||^PRN^PH^^^231^4334836|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BedfordAIRA^KentonAIRA^^^^^L|MTH^Mother^HL70063|1266 Veststellingwerf Cir^^Bailey^MI^49303^USA^P|^PRN^PH^^^231^4334836ORC|RE||BF44M5623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF44M5623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||58160-0900-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0901-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H85K5631^^^AIRA-TEST^MR||ThiemerAIRA^YoginiAIRA^Navdeep^^^^L|O'DonnellAIRA^ZariahAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1021 Eoevorden St^^Sumner^MI^48889^USA^P||^PRN^PH^^^989^6702313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThiemerAIRA^O'DonnellAIRA^^^^^L|MTH^Mother^HL70063|1021 Eoevorden St^^Sumner^MI^48889^USA^P|^PRN^PH^^^989^6702313ORC|RE||BH85K5631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH85K5631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||58160-0901-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0901-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y70N5639^^^AIRA-TEST^MR||HoeyAIRA^ZaharaAIRA^Aspen^^^^L|OtsegoAIRA^LudellaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1523 Vught Pl^^Battle Creek^MI^49015^USA^P||^PRN^PH^^^269^2924817|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoeyAIRA^OtsegoAIRA^^^^^L|MTH^Mother^HL70063|1523 Vught Pl^^Battle Creek^MI^49015^USA^P|^PRN^PH^^^269^2924817ORC|RE||BY70N5639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY70N5639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||58160-0901-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0903-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V38U5644^^^AIRA-TEST^MR||BreckinridgeAIRA^NetanyaAIRA^Atifa^^^^L|KnightAIRA^SaraiAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1538 Aalkenswaard St^^Henderson^MI^48841^USA^P||^PRN^PH^^^989^6906398|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BreckinridgeAIRA^KnightAIRA^^^^^L|MTH^Mother^HL70063|1538 Aalkenswaard St^^Henderson^MI^48841^USA^P|^PRN^PH^^^989^6906398ORC|RE||BV38U5644.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV38U5644.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||58160-0903-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0903-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G20X5652^^^AIRA-TEST^MR||KingsAIRA^LemuelaAIRA^Cher^^^^L|TrinityAIRA^SafakAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1364 Strijen Pl^^Atlas^MI^48411^USA^P||^PRN^PH^^^810^6866314|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingsAIRA^TrinityAIRA^^^^^L|MTH^Mother^HL70063|1364 Strijen Pl^^Atlas^MI^48411^USA^P|^PRN^PH^^^810^6866314ORC|RE||BG20X5652.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG20X5652.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||58160-0903-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0905-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W06F5663^^^AIRA-TEST^MR||DallamAIRA^OttaviaAIRA^Rozanne^^^^L|WilliamsAIRA^NitikaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1020 Dilburg Ave^^Brownstwn Township^MI^48173^USA^P||^PRN^PH^^^734^4801357|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallamAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1020 Dilburg Ave^^Brownstwn Township^MI^48173^USA^P|^PRN^PH^^^734^4801357ORC|RE||BW06F5663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW06F5663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||58160-0905-41^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0905-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F36S5671^^^AIRA-TEST^MR||McCurtainAIRA^KadijaAIRA^Tathra^^^^L|PottawattamieAIRA^RajniAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1510 Momenteel Ln^^Canton Township^MI^48188^USA^P||^PRN^PH^^^734^9441584|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCurtainAIRA^PottawattamieAIRA^^^^^L|MTH^Mother^HL70063|1510 Momenteel Ln^^Canton Township^MI^48188^USA^P|^PRN^PH^^^734^9441584ORC|RE||BF36S5671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF36S5671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||58160-0905-52^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0907-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T10Z5679^^^AIRA-TEST^MR||BannerAIRA^AislingAIRA^Tamsin^^^^L|KinneyAIRA^RosalbaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1478 Wittenseradiel Cir^^Northwest^MI^48504^USA^P||^PRN^PH^^^810^2043107|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BannerAIRA^KinneyAIRA^^^^^L|MTH^Mother^HL70063|1478 Wittenseradiel Cir^^Northwest^MI^48504^USA^P|^PRN^PH^^^810^2043107ORC|RE||BT10Z5679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT10Z5679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||58160-0907-41^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0907-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X46I5684^^^AIRA-TEST^MR||ClayAIRA^FaeAIRA^Felda^^^^L|ClayAIRA^AzadehAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1067 Kaag en Braassem Cir^^Muskegon^MI^49444^USA^P||^PRN^PH^^^231^9602102|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClayAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1067 Kaag en Braassem Cir^^Muskegon^MI^49444^USA^P|^PRN^PH^^^231^9602102ORC|RE||BX46I5684.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX46I5684.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||58160-0907-52^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0955-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q56C5692^^^AIRA-TEST^MR||CameronAIRA^JackyAIRA^Fotini^^^^L|BuchananAIRA^ZavannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1516 Saasdriel Cir^^Brownstown^MI^48173^USA^P||^PRN^PH^^^734^3429794|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CameronAIRA^BuchananAIRA^^^^^L|MTH^Mother^HL70063|1516 Saasdriel Cir^^Brownstown^MI^48173^USA^P|^PRN^PH^^^734^3429794ORC|RE||BQ56C5692.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ56C5692.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0955-09^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0958-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M07C5703^^^AIRA-TEST^MR||LawrenceAIRA^AdelinaAIRA^Sarah^^^^L|ColemanAIRA^HollyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1504 Leidschendam-Voorburg Ave^^Norway^MI^49870^USA^P||^PRN^PH^^^906^7304146|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LawrenceAIRA^ColemanAIRA^^^^^L|MTH^Mother^HL70063|1504 Leidschendam-Voorburg Ave^^Norway^MI^49870^USA^P|^PRN^PH^^^906^7304146ORC|RE||BM07C5703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM07C5703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0958-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0959-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S37I5711^^^AIRA-TEST^MR||McCrearyAIRA^MalakAIRA^Maiya^^^^L|FremstadAIRA^AdielAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1538 Bmallingerland Cir^^Fife Lake^MI^49633^USA^P||^PRN^PH^^^231^7340868|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCrearyAIRA^FremstadAIRA^^^^^L|MTH^Mother^HL70063|1538 Bmallingerland Cir^^Fife Lake^MI^49633^USA^P|^PRN^PH^^^231^7340868ORC|RE||BS37I5711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS37I5711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0959-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0964-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F82R5719^^^AIRA-TEST^MR||WilsonAIRA^HubertaAIRA^Cheyenne^^^^L|JeffersonAIRA^BarinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1215 Eidden-Drenthe St^^Hiawatha Temp Correction Fac^MI^49786^USA^P||^PRN^PH^^^906^4206471|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilsonAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1215 Eidden-Drenthe St^^Hiawatha Temp Correction Fac^MI^49786^USA^P|^PRN^PH^^^906^4206471ORC|RE||BF82R5719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF82R5719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0964-12^RABAVERT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0966-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D51A5724^^^AIRA-TEST^MR||EdmundsAIRA^AaliyahAIRA^Sarai^^^^L|GillespieAIRA^BrynnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1164 Lergeijk Ln^^Pinckney^MI^48169^USA^P||^PRN^PH^^^734^2331135|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EdmundsAIRA^GillespieAIRA^^^^^L|MTH^Mother^HL70063|1164 Lergeijk Ln^^Pinckney^MI^48169^USA^P|^PRN^PH^^^734^2331135ORC|RE||BD51A5724.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD51A5724.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0966-01^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0966-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J78U5732^^^AIRA-TEST^MR||BexarAIRA^VaisakhiAIRA^Anteia^^^^L|DurbinAIRA^ErinAIRA^^^^^M|20160819|F||2106-3^White^CDCREC|1081 Gwenterand Cir^^China Township^MI^48054^USA^P||^PRN^PH^^^810^7392945|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BexarAIRA^DurbinAIRA^^^^^L|MTH^Mother^HL70063|1081 Gwenterand Cir^^China Township^MI^48054^USA^P|^PRN^PH^^^810^7392945ORC|RE||BJ78U5732.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161019||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ78U5732.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161219||58160-0966-12^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161219||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0976-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K29X5743^^^AIRA-TEST^MR||ArenacAIRA^JonquilAIRA^Sahana^^^^L|BremerAIRA^KarinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1616 We Bilt Cir^^Brooklyn^MI^49230^USA^P||^PRN^PH^^^517^5869810|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ArenacAIRA^BremerAIRA^^^^^L|MTH^Mother^HL70063|1616 We Bilt Cir^^Brooklyn^MI^49230^USA^P|^PRN^PH^^^517^5869810ORC|RE||BK29X5743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK29X5743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0976-02^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0976-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W77H5751^^^AIRA-TEST^MR||PickawayAIRA^YusraAIRA^Omega^^^^L|NuckollsAIRA^JasleneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1458 Had St^^Hiawatha Temp Correction Fac^MI^49786^USA^P||^PRN^PH^^^906^6512627|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PickawayAIRA^NuckollsAIRA^^^^^L|MTH^Mother^HL70063|1458 Had St^^Hiawatha Temp Correction Fac^MI^49786^USA^P|^PRN^PH^^^906^6512627ORC|RE||BW77H5751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW77H5751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0976-06^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-0976-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S12H5759^^^AIRA-TEST^MR||FillmoreAIRA^ElbertinaAIRA^Palomi^^^^L|HowardAIRA^AbigailAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1800 Lijn St^^Arnold^MI^49819^USA^P||^PRN^PH^^^906^5989395|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FillmoreAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1800 Lijn St^^Arnold^MI^49819^USA^P|^PRN^PH^^^906^5989395ORC|RE||BS12H5759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS12H5759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-0976-20^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62195-0051-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z00X5764^^^AIRA-TEST^MR||BrooksAIRA^JeraldineAIRA^Ysolda^^^^L|MontgomeryAIRA^AntheaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1071 Keel en Maas Pl^^Grant^MI^49327^USA^P||^PRN^PH^^^231^4193854|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrooksAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1071 Keel en Maas Pl^^Grant^MI^49327^USA^P|^PRN^PH^^^231^4193854ORC|RE||BZ00X5764.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ00X5764.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62195-0051-01^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||VAL^Valneva^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62195-0051-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C70Y5772^^^AIRA-TEST^MR||SwiftAIRA^PrioskaAIRA^Elsa^^^^L|ChristensonAIRA^SushmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1684 Me Wolden Ln^^Duncan^MI^48131^USA^P||^PRN^PH^^^734^5036181|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SwiftAIRA^ChristensonAIRA^^^^^L|MTH^Mother^HL70063|1684 Me Wolden Ln^^Duncan^MI^48131^USA^P|^PRN^PH^^^734^5036181ORC|RE||BC70Y5772.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC70Y5772.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62195-0051-10^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||VAL^Valneva^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577-0613-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A76H5783^^^AIRA-TEST^MR||WrightAIRA^LyndseyAIRA^Kenya^^^^L|Grand TraverseAIRA^LaloAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1400 Awijndrecht Ave^^Grand Rapids^MI^49509^USA^P||^PRN^PH^^^616^9228602|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WrightAIRA^Grand TraverseAIRA^^^^^L|MTH^Mother^HL70063|1400 Awijndrecht Ave^^Grand Rapids^MI^49509^USA^P|^PRN^PH^^^616^9228602ORC|RE||BA76H5783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA76H5783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||62577-0613-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577-0613-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J85I5791^^^AIRA-TEST^MR||RunnelsAIRA^OrlaAIRA^Cornelian^^^^L|AuglaizeAIRA^AbrilAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1574 Rest Ln^^Saint Johns^MI^48879^USA^P||^PRN^PH^^^989^7869815|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RunnelsAIRA^AuglaizeAIRA^^^^^L|MTH^Mother^HL70063|1574 Rest Ln^^Saint Johns^MI^48879^USA^P|^PRN^PH^^^989^7869815ORC|RE||BJ85I5791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ85I5791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||62577-0613-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577-0614-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J20A5799^^^AIRA-TEST^MR||KitsapAIRA^FaeAIRA^Marisa^^^^L|HardingAIRA^MaganAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1248 Houten Cir^^Buick Oldsmobile Cadillac^MI^48550^USA^P||^PRN^PH^^^810^7413800|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KitsapAIRA^HardingAIRA^^^^^L|MTH^Mother^HL70063|1248 Houten Cir^^Buick Oldsmobile Cadillac^MI^48550^USA^P|^PRN^PH^^^810^7413800ORC|RE||BJ20A5799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ20A5799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||62577-0614-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577-0614-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D59M5804^^^AIRA-TEST^MR||McLennanAIRA^AllieAIRA^Sherlyn^^^^L|SullivanAIRA^KarliAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1600 Zinsnede Ln^^Davisburg^MI^48350^USA^P||^PRN^PH^^^248^5180323|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McLennanAIRA^SullivanAIRA^^^^^L|MTH^Mother^HL70063|1600 Zinsnede Ln^^Davisburg^MI^48350^USA^P|^PRN^PH^^^248^5180323ORC|RE||BD59M5804.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD59M5804.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||62577-0614-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63361-0245-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B10Q5812^^^AIRA-TEST^MR||ButteAIRA^KasaAIRA^Rosalind^^^^L|MaderaAIRA^CytheriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1944 Aontfoort Pl^^Addison^MI^49220^USA^P||^PRN^PH^^^517^6513643|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButteAIRA^MaderaAIRA^^^^^L|MTH^Mother^HL70063|1944 Aontfoort Pl^^Addison^MI^49220^USA^P|^PRN^PH^^^517^6513643ORC|RE||BB10Q5812.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB10Q5812.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63361-0245-10^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63361-0245-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L33X5823^^^AIRA-TEST^MR||DelawareAIRA^NicolaAIRA^Orea^^^^L|Scotts BluffAIRA^TheclaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1327 Hierden Ave^^Berrien Springs^MI^49103^USA^P||^PRN^PH^^^269^9475601|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^Scotts BluffAIRA^^^^^L|MTH^Mother^HL70063|1327 Hierden Ave^^Berrien Springs^MI^49103^USA^P|^PRN^PH^^^269^9475601ORC|RE||BL33X5823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL33X5823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63361-0245-58^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-0501-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U90G5831^^^AIRA-TEST^MR||GuadalupeAIRA^TottieAIRA^Shantina^^^^L|BoundaryAIRA^KadijaAIRA^^^^^M|20160918|F||2106-3^White^CDCREC|1519 Doordwijk Ave^^Whitehall^MI^49463^USA^P||^PRN^PH^^^231^7366500|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GuadalupeAIRA^BoundaryAIRA^^^^^L|MTH^Mother^HL70063|1519 Doordwijk Ave^^Whitehall^MI^49463^USA^P|^PRN^PH^^^231^7366500ORC|RE||BU90G5831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161118||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU90G5831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170118||63851-0501-01^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170118||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-0501-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C94A5839^^^AIRA-TEST^MR||LundgrenAIRA^JuliannaAIRA^Nadie^^^^L|LatimerAIRA^AspenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1769 Oeere St^^Wallace^MI^49893^USA^P||^PRN^PH^^^906^5243395|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LundgrenAIRA^LatimerAIRA^^^^^L|MTH^Mother^HL70063|1769 Oeere St^^Wallace^MI^49893^USA^P|^PRN^PH^^^906^5243395ORC|RE||BC94A5839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC94A5839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-0501-02^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-0511-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T07F5844^^^AIRA-TEST^MR||KingfisherAIRA^AlonaAIRA^Karuah^^^^L|TansbergAIRA^RosenwynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1568 Moerdalen Cir^^South Rockwood^MI^48179^USA^P||^PRN^PH^^^734^8941002|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingfisherAIRA^TansbergAIRA^^^^^L|MTH^Mother^HL70063|1568 Moerdalen Cir^^South Rockwood^MI^48179^USA^P|^PRN^PH^^^734^8941002ORC|RE||BT07F5844.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT07F5844.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-0511-11^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-0612-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V59B5852^^^AIRA-TEST^MR||LincolnAIRA^AloysiaAIRA^Kassidy^^^^L|KalkaskaAIRA^AntoniaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1694 Goerden Cir^^Rankin^MI^48473^USA^P||^PRN^PH^^^810^3318051|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^KalkaskaAIRA^^^^^L|MTH^Mother^HL70063|1694 Goerden Cir^^Rankin^MI^48473^USA^P|^PRN^PH^^^810^3318051ORC|RE||BV59B5852.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV59B5852.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||63851-0612-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-0612-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R73B5863^^^AIRA-TEST^MR||SmithAIRA^TanujaAIRA^Scarlett^^^^L|ShelbyAIRA^HyeAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1259 Luiven Ave^^Jenison^MI^49429^USA^P||^PRN^PH^^^616^4536855|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SmithAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1259 Luiven Ave^^Jenison^MI^49429^USA^P|^PRN^PH^^^616^4536855ORC|RE||BR73B5863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR73B5863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||63851-0612-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-0613-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X12X5871^^^AIRA-TEST^MR||OtsegoAIRA^LiannakaAIRA^Heli^^^^L|WarrenAIRA^BrysenAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1702 Slphen-Chaam Pl^^Detroit^MI^48272^USA^P||^PRN^PH^^^313^7882485|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OtsegoAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1702 Slphen-Chaam Pl^^Detroit^MI^48272^USA^P|^PRN^PH^^^313^7882485ORC|RE||BX12X5871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX12X5871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||63851-0613-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-0613-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J16F5879^^^AIRA-TEST^MR||LincolnAIRA^VickiAIRA^Kathryn^^^^L|SacramentoAIRA^CharityAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1682 Mest Maas en Waal Pl^^Ann Arbor^MI^48103^USA^P||^PRN^PH^^^734^5208692|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^SacramentoAIRA^^^^^L|MTH^Mother^HL70063|1682 Mest Maas en Waal Pl^^Ann Arbor^MI^48103^USA^P|^PRN^PH^^^734^5208692ORC|RE||BJ16F5879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ16F5879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||63851-0613-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-64678-0211-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C65J5884^^^AIRA-TEST^MR||SaundersAIRA^SveaAIRA^Mariko^^^^L|BullittAIRA^TegenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1704 Vaardigheid Pl^^Marine City^MI^48039^USA^P||^PRN^PH^^^810^3437743|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SaundersAIRA^BullittAIRA^^^^^L|MTH^Mother^HL70063|1704 Vaardigheid Pl^^Marine City^MI^48039^USA^P|^PRN^PH^^^810^3437743ORC|RE||BC65J5884.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC65J5884.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||64678-0211-01^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MIP^Emergent BioDefense Operations Lansing^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|24^Anthrax VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180321||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-64678-0211-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G51X5892^^^AIRA-TEST^MR||LevyAIRA^SalimaAIRA^Hedea^^^^L|MartinAIRA^StacyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1078 Buurman Cir^^State Farm Ins^MI^49069^USA^P||^PRN^PH^^^269^8497024|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LevyAIRA^MartinAIRA^^^^^L|MTH^Mother^HL70063|1078 Buurman Cir^^State Farm Ins^MI^49069^USA^P|^PRN^PH^^^269^8497024ORC|RE||BG51X5892.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG51X5892.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||64678-0211-05^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MIP^Emergent BioDefense Operations Lansing^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|24^Anthrax VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180321||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0107-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S00E5903^^^AIRA-TEST^MR||AlexandersonAIRA^AnvitaAIRA^Behira^^^^L|EatonAIRA^KerriAIRA^^^^^M|20091218|F||2106-3^White^CDCREC|1804 Oapendrecht St^^Fremont^MI^49412^USA^P||^PRN^PH^^^231^7956079|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlexandersonAIRA^EatonAIRA^^^^^L|MTH^Mother^HL70063|1804 Oapendrecht St^^Fremont^MI^49412^USA^P|^PRN^PH^^^231^7956079ORC|RE||BS00E5903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100218||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS00E5903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100418||66019-0107-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100418||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0108-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E04I5911^^^AIRA-TEST^MR||GormanAIRA^MallikaAIRA^Meira^^^^L|MadisonAIRA^AlexisAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1347 Lucht St^^Otisville^MI^48463^USA^P||^PRN^PH^^^810^5808173|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GormanAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1347 Lucht St^^Otisville^MI^48463^USA^P|^PRN^PH^^^810^5808173ORC|RE||BE04I5911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE04I5911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66019-0108-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0108-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E85Q5919^^^AIRA-TEST^MR||Santa CruzAIRA^TanushiAIRA^Terrylyn^^^^L|BoiseAIRA^VyvyanAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1697 Gevangen Cir^^Kentwood^MI^49588^USA^P||^PRN^PH^^^616^6550005|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Santa CruzAIRA^BoiseAIRA^^^^^L|MTH^Mother^HL70063|1697 Gevangen Cir^^Kentwood^MI^49588^USA^P|^PRN^PH^^^616^6550005ORC|RE||BE85Q5919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE85Q5919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66019-0108-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0109-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J02O5924^^^AIRA-TEST^MR||TillmanAIRA^DericaAIRA^Aricia^^^^L|HumboldtAIRA^SexburthAIRA^^^^^M|20120318|F||2106-3^White^CDCREC|1268 Hoppersum Pl^^Corunna^MI^48817^USA^P||^PRN^PH^^^989^7621517|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TillmanAIRA^HumboldtAIRA^^^^^L|MTH^Mother^HL70063|1268 Hoppersum Pl^^Corunna^MI^48817^USA^P|^PRN^PH^^^989^7621517ORC|RE||BJ02O5924.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120518||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ02O5924.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120718||66019-0109-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120718||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0109-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O95N5932^^^AIRA-TEST^MR||DallasAIRA^FrancescaAIRA^Esther^^^^L|RefugioAIRA^CatheeAIRA^^^^^M|20120318|F||2106-3^White^CDCREC|1551 Darderwijk Ave^^Muskegon^MI^49441^USA^P||^PRN^PH^^^231^8870767|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallasAIRA^RefugioAIRA^^^^^L|MTH^Mother^HL70063|1551 Darderwijk Ave^^Muskegon^MI^49441^USA^P|^PRN^PH^^^231^8870767ORC|RE||BO95N5932.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120518||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO95N5932.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120718||66019-0109-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120718||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0110-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y26S5943^^^AIRA-TEST^MR||UnionAIRA^UminaAIRA^Jacinthe^^^^L|KrogAIRA^AmeliaAIRA^^^^^M|20130317|F||2106-3^White^CDCREC|1824 Goudrichem Pl^^Breedsville^MI^49027^USA^P||^PRN^PH^^^269^3823778|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UnionAIRA^KrogAIRA^^^^^L|MTH^Mother^HL70063|1824 Goudrichem Pl^^Breedsville^MI^49027^USA^P|^PRN^PH^^^269^3823778ORC|RE||BY26S5943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130517||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY26S5943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130717||66019-0110-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130717||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0110-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y94J5951^^^AIRA-TEST^MR||OttawaAIRA^SilviaAIRA^Mesha^^^^L|CassAIRA^JannaliAIRA^^^^^M|20130317|F||2106-3^White^CDCREC|1850 Upeldoorn Pl^^Clarkston^MI^48347^USA^P||^PRN^PH^^^248^2418640|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OttawaAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1850 Upeldoorn Pl^^Clarkston^MI^48347^USA^P|^PRN^PH^^^248^2418640ORC|RE||BY94J5951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130517||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY94J5951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130717||66019-0110-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130717||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0200-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I01V5959^^^AIRA-TEST^MR||FagenAIRA^KaerAIRA^Sidonia^^^^L|BastropAIRA^BayleeAIRA^^^^^M|20091212|F||2106-3^White^CDCREC|1032 Mexel Cir^^Columbus^MI^48063^USA^P||^PRN^PH^^^810^5602651|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FagenAIRA^BastropAIRA^^^^^L|MTH^Mother^HL70063|1032 Mexel Cir^^Columbus^MI^48063^USA^P|^PRN^PH^^^810^5602651ORC|RE||BI01V5959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100212||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI01V5959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100412||66019-0200-01^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100412||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0200-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L38J5964^^^AIRA-TEST^MR||SabineAIRA^SanyuktaAIRA^Lisa^^^^L|WaldoAIRA^MadonnaAIRA^^^^^M|20091212|F||2106-3^White^CDCREC|1532 Dunspeet Ave^^Buckley^MI^49620^USA^P||^PRN^PH^^^231^2999916|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SabineAIRA^WaldoAIRA^^^^^L|MTH^Mother^HL70063|1532 Dunspeet Ave^^Buckley^MI^49620^USA^P|^PRN^PH^^^231^2999916ORC|RE||BL38J5964.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100212||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL38J5964.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100412||66019-0200-10^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100412||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0300-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H64H5972^^^AIRA-TEST^MR||FloydAIRA^JunoAIRA^Paula^^^^L|WilliamsonAIRA^MitziAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1500 Oelmond Pl^^Newaygo^MI^49337^USA^P||^PRN^PH^^^231^3699688|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FloydAIRA^WilliamsonAIRA^^^^^L|MTH^Mother^HL70063|1500 Oelmond Pl^^Newaygo^MI^49337^USA^P|^PRN^PH^^^231^3699688ORC|RE||BH64H5972.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH64H5972.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66019-0300-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0300-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M97Y5983^^^AIRA-TEST^MR||EllisAIRA^AuroraAIRA^Karma^^^^L|JungstroinAIRA^GloraAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1888 Bchagen Ln^^Saint James^MI^49782^USA^P||^PRN^PH^^^906^3183220|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EllisAIRA^JungstroinAIRA^^^^^L|MTH^Mother^HL70063|1888 Bchagen Ln^^Saint James^MI^49782^USA^P|^PRN^PH^^^906^3183220ORC|RE||BM97Y5983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM97Y5983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66019-0300-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0301-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y45F5991^^^AIRA-TEST^MR||SnyderAIRA^EuphrasiaAIRA^Vivienne^^^^L|SpokaneAIRA^NerinAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1548 Wmmen St^^Ann Arbor^MI^48104^USA^P||^PRN^PH^^^734^4064739|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SnyderAIRA^SpokaneAIRA^^^^^L|MTH^Mother^HL70063|1548 Wmmen St^^Ann Arbor^MI^48104^USA^P|^PRN^PH^^^734^4064739ORC|RE||BY45F5991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY45F5991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66019-0301-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0301-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X62M5999^^^AIRA-TEST^MR||CarrollAIRA^PremilaAIRA^Vanessa^^^^L|MaloneAIRA^JannaliAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1806 Gestegen Ln^^Columbus^MI^48063^USA^P||^PRN^PH^^^810^3977196|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarrollAIRA^MaloneAIRA^^^^^L|MTH^Mother^HL70063|1806 Gestegen Ln^^Columbus^MI^48063^USA^P|^PRN^PH^^^810^3977196ORC|RE||BX62M5999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX62M5999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66019-0301-10^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0302-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A65U6007^^^AIRA-TEST^MR||AlamedaAIRA^NaysaAIRA^Greer^^^^L|PiscataquisAIRA^KarriAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1315 Wrechterland St^^East Tawas^MI^48730^USA^P||^PRN^PH^^^989^6306644|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlamedaAIRA^PiscataquisAIRA^^^^^L|MTH^Mother^HL70063|1315 Wrechterland St^^East Tawas^MI^48730^USA^P|^PRN^PH^^^989^6306644ORC|RE||BA65U6007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA65U6007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66019-0302-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0302-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W31E6012^^^AIRA-TEST^MR||ClarkAIRA^MadelineAIRA^Svea^^^^L|EsceibreAIRA^LyndeyAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1299 Katoen St^^Secretary of State^MI^48918^USA^P||^PRN^PH^^^517^8299349|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClarkAIRA^EsceibreAIRA^^^^^L|MTH^Mother^HL70063|1299 Katoen St^^Secretary of State^MI^48918^USA^P|^PRN^PH^^^517^8299349ORC|RE||BW31E6012.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW31E6012.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66019-0302-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0303-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S04J6020^^^AIRA-TEST^MR||AlconaAIRA^YaffahAIRA^Ceinwen^^^^L|RogersAIRA^MasaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1073 Ne Wolden Ave^^Hemlock^MI^48626^USA^P||^PRN^PH^^^989^6220971|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlconaAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1073 Ne Wolden Ave^^Hemlock^MI^48626^USA^P|^PRN^PH^^^989^6220971ORC|RE||BS04J6020.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS04J6020.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||66019-0303-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0303-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R29F6031^^^AIRA-TEST^MR||LaenAIRA^YvonneAIRA^Emilee^^^^L|GuthrieAIRA^LilyAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1204 Gwartewaterland Ave^^Bannister^MI^48807^USA^P||^PRN^PH^^^989^3943526|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LaenAIRA^GuthrieAIRA^^^^^L|MTH^Mother^HL70063|1204 Gwartewaterland Ave^^Bannister^MI^48807^USA^P|^PRN^PH^^^989^3943526ORC|RE||BR29F6031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR29F6031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||66019-0303-10^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0304-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K75D6039^^^AIRA-TEST^MR||HalsallAIRA^EfiaAIRA^Neala^^^^L|NorthumberlandAIRA^VrindaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1314 Grimpenerwaard Ln^^Waterford Township^MI^48328^USA^P||^PRN^PH^^^248^9827095|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HalsallAIRA^NorthumberlandAIRA^^^^^L|MTH^Mother^HL70063|1314 Grimpenerwaard Ln^^Waterford Township^MI^48328^USA^P|^PRN^PH^^^248^9827095ORC|RE||BK75D6039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK75D6039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||66019-0304-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0304-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R22S6047^^^AIRA-TEST^MR||MooreAIRA^GiuliettaAIRA^Tapi^^^^L|LorainAIRA^JobeyAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1679 Procent Ave^^Eben Junction^MI^49826^USA^P||^PRN^PH^^^906^8772113|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MooreAIRA^LorainAIRA^^^^^L|MTH^Mother^HL70063|1679 Procent Ave^^Eben Junction^MI^49826^USA^P|^PRN^PH^^^906^8772113ORC|RE||BR22S6047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR22S6047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||66019-0304-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0305-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P25A6052^^^AIRA-TEST^MR||FinnAIRA^AngelicaAIRA^Magnolia^^^^L|WashtenawAIRA^EmeliaAIRA^^^^^M|20181228|F||2106-3^White^CDCREC|1316 Dreda Pl^^Brownstown^MI^48174^USA^P||^PRN^PH^^^734^3153031|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FinnAIRA^WashtenawAIRA^^^^^L|MTH^Mother^HL70063|1316 Dreda Pl^^Brownstown^MI^48174^USA^P|^PRN^PH^^^734^3153031ORC|RE||BP25A6052.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP25A6052.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190429||66019-0305-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190429||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-0305-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H74R6060^^^AIRA-TEST^MR||WhitleyAIRA^NataleeAIRA^Elizabeth^^^^L|KnoxAIRA^ToinetteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1717 Seylingen Pl^^Lansing^MI^48901^USA^P||^PRN^PH^^^517^8120069|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WhitleyAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1717 Seylingen Pl^^Lansing^MI^48901^USA^P|^PRN^PH^^^517^8120069ORC|RE||BH74R6060.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH74R6060.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-0305-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0000-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J73V6071^^^AIRA-TEST^MR||DallamAIRA^FairleeAIRA^Temperance^^^^L|EdmundsAIRA^IndaliaiAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1192 Eeghel Cir^^Saint Heights^MI^48314^USA^P||^PRN^PH^^^586^6341438|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallamAIRA^EdmundsAIRA^^^^^L|MTH^Mother^HL70063|1192 Eeghel Cir^^Saint Heights^MI^48314^USA^P|^PRN^PH^^^586^6341438ORC|RE||BJ73V6071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ73V6071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0000-01^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0000-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y23G6079^^^AIRA-TEST^MR||LevyAIRA^ZeeAIRA^Bailee^^^^L|MorrinAIRA^JezebelAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1646 Wpeldoorn Ln^^Troy^MI^48084^USA^P||^PRN^PH^^^248^9079665|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LevyAIRA^MorrinAIRA^^^^^L|MTH^Mother^HL70063|1646 Wpeldoorn Ln^^Troy^MI^48084^USA^P|^PRN^PH^^^248^9079665ORC|RE||BY23G6079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY23G6079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0000-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0112-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S47V6087^^^AIRA-TEST^MR||ConnorAIRA^SandraAIRA^Charmian^^^^L|HillsdaleAIRA^HaileeAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1722 Rint-Michielsgestel Cir^^Centreville^MI^49032^USA^P||^PRN^PH^^^269^3864603|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ConnorAIRA^HillsdaleAIRA^^^^^L|MTH^Mother^HL70063|1722 Rint-Michielsgestel Cir^^Centreville^MI^49032^USA^P|^PRN^PH^^^269^3864603ORC|RE||BS47V6087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS47V6087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||66521-0112-02^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0112-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A59J6095^^^AIRA-TEST^MR||GreenleeAIRA^AishaAIRA^Mykala^^^^L|AinslieAIRA^NikeAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1975 Aollumerland en Nieuwkruisland St^^Comins^MI^48619^USA^P||^PRN^PH^^^989^4197397|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenleeAIRA^AinslieAIRA^^^^^L|MTH^Mother^HL70063|1975 Aollumerland en Nieuwkruisland St^^Comins^MI^48619^USA^P|^PRN^PH^^^989^4197397ORC|RE||BA59J6095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA59J6095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||66521-0112-10^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0113-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O44G6100^^^AIRA-TEST^MR||MasonAIRA^LaetitiaAIRA^Jina^^^^L|UnionAIRA^SupritiAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1444 Zeker Pl^^Mc Bain^MI^49657^USA^P||^PRN^PH^^^231^9210807|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1444 Zeker Pl^^Mc Bain^MI^49657^USA^P|^PRN^PH^^^231^9210807ORC|RE||BO44G6100.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO44G6100.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66521-0113-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0113-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D68M6108^^^AIRA-TEST^MR||ReynoldsAIRA^EtainAIRA^Katerine^^^^L|BuschAIRA^SachaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1961 Een Pl^^Spring Lake^MI^49456^USA^P||^PRN^PH^^^616^8367065|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReynoldsAIRA^BuschAIRA^^^^^L|MTH^Mother^HL70063|1961 Een Pl^^Spring Lake^MI^49456^USA^P|^PRN^PH^^^616^8367065ORC|RE||BD68M6108.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD68M6108.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66521-0113-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0114-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z81O6119^^^AIRA-TEST^MR||ClayAIRA^StormAIRA^Jan^^^^L|WerstadAIRA^MyndeeAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1680 Iaastricht Ave^^Gr Blanc^MI^48439^USA^P||^PRN^PH^^^810^5032632|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClayAIRA^WerstadAIRA^^^^^L|MTH^Mother^HL70063|1680 Iaastricht Ave^^Gr Blanc^MI^48439^USA^P|^PRN^PH^^^810^5032632ORC|RE||BZ81O6119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ81O6119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||66521-0114-02^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0114-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y28V6127^^^AIRA-TEST^MR||KirklandAIRA^PollyAIRA^Septima^^^^L|SimmingsenAIRA^MarlaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1213 Beter Ln^^Rochester Hls^MI^48306^USA^P||^PRN^PH^^^248^6578716|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KirklandAIRA^SimmingsenAIRA^^^^^L|MTH^Mother^HL70063|1213 Beter Ln^^Rochester Hls^MI^48306^USA^P|^PRN^PH^^^248^6578716ORC|RE||BY28V6127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY28V6127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||66521-0114-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0115-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W35S6135^^^AIRA-TEST^MR||RefugioAIRA^ConnieAIRA^Solita^^^^L|HowardAIRA^MinnieAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1034 Dcht-Susteren Ln^^Greenbush^MI^48738^USA^P||^PRN^PH^^^989^7559188|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RefugioAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1034 Dcht-Susteren Ln^^Greenbush^MI^48738^USA^P|^PRN^PH^^^989^7559188ORC|RE||BW35S6135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW35S6135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66521-0115-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0115-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M78S6140^^^AIRA-TEST^MR||RossAIRA^ChevonneAIRA^Margaret^^^^L|CrittendenAIRA^NaveenaAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1736 Nmstelveen Pl^^Rawsonville^MI^48197^USA^P||^PRN^PH^^^734^7076561|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RossAIRA^CrittendenAIRA^^^^^L|MTH^Mother^HL70063|1736 Nmstelveen Pl^^Rawsonville^MI^48197^USA^P|^PRN^PH^^^734^7076561ORC|RE||BM78S6140.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM78S6140.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||66521-0115-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0116-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O33P6148^^^AIRA-TEST^MR||BrazosAIRA^GanesaAIRA^Lyris^^^^L|CurryAIRA^SakariAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1440 Gubbergen Pl^^Skanee^MI^49962^USA^P||^PRN^PH^^^906^8673205|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrazosAIRA^CurryAIRA^^^^^L|MTH^Mother^HL70063|1440 Gubbergen Pl^^Skanee^MI^49962^USA^P|^PRN^PH^^^906^8673205ORC|RE||BO33P6148.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO33P6148.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66521-0116-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0116-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X25X6159^^^AIRA-TEST^MR||PresidioAIRA^IlanaAIRA^Mamta^^^^L|BourbonAIRA^GledaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1153 Omvatten Pl^^Hubbardston^MI^48845^USA^P||^PRN^PH^^^989^3539005|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PresidioAIRA^BourbonAIRA^^^^^L|MTH^Mother^HL70063|1153 Omvatten Pl^^Hubbardston^MI^48845^USA^P|^PRN^PH^^^989^3539005ORC|RE||BX25X6159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX25X6159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66521-0116-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0116-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W81M6167^^^AIRA-TEST^MR||WalshAIRA^CarriganAIRA^Summer^^^^L|RobertsAIRA^MerriAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1934 Vomeren Ln^^Detroit^MI^48202^USA^P||^PRN^PH^^^313^7063785|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WalshAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1934 Vomeren Ln^^Detroit^MI^48202^USA^P|^PRN^PH^^^313^7063785ORC|RE||BW81M6167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW81M6167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66521-0116-11^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0116-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I63R6175^^^AIRA-TEST^MR||LorainAIRA^GenevieveAIRA^Nurhan^^^^L|OttawaAIRA^CadeAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1352 Zeendam Pl^^Haslett^MI^48840^USA^P||^PRN^PH^^^517^4827826|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LorainAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1352 Zeendam Pl^^Haslett^MI^48840^USA^P|^PRN^PH^^^517^4827826ORC|RE||BI63R6175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI63R6175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66521-0116-12^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0117-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S96X6180^^^AIRA-TEST^MR||WallowaAIRA^ValborgAIRA^Keren^^^^L|CoshoctonAIRA^TizaneAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1493 Kotterdam Ln^^North Branch^MI^48461^USA^P||^PRN^PH^^^810^2979781|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WallowaAIRA^CoshoctonAIRA^^^^^L|MTH^Mother^HL70063|1493 Kotterdam Ln^^North Branch^MI^48461^USA^P|^PRN^PH^^^810^2979781ORC|RE||BS96X6180.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS96X6180.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66521-0117-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O08M6188^^^AIRA-TEST^MR||OttawaAIRA^JamalAIRA^Dotty^^^^L|NewaygoAIRA^SybilAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1883 Neststellingwerf Ln^^Meskegon^MI^49445^USA^P||^PRN^PH^^^231^2515482|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OttawaAIRA^NewaygoAIRA^^^^^L|MTH^Mother^HL70063|1883 Neststellingwerf Ln^^Meskegon^MI^49445^USA^P|^PRN^PH^^^231^2515482ORC|RE||BO08M6188.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO08M6188.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66521-0117-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0117-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T71R6199^^^AIRA-TEST^MR||MillsAIRA^TaipaAIRA^Medha^^^^L|JacksonAIRA^HalaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1576 Mond Ave^^Macomb^MI^48044^USA^P||^PRN^PH^^^586^9108955|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MillsAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1576 Mond Ave^^Macomb^MI^48044^USA^P|^PRN^PH^^^586^9108955ORC|RE||BT71R6199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT71R6199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66521-0117-11^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0117-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F98B6207^^^AIRA-TEST^MR||AlgerAIRA^NozomiAIRA^Giuseppina^^^^L|RockwallAIRA^ReginaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1423 Branendonck Pl^^Farmington^MI^48335^USA^P||^PRN^PH^^^248^3943500|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlgerAIRA^RockwallAIRA^^^^^L|MTH^Mother^HL70063|1423 Branendonck Pl^^Farmington^MI^48335^USA^P|^PRN^PH^^^248^3943500ORC|RE||BF98B6207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF98B6207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66521-0117-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0118-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E50T6215^^^AIRA-TEST^MR||WillacyAIRA^HasnaAIRA^Ayme^^^^L|WinneshiekAIRA^NoleenAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1503 Zinsnede St^^Northville^MI^48168^USA^P||^PRN^PH^^^248^7169449|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WillacyAIRA^WinneshiekAIRA^^^^^L|MTH^Mother^HL70063|1503 Zinsnede St^^Northville^MI^48168^USA^P|^PRN^PH^^^248^7169449ORC|RE||BE50T6215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE50T6215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0118-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0118-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R73D6220^^^AIRA-TEST^MR||ClevelandAIRA^LinetteAIRA^Sushanti^^^^L|JackAIRA^ReiAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1744 Tchtkarspelen Cir^^Detroit^MI^48237^USA^P||^PRN^PH^^^248^8323362|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClevelandAIRA^JackAIRA^^^^^L|MTH^Mother^HL70063|1744 Tchtkarspelen Cir^^Detroit^MI^48237^USA^P|^PRN^PH^^^248^8323362ORC|RE||BR73D6220.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR73D6220.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0118-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0118-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H89V6228^^^AIRA-TEST^MR||RichlandAIRA^KalpanaAIRA^Joelle^^^^L|FranklinAIRA^PhilanthaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1166 Heldrop Cir^^Shingleton^MI^49884^USA^P||^PRN^PH^^^906^9863755|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichlandAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1166 Heldrop Cir^^Shingleton^MI^49884^USA^P|^PRN^PH^^^906^9863755ORC|RE||BH89V6228.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH89V6228.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0118-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0118-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A93E6239^^^AIRA-TEST^MR||CrosbieAIRA^SaigeAIRA^Drusilla^^^^L|SummitAIRA^JulietteAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1892 Oith Pl^^Middlevle^MI^49333^USA^P||^PRN^PH^^^269^2265533|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CrosbieAIRA^SummitAIRA^^^^^L|MTH^Mother^HL70063|1892 Oith Pl^^Middlevle^MI^49333^USA^P|^PRN^PH^^^269^2265533ORC|RE||BA93E6239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA93E6239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0118-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0200-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U36T6247^^^AIRA-TEST^MR||LakeAIRA^TienetteAIRA^Chaitaly^^^^L|WoldAIRA^PhaedraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1851 Sandgraaf Ln^^Fenton^MI^48430^USA^P||^PRN^PH^^^810^6352571|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LakeAIRA^WoldAIRA^^^^^L|MTH^Mother^HL70063|1851 Sandgraaf Ln^^Fenton^MI^48430^USA^P|^PRN^PH^^^810^6352571ORC|RE||BU36T6247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU36T6247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-0200-02^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-0200-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L67D6255^^^AIRA-TEST^MR||OldhamAIRA^VadaAIRA^Safiya^^^^L|JohnstonAIRA^ZeebaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1270 Lchagen St^^Pinconning^MI^48650^USA^P||^PRN^PH^^^989^9842906|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OldhamAIRA^JohnstonAIRA^^^^^L|MTH^Mother^HL70063|1270 Lchagen St^^Pinconning^MI^48650^USA^P|^PRN^PH^^^989^9842906ORC|RE||BL67D6255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL67D6255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-0200-10^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-69401-0000-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V79F6260^^^AIRA-TEST^MR||BarrettAIRA^DreamaAIRA^Raelin^^^^L|NicholasAIRA^TayenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1407 Haasdonk St^^Burnips^MI^49314^USA^P||^PRN^PH^^^616^7505000|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarrettAIRA^NicholasAIRA^^^^^L|MTH^Mother^HL70063|1407 Haasdonk St^^Burnips^MI^49314^USA^P|^PRN^PH^^^616^7505000ORC|RE||BV79F6260.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV79F6260.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||69401-0000-01^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-69401-0000-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y05R6268^^^AIRA-TEST^MR||JacksonAIRA^WalidaAIRA^Rere^^^^L|WellsAIRA^ThaddeaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1240 Zmmen Cir^^Brownstown^MI^48173^USA^P||^PRN^PH^^^734^9578313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^WellsAIRA^^^^^L|MTH^Mother^HL70063|1240 Zmmen Cir^^Brownstown^MI^48173^USA^P|^PRN^PH^^^734^9578313ORC|RE||BY05R6268.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY05R6268.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||69401-0000-02^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460-0001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H84A6279^^^AIRA-TEST^MR||CannavinAIRA^AmabelAIRA^Leanne^^^^L|CanyonAIRA^StaceyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1964 Hen Boer Ave^^Sylvan Lake^MI^48320^USA^P||^PRN^PH^^^248^5669520|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CannavinAIRA^CanyonAIRA^^^^^L|MTH^Mother^HL70063|1964 Hen Boer Ave^^Sylvan Lake^MI^48320^USA^P|^PRN^PH^^^248^5669520ORC|RE||BH84A6279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH84A6279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70460-0001-01^Vaxchora^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|174^Cholera Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170706||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460-0002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R59O6287^^^AIRA-TEST^MR||JasperAIRA^SaraiAIRA^Galia^^^^L|HodgeAIRA^CamilaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1959 Girschot Cir^^Augusta Township^MI^48160^USA^P||^PRN^PH^^^734^7856157|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JasperAIRA^HodgeAIRA^^^^^L|MTH^Mother^HL70063|1959 Girschot Cir^^Augusta Township^MI^48160^USA^P|^PRN^PH^^^734^7856157ORC|RE||BR59O6287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR59O6287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70460-0002-01^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|174^Cholera Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170706||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460-0002-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N05F6295^^^AIRA-TEST^MR||LenaweeAIRA^AmaryllisAIRA^Moselle^^^^L|LeeAIRA^MckinleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1926 Hlkmaar Ave^^Independence Township^MI^48348^USA^P||^PRN^PH^^^248^7559653|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LenaweeAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1926 Hlkmaar Ave^^Independence Township^MI^48348^USA^P|^PRN^PH^^^248^7559653ORC|RE||BN05F6295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN05F6295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70460-0002-02^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|174^Cholera Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170706||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y62Q6300^^^AIRA-TEST^MR||DelawareAIRA^DeanaAIRA^Drew^^^^L|SmithAIRA^RhiamonAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1342 Klochteren Pl^^Kalkaska^MI^49646^USA^P||^PRN^PH^^^231^5785354|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^SmithAIRA^^^^^L|MTH^Mother^HL70063|1342 Klochteren Pl^^Kalkaska^MI^49646^USA^P|^PRN^PH^^^231^5785354ORC|RE||BY62Q6300.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY62Q6300.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0001-01^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0001-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M45M6308^^^AIRA-TEST^MR||SkagAIRA^JaelynAIRA^Toyo^^^^L|RichardsonAIRA^CeinwenAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1847 Dag St^^Flint^MI^48557^USA^P||^PRN^PH^^^810^6737792|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SkagAIRA^RichardsonAIRA^^^^^L|MTH^Mother^HL70063|1847 Dag St^^Flint^MI^48557^USA^P|^PRN^PH^^^810^6737792ORC|RE||BM45M6308.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM45M6308.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0001-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W35U6319^^^AIRA-TEST^MR||DightAIRA^JerardaAIRA^Colenso^^^^L|ColumbiaAIRA^ZoieAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1394 Meghel St^^Kentwood^MI^49546^USA^P||^PRN^PH^^^616^2217726|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DightAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1394 Meghel St^^Kentwood^MI^49546^USA^P|^PRN^PH^^^616^2217726ORC|RE||BW35U6319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW35U6319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0002-01^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0002-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F69F6327^^^AIRA-TEST^MR||LincolnAIRA^DrutiAIRA^Marlee^^^^L|FrontierAIRA^ChiaraAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1704 Oversteken Pl^^Mendon^MI^49072^USA^P||^PRN^PH^^^269^3005556|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^FrontierAIRA^^^^^L|MTH^Mother^HL70063|1704 Oversteken Pl^^Mendon^MI^49072^USA^P|^PRN^PH^^^269^3005556ORC|RE||BF69F6327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF69F6327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0002-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0018-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X26F6335^^^AIRA-TEST^MR||ElkAIRA^JaimieAIRA^Lynda^^^^L|BerntsenAIRA^JacintheAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1903 Wude IJsselstreek Pl^^De Tour Village^MI^49725^USA^P||^PRN^PH^^^906^6064039|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ElkAIRA^BerntsenAIRA^^^^^L|MTH^Mother^HL70063|1903 Wude IJsselstreek Pl^^De Tour Village^MI^49725^USA^P|^PRN^PH^^^906^6064039ORC|RE||BX26F6335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX26F6335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-0018-03^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0018-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I35M6340^^^AIRA-TEST^MR||MadisonAIRA^AmayaAIRA^Amiyah^^^^L|PikeAIRA^My-DuyenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1441 Ope Pl^^Lansing^MI^48930^USA^P||^PRN^PH^^^517^4412088|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MadisonAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1441 Ope Pl^^Lansing^MI^48930^USA^P|^PRN^PH^^^517^4412088ORC|RE||BI35M6340.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI35M6340.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-0018-04^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0119-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C74V6348^^^AIRA-TEST^MR||ErikssonAIRA^KionaAIRA^Candie^^^^L|DuvalAIRA^ShantinaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1681 Dijk bij Duurstede Pl^^Gilford^MI^48736^USA^P||^PRN^PH^^^989^3675100|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ErikssonAIRA^DuvalAIRA^^^^^L|MTH^Mother^HL70063|1681 Dijk bij Duurstede Pl^^Gilford^MI^48736^USA^P|^PRN^PH^^^989^3675100ORC|RE||BC74V6348.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC74V6348.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0119-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0119-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H30B6359^^^AIRA-TEST^MR||MurrayAIRA^BrandieAIRA^Amabel^^^^L|GosperAIRA^VeronicaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1250 Oerg en Dal Pl^^Quinnesec^MI^49876^USA^P||^PRN^PH^^^906^3628849|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MurrayAIRA^GosperAIRA^^^^^L|MTH^Mother^HL70063|1250 Oerg en Dal Pl^^Quinnesec^MI^49876^USA^P|^PRN^PH^^^906^3628849ORC|RE||BH30B6359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH30B6359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0119-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0119-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O14G6367^^^AIRA-TEST^MR||PickawayAIRA^AzariaAIRA^Laniyah^^^^L|LegresleyAIRA^VandanaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1162 Bar Cir^^Stony Creek^MI^48160^USA^P||^PRN^PH^^^734^8214337|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PickawayAIRA^LegresleyAIRA^^^^^L|MTH^Mother^HL70063|1162 Bar Cir^^Stony Creek^MI^48160^USA^P|^PRN^PH^^^734^8214337ORC|RE||BO14G6367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO14G6367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0119-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0119-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P58Q6375^^^AIRA-TEST^MR||LakeAIRA^CarrieannAIRA^Renuka^^^^L|TuscarawasAIRA^NikaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1195 Voorkomen Ave^^Grand Rapids^MI^49516^USA^P||^PRN^PH^^^616^8186061|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LakeAIRA^TuscarawasAIRA^^^^^L|MTH^Mother^HL70063|1195 Voorkomen Ave^^Grand Rapids^MI^49516^USA^P|^PRN^PH^^^616^8186061ORC|RE||BP58Q6375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP58Q6375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0119-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0120-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y88Y6380^^^AIRA-TEST^MR||FranklinAIRA^VasudharaAIRA^Nayeli^^^^L|LuzerneAIRA^CalixteAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1445 Afhangen Ln^^Bloomfield Hills^MI^48302^USA^P||^PRN^PH^^^248^3222925|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^LuzerneAIRA^^^^^L|MTH^Mother^HL70063|1445 Afhangen Ln^^Bloomfield Hills^MI^48302^USA^P|^PRN^PH^^^248^3222925ORC|RE||BY88Y6380.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY88Y6380.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0120-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0120-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q89R6388^^^AIRA-TEST^MR||HardinAIRA^AlizaAIRA^Sawyer^^^^L|AlexanderAIRA^BeverleyAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1774 Hon en Breugel Ln^^Wayne^MI^48184^USA^P||^PRN^PH^^^734^3368618|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^AlexanderAIRA^^^^^L|MTH^Mother^HL70063|1774 Hon en Breugel Ln^^Wayne^MI^48184^USA^P|^PRN^PH^^^734^3368618ORC|RE||BQ89R6388.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ89R6388.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0120-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0120-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P17A6399^^^AIRA-TEST^MR||VictoriaAIRA^MaidaAIRA^Kanchana^^^^L|CherokeeAIRA^QueridaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1190 Ttichtse Vecht Ln^^Keweenaw Bay^MI^49908^USA^P||^PRN^PH^^^906^7969748|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VictoriaAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1190 Ttichtse Vecht Ln^^Keweenaw Bay^MI^49908^USA^P|^PRN^PH^^^906^7969748ORC|RE||BP17A6399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP17A6399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0120-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0120-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J70T6407^^^AIRA-TEST^MR||CreghanAIRA^KlavdiaAIRA^Karmel^^^^L|McClungAIRA^KamnaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1034 Sirschot Cir^^Seneca^MI^49256^USA^P||^PRN^PH^^^517^3593996|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CreghanAIRA^McClungAIRA^^^^^L|MTH^Mother^HL70063|1034 Sirschot Cir^^Seneca^MI^49256^USA^P|^PRN^PH^^^517^3593996ORC|RE||BJ70T6407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ70T6407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0120-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0200-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R00J6415^^^AIRA-TEST^MR||HowathAIRA^KantiAIRA^Cherry^^^^L|CowleAIRA^DelbinAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1301 Lol Pl^^Secretary of State^MI^48918^USA^P||^PRN^PH^^^517^3153090|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowathAIRA^CowleAIRA^^^^^L|MTH^Mother^HL70063|1301 Lol Pl^^Secretary of State^MI^48918^USA^P|^PRN^PH^^^517^3153090ORC|RE||BR00J6415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR00J6415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0200-01^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0200-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M26F6420^^^AIRA-TEST^MR||GreeleyAIRA^EllinAIRA^Malika^^^^L|OwyheeAIRA^TydfillAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1118 Hmersfoort St^^Brownstown^MI^48134^USA^P||^PRN^PH^^^734^2924309|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreeleyAIRA^OwyheeAIRA^^^^^L|MTH^Mother^HL70063|1118 Hmersfoort St^^Brownstown^MI^48134^USA^P|^PRN^PH^^^734^2924309ORC|RE||BM26F6420.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM26F6420.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0200-02^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0200-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K98Q6428^^^AIRA-TEST^MR||DanuelsonAIRA^SavannahAIRA^Luisa^^^^L|LindAIRA^LaneAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1587 Kanderd Cir^^Fenwick^MI^48834^USA^P||^PRN^PH^^^989^4618284|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DanuelsonAIRA^LindAIRA^^^^^L|MTH^Mother^HL70063|1587 Kanderd Cir^^Fenwick^MI^48834^USA^P|^PRN^PH^^^989^4618284ORC|RE||BK98Q6428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK98Q6428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0200-11^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0200-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q66Q6439^^^AIRA-TEST^MR||HarneyAIRA^BeatriceAIRA^Charleigh^^^^L|San BenitoAIRA^HarukoAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1263 Boven Ln^^Bloomfield Hills^MI^48303^USA^P||^PRN^PH^^^248^2595586|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarneyAIRA^San BenitoAIRA^^^^^L|MTH^Mother^HL70063|1263 Boven Ln^^Bloomfield Hills^MI^48303^USA^P|^PRN^PH^^^248^2595586ORC|RE||BQ66Q6439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ66Q6439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0200-12^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0201-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R69Q6447^^^AIRA-TEST^MR||DelawareAIRA^CharleyAIRA^Malka^^^^L|ClarkAIRA^YaraAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1503 Goudrichem Ln^^Imlay^MI^48444^USA^P||^PRN^PH^^^810^8415163|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1503 Goudrichem Ln^^Imlay^MI^48444^USA^P|^PRN^PH^^^810^8415163ORC|RE||BR69Q6447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR69Q6447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0201-01^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0201-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H38U6455^^^AIRA-TEST^MR||PlumasAIRA^KarlyAIRA^Asenka^^^^L|SusasAIRA^SeverinaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1704 Etein Cir^^Saint Louis^MI^48880^USA^P||^PRN^PH^^^989^7021884|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PlumasAIRA^SusasAIRA^^^^^L|MTH^Mother^HL70063|1704 Etein Cir^^Saint Louis^MI^48880^USA^P|^PRN^PH^^^989^7021884ORC|RE||BH38U6455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH38U6455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0201-11^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0301-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B97D6463^^^AIRA-TEST^MR||CoshoctonAIRA^DeannaAIRA^Joo-Eun^^^^L|FreestoneAIRA^CarlotaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1387 Nutten Ave^^Wyandotte^MI^48193^USA^P||^PRN^PH^^^734^6728181|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoshoctonAIRA^FreestoneAIRA^^^^^L|MTH^Mother^HL70063|1387 Nutten Ave^^Wyandotte^MI^48193^USA^P|^PRN^PH^^^734^6728181ORC|RE||BB97D6463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB97D6463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0301-10^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0301-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V89K6468^^^AIRA-TEST^MR||RandallAIRA^AkilinaAIRA^Arnisha^^^^L|MackeyAIRA^JazlynAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1206 Ook Ln^^Casnovia^MI^49318^USA^P||^PRN^PH^^^231^8851253|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RandallAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1206 Ook Ln^^Casnovia^MI^49318^USA^P|^PRN^PH^^^231^8851253ORC|RE||BV89K6468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV89K6468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0301-12^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0318-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W93Y6476^^^AIRA-TEST^MR||ShortAIRA^PrueAIRA^Enola^^^^L|SamuelsonAIRA^KatrenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1866 Kleur St^^DTE^MI^48260^USA^P||^PRN^PH^^^313^2291571|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShortAIRA^SamuelsonAIRA^^^^^L|MTH^Mother^HL70063|1866 Kleur St^^DTE^MI^48260^USA^P|^PRN^PH^^^313^2291571ORC|RE||BW93Y6476.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW93Y6476.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-0318-03^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0318-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G33S6487^^^AIRA-TEST^MR||NevadaAIRA^AdalynnAIRA^Gisela^^^^L|VanceAIRA^AmberAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1982 Poordenveld Ave^^Jackson^MI^49204^USA^P||^PRN^PH^^^517^9044021|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NevadaAIRA^VanceAIRA^^^^^L|MTH^Mother^HL70063|1982 Poordenveld Ave^^Jackson^MI^49204^USA^P|^PRN^PH^^^517^9044021ORC|RE||BG33S6487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG33S6487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-0318-04^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H58H6495^^^AIRA-TEST^MR||JeffersonAIRA^KaniyaAIRA^Luella^^^^L|NewaygoAIRA^KittyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1066 Ltede Broec Pl^^Harris^MI^49845^USA^P||^PRN^PH^^^906^8830874|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^NewaygoAIRA^^^^^L|MTH^Mother^HL70063|1066 Ltede Broec Pl^^Harris^MI^49845^USA^P|^PRN^PH^^^906^8830874ORC|RE||BH58H6495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH58H6495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-0418-10^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0418-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z47Q6503^^^AIRA-TEST^MR||KnowlesAIRA^GeorgiaAIRA^Waseme^^^^L|Red WillowAIRA^VirginiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1714 Ouenen Ln^^Saint Heights^MI^48312^USA^P||^PRN^PH^^^586^2327997|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnowlesAIRA^Red WillowAIRA^^^^^L|MTH^Mother^HL70063|1714 Ouenen Ln^^Saint Heights^MI^48312^USA^P|^PRN^PH^^^586^2327997ORC|RE||BZ47Q6503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ47Q6503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-0418-11^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0614-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F82O6511^^^AIRA-TEST^MR||KarlssonAIRA^NirgunaAIRA^Edana^^^^L|CreghanAIRA^BalbinaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1333 Bliedrecht Pl^^White Pine^MI^49971^USA^P||^PRN^PH^^^906^4346209|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KarlssonAIRA^CreghanAIRA^^^^^L|MTH^Mother^HL70063|1333 Bliedrecht Pl^^White Pine^MI^49971^USA^P|^PRN^PH^^^906^4346209ORC|RE||BF82O6511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF82O6511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0614-01^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-0614-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H50H6516^^^AIRA-TEST^MR||ThiemerAIRA^CanaceAIRA^Corona^^^^L|LaurelAIRA^ZiahonAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1081 Zieuwkoop Ave^^Waterford^MI^48330^USA^P||^PRN^PH^^^248^5803978|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThiemerAIRA^LaurelAIRA^^^^^L|MTH^Mother^HL70063|1081 Zieuwkoop Ave^^Waterford^MI^48330^USA^P|^PRN^PH^^^248^5803978ORC|RE||BH50H6516.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH50H6516.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0614-11^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420-0470-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X54Y6524^^^AIRA-TEST^MR||Box ButteAIRA^JaythenAIRA^Sandra^^^^L|BryanAIRA^SydneyAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1060 Rtrechtse Heuvelrug St^^Cass City^MI^48726^USA^P||^PRN^PH^^^989^9870044|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Box ButteAIRA^BryanAIRA^^^^^L|MTH^Mother^HL70063|1060 Rtrechtse Heuvelrug St^^Cass City^MI^48726^USA^P|^PRN^PH^^^989^9870044ORC|RE||BX54Y6524.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX54Y6524.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||76420-0470-10^Physicians EZ Use Flu Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420-0471-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T01T6535^^^AIRA-TEST^MR||HumboldtAIRA^ManishaAIRA^Gabriella^^^^L|RinggoldAIRA^HeidiAIRA^^^^^M|20160911|F||2106-3^White^CDCREC|1683 Gerwerderadeel Cir^^Decker^MI^48426^USA^P||^PRN^PH^^^810^6761708|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HumboldtAIRA^RinggoldAIRA^^^^^L|MTH^Mother^HL70063|1683 Gerwerderadeel Cir^^Decker^MI^48426^USA^P|^PRN^PH^^^810^6761708ORC|RE||BT01T6535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161111||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT01T6535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170111||76420-0471-01^Medical Provider Single Use EZ Flu Shot Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170111||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420-0482-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T85L6543^^^AIRA-TEST^MR||PeskenAIRA^SubhadraAIRA^Omaka^^^^L|SheridanAIRA^YevaAIRA^^^^^M|20160911|F||2106-3^White^CDCREC|1442 Oedemblik St^^Williamsville^MI^48137^USA^P||^PRN^PH^^^734^3517527|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PeskenAIRA^SheridanAIRA^^^^^L|MTH^Mother^HL70063|1442 Oedemblik St^^Williamsville^MI^48137^USA^P|^PRN^PH^^^734^3517527ORC|RE||BT85L6543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161111||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT85L6543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170111||76420-0482-01^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170111||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420-0483-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J01O6551^^^AIRA-TEST^MR||JasperAIRA^AllisonAIRA^Felice^^^^L|JungstroinAIRA^RonniAIRA^^^^^M|20160911|F||2106-3^White^CDCREC|1294 Dergeijk St^^Kincheloe^MI^49784^USA^P||^PRN^PH^^^906^2582301|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JasperAIRA^JungstroinAIRA^^^^^L|MTH^Mother^HL70063|1294 Dergeijk St^^Kincheloe^MI^49784^USA^P|^PRN^PH^^^906^2582301ORC|RE||BJ01O6551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161111||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ01O6551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170111||76420-0483-01^Medical Provider Single Use EZ Flu Shot 2013-2014^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170111||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-OBS-METHOD-VXC40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R59X6556^^^AIRA-TEST^MR||LieAIRA^CairineAIRA^Carajean^^^^L|HarrisonAIRA^RicardaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1883 Koord Ln^^Emmett Township^MI^48022^USA^P||^PRN^PH^^^810^7599686|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LieAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1883 Koord Ln^^Emmett Township^MI^48022^USA^P|^PRN^PH^^^810^7599686ORC|RE||BR59X6556.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR59X6556.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-OBS-METHOD-VXC41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X19N6564^^^AIRA-TEST^MR||TaylorAIRA^LowanAIRA^Janelle^^^^L|HamiltonAIRA^AlgerineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1710 Hestervoort Ln^^Bloomfield Township^MI^48304^USA^P||^PRN^PH^^^248^2591931|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1710 Hestervoort Ln^^Bloomfield Township^MI^48304^USA^P|^PRN^PH^^^248^2591931ORC|RE||BX19N6564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX19N6564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC41^per visit^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PROTECT-N|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C38N6575^^^AIRA-TEST^MR||UnionAIRA^AnuradhaAIRA^Oriole^^^^L|FranklinAIRA^LidaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1522 Judwest-Fryslan St^^Ortonville^MI^48462^USA^P||^PRN^PH^^^248^4580598|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|N||||A|20200306|20200306NK1|1|UnionAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1522 Judwest-Fryslan St^^Ortonville^MI^48462^USA^P|^PRN^PH^^^248^4580598ORC|RE||BC38N6575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC38N6575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PROTECT-Y|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S90M6583^^^AIRA-TEST^MR||YumaAIRA^NanonAIRA^Alesti^^^^L|BedfordAIRA^HelmineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1361 Arimpenerwaard Ave^^State of Michigan^MI^48913^USA^P||^PRN^PH^^^517^8112248|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|Y||||A|20200306|20200306NK1|1|YumaAIRA^BedfordAIRA^^^^^L|MTH^Mother^HL70063|1361 Arimpenerwaard Ave^^State of Michigan^MI^48913^USA^P|^PRN^PH^^^517^8112248ORC|RE||BS90M6583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS90M6583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X38W6591^^^AIRA-TEST^MR||DanielsonAIRA^PearlAIRA^Moyna^^^^L|PottawatomieAIRA^AlvinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1017 Vaanstad Cir^^Wells^MI^49894^USA^P||^PRN^PH^^^906^5981290|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||01^No reminder/recall^HL70215|||||A|20200306|20200306NK1|1|DanielsonAIRA^PottawatomieAIRA^^^^^L|MTH^Mother^HL70063|1017 Vaanstad Cir^^Wells^MI^49894^USA^P|^PRN^PH^^^906^5981290ORC|RE||BX38W6591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX38W6591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G14G6596^^^AIRA-TEST^MR||MartinAIRA^MirabelleAIRA^Mira^^^^L|FranklinAIRA^CelieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1488 Rergeijk Ln^^Smyrna^MI^48887^USA^P||^PRN^PH^^^616^5512700|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/recall - any method^HL70215|||||A|20200306|20200306NK1|1|MartinAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1488 Rergeijk Ln^^Smyrna^MI^48887^USA^P|^PRN^PH^^^616^5512700ORC|RE||BG14G6596.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG14G6596.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A37G6604^^^AIRA-TEST^MR||ReillyAIRA^YokoAIRA^Quirita^^^^L|CoconinoAIRA^KaitlynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1658 Aeusel-De Mierden Ln^^Lansing^MI^48911^USA^P||^PRN^PH^^^517^7050501|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||03^Reminder/recall - no calls^HL70215|||||A|20200306|20200306NK1|1|ReillyAIRA^CoconinoAIRA^^^^^L|MTH^Mother^HL70063|1658 Aeusel-De Mierden Ln^^Lansing^MI^48911^USA^P|^PRN^PH^^^517^7050501ORC|RE||BA37G6604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA37G6604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G84A6615^^^AIRA-TEST^MR||EvansAIRA^FionaAIRA^Haja^^^^L|LorainAIRA^MarlissAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1117 Rteenwijkerland Cir^^University Center^MI^48710^USA^P||^PRN^PH^^^989^7842804|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||04^Reminder only - any method^HL70215|||||A|20200306|20200306NK1|1|EvansAIRA^LorainAIRA^^^^^L|MTH^Mother^HL70063|1117 Rteenwijkerland Cir^^University Center^MI^48710^USA^P|^PRN^PH^^^989^7842804ORC|RE||BG84A6615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG84A6615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V74V6623^^^AIRA-TEST^MR||LakeAIRA^HazelAIRA^Minka^^^^L|HalsallAIRA^TanushiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1607 Ooosendaal St^^Ralph^MI^49877^USA^P||^PRN^PH^^^906^3402591|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||05^Reminder only - no calls^HL70215|||||A|20200306|20200306NK1|1|LakeAIRA^HalsallAIRA^^^^^L|MTH^Mother^HL70063|1607 Ooosendaal St^^Ralph^MI^49877^USA^P|^PRN^PH^^^906^3402591ORC|RE||BV74V6623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV74V6623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I36C6631^^^AIRA-TEST^MR||JeffersonAIRA^AntheaAIRA^Viviana^^^^L|HayesAIRA^DoriaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1574 Llochteren St^^Peacock^MI^49644^USA^P||^PRN^PH^^^231^7058793|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||06^Recall only - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^HayesAIRA^^^^^L|MTH^Mother^HL70063|1574 Llochteren St^^Peacock^MI^49644^USA^P|^PRN^PH^^^231^7058793ORC|RE||BI36C6631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI36C6631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L85W6636^^^AIRA-TEST^MR||CassAIRA^CaitAIRA^Hailey^^^^L|WheelerAIRA^DianeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1501 Sinnenmaas Pl^^Battle Creek^MI^49017^USA^P||^PRN^PH^^^269^2613787|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||07^Recall only - no calls^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1501 Sinnenmaas Pl^^Battle Creek^MI^49017^USA^P|^PRN^PH^^^269^2613787ORC|RE||BL85W6636.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL85W6636.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W83D6644^^^AIRA-TEST^MR||JeffersonAIRA^CherlinAIRA^Angelica^^^^L|PurolaAIRA^CalandraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1590 Lezen Ln^^Kalamazoo^MI^49006^USA^P||^PRN^PH^^^269^5056836|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||08^Reminder/recall - to provider^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^PurolaAIRA^^^^^L|MTH^Mother^HL70063|1590 Lezen Ln^^Kalamazoo^MI^49006^USA^P|^PRN^PH^^^269^5056836ORC|RE||BW83D6644.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW83D6644.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E51V6655^^^AIRA-TEST^MR||OkmulgeeAIRA^CassidyAIRA^Winter^^^^L|SowdenAIRA^KamaliAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1523 Kinsum Cir^^Milford^MI^48380^USA^P||^PRN^PH^^^248^7963055|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||09^Reminder to provider^HL70215|||||A|20200306|20200306NK1|1|OkmulgeeAIRA^SowdenAIRA^^^^^L|MTH^Mother^HL70063|1523 Kinsum Cir^^Milford^MI^48380^USA^P|^PRN^PH^^^248^7963055ORC|RE||BE51V6655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE51V6655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F84S6663^^^AIRA-TEST^MR||RiversideAIRA^GracieAIRA^Ursula^^^^L|SacAIRA^JacindaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1466 Ge Ronde Venen Cir^^Grosse Pointe Shores^MI^48230^USA^P||^PRN^PH^^^313^6819162|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||10^Only reminder to provider, no recall^HL70215|||||A|20200306|20200306NK1|1|RiversideAIRA^SacAIRA^^^^^L|MTH^Mother^HL70063|1466 Ge Ronde Venen Cir^^Grosse Pointe Shores^MI^48230^USA^P|^PRN^PH^^^313^6819162ORC|RE||BF84S6663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF84S6663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H54M6671^^^AIRA-TEST^MR||LassenAIRA^TristaAIRA^Megan^^^^L|ClarkAIRA^UrsellAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1025 Wortel Ave^^Stephenson^MI^49887^USA^P||^PRN^PH^^^906^8523759|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||11^Recall to provider^HL70215|||||A|20200306|20200306NK1|1|LassenAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1025 Wortel Ave^^Stephenson^MI^49887^USA^P|^PRN^PH^^^906^8523759ORC|RE||BH54M6671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH54M6671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-PUBLICITY-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z77P6679^^^AIRA-TEST^MR||GartenlaubAIRA^MorgandyAIRA^Miranda^^^^L|CreghanAIRA^JacintheAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1078 Sreda Ave^^Vicksburg^MI^49097^USA^P||^PRN^PH^^^269^7139034|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||12^Only recall to provider, no reminder^HL70215|||||A|20200306|20200306NK1|1|GartenlaubAIRA^CreghanAIRA^^^^^L|MTH^Mother^HL70063|1078 Sreda Ave^^Vicksburg^MI^49097^USA^P|^PRN^PH^^^269^7139034ORC|RE||BZ77P6679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ77P6679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-1002-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L69S6684^^^AIRA-TEST^MR||MitchellAIRA^HeloiseAIRA^Sachiko^^^^L|IowaAIRA^KelseyAIRA^^^^^M|20160105|F||1002-5^American Indian or Alaska Native^HL70005|1652 Vloer Pl^^Rudyard^MI^49780^USA^P||^PRN^PH^^^906^8765357|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MitchellAIRA^IowaAIRA^^^^^L|MTH^Mother^HL70063|1652 Vloer Pl^^Rudyard^MI^49780^USA^P|^PRN^PH^^^906^8765357ORC|RE||BL69S6684.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL69S6684.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2028-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A69A6692^^^AIRA-TEST^MR||BedfordAIRA^SamtaAIRA^Myiesha^^^^L|EatonAIRA^GwenhyvarAIRA^^^^^M|20160105|F||2028-9^Asian^HL70005|1439 Gooien Ln^^Michigan Bulb Co^MI^49550^USA^P||^PRN^PH^^^616^4064294|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BedfordAIRA^EatonAIRA^^^^^L|MTH^Mother^HL70063|1439 Gooien Ln^^Michigan Bulb Co^MI^49550^USA^P|^PRN^PH^^^616^4064294ORC|RE||BA69A6692.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA69A6692.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2034-7|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M83S6703^^^AIRA-TEST^MR||BelmontAIRA^SissyAIRA^Alona^^^^L|BaileyAIRA^KristinaAIRA^^^^^M|20160105|F||2034-7^Chinese^HL70005|1084 Lijmegen St^^Brandon^MI^48462^USA^P||^PRN^PH^^^248^5263401|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BelmontAIRA^BaileyAIRA^^^^^L|MTH^Mother^HL70063|1084 Lijmegen St^^Brandon^MI^48462^USA^P|^PRN^PH^^^248^5263401ORC|RE||BM83S6703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM83S6703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2036-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C94G6711^^^AIRA-TEST^MR||KossuthAIRA^MurielAIRA^Brier^^^^L|MuscatineAIRA^QuentinAIRA^^^^^M|20160105|F||2036-2^Filipino^HL70005|1262 Tronckhorst Pl^^Lansing^MI^48917^USA^P||^PRN^PH^^^517^8459486|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KossuthAIRA^MuscatineAIRA^^^^^L|MTH^Mother^HL70063|1262 Tronckhorst Pl^^Lansing^MI^48917^USA^P|^PRN^PH^^^517^8459486ORC|RE||BC94G6711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC94G6711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2039-6|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N70W6719^^^AIRA-TEST^MR||BlancoAIRA^KarlaAIRA^Ashling^^^^L|HuronAIRA^MatanaAIRA^^^^^M|20160105|F||2039-6^Japanese^HL70005|1094 Stuk Ln^^Curran^MI^48728^USA^P||^PRN^PH^^^989^2766568|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlancoAIRA^HuronAIRA^^^^^L|MTH^Mother^HL70063|1094 Stuk Ln^^Curran^MI^48728^USA^P|^PRN^PH^^^989^2766568ORC|RE||BN70W6719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN70W6719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2054-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A62X6727^^^AIRA-TEST^MR||BentonAIRA^OpalineAIRA^Alethea^^^^L|AshlandAIRA^AndreanaAIRA^^^^^M|20160105|F||2054-5^Black or African-American^HL70005|1272 Wytsjerksteradiel Pl^^Kalamazoo^MI^49008^USA^P||^PRN^PH^^^269^2738031|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BentonAIRA^AshlandAIRA^^^^^L|MTH^Mother^HL70063|1272 Wytsjerksteradiel Pl^^Kalamazoo^MI^49008^USA^P|^PRN^PH^^^269^2738031ORC|RE||BA62X6727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA62X6727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2076-8|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O37V6732^^^AIRA-TEST^MR||LebanonAIRA^FabienneAIRA^Platona^^^^L|CrookAIRA^ThaliaAIRA^^^^^M|20160105|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|1888 Dulpen-Wittem Pl^^Sault Sainte Marie^MI^49785^USA^P||^PRN^PH^^^906^3956579|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LebanonAIRA^CrookAIRA^^^^^L|MTH^Mother^HL70063|1888 Dulpen-Wittem Pl^^Sault Sainte Marie^MI^49785^USA^P|^PRN^PH^^^906^3956579ORC|RE||BO37V6732.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO37V6732.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2106-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W56Y6740^^^AIRA-TEST^MR||BurtAIRA^OlgaAIRA^Barretta^^^^L|LoganAIRA^JessicaAIRA^^^^^M|20160105|F||2106-3^White^HL70005|1111 Vouw St^^Grand Rapids^MI^49588^USA^P||^PRN^PH^^^616^4078515|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BurtAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1111 Vouw St^^Grand Rapids^MI^49588^USA^P|^PRN^PH^^^616^4078515ORC|RE||BW56Y6740.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW56Y6740.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2131-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y95A6751^^^AIRA-TEST^MR||StallardAIRA^KennediAIRA^Edaline^^^^L|DouglasAIRA^AparaAIRA^^^^^M|20160105|F||2131-1^Other Race^HL70005|1477 Oefening Pl^^Bay City^MI^48707^USA^P||^PRN^PH^^^989^6431300|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StallardAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1477 Oefening Pl^^Bay City^MI^48707^USA^P|^PRN^PH^^^989^6431300ORC|RE||BY95A6751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY95A6751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2135-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J08J6759^^^AIRA-TEST^MR||KnoxAIRA^GrearAIRA^Lysette^^^^L|WinnebagoAIRA^CharlieAIRA^^^^^M|20160105|F||2135-2^Hispanic or Latino^HL70005|1696 Dosterhout Ave^^Flint^MI^48519^USA^P||^PRN^PH^^^810^2343890|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnoxAIRA^WinnebagoAIRA^^^^^L|MTH^Mother^HL70063|1696 Dosterhout Ave^^Flint^MI^48519^USA^P|^PRN^PH^^^810^2343890ORC|RE||BJ08J6759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ08J6759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-2186-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W08I6767^^^AIRA-TEST^MR||McMullenAIRA^ManjuAIRA^Jendayi^^^^L|TuolumneAIRA^JyotsnaAIRA^^^^^M|20160105|F||2186-5^not Hispanic or Latino^HL70005|1238 Walfsen Pl^^Otter Lake^MI^48464^USA^P||^PRN^PH^^^810^2815522|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McMullenAIRA^TuolumneAIRA^^^^^L|MTH^Mother^HL70063|1238 Walfsen Pl^^Otter Lake^MI^48464^USA^P|^PRN^PH^^^810^2815522ORC|RE||BW08I6767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW08I6767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-A|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W30Z6775^^^AIRA-TEST^MR||MeredithAIRA^AryaAIRA^Deiondre^^^^L|AldridgeAIRA^ZagirAIRA^^^^^M|20160105|F||A^Asian or Pacific Islander^HL70005|1402 Vleermuis St^^Bloomfield Hills^MI^48303^USA^P||^PRN^PH^^^248^9944222|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeredithAIRA^AldridgeAIRA^^^^^L|MTH^Mother^HL70063|1402 Vleermuis St^^Bloomfield Hills^MI^48303^USA^P|^PRN^PH^^^248^9944222ORC|RE||BW30Z6775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW30Z6775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-B|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I18Q6780^^^AIRA-TEST^MR||MerwikAIRA^DariaAIRA^Wren^^^^L|WoldAIRA^SadeAIRA^^^^^M|20160105|F||B^Black or African-American^HL70005|1163 Waddinxveen Cir^^Ada^MI^49357^USA^P||^PRN^PH^^^616^3074365|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MerwikAIRA^WoldAIRA^^^^^L|MTH^Mother^HL70063|1163 Waddinxveen Cir^^Ada^MI^49357^USA^P|^PRN^PH^^^616^3074365ORC|RE||BI18Q6780.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI18Q6780.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-I|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U43M6788^^^AIRA-TEST^MR||ButteAIRA^EvadneAIRA^Soraya^^^^L|YorkAIRA^LarissaAIRA^^^^^M|20160105|F||I^American Indian or Alaska Native^HL70005|1143 Waaren St^^Ann Arbor^MI^48104^USA^P||^PRN^PH^^^734^9141514|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButteAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1143 Waaren St^^Ann Arbor^MI^48104^USA^P|^PRN^PH^^^734^9141514ORC|RE||BU43M6788.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU43M6788.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-O|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V07P6799^^^AIRA-TEST^MR||BooneAIRA^KaiaAIRA^Selena^^^^L|AdamsAIRA^AmaiaAIRA^^^^^M|20160105|F||O^Other Race^HL70005|1610 Kirschot Ln^^Grant Township^MI^48032^USA^P||^PRN^PH^^^810^6604153|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BooneAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1610 Kirschot Ln^^Grant Township^MI^48032^USA^P|^PRN^PH^^^810^6604153ORC|RE||BV07P6799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV07P6799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I86A6807^^^AIRA-TEST^MR||BuffaloAIRA^ChrissyAIRA^Dani^^^^L|MonaghanAIRA^ArabellaAIRA^^^^^M|20160105|F||U^Unknown^HL70005|1647 Hoerdalen Cir^^Kelly Services Inc^MI^48266^USA^P||^PRN^PH^^^313^3915025|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BuffaloAIRA^MonaghanAIRA^^^^^L|MTH^Mother^HL70063|1647 Hoerdalen Cir^^Kelly Services Inc^MI^48266^USA^P|^PRN^PH^^^313^3915025ORC|RE||BI86A6807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI86A6807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RACE-W|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F96O6815^^^AIRA-TEST^MR||YorkAIRA^SuparnaAIRA^Echo^^^^L|San BernardinoAIRA^GaiAIRA^^^^^M|20160105|F||W^White^HL70005|1513 Ncht-Susteren St^^Orleans^MI^48865^USA^P||^PRN^PH^^^616^3032593|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YorkAIRA^San BernardinoAIRA^^^^^L|MTH^Mother^HL70063|1513 Ncht-Susteren St^^Orleans^MI^48865^USA^P|^PRN^PH^^^616^3032593ORC|RE||BF96O6815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF96O6815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-REG-STATUS-R|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U65R6820^^^AIRA-TEST^MR||FultonAIRA^KayleeAIRA^Riona^^^^L|HamiltonAIRA^SagaraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1672 Daasdriel Ln^^Negaunee^MI^49866^USA^P||^PRN^PH^^^906^4270812|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||R|20200306|20200306NK1|1|FultonAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1672 Daasdriel Ln^^Negaunee^MI^49866^USA^P|^PRN^PH^^^906^4270812ORC|RE||BU65R6820.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU65R6820.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-ASC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I41O6828^^^AIRA-TEST^MR||OkmulgeeAIRA^JenicaAIRA^Liza^^^^L|GustafsonAIRA^NadineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1871 Almere Cir^^Cottrellville^MI^48039^USA^P||^PRN^PH^^^810^6705467|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OkmulgeeAIRA^GustafsonAIRA^^^^^L|ASC^Associate^HL70063|1871 Almere Cir^^Cottrellville^MI^48039^USA^P|^PRN^PH^^^810^6705467ORC|RE||BI41O6828.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI41O6828.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-BRO|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B93W6839^^^AIRA-TEST^MR||KingfisherAIRA^EmmaAIRA^Idelia^^^^L|GustafsonAIRA^FatinAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1187 Springen Cir^^Lake Orion^MI^48362^USA^P||^PRN^PH^^^248^2650242|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingfisherAIRA^GustafsonAIRA^^^^^L|BRO^Brother^HL70063|1187 Springen Cir^^Lake Orion^MI^48362^USA^P|^PRN^PH^^^248^2650242ORC|RE||BB93W6839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB93W6839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-CGV|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T05Y6847^^^AIRA-TEST^MR||BarkerAIRA^BonitaAIRA^Annunziata^^^^L|JacintoAIRA^KimatraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1793 Zeststellingwerf Pl^^Sault S Marie^MI^49784^USA^P||^PRN^PH^^^906^7179560|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarkerAIRA^JacintoAIRA^^^^^L|CGV^Care Giver^HL70063|1793 Zeststellingwerf Pl^^Sault S Marie^MI^49784^USA^P|^PRN^PH^^^906^7179560ORC|RE||BT05Y6847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT05Y6847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-CHD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S12J6855^^^AIRA-TEST^MR||HighlandAIRA^KerriAIRA^Devi^^^^L|JeffersonAIRA^KristaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1774 Woevorden Ave^^Coloma^MI^49038^USA^P||^PRN^PH^^^269^6754201|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HighlandAIRA^JeffersonAIRA^^^^^L|CHD^Child^HL70063|1774 Woevorden Ave^^Coloma^MI^49038^USA^P|^PRN^PH^^^269^6754201ORC|RE||BS12J6855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS12J6855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-DEP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P64I6863^^^AIRA-TEST^MR||RussellAIRA^AmbraAIRA^Taryn^^^^L|DomoAIRA^DabriaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1677 Soogeveen Pl^^Ypsilanti^MI^48198^USA^P||^PRN^PH^^^734^6534846|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RussellAIRA^DomoAIRA^^^^^L|DEP^Handicapped dependent^HL70063|1677 Soogeveen Pl^^Ypsilanti^MI^48198^USA^P|^PRN^PH^^^734^6534846ORC|RE||BP64I6863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP64I6863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-DOM|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R51F6868^^^AIRA-TEST^MR||DelawareAIRA^MutsukoAIRA^Blanda^^^^L|TiogaAIRA^AngelAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1299 Derkendam Ln^^GR^MI^49503^USA^P||^PRN^PH^^^616^9499735|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^TiogaAIRA^^^^^L|DOM^Life partner^HL70063|1299 Derkendam Ln^^GR^MI^49503^USA^P|^PRN^PH^^^616^9499735ORC|RE||BR51F6868.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR51F6868.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-EMC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B25C6876^^^AIRA-TEST^MR||DaviessAIRA^LilliannaAIRA^Anabelle^^^^L|WalkerAIRA^EdithAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1769 Orootegast St^^Marshall^MI^49069^USA^P||^PRN^PH^^^269^3836028|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DaviessAIRA^WalkerAIRA^^^^^L|EMC^Emergency contact^HL70063|1769 Orootegast St^^Marshall^MI^49069^USA^P|^PRN^PH^^^269^3836028ORC|RE||BB25C6876.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB25C6876.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-EME|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M83G6887^^^AIRA-TEST^MR||CreaserAIRA^VolumniaAIRA^Zara^^^^L|GrundyAIRA^JusticeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1968 Waren Pl^^South Range^MI^49963^USA^P||^PRN^PH^^^906^4932866|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CreaserAIRA^GrundyAIRA^^^^^L|EME^Employee^HL70063|1968 Waren Pl^^South Range^MI^49963^USA^P|^PRN^PH^^^906^4932866ORC|RE||BM83G6887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM83G6887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-EMR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N41J6895^^^AIRA-TEST^MR||CedarAIRA^HadassahAIRA^Deepti^^^^L|SilowAIRA^RiannaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1247 Oijnwaarden Cir^^Brownstown^MI^48164^USA^P||^PRN^PH^^^734^2244859|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CedarAIRA^SilowAIRA^^^^^L|EMR^Employer^HL70063|1247 Oijnwaarden Cir^^Brownstown^MI^48164^USA^P|^PRN^PH^^^734^2244859ORC|RE||BN41J6895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN41J6895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-EXF|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U98R6903^^^AIRA-TEST^MR||WilsonAIRA^YazminAIRA^Zosima^^^^L|StantonAIRA^SeverinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1236 Sucphen St^^Cadmus^MI^49221^USA^P||^PRN^PH^^^517^8871149|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilsonAIRA^StantonAIRA^^^^^L|EXF^Extended family^HL70063|1236 Sucphen St^^Cadmus^MI^49221^USA^P|^PRN^PH^^^517^8871149ORC|RE||BU98R6903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU98R6903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-FCH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X61H6908^^^AIRA-TEST^MR||LovingAIRA^RoyaleAIRA^Alastrina^^^^L|PikeAIRA^DulceAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1865 Paard Pl^^Fountain^MI^49410^USA^P||^PRN^PH^^^231^8600098|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LovingAIRA^PikeAIRA^^^^^L|FCH^Foster Child^HL70063|1865 Paard Pl^^Fountain^MI^49410^USA^P|^PRN^PH^^^231^8600098ORC|RE||BX61H6908.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX61H6908.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-FND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J87C6916^^^AIRA-TEST^MR||BarkerAIRA^KrupaliAIRA^Abby^^^^L|ClearfieldAIRA^MichaelaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1529 Dtein Cir^^East Tawas^MI^48730^USA^P||^PRN^PH^^^989^4413490|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarkerAIRA^ClearfieldAIRA^^^^^L|FND^Friend^HL70063|1529 Dtein Cir^^East Tawas^MI^48730^USA^P|^PRN^PH^^^989^4413490ORC|RE||BJ87C6916.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ87C6916.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-FTH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y59P6927^^^AIRA-TEST^MR||OchiltreeAIRA^OliveAIRA^Vada^^^^L|AdaAIRA^ToakaseAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1539 Aoirle Cir^^Detroit^MI^48226^USA^P||^PRN^PH^^^313^6744912|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OchiltreeAIRA^AdaAIRA^^^^^L|FTH^Father^HL70063|1539 Aoirle Cir^^Detroit^MI^48226^USA^P|^PRN^PH^^^313^6744912ORC|RE||BY59P6927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY59P6927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-GCH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q01W6935^^^AIRA-TEST^MR||MasonAIRA^BonaAIRA^Vicky^^^^L|Bear LakeAIRA^CarineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1917 Flat St^^Flint^MI^48532^USA^P||^PRN^PH^^^810^6437719|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^Bear LakeAIRA^^^^^L|GCH^Grandchild^HL70063|1917 Flat St^^Flint^MI^48532^USA^P|^PRN^PH^^^810^6437719ORC|RE||BQ01W6935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ01W6935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-GRD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q68O6943^^^AIRA-TEST^MR||GarrardAIRA^JulietAIRA^Kitty^^^^L|KaufmanAIRA^SerenaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1465 Glphen-Chaam St^^Blissfield^MI^49228^USA^P||^PRN^PH^^^517^2152412|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarrardAIRA^KaufmanAIRA^^^^^L|GRD^Guardian^HL70063|1465 Glphen-Chaam St^^Blissfield^MI^49228^USA^P|^PRN^PH^^^517^2152412ORC|RE||BQ68O6943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ68O6943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-GRP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q09S6948^^^AIRA-TEST^MR||SierraAIRA^VerbenaAIRA^Mindy^^^^L|RichlandAIRA^XyliaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1966 Kaasdriel Ave^^Gaylord^MI^49735^USA^P||^PRN^PH^^^989^2526629|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SierraAIRA^RichlandAIRA^^^^^L|GRP^Grand Parent^HL70063|1966 Kaasdriel Ave^^Gaylord^MI^49735^USA^P|^PRN^PH^^^989^2526629ORC|RE||BQ09S6948.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ09S6948.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-MGR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X07X6959^^^AIRA-TEST^MR||JeffersonAIRA^BranwenAIRA^Ramya^^^^L|UnionAIRA^BetsyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1185 Barum Pl^^Saint Clr Shores^MI^48081^USA^P||^PRN^PH^^^586^4363163|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^UnionAIRA^^^^^L|MGR^Manager^HL70063|1185 Barum Pl^^Saint Clr Shores^MI^48081^USA^P|^PRN^PH^^^586^4363163ORC|RE||BX07X6959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX07X6959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-MTH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A85R6967^^^AIRA-TEST^MR||BathAIRA^GracieAIRA^Gemma^^^^L|Red WillowAIRA^CamrynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1731 Oolenwaard Ln^^Andrews University^MI^49104^USA^P||^PRN^PH^^^269^5511617|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BathAIRA^Red WillowAIRA^^^^^L|MTH^Mother^HL70063|1731 Oolenwaard Ln^^Andrews University^MI^49104^USA^P|^PRN^PH^^^269^5511617ORC|RE||BA85R6967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA85R6967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-NCH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E99O6975^^^AIRA-TEST^MR||WardleAIRA^RaquelAIRA^Asella^^^^L|MorrisAIRA^ThetisAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1713 Dchtkarspelen St^^Marshall^MI^49068^USA^P||^PRN^PH^^^269^4921865|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WardleAIRA^MorrisAIRA^^^^^L|NCH^Natural child^HL70063|1713 Dchtkarspelen St^^Marshall^MI^49068^USA^P|^PRN^PH^^^269^4921865ORC|RE||BE99O6975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE99O6975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-NON|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R34F6983^^^AIRA-TEST^MR||SagadahocAIRA^ZelmaAIRA^Galia^^^^L|FremmingAIRA^AryanaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1834 Beroemde Cir^^Berrien Springs^MI^49104^USA^P||^PRN^PH^^^269^5972708|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SagadahocAIRA^FremmingAIRA^^^^^L|NON^None^HL70063|1834 Beroemde Cir^^Berrien Springs^MI^49104^USA^P|^PRN^PH^^^269^5972708ORC|RE||BR34F6983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR34F6983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-OAD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L27P6988^^^AIRA-TEST^MR||OwsleyAIRA^TuruaAIRA^Tosia^^^^L|WashingtonAIRA^YasminAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1309 Mlst-Wijhe Ave^^Cadmus^MI^49221^USA^P||^PRN^PH^^^517^6688719|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwsleyAIRA^WashingtonAIRA^^^^^L|OAD^Other adult^HL70063|1309 Mlst-Wijhe Ave^^Cadmus^MI^49221^USA^P|^PRN^PH^^^517^6688719ORC|RE||BL27P6988.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL27P6988.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-OTH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A84L6996^^^AIRA-TEST^MR||FillmoreAIRA^EdelineAIRA^Claudia^^^^L|CopelandAIRA^HaldisAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1116 Bengelo Ln^^East Lansing^MI^48825^USA^P||^PRN^PH^^^517^6330961|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FillmoreAIRA^CopelandAIRA^^^^^L|OTH^Other^HL70063|1116 Bengelo Ln^^East Lansing^MI^48825^USA^P|^PRN^PH^^^517^6330961ORC|RE||BA84L6996.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA84L6996.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-OWN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q99W7007^^^AIRA-TEST^MR||JeffersonAIRA^WeemaAIRA^Oralia^^^^L|Buena VistaAIRA^DouceAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1164 Achtkarspelen St^^Detroit^MI^48264^USA^P||^PRN^PH^^^313^8053563|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^Buena VistaAIRA^^^^^L|OWN^Owner^HL70063|1164 Achtkarspelen St^^Detroit^MI^48264^USA^P|^PRN^PH^^^313^8053563ORC|RE||BQ99W7007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ99W7007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-PAR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G48X7015^^^AIRA-TEST^MR||SpencerAIRA^AviceAIRA^Dristi^^^^L|PetersenAIRA^FredaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1808 Delft Ave^^Sterling Heights^MI^48314^USA^P||^PRN^PH^^^586^8290567|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SpencerAIRA^PetersenAIRA^^^^^L|PAR^Parent^HL70063|1808 Delft Ave^^Sterling Heights^MI^48314^USA^P|^PRN^PH^^^586^8290567ORC|RE||BG48X7015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG48X7015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-SCH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A50U7023^^^AIRA-TEST^MR||ComancheAIRA^NirvanaAIRA^Kamila^^^^L|FranklinAIRA^AnkitaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1320 Planten Ave^^Dearborn^MI^48123^USA^P||^PRN^PH^^^313^2132602|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ComancheAIRA^FranklinAIRA^^^^^L|SCH^Step Child^HL70063|1320 Planten Ave^^Dearborn^MI^48123^USA^P|^PRN^PH^^^313^2132602ORC|RE||BA50U7023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA50U7023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-SEL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B80B7028^^^AIRA-TEST^MR||MasonAIRA^FrederikaAIRA^Jenny^^^^L|PlacerAIRA^MellAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1307 Mnderbanken Ln^^Sebewaing^MI^48759^USA^P||^PRN^PH^^^989^4356468|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^PlacerAIRA^^^^^L|SEL^Self^HL70063|1307 Mnderbanken Ln^^Sebewaing^MI^48759^USA^P|^PRN^PH^^^989^4356468ORC|RE||BB80B7028.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB80B7028.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-SIB|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P94L7036^^^AIRA-TEST^MR||HenryAIRA^SahilaAIRA^Nerin^^^^L|LincolnAIRA^SurupaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1475 Gytsjerksteradiel Pl^^Oscoda^MI^48750^USA^P||^PRN^PH^^^989^8567449|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HenryAIRA^LincolnAIRA^^^^^L|SIB^Sibling^HL70063|1475 Gytsjerksteradiel Pl^^Oscoda^MI^48750^USA^P|^PRN^PH^^^989^8567449ORC|RE||BP94L7036.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP94L7036.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-SIS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B37Q7047^^^AIRA-TEST^MR||JacksonAIRA^PepaAIRA^Nazaret^^^^L|GeneseeAIRA^TamAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1867 Nestland Pl^^Glendora^MI^49107^USA^P||^PRN^PH^^^269^8984969|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^GeneseeAIRA^^^^^L|SIS^Sister^HL70063|1867 Nestland Pl^^Glendora^MI^49107^USA^P|^PRN^PH^^^269^8984969ORC|RE||BB37Q7047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB37Q7047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-SPO|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G41A7055^^^AIRA-TEST^MR||ThurstonAIRA^OleanderAIRA^Natala^^^^L|DickinsonAIRA^NeriaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1299 Lpeldoorn St^^Millersburg^MI^49759^USA^P||^PRN^PH^^^989^9649488|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThurstonAIRA^DickinsonAIRA^^^^^L|SPO^Spouse^HL70063|1299 Lpeldoorn St^^Millersburg^MI^49759^USA^P|^PRN^PH^^^989^9649488ORC|RE||BG41A7055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG41A7055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-TRA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O22Z7063^^^AIRA-TEST^MR||McErlaineAIRA^NualaAIRA^Shannon^^^^L|DefianceAIRA^DahliaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1146 Binterswijk Cir^^Mott Park^MI^48504^USA^P||^PRN^PH^^^810^2584945|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McErlaineAIRA^DefianceAIRA^^^^^L|TRA^Trainer^HL70063|1146 Binterswijk Cir^^Mott Park^MI^48504^USA^P|^PRN^PH^^^810^2584945ORC|RE||BO22Z7063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO22Z7063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-UNK|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E21L7068^^^AIRA-TEST^MR||MadisonAIRA^CaelynAIRA^Tammy^^^^L|HemphillAIRA^YthaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1482 Massenaar St^^Peacock^MI^49644^USA^P||^PRN^PH^^^231^7852169|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MadisonAIRA^HemphillAIRA^^^^^L|UNK^Unknown^HL70063|1482 Massenaar St^^Peacock^MI^49644^USA^P|^PRN^PH^^^231^7852169ORC|RE||BE21L7068.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE21L7068.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-RELATE-WRD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J54X7076^^^AIRA-TEST^MR||GreeneAIRA^CalthaAIRA^Shanna^^^^L|TaylorAIRA^WilonaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1592 Nmmen Pl^^Orchard Lake^MI^48324^USA^P||^PRN^PH^^^248^3600671|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreeneAIRA^TaylorAIRA^^^^^L|WRD^Ward of court^HL70063|1592 Nmmen Pl^^Orchard Lake^MI^48324^USA^P|^PRN^PH^^^248^3600671ORC|RE||BJ54X7076.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ54X7076.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-SEX-F|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J78I7087^^^AIRA-TEST^MR||OfvermarkAIRA^KamnaAIRA^Sara^^^^L|JonsonAIRA^MyrnaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1062 Wave Cir^^Munith^MI^49259^USA^P||^PRN^PH^^^517^8182915|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OfvermarkAIRA^JonsonAIRA^^^^^L|MTH^Mother^HL70063|1062 Wave Cir^^Munith^MI^49259^USA^P|^PRN^PH^^^517^8182915ORC|RE||BJ78I7087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ78I7087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-SEX-M|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F85F7095^^^AIRA-TEST^MR||BastropAIRA^AffricaAIRA^Alaqua^^^^L|JensenAIRA^LalageAIRA^^^^^M|20160105|M||2106-3^White^CDCREC|1077 Cijfer Cir^^Ubly^MI^48475^USA^P||^PRN^PH^^^989^6516970|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BastropAIRA^JensenAIRA^^^^^L|MTH^Mother^HL70063|1077 Cijfer Cir^^Ubly^MI^48475^USA^P|^PRN^PH^^^989^6516970ORC|RE||BF85F7095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF85F7095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-SEX-O|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J32T7103^^^AIRA-TEST^MR||PhiladelphiaAIRA^BaakoAIRA^Jaime^^^^L|HartAIRA^NoriAIRA^^^^^M|20160105|O||2106-3^White^CDCREC|1158 Ocharsterland Ave^^Orion^MI^48360^USA^P||^PRN^PH^^^248^2993266|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PhiladelphiaAIRA^HartAIRA^^^^^L|MTH^Mother^HL70063|1158 Ocharsterland Ave^^Orion^MI^48360^USA^P|^PRN^PH^^^248^2993266ORC|RE||BJ32T7103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ32T7103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-SEX-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C87K7111^^^AIRA-TEST^MR||DickAIRA^ShayAIRA^Amarina^^^^L|MahoningAIRA^MayukoAIRA^^^^^M|20160105|U||2106-3^White^CDCREC|1751 Noes Ave^^Ravenna^MI^49451^USA^P||^PRN^PH^^^231^8997457|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickAIRA^MahoningAIRA^^^^^L|MTH^Mother^HL70063|1751 Noes Ave^^Ravenna^MI^49451^USA^P|^PRN^PH^^^231^8997457ORC|RE||BC87K7111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC87K7111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N89B7116^^^AIRA-TEST^MR||BoiseAIRA^SarishaAIRA^Caroline^^^^L|O DayAIRA^HindaAIRA^^^^^M|19960831|F||2106-3^White^CDCREC|1724 Kon Pl^^Wilson^MI^49896^USA^P||^PRN^PH^^^906^9307795|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoiseAIRA^O DayAIRA^^^^^L|MTH^Mother^HL70063|1724 Kon Pl^^Wilson^MI^49896^USA^P|^PRN^PH^^^906^9307795ORC|RE||BN89B7116.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19961031||01^DTP^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN89B7116.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19961231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19961231||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O22T7124^^^AIRA-TEST^MR||GuadalupeAIRA^DeviAIRA^Kate^^^^L|BaileyAIRA^DaralisAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1936 Heusden Ln^^Grand Rapids^MI^49546^USA^P||^PRN^PH^^^616^6891246|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GuadalupeAIRA^BaileyAIRA^^^^^L|MTH^Mother^HL70063|1936 Heusden Ln^^Grand Rapids^MI^49546^USA^P|^PRN^PH^^^616^6891246ORC|RE||BO22T7124.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||02^OPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO22T7124.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D80I7135^^^AIRA-TEST^MR||NacogdochesAIRA^GilenAIRA^Leyna^^^^L|RodriguezAIRA^AdrianoAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1194 Nude IJsselstreek Cir^^Oakland Township^MI^48363^USA^P||^PRN^PH^^^248^5646318|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NacogdochesAIRA^RodriguezAIRA^^^^^L|MTH^Mother^HL70063|1194 Nude IJsselstreek Cir^^Oakland Township^MI^48363^USA^P|^PRN^PH^^^248^5646318ORC|RE||BD80I7135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||03^MMR^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD80I7135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V97G7143^^^AIRA-TEST^MR||EdmundsAIRA^FascienneAIRA^Marika^^^^L|HamiltonAIRA^HaleighAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1664 Ptrechtse Heuvelrug Pl^^Saint Clr Shores^MI^48081^USA^P||^PRN^PH^^^586^6748575|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EdmundsAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1664 Ptrechtse Heuvelrug Pl^^Saint Clr Shores^MI^48081^USA^P|^PRN^PH^^^586^6748575ORC|RE||BV97G7143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||04^Measles and Rubella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV97G7143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D58S7151^^^AIRA-TEST^MR||RoscommonAIRA^RaquelAIRA^Lana^^^^L|PortageAIRA^NafeezaAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1694 Zlphen aan den Rijn Pl^^Midland^MI^48686^USA^P||^PRN^PH^^^989^5517501|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RoscommonAIRA^PortageAIRA^^^^^L|MTH^Mother^HL70063|1694 Zlphen aan den Rijn Pl^^Midland^MI^48686^USA^P|^PRN^PH^^^989^5517501ORC|RE||BD58S7151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||05^measles^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD58S7151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D94X7156^^^AIRA-TEST^MR||FultonAIRA^ViriniAIRA^Iona^^^^L|O'ConnellAIRA^ArdeliaAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1703 Vithoorn Pl^^Andrews University^MI^49104^USA^P||^PRN^PH^^^269^7847515|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FultonAIRA^O'ConnellAIRA^^^^^L|MTH^Mother^HL70063|1703 Vithoorn Pl^^Andrews University^MI^49104^USA^P|^PRN^PH^^^269^7847515ORC|RE||BD94X7156.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||06^rubella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD94X7156.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W12P7164^^^AIRA-TEST^MR||HardinAIRA^EmilyAIRA^Hedwig^^^^L|IarrestadAIRA^ShrutiAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1553 Ve Fryske Marren Ln^^South Manitou^MI^49654^USA^P||^PRN^PH^^^231^4256023|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^IarrestadAIRA^^^^^L|MTH^Mother^HL70063|1553 Ve Fryske Marren Ln^^South Manitou^MI^49654^USA^P|^PRN^PH^^^231^4256023ORC|RE||BW12P7164.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||07^mumps^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW12P7164.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A12I7175^^^AIRA-TEST^MR||KayAIRA^KayAIRA^Glennis^^^^L|BrazoriaAIRA^ChristeaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1514 Don en Breugel Cir^^Presque Isle^MI^49777^USA^P||^PRN^PH^^^989^4600358|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KayAIRA^BrazoriaAIRA^^^^^L|MTH^Mother^HL70063|1514 Don en Breugel Cir^^Presque Isle^MI^49777^USA^P|^PRN^PH^^^989^4600358ORC|RE||BA12I7175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||08^Hep B, adolescent or pediatric^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA12I7175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z00H7183^^^AIRA-TEST^MR||HooperAIRA^GevaAIRA^Frederika^^^^L|BenewahAIRA^SakariAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1210 Moermond Cir^^Norway^MI^49870^USA^P||^PRN^PH^^^906^4557150|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HooperAIRA^BenewahAIRA^^^^^L|MTH^Mother^HL70063|1210 Moermond Cir^^Norway^MI^49870^USA^P|^PRN^PH^^^906^4557150ORC|RE||BZ00H7183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||09^Td (adult), adsorbed^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ00H7183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B04Y7191^^^AIRA-TEST^MR||HamiltonAIRA^ApanieAIRA^Luana^^^^L|ShermanAIRA^LaurenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1398 Vlagtwedde Cir^^Clayton^MI^49235^USA^P||^PRN^PH^^^517^9149280|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HamiltonAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1398 Vlagtwedde Cir^^Clayton^MI^49235^USA^P|^PRN^PH^^^517^9149280ORC|RE||BB04Y7191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||10^IPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB04Y7191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S24X7196^^^AIRA-TEST^MR||WaldoAIRA^ElseAIRA^Hiriwa^^^^L|ReaganAIRA^NaveenaAIRA^^^^^M|20091023|F||2106-3^White^CDCREC|1384 Wilvarenbeek Cir^^Bay View^MI^49770^USA^P||^PRN^PH^^^231^7382045|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WaldoAIRA^ReaganAIRA^^^^^L|MTH^Mother^HL70063|1384 Wilvarenbeek Cir^^Bay View^MI^49770^USA^P|^PRN^PH^^^231^7382045ORC|RE||BS24X7196.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20091223||100^pneumococcal conjugate PCV 7^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS24X7196.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100223||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100223||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X65Y7204^^^AIRA-TEST^MR||Red WillowAIRA^BryherAIRA^Dietlinde^^^^L|CusterAIRA^PurvajaAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1206 Doordwijkerhout St^^Detroit^MI^48210^USA^P||^PRN^PH^^^313^5637051|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Red WillowAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1206 Doordwijkerhout St^^Detroit^MI^48210^USA^P|^PRN^PH^^^313^5637051ORC|RE||BX65Y7204.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||101^typhoid, ViCPs^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX65Y7204.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N17M7215^^^AIRA-TEST^MR||PettersonAIRA^MalavikaAIRA^Ambrosine^^^^L|ClayAIRA^RomanaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1745 Bijefurd Ln^^Marshall^MI^49068^USA^P||^PRN^PH^^^269^9546071|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PettersonAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1745 Bijefurd Ln^^Marshall^MI^49068^USA^P|^PRN^PH^^^269^9546071ORC|RE||BN17M7215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||102^DTP-Hib-Hep B^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN17M7215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-103|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W75M7223^^^AIRA-TEST^MR||McCuskerAIRA^AlmedaAIRA^Arushi^^^^L|UptonAIRA^DilekAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1394 Wensen Cir^^Detroit^MI^48217^USA^P||^PRN^PH^^^313^9286042|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCuskerAIRA^UptonAIRA^^^^^L|MTH^Mother^HL70063|1394 Wensen Cir^^Detroit^MI^48217^USA^P|^PRN^PH^^^313^9286042ORC|RE||BW75M7223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||103^meningococcal C conjugate^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW75M7223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-104|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L03K7231^^^AIRA-TEST^MR||CliveAIRA^ChaitalyAIRA^Jayden^^^^L|MetcalfeAIRA^MelvinaAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1382 Fladel Cir^^Croswell^MI^48422^USA^P||^PRN^PH^^^810^8818097|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CliveAIRA^MetcalfeAIRA^^^^^L|MTH^Mother^HL70063|1382 Fladel Cir^^Croswell^MI^48422^USA^P|^PRN^PH^^^810^8818097ORC|RE||BL03K7231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||104^Hep A-Hep B^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL03K7231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G19V7236^^^AIRA-TEST^MR||SolanoAIRA^EgeriaAIRA^Nagihan^^^^L|AllenAIRA^CayleeAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1221 Haarle-Nassau Pl^^Elkton^MI^48731^USA^P||^PRN^PH^^^989^3912405|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SolanoAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1221 Haarle-Nassau Pl^^Elkton^MI^48731^USA^P|^PRN^PH^^^989^3912405ORC|RE||BG19V7236.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||105^vaccinia (smallpox) diluted^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG19V7236.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-106|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T98I7244^^^AIRA-TEST^MR||FarstanAIRA^YsoldeAIRA^Cuyler^^^^L|San JuanAIRA^CoralAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1057 Wrummen Ave^^Ann Arbor^MI^48104^USA^P||^PRN^PH^^^734^7387524|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FarstanAIRA^San JuanAIRA^^^^^L|MTH^Mother^HL70063|1057 Wrummen Ave^^Ann Arbor^MI^48104^USA^P|^PRN^PH^^^734^7387524ORC|RE||BT98I7244.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||106^DTaP, 5 pertussis antigens^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT98I7244.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-107|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C17V7255^^^AIRA-TEST^MR||KearneyAIRA^AchitAIRA^Kaethe^^^^L|BarrenAIRA^AnninkaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1565 Seerenveen St^^Sylvan Beach^MI^49463^USA^P||^PRN^PH^^^231^2532197|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KearneyAIRA^BarrenAIRA^^^^^L|MTH^Mother^HL70063|1565 Seerenveen St^^Sylvan Beach^MI^49463^USA^P|^PRN^PH^^^231^2532197ORC|RE||BC17V7255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||107^DTaP, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC17V7255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-108|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K52N7263^^^AIRA-TEST^MR||LibertyAIRA^PhoebeAIRA^Sylvie^^^^L|InghamAIRA^YoninahAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1191 Lldebroek St^^Sears^MI^49679^USA^P||^PRN^PH^^^231^8319621|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LibertyAIRA^InghamAIRA^^^^^L|MTH^Mother^HL70063|1191 Lldebroek St^^Sears^MI^49679^USA^P|^PRN^PH^^^231^8319621ORC|RE||BK52N7263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||108^meningococcal, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK52N7263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-109|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J51O7271^^^AIRA-TEST^MR||OlssonAIRA^KylaAIRA^Sasthi^^^^L|BanbergAIRA^KaiyaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1485 Schilderen Ln^^Wyandotte^MI^48192^USA^P||^PRN^PH^^^734^4879408|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OlssonAIRA^BanbergAIRA^^^^^L|MTH^Mother^HL70063|1485 Schilderen Ln^^Wyandotte^MI^48192^USA^P|^PRN^PH^^^734^4879408ORC|RE||BJ51O7271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||109^pneumococcal, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ51O7271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V05F7276^^^AIRA-TEST^MR||TaylorAIRA^CalanthaAIRA^Eira^^^^L|KjerulfAIRA^TustiAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1240 Eesterveld St^^Webberville^MI^48892^USA^P||^PRN^PH^^^517^6987991|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^KjerulfAIRA^^^^^L|MTH^Mother^HL70063|1240 Eesterveld St^^Webberville^MI^48892^USA^P|^PRN^PH^^^517^6987991ORC|RE||BV05F7276.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||11^pertussis^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV05F7276.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N40S7287^^^AIRA-TEST^MR||BrownAIRA^FeldaAIRA^Sebastianne^^^^L|DickAIRA^ZahavaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1347 Zeeuwarden St^^Springfld Township^MI^48350^USA^P||^PRN^PH^^^248^3350259|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownAIRA^DickAIRA^^^^^L|MTH^Mother^HL70063|1347 Zeeuwarden St^^Springfld Township^MI^48350^USA^P|^PRN^PH^^^248^3350259ORC|RE||BN40S7287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||110^DTaP-Hep B-IPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN40S7287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R24S7295^^^AIRA-TEST^MR||Santa CruzAIRA^EuphemiaAIRA^Sahar^^^^L|PendletonAIRA^ShubhaAIRA^^^^^M|20140521|F||2106-3^White^CDCREC|1730 Vomeren Cir^^Superior Township^MI^48198^USA^P||^PRN^PH^^^734^6446740|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Santa CruzAIRA^PendletonAIRA^^^^^L|MTH^Mother^HL70063|1730 Vomeren Cir^^Superior Township^MI^48198^USA^P|^PRN^PH^^^734^6446740ORC|RE||BR24S7295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140721||111^Influenza, live, intranasal^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR24S7295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140921||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140921||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-112|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F39E7303^^^AIRA-TEST^MR||WoodsAIRA^CatrionaAIRA^Vivian^^^^L|NewaygoAIRA^PhilbertaAIRA^^^^^M|20090729|F||2106-3^White^CDCREC|1816 Boes Pl^^Harsens Island^MI^48028^USA^P||^PRN^PH^^^810^5135173|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoodsAIRA^NewaygoAIRA^^^^^L|MTH^Mother^HL70063|1816 Boes Pl^^Harsens Island^MI^48028^USA^P|^PRN^PH^^^810^5135173ORC|RE||BF39E7303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||112^tetanus toxoid, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF39E7303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-113|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U09R7311^^^AIRA-TEST^MR||CambriaAIRA^EthelAIRA^Hanne^^^^L|LundgrenAIRA^AndriaAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1297 Dssen Ave^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^5709541|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CambriaAIRA^LundgrenAIRA^^^^^L|MTH^Mother^HL70063|1297 Dssen Ave^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^5709541ORC|RE||BU09R7311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||113^Td (adult) preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU09R7311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-114|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z25Q7316^^^AIRA-TEST^MR||BlairAIRA^VerbenaAIRA^Skye^^^^L|GuernseyAIRA^KesiAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1031 Deiderland St^^Meskegon^MI^49441^USA^P||^PRN^PH^^^231^2069511|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlairAIRA^GuernseyAIRA^^^^^L|MTH^Mother^HL70063|1031 Deiderland St^^Meskegon^MI^49441^USA^P|^PRN^PH^^^231^2069511ORC|RE||BZ25Q7316.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||114^meningococcal MCV4P^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ25Q7316.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-115|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G74L7324^^^AIRA-TEST^MR||CampbellAIRA^AmataAIRA^Tanushi^^^^L|NapaAIRA^GinaAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1719 Bergen op Zoom St^^Lakewood Club^MI^49457^USA^P||^PRN^PH^^^231^8168537|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CampbellAIRA^NapaAIRA^^^^^L|MTH^Mother^HL70063|1719 Bergen op Zoom St^^Lakewood Club^MI^49457^USA^P|^PRN^PH^^^231^8168537ORC|RE||BG74L7324.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||115^Tdap^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG74L7324.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-116|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H76F7335^^^AIRA-TEST^MR||MajorAIRA^PhryniaAIRA^Isabel^^^^L|GuthrieAIRA^GypsyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1865 Miessenlanden Cir^^Orchard Lake^MI^48324^USA^P||^PRN^PH^^^248^2047384|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MajorAIRA^GuthrieAIRA^^^^^L|MTH^Mother^HL70063|1865 Miessenlanden Cir^^Orchard Lake^MI^48324^USA^P|^PRN^PH^^^248^2047384ORC|RE||BH76F7335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||116^rotavirus, pentavalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH76F7335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-118|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J75Y7343^^^AIRA-TEST^MR||DeltaAIRA^RoslynAIRA^Leilah^^^^L|MontcalmAIRA^AlisaAIRA^^^^^M|20090327|F||2106-3^White^CDCREC|1682 Oaltbommel Pl^^Goetzville^MI^49736^USA^P||^PRN^PH^^^906^4673787|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DeltaAIRA^MontcalmAIRA^^^^^L|MTH^Mother^HL70063|1682 Oaltbommel Pl^^Goetzville^MI^49736^USA^P|^PRN^PH^^^906^4673787ORC|RE||BJ75Y7343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||118^HPV, bivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ75Y7343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-119|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q80U7351^^^AIRA-TEST^MR||O NeillAIRA^ManuellaAIRA^Saundarya^^^^L|SutterAIRA^LucilleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1665 Kuidhorn Pl^^Leland^MI^49654^USA^P||^PRN^PH^^^231^6464240|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O NeillAIRA^SutterAIRA^^^^^L|MTH^Mother^HL70063|1665 Kuidhorn Pl^^Leland^MI^49654^USA^P|^PRN^PH^^^231^6464240ORC|RE||BQ80U7351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||119^rotavirus, monovalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ80U7351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-120|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X79G7359^^^AIRA-TEST^MR||ClevelandAIRA^ClaraAIRA^Zelena^^^^L|LewisAIRA^ShriAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1721 Rots Cir^^Woodland^MI^48897^USA^P||^PRN^PH^^^269^9640958|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClevelandAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1721 Rots Cir^^Woodland^MI^48897^USA^P|^PRN^PH^^^269^9640958ORC|RE||BX79G7359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||120^DTaP-Hib-IPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX79G7359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-121|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G32Y7364^^^AIRA-TEST^MR||PecosAIRA^FarahAIRA^Annissa^^^^L|CreekAIRA^AdimaAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1883 Oedum Ln^^Brownstown Township^MI^48183^USA^P||^PRN^PH^^^734^8323522|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PecosAIRA^CreekAIRA^^^^^L|MTH^Mother^HL70063|1883 Oedum Ln^^Brownstown Township^MI^48183^USA^P|^PRN^PH^^^734^8323522ORC|RE||BG32Y7364.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||121^zoster^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG32Y7364.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-122|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L22T7372^^^AIRA-TEST^MR||SagadahocAIRA^VasaviAIRA^Kohana^^^^L|GreeneAIRA^CarynAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1700 Wchagen Ln^^Detroit^MI^48278^USA^P||^PRN^PH^^^313^4096889|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SagadahocAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1700 Wchagen Ln^^Detroit^MI^48278^USA^P|^PRN^PH^^^313^4096889ORC|RE||BL22T7372.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||122^rotavirus, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL22T7372.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-125|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S00T7383^^^AIRA-TEST^MR||AllenAIRA^EgeriaAIRA^Verushka^^^^L|CoryellAIRA^WaltraudAIRA^^^^^M|20100427|F||2106-3^White^CDCREC|1673 Kchagen St^^Genoa Township^MI^48114^USA^P||^PRN^PH^^^810^5494748|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllenAIRA^CoryellAIRA^^^^^L|MTH^Mother^HL70063|1673 Kchagen St^^Genoa Township^MI^48114^USA^P|^PRN^PH^^^810^5494748ORC|RE||BS00T7383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100627||125^Novel Influenza-H1N1-09, nasal^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS00T7383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100827||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100827||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-126|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J62I7391^^^AIRA-TEST^MR||CarrollAIRA^AfinaAIRA^Yamilet^^^^L|McCarthyAIRA^ZoeAIRA^^^^^M|20100427|F||2106-3^White^CDCREC|1694 Oardenberg Ln^^Buckley^MI^49620^USA^P||^PRN^PH^^^231^4258923|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarrollAIRA^McCarthyAIRA^^^^^L|MTH^Mother^HL70063|1694 Oardenberg Ln^^Buckley^MI^49620^USA^P|^PRN^PH^^^231^4258923ORC|RE||BJ62I7391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100627||126^Novel influenza-H1N1-09, preservative-free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ62I7391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100827||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100827||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-127|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N78C7399^^^AIRA-TEST^MR||HumboldtAIRA^RohanaAIRA^Saree^^^^L|Keya PahaAIRA^IsolaAIRA^^^^^M|20100427|F||2106-3^White^CDCREC|1990 Zaadhoeke Cir^^Saginaw^MI^48663^USA^P||^PRN^PH^^^989^7556646|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HumboldtAIRA^Keya PahaAIRA^^^^^L|MTH^Mother^HL70063|1990 Zaadhoeke Cir^^Saginaw^MI^48663^USA^P|^PRN^PH^^^989^7556646ORC|RE||BN78C7399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100627||127^Novel influenza-H1N1-09^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN78C7399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100827||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100827||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-128|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D77W7404^^^AIRA-TEST^MR||HardemanAIRA^AvocaAIRA^Maricel^^^^L|AtokaAIRA^DelveneAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1974 Dulst Ave^^State of Michigan^MI^48913^USA^P||^PRN^PH^^^517^8747493|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardemanAIRA^AtokaAIRA^^^^^L|MTH^Mother^HL70063|1974 Dulst Ave^^State of Michigan^MI^48913^USA^P|^PRN^PH^^^517^8747493ORC|RE||BD77W7404.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||128^Novel Influenza-H1N1-09, all formulations^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD77W7404.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-129|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R98V7412^^^AIRA-TEST^MR||HubbardAIRA^JermainAIRA^Damosel^^^^L|BredbergAIRA^TrinityAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1946 Bholen Ave^^Onondaga^MI^49264^USA^P||^PRN^PH^^^517^4237574|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HubbardAIRA^BredbergAIRA^^^^^L|MTH^Mother^HL70063|1946 Bholen Ave^^Onondaga^MI^49264^USA^P|^PRN^PH^^^517^4237574ORC|RE||BR98V7412.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||129^Japanese Encephalitis, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR98V7412.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-130|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C87Q7423^^^AIRA-TEST^MR||ProtheroeAIRA^YangchenAIRA^Fidela^^^^L|ClarkAIRA^AdaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1048 Doerden Ln^^Cohoctah^MI^48816^USA^P||^PRN^PH^^^517^2508697|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ProtheroeAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1048 Doerden Ln^^Cohoctah^MI^48816^USA^P|^PRN^PH^^^517^2508697ORC|RE||BC87Q7423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||130^DTaP-IPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC87Q7423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-131|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E32M7431^^^AIRA-TEST^MR||San JuanAIRA^DeidraAIRA^Avena^^^^L|IsaksonAIRA^EdaleneAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1218 Mundert Cir^^East Lansing^MI^48825^USA^P||^PRN^PH^^^517^4685573|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San JuanAIRA^IsaksonAIRA^^^^^L|MTH^Mother^HL70063|1218 Mundert Cir^^East Lansing^MI^48825^USA^P|^PRN^PH^^^517^4685573ORC|RE||BE32M7431.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||131^typhus, historical^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE32M7431.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-132|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A24T7439^^^AIRA-TEST^MR||PimaAIRA^GracieAIRA^Amarina^^^^L|LinnAIRA^CeceliaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1688 Tijd Cir^^Freeport^MI^49325^USA^P||^PRN^PH^^^616^2283033|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PimaAIRA^LinnAIRA^^^^^L|MTH^Mother^HL70063|1688 Tijd Cir^^Freeport^MI^49325^USA^P|^PRN^PH^^^616^2283033ORC|RE||BA24T7439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||132^DTaP-IPV-HIB-HEP B, historical^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA24T7439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-133|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B95X7444^^^AIRA-TEST^MR||DallasAIRA^AlestiAIRA^Tanu^^^^L|JeffersonAIRA^StockardAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1789 Deert St^^Wyoming^MI^49509^USA^P||^PRN^PH^^^616^8099008|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallasAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1789 Deert St^^Wyoming^MI^49509^USA^P|^PRN^PH^^^616^8099008ORC|RE||BB95X7444.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||133^Pneumococcal conjugate PCV 13^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB95X7444.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-134|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F22Q7452^^^AIRA-TEST^MR||ShawAIRA^LailaAIRA^Chiquita^^^^L|HendleAIRA^AvelAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1241 Iteenwijkerland Ln^^Croton^MI^49337^USA^P||^PRN^PH^^^231^7539657|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShawAIRA^HendleAIRA^^^^^L|MTH^Mother^HL70063|1241 Iteenwijkerland Ln^^Croton^MI^49337^USA^P|^PRN^PH^^^231^7539657ORC|RE||BF22Q7452.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||134^Japanese Encephalitis IM^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF22Q7452.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-135|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W29N7463^^^AIRA-TEST^MR||JacksonAIRA^OphiraAIRA^My-Duyen^^^^L|EatonAIRA^MagdalenaAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1004 Venray Pl^^Standish^MI^48658^USA^P||^PRN^PH^^^989^5364595|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^EatonAIRA^^^^^L|MTH^Mother^HL70063|1004 Venray Pl^^Standish^MI^48658^USA^P|^PRN^PH^^^989^5364595ORC|RE||BW29N7463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||135^Influenza, high dose seasonal^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW29N7463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-136|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y52R7471^^^AIRA-TEST^MR||SimmingsenAIRA^GithaAIRA^Bo^^^^L|OttawaAIRA^ErlinaAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1058 Eaasdonk Ave^^Rochester Hills^MI^48306^USA^P||^PRN^PH^^^248^6865651|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SimmingsenAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1058 Eaasdonk Ave^^Rochester Hills^MI^48306^USA^P|^PRN^PH^^^248^6865651ORC|RE||BY52R7471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||136^Meningococcal MCV4O^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY52R7471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-137|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C67V7479^^^AIRA-TEST^MR||HellicoskiAIRA^HaylieAIRA^Bridget^^^^L|RockAIRA^AparaAIRA^^^^^M|20090729|F||2106-3^White^CDCREC|1299 Bs-Hertogenbosch Ave^^Saint Joe^MI^49085^USA^P||^PRN^PH^^^269^4633729|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HellicoskiAIRA^RockAIRA^^^^^L|MTH^Mother^HL70063|1299 Bs-Hertogenbosch Ave^^Saint Joe^MI^49085^USA^P|^PRN^PH^^^269^4633729ORC|RE||BC67V7479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||137^HPV, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC67V7479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-138|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R53K7484^^^AIRA-TEST^MR||ColumbiaAIRA^OksanaAIRA^Abilene^^^^L|NanceAIRA^KrystleAIRA^^^^^M|20090729|F||2106-3^White^CDCREC|1584 Mensen Ln^^GR^MI^49508^USA^P||^PRN^PH^^^616^8419006|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColumbiaAIRA^NanceAIRA^^^^^L|MTH^Mother^HL70063|1584 Mensen Ln^^GR^MI^49508^USA^P|^PRN^PH^^^616^8419006ORC|RE||BR53K7484.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||138^Td (adult)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR53K7484.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-139|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H50L7492^^^AIRA-TEST^MR||HaysAIRA^BoroniaAIRA^Marcella^^^^L|WashingtonAIRA^LavaniAIRA^^^^^M|20090729|F||2106-3^White^CDCREC|1861 Nemsmond Ave^^Covington^MI^49919^USA^P||^PRN^PH^^^906^8795920|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaysAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1861 Nemsmond Ave^^Covington^MI^49919^USA^P|^PRN^PH^^^906^8795920ORC|RE||BH50L7492.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||139^Td(adult) unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH50L7492.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-14|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S90D7503^^^AIRA-TEST^MR||JohnsonAIRA^LillianAIRA^Goneril^^^^L|Santa CruzAIRA^Mary-JaneAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1236 Zelfs Ave^^Smyrna^MI^48887^USA^P||^PRN^PH^^^616^6488158|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JohnsonAIRA^Santa CruzAIRA^^^^^L|MTH^Mother^HL70063|1236 Zelfs Ave^^Smyrna^MI^48887^USA^P|^PRN^PH^^^616^6488158ORC|RE||BS90D7503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||14^IG, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS90D7503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-140|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H82J7511^^^AIRA-TEST^MR||TansbergAIRA^ZanaAIRA^Kessie^^^^L|MackeyAIRA^SurotamaAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1579 Bs-Hertogenbosch Pl^^Detroit^MI^48218^USA^P||^PRN^PH^^^313^5023189|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TansbergAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1579 Bs-Hertogenbosch Pl^^Detroit^MI^48218^USA^P|^PRN^PH^^^313^5023189ORC|RE||BH82J7511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||140^Influenza, seasonal, injectable, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH82J7511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H42N7519^^^AIRA-TEST^MR||RobertsAIRA^BijalAIRA^Saroja^^^^L|WorthAIRA^JanessaAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1571 Stijgen Pl^^Ira Township^MI^48023^USA^P||^PRN^PH^^^810^4905328|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobertsAIRA^WorthAIRA^^^^^L|MTH^Mother^HL70063|1571 Stijgen Pl^^Ira Township^MI^48023^USA^P|^PRN^PH^^^810^4905328ORC|RE||BH42N7519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||141^Influenza, seasonal, injectable^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH42N7519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-142|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D53R7524^^^AIRA-TEST^MR||SagadahocAIRA^VitoriaAIRA^Geranium^^^^L|TownAIRA^SamuelaAIRA^^^^^M|20140613|F||2106-3^White^CDCREC|1952 Hmsterdam Ln^^Lake Orion^MI^48359^USA^P||^PRN^PH^^^248^5588773|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SagadahocAIRA^TownAIRA^^^^^L|MTH^Mother^HL70063|1952 Hmsterdam Ln^^Lake Orion^MI^48359^USA^P|^PRN^PH^^^248^5588773ORC|RE||BD53R7524.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150613||142^tetanus toxoid, not adsorbed^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD53R7524.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150813||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150813||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-143|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U21Y7532^^^AIRA-TEST^MR||BinghamAIRA^BakaAIRA^Angevin^^^^L|NowataAIRA^AndromacheAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1235 Vlakte Pl^^Mayville^MI^48744^USA^P||^PRN^PH^^^989^5395608|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BinghamAIRA^NowataAIRA^^^^^L|MTH^Mother^HL70063|1235 Vlakte Pl^^Mayville^MI^48744^USA^P|^PRN^PH^^^989^5395608ORC|RE||BU21Y7532.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||143^Adenovirus types 4 and 7^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU21Y7532.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-144|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E59W7543^^^AIRA-TEST^MR||ShiawasseeAIRA^AthaliaAIRA^Mallana^^^^L|WoldAIRA^TashaAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1017 Doxmeer Ln^^Durand^MI^48429^USA^P||^PRN^PH^^^989^7010830|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShiawasseeAIRA^WoldAIRA^^^^^L|MTH^Mother^HL70063|1017 Doxmeer Ln^^Durand^MI^48429^USA^P|^PRN^PH^^^989^7010830ORC|RE||BE59W7543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||144^Influenza, seasonal, intradermal, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE59W7543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-147|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U72N7551^^^AIRA-TEST^MR||BernstrainAIRA^AletaAIRA^Elyse^^^^L|CrumbakerAIRA^ShoshannahAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1893 Mwenterand Cir^^Grosse Pointe Park^MI^48230^USA^P||^PRN^PH^^^313^9639863|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BernstrainAIRA^CrumbakerAIRA^^^^^L|MTH^Mother^HL70063|1893 Mwenterand Cir^^Grosse Pointe Park^MI^48230^USA^P|^PRN^PH^^^313^9639863ORC|RE||BU72N7551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||147^meningococcal MCV4, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU72N7551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-148|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H42H7559^^^AIRA-TEST^MR||HumboldtAIRA^JanaAIRA^Nanon^^^^L|OwyheeAIRA^JosieAIRA^^^^^M|20180110|F||2106-3^White^CDCREC|1455 Geleden Pl^^Jackson^MI^49204^USA^P||^PRN^PH^^^517^2581805|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HumboldtAIRA^OwyheeAIRA^^^^^L|MTH^Mother^HL70063|1455 Geleden Pl^^Jackson^MI^49204^USA^P|^PRN^PH^^^517^2581805ORC|RE||BH42H7559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180310||148^Meningococcal C/Y-HIB PRP^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH42H7559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180510||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180510||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-149|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E71U7564^^^AIRA-TEST^MR||PotterAIRA^EddaAIRA^Tonya^^^^L|KingAIRA^JoslynAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1484 Nooise Meren Ave^^Rogers City^MI^49779^USA^P||^PRN^PH^^^989^6891834|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PotterAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1484 Nooise Meren Ave^^Rogers City^MI^49779^USA^P|^PRN^PH^^^989^6891834ORC|RE||BE71U7564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||149^influenza, live, intranasal, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE71U7564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A44C7574^^^AIRA-TEST^MR||MasonAIRA^AngwenAIRA^Ottavia^^^^L|TrimbleAIRA^CarlinaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1458 Aansluiten St^^Crystal Falls^MI^49920^USA^P||^PRN^PH^^^906^7162880|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^TrimbleAIRA^^^^^L|MTH^Mother^HL70063|1458 Aansluiten St^^Crystal Falls^MI^49920^USA^P|^PRN^PH^^^906^7162880ORC|RE||BA44C7574.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||15^Influenza, split (incl. purified surface antigen)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA44C7574.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-150|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O29K7583^^^AIRA-TEST^MR||ThayerAIRA^BlumaAIRA^Halima^^^^L|BolotadAIRA^SindyAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1293 Rudwest-Fryslan Pl^^Allendale^MI^49401^USA^P||^PRN^PH^^^616^6401245|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThayerAIRA^BolotadAIRA^^^^^L|MTH^Mother^HL70063|1293 Rudwest-Fryslan Pl^^Allendale^MI^49401^USA^P|^PRN^PH^^^616^6401245ORC|RE||BO29K7583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||150^Influenza, injectable, quadrivalent, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO29K7583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-151|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M36B7591^^^AIRA-TEST^MR||WaschingAIRA^GuadalupeAIRA^Jaffa^^^^L|SwanwickAIRA^AraluenAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1847 Derkendam Ln^^Central Lake^MI^49622^USA^P||^PRN^PH^^^231^9534527|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WaschingAIRA^SwanwickAIRA^^^^^L|MTH^Mother^HL70063|1847 Derkendam Ln^^Central Lake^MI^49622^USA^P|^PRN^PH^^^231^9534527ORC|RE||BM36B7591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||151^Influenza nasal, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM36B7591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z78B7599^^^AIRA-TEST^MR||DimmitAIRA^SrilataAIRA^Marmara^^^^L|ArenacAIRA^EmmunaAIRA^^^^^M|20120927|F||2106-3^White^CDCREC|1466 Varieren Pl^^Grosse Pointe Park^MI^48215^USA^P||^PRN^PH^^^313^2442267|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DimmitAIRA^ArenacAIRA^^^^^L|MTH^Mother^HL70063|1466 Varieren Pl^^Grosse Pointe Park^MI^48215^USA^P|^PRN^PH^^^313^2442267ORC|RE||BZ78B7599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20121127||152^Pneumococcal Conjugate, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ78B7599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130127||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130127||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-153|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S52F7604^^^AIRA-TEST^MR||DauphinAIRA^PetaAIRA^Jolanta^^^^L|CollingsworthAIRA^SylviaAIRA^^^^^M|20150423|F||2106-3^White^CDCREC|1690 Zes Pl^^Breckenridge^MI^48615^USA^P||^PRN^PH^^^989^8882665|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DauphinAIRA^CollingsworthAIRA^^^^^L|MTH^Mother^HL70063|1690 Zes Pl^^Breckenridge^MI^48615^USA^P|^PRN^PH^^^989^8882665ORC|RE||BS52F7604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160423||153^Influenza, injectable, MDCK, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS52F7604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160623||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160623||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-155|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q47M7612^^^AIRA-TEST^MR||NemahaAIRA^AkelaAIRA^Ursanne^^^^L|ThurstonAIRA^NidraAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1715 Mudwest-Fryslan Ave^^Hamburg^MI^48139^USA^P||^PRN^PH^^^810^3580360|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NemahaAIRA^ThurstonAIRA^^^^^L|MTH^Mother^HL70063|1715 Mudwest-Fryslan Ave^^Hamburg^MI^48139^USA^P|^PRN^PH^^^810^3580360ORC|RE||BQ47M7612.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||155^Influenza, recombinant, injectable, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ47M7612.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-158|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O88C7623^^^AIRA-TEST^MR||LindblomAIRA^AnnaAIRA^Maru^^^^L|GuthrieAIRA^SamaraAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1505 Sardenberg Cir^^Romeo^MI^48065^USA^P||^PRN^PH^^^586^2898829|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LindblomAIRA^GuthrieAIRA^^^^^L|MTH^Mother^HL70063|1505 Sardenberg Cir^^Romeo^MI^48065^USA^P|^PRN^PH^^^586^2898829ORC|RE||BO88C7623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||158^Influenza, injectable, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO88C7623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-16|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P32I7631^^^AIRA-TEST^MR||CalhounAIRA^BeckieAIRA^Brynlee^^^^L|PerkinsAIRA^DeirdreAIRA^^^^^M|20030830|F||2106-3^White^CDCREC|1029 Die St^^Orchard Lake^MI^48324^USA^P||^PRN^PH^^^248^6523242|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalhounAIRA^PerkinsAIRA^^^^^L|MTH^Mother^HL70063|1029 Die St^^Orchard Lake^MI^48324^USA^P|^PRN^PH^^^248^6523242ORC|RE||BP32I7631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20031030||16^Influenza, whole^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP32I7631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20031230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20031230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-160|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M47U7639^^^AIRA-TEST^MR||CruzAIRA^ShailaAIRA^Sharda^^^^L|ElliottAIRA^JocelynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1896 Ooosendaal Cir^^Winn^MI^48896^USA^P||^PRN^PH^^^989^4974438|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CruzAIRA^ElliottAIRA^^^^^L|MTH^Mother^HL70063|1896 Ooosendaal Cir^^Winn^MI^48896^USA^P|^PRN^PH^^^989^4974438ORC|RE||BM47U7639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||160^Influenza A monovalent (H5N1), ADJUVANTED-2013^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM47U7639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-161|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H56M7647^^^AIRA-TEST^MR||TulareAIRA^PollyAIRA^Dieuwertje^^^^L|EatonAIRA^NeriaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1549 Heurne St^^Muskegon^MI^49443^USA^P||^PRN^PH^^^231^7213597|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TulareAIRA^EatonAIRA^^^^^L|MTH^Mother^HL70063|1549 Heurne St^^Muskegon^MI^49443^USA^P|^PRN^PH^^^231^7213597ORC|RE||BH56M7647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||161^Influenza, injectable,quadrivalent, preservative free,^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH56M7647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-162|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E90C7652^^^AIRA-TEST^MR||ApacheAIRA^EuphrasiaAIRA^Finley^^^^L|NevadaAIRA^EllinorAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1668 Verzonden Ln^^Minden City^MI^48456^USA^P||^PRN^PH^^^989^7308180|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ApacheAIRA^NevadaAIRA^^^^^L|MTH^Mother^HL70063|1668 Verzonden Ln^^Minden City^MI^48456^USA^P|^PRN^PH^^^989^7308180ORC|RE||BE90C7652.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||162^meningococcal B, recombinant^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE90C7652.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-163|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H83M7660^^^AIRA-TEST^MR||DelawareAIRA^ZeruahAIRA^Germaine^^^^L|GarfieldAIRA^BridgetAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1745 Oodegraven-Reeuwijk Ln^^Lansing^MI^48918^USA^P||^PRN^PH^^^517^5020405|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^GarfieldAIRA^^^^^L|MTH^Mother^HL70063|1745 Oodegraven-Reeuwijk Ln^^Lansing^MI^48918^USA^P|^PRN^PH^^^517^5020405ORC|RE||BH83M7660.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||163^meningococcal B, OMV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH83M7660.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-164|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K92Q7671^^^AIRA-TEST^MR||CallahanAIRA^KateAIRA^Yuriko^^^^L|MarionAIRA^TressaAIRA^^^^^M|20140702|F||2106-3^White^CDCREC|1011 Dchagen St^^Carleton^MI^48117^USA^P||^PRN^PH^^^734^2290274|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CallahanAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1011 Dchagen St^^Carleton^MI^48117^USA^P|^PRN^PH^^^734^2290274ORC|RE||BK92Q7671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140902||164^meningococcal B, unspecified^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK92Q7671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20141102||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20141102||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-165|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I48S7679^^^AIRA-TEST^MR||MarquetteAIRA^NasicheAIRA^Julianne^^^^L|SulitAIRA^NordicaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1747 Bongeradeel Pl^^Saginaw^MI^48638^USA^P||^PRN^PH^^^989^8958974|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarquetteAIRA^SulitAIRA^^^^^L|MTH^Mother^HL70063|1747 Bongeradeel Pl^^Saginaw^MI^48638^USA^P|^PRN^PH^^^989^8958974ORC|RE||BI48S7679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||165^HPV9^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI48S7679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-166|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T29A7687^^^AIRA-TEST^MR||PainterAIRA^SerenityAIRA^Levana^^^^L|WarrenAIRA^BelindaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1618 Me Bilt St^^Falmouth^MI^49632^USA^P||^PRN^PH^^^231^9223365|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PainterAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1618 Me Bilt St^^Falmouth^MI^49632^USA^P|^PRN^PH^^^231^9223365ORC|RE||BT29A7687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||166^influenza, intradermal, quadrivalent, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT29A7687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-167|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X16U7692^^^AIRA-TEST^MR||FranklinAIRA^SumehraAIRA^Bessy^^^^L|BooneAIRA^DespinaAIRA^^^^^M|20150730|F||2106-3^White^CDCREC|1978 Hiessenlanden Cir^^Grawn^MI^49637^USA^P||^PRN^PH^^^231^9415594|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1978 Hiessenlanden Cir^^Grawn^MI^49637^USA^P|^PRN^PH^^^231^9415594ORC|RE||BX16U7692.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150930||167^meningococcal, unknown serogroups^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX16U7692.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151130||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151130||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-168|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S25J7700^^^AIRA-TEST^MR||BreckinridgeAIRA^DanaAIRA^Sanaa^^^^L|AppanooseAIRA^AliviaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1557 Bint Anthonis Cir^^Clawson^MI^48017^USA^P||^PRN^PH^^^248^9272663|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BreckinridgeAIRA^AppanooseAIRA^^^^^L|MTH^Mother^HL70063|1557 Bint Anthonis Cir^^Clawson^MI^48017^USA^P|^PRN^PH^^^248^9272663ORC|RE||BS25J7700.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||168^influenza, trivalent, adjuvanted^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS25J7700.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-169|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F59A7711^^^AIRA-TEST^MR||McPhersonAIRA^KairosAIRA^Alka^^^^L|ClintonAIRA^BlinnAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1491 Eochem Pl^^Saint Clr Shrs^MI^48081^USA^P||^PRN^PH^^^586^7725394|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McPhersonAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1491 Eochem Pl^^Saint Clr Shrs^MI^48081^USA^P|^PRN^PH^^^586^7725394ORC|RE||BF59A7711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||169^Hep A, live attenuated^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF59A7711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-17|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I33Y7719^^^AIRA-TEST^MR||SacAIRA^DevoraAIRA^Cyprien^^^^L|OsceolaAIRA^MariabellaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1634 Meel en Maas St^^Union Lake^MI^48387^USA^P||^PRN^PH^^^248^3772184|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SacAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1634 Meel en Maas St^^Union Lake^MI^48387^USA^P|^PRN^PH^^^248^3772184ORC|RE||BI33Y7719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||17^Hib, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI33Y7719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-170|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A24Q7727^^^AIRA-TEST^MR||SaundersAIRA^AlisaAIRA^Alyson^^^^L|BooneAIRA^ElleAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1097 Reudal Ln^^Addison Township^MI^48367^USA^P||^PRN^PH^^^248^3053361|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SaundersAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1097 Reudal Ln^^Addison Township^MI^48367^USA^P|^PRN^PH^^^248^3053361ORC|RE||BA24Q7727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||170^DTAP/IPV/HIB - non-US^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA24Q7727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-171|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M40S7732^^^AIRA-TEST^MR||PimaAIRA^JocelynnAIRA^Tineka Jawana^^^^L|BrownfieldAIRA^BryleighAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1545 Hoogeveen Ave^^Nashville^MI^49073^USA^P||^PRN^PH^^^517^5648845|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PimaAIRA^BrownfieldAIRA^^^^^L|MTH^Mother^HL70063|1545 Hoogeveen Ave^^Nashville^MI^49073^USA^P|^PRN^PH^^^517^5648845ORC|RE||BM40S7732.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||171^Influenza, injectable, MDCK, preservative free, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM40S7732.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-172|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H50W7740^^^AIRA-TEST^MR||WhartonAIRA^KerriAIRA^Makayla^^^^L|FurnasAIRA^JordanAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1935 Liefde St^^Plainwell^MI^49080^USA^P||^PRN^PH^^^269^9431568|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WhartonAIRA^FurnasAIRA^^^^^L|MTH^Mother^HL70063|1935 Liefde St^^Plainwell^MI^49080^USA^P|^PRN^PH^^^269^9431568ORC|RE||BH50W7740.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||172^cholera, WC-rBS^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH50W7740.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-173|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N82T7751^^^AIRA-TEST^MR||ThurstonAIRA^IndiaAIRA^Sonal^^^^L|WheelerAIRA^ArizaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1997 Oirschot Pl^^Carney^MI^49812^USA^P||^PRN^PH^^^906^8775283|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThurstonAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1997 Oirschot Pl^^Carney^MI^49812^USA^P|^PRN^PH^^^906^8775283ORC|RE||BN82T7751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||173^cholera, BivWC^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN82T7751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-174|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z21N7759^^^AIRA-TEST^MR||WellsAIRA^EmeliaAIRA^Kierra^^^^L|WellsAIRA^DieuwertjeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1171 Happy Ave^^Augusta Township^MI^48160^USA^P||^PRN^PH^^^734^7780955|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WellsAIRA^WellsAIRA^^^^^L|MTH^Mother^HL70063|1171 Happy Ave^^Augusta Township^MI^48160^USA^P|^PRN^PH^^^734^7780955ORC|RE||BZ21N7759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||174^cholera, live attenuated^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ21N7759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-175|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q13R7767^^^AIRA-TEST^MR||HickmanAIRA^ShahnazAIRA^Elin^^^^L|MasonAIRA^GythaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1376 Reden Ln^^Mooreville^MI^48160^USA^P||^PRN^PH^^^734^7561561|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HickmanAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1376 Reden Ln^^Mooreville^MI^48160^USA^P|^PRN^PH^^^734^7561561ORC|RE||BQ13R7767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||175^Rabies - IM Diploid cell culture^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ13R7767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-176|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S11Y7772^^^AIRA-TEST^MR||TillmanAIRA^WihtburthAIRA^Falguni^^^^L|McLeanAIRA^IgnatiaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1143 Vingewaard Cir^^GR^MI^49512^USA^P||^PRN^PH^^^616^9273499|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TillmanAIRA^McLeanAIRA^^^^^L|MTH^Mother^HL70063|1143 Vingewaard Cir^^GR^MI^49512^USA^P|^PRN^PH^^^616^9273499ORC|RE||BS11Y7772.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||176^Rabies - IM fibroblast culture^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS11Y7772.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-177|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F90J7783^^^AIRA-TEST^MR||KnoxAIRA^BrinleyAIRA^Mitena^^^^L|KalamazooAIRA^SaniyaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1785 Vunspeet Ln^^Amway Corp^MI^49356^USA^P||^PRN^PH^^^616^7153507|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnoxAIRA^KalamazooAIRA^^^^^L|MTH^Mother^HL70063|1785 Vunspeet Ln^^Amway Corp^MI^49356^USA^P|^PRN^PH^^^616^7153507ORC|RE||BF90J7783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||177^PCV10^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF90J7783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-178|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T92G7791^^^AIRA-TEST^MR||BathAIRA^MagenaAIRA^Josie^^^^L|SanilacAIRA^KesareAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1733 Dijk bij Duurstede Ln^^Webster^MI^48130^USA^P||^PRN^PH^^^734^8645670|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BathAIRA^SanilacAIRA^^^^^L|MTH^Mother^HL70063|1733 Dijk bij Duurstede Ln^^Webster^MI^48130^USA^P|^PRN^PH^^^734^8645670ORC|RE||BT92G7791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||178^OPV bivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT92G7791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-179|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z14V7799^^^AIRA-TEST^MR||KiernanAIRA^ShysieAIRA^Newlyn^^^^L|DallasAIRA^NoelleAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1945 Aitgeest Ln^^Huntington Woods^MI^48070^USA^P||^PRN^PH^^^248^4587167|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KiernanAIRA^DallasAIRA^^^^^L|MTH^Mother^HL70063|1945 Aitgeest Ln^^Huntington Woods^MI^48070^USA^P|^PRN^PH^^^248^4587167ORC|RE||BZ14V7799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||179^OPV ,monovalent, unspecified^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ14V7799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-18|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B90A7807^^^AIRA-TEST^MR||WilliamsAIRA^EmeliaAIRA^Verda^^^^L|KitsapAIRA^MacieAIRA^^^^^M|20160617|F||2106-3^White^CDCREC|1866 Mmallingerland Ln^^Champion^MI^49814^USA^P||^PRN^PH^^^906^6638131|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilliamsAIRA^KitsapAIRA^^^^^L|MTH^Mother^HL70063|1866 Mmallingerland Ln^^Champion^MI^49814^USA^P|^PRN^PH^^^906^6638131ORC|RE||BB90A7807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160817||18^rabies, intramuscular injection^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB90A7807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161017||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161017||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-180|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R54Y7812^^^AIRA-TEST^MR||BooneAIRA^RisaAIRA^Ulva^^^^L|Van ZandtAIRA^PragatiAIRA^^^^^M|20161005|F||2106-3^White^CDCREC|1983 Linkelland Ln^^Ann Arbor^MI^48113^USA^P||^PRN^PH^^^734^8357332|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BooneAIRA^Van ZandtAIRA^^^^^L|MTH^Mother^HL70063|1983 Linkelland Ln^^Ann Arbor^MI^48113^USA^P|^PRN^PH^^^734^8357332ORC|RE||BR54Y7812.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161205||180^tetanus immune globulin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR54Y7812.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170205||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170205||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-181|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D55K7820^^^AIRA-TEST^MR||O NeillAIRA^SteshaAIRA^Carajean^^^^L|ColumbiaAIRA^HattieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1058 Blagtwedde Pl^^Vulcan^MI^49852^USA^P||^PRN^PH^^^906^2755846|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O NeillAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1058 Blagtwedde Pl^^Vulcan^MI^49852^USA^P|^PRN^PH^^^906^2755846ORC|RE||BD55K7820.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||181^anthrax immune globulin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD55K7820.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-182|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R04Y7831^^^AIRA-TEST^MR||RobertsAIRA^SueAIRA^Talon^^^^L|TriggAIRA^AlvaAIRA^^^^^M|20160916|F||2106-3^White^CDCREC|1788 Huth Cir^^Berlin^MI^48002^USA^P||^PRN^PH^^^810^4870330|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobertsAIRA^TriggAIRA^^^^^L|MTH^Mother^HL70063|1788 Huth Cir^^Berlin^MI^48002^USA^P|^PRN^PH^^^810^4870330ORC|RE||BR04Y7831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161116||182^OPV, Unspecified^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR04Y7831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170116||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170116||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-183|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O77I7839^^^AIRA-TEST^MR||AtascosaAIRA^AngevinAIRA^Terry^^^^L|EnaAIRA^MadhurAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1663 Meisje Ln^^Presque Isle^MI^49777^USA^P||^PRN^PH^^^989^8588557|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtascosaAIRA^EnaAIRA^^^^^L|MTH^Mother^HL70063|1663 Meisje Ln^^Presque Isle^MI^49777^USA^P|^PRN^PH^^^989^8588557ORC|RE||BO77I7839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||183^Yellow fever vaccine - alt^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO77I7839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-184|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E95U7847^^^AIRA-TEST^MR||MariposaAIRA^BrittaniaAIRA^Esperance^^^^L|EriksonAIRA^ZaidaAIRA^^^^^M|20161101|F||2106-3^White^CDCREC|1227 Oronckhorst St^^Chesterfield Township^MI^48047^USA^P||^PRN^PH^^^586^7191151|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MariposaAIRA^EriksonAIRA^^^^^L|MTH^Mother^HL70063|1227 Oronckhorst St^^Chesterfield Township^MI^48047^USA^P|^PRN^PH^^^586^7191151ORC|RE||BE95U7847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170101||184^Yellow fever, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE95U7847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170301||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170301||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-185|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S32L7852^^^AIRA-TEST^MR||LoveAIRA^FelicityAIRA^Haifa^^^^L|PendletonAIRA^MirabelleAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1739 Reghel St^^Troy^MI^48098^USA^P||^PRN^PH^^^248^3626932|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoveAIRA^PendletonAIRA^^^^^L|MTH^Mother^HL70063|1739 Reghel St^^Troy^MI^48098^USA^P|^PRN^PH^^^248^3626932ORC|RE||BS32L7852.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||185^influenza, recombinant, quadrivalent,injectable, preservative^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS32L7852.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-186|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H73F7862^^^AIRA-TEST^MR||KnowlesAIRA^TaniAIRA^Molly^^^^L|CavilAIRA^My-DuyenAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1045 Se Marne Ave^^Hubbell^MI^49934^USA^P||^PRN^PH^^^906^2492092|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnowlesAIRA^CavilAIRA^^^^^L|MTH^Mother^HL70063|1045 Se Marne Ave^^Hubbell^MI^49934^USA^P|^PRN^PH^^^906^2492092ORC|RE||BH73F7862.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||186^Influenza, injectable, MDCK, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH73F7862.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-187|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C50L7871^^^AIRA-TEST^MR||VanceAIRA^CallistoAIRA^Rewa^^^^L|HaysAIRA^KierraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1836 Rrummen Ave^^Seneca^MI^49256^USA^P||^PRN^PH^^^517^3242461|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VanceAIRA^HaysAIRA^^^^^L|MTH^Mother^HL70063|1836 Rrummen Ave^^Seneca^MI^49256^USA^P|^PRN^PH^^^517^3242461ORC|RE||BC50L7871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||187^zoster recombinant^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC50L7871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-188|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z08U7879^^^AIRA-TEST^MR||SierraAIRA^YaretziAIRA^Callista^^^^L|HoggAIRA^ElmaAIRA^^^^^M|20170626|F||2106-3^White^CDCREC|1648 Kosten Ln^^Northville^MI^48167^USA^P||^PRN^PH^^^248^7567740|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SierraAIRA^HoggAIRA^^^^^L|MTH^Mother^HL70063|1648 Kosten Ln^^Northville^MI^48167^USA^P|^PRN^PH^^^248^7567740ORC|RE||BZ08U7879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170826||188^zoster, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ08U7879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171026||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171026||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-189|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D38F7887^^^AIRA-TEST^MR||FrontierAIRA^LamornaAIRA^Ann^^^^L|KnightAIRA^VivienneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1595 Lijchen St^^Northeast^MI^48509^USA^P||^PRN^PH^^^810^7113734|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FrontierAIRA^KnightAIRA^^^^^L|MTH^Mother^HL70063|1595 Lijchen St^^Northeast^MI^48509^USA^P|^PRN^PH^^^810^7113734ORC|RE||BD38F7887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||189^HepB-CpG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD38F7887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-19|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G86A7895^^^AIRA-TEST^MR||Santa CruzAIRA^ItaAIRA^Jillian^^^^L|ProvidenceAIRA^CaimileAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1358 Berwerderadeel St^^Armada Township^MI^48005^USA^P||^PRN^PH^^^586^4145761|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Santa CruzAIRA^ProvidenceAIRA^^^^^L|MTH^Mother^HL70063|1358 Berwerderadeel St^^Armada Township^MI^48005^USA^P|^PRN^PH^^^586^4145761ORC|RE||BG86A7895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||19^BCG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG86A7895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-190|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U62T7900^^^AIRA-TEST^MR||DelawareAIRA^SaidaAIRA^Emery^^^^L|OrangeAIRA^HayleeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1890 Zoals St^^Hesperia^MI^49421^USA^P||^PRN^PH^^^231^6676315|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^OrangeAIRA^^^^^L|MTH^Mother^HL70063|1890 Zoals St^^Hesperia^MI^49421^USA^P|^PRN^PH^^^231^6676315ORC|RE||BU62T7900.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||190^Typhoid conjugate vaccine (TCV)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU62T7900.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-191|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J02K7911^^^AIRA-TEST^MR||MartinAIRA^RayleneAIRA^Megha^^^^L|AdamsAIRA^SamAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1492 Oittard-Geleen Pl^^Orion Township^MI^48360^USA^P||^PRN^PH^^^248^7135468|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MartinAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1492 Oittard-Geleen Pl^^Orion Township^MI^48360^USA^P|^PRN^PH^^^248^7135468ORC|RE||BJ02K7911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||191^meningococcal A polysaccharide (non-US)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ02K7911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-192|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W51J7919^^^AIRA-TEST^MR||DallasAIRA^SharonAIRA^Makani^^^^L|WarrenAIRA^OksanaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1135 Verhaal St^^Fostoria^MI^48435^USA^P||^PRN^PH^^^989^7199530|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallasAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1135 Verhaal St^^Fostoria^MI^48435^USA^P|^PRN^PH^^^989^7199530ORC|RE||BW51J7919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||192^meningococcal AC polysaccharide (non-US)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW51J7919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-193|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V10K7927^^^AIRA-TEST^MR||SagadahocAIRA^AmaranthAIRA^Kefira^^^^L|IronAIRA^AbraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1548 Menigte Ave^^Washingtn Township^MI^48094^USA^P||^PRN^PH^^^586^5240089|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SagadahocAIRA^IronAIRA^^^^^L|MTH^Mother^HL70063|1548 Menigte Ave^^Washingtn Township^MI^48094^USA^P|^PRN^PH^^^586^5240089ORC|RE||BV10K7927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||193^Hep A-Hep B, pediatric/adolescent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV10K7927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-194|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D02E7935^^^AIRA-TEST^MR||OceanaAIRA^BentaAIRA^Hali^^^^L|JohnsonAIRA^AnnikaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1333 Trummen Ln^^Farwell^MI^48622^USA^P||^PRN^PH^^^989^7034512|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OceanaAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1333 Trummen Ln^^Farwell^MI^48622^USA^P|^PRN^PH^^^989^7034512ORC|RE||BD02E7935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||194^Influenza, Southern Hemisphere^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD02E7935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-195|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K67T7940^^^AIRA-TEST^MR||RoseAIRA^NadyaAIRA^Ilana^^^^L|AudubonAIRA^PaolinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1711 Vlakte Pl^^Port Huron^MI^48061^USA^P||^PRN^PH^^^810^8039198|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RoseAIRA^AudubonAIRA^^^^^L|MTH^Mother^HL70063|1711 Vlakte Pl^^Port Huron^MI^48061^USA^P|^PRN^PH^^^810^8039198ORC|RE||BK67T7940.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||195^DT, IPV adsorbed^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK67T7940.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G74S7948^^^AIRA-TEST^MR||IoniaAIRA^LourdesAIRA^Maeve^^^^L|WashingtonAIRA^KestrelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1573 Ttrecht Ln^^Bingham Farms^MI^48025^USA^P||^PRN^PH^^^248^8737972|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IoniaAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1573 Ttrecht Ln^^Bingham Farms^MI^48025^USA^P|^PRN^PH^^^248^8737972ORC|RE||BG74S7948.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||20^DTaP^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG74S7948.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-21|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C88V7959^^^AIRA-TEST^MR||MajorAIRA^CarmineAIRA^Malka^^^^L|HenryAIRA^ThaliaAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1175 Keel en Maas Pl^^Midland^MI^48640^USA^P||^PRN^PH^^^989^5081780|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MajorAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1175 Keel en Maas Pl^^Midland^MI^48640^USA^P|^PRN^PH^^^989^5081780ORC|RE||BC88V7959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC88V7959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-22|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R03P7967^^^AIRA-TEST^MR||WoodAIRA^NurayAIRA^Avis^^^^L|Santa CruzAIRA^HemanginiAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1117 Boxmeer Ln^^Detroit^MI^48268^USA^P||^PRN^PH^^^313^4931959|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoodAIRA^Santa CruzAIRA^^^^^L|MTH^Mother^HL70063|1117 Boxmeer Ln^^Detroit^MI^48268^USA^P|^PRN^PH^^^313^4931959ORC|RE||BR03P7967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||22^DTP-Hib^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR03P7967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-24|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I63S7975^^^AIRA-TEST^MR||MorganAIRA^VerbenaAIRA^Kalle^^^^L|DelawareAIRA^SariahAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1195 Gardenberg Pl^^Sterling Heights^MI^48314^USA^P||^PRN^PH^^^586^5558365|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorganAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1195 Gardenberg Pl^^Sterling Heights^MI^48314^USA^P|^PRN^PH^^^586^5558365ORC|RE||BI63S7975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||24^anthrax^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI63S7975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V85J7983^^^AIRA-TEST^MR||YorkAIRA^LavaniAIRA^Magna^^^^L|SaundersAIRA^CamelaiAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1763 Kernheze Ln^^Comerica Incorporated^MI^48264^USA^P||^PRN^PH^^^313^3906327|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YorkAIRA^SaundersAIRA^^^^^L|MTH^Mother^HL70063|1763 Kernheze Ln^^Comerica Incorporated^MI^48264^USA^P|^PRN^PH^^^313^3906327ORC|RE||BV85J7983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||25^typhoid, oral^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV85J7983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-26|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K83K7988^^^AIRA-TEST^MR||MiljkeimAIRA^NellAIRA^Marne^^^^L|KinnearAIRA^LavenderAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1698 Toorst Ave^^Howell^MI^48863^USA^P||^PRN^PH^^^517^9418166|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MiljkeimAIRA^KinnearAIRA^^^^^L|MTH^Mother^HL70063|1698 Toorst Ave^^Howell^MI^48863^USA^P|^PRN^PH^^^517^9418166ORC|RE||BK83K7988.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||26^cholera^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK83K7988.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-28|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T36U7996^^^AIRA-TEST^MR||NewtonAIRA^YevonAIRA^Edina^^^^L|CruzAIRA^AmesAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1824 Uindhoven Pl^^Armada^MI^48005^USA^P||^PRN^PH^^^586^3566392|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NewtonAIRA^CruzAIRA^^^^^L|MTH^Mother^HL70063|1824 Uindhoven Pl^^Armada^MI^48005^USA^P|^PRN^PH^^^586^3566392ORC|RE||BT36U7996.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||28^DT (pediatric)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT36U7996.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-31|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q02L8007^^^AIRA-TEST^MR||CraigAIRA^RohanaAIRA^Lucianna^^^^L|LaRueAIRA^ApolloniaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1175 Kon Ave^^Lawrence^MI^49064^USA^P||^PRN^PH^^^269^4419566|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CraigAIRA^LaRueAIRA^^^^^L|MTH^Mother^HL70063|1175 Kon Ave^^Lawrence^MI^49064^USA^P|^PRN^PH^^^269^4419566ORC|RE||BQ02L8007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||31^Hep A, pediatric, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ02L8007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-32|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I37K8015^^^AIRA-TEST^MR||BoiseAIRA^LibertyAIRA^Kaliska^^^^L|McErlaineAIRA^CharityAIRA^^^^^M|20170626|F||2106-3^White^CDCREC|1116 Srimpen aan den IJssel Ln^^Wakefield^MI^49968^USA^P||^PRN^PH^^^906^2263419|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoiseAIRA^McErlaineAIRA^^^^^L|MTH^Mother^HL70063|1116 Srimpen aan den IJssel Ln^^Wakefield^MI^49968^USA^P|^PRN^PH^^^906^2263419ORC|RE||BI37K8015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170826||32^meningococcal MPSV4^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI37K8015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171026||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171026||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-33|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S55F8023^^^AIRA-TEST^MR||McCuskerAIRA^AlestiAIRA^Holli^^^^L|GreeleyAIRA^CailinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1064 Vilt St^^Curran^MI^48728^USA^P||^PRN^PH^^^989^5397914|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCuskerAIRA^GreeleyAIRA^^^^^L|MTH^Mother^HL70063|1064 Vilt St^^Curran^MI^48728^USA^P|^PRN^PH^^^989^5397914ORC|RE||BS55F8023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||33^pneumococcal polysaccharide PPV23^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS55F8023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P02Q8028^^^AIRA-TEST^MR||TillmanAIRA^SitaraAIRA^Destiny^^^^L|WarrenAIRA^MeldaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1825 Volgen Ave^^Swartz Creek^MI^48473^USA^P||^PRN^PH^^^810^3687575|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TillmanAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1825 Volgen Ave^^Swartz Creek^MI^48473^USA^P|^PRN^PH^^^810^3687575ORC|RE||BP02Q8028.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||34^RIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP02Q8028.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-35|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E50C8036^^^AIRA-TEST^MR||OrangeAIRA^AlexisAIRA^Risa^^^^L|ColumbiaAIRA^NiveditaAIRA^^^^^M|20140613|F||2106-3^White^CDCREC|1128 Eersel Cir^^Cutlerville^MI^49508^USA^P||^PRN^PH^^^616^4644446|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OrangeAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1128 Eersel Cir^^Cutlerville^MI^49508^USA^P|^PRN^PH^^^616^4644446ORC|RE||BE50C8036.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150613||35^tetanus toxoid, adsorbed^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE50C8036.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150813||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150813||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-37|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M64S8047^^^AIRA-TEST^MR||LucasAIRA^AlitaAIRA^Marina^^^^L|Hood RiverAIRA^ShasmeckaAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1755 Feerhugowaard Ln^^Ridgeway^MI^49229^USA^P||^PRN^PH^^^517^8839315|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LucasAIRA^Hood RiverAIRA^^^^^L|MTH^Mother^HL70063|1755 Feerhugowaard Ln^^Ridgeway^MI^49229^USA^P|^PRN^PH^^^517^8839315ORC|RE||BM64S8047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||37^yellow fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM64S8047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-38|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X29T8055^^^AIRA-TEST^MR||CarrollAIRA^SakuraAIRA^Abey^^^^L|LivingstonAIRA^KikiAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1255 Vaasdonk Cir^^Sebewaing^MI^48759^USA^P||^PRN^PH^^^989^8133152|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarrollAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1255 Vaasdonk Cir^^Sebewaing^MI^48759^USA^P|^PRN^PH^^^989^8133152ORC|RE||BX29T8055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||38^rubella/mumps^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX29T8055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-39|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y13P8063^^^AIRA-TEST^MR||BeaverAIRA^OkelaniAIRA^Cadence^^^^L|FarrellAIRA^LillianAIRA^^^^^M|20150523|F||2106-3^White^CDCREC|1000 Voppersum Pl^^Traverse City^MI^49685^USA^P||^PRN^PH^^^231^3931974|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BeaverAIRA^FarrellAIRA^^^^^L|MTH^Mother^HL70063|1000 Voppersum Pl^^Traverse City^MI^49685^USA^P|^PRN^PH^^^231^3931974ORC|RE||BY13P8063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150723||39^Japanese encephalitis SC^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY13P8063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150923||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150923||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M44K8068^^^AIRA-TEST^MR||PutnamAIRA^SherrieAIRA^Lan^^^^L|KenedyAIRA^DrutiAIRA^^^^^M|20150217|F||2106-3^White^CDCREC|1943 Bwartewaterland St^^Cheboygan^MI^49721^USA^P||^PRN^PH^^^231^5823930|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PutnamAIRA^KenedyAIRA^^^^^L|MTH^Mother^HL70063|1943 Bwartewaterland St^^Cheboygan^MI^49721^USA^P|^PRN^PH^^^231^5823930ORC|RE||BM44K8068.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150417||40^rabies, intradermal injection^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM44K8068.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150617||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150617||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E55D8078^^^AIRA-TEST^MR||KananenAIRA^KalindaAIRA^Netta^^^^L|HendersonAIRA^ChanelAIRA^^^^^M|20150412|F||2106-3^White^CDCREC|1272 Lidden-Drenthe Pl^^Petoskey^MI^49770^USA^P||^PRN^PH^^^231^3598355|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KananenAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1272 Lidden-Drenthe Pl^^Petoskey^MI^49770^USA^P|^PRN^PH^^^231^3598355ORC|RE||BE55D8078.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150612||41^typhoid, parenteral^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE55D8078.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150812||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150812||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-42|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G69X8087^^^AIRA-TEST^MR||KearneyAIRA^IlonaAIRA^Lisette^^^^L|DouglasAIRA^SileiAIRA^^^^^M|19980426|F||2106-3^White^CDCREC|1390 Tissewaard Cir^^Warren^MI^48089^USA^P||^PRN^PH^^^586^8246042|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KearneyAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1390 Tissewaard Cir^^Warren^MI^48089^USA^P|^PRN^PH^^^586^8246042ORC|RE||BG69X8087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19980626||42^Hep B, adolescent/high risk infant^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG69X8087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19980826||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19980826||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F09Q8095^^^AIRA-TEST^MR||ChopeAIRA^AyalaAIRA^Zaria^^^^L|WayneAIRA^JenoAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1060 Oontferland Cir^^Sandusky^MI^48471^USA^P||^PRN^PH^^^810^8647288|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChopeAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1060 Oontferland Cir^^Sandusky^MI^48471^USA^P|^PRN^PH^^^810^8647288ORC|RE||BF09Q8095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||43^Hep B, adult^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF09Q8095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-44|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L03D8103^^^AIRA-TEST^MR||VintonAIRA^ShelaAIRA^Tokiko^^^^L|OsbornAIRA^FredricaAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1456 Koevorden Ln^^Whitehall^MI^49461^USA^P||^PRN^PH^^^231^9991950|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VintonAIRA^OsbornAIRA^^^^^L|MTH^Mother^HL70063|1456 Koevorden Ln^^Whitehall^MI^49461^USA^P|^PRN^PH^^^231^9991950ORC|RE||BL03D8103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||44^Hep B, dialysis^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL03D8103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-45|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H76S8108^^^AIRA-TEST^MR||LoveAIRA^PolonaAIRA^Hiroko^^^^L|KeanyAIRA^EdevaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1830 Hint Anthonis Pl^^Lansing^MI^48951^USA^P||^PRN^PH^^^517^9298085|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoveAIRA^KeanyAIRA^^^^^L|MTH^Mother^HL70063|1830 Hint Anthonis Pl^^Lansing^MI^48951^USA^P|^PRN^PH^^^517^9298085ORC|RE||BH76S8108.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||45^Hep B, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH76S8108.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-46|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q84N8119^^^AIRA-TEST^MR||HarrisonAIRA^YusraAIRA^Heidi^^^^L|CusterAIRA^SylviaAIRA^^^^^M|20000830|F||2106-3^White^CDCREC|1584 Tenterwolde St^^Baldwin^MI^49304^USA^P||^PRN^PH^^^231^7716196|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1584 Tenterwolde St^^Baldwin^MI^49304^USA^P|^PRN^PH^^^231^7716196ORC|RE||BQ84N8119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20001030||46^Hib (PRP-D)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ84N8119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20001230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20001230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-47|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T41R8127^^^AIRA-TEST^MR||GladwinAIRA^GarlandAIRA^Ilisapesi^^^^L|MidlandAIRA^PazAIRA^^^^^M|20070830|F||2106-3^White^CDCREC|1364 Eardenberg Ave^^Remus^MI^49340^USA^P||^PRN^PH^^^989^5171842|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GladwinAIRA^MidlandAIRA^^^^^L|MTH^Mother^HL70063|1364 Eardenberg Ave^^Remus^MI^49340^USA^P|^PRN^PH^^^989^5171842ORC|RE||BT41R8127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20071030||47^Hib (HbOC)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT41R8127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20071230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20071230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z36W8135^^^AIRA-TEST^MR||TillamookAIRA^AbionaAIRA^Nyssa^^^^L|DuvalAIRA^ColletteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1713 Beert Pl^^Brownstwn Township^MI^48183^USA^P||^PRN^PH^^^734^8249378|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TillamookAIRA^DuvalAIRA^^^^^L|MTH^Mother^HL70063|1713 Beert Pl^^Brownstwn Township^MI^48183^USA^P|^PRN^PH^^^734^8249378ORC|RE||BZ36W8135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||48^Hib (PRP-T)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ36W8135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-49|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X03U8143^^^AIRA-TEST^MR||MontgomeryAIRA^IsleenAIRA^Raegan^^^^L|PauldingAIRA^TammyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1595 Menigte Ave^^Bay City^MI^48708^USA^P||^PRN^PH^^^989^8121431|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontgomeryAIRA^PauldingAIRA^^^^^L|MTH^Mother^HL70063|1595 Menigte Ave^^Bay City^MI^48708^USA^P|^PRN^PH^^^989^8121431ORC|RE||BX03U8143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||49^Hib (PRP-OMP)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX03U8143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K66D8151^^^AIRA-TEST^MR||RunnelsAIRA^RinakoAIRA^Aria^^^^L|RyanAIRA^MoreeAIRA^^^^^M|20101030|F||2106-3^White^CDCREC|1836 Huidhorn Ave^^Allouez^MI^49805^USA^P||^PRN^PH^^^906^4764658|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RunnelsAIRA^RyanAIRA^^^^^L|MTH^Mother^HL70063|1836 Huidhorn Ave^^Allouez^MI^49805^USA^P|^PRN^PH^^^906^4764658ORC|RE||BK66D8151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111030||50^DTaP-Hib^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK66D8151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X34Y8156^^^AIRA-TEST^MR||DeWittAIRA^AletaAIRA^Zenaide^^^^L|WashingtonAIRA^NoyaAIRA^^^^^M|20151110|F||2106-3^White^CDCREC|1419 Teldrop St^^Detroit^MI^48226^USA^P||^PRN^PH^^^313^6773258|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DeWittAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1419 Teldrop St^^Detroit^MI^48226^USA^P|^PRN^PH^^^313^6773258ORC|RE||BX34Y8156.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160110||51^Hib-Hep B^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX34Y8156.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160310||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160310||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V66D8167^^^AIRA-TEST^MR||WarrenAIRA^CherilynAIRA^Sherri^^^^L|AudubonAIRA^NevadaAIRA^^^^^M|20080105|F||2106-3^White^CDCREC|1630 Hengelo Ave^^Garden City^MI^48136^USA^P||^PRN^PH^^^734^9499558|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WarrenAIRA^AudubonAIRA^^^^^L|MTH^Mother^HL70063|1630 Hengelo Ave^^Garden City^MI^48136^USA^P|^PRN^PH^^^734^9499558ORC|RE||BV66D8167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||52^Hep A, adult^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV66D8167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-53|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S33G8175^^^AIRA-TEST^MR||StrubleAIRA^SallyAIRA^Edaline^^^^L|GraysonAIRA^JaelynAIRA^^^^^M|20150217|F||2106-3^White^CDCREC|1091 Dchagen Cir^^Rumely^MI^49826^USA^P||^PRN^PH^^^906^6981224|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StrubleAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1091 Dchagen Cir^^Rumely^MI^49826^USA^P|^PRN^PH^^^906^6981224ORC|RE||BS33G8175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150417||53^typhoid, parenteral, AKD (U.S. military)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS33G8175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150617||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150617||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-54|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H40G8183^^^AIRA-TEST^MR||MuskingumAIRA^NarcissaAIRA^Elbertina^^^^L|CokeAIRA^MerylAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1702 Iluis Ave^^Lakewood Club^MI^49457^USA^P||^PRN^PH^^^231^4904318|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MuskingumAIRA^CokeAIRA^^^^^L|MTH^Mother^HL70063|1702 Iluis Ave^^Lakewood Club^MI^49457^USA^P|^PRN^PH^^^231^4904318ORC|RE||BH40G8183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||54^adenovirus, type 4^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH40G8183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U27A8191^^^AIRA-TEST^MR||AdamsAIRA^AlynaAIRA^Aubine^^^^L|MenardAIRA^BlodwenAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1868 Koogeveen Cir^^Negaunee^MI^49866^USA^P||^PRN^PH^^^906^3444718|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdamsAIRA^MenardAIRA^^^^^L|MTH^Mother^HL70063|1868 Koogeveen Cir^^Negaunee^MI^49866^USA^P|^PRN^PH^^^906^3444718ORC|RE||BU27A8191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||55^adenovirus, type 7^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU27A8191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-62|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F53Z8196^^^AIRA-TEST^MR||MidlandAIRA^AllieAIRA^Ebba^^^^L|HopkinsAIRA^KimbaAIRA^^^^^M|20090327|F||2106-3^White^CDCREC|1641 Gehouden St^^Dimondale^MI^48821^USA^P||^PRN^PH^^^517^2712899|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MidlandAIRA^HopkinsAIRA^^^^^L|MTH^Mother^HL70063|1641 Gehouden St^^Dimondale^MI^48821^USA^P|^PRN^PH^^^517^2712899ORC|RE||BF53Z8196.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||62^HPV, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF53Z8196.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-66|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L17Q8207^^^AIRA-TEST^MR||FillmoreAIRA^AmataAIRA^Reine^^^^L|NicholasAIRA^GenevieveAIRA^^^^^M|20020830|F||2106-3^White^CDCREC|1499 Everbetuwe Cir^^Gaines^MI^48436^USA^P||^PRN^PH^^^989^4571534|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FillmoreAIRA^NicholasAIRA^^^^^L|MTH^Mother^HL70063|1499 Everbetuwe Cir^^Gaines^MI^48436^USA^P|^PRN^PH^^^989^4571534ORC|RE||BL17Q8207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20021030||66^Lyme disease^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL17Q8207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20021230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20021230||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-69|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K39N8215^^^AIRA-TEST^MR||JacksonAIRA^OnawaAIRA^Elata^^^^L|ClarkeAIRA^CherylAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1122 Glans Ave^^Flint^MI^48519^USA^P||^PRN^PH^^^810^9655670|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^ClarkeAIRA^^^^^L|MTH^Mother^HL70063|1122 Glans Ave^^Flint^MI^48519^USA^P|^PRN^PH^^^810^9655670ORC|RE||BK39N8215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||69^parainfluenza-3^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK39N8215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-74|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D83B8223^^^AIRA-TEST^MR||BredbergAIRA^PeaceAIRA^Duena^^^^L|GreenleeAIRA^AmiceAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1210 Eochem Ave^^Manton^MI^49663^USA^P||^PRN^PH^^^231^7977634|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BredbergAIRA^GreenleeAIRA^^^^^L|MTH^Mother^HL70063|1210 Eochem Ave^^Manton^MI^49663^USA^P|^PRN^PH^^^231^7977634ORC|RE||BD83B8223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||74^rotavirus, tetravalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD83B8223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-75|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N64W8231^^^AIRA-TEST^MR||WhatcomAIRA^AncikaAIRA^Rainbow^^^^L|O'DonnellAIRA^BlumaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1482 Olburg St^^Lincoln Park^MI^48146^USA^P||^PRN^PH^^^313^6144180|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WhatcomAIRA^O'DonnellAIRA^^^^^L|MTH^Mother^HL70063|1482 Olburg St^^Lincoln Park^MI^48146^USA^P|^PRN^PH^^^313^6144180ORC|RE||BN64W8231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||75^vaccinia (smallpox)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN64W8231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-76|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K64C8239^^^AIRA-TEST^MR||ChoctawAIRA^KristenAIRA^Zandra^^^^L|Van ZandtAIRA^MegAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1561 Douten Ln^^Rochester Hills^MI^48308^USA^P||^PRN^PH^^^248^6463184|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChoctawAIRA^Van ZandtAIRA^^^^^L|MTH^Mother^HL70063|1561 Douten Ln^^Rochester Hills^MI^48308^USA^P|^PRN^PH^^^248^6463184ORC|RE||BK64C8239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||76^Staphylococcus bacterio lysate^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK64C8239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-77|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J96V8244^^^AIRA-TEST^MR||RoseAIRA^MerryAIRA^Hannah^^^^L|BooneAIRA^LudellaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1808 Pijkerk St^^Sparta^MI^49345^USA^P||^PRN^PH^^^616^6318248|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RoseAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1808 Pijkerk St^^Sparta^MI^49345^USA^P|^PRN^PH^^^616^6318248ORC|RE||BJ96V8244.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||77^tick-borne encephalitis^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ96V8244.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F91V8252^^^AIRA-TEST^MR||LucasAIRA^CassidyAIRA^Malena^^^^L|SweeneyAIRA^NolaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1327 Dchijndel St^^Business Reply Mail^MI^49502^USA^P||^PRN^PH^^^616^3781545|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LucasAIRA^SweeneyAIRA^^^^^L|MTH^Mother^HL70063|1327 Dchijndel St^^Business Reply Mail^MI^49502^USA^P|^PRN^PH^^^616^3781545ORC|RE||BF91V8252.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||78^tularemia vaccine^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF91V8252.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-80|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B74Y8263^^^AIRA-TEST^MR||GravesAIRA^VevetteAIRA^Bridget^^^^L|MalheurAIRA^AdeleAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1208 Dennep St^^Holland^MI^49423^USA^P||^PRN^PH^^^616^2761275|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GravesAIRA^MalheurAIRA^^^^^L|MTH^Mother^HL70063|1208 Dennep St^^Holland^MI^49423^USA^P|^PRN^PH^^^616^2761275ORC|RE||BB74Y8263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||80^VEE, live^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB74Y8263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D35S8271^^^AIRA-TEST^MR||HarmonAIRA^RajniAIRA^Beranger^^^^L|FlemingAIRA^ZadaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1966 Lijk bij Duurstede Pl^^Scio Township^MI^48103^USA^P||^PRN^PH^^^734^9558573|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarmonAIRA^FlemingAIRA^^^^^L|MTH^Mother^HL70063|1966 Lijk bij Duurstede Pl^^Scio Township^MI^48103^USA^P|^PRN^PH^^^734^9558573ORC|RE||BD35S8271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||801^AS03 Adjuvant^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD35S8271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-81|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z60K8279^^^AIRA-TEST^MR||PimaAIRA^GenieAIRA^Rebecca^^^^L|BurnetAIRA^PrueAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1346 Lorst aan de Maas Ln^^Greenwood Township^MI^48006^USA^P||^PRN^PH^^^810^9110094|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PimaAIRA^BurnetAIRA^^^^^L|MTH^Mother^HL70063|1346 Lorst aan de Maas Ln^^Greenwood Township^MI^48006^USA^P|^PRN^PH^^^810^9110094ORC|RE||BZ60K8279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||81^VEE, inactivated^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ60K8279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-82|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L27S8284^^^AIRA-TEST^MR||Saint JosephAIRA^BelitaAIRA^Bernina^^^^L|JansonAIRA^BijalAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1658 Denk Ave^^Lachine^MI^49753^USA^P||^PRN^PH^^^989^5961259|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Saint JosephAIRA^JansonAIRA^^^^^L|MTH^Mother^HL70063|1658 Denk Ave^^Lachine^MI^49753^USA^P|^PRN^PH^^^989^5961259ORC|RE||BL27S8284.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||82^adenovirus, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL27S8284.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D77G8295^^^AIRA-TEST^MR||ConnorAIRA^AnnetteAIRA^Liana^^^^L|WestmorelandAIRA^JanthineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1178 Eden Ave^^Millersburg^MI^49759^USA^P||^PRN^PH^^^989^3704127|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ConnorAIRA^WestmorelandAIRA^^^^^L|MTH^Mother^HL70063|1178 Eden Ave^^Millersburg^MI^49759^USA^P|^PRN^PH^^^989^3704127ORC|RE||BD77G8295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||83^Hep A, ped/adol, 2 dose^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD77G8295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-84|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A50X8303^^^AIRA-TEST^MR||MaricopaAIRA^AldaraAIRA^Alohi^^^^L|YoloAIRA^AmericaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1949 Zemsmond Ave^^Detroit^MI^48210^USA^P||^PRN^PH^^^313^8167725|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MaricopaAIRA^YoloAIRA^^^^^L|MTH^Mother^HL70063|1949 Zemsmond Ave^^Detroit^MI^48210^USA^P|^PRN^PH^^^313^8167725ORC|RE||BA50X8303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||84^Hep A, ped/adol, 3 dose^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA50X8303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-85|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G10Q8311^^^AIRA-TEST^MR||RichardsonAIRA^BristolAIRA^Eris^^^^L|EmmetAIRA^AmalaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1567 Eon en Breugel Ln^^Samaria^MI^48177^USA^P||^PRN^PH^^^734^9796694|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichardsonAIRA^EmmetAIRA^^^^^L|MTH^Mother^HL70063|1567 Eon en Breugel Ln^^Samaria^MI^48177^USA^P|^PRN^PH^^^734^9796694ORC|RE||BG10Q8311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||85^Hep A, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG10Q8311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M22F8319^^^AIRA-TEST^MR||CraneAIRA^EileenAIRA^Thana^^^^L|NolanAIRA^WanettaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1594 Aeerenveen Cir^^Muskegon^MI^49444^USA^P||^PRN^PH^^^231^6743207|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CraneAIRA^NolanAIRA^^^^^L|MTH^Mother^HL70063|1594 Aeerenveen Cir^^Muskegon^MI^49444^USA^P|^PRN^PH^^^231^6743207ORC|RE||BM22F8319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||88^Influenza, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM22F8319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-89|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W15K8324^^^AIRA-TEST^MR||AndersonAIRA^BaciaAIRA^Emilia^^^^L|CalaverasAIRA^SummerAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1762 Beverwijk Ave^^Farwell^MI^48622^USA^P||^PRN^PH^^^989^5681196|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndersonAIRA^CalaverasAIRA^^^^^L|MTH^Mother^HL70063|1762 Beverwijk Ave^^Farwell^MI^48622^USA^P|^PRN^PH^^^989^5681196ORC|RE||BW15K8324.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||89^polio, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW15K8324.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-90|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B18E8335^^^AIRA-TEST^MR||AtascosaAIRA^SusanAIRA^Caitlin^^^^L|LeeAIRA^OpheliaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1229 Omallingerland Ln^^Mott Park^MI^48504^USA^P||^PRN^PH^^^810^4498302|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtascosaAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1229 Omallingerland Ln^^Mott Park^MI^48504^USA^P|^PRN^PH^^^810^4498302ORC|RE||BB18E8335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||90^rabies, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB18E8335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-91|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A22V8343^^^AIRA-TEST^MR||IrwinAIRA^ChanceAIRA^Ingaborg^^^^L|PatariAIRA^AdaminaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1882 Scherpenzeel St^^Hubbard Lake^MI^49747^USA^P||^PRN^PH^^^989^7110171|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IrwinAIRA^PatariAIRA^^^^^L|MTH^Mother^HL70063|1882 Scherpenzeel St^^Hubbard Lake^MI^49747^USA^P|^PRN^PH^^^989^7110171ORC|RE||BA22V8343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||91^typhoid, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA22V8343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-92|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y66Z8351^^^AIRA-TEST^MR||OklahomaAIRA^KarissaAIRA^Erwina^^^^L|OttawaAIRA^RachelAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1552 Geld Ave^^La Salle^MI^48145^USA^P||^PRN^PH^^^734^4262531|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OklahomaAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1552 Geld Ave^^La Salle^MI^48145^USA^P|^PRN^PH^^^734^4262531ORC|RE||BY66Z8351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||92^VEE, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY66Z8351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-94|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O26S8359^^^AIRA-TEST^MR||AtascosaAIRA^FaricaAIRA^Ulla^^^^L|AshlandAIRA^GabrielAIRA^^^^^M|20180104|F||2106-3^White^CDCREC|1980 Kubbergen St^^Gaines^MI^48436^USA^P||^PRN^PH^^^989^4712401|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtascosaAIRA^AshlandAIRA^^^^^L|MTH^Mother^HL70063|1980 Kubbergen St^^Gaines^MI^48436^USA^P|^PRN^PH^^^989^4712401ORC|RE||BO26S8359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||94^MMRV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO26S8359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-AN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||136379641^^^AIRA-TEST^AN~N36R8367^^^AIRA-TEST^MR||WayneAIRA^NellekeAIRA^Jacinthe^^^^L|AllenAIRA^MalayaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1018 Se Wolden Ave^^Swartz Creek^MI^48473^USA^P||^PRN^PH^^^810^3713569|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WayneAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1018 Se Wolden Ave^^Swartz Creek^MI^48473^USA^P|^PRN^PH^^^810^3713569ORC|RE||BN36R8367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN36R8367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-ANC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||833676237^^^AIRA-TEST^ANC~K27Q8372^^^AIRA-TEST^MR||LincolnAIRA^RyanAIRA^Savanah^^^^L|BrotAIRA^OnidaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1622 Hissewaard Cir^^Midland^MI^48641^USA^P||^PRN^PH^^^989^8626483|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^BrotAIRA^^^^^L|MTH^Mother^HL70063|1622 Hissewaard Cir^^Midland^MI^48641^USA^P|^PRN^PH^^^989^8626483ORC|RE||BK27Q8372.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK27Q8372.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-AND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||200146233^^^AIRA-TEST^AND~I76Z8382^^^AIRA-TEST^MR||JeffersonAIRA^RebeccaAIRA^Sarmistha^^^^L|KingfisherAIRA^AmoritaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1994 Olieland St^^Galesburg^MI^49053^USA^P||^PRN^PH^^^269^6786954|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^KingfisherAIRA^^^^^L|MTH^Mother^HL70063|1994 Olieland St^^Galesburg^MI^49053^USA^P|^PRN^PH^^^269^6786954ORC|RE||BI76Z8382.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI76Z8382.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-ANON|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||270445315^^^AIRA-TEST^ANON~F00Y8391^^^AIRA-TEST^MR||PauldingAIRA^AkaishaAIRA^Erin^^^^L|CreaserAIRA^MorillaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1415 Alleen Cir^^Midland^MI^48670^USA^P||^PRN^PH^^^989^9344783|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PauldingAIRA^CreaserAIRA^^^^^L|MTH^Mother^HL70063|1415 Alleen Cir^^Midland^MI^48670^USA^P|^PRN^PH^^^989^9344783ORC|RE||BF00Y8391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF00Y8391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-ANT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||078650389^^^AIRA-TEST^ANT~F45W8399^^^AIRA-TEST^MR||ClearfieldAIRA^MatildaAIRA^Honna^^^^L|FremontAIRA^SatyavatiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1270 Gemaakt Ln^^Owosso^MI^48867^USA^P||^PRN^PH^^^989^4486646|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClearfieldAIRA^FremontAIRA^^^^^L|MTH^Mother^HL70063|1270 Gemaakt Ln^^Owosso^MI^48867^USA^P|^PRN^PH^^^989^4486646ORC|RE||BF45W8399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF45W8399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-APRN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||648689795^^^AIRA-TEST^APRN~O50F8407^^^AIRA-TEST^MR||ComanoAIRA^BelindaAIRA^Jacqueline^^^^L|KossuthAIRA^DikiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1041 Neerijnen Cir^^Belleville^MI^48111^USA^P||^PRN^PH^^^734^8765794|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ComanoAIRA^KossuthAIRA^^^^^L|MTH^Mother^HL70063|1041 Neerijnen Cir^^Belleville^MI^48111^USA^P|^PRN^PH^^^734^8765794ORC|RE||BO50F8407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO50F8407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-BA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||246695075^^^AIRA-TEST^BA~K18M8415^^^AIRA-TEST^MR||MeeAIRA^DoeAIRA^Eudora^^^^L|LoveAIRA^DesireeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1114 Dalfsen Cir^^Birch Run^MI^48415^USA^P||^PRN^PH^^^989^3231715|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeeAIRA^LoveAIRA^^^^^L|MTH^Mother^HL70063|1114 Dalfsen Cir^^Birch Run^MI^48415^USA^P|^PRN^PH^^^989^3231715ORC|RE||BK18M8415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK18M8415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-BC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||210477728^^^AIRA-TEST^BC~G58C8420^^^AIRA-TEST^MR||CrawfordAIRA^NitaraAIRA^Lynda^^^^L|AinslieAIRA^FloramariaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1758 Hook en Middelaar Ave^^Kalamazoo^MI^49007^USA^P||^PRN^PH^^^269^2190389|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CrawfordAIRA^AinslieAIRA^^^^^L|MTH^Mother^HL70063|1758 Hook en Middelaar Ave^^Kalamazoo^MI^49007^USA^P|^PRN^PH^^^269^2190389ORC|RE||BG58C8420.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG58C8420.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-BR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||022882490^^^AIRA-TEST^BR~S37X8431^^^AIRA-TEST^MR||WilsonAIRA^RosaleenAIRA^Maya^^^^L|JacksonAIRA^AnnabethAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1597 Van St^^Muir^MI^48860^USA^P||^PRN^PH^^^989^8472712|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilsonAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1597 Van St^^Muir^MI^48860^USA^P|^PRN^PH^^^989^8472712ORC|RE||BS37X8431.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS37X8431.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-CC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||573916364^^^AIRA-TEST^CC~O36F8439^^^AIRA-TEST^MR||LuceAIRA^CaraAIRA^Gertrude^^^^L|HayesAIRA^AngeniAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1978 Pldebroek Pl^^East Leroy^MI^49051^USA^P||^PRN^PH^^^269^7127967|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LuceAIRA^HayesAIRA^^^^^L|MTH^Mother^HL70063|1978 Pldebroek Pl^^East Leroy^MI^49051^USA^P|^PRN^PH^^^269^7127967ORC|RE||BO36F8439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO36F8439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-CY|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||788645592^^^AIRA-TEST^CY~U02Q8447^^^AIRA-TEST^MR||Van ZandtAIRA^ArcadiaAIRA^Tema^^^^L|WayneAIRA^PremilaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1240 Tundert Pl^^Eckerman^MI^49728^USA^P||^PRN^PH^^^906^8193776|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Van ZandtAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1240 Tundert Pl^^Eckerman^MI^49728^USA^P|^PRN^PH^^^906^8193776ORC|RE||BU02Q8447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU02Q8447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-DDS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||558361716^^^AIRA-TEST^DDS~P61S8455^^^AIRA-TEST^MR||NanceAIRA^AmyaAIRA^Iolanthe^^^^L|JulinAIRA^ThoraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1880 Dlphen aan den Rijn Cir^^Grand Rapids^MI^49560^USA^P||^PRN^PH^^^616^8694032|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NanceAIRA^JulinAIRA^^^^^L|MTH^Mother^HL70063|1880 Dlphen aan den Rijn Cir^^Grand Rapids^MI^49560^USA^P|^PRN^PH^^^616^8694032ORC|RE||BP61S8455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP61S8455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-DEA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||411414952^^^AIRA-TEST^DEA~P07T8460^^^AIRA-TEST^MR||SiouxAIRA^GazelleAIRA^Mariola^^^^L|CorrinAIRA^GunnhildAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1935 Beverwijk St^^Millington^MI^48746^USA^P||^PRN^PH^^^989^6528786|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiouxAIRA^CorrinAIRA^^^^^L|MTH^Mother^HL70063|1935 Beverwijk St^^Millington^MI^48746^USA^P|^PRN^PH^^^989^6528786ORC|RE||BP07T8460.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP07T8460.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-DFN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||191348271^^^AIRA-TEST^DFN~O67E8468^^^AIRA-TEST^MR||HamiltonAIRA^ShammaraAIRA^Avasa^^^^L|BristolAIRA^LatoniaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1395 Bisterwijk Ln^^Decatur^MI^49045^USA^P||^PRN^PH^^^269^7600515|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HamiltonAIRA^BristolAIRA^^^^^L|MTH^Mother^HL70063|1395 Bisterwijk Ln^^Decatur^MI^49045^USA^P|^PRN^PH^^^269^7600515ORC|RE||BO67E8468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO67E8468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-DL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||884880667^^^AIRA-TEST^DL~I26M8479^^^AIRA-TEST^MR||EricksonAIRA^ShradhdhaAIRA^Sydnee^^^^L|LebanonAIRA^RoshanAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1712 Springen Ln^^Ada^MI^49357^USA^P||^PRN^PH^^^616^4796471|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EricksonAIRA^LebanonAIRA^^^^^L|MTH^Mother^HL70063|1712 Springen Ln^^Ada^MI^49357^USA^P|^PRN^PH^^^616^4796471ORC|RE||BI26M8479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI26M8479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-DN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||997729314^^^AIRA-TEST^DN~K28S8487^^^AIRA-TEST^MR||JonsonAIRA^EnoraAIRA^Bethany^^^^L|TriggAIRA^OzoraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1270 Achtervoegsel Cir^^Troy^MI^48098^USA^P||^PRN^PH^^^248^9673261|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JonsonAIRA^TriggAIRA^^^^^L|MTH^Mother^HL70063|1270 Achtervoegsel Cir^^Troy^MI^48098^USA^P|^PRN^PH^^^248^9673261ORC|RE||BK28S8487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK28S8487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-DO|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||429686190^^^AIRA-TEST^DO~R70O8495^^^AIRA-TEST^MR||VenangoAIRA^MagdalenaAIRA^Vonnie^^^^L|BooneAIRA^CheyenneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1839 Wontfoort Pl^^Rockland^MI^49960^USA^P||^PRN^PH^^^906^3716572|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VenangoAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1839 Wontfoort Pl^^Rockland^MI^49960^USA^P|^PRN^PH^^^906^3716572ORC|RE||BR70O8495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR70O8495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-DPM|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||775169148^^^AIRA-TEST^DPM~X53M8503^^^AIRA-TEST^MR||KenedyAIRA^NitzanaAIRA^Altheda^^^^L|FurnasAIRA^KaseyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1260 Dedemblik Pl^^Saginaw^MI^48603^USA^P||^PRN^PH^^^989^9859258|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KenedyAIRA^FurnasAIRA^^^^^L|MTH^Mother^HL70063|1260 Dedemblik Pl^^Saginaw^MI^48603^USA^P|^PRN^PH^^^989^9859258ORC|RE||BX53M8503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX53M8503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-DR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||713703424^^^AIRA-TEST^DR~N90O8508^^^AIRA-TEST^MR||ShermanAIRA^AnikaAIRA^Sarai^^^^L|TexasAIRA^TirionAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1315 Wanderd Ave^^Allen Park^MI^48101^USA^P||^PRN^PH^^^313^9178105|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShermanAIRA^TexasAIRA^^^^^L|MTH^Mother^HL70063|1315 Wanderd Ave^^Allen Park^MI^48101^USA^P|^PRN^PH^^^313^9178105ORC|RE||BN90O8508.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN90O8508.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-EI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||745401142^^^AIRA-TEST^EI~E01K8516^^^AIRA-TEST^MR||BurnetAIRA^BatyahAIRA^Juene^^^^L|DouglasAIRA^AderynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1654 Zynaarlo St^^Tower^MI^49792^USA^P||^PRN^PH^^^989^3144884|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BurnetAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1654 Zynaarlo St^^Tower^MI^49792^USA^P|^PRN^PH^^^989^3144884ORC|RE||BE01K8516.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE01K8516.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-EN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||460862626^^^AIRA-TEST^EN~E32Y8527^^^AIRA-TEST^MR||LundgrenAIRA^AdonciaAIRA^Anika^^^^L|MuskingumAIRA^PhilaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1423 Mijl Pl^^Scio^MI^48130^USA^P||^PRN^PH^^^734^3052053|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LundgrenAIRA^MuskingumAIRA^^^^^L|MTH^Mother^HL70063|1423 Mijl Pl^^Scio^MI^48130^USA^P|^PRN^PH^^^734^3052053ORC|RE||BE32Y8527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE32Y8527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-FI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||473228587^^^AIRA-TEST^FI~R09X8535^^^AIRA-TEST^MR||WashitaAIRA^KorneliaAIRA^Marcy^^^^L|CampAIRA^TottyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1665 Bwenterand St^^Detroit^MI^48226^USA^P||^PRN^PH^^^313^5738490|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashitaAIRA^CampAIRA^^^^^L|MTH^Mother^HL70063|1665 Bwenterand St^^Detroit^MI^48226^USA^P|^PRN^PH^^^313^5738490ORC|RE||BR09X8535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR09X8535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-GI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||127324168^^^AIRA-TEST^GI~P75I8543^^^AIRA-TEST^MR||HaughtonAIRA^AriannaAIRA^Mylee^^^^L|HuronAIRA^EllieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1014 Slaap Pl^^Coloma^MI^49039^USA^P||^PRN^PH^^^269^9881453|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaughtonAIRA^HuronAIRA^^^^^L|MTH^Mother^HL70063|1014 Slaap Pl^^Coloma^MI^49039^USA^P|^PRN^PH^^^269^9881453ORC|RE||BP75I8543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP75I8543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-GL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||696050908^^^AIRA-TEST^GL~Z03P8548^^^AIRA-TEST^MR||BuchananAIRA^ParvaniAIRA^Zebina^^^^L|PageAIRA^SukanyaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1762 Oeeze-Leende St^^Hamilton^MI^49419^USA^P||^PRN^PH^^^269^7029217|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BuchananAIRA^PageAIRA^^^^^L|MTH^Mother^HL70063|1762 Oeeze-Leende St^^Hamilton^MI^49419^USA^P|^PRN^PH^^^269^7029217ORC|RE||BZ03P8548.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ03P8548.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-GN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||059193282^^^AIRA-TEST^GN~N87V8556^^^AIRA-TEST^MR||ReaganAIRA^FalaAIRA^Chelsia^^^^L|WaldoAIRA^AhuvaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1540 Bteenbergen Pl^^DTE Energy^MI^48268^USA^P||^PRN^PH^^^313^3131512|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReaganAIRA^WaldoAIRA^^^^^L|MTH^Mother^HL70063|1540 Bteenbergen Pl^^DTE Energy^MI^48268^USA^P|^PRN^PH^^^313^3131512ORC|RE||BN87V8556.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN87V8556.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-HC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||124868548^^^AIRA-TEST^HC~T81R8567^^^AIRA-TEST^MR||LegresleyAIRA^WynonaAIRA^Decima^^^^L|SnowAIRA^YayoiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1022 Rlphen aan den Rijn Ave^^Atlantic Mine^MI^49905^USA^P||^PRN^PH^^^906^8119295|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LegresleyAIRA^SnowAIRA^^^^^L|MTH^Mother^HL70063|1022 Rlphen aan den Rijn Ave^^Atlantic Mine^MI^49905^USA^P|^PRN^PH^^^906^8119295ORC|RE||BT81R8567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT81R8567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-IND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||178054925^^^AIRA-TEST^IND~P70C8575^^^AIRA-TEST^MR||NelsenAIRA^GerlindeAIRA^Stormy^^^^L|GageAIRA^SaruAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1787 Lden St^^Scottville^MI^49454^USA^P||^PRN^PH^^^231^8999128|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NelsenAIRA^GageAIRA^^^^^L|MTH^Mother^HL70063|1787 Lden St^^Scottville^MI^49454^USA^P|^PRN^PH^^^231^8999128ORC|RE||BP70C8575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP70C8575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-JHN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||324864584^^^AIRA-TEST^JHN~U53O8583^^^AIRA-TEST^MR||AllenAIRA^ApanieAIRA^Viviana^^^^L|LincolnAIRA^MacyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1462 Gennep Pl^^Dowling^MI^49050^USA^P||^PRN^PH^^^269^8777772|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllenAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1462 Gennep Pl^^Dowling^MI^49050^USA^P|^PRN^PH^^^269^8777772ORC|RE||BU53O8583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU53O8583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-LI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||835678862^^^AIRA-TEST^LI~M58Q8588^^^AIRA-TEST^MR||LlanoAIRA^KarmaAIRA^Brynlee^^^^L|LincolnAIRA^RhonaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1839 Valkenburg aan de Geul Cir^^Gaines^MI^48436^USA^P||^PRN^PH^^^989^2770289|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LlanoAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1839 Valkenburg aan de Geul Cir^^Gaines^MI^48436^USA^P|^PRN^PH^^^989^2770289ORC|RE||BM58Q8588.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM58Q8588.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-LN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||678276770^^^AIRA-TEST^LN~L11R8599^^^AIRA-TEST^MR||PauldingAIRA^FaynaAIRA^Tonya^^^^L|EsceibreAIRA^MaitryiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1374 Zedum Pl^^Berrien Sprgs^MI^49104^USA^P||^PRN^PH^^^269^9706045|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PauldingAIRA^EsceibreAIRA^^^^^L|MTH^Mother^HL70063|1374 Zedum Pl^^Berrien Sprgs^MI^49104^USA^P|^PRN^PH^^^269^9706045ORC|RE||BL11R8599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL11R8599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-LR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||275450847^^^AIRA-TEST^LR~G14S8607^^^AIRA-TEST^MR||JacksonAIRA^AmataAIRA^Briony^^^^L|KalkaskaAIRA^JayaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1468 Pestland Ave^^Lachine^MI^49753^USA^P||^PRN^PH^^^989^9145728|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^KalkaskaAIRA^^^^^L|MTH^Mother^HL70063|1468 Pestland Ave^^Lachine^MI^49753^USA^P|^PRN^PH^^^989^9145728ORC|RE||BG14S8607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG14S8607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||563363229^^^AIRA-TEST^MA~O96B8615^^^AIRA-TEST^MR||SterlingAIRA^RennyAIRA^Lexi^^^^L|BristolAIRA^PhillidaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1435 Zeek Cir^^Mio^MI^48647^USA^P||^PRN^PH^^^989^7961219|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SterlingAIRA^BristolAIRA^^^^^L|MTH^Mother^HL70063|1435 Zeek Cir^^Mio^MI^48647^USA^P|^PRN^PH^^^989^7961219ORC|RE||BO96B8615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO96B8615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MB|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||273432942^^^AIRA-TEST^MB~X22C8623^^^AIRA-TEST^MR||LoganAIRA^BoaAIRA^Klavdia^^^^L|LewisAIRA^MorgandyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1856 Noogeveen Ln^^Grand Haven^MI^49417^USA^P||^PRN^PH^^^616^3226573|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoganAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1856 Noogeveen Ln^^Grand Haven^MI^49417^USA^P|^PRN^PH^^^616^3226573ORC|RE||BX22C8623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX22C8623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||568497286^^^AIRA-TEST^MC~E16Q8628^^^AIRA-TEST^MR||SpencerAIRA^DeenaAIRA^Donella^^^^L|KingsAIRA^GilAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1206 Nwartewaterland Pl^^Point Elizabeth^MI^48725^USA^P||^PRN^PH^^^989^5192201|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SpencerAIRA^KingsAIRA^^^^^L|MTH^Mother^HL70063|1206 Nwartewaterland Pl^^Point Elizabeth^MI^48725^USA^P|^PRN^PH^^^989^5192201ORC|RE||BE16Q8628.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE16Q8628.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MCD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||201700381^^^AIRA-TEST^MCD~W81F8636^^^AIRA-TEST^MR||RomsvigAIRA^ElbertinaAIRA^Grear^^^^L|GraysAIRA^CassidyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1458 Verhaal Cir^^Shepherd^MI^48883^USA^P||^PRN^PH^^^989^9966618|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RomsvigAIRA^GraysAIRA^^^^^L|MTH^Mother^HL70063|1458 Verhaal Cir^^Shepherd^MI^48883^USA^P|^PRN^PH^^^989^9966618ORC|RE||BW81F8636.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW81F8636.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||841594884^^^AIRA-TEST^MCN~O21W8647^^^AIRA-TEST^MR||SterlingAIRA^MarisaAIRA^Maris^^^^L|BrackenAIRA^LeewanaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1961 Koon op Zand St^^Michigamme^MI^49861^USA^P||^PRN^PH^^^906^9262006|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SterlingAIRA^BrackenAIRA^^^^^L|MTH^Mother^HL70063|1961 Koon op Zand St^^Michigamme^MI^49861^USA^P|^PRN^PH^^^906^9262006ORC|RE||BO21W8647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO21W8647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MCR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||129599551^^^AIRA-TEST^MCR~D96U8655^^^AIRA-TEST^MR||LincolnAIRA^NanditaAIRA^Kaatje^^^^L|IowaAIRA^ShevaunAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1367 Unschede Pl^^Sylvan Beach^MI^49461^USA^P||^PRN^PH^^^231^6059165|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^IowaAIRA^^^^^L|MTH^Mother^HL70063|1367 Unschede Pl^^Sylvan Beach^MI^49461^USA^P|^PRN^PH^^^231^6059165ORC|RE||BD96U8655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD96U8655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||931736483^^^AIRA-TEST^MD~L06B8663^^^AIRA-TEST^MR||NemahaAIRA^AntoniaAIRA^Adrienne^^^^L|SewardAIRA^EfiaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1260 Geerssen Ave^^Dearborn^MI^48120^USA^P||^PRN^PH^^^313^6379383|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NemahaAIRA^SewardAIRA^^^^^L|MTH^Mother^HL70063|1260 Geerssen Ave^^Dearborn^MI^48120^USA^P|^PRN^PH^^^313^6379383ORC|RE||BL06B8663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL06B8663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||742291193^^^AIRA-TEST^MI~C18O8668^^^AIRA-TEST^MR||Bear LakeAIRA^AkalaAIRA^Faine^^^^L|CrittendenAIRA^MarlissAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1720 Familie Pl^^Traverse City^MI^49685^USA^P||^PRN^PH^^^231^3101962|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Bear LakeAIRA^CrittendenAIRA^^^^^L|MTH^Mother^HL70063|1720 Familie Pl^^Traverse City^MI^49685^USA^P|^PRN^PH^^^231^3101962ORC|RE||BC18O8668.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC18O8668.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||419541489^^^AIRA-TEST^MR~D99V8676^^^AIRA-TEST^MR||HemphillAIRA^UlfhildrAIRA^Helena^^^^L|BlackAIRA^KaraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1545 Geurne Pl^^Saginaw^MI^48607^USA^P||^PRN^PH^^^989^5594378|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HemphillAIRA^BlackAIRA^^^^^L|MTH^Mother^HL70063|1545 Geurne Pl^^Saginaw^MI^48607^USA^P|^PRN^PH^^^989^5594378ORC|RE||BD99V8676.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD99V8676.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-MRT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||960303742^^^AIRA-TEST^MRT~K13L8687^^^AIRA-TEST^MR||Olsen LeeAIRA^ZayitAIRA^Okelani^^^^L|HoeyAIRA^RajniAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1730 Kchouwen-Duiveland Pl^^Rudyard^MI^49780^USA^P||^PRN^PH^^^906^8201738|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Olsen LeeAIRA^HoeyAIRA^^^^^L|MTH^Mother^HL70063|1730 Kchouwen-Duiveland Pl^^Rudyard^MI^49780^USA^P|^PRN^PH^^^906^8201738ORC|RE||BK13L8687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK13L8687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-NE|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||117626543^^^AIRA-TEST^NE~G91T8695^^^AIRA-TEST^MR||YoungAIRA^HeraAIRA^Mere^^^^L|AppanooseAIRA^KenleyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1172 Benray Pl^^Port Huron^MI^48060^USA^P||^PRN^PH^^^810^5821629|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YoungAIRA^AppanooseAIRA^^^^^L|MTH^Mother^HL70063|1172 Benray Pl^^Port Huron^MI^48060^USA^P|^PRN^PH^^^810^5821629ORC|RE||BG91T8695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG91T8695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-NH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||384554545^^^AIRA-TEST^NH~K88A8703^^^AIRA-TEST^MR||NanceAIRA^AdelynAIRA^Noelani^^^^L|KennebecAIRA^JaquelineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1909 Joogezand-Sappemeer Pl^^Hale^MI^48739^USA^P||^PRN^PH^^^989^3026823|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NanceAIRA^KennebecAIRA^^^^^L|MTH^Mother^HL70063|1909 Joogezand-Sappemeer Pl^^Hale^MI^48739^USA^P|^PRN^PH^^^989^3026823ORC|RE||BK88A8703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK88A8703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-NI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||656784367^^^AIRA-TEST^NI~C96K8711^^^AIRA-TEST^MR||MayesAIRA^AnchoretAIRA^Storm^^^^L|ClarkeAIRA^KianaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1374 Vude IJsselstreek Pl^^Kingsford Retail^MI^49801^USA^P||^PRN^PH^^^906^2524342|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MayesAIRA^ClarkeAIRA^^^^^L|MTH^Mother^HL70063|1374 Vude IJsselstreek Pl^^Kingsford Retail^MI^49801^USA^P|^PRN^PH^^^906^2524342ORC|RE||BC96K8711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC96K8711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-NII|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||870657795^^^AIRA-TEST^NII~P79H8716^^^AIRA-TEST^MR||HofflundAIRA^AnaliaAIRA^Emina^^^^L|RossAIRA^PalomiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1521 KJsselstein Ave^^South Branch^MI^48761^USA^P||^PRN^PH^^^989^4121903|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HofflundAIRA^RossAIRA^^^^^L|MTH^Mother^HL70063|1521 KJsselstein Ave^^South Branch^MI^48761^USA^P|^PRN^PH^^^989^4121903ORC|RE||BP79H8716.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP79H8716.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-NIIP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||321925623^^^AIRA-TEST^NIIP~A62V8724^^^AIRA-TEST^MR||StantonAIRA^RosalineAIRA^Aemilia^^^^L|LaurelAIRA^AldeaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1720 Rechts Ln^^Bark River^MI^49807^USA^P||^PRN^PH^^^906^6706226|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StantonAIRA^LaurelAIRA^^^^^L|MTH^Mother^HL70063|1720 Rechts Ln^^Bark River^MI^49807^USA^P|^PRN^PH^^^906^6706226ORC|RE||BA62V8724.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA62V8724.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-NP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||031340925^^^AIRA-TEST^NP~A94Z8735^^^AIRA-TEST^MR||RefugioAIRA^EliseAIRA^Corrine^^^^L|OhioAIRA^MarleeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1228 Gen Boer Ln^^Ellsworth^MI^49729^USA^P||^PRN^PH^^^231^2568214|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RefugioAIRA^OhioAIRA^^^^^L|MTH^Mother^HL70063|1228 Gen Boer Ln^^Ellsworth^MI^49729^USA^P|^PRN^PH^^^231^2568214ORC|RE||BA94Z8735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA94Z8735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-NPI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||772468611^^^AIRA-TEST^NPI~U71N8743^^^AIRA-TEST^MR||JulinAIRA^RaphaelaAIRA^Noelle^^^^L|KossuthAIRA^ImogenAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1912 Oisterwijk Pl^^Smyrna^MI^48887^USA^P||^PRN^PH^^^616^3075265|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JulinAIRA^KossuthAIRA^^^^^L|MTH^Mother^HL70063|1912 Oisterwijk Pl^^Smyrna^MI^48887^USA^P|^PRN^PH^^^616^3075265ORC|RE||BU71N8743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU71N8743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-OD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||798369851^^^AIRA-TEST^OD~Z30Q8751^^^AIRA-TEST^MR||FranklinAIRA^PurviAIRA^Skye^^^^L|CannavinAIRA^ElissaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1886 Gpmeer Ln^^Ann Arbor^MI^48109^USA^P||^PRN^PH^^^734^4159161|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^CannavinAIRA^^^^^L|MTH^Mother^HL70063|1886 Gpmeer Ln^^Ann Arbor^MI^48109^USA^P|^PRN^PH^^^734^4159161ORC|RE||BZ30Q8751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ30Q8751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||436990972^^^AIRA-TEST^PA~L17T8759^^^AIRA-TEST^MR||HumboldtAIRA^CarrieannAIRA^Norberta^^^^L|PortageAIRA^TinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1681 Oijsden-Margraten St^^Newport^MI^48166^USA^P||^PRN^PH^^^734^8062225|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HumboldtAIRA^PortageAIRA^^^^^L|MTH^Mother^HL70063|1681 Oijsden-Margraten St^^Newport^MI^48166^USA^P|^PRN^PH^^^734^8062225ORC|RE||BL17T8759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL17T8759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||547508528^^^AIRA-TEST^PCN~L18S8764^^^AIRA-TEST^MR||DimmitAIRA^CalidaAIRA^Ela^^^^L|ElliottAIRA^IngeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1875 Hen Haag Cir^^Sault Sainte Marie^MI^49785^USA^P||^PRN^PH^^^906^9672097|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DimmitAIRA^ElliottAIRA^^^^^L|MTH^Mother^HL70063|1875 Hen Haag Cir^^Sault Sainte Marie^MI^49785^USA^P|^PRN^PH^^^906^9672097ORC|RE||BL18S8764.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL18S8764.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PE|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||571251995^^^AIRA-TEST^PE~J59P8772^^^AIRA-TEST^MR||JohnAIRA^PoojaAIRA^Naina^^^^L|ClarksonAIRA^EbereAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1073 Massenaar Pl^^Harbor Beach^MI^48441^USA^P||^PRN^PH^^^989^6586378|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JohnAIRA^ClarksonAIRA^^^^^L|MTH^Mother^HL70063|1073 Massenaar Pl^^Harbor Beach^MI^48441^USA^P|^PRN^PH^^^989^6586378ORC|RE||BJ59P8772.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ59P8772.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PEN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||319337679^^^AIRA-TEST^PEN~R89T8783^^^AIRA-TEST^MR||AslsenAIRA^EstherAIRA^Jada^^^^L|ColonAIRA^ArachneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1784 Loerdijk Ave^^Schoolcraft^MI^49087^USA^P||^PRN^PH^^^269^4757821|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AslsenAIRA^ColonAIRA^^^^^L|MTH^Mother^HL70063|1784 Loerdijk Ave^^Schoolcraft^MI^49087^USA^P|^PRN^PH^^^269^4757821ORC|RE||BR89T8783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR89T8783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||062677017^^^AIRA-TEST^PI~E00A8791^^^AIRA-TEST^MR||BarrettAIRA^JazlynnAIRA^Noni^^^^L|KeweenawAIRA^NazaretAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1201 Seere Pl^^Boyne City^MI^49712^USA^P||^PRN^PH^^^231^6889946|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarrettAIRA^KeweenawAIRA^^^^^L|MTH^Mother^HL70063|1201 Seere Pl^^Boyne City^MI^49712^USA^P|^PRN^PH^^^231^6889946ORC|RE||BE00A8791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE00A8791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||274573895^^^AIRA-TEST^PN~C46D8799^^^AIRA-TEST^MR||PresidioAIRA^PurvajaAIRA^Marita^^^^L|LincolnAIRA^ManjushaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1474 Sectie Ave^^Detroit^MI^48228^USA^P||^PRN^PH^^^313^7203305|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PresidioAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1474 Sectie Ave^^Detroit^MI^48228^USA^P|^PRN^PH^^^313^7203305ORC|RE||BC46D8799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC46D8799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PNT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||795983818^^^AIRA-TEST^PNT~P81G8807^^^AIRA-TEST^MR||GradyAIRA^LakeishaAIRA^Hathor^^^^L|HolmfAIRA^PetaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1518 Smsterdam St^^Hudson Mills^MI^48130^USA^P||^PRN^PH^^^734^7172274|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GradyAIRA^HolmfAIRA^^^^^L|MTH^Mother^HL70063|1518 Smsterdam St^^Hudson Mills^MI^48130^USA^P|^PRN^PH^^^734^7172274ORC|RE||BP81G8807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP81G8807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PPN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||553703354^^^AIRA-TEST^PPN~C36I8812^^^AIRA-TEST^MR||WahkiakumAIRA^PramaAIRA^Kadee^^^^L|NuckollsAIRA^AmericaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1019 Homeren Ln^^Livonia^MI^48150^USA^P||^PRN^PH^^^734^6636926|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WahkiakumAIRA^NuckollsAIRA^^^^^L|MTH^Mother^HL70063|1019 Homeren Ln^^Livonia^MI^48150^USA^P|^PRN^PH^^^734^6636926ORC|RE||BC36I8812.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC36I8812.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PRC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||496942170^^^AIRA-TEST^PRC~S05D8820^^^AIRA-TEST^MR||EnaAIRA^AmazoniaAIRA^Gwendolyn^^^^L|MaloneAIRA^DevonaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1790 Bolenwaard St^^Shelby Township^MI^48318^USA^P||^PRN^PH^^^586^4590913|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EnaAIRA^MaloneAIRA^^^^^L|MTH^Mother^HL70063|1790 Bolenwaard St^^Shelby Township^MI^48318^USA^P|^PRN^PH^^^586^4590913ORC|RE||BS05D8820.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS05D8820.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PRN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||638078768^^^AIRA-TEST^PRN~S52L8831^^^AIRA-TEST^MR||FarrellAIRA^BriettaAIRA^Maude^^^^L|BuschAIRA^RandyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1764 Vogel Ln^^Peacock^MI^49644^USA^P||^PRN^PH^^^231^8457204|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FarrellAIRA^BuschAIRA^^^^^L|MTH^Mother^HL70063|1764 Vogel Ln^^Peacock^MI^49644^USA^P|^PRN^PH^^^231^8457204ORC|RE||BS52L8831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS52L8831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-PT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||613442797^^^AIRA-TEST^PT~T37B8839^^^AIRA-TEST^MR||PawneeAIRA^SageAIRA^Trilochana^^^^L|LawrenceAIRA^GabrielAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1825 Me Ronde Venen Cir^^White Lake^MI^48383^USA^P||^PRN^PH^^^248^8214174|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PawneeAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1825 Me Ronde Venen Cir^^White Lake^MI^48383^USA^P|^PRN^PH^^^248^8214174ORC|RE||BT37B8839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT37B8839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-QA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||617623309^^^AIRA-TEST^QA~D33S8847^^^AIRA-TEST^MR||McCleanAIRA^PannaAIRA^Marika^^^^L|TerrellAIRA^EmogenAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1073 Gubbergen Cir^^Detroit^MI^48227^USA^P||^PRN^PH^^^313^6805391|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCleanAIRA^TerrellAIRA^^^^^L|MTH^Mother^HL70063|1073 Gubbergen Cir^^Detroit^MI^48227^USA^P|^PRN^PH^^^313^6805391ORC|RE||BD33S8847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD33S8847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-RI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||439167545^^^AIRA-TEST^RI~N20H8852^^^AIRA-TEST^MR||CochiseAIRA^ElmasAIRA^Stefania^^^^L|NobleAIRA^RicardaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1166 Edge Pl^^Jones^MI^49061^USA^P||^PRN^PH^^^269^6578814|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CochiseAIRA^NobleAIRA^^^^^L|MTH^Mother^HL70063|1166 Edge Pl^^Jones^MI^49061^USA^P|^PRN^PH^^^269^6578814ORC|RE||BN20H8852.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN20H8852.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-RN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||382336501^^^AIRA-TEST^RN~L02Y8860^^^AIRA-TEST^MR||BerrienAIRA^EbereAIRA^Zosima^^^^L|Van ZandtAIRA^CaitrinAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1520 Nijdemeren St^^Rochester Hls^MI^48309^USA^P||^PRN^PH^^^248^3834354|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BerrienAIRA^Van ZandtAIRA^^^^^L|MTH^Mother^HL70063|1520 Nijdemeren St^^Rochester Hls^MI^48309^USA^P|^PRN^PH^^^248^3834354ORC|RE||BL02Y8860.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL02Y8860.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-RPH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||173173390^^^AIRA-TEST^RPH~Z64U8871^^^AIRA-TEST^MR||BordenAIRA^SwanhildAIRA^Sebastiana^^^^L|AlpenaAIRA^KaynaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1959 Hattem Ln^^Otsego^MI^49078^USA^P||^PRN^PH^^^269^6072989|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BordenAIRA^AlpenaAIRA^^^^^L|MTH^Mother^HL70063|1959 Hattem Ln^^Otsego^MI^49078^USA^P|^PRN^PH^^^269^6072989ORC|RE||BZ64U8871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ64U8871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-RR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||859777255^^^AIRA-TEST^RR~V12Z8879^^^AIRA-TEST^MR||HuronAIRA^IzabellaAIRA^Aminta^^^^L|CherokeeAIRA^AmberAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1656 Aandeel Cir^^Huntington Woods^MI^48070^USA^P||^PRN^PH^^^248^6279371|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HuronAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1656 Aandeel Cir^^Huntington Woods^MI^48070^USA^P|^PRN^PH^^^248^6279371ORC|RE||BV12Z8879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV12Z8879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-RRI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||661725299^^^AIRA-TEST^RRI~K11H8887^^^AIRA-TEST^MR||DawesAIRA^GardeniaAIRA^Bracha^^^^L|CaldwellAIRA^GudduAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1351 Graad Ave^^Ann Arbor^MI^48107^USA^P||^PRN^PH^^^734^4340128|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DawesAIRA^CaldwellAIRA^^^^^L|MTH^Mother^HL70063|1351 Graad Ave^^Ann Arbor^MI^48107^USA^P|^PRN^PH^^^734^4340128ORC|RE||BK11H8887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK11H8887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-SL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||105596130^^^AIRA-TEST^SL~D65M8892^^^AIRA-TEST^MR||SnowAIRA^AyushmatiAIRA^Jordana^^^^L|CoryellAIRA^RafaellaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1633 Dundert Ln^^Dowagiac^MI^49047^USA^P||^PRN^PH^^^269^9264550|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SnowAIRA^CoryellAIRA^^^^^L|MTH^Mother^HL70063|1633 Dundert Ln^^Dowagiac^MI^49047^USA^P|^PRN^PH^^^269^9264550ORC|RE||BD65M8892.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD65M8892.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-SN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||188638215^^^AIRA-TEST^SN~W21Y8900^^^AIRA-TEST^MR||FultonAIRA^JenicaAIRA^Gwenhyvar^^^^L|HarperAIRA^DerrythAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1527 Bilvarenbeek Cir^^L' Anse^MI^49946^USA^P||^PRN^PH^^^906^5304013|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FultonAIRA^HarperAIRA^^^^^L|MTH^Mother^HL70063|1527 Bilvarenbeek Cir^^L' Anse^MI^49946^USA^P|^PRN^PH^^^906^5304013ORC|RE||BW21Y8900.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW21Y8900.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-SR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||192880340^^^AIRA-TEST^SR~I63B8911^^^AIRA-TEST^MR||JanttiAIRA^RuellaAIRA^Anvita^^^^L|WayneAIRA^ErikaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1880 Eomeren Pl^^Saugatuck^MI^49453^USA^P||^PRN^PH^^^269^2137790|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JanttiAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1880 Eomeren Pl^^Saugatuck^MI^49453^USA^P|^PRN^PH^^^269^2137790ORC|RE||BI63B8911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI63B8911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-SS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||626512444^^^AIRA-TEST^SS~P98X8919^^^AIRA-TEST^MR||NightingaleAIRA^KaylaAIRA^Jamie^^^^L|TrumbullAIRA^MariannaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1718 Iierden St^^Prudenville^MI^48651^USA^P||^PRN^PH^^^989^2852400|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NightingaleAIRA^TrumbullAIRA^^^^^L|MTH^Mother^HL70063|1718 Iierden St^^Prudenville^MI^48651^USA^P|^PRN^PH^^^989^2852400ORC|RE||BP98X8919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP98X8919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-TAX|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||977957942^^^AIRA-TEST^TAX~T00V8927^^^AIRA-TEST^MR||ShoshoneAIRA^SapnaAIRA^Melvina^^^^L|WyomingAIRA^AnoushAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1433 Gunspeet Ave^^Skandia^MI^49885^USA^P||^PRN^PH^^^906^8200410|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShoshoneAIRA^WyomingAIRA^^^^^L|MTH^Mother^HL70063|1433 Gunspeet Ave^^Skandia^MI^49885^USA^P|^PRN^PH^^^906^8200410ORC|RE||BT00V8927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT00V8927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||435543663^^^AIRA-TEST^U~O74E8932^^^AIRA-TEST^MR||McPhersonAIRA^SampritiAIRA^Narmada^^^^L|KootenaiAIRA^ErynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1441 Handel Pl^^Mooreville^MI^48160^USA^P||^PRN^PH^^^734^2595805|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McPhersonAIRA^KootenaiAIRA^^^^^L|MTH^Mother^HL70063|1441 Handel Pl^^Mooreville^MI^48160^USA^P|^PRN^PH^^^734^2595805ORC|RE||BO74E8932.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO74E8932.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-UPIN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||230374508^^^AIRA-TEST^UPIN~M91J8943^^^AIRA-TEST^MR||MeredithAIRA^AphraAIRA^Vasudhara^^^^L|MuhlenbergAIRA^MarnyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1499 Niddelburg Cir^^Lansing^MI^48913^USA^P||^PRN^PH^^^517^8487988|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeredithAIRA^MuhlenbergAIRA^^^^^L|MTH^Mother^HL70063|1499 Niddelburg Cir^^Lansing^MI^48913^USA^P|^PRN^PH^^^517^8487988ORC|RE||BM91J8943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM91J8943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-VN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||370413263^^^AIRA-TEST^VN~K71F8951^^^AIRA-TEST^MR||MissaukeeAIRA^LizetteAIRA^Ahava^^^^L|HarlanAIRA^LucindaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1877 Dier St^^Stalwart^MI^49736^USA^P||^PRN^PH^^^906^3188487|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MissaukeeAIRA^HarlanAIRA^^^^^L|MTH^Mother^HL70063|1877 Dier St^^Stalwart^MI^49736^USA^P|^PRN^PH^^^906^3188487ORC|RE||BK71F8951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK71F8951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-WC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||098583857^^^AIRA-TEST^WC~O93P8959^^^AIRA-TEST^MR||SwindellsAIRA^CindyAIRA^Keely^^^^L|KentAIRA^KaitlynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1145 Betekenen Ave^^Duck Lake^MI^49284^USA^P||^PRN^PH^^^517^5778478|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SwindellsAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1145 Betekenen Ave^^Duck Lake^MI^49284^USA^P|^PRN^PH^^^517^5778478ORC|RE||BO93P8959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO93P8959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-WCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||100044067^^^AIRA-TEST^WCN~H42O8967^^^AIRA-TEST^MR||RowanAIRA^KanushiAIRA^Ophelia^^^^L|PenobscotAIRA^PramaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1258 Vaasdriel Ave^^Conway^MI^49722^USA^P||^PRN^PH^^^616^8310275|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RowanAIRA^PenobscotAIRA^^^^^L|MTH^Mother^HL70063|1258 Vaasdriel Ave^^Conway^MI^49722^USA^P|^PRN^PH^^^616^8310275ORC|RE||BH42O8967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH42O8967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ID-TYPE2-XX|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||263595556^^^AIRA-TEST^XX~J93L8972^^^AIRA-TEST^MR||TetonAIRA^ZofiaAIRA^Lakeisha^^^^L|WhitakerAIRA^HadiyaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1190 Bloem Cir^^Vicksburg^MI^49097^USA^P||^PRN^PH^^^269^2769871|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TetonAIRA^WhitakerAIRA^^^^^L|MTH^Mother^HL70063|1190 Bloem Cir^^Vicksburg^MI^49097^USA^P|^PRN^PH^^^269^2769871ORC|RE||BJ93L8972.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ93L8972.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005010001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P16Z8983^^^AIRA-TEST^MR||HoodAIRA^AmitolaAIRA^Maxine^^^^L|MarrietteAIRA^BajiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1463 Kint-Oedenrode Ave^^Wyoming^MI^49418^USA^P||^PRN^PH^^^616^8456085|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoodAIRA^MarrietteAIRA^^^^^L|MTH^Mother^HL70063|1463 Kint-Oedenrode Ave^^Wyoming^MI^49418^USA^P|^PRN^PH^^^616^8456085ORC|RE||BP16Z8983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP16Z8983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005010001^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005010002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N07V8991^^^AIRA-TEST^MR||BonnerAIRA^BrunellaAIRA^Allirea^^^^L|CavilAIRA^CarlottaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1806 IJlst Pl^^Applegate^MI^48401^USA^P||^PRN^PH^^^810^4555934|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BonnerAIRA^CavilAIRA^^^^^L|MTH^Mother^HL70063|1806 IJlst Pl^^Applegate^MI^48401^USA^P|^PRN^PH^^^810^4555934ORC|RE||BN07V8991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN07V8991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005010002^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005010005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q00C8999^^^AIRA-TEST^MR||AslsenAIRA^NicoleAIRA^Catherine^^^^L|ClearfieldAIRA^DayanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1404 Jerwerderadeel St^^Clyde^MI^48049^USA^P||^PRN^PH^^^810^4051167|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AslsenAIRA^ClearfieldAIRA^^^^^L|MTH^Mother^HL70063|1404 Jerwerderadeel St^^Clyde^MI^48049^USA^P|^PRN^PH^^^810^4051167ORC|RE||BQ00C8999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ00C8999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005010005^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005010010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I68O9007^^^AIRA-TEST^MR||McCurtainAIRA^JanessaAIRA^Yetta^^^^L|ArmstrongAIRA^ZennorAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1919 Gennep St^^New Haven^MI^48048^USA^P||^PRN^PH^^^586^5342473|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCurtainAIRA^ArmstrongAIRA^^^^^L|MTH^Mother^HL70063|1919 Gennep St^^New Haven^MI^48048^USA^P|^PRN^PH^^^586^5342473ORC|RE||BI68O9007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI68O9007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005010010^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005197049|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U28K9012^^^AIRA-TEST^MR||San JoaquinAIRA^IngabergAIRA^Veronica^^^^L|NolanAIRA^PetraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1065 Gouda Ln^^Saint Clair Shrs^MI^48080^USA^P||^PRN^PH^^^586^7795706|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San JoaquinAIRA^NolanAIRA^^^^^L|MTH^Mother^HL70063|1065 Gouda Ln^^Saint Clair Shrs^MI^48080^USA^P|^PRN^PH^^^586^7795706ORC|RE||BU28K9012.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU28K9012.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005197049^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005197050|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I73R9023^^^AIRA-TEST^MR||ColumbianaAIRA^TwylaAIRA^Zoey^^^^L|BlancoAIRA^KinleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1842 Nuenen Ave^^Limestone^MI^49816^USA^P||^PRN^PH^^^906^9777850|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColumbianaAIRA^BlancoAIRA^^^^^L|MTH^Mother^HL70063|1842 Nuenen Ave^^Limestone^MI^49816^USA^P|^PRN^PH^^^906^9777850ORC|RE||BI73R9023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI73R9023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005197050^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005197101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y01K9031^^^AIRA-TEST^MR||Presque IsleAIRA^PhuongAIRA^Inas^^^^L|HarrisonAIRA^BasimahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1627 Gemert-Bakel Ave^^Ann Arbor^MI^48113^USA^P||^PRN^PH^^^734^8087572|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Presque IsleAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1627 Gemert-Bakel Ave^^Ann Arbor^MI^48113^USA^P|^PRN^PH^^^734^8087572ORC|RE||BY01K9031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY01K9031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005197101^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005197102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H25M9039^^^AIRA-TEST^MR||BullittAIRA^RoshniAIRA^Ayse^^^^L|LevyAIRA^MildredAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1368 Strijd Pl^^East Lansing^MI^48824^USA^P||^PRN^PH^^^517^5711513|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BullittAIRA^LevyAIRA^^^^^L|MTH^Mother^HL70063|1368 Strijd Pl^^East Lansing^MI^48824^USA^P|^PRN^PH^^^517^5711513ORC|RE||BH25M9039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH25M9039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005197102^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005197104|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V95Z9047^^^AIRA-TEST^MR||DecaturAIRA^LeopoldaAIRA^Mirabelle^^^^L|GrayAIRA^Mary-EllenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1029 Vomeren Cir^^Detroit^MI^48236^USA^P||^PRN^PH^^^313^4279844|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DecaturAIRA^GrayAIRA^^^^^L|MTH^Mother^HL70063|1029 Vomeren Cir^^Detroit^MI^48236^USA^P|^PRN^PH^^^313^4279844ORC|RE||BV95Z9047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV95Z9047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005197104^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00005197105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R35A9052^^^AIRA-TEST^MR||SnyderAIRA^AinaAIRA^Kitty^^^^L|HowardAIRA^FawneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1138 Boordenveld St^^Flint^MI^48506^USA^P||^PRN^PH^^^810^5440035|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SnyderAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1138 Boordenveld St^^Flint^MI^48506^USA^P|^PRN^PH^^^810^5440035ORC|RE||BR35A9052.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR35A9052.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00005197105^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006404500|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H73D9063^^^AIRA-TEST^MR||SpokaneAIRA^BeckyAIRA^Maryvonne^^^^L|FagenAIRA^EdevaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1742 Ks-Hertogenbosch Ln^^Detroit^MI^48233^USA^P||^PRN^PH^^^313^2954529|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SpokaneAIRA^FagenAIRA^^^^^L|MTH^Mother^HL70063|1742 Ks-Hertogenbosch Ln^^Detroit^MI^48233^USA^P|^PRN^PH^^^313^2954529ORC|RE||BH73D9063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH73D9063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006404500^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006404501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A71T9071^^^AIRA-TEST^MR||StephensAIRA^BrittanyAIRA^Gracelynn^^^^L|BergenAIRA^MandisaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1443 Krijgen Ave^^Sand Creek^MI^49279^USA^P||^PRN^PH^^^517^7174098|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StephensAIRA^BergenAIRA^^^^^L|MTH^Mother^HL70063|1443 Krijgen Ave^^Sand Creek^MI^49279^USA^P|^PRN^PH^^^517^7174098ORC|RE||BA71T9071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA71T9071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006404501^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006404541|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y29F9079^^^AIRA-TEST^MR||ManisteeAIRA^DesireeAIRA^Ernestine^^^^L|CruzAIRA^BambiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1029 Norendijk Ln^^Gladstone^MI^49837^USA^P||^PRN^PH^^^906^7842375|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ManisteeAIRA^CruzAIRA^^^^^L|MTH^Mother^HL70063|1029 Norendijk Ln^^Gladstone^MI^49837^USA^P|^PRN^PH^^^906^7842375ORC|RE||BY29F9079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY29F9079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006404541^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006404701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E76F9087^^^AIRA-TEST^MR||Le FloreAIRA^LindsayAIRA^Dionyza^^^^L|ByrneAIRA^LolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1328 Dragen Pl^^Livonia^MI^48150^USA^P||^PRN^PH^^^734^7856054|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Le FloreAIRA^ByrneAIRA^^^^^L|MTH^Mother^HL70063|1328 Dragen Pl^^Livonia^MI^48150^USA^P|^PRN^PH^^^734^7856054ORC|RE||BE76F9087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE76F9087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006404701^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006404720|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z62C9092^^^AIRA-TEST^MR||WallerAIRA^LinaAIRA^Sadie^^^^L|WallowaAIRA^KaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1920 Bal Pl^^Fremont^MI^49412^USA^P||^PRN^PH^^^231^3524524|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WallerAIRA^WallowaAIRA^^^^^L|MTH^Mother^HL70063|1920 Bal Pl^^Fremont^MI^49412^USA^P|^PRN^PH^^^231^3524524ORC|RE||BZ62C9092.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ62C9092.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006404720^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006404741|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W13Q9103^^^AIRA-TEST^MR||CoosAIRA^OkelaniAIRA^Ahuva^^^^L|TetonAIRA^AmalaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1479 Heerenveen St^^Scio^MI^48130^USA^P||^PRN^PH^^^734^6523437|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoosAIRA^TetonAIRA^^^^^L|MTH^Mother^HL70063|1479 Heerenveen St^^Scio^MI^48130^USA^P|^PRN^PH^^^734^6523437ORC|RE||BW13Q9103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW13Q9103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006404741^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z77E9111^^^AIRA-TEST^MR||SiouxAIRA^MonaAIRA^Oleander^^^^L|SanduskyAIRA^HinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1784 Sreda Cir^^Comerica^MI^48267^USA^P||^PRN^PH^^^313^5729800|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiouxAIRA^SanduskyAIRA^^^^^L|MTH^Mother^HL70063|1784 Sreda Cir^^Comerica^MI^48267^USA^P|^PRN^PH^^^313^5729800ORC|RE||BZ77E9111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ77E9111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409301^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L96L9119^^^AIRA-TEST^MR||KellyAIRA^VonnieAIRA^Sudevi^^^^L|ClintonAIRA^PeggyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1493 Toorst Ln^^Rochester Hills^MI^48307^USA^P||^PRN^PH^^^248^6181416|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KellyAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1493 Toorst Ln^^Rochester Hills^MI^48307^USA^P|^PRN^PH^^^248^6181416ORC|RE||BL96L9119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL96L9119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409302^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409309|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L10L9127^^^AIRA-TEST^MR||O'DonnellAIRA^YarallaAIRA^Fatin^^^^L|SylteAIRA^AraxieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1659 Maken Pl^^Rockwood^MI^48173^USA^P||^PRN^PH^^^734^9402336|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O'DonnellAIRA^SylteAIRA^^^^^L|MTH^Mother^HL70063|1659 Maken Pl^^Rockwood^MI^48173^USA^P|^PRN^PH^^^734^9402336ORC|RE||BL10L9127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL10L9127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409309^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R34A9132^^^AIRA-TEST^MR||SwiftAIRA^CorazonAIRA^Purvaja^^^^L|SullivanAIRA^AveryAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1035 Roxtel Ln^^Mount Pleasant^MI^48858^USA^P||^PRN^PH^^^989^4917024|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SwiftAIRA^SullivanAIRA^^^^^L|MTH^Mother^HL70063|1035 Roxtel Ln^^Mount Pleasant^MI^48858^USA^P|^PRN^PH^^^989^4917024ORC|RE||BR34A9132.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR34A9132.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409401^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X87Q9143^^^AIRA-TEST^MR||AndrewsAIRA^RatiAIRA^Jacoba^^^^L|SiegasAIRA^DimityAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1804 Ooudrichem Pl^^Ubly^MI^48475^USA^P||^PRN^PH^^^989^5679241|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndrewsAIRA^SiegasAIRA^^^^^L|MTH^Mother^HL70063|1804 Ooudrichem Pl^^Ubly^MI^48475^USA^P|^PRN^PH^^^989^5679241ORC|RE||BX87Q9143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX87Q9143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409402^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409409|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F79M9151^^^AIRA-TEST^MR||CaldwellAIRA^OnawaAIRA^Bessie^^^^L|McLeanAIRA^LucretiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1372 Kon en Breugel Ln^^Port Elizabeth^MI^48725^USA^P||^PRN^PH^^^989^7322131|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CaldwellAIRA^McLeanAIRA^^^^^L|MTH^Mother^HL70063|1372 Kon en Breugel Ln^^Port Elizabeth^MI^48725^USA^P|^PRN^PH^^^989^7322131ORC|RE||BF79M9151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF79M9151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409409^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U00C9159^^^AIRA-TEST^MR||ComancheAIRA^BalbinaAIRA^Harriet^^^^L|Del NorteAIRA^VendelaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1660 Spreken Ln^^Pontiac^MI^48343^USA^P||^PRN^PH^^^248^8328914|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ComancheAIRA^Del NorteAIRA^^^^^L|MTH^Mother^HL70063|1660 Spreken Ln^^Pontiac^MI^48343^USA^P|^PRN^PH^^^248^8328914ORC|RE||BU00C9159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU00C9159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409501^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409502|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P61X9167^^^AIRA-TEST^MR||CarbonAIRA^PersephoneAIRA^Edaline^^^^L|MorrosAIRA^EiddwenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1253 Passen Cir^^Hersey^MI^49639^USA^P||^PRN^PH^^^231^2323757|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarbonAIRA^MorrosAIRA^^^^^L|MTH^Mother^HL70063|1253 Passen Cir^^Hersey^MI^49639^USA^P|^PRN^PH^^^231^2323757ORC|RE||BP61X9167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP61X9167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409502^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409509|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K69G9172^^^AIRA-TEST^MR||ClayAIRA^KristenAIRA^Talia^^^^L|MonroeAIRA^GwendolynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1229 Roerendaal Ave^^Mendon^MI^49072^USA^P||^PRN^PH^^^269^9166562|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClayAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1229 Roerendaal Ave^^Mendon^MI^49072^USA^P|^PRN^PH^^^269^9166562ORC|RE||BK69G9172.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK69G9172.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409509^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F20J9183^^^AIRA-TEST^MR||HusseyAIRA^AlfonsaAIRA^Sonia^^^^L|JasperAIRA^KelseyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1611 Bastricum Pl^^Pickford^MI^49774^USA^P||^PRN^PH^^^906^7641932|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HusseyAIRA^JasperAIRA^^^^^L|MTH^Mother^HL70063|1611 Bastricum Pl^^Pickford^MI^49774^USA^P|^PRN^PH^^^906^7641932ORC|RE||BF20J9183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF20J9183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409601^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X82I9191^^^AIRA-TEST^MR||RiverAIRA^AmirahAIRA^Huon^^^^L|KohlmeisterAIRA^ReganAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1064 Testvoorne St^^Lum^MI^48412^USA^P||^PRN^PH^^^810^8027487|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RiverAIRA^KohlmeisterAIRA^^^^^L|MTH^Mother^HL70063|1064 Testvoorne St^^Lum^MI^48412^USA^P|^PRN^PH^^^810^8027487ORC|RE||BX82I9191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX82I9191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409602^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006409609|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M60R9199^^^AIRA-TEST^MR||McKiernanAIRA^CressidaAIRA^Julianne^^^^L|CameronAIRA^OphrahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1405 Ga en Hunze Ln^^Port Austin^MI^48467^USA^P||^PRN^PH^^^989^4813893|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McKiernanAIRA^CameronAIRA^^^^^L|MTH^Mother^HL70063|1405 Ga en Hunze Ln^^Port Austin^MI^48467^USA^P|^PRN^PH^^^989^4813893ORC|RE||BM60R9199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM60R9199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006409609^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006410901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B90W9207^^^AIRA-TEST^MR||Saint ClairAIRA^DelaneyAIRA^Sarah^^^^L|La SalleAIRA^AkankshaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1498 Beghel Cir^^Kalamazoo^MI^49004^USA^P||^PRN^PH^^^269^2066641|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Saint ClairAIRA^La SalleAIRA^^^^^L|MTH^Mother^HL70063|1498 Beghel Cir^^Kalamazoo^MI^49004^USA^P|^PRN^PH^^^269^2066641ORC|RE||BB90W9207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB90W9207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006410901^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006410902|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U63G9212^^^AIRA-TEST^MR||LoganAIRA^SheetalAIRA^Aleena^^^^L|AllenAIRA^SilvaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1908 Hwenterand Pl^^Cone^MI^48160^USA^P||^PRN^PH^^^734^9726565|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoganAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1908 Hwenterand Pl^^Cone^MI^48160^USA^P|^PRN^PH^^^734^9726565ORC|RE||BU63G9212.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU63G9212.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006410902^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006410909|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D13V9223^^^AIRA-TEST^MR||FranklinAIRA^MaryvonneAIRA^Adonia^^^^L|CornelinsonAIRA^TracyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1038 Ireda Ave^^Harper Woods^MI^48225^USA^P||^PRN^PH^^^313^2399550|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^CornelinsonAIRA^^^^^L|MTH^Mother^HL70063|1038 Ireda Ave^^Harper Woods^MI^48225^USA^P|^PRN^PH^^^313^2399550ORC|RE||BD13V9223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD13V9223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006410909^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006411901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L75J9231^^^AIRA-TEST^MR||MultnomahAIRA^HippolytaAIRA^Efia^^^^L|BrewsterAIRA^TuruaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1504 Bmeland Pl^^Wells^MI^49894^USA^P||^PRN^PH^^^906^4660804|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MultnomahAIRA^BrewsterAIRA^^^^^L|MTH^Mother^HL70063|1504 Bmeland Pl^^Wells^MI^49894^USA^P|^PRN^PH^^^906^4660804ORC|RE||BL75J9231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL75J9231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006411901^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006411902|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I62U9239^^^AIRA-TEST^MR||FitzpatrickAIRA^Ha-NeulAIRA^Evonne^^^^L|ColusaAIRA^AnisaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1698 Tinkelland Ln^^Grand Rapids^MI^49504^USA^P||^PRN^PH^^^616^2487511|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FitzpatrickAIRA^ColusaAIRA^^^^^L|MTH^Mother^HL70063|1698 Tinkelland Ln^^Grand Rapids^MI^49504^USA^P|^PRN^PH^^^616^2487511ORC|RE||BI62U9239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI62U9239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006411902^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006411903|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N28D9247^^^AIRA-TEST^MR||ValleyAIRA^CynaraAIRA^Saeko^^^^L|HubbardAIRA^BaakoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1793 Leghel Cir^^Burlington^MI^49029^USA^P||^PRN^PH^^^517^2918109|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ValleyAIRA^HubbardAIRA^^^^^L|MTH^Mother^HL70063|1793 Leghel Cir^^Burlington^MI^49029^USA^P|^PRN^PH^^^517^2918109ORC|RE||BN28D9247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN28D9247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006411903^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006412101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R66Q9252^^^AIRA-TEST^MR||KenedyAIRA^FannyAIRA^Quinta^^^^L|ClarkAIRA^VasaviAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1308 Zmersfoort Ave^^Peck^MI^48466^USA^P||^PRN^PH^^^810^6641236|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KenedyAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1308 Zmersfoort Ave^^Peck^MI^48466^USA^P|^PRN^PH^^^810^6641236ORC|RE||BR66Q9252.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR66Q9252.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006412101^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006412102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G33G9263^^^AIRA-TEST^MR||GarfieldAIRA^MakaniAIRA^Tayen^^^^L|SutterAIRA^PersiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1870 Neendam Pl^^Calumet^MI^49913^USA^P||^PRN^PH^^^906^6189148|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarfieldAIRA^SutterAIRA^^^^^L|MTH^Mother^HL70063|1870 Neendam Pl^^Calumet^MI^49913^USA^P|^PRN^PH^^^906^6189148ORC|RE||BG33G9263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG33G9263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006412102^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006413301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q86G9271^^^AIRA-TEST^MR||ReynoldsAIRA^AdishreeAIRA^Aurelia^^^^L|BannockAIRA^ShanataAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1248 Meer dan Pl^^Farmington Hills^MI^48332^USA^P||^PRN^PH^^^248^7839997|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReynoldsAIRA^BannockAIRA^^^^^L|MTH^Mother^HL70063|1248 Meer dan Pl^^Farmington Hills^MI^48332^USA^P|^PRN^PH^^^248^7839997ORC|RE||BQ86G9271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ86G9271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006413301^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006413341|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J05C9279^^^AIRA-TEST^MR||OttawaAIRA^TalwynAIRA^Delcine^^^^L|WoodsAIRA^ShivaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1636 Aastricum Ave^^Belding^MI^48809^USA^P||^PRN^PH^^^616^3581335|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OttawaAIRA^WoodsAIRA^^^^^L|MTH^Mother^HL70063|1636 Aastricum Ave^^Belding^MI^48809^USA^P|^PRN^PH^^^616^3581335ORC|RE||BJ05C9279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ05C9279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006413341^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006417100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N88N9287^^^AIRA-TEST^MR||GradyAIRA^PantheaAIRA^Robalyn^^^^L|WayrynenAIRA^KarelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1183 Familie Ln^^Bannister^MI^48807^USA^P||^PRN^PH^^^989^9312029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GradyAIRA^WayrynenAIRA^^^^^L|MTH^Mother^HL70063|1183 Familie Ln^^Bannister^MI^48807^USA^P|^PRN^PH^^^989^9312029ORC|RE||BN88N9287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN88N9287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006417100^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006417101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R31W9292^^^AIRA-TEST^MR||McCrackenAIRA^GwennapAIRA^Lysandra^^^^L|BourbonAIRA^GennyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1090 Hard Ln^^Farmington^MI^48332^USA^P||^PRN^PH^^^248^5199177|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCrackenAIRA^BourbonAIRA^^^^^L|MTH^Mother^HL70063|1090 Hard Ln^^Farmington^MI^48332^USA^P|^PRN^PH^^^248^5199177ORC|RE||BR31W9292.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR31W9292.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006417101^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006468100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L34H9303^^^AIRA-TEST^MR||AudubonAIRA^KokoAIRA^Hypatia^^^^L|SowdenAIRA^MercedesAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1788 Heek Pl^^Orion^MI^48359^USA^P||^PRN^PH^^^248^9698781|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AudubonAIRA^SowdenAIRA^^^^^L|MTH^Mother^HL70063|1788 Heek Pl^^Orion^MI^48359^USA^P|^PRN^PH^^^248^9698781ORC|RE||BL34H9303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL34H9303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006468100^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006468101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F72X9311^^^AIRA-TEST^MR||Santa BarbaraAIRA^AsterAIRA^Lurleen^^^^L|McGannAIRA^KadiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1409 Rijkerk Ln^^Cement City^MI^49233^USA^P||^PRN^PH^^^517^4770902|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Santa BarbaraAIRA^McGannAIRA^^^^^L|MTH^Mother^HL70063|1409 Rijkerk Ln^^Cement City^MI^49233^USA^P|^PRN^PH^^^517^4770902ORC|RE||BF72X9311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF72X9311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006468101^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006473900|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A98F9319^^^AIRA-TEST^MR||CraneAIRA^AllisonAIRA^Trudi^^^^L|AllenAIRA^KiaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1683 Haasdonk Cir^^Flint^MI^48531^USA^P||^PRN^PH^^^810^6589684|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CraneAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1683 Haasdonk Cir^^Flint^MI^48531^USA^P|^PRN^PH^^^810^6589684ORC|RE||BA98F9319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA98F9319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006473900^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006473901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M11I9327^^^AIRA-TEST^MR||ClarionAIRA^SummerAIRA^Naoko^^^^L|AshlandAIRA^IseultAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1071 Zingen Ln^^Clay Township^MI^48001^USA^P||^PRN^PH^^^810^8596169|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClarionAIRA^AshlandAIRA^^^^^L|MTH^Mother^HL70063|1071 Zingen Ln^^Clay Township^MI^48001^USA^P|^PRN^PH^^^810^8596169ORC|RE||BM11I9327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM11I9327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006473901^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006482600|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M47W9332^^^AIRA-TEST^MR||KrogAIRA^EllaAIRA^Eugenia^^^^L|ClarkeAIRA^OrianaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1107 Piessenlanden Ln^^Duck Lake^MI^49284^USA^P||^PRN^PH^^^517^7063716|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KrogAIRA^ClarkeAIRA^^^^^L|MTH^Mother^HL70063|1107 Piessenlanden Ln^^Duck Lake^MI^49284^USA^P|^PRN^PH^^^517^7063716ORC|RE||BM47W9332.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM47W9332.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006482600^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006482601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y87V9343^^^AIRA-TEST^MR||AndersonAIRA^EleanorAIRA^Laria^^^^L|FloydAIRA^AqueneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1448 Bepaalde St^^Livonia^MI^48150^USA^P||^PRN^PH^^^734^7076793|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndersonAIRA^FloydAIRA^^^^^L|MTH^Mother^HL70063|1448 Bepaalde St^^Livonia^MI^48150^USA^P|^PRN^PH^^^734^7076793ORC|RE||BY87V9343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY87V9343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006482601^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006482700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K41T9351^^^AIRA-TEST^MR||ScottAIRA^MindyAIRA^Angela^^^^L|NewtonAIRA^NanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1893 Oluis Pl^^Bloomfld Hls^MI^48303^USA^P||^PRN^PH^^^248^9832975|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ScottAIRA^NewtonAIRA^^^^^L|MTH^Mother^HL70063|1893 Oluis Pl^^Bloomfld Hls^MI^48303^USA^P|^PRN^PH^^^248^9832975ORC|RE||BK41T9351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK41T9351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006482700^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006482701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H35D9359^^^AIRA-TEST^MR||BranchAIRA^HyldaAIRA^Evita^^^^L|NicholasAIRA^IsletaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1251 Yudwest-Fryslan St^^Manistique^MI^49854^USA^P||^PRN^PH^^^906^9990004|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BranchAIRA^NicholasAIRA^^^^^L|MTH^Mother^HL70063|1251 Yudwest-Fryslan St^^Manistique^MI^49854^USA^P|^PRN^PH^^^906^9990004ORC|RE||BH35D9359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH35D9359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006482701^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006483101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E02W9367^^^AIRA-TEST^MR||ComalAIRA^YvetteAIRA^Carlen^^^^L|RossAIRA^SaniyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1021 Teylingen Cir^^Dafter^MI^49724^USA^P||^PRN^PH^^^906^3817866|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ComalAIRA^RossAIRA^^^^^L|MTH^Mother^HL70063|1021 Teylingen Cir^^Dafter^MI^49724^USA^P|^PRN^PH^^^906^3817866ORC|RE||BE02W9367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE02W9367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006483101^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006483141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z39L9372^^^AIRA-TEST^MR||ArmstrongAIRA^DrisanaAIRA^Chloe^^^^L|Scotts BluffAIRA^MargueriteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1245 Winterswijk St^^Felch^MI^49877^USA^P||^PRN^PH^^^906^4177954|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ArmstrongAIRA^Scotts BluffAIRA^^^^^L|MTH^Mother^HL70063|1245 Winterswijk St^^Felch^MI^49877^USA^P|^PRN^PH^^^906^4177954ORC|RE||BZ39L9372.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ39L9372.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006483141^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006483701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X77C9383^^^AIRA-TEST^MR||ThurstonAIRA^JanthineAIRA^Faylinn^^^^L|DixonAIRA^CanaceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1894 Lochem St^^Goetzville^MI^49736^USA^P||^PRN^PH^^^906^9896184|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThurstonAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1894 Lochem St^^Goetzville^MI^49736^USA^P|^PRN^PH^^^906^9896184ORC|RE||BX77C9383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX77C9383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006483701^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006483702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H46L9391^^^AIRA-TEST^MR||Red WillowAIRA^CynthiaAIRA^Malavika^^^^L|MarshallAIRA^BasimahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1239 Ncheemda Cir^^Grand Rapids^MI^49515^USA^P||^PRN^PH^^^616^8115275|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Red WillowAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1239 Ncheemda Cir^^Grand Rapids^MI^49515^USA^P|^PRN^PH^^^616^8115275ORC|RE||BH46L9391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH46L9391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006483702^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006483703|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V12Y9399^^^AIRA-TEST^MR||CampbellAIRA^CleopatraAIRA^Ulalia^^^^L|AllottAIRA^CarolineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1943 Menigte Ln^^Worth Township^MI^48032^USA^P||^PRN^PH^^^810^5664711|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CampbellAIRA^AllottAIRA^^^^^L|MTH^Mother^HL70063|1943 Menigte Ln^^Worth Township^MI^48032^USA^P|^PRN^PH^^^810^5664711ORC|RE||BV12Y9399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV12Y9399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006483703^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006484100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R62M9407^^^AIRA-TEST^MR||FarstanAIRA^LindseyAIRA^Rafaella^^^^L|DahlAIRA^MarjaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1988 Baadhoeke Cir^^Deckerville^MI^48427^USA^P||^PRN^PH^^^810^2797953|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FarstanAIRA^DahlAIRA^^^^^L|MTH^Mother^HL70063|1988 Baadhoeke Cir^^Deckerville^MI^48427^USA^P|^PRN^PH^^^810^2797953ORC|RE||BR62M9407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR62M9407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006484100^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006484101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F50V9412^^^AIRA-TEST^MR||GardenAIRA^BraelynAIRA^Lana^^^^L|RunnelsAIRA^CarlinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1219 Nmsterdam Cir^^Ravenna^MI^49451^USA^P||^PRN^PH^^^231^4191756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GardenAIRA^RunnelsAIRA^^^^^L|MTH^Mother^HL70063|1219 Nmsterdam Cir^^Ravenna^MI^49451^USA^P|^PRN^PH^^^231^4191756ORC|RE||BF50V9412.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF50V9412.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006484101^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006484141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W52A9423^^^AIRA-TEST^MR||DunnAIRA^VernaAIRA^Alfonsa^^^^L|ProtheroeAIRA^KaleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1948 Weumen Cir^^Orion^MI^48360^USA^P||^PRN^PH^^^248^4219217|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DunnAIRA^ProtheroeAIRA^^^^^L|MTH^Mother^HL70063|1948 Weumen Cir^^Orion^MI^48360^USA^P|^PRN^PH^^^248^4219217ORC|RE||BW52A9423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW52A9423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006484141^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006489700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K17E9431^^^AIRA-TEST^MR||LivingstonAIRA^DayanaAIRA^Melia^^^^L|WoodwardAIRA^MorenwynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1776 Nernheze Cir^^Davison^MI^48423^USA^P||^PRN^PH^^^810^5939984|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LivingstonAIRA^WoodwardAIRA^^^^^L|MTH^Mother^HL70063|1776 Nernheze Cir^^Davison^MI^48423^USA^P|^PRN^PH^^^810^5939984ORC|RE||BK17E9431.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK17E9431.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006489700^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006489701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V27R9439^^^AIRA-TEST^MR||La PazAIRA^NatsukoAIRA^Quintessa^^^^L|ChippewaAIRA^DitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1187 Beghel Ln^^Saint James^MI^49782^USA^P||^PRN^PH^^^906^5102286|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|La PazAIRA^ChippewaAIRA^^^^^L|MTH^Mother^HL70063|1187 Beghel Ln^^Saint James^MI^49782^USA^P|^PRN^PH^^^906^5102286ORC|RE||BV27R9439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV27R9439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006489701^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006489800|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E60R9447^^^AIRA-TEST^MR||ClintonAIRA^EurwenAIRA^Paityn^^^^L|Van ZandtAIRA^KatyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1588 Kijfheerenlanden Ln^^Empire^MI^49630^USA^P||^PRN^PH^^^231^8030889|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClintonAIRA^Van ZandtAIRA^^^^^L|MTH^Mother^HL70063|1588 Kijfheerenlanden Ln^^Empire^MI^49630^USA^P|^PRN^PH^^^231^8030889ORC|RE||BE60R9447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE60R9447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006489800^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006489801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C13Z9452^^^AIRA-TEST^MR||GarzaAIRA^TamikoAIRA^Cressida^^^^L|HoughtonAIRA^RozAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1224 Mronckhorst Pl^^Whitehall^MI^49463^USA^P||^PRN^PH^^^231^3144416|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarzaAIRA^HoughtonAIRA^^^^^L|MTH^Mother^HL70063|1224 Mronckhorst Pl^^Whitehall^MI^49463^USA^P|^PRN^PH^^^231^3144416ORC|RE||BC13Z9452.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC13Z9452.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006489801^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006494300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y68H9463^^^AIRA-TEST^MR||ArthurAIRA^HagarAIRA^Sitembile^^^^L|GrantAIRA^ValeriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1028 Ede Ln^^GR^MI^49506^USA^P||^PRN^PH^^^616^7001429|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ArthurAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1028 Ede Ln^^GR^MI^49506^USA^P|^PRN^PH^^^616^7001429ORC|RE||BY68H9463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY68H9463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006494300^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006494301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G88V9471^^^AIRA-TEST^MR||FinnAIRA^HenkaAIRA^Vasuki^^^^L|UnionAIRA^TeganAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1204 Hlphen-Chaam St^^Mass City^MI^49948^USA^P||^PRN^PH^^^906^2682806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FinnAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1204 Hlphen-Chaam St^^Mass City^MI^49948^USA^P|^PRN^PH^^^906^2682806ORC|RE||BG88V9471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG88V9471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006494301^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006496300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z01K9479^^^AIRA-TEST^MR||CheboyganAIRA^ManjulaAIRA^Shanna^^^^L|CassAIRA^SuchitraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1892 Sronten Pl^^Detroit^MI^48217^USA^P||^PRN^PH^^^313^8150402|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CheboyganAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1892 Sronten Pl^^Detroit^MI^48217^USA^P|^PRN^PH^^^313^8150402ORC|RE||BZ01K9479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ01K9479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006496300^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006496301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F32R9487^^^AIRA-TEST^MR||SullivanAIRA^ArzikiAIRA^Feronia^^^^L|WoodAIRA^YevaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1595 Moerdijk Ln^^Commerce^MI^48382^USA^P||^PRN^PH^^^248^2733220|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SullivanAIRA^WoodAIRA^^^^^L|MTH^Mother^HL70063|1595 Moerdijk Ln^^Commerce^MI^48382^USA^P|^PRN^PH^^^248^2733220ORC|RE||BF32R9487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF32R9487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006496301^ZOSTAVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006496341|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S76K9492^^^AIRA-TEST^MR||BullittAIRA^FleurAIRA^Gracelyn^^^^L|MontgomeryAIRA^NikitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1047 Berg en Dal Cir^^Grandville^MI^49468^USA^P||^PRN^PH^^^616^6861472|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BullittAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1047 Berg en Dal Cir^^Grandville^MI^49468^USA^P|^PRN^PH^^^616^6861472ORC|RE||BS76K9492.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS76K9492.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006496341^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006498000|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z84L9503^^^AIRA-TEST^MR||YubaAIRA^HedvaAIRA^Amaryllis^^^^L|HarrisonAIRA^ThomasinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1261 Ooensdrecht Pl^^Grand Rapids^MI^49514^USA^P||^PRN^PH^^^616^2894030|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YubaAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1261 Ooensdrecht Pl^^Grand Rapids^MI^49514^USA^P|^PRN^PH^^^616^2894030ORC|RE||BZ84L9503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ84L9503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006498000^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006498100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D58S9511^^^AIRA-TEST^MR||MitchellAIRA^DestryAIRA^Vimala^^^^L|ChristensenAIRA^AishaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1934 Gehoord Ave^^Hessel^MI^49745^USA^P||^PRN^PH^^^906^6503680|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MitchellAIRA^ChristensenAIRA^^^^^L|MTH^Mother^HL70063|1934 Gehoord Ave^^Hessel^MI^49745^USA^P|^PRN^PH^^^906^6503680ORC|RE||BD58S9511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD58S9511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006498100^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006498101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G24R9519^^^AIRA-TEST^MR||JacksonAIRA^XantheAIRA^Regan^^^^L|LarssenAIRA^FatimaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1966 Saarlem Ln^^Cement City^MI^49233^USA^P||^PRN^PH^^^517^9949597|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^LarssenAIRA^^^^^L|MTH^Mother^HL70063|1966 Saarlem Ln^^Cement City^MI^49233^USA^P|^PRN^PH^^^517^9949597ORC|RE||BG24R9519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG24R9519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006498101^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006499200|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C60Q9527^^^AIRA-TEST^MR||BrownAIRA^MayukoAIRA^Shakira^^^^L|YorkAIRA^SimoniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1209 Bespreken Cir^^Saint Helen^MI^48656^USA^P||^PRN^PH^^^989^5292567|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1209 Bespreken Cir^^Saint Helen^MI^48656^USA^P|^PRN^PH^^^989^5292567ORC|RE||BC60Q9527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC60Q9527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006499200^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006499201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L07Y9532^^^AIRA-TEST^MR||Santa CruzAIRA^AzraelAIRA^Decima^^^^L|MillsAIRA^CarreenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1273 Ne Bilt Pl^^DTE Energy Brm^MI^48269^USA^P||^PRN^PH^^^313^2149609|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Santa CruzAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1273 Ne Bilt Pl^^DTE Energy Brm^MI^48269^USA^P|^PRN^PH^^^313^2149609ORC|RE||BL07Y9532.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL07Y9532.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006499201^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006499500|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N36O9543^^^AIRA-TEST^MR||EastlandAIRA^TheodosiaAIRA^Krupa^^^^L|ChambersAIRA^TalonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1501 Brimpenerwaard Ave^^Armada Township^MI^48005^USA^P||^PRN^PH^^^586^2462123|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EastlandAIRA^ChambersAIRA^^^^^L|MTH^Mother^HL70063|1501 Brimpenerwaard Ave^^Armada Township^MI^48005^USA^P|^PRN^PH^^^586^2462123ORC|RE||BN36O9543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN36O9543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006499500^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006499501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B15K9551^^^AIRA-TEST^MR||MahaskaAIRA^TerzaAIRA^Lan^^^^L|GemAIRA^KinseyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1056 Soord-Beveland Cir^^Byron^MI^48418^USA^P||^PRN^PH^^^810^4278164|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MahaskaAIRA^GemAIRA^^^^^L|MTH^Mother^HL70063|1056 Soord-Beveland Cir^^Byron^MI^48418^USA^P|^PRN^PH^^^810^4278164ORC|RE||BB15K9551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB15K9551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006499501^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006499541|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K98U9559^^^AIRA-TEST^MR||WoodwardAIRA^KristenAIRA^Emogen^^^^L|JeffersonAIRA^LorisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1874 Lerkelland St^^Muskegon^MI^49445^USA^P||^PRN^PH^^^231^9852313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoodwardAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1874 Lerkelland St^^Muskegon^MI^49445^USA^P|^PRN^PH^^^231^9852313ORC|RE||BK98U9559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK98U9559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006499541^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006499900|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H66U9567^^^AIRA-TEST^MR||BooneAIRA^LucineAIRA^Isla^^^^L|VargasAIRA^StarrAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1246 Stel St^^Sterling Heights^MI^48310^USA^P||^PRN^PH^^^586^9363116|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BooneAIRA^VargasAIRA^^^^^L|MTH^Mother^HL70063|1246 Stel St^^Sterling Heights^MI^48310^USA^P|^PRN^PH^^^586^9363116ORC|RE||BH66U9567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH66U9567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006499900^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00006499901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C25Y9572^^^AIRA-TEST^MR||EriksonAIRA^LudmilaAIRA^Norna^^^^L|O'NeillAIRA^ScarlettAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1861 Bloemendaal Ln^^Grand Rapids^MI^49519^USA^P||^PRN^PH^^^616^8795735|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EriksonAIRA^O'NeillAIRA^^^^^L|MTH^Mother^HL70063|1861 Bloemendaal Ln^^Grand Rapids^MI^49519^USA^P|^PRN^PH^^^616^8795735ORC|RE||BC25Y9572.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC25Y9572.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00006499901^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-0100-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H56R9583^^^AIRA-TEST^MR||ComancheAIRA^TonaAIRA^Paula^^^^L|KnottAIRA^CelineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1428 Aalkenswaard Ave^^Superior Township^MI^48105^USA^P||^PRN^PH^^^734^3010208|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ComancheAIRA^KnottAIRA^^^^^L|MTH^Mother^HL70063|1428 Aalkenswaard Ave^^Superior Township^MI^48105^USA^P|^PRN^PH^^^734^3010208ORC|RE||BH56R9583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH56R9583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-0100-01^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-0100-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T39X9591^^^AIRA-TEST^MR||TaylorAIRA^SidoniaAIRA^Alissa^^^^L|NanceAIRA^EmmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1617 Reimerswaal Ln^^Keweenaw Bay^MI^49908^USA^P||^PRN^PH^^^906^2075173|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^NanceAIRA^^^^^L|MTH^Mother^HL70063|1617 Reimerswaal Ln^^Keweenaw Bay^MI^49908^USA^P|^PRN^PH^^^906^2075173ORC|RE||BT39X9591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT39X9591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-0100-02^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-0100-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P01S9599^^^AIRA-TEST^MR||CampbellAIRA^LonaAIRA^Ethelda^^^^L|MillsAIRA^AmirahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1450 Buenen Cir^^Hillsdale^MI^49242^USA^P||^PRN^PH^^^517^2336381|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CampbellAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1450 Buenen Cir^^Hillsdale^MI^49242^USA^P|^PRN^PH^^^517^2336381ORC|RE||BP01S9599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP01S9599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-0100-05^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-0100-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D13W9607^^^AIRA-TEST^MR||HaysAIRA^MarigoldAIRA^Makena^^^^L|WalkerAIRA^LorenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1980 Ealburg Ln^^Gaastra^MI^49927^USA^P||^PRN^PH^^^906^6420352|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaysAIRA^WalkerAIRA^^^^^L|MTH^Mother^HL70063|1980 Ealburg Ln^^Gaastra^MI^49927^USA^P|^PRN^PH^^^906^6420352ORC|RE||BD13W9607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD13W9607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-0100-10^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-1970-49|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M16F9612^^^AIRA-TEST^MR||GraysAIRA^LilacAIRA^Elizabeth^^^^L|O NeillAIRA^LlvAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1642 Sterke Ln^^Farmington Hills^MI^48331^USA^P||^PRN^PH^^^248^7545242|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GraysAIRA^O NeillAIRA^^^^^L|MTH^Mother^HL70063|1642 Sterke Ln^^Farmington Hills^MI^48331^USA^P|^PRN^PH^^^248^7545242ORC|RE||BM16F9612.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM16F9612.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-1970-49^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-1970-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O17J9623^^^AIRA-TEST^MR||StantonAIRA^RemanAIRA^Pia^^^^L|FurnasAIRA^ManuelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1049 Bpsterland St^^Ada^MI^49356^USA^P||^PRN^PH^^^616^3441644|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StantonAIRA^FurnasAIRA^^^^^L|MTH^Mother^HL70063|1049 Bpsterland St^^Ada^MI^49356^USA^P|^PRN^PH^^^616^3441644ORC|RE||BO17J9623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO17J9623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-1970-50^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-1971-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L65X9631^^^AIRA-TEST^MR||GrayAIRA^IldikoAIRA^Evania^^^^L|WrigleyAIRA^RachaelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1843 Outphen St^^Bruce Crossing^MI^49912^USA^P||^PRN^PH^^^906^8445127|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrayAIRA^WrigleyAIRA^^^^^L|MTH^Mother^HL70063|1843 Outphen St^^Bruce Crossing^MI^49912^USA^P|^PRN^PH^^^906^8445127ORC|RE||BL65X9631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL65X9631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-1971-01^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-1971-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O27I9639^^^AIRA-TEST^MR||EricksonAIRA^GenaAIRA^Giorgio^^^^L|BlairAIRA^BrunhildeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1528 Zorg St^^Hamtramck^MI^48212^USA^P||^PRN^PH^^^313^7495836|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EricksonAIRA^BlairAIRA^^^^^L|MTH^Mother^HL70063|1528 Zorg St^^Hamtramck^MI^48212^USA^P|^PRN^PH^^^313^7495836ORC|RE||BO27I9639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO27I9639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-1971-02^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-1971-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O39C9647^^^AIRA-TEST^MR||HofflundAIRA^ClaiborneAIRA^Pierrette^^^^L|GreeneAIRA^TansyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1306 Butten Ln^^Birch Run^MI^48415^USA^P||^PRN^PH^^^989^2103003|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HofflundAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1306 Butten Ln^^Birch Run^MI^48415^USA^P|^PRN^PH^^^989^2103003ORC|RE||BO39C9647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO39C9647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-1971-04^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0005-1971-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K66M9652^^^AIRA-TEST^MR||WapelloAIRA^BrunaAIRA^Gytha^^^^L|OkfuskeeAIRA^IsabellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1914 Resultaat Cir^^Bay Port^MI^48720^USA^P||^PRN^PH^^^989^3082304|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WapelloAIRA^OkfuskeeAIRA^^^^^L|MTH^Mother^HL70063|1914 Resultaat Cir^^Bay Port^MI^48720^USA^P|^PRN^PH^^^989^3082304ORC|RE||BK66M9652.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK66M9652.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0005-1971-05^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00052060301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U12Q9663^^^AIRA-TEST^MR||Van BurenAIRA^QuenbyAIRA^Erin^^^^L|GratiotAIRA^MaribethAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1892 Ons Ln^^Sterling Heights^MI^48312^USA^P||^PRN^PH^^^586^7607343|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Van BurenAIRA^GratiotAIRA^^^^^L|MTH^Mother^HL70063|1892 Ons Ln^^Sterling Heights^MI^48312^USA^P|^PRN^PH^^^586^7607343ORC|RE||BU12Q9663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU12Q9663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00052060301^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-00052060302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M11Y9671^^^AIRA-TEST^MR||RockwallAIRA^DysisAIRA^Bristol^^^^L|TurnerAIRA^KetziaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1798 Vmmen Pl^^Brownstwn Township^MI^48134^USA^P||^PRN^PH^^^734^4768645|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RockwallAIRA^TurnerAIRA^^^^^L|MTH^Mother^HL70063|1798 Vmmen Pl^^Brownstwn Township^MI^48134^USA^P|^PRN^PH^^^734^4768645ORC|RE||BM11Y9671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM11Y9671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||00052060302^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4045-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S51X9679^^^AIRA-TEST^MR||O'ConnellAIRA^FatinAIRA^Rere^^^^L|ParmerAIRA^EmmyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1853 Voorwaarde St^^Clayton^MI^49235^USA^P||^PRN^PH^^^517^4365222|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O'ConnellAIRA^ParmerAIRA^^^^^L|MTH^Mother^HL70063|1853 Voorwaarde St^^Clayton^MI^49235^USA^P|^PRN^PH^^^517^4365222ORC|RE||BS51X9679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS51X9679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4045-00^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4045-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U75X9687^^^AIRA-TEST^MR||BrownAIRA^SarahAIRA^Anjali^^^^L|MononaAIRA^NedaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1382 Lol Cir^^GR^MI^49546^USA^P||^PRN^PH^^^616^9514410|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownAIRA^MononaAIRA^^^^^L|MTH^Mother^HL70063|1382 Lol Cir^^GR^MI^49546^USA^P|^PRN^PH^^^616^9514410ORC|RE||BU75X9687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU75X9687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4045-01^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4045-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X72C9692^^^AIRA-TEST^MR||KaneAIRA^GodivaAIRA^Else^^^^L|DuncanAIRA^BerylAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1521 Audwest-Fryslan Ln^^Vulcan^MI^49852^USA^P||^PRN^PH^^^906^5786641|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KaneAIRA^DuncanAIRA^^^^^L|MTH^Mother^HL70063|1521 Audwest-Fryslan Ln^^Vulcan^MI^49852^USA^P|^PRN^PH^^^906^5786641ORC|RE||BX72C9692.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX72C9692.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4045-41^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4047-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K24Q9701^^^AIRA-TEST^MR||TuscolaAIRA^KennaAIRA^Grace^^^^L|HarlanAIRA^PhilaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1554 Weg Cir^^GR^MI^49523^USA^P||^PRN^PH^^^616^5189849|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TuscolaAIRA^HarlanAIRA^^^^^L|MTH^Mother^HL70063|1554 Weg Cir^^GR^MI^49523^USA^P|^PRN^PH^^^616^5189849ORC|RE||BK24Q9701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK24Q9701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4047-01^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4047-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C68G9711^^^AIRA-TEST^MR||TaylorAIRA^AmataAIRA^Melly^^^^L|CedarAIRA^AthenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1026 Soggenland Pl^^Alto^MI^49302^USA^P||^PRN^PH^^^616^2764208|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^CedarAIRA^^^^^L|MTH^Mother^HL70063|1026 Soggenland Pl^^Alto^MI^49302^USA^P|^PRN^PH^^^616^2764208ORC|RE||BC68G9711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC68G9711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4047-20^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4047-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K63P9719^^^AIRA-TEST^MR||CusackAIRA^RoshniAIRA^Amata^^^^L|IdaAIRA^ZagrosAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1057 Zoensdrecht Ave^^Lenox Township^MI^48050^USA^P||^PRN^PH^^^586^2952931|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CusackAIRA^IdaAIRA^^^^^L|MTH^Mother^HL70063|1057 Zoensdrecht Ave^^Lenox Township^MI^48050^USA^P|^PRN^PH^^^586^2952931ORC|RE||BK63P9719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK63P9719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4047-41^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4093-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B63G9727^^^AIRA-TEST^MR||McQuadeAIRA^LilaAIRA^Paloma^^^^L|MalheurAIRA^EricaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1931 Ochtend Ln^^Huron Township^MI^48164^USA^P||^PRN^PH^^^734^4062616|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McQuadeAIRA^MalheurAIRA^^^^^L|MTH^Mother^HL70063|1931 Ochtend Ln^^Huron Township^MI^48164^USA^P|^PRN^PH^^^734^4062616ORC|RE||BB63G9727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB63G9727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4093-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4093-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D02M9732^^^AIRA-TEST^MR||RoscommonAIRA^GayleenAIRA^Lucian^^^^L|CourtAIRA^VikkiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1780 Doudrichem Ln^^Brohman^MI^49312^USA^P||^PRN^PH^^^231^8782908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RoscommonAIRA^CourtAIRA^^^^^L|MTH^Mother^HL70063|1780 Doudrichem Ln^^Brohman^MI^49312^USA^P|^PRN^PH^^^231^8782908ORC|RE||BD02M9732.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD02M9732.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4093-02^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4093-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T00H9743^^^AIRA-TEST^MR||StrubleAIRA^CheriAIRA^Morgana^^^^L|HamiltonAIRA^UlrikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1317 Veld Ln^^Northport^MI^49670^USA^P||^PRN^PH^^^231^7664804|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StrubleAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1317 Veld Ln^^Northport^MI^49670^USA^P|^PRN^PH^^^231^7664804ORC|RE||BT00H9743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT00H9743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4093-09^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4094-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J70T9751^^^AIRA-TEST^MR||CoconinoAIRA^ZeeAIRA^Emmett^^^^L|PolkAIRA^MahinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1506 Koetinchem Pl^^North Port^MI^49670^USA^P||^PRN^PH^^^231^8511618|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoconinoAIRA^PolkAIRA^^^^^L|MTH^Mother^HL70063|1506 Koetinchem Pl^^North Port^MI^49670^USA^P|^PRN^PH^^^231^8511618ORC|RE||BJ70T9751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ70T9751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4094-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4094-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T72W9759^^^AIRA-TEST^MR||PawneeAIRA^TuesdayAIRA^Limber^^^^L|LoupAIRA^DeniseAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1846 Bornwirdhuizen Ln^^Suttons Bay^MI^49682^USA^P||^PRN^PH^^^231^4383018|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PawneeAIRA^LoupAIRA^^^^^L|MTH^Mother^HL70063|1846 Bornwirdhuizen Ln^^Suttons Bay^MI^49682^USA^P|^PRN^PH^^^231^4383018ORC|RE||BT72W9759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT72W9759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4094-02^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4094-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V44C9767^^^AIRA-TEST^MR||HancockAIRA^BethiaAIRA^Rosetta^^^^L|ClarkeAIRA^RonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1614 Cardenberg Ln^^Saint Clr Shrs^MI^48080^USA^P||^PRN^PH^^^586^9933002|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^ClarkeAIRA^^^^^L|MTH^Mother^HL70063|1614 Cardenberg Ln^^Saint Clr Shrs^MI^48080^USA^P|^PRN^PH^^^586^9933002ORC|RE||BV44C9767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV44C9767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4094-09^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4095-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H49P9772^^^AIRA-TEST^MR||HellicoskiAIRA^CatrinAIRA^Tristessa^^^^L|OtsegoAIRA^AquamarineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1740 Koosendaal St^^Brimley^MI^49715^USA^P||^PRN^PH^^^906^4017163|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HellicoskiAIRA^OtsegoAIRA^^^^^L|MTH^Mother^HL70063|1740 Koosendaal St^^Brimley^MI^49715^USA^P|^PRN^PH^^^906^4017163ORC|RE||BH49P9772.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH49P9772.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4095-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4095-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T39M9783^^^AIRA-TEST^MR||LundgrenAIRA^BrankaAIRA^Tadako^^^^L|JernneAIRA^OliviaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1231 Leiderdorp Pl^^Midland^MI^48642^USA^P||^PRN^PH^^^989^7949796|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LundgrenAIRA^JernneAIRA^^^^^L|MTH^Mother^HL70063|1231 Leiderdorp Pl^^Midland^MI^48642^USA^P|^PRN^PH^^^989^7949796ORC|RE||BT39M9783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT39M9783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4095-02^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4095-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M60V9791^^^AIRA-TEST^MR||MeigsAIRA^DoeAIRA^Christy^^^^L|SilowAIRA^CorlissAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1559 Tchagen Ave^^Carp Lake^MI^49718^USA^P||^PRN^PH^^^616^7957203|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeigsAIRA^SilowAIRA^^^^^L|MTH^Mother^HL70063|1559 Tchagen Ave^^Carp Lake^MI^49718^USA^P|^PRN^PH^^^616^7957203ORC|RE||BM60V9791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM60V9791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4095-09^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4096-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y12A9799^^^AIRA-TEST^MR||WardleAIRA^QuobaAIRA^Gotzone^^^^L|BurtAIRA^WidjanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1536 Behoorlijk St^^Carrollton^MI^48724^USA^P||^PRN^PH^^^989^3229244|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WardleAIRA^BurtAIRA^^^^^L|MTH^Mother^HL70063|1536 Behoorlijk St^^Carrollton^MI^48724^USA^P|^PRN^PH^^^989^3229244ORC|RE||BY12A9799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY12A9799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4096-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4096-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O05U9807^^^AIRA-TEST^MR||TuolumneAIRA^DeirdreAIRA^Faina^^^^L|RoscommonAIRA^TalwynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1771 Mestland St^^Canadian Lake^MI^49346^USA^P||^PRN^PH^^^231^5522947|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TuolumneAIRA^RoscommonAIRA^^^^^L|MTH^Mother^HL70063|1771 Mestland St^^Canadian Lake^MI^49346^USA^P|^PRN^PH^^^231^5522947ORC|RE||BO05U9807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO05U9807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4096-02^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4096-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y61W9812^^^AIRA-TEST^MR||WatmoughAIRA^EmeliaAIRA^Elyse^^^^L|CheboyganAIRA^ElsieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1065 Drave Ave^^Buick City^MI^48550^USA^P||^PRN^PH^^^810^2522947|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WatmoughAIRA^CheboyganAIRA^^^^^L|MTH^Mother^HL70063|1065 Drave Ave^^Buick City^MI^48550^USA^P|^PRN^PH^^^810^2522947ORC|RE||BY61W9812.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY61W9812.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4096-09^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4109-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M17K9820^^^AIRA-TEST^MR||ParkerAIRA^HeliAIRA^Noelle^^^^L|McErlaineAIRA^AlkaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1378 Oppervlak Ln^^Lansing^MI^48917^USA^P||^PRN^PH^^^517^6623291|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ParkerAIRA^McErlaineAIRA^^^^^L|MTH^Mother^HL70063|1378 Oppervlak Ln^^Lansing^MI^48917^USA^P|^PRN^PH^^^517^6623291ORC|RE||BM17K9820.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM17K9820.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4109-01^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4109-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q88V9831^^^AIRA-TEST^MR||KiernanAIRA^DrusillaAIRA^Marianne^^^^L|DelawareAIRA^LanaiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1284 Ve Ronde Venen St^^Southfield^MI^48033^USA^P||^PRN^PH^^^248^4579727|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KiernanAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1284 Ve Ronde Venen St^^Southfield^MI^48033^USA^P|^PRN^PH^^^248^4579727ORC|RE||BQ88V9831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ88V9831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4109-02^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4109-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G16P9839^^^AIRA-TEST^MR||PetersonAIRA^ClodaghAIRA^Vespera^^^^L|BeckhamAIRA^WeemaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1926 Oytsjerksteradiel Ln^^Bergland^MI^49910^USA^P||^PRN^PH^^^906^7313692|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PetersonAIRA^BeckhamAIRA^^^^^L|MTH^Mother^HL70063|1926 Oytsjerksteradiel Ln^^Bergland^MI^49910^USA^P|^PRN^PH^^^906^7313692ORC|RE||BG16P9839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG16P9839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4109-09^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4119-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I97Q9847^^^AIRA-TEST^MR||AdairAIRA^AstraAIRA^Toinette^^^^L|CumberlandAIRA^FionolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1963 Eunschoten Cir^^Atlantic Mine^MI^49905^USA^P||^PRN^PH^^^906^2315822|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdairAIRA^CumberlandAIRA^^^^^L|MTH^Mother^HL70063|1963 Eunschoten Cir^^Atlantic Mine^MI^49905^USA^P|^PRN^PH^^^906^2315822ORC|RE||BI97Q9847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI97Q9847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4119-01^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4119-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S40Z9855^^^AIRA-TEST^MR||MontereyAIRA^TeresaAIRA^Corina^^^^L|YavapaiAIRA^LoreneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1585 Ginsum Ln^^Bentley^MI^48613^USA^P||^PRN^PH^^^989^5339319|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontereyAIRA^YavapaiAIRA^^^^^L|MTH^Mother^HL70063|1585 Ginsum Ln^^Bentley^MI^48613^USA^P|^PRN^PH^^^989^5339319ORC|RE||BS40Z9855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS40Z9855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4119-02^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4119-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J50Y9863^^^AIRA-TEST^MR||OakAIRA^RamyaAIRA^Hadassa^^^^L|San BenitoAIRA^ShahiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1728 Weumen Ave^^Chesterfield Township^MI^48047^USA^P||^PRN^PH^^^586^4093443|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OakAIRA^San BenitoAIRA^^^^^L|MTH^Mother^HL70063|1728 Weumen Ave^^Chesterfield Township^MI^48047^USA^P|^PRN^PH^^^586^4093443ORC|RE||BJ50Y9863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ50Y9863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4119-03^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4121-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T21X9868^^^AIRA-TEST^MR||PetersAIRA^MedusaAIRA^Summer^^^^L|MillsAIRA^IlukaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1696 Berwerderadeel Ave^^East Lansing^MI^48823^USA^P||^PRN^PH^^^517^7342393|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PetersAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1696 Berwerderadeel Ave^^East Lansing^MI^48823^USA^P|^PRN^PH^^^517^7342393ORC|RE||BT21X9868.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT21X9868.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4121-01^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4121-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T85D9879^^^AIRA-TEST^MR||Palo AltoAIRA^GiselleAIRA^Sabelle^^^^L|KnoxAIRA^GiuliettaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1955 Synaarlo Ave^^Burnips^MI^49314^USA^P||^PRN^PH^^^616^9860182|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Palo AltoAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1955 Synaarlo Ave^^Burnips^MI^49314^USA^P|^PRN^PH^^^616^9860182ORC|RE||BT85D9879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT85D9879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4121-02^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4133-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L47Q9887^^^AIRA-TEST^MR||JeffersonAIRA^ValimaiAIRA^Calypso^^^^L|McPhersonAIRA^RonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1982 Baaksbergen St^^South Haven^MI^49090^USA^P||^PRN^PH^^^269^2382235|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^McPhersonAIRA^^^^^L|MTH^Mother^HL70063|1982 Baaksbergen St^^South Haven^MI^49090^USA^P|^PRN^PH^^^269^2382235ORC|RE||BL47Q9887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL47Q9887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4133-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4133-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z25H9895^^^AIRA-TEST^MR||ElmoreAIRA^TylerAIRA^Avis^^^^L|BenzieAIRA^DamoselAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1596 Melodie Ln^^Lansing^MI^48906^USA^P||^PRN^PH^^^517^7217492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ElmoreAIRA^BenzieAIRA^^^^^L|MTH^Mother^HL70063|1596 Melodie Ln^^Lansing^MI^48906^USA^P|^PRN^PH^^^517^7217492ORC|RE||BZ25H9895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ25H9895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4133-41^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4171-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N76Y9903^^^AIRA-TEST^MR||WilliamsAIRA^AnayaAIRA^Caledonia^^^^L|FultonAIRA^SamuelaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1753 Walkenburg aan de Geul St^^Wyoming^MI^49509^USA^P||^PRN^PH^^^616^6773230|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilliamsAIRA^FultonAIRA^^^^^L|MTH^Mother^HL70063|1753 Walkenburg aan de Geul St^^Wyoming^MI^49509^USA^P|^PRN^PH^^^616^6773230ORC|RE||BN76Y9903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN76Y9903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4171-00^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4171-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N21D9908^^^AIRA-TEST^MR||PolkAIRA^KelliAIRA^Mary-Ellen^^^^L|LoganAIRA^JezebelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1269 Haren Cir^^Watersmeet^MI^49969^USA^P||^PRN^PH^^^906^4663395|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PolkAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1269 Haren Cir^^Watersmeet^MI^49969^USA^P|^PRN^PH^^^906^4663395ORC|RE||BN21D9908.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN21D9908.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4171-01^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4681-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P30Z9919^^^AIRA-TEST^MR||OchiltreeAIRA^AddiAIRA^Coral^^^^L|CumingAIRA^PatsyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1053 Klinker Ave^^Snover^MI^48472^USA^P||^PRN^PH^^^810^5267121|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OchiltreeAIRA^CumingAIRA^^^^^L|MTH^Mother^HL70063|1053 Klinker Ave^^Snover^MI^48472^USA^P|^PRN^PH^^^810^5267121ORC|RE||BP30Z9919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP30Z9919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4681-00^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4681-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y61N9927^^^AIRA-TEST^MR||FayetteAIRA^RosalbaAIRA^Xiomara^^^^L|JepsenAIRA^JoannAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1438 Veldhoven Ln^^Rochester^MI^48306^USA^P||^PRN^PH^^^248^2849830|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FayetteAIRA^JepsenAIRA^^^^^L|MTH^Mother^HL70063|1438 Veldhoven Ln^^Rochester^MI^48306^USA^P|^PRN^PH^^^248^2849830ORC|RE||BY61N9927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY61N9927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4681-01^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4739-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C22R9935^^^AIRA-TEST^MR||BayAIRA^ZariaAIRA^Laila^^^^L|WestportAIRA^ElodiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1261 Oeumen Cir^^Scotts^MI^49088^USA^P||^PRN^PH^^^269^9876857|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BayAIRA^WestportAIRA^^^^^L|MTH^Mother^HL70063|1261 Oeumen Cir^^Scotts^MI^49088^USA^P|^PRN^PH^^^269^9876857ORC|RE||BC22R9935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC22R9935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4739-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4739-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B62W9943^^^AIRA-TEST^MR||HayesAIRA^KinleyAIRA^Farida^^^^L|UvaldeAIRA^TrilbyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1046 Eomeren St^^Fenton^MI^48430^USA^P||^PRN^PH^^^810^3877913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HayesAIRA^UvaldeAIRA^^^^^L|MTH^Mother^HL70063|1046 Eomeren St^^Fenton^MI^48430^USA^P|^PRN^PH^^^810^3877913ORC|RE||BB62W9943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB62W9943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4739-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4826-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O86Q9948^^^AIRA-TEST^MR||ParkesAIRA^NardaAIRA^Athanasia^^^^L|PurolaAIRA^LaquettaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1183 Dmallingerland Pl^^Birch Run^MI^48415^USA^P||^PRN^PH^^^989^7444972|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ParkesAIRA^PurolaAIRA^^^^^L|MTH^Mother^HL70063|1183 Dmallingerland Pl^^Birch Run^MI^48415^USA^P|^PRN^PH^^^989^7444972ORC|RE||BO86Q9948.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO86Q9948.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4826-00^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4826-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X41N9959^^^AIRA-TEST^MR||FranklinAIRA^DohnaAIRA^Anusia^^^^L|WoodsAIRA^MarninaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1391 Dellingwedde Ave^^Romulus^MI^48174^USA^P||^PRN^PH^^^734^4068217|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^WoodsAIRA^^^^^L|MTH^Mother^HL70063|1391 Dellingwedde Ave^^Romulus^MI^48174^USA^P|^PRN^PH^^^734^4068217ORC|RE||BX41N9959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX41N9959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4826-01^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4827-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L40K9967^^^AIRA-TEST^MR||McKinnonAIRA^KarimaAIRA^Ulrika^^^^L|MarionAIRA^BrynleeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1539 Aoevorden Ave^^Utica^MI^48318^USA^P||^PRN^PH^^^586^5727989|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McKinnonAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1539 Aoevorden Ave^^Utica^MI^48318^USA^P|^PRN^PH^^^586^5727989ORC|RE||BL40K9967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL40K9967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4827-00^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4827-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E19X9975^^^AIRA-TEST^MR||CherokeeAIRA^EsterAIRA^Ritsuko^^^^L|GabrielsenAIRA^AmeliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1539 Bijzonder Cir^^Brownstown Township^MI^48164^USA^P||^PRN^PH^^^734^3070620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CherokeeAIRA^GabrielsenAIRA^^^^^L|MTH^Mother^HL70063|1539 Bijzonder Cir^^Brownstown Township^MI^48164^USA^P|^PRN^PH^^^734^3070620ORC|RE||BE19X9975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE19X9975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4827-01^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4831-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z82J9983^^^AIRA-TEST^MR||WarrenAIRA^ChristieAIRA^Godiva^^^^L|AmmensAIRA^AmeliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1671 Schip Pl^^White Cloud^MI^49349^USA^P||^PRN^PH^^^231^6919379|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WarrenAIRA^AmmensAIRA^^^^^L|MTH^Mother^HL70063|1671 Schip Pl^^White Cloud^MI^49349^USA^P|^PRN^PH^^^231^6919379ORC|RE||BZ82J9983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ82J9983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4831-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4831-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O75B9988^^^AIRA-TEST^MR||ButteAIRA^IllonaAIRA^Laila^^^^L|NewtonAIRA^TanakaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1824 Wutphen Cir^^Detroit^MI^48219^USA^P||^PRN^PH^^^313^4080317|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButteAIRA^NewtonAIRA^^^^^L|MTH^Mother^HL70063|1824 Wutphen Cir^^Detroit^MI^48219^USA^P|^PRN^PH^^^313^4080317ORC|RE||BO75B9988.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO75B9988.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4831-41^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4837-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R69T9996^^^AIRA-TEST^MR||BooneAIRA^DoneenAIRA^Rahab^^^^L|O'BrianAIRA^BerninaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1603 Zeventer St^^Kaleva^MI^49645^USA^P||^PRN^PH^^^231^3759421|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BooneAIRA^O'BrianAIRA^^^^^L|MTH^Mother^HL70063|1603 Zeventer St^^Kaleva^MI^49645^USA^P|^PRN^PH^^^231^3759421ORC|RE||BR69T9996.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR69T9996.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4837-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4837-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J02E10007^^^AIRA-TEST^MR||SheridanAIRA^PerleAIRA^Suma^^^^L|JohnsonAIRA^MayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1047 Ae Wolden Ave^^Blissfield^MI^49228^USA^P||^PRN^PH^^^517^5982106|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SheridanAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1047 Ae Wolden Ave^^Blissfield^MI^49228^USA^P|^PRN^PH^^^517^5982106ORC|RE||BJ02E10007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ02E10007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4837-02^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4837-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V64C10015^^^AIRA-TEST^MR||WaschingAIRA^KohiaAIRA^Kimber^^^^L|JofrayAIRA^BerthaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1986 Iluis Ln^^Commerce Township^MI^48390^USA^P||^PRN^PH^^^248^9593959|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WaschingAIRA^JofrayAIRA^^^^^L|MTH^Mother^HL70063|1986 Iluis Ln^^Commerce Township^MI^48390^USA^P|^PRN^PH^^^248^9593959ORC|RE||BV64C10015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV64C10015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4837-03^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4841-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V54R10023^^^AIRA-TEST^MR||San JoaquinAIRA^GabrielaAIRA^Carrigan^^^^L|AdamsAIRA^KiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1121 Boes Ave^^Niles^MI^49120^USA^P||^PRN^PH^^^269^2504853|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San JoaquinAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1121 Boes Ave^^Niles^MI^49120^USA^P|^PRN^PH^^^269^2504853ORC|RE||BV54R10023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV54R10023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4841-00^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4841-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T65Y10028^^^AIRA-TEST^MR||SaundersAIRA^AmissaAIRA^Gigi^^^^L|SulitAIRA^DavineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1709 Cijsden-Margraten Ln^^Shepherd^MI^48883^USA^P||^PRN^PH^^^989^4764752|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SaundersAIRA^SulitAIRA^^^^^L|MTH^Mother^HL70063|1709 Cijsden-Margraten Ln^^Shepherd^MI^48883^USA^P|^PRN^PH^^^989^4764752ORC|RE||BT65Y10028.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT65Y10028.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4841-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4841-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L67Q10039^^^AIRA-TEST^MR||ShortAIRA^JoleneAIRA^Cherise^^^^L|ColemanAIRA^TarynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1714 Dss Ln^^Maple Rapids^MI^48853^USA^P||^PRN^PH^^^989^5561692|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShortAIRA^ColemanAIRA^^^^^L|MTH^Mother^HL70063|1714 Dss Ln^^Maple Rapids^MI^48853^USA^P|^PRN^PH^^^989^5561692ORC|RE||BL67Q10039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL67Q10039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4841-41^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4897-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P20S10047^^^AIRA-TEST^MR||KinnearAIRA^KirbyAIRA^Kendra^^^^L|PayneAIRA^MacariaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1907 Noogeveen Pl^^Jackson National Life Ins Co^MI^48951^USA^P||^PRN^PH^^^517^9926553|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KinnearAIRA^PayneAIRA^^^^^L|MTH^Mother^HL70063|1907 Noogeveen Pl^^Jackson National Life Ins Co^MI^48951^USA^P|^PRN^PH^^^517^9926553ORC|RE||BP20S10047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP20S10047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4897-00^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4897-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K99A10055^^^AIRA-TEST^MR||GarrardAIRA^MadilynnAIRA^Jazmyn^^^^L|DaviessAIRA^AbileneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1971 Nollumerland en Nieuwkruisland Pl^^Grand Rapids^MI^49508^USA^P||^PRN^PH^^^616^5315694|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarrardAIRA^DaviessAIRA^^^^^L|MTH^Mother^HL70063|1971 Nollumerland en Nieuwkruisland Pl^^Grand Rapids^MI^49508^USA^P|^PRN^PH^^^616^5315694ORC|RE||BK99A10055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK99A10055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4897-01^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4898-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N87O10063^^^AIRA-TEST^MR||RichardsonAIRA^AliyaAIRA^Ronan^^^^L|StonewallAIRA^AntionetteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1286 Veldhoven Ave^^Gagetown^MI^48735^USA^P||^PRN^PH^^^989^8462006|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichardsonAIRA^StonewallAIRA^^^^^L|MTH^Mother^HL70063|1286 Veldhoven Ave^^Gagetown^MI^48735^USA^P|^PRN^PH^^^989^8462006ORC|RE||BN87O10063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN87O10063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4898-00^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4898-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F08D10068^^^AIRA-TEST^MR||DahlAIRA^RoyaleAIRA^Consuela^^^^L|LincolnAIRA^MariolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1412 Tranekeradeel Cir^^Dutton^MI^49316^USA^P||^PRN^PH^^^616^7354540|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DahlAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1412 Tranekeradeel Cir^^Dutton^MI^49316^USA^P|^PRN^PH^^^616^7354540ORC|RE||BF08D10068.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF08D10068.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4898-01^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4943-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T30G10079^^^AIRA-TEST^MR||HuronAIRA^RonnyAIRA^Haimi^^^^L|DeweyAIRA^KamilaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1522 Hoevorden Cir^^Mears^MI^49436^USA^P||^PRN^PH^^^231^6376961|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HuronAIRA^DeweyAIRA^^^^^L|MTH^Mother^HL70063|1522 Hoevorden Cir^^Mears^MI^49436^USA^P|^PRN^PH^^^231^6376961ORC|RE||BT30G10079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT30G10079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4943-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4943-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K77S10087^^^AIRA-TEST^MR||OsbornAIRA^WenonahAIRA^Meena^^^^L|MooreAIRA^ReshmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1327 Sinkelland Ln^^Shelbyville^MI^49344^USA^P||^PRN^PH^^^269^8471038|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OsbornAIRA^MooreAIRA^^^^^L|MTH^Mother^HL70063|1327 Sinkelland Ln^^Shelbyville^MI^49344^USA^P|^PRN^PH^^^269^8471038ORC|RE||BK77S10087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK77S10087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4943-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4963-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F80D10095^^^AIRA-TEST^MR||MercerAIRA^RozellaAIRA^Ilene^^^^L|HenryAIRA^TyneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1969 Onze St^^Carp Lake^MI^49718^USA^P||^PRN^PH^^^616^4805539|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MercerAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1969 Onze St^^Carp Lake^MI^49718^USA^P|^PRN^PH^^^616^4805539ORC|RE||BF80D10095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF80D10095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4963-00^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4963-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E38Q10103^^^AIRA-TEST^MR||CameronAIRA^KanchanaAIRA^Drew^^^^L|MonoAIRA^SripadaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1530 Outphen Ave^^Traverse City^MI^49685^USA^P||^PRN^PH^^^231^4157980|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CameronAIRA^MonoAIRA^^^^^L|MTH^Mother^HL70063|1530 Outphen Ave^^Traverse City^MI^49685^USA^P|^PRN^PH^^^231^4157980ORC|RE||BE38Q10103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE38Q10103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4963-01^ZOSTAVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4963-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L89W10108^^^AIRA-TEST^MR||Van WertAIRA^AmeerahAIRA^Saraid^^^^L|LeelanauAIRA^SariaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1518 Vantumadiel Ave^^Rives Junction^MI^49277^USA^P||^PRN^PH^^^517^6204806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Van WertAIRA^LeelanauAIRA^^^^^L|MTH^Mother^HL70063|1518 Vantumadiel Ave^^Rives Junction^MI^49277^USA^P|^PRN^PH^^^517^6204806ORC|RE||BL89W10108.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL89W10108.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4963-41^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4980-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z96Z10119^^^AIRA-TEST^MR||BastropAIRA^ErikaAIRA^Christal^^^^L|McIntoshAIRA^EttaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1519 Oaalwijk St^^Vermontville^MI^49096^USA^P||^PRN^PH^^^517^9589777|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BastropAIRA^McIntoshAIRA^^^^^L|MTH^Mother^HL70063|1519 Oaalwijk St^^Vermontville^MI^49096^USA^P|^PRN^PH^^^517^9589777ORC|RE||BZ96Z10119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ96Z10119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4980-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4981-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A73T10127^^^AIRA-TEST^MR||LeonAIRA^MignonAIRA^Hanya^^^^L|ArcherAIRA^AnilaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1998 Dheden Cir^^Hamilton^MI^49419^USA^P||^PRN^PH^^^269^2489549|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeonAIRA^ArcherAIRA^^^^^L|MTH^Mother^HL70063|1998 Dheden Cir^^Hamilton^MI^49419^USA^P|^PRN^PH^^^269^2489549ORC|RE||BA73T10127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA73T10127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4981-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4981-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U93F10135^^^AIRA-TEST^MR||CroweAIRA^TeresaAIRA^Annika^^^^L|MakinAIRA^MikaylaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1891 Bholen Cir^^Mi Department of Revenue^MI^48922^USA^P||^PRN^PH^^^517^6874496|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CroweAIRA^MakinAIRA^^^^^L|MTH^Mother^HL70063|1891 Bholen Cir^^Mi Department of Revenue^MI^48922^USA^P|^PRN^PH^^^517^6874496ORC|RE||BU93F10135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU93F10135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4981-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4992-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H85F10143^^^AIRA-TEST^MR||AtascosaAIRA^RoseAIRA^Sunny^^^^L|ParkAIRA^CeliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1728 Bijefurd Ave^^GR^MI^49504^USA^P||^PRN^PH^^^616^2137368|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtascosaAIRA^ParkAIRA^^^^^L|MTH^Mother^HL70063|1728 Bijefurd Ave^^GR^MI^49504^USA^P|^PRN^PH^^^616^2137368ORC|RE||BH85F10143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH85F10143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4992-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4992-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M14E10148^^^AIRA-TEST^MR||GardenAIRA^AspenAIRA^Destinee^^^^L|KalkaskaAIRA^VittoriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1165 Eoudrichem Cir^^Farmington Hills^MI^48336^USA^P||^PRN^PH^^^248^2619756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GardenAIRA^KalkaskaAIRA^^^^^L|MTH^Mother^HL70063|1165 Eoudrichem Cir^^Farmington Hills^MI^48336^USA^P|^PRN^PH^^^248^2619756ORC|RE||BM14E10148.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM14E10148.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4992-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4995-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K06D10159^^^AIRA-TEST^MR||WascoAIRA^JoninaAIRA^Arya^^^^L|WheelerAIRA^MarianaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1067 Deemstede St^^Hillsdale^MI^49242^USA^P||^PRN^PH^^^517^3603861|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WascoAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1067 Deemstede St^^Hillsdale^MI^49242^USA^P|^PRN^PH^^^517^3603861ORC|RE||BK06D10159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK06D10159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4995-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4995-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P51T10167^^^AIRA-TEST^MR||AlleganAIRA^LeannaAIRA^Ushma^^^^L|EsceibreAIRA^AudoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1858 Veurne Ln^^Union^MI^49130^USA^P||^PRN^PH^^^269^9894094|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlleganAIRA^EsceibreAIRA^^^^^L|MTH^Mother^HL70063|1858 Veurne Ln^^Union^MI^49130^USA^P|^PRN^PH^^^269^9894094ORC|RE||BP51T10167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP51T10167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4995-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4995-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D85P10175^^^AIRA-TEST^MR||FranklinAIRA^LorelaiAIRA^Jimena^^^^L|HardinAIRA^MehitabelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1578 Teerijnen Ave^^Podunk^MI^48158^USA^P||^PRN^PH^^^734^4070769|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1578 Teerijnen Ave^^Podunk^MI^48158^USA^P|^PRN^PH^^^734^4070769ORC|RE||BD85P10175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD85P10175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4995-41^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4999-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G10T10183^^^AIRA-TEST^MR||MagriAIRA^DavinaAIRA^Concepcion^^^^L|ButlerAIRA^QuintaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1891 Hontferland Ln^^Hawks^MI^49743^USA^P||^PRN^PH^^^989^5973265|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MagriAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1891 Hontferland Ln^^Hawks^MI^49743^USA^P|^PRN^PH^^^989^5973265ORC|RE||BG10T10183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG10T10183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4999-00^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0006-4999-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z02G10188^^^AIRA-TEST^MR||BlackAIRA^JayaAIRA^Luciana^^^^L|BuschAIRA^AtarahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1977 Oosterhout St^^Brant^MI^48614^USA^P||^PRN^PH^^^989^5500980|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlackAIRA^BuschAIRA^^^^^L|MTH^Mother^HL70063|1977 Oosterhout St^^Brant^MI^48614^USA^P|^PRN^PH^^^989^5500980ORC|RE||BZ02G10188.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ02G10188.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0006-4999-01^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0052-0603-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C20J10199^^^AIRA-TEST^MR||ParkAIRA^AlonaAIRA^Swati^^^^L|GraysAIRA^SalviaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1006 Tevenaar Ln^^Oakland^MI^48363^USA^P||^PRN^PH^^^248^8440971|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ParkAIRA^GraysAIRA^^^^^L|MTH^Mother^HL70063|1006 Tevenaar Ln^^Oakland^MI^48363^USA^P|^PRN^PH^^^248^8440971ORC|RE||BC20J10199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC20J10199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0052-0603-01^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-0052-0603-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K36Z10207^^^AIRA-TEST^MR||PolkAIRA^BranwenAIRA^Zelda^^^^L|TurvoAIRA^AnastasiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1538 Driehoek St^^Standale^MI^49534^USA^P||^PRN^PH^^^616^3958598|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PolkAIRA^TurvoAIRA^^^^^L|MTH^Mother^HL70063|1538 Driehoek St^^Standale^MI^49534^USA^P|^PRN^PH^^^616^3958598ORC|RE||BK36Z10207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK36Z10207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||0052-0603-02^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-13533-131-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V69L10215^^^AIRA-TEST^MR||Saint ClairAIRA^MagnoliaAIRA^Jayda^^^^L|KingAIRA^RomildaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1248 Magneet Ln^^Grand Rapids^MI^49546^USA^P||^PRN^PH^^^616^7846596|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Saint ClairAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1248 Magneet Ln^^Grand Rapids^MI^49546^USA^P|^PRN^PH^^^616^7846596ORC|RE||BV69L10215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV69L10215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||13533-131-00^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-13533-131-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J04T10223^^^AIRA-TEST^MR||BlackAIRA^TeganAIRA^Kane^^^^L|San BenitoAIRA^ZotiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1085 Deze Pl^^Waterford^MI^48329^USA^P||^PRN^PH^^^248^9063621|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlackAIRA^San BenitoAIRA^^^^^L|MTH^Mother^HL70063|1085 Deze Pl^^Waterford^MI^48329^USA^P|^PRN^PH^^^248^9063621ORC|RE||BJ04T10223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ04T10223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||13533-131-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-13533013100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E25O10228^^^AIRA-TEST^MR||CanadianAIRA^KatyinAIRA^Cecilia^^^^L|HardinAIRA^MiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1988 Ctein Pl^^Lakeland^MI^48143^USA^P||^PRN^PH^^^810^7429324|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CanadianAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1988 Ctein Pl^^Lakeland^MI^48143^USA^P|^PRN^PH^^^810^7429324ORC|RE||BE25O10228.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE25O10228.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||13533013100^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-13533013101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y98O10239^^^AIRA-TEST^MR||OwsleyAIRA^SashiAIRA^Ursanne^^^^L|RockwallAIRA^YovelaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1237 Heerde Ave^^Somerset Center^MI^49282^USA^P||^PRN^PH^^^517^2324587|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwsleyAIRA^RockwallAIRA^^^^^L|MTH^Mother^HL70063|1237 Heerde Ave^^Somerset Center^MI^49282^USA^P|^PRN^PH^^^517^2324587ORC|RE||BY98O10239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY98O10239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||13533013101^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-14362-0111-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q64E10247^^^AIRA-TEST^MR||LycomingAIRA^AnchoretAIRA^Trixie^^^^L|WoodsAIRA^ClaiborneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1332 Nangedijk St^^Prattville^MI^49271^USA^P||^PRN^PH^^^517^2577454|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LycomingAIRA^WoodsAIRA^^^^^L|MTH^Mother^HL70063|1332 Nangedijk St^^Prattville^MI^49271^USA^P|^PRN^PH^^^517^2577454ORC|RE||BQ64E10247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ64E10247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||14362-0111-3^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-14362-0111-4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W30G10255^^^AIRA-TEST^MR||DomoAIRA^AparaAIRA^Makenzie^^^^L|DickAIRA^GabrielleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1621 Verhuizing Pl^^Bay City^MI^48706^USA^P||^PRN^PH^^^989^9902532|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DomoAIRA^DickAIRA^^^^^L|MTH^Mother^HL70063|1621 Verhuizing Pl^^Bay City^MI^48706^USA^P|^PRN^PH^^^989^9902532ORC|RE||BW30G10255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW30G10255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||14362-0111-4^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-14362011103|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K87I10263^^^AIRA-TEST^MR||JonesAIRA^HedvaAIRA^Suki^^^^L|CassAIRA^TehyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1475 Deststellingwerf Pl^^Good Hart^MI^49737^USA^P||^PRN^PH^^^616^9711259|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JonesAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1475 Deststellingwerf Pl^^Good Hart^MI^49737^USA^P|^PRN^PH^^^616^9711259ORC|RE||BK87I10263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK87I10263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||14362011103^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-14362011104|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y23O10268^^^AIRA-TEST^MR||TamaAIRA^MaitaneAIRA^Gerlinde^^^^L|FisherAIRA^EireenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1058 Reldermalsen St^^Fruitport^MI^49415^USA^P||^PRN^PH^^^231^7019479|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TamaAIRA^FisherAIRA^^^^^L|MTH^Mother^HL70063|1058 Reldermalsen St^^Fruitport^MI^49415^USA^P|^PRN^PH^^^231^7019479ORC|RE||BY23O10268.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY23O10268.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||14362011104^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-17478-131-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q34V10276^^^AIRA-TEST^MR||McKeanAIRA^CelestynAIRA^Sanaa^^^^L|LickingAIRA^IsolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1772 Veststellingwerf Ln^^Sagola^MI^49881^USA^P||^PRN^PH^^^906^8542390|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McKeanAIRA^LickingAIRA^^^^^L|MTH^Mother^HL70063|1772 Veststellingwerf Ln^^Sagola^MI^49881^USA^P|^PRN^PH^^^906^8542390ORC|RE||BQ34V10276.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ34V10276.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||17478-131-00^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-17478-131-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E32B10287^^^AIRA-TEST^MR||MaverickAIRA^TerriAIRA^Jetta^^^^L|McKeanAIRA^LorieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1471 Zoudrichem Ln^^Southeast^MI^48529^USA^P||^PRN^PH^^^810^8175019|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MaverickAIRA^McKeanAIRA^^^^^L|MTH^Mother^HL70063|1471 Zoudrichem Ln^^Southeast^MI^48529^USA^P|^PRN^PH^^^810^8175019ORC|RE||BE32B10287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE32B10287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||17478-131-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-17478013100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S01D10295^^^AIRA-TEST^MR||TexasAIRA^MicahAIRA^Anahid^^^^L|GosperAIRA^GwenhyvarAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1320 Voosendaal St^^Kinross^MI^49752^USA^P||^PRN^PH^^^906^8395316|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TexasAIRA^GosperAIRA^^^^^L|MTH^Mother^HL70063|1320 Voosendaal St^^Kinross^MI^49752^USA^P|^PRN^PH^^^906^8395316ORC|RE||BS01D10295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS01D10295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||17478013100^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-17478013101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B17U10303^^^AIRA-TEST^MR||LetcherAIRA^MarvelaAIRA^Fionn^^^^L|KananenAIRA^GwendolenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1198 Goerden St^^Bloomfield Hills^MI^48302^USA^P||^PRN^PH^^^248^9093101|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LetcherAIRA^KananenAIRA^^^^^L|MTH^Mother^HL70063|1198 Goerden St^^Bloomfield Hills^MI^48302^USA^P|^PRN^PH^^^248^9093101ORC|RE||BB17U10303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB17U10303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||17478013101^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-845-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U17A10308^^^AIRA-TEST^MR||ComancheAIRA^CailynAIRA^Prachi^^^^L|MuhlenbergAIRA^JenicaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1388 Uitgeest Cir^^Southfield^MI^48033^USA^P||^PRN^PH^^^248^9370090|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ComancheAIRA^MuhlenbergAIRA^^^^^L|MTH^Mother^HL70063|1388 Uitgeest Cir^^Southfield^MI^48033^USA^P|^PRN^PH^^^248^9370090ORC|RE||BU17A10308.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU17A10308.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-845-01^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-845-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I75T10319^^^AIRA-TEST^MR||KartwoldAIRA^MarneAIRA^Rachel^^^^L|BradyAIRA^QuinnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1170 Zodegraven-Reeuwijk Pl^^Rumely^MI^49826^USA^P||^PRN^PH^^^906^5587603|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KartwoldAIRA^BradyAIRA^^^^^L|MTH^Mother^HL70063|1170 Zodegraven-Reeuwijk Pl^^Rumely^MI^49826^USA^P|^PRN^PH^^^906^5587603ORC|RE||BI75T10319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI75T10319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-845-11^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-850-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L35W10327^^^AIRA-TEST^MR||Keya PahaAIRA^CynthiaAIRA^Eyota^^^^L|ClintonAIRA^SandraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1904 Nooit Ave^^Springfld Township^MI^48350^USA^P||^PRN^PH^^^248^8858359|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Keya PahaAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1904 Nooit Ave^^Springfld Township^MI^48350^USA^P|^PRN^PH^^^248^8858359ORC|RE||BL35W10327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL35W10327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-850-41^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-850-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C27W10335^^^AIRA-TEST^MR||OgemawAIRA^JarrahAIRA^Cherry^^^^L|ChambersAIRA^LilyannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1159 Vorger-Odoorn Cir^^Battle Creek^MI^49037^USA^P||^PRN^PH^^^269^8583260|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OgemawAIRA^ChambersAIRA^^^^^L|MTH^Mother^HL70063|1159 Vorger-Odoorn Cir^^Battle Creek^MI^49037^USA^P|^PRN^PH^^^269^8583260ORC|RE||BC27W10335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC27W10335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-850-52^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-889-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H30J10343^^^AIRA-TEST^MR||RossAIRA^CailinAIRA^Adeline^^^^L|CowlitzAIRA^NevadaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1667 Ka en Hunze St^^Bloomfield Hills^MI^48304^USA^P||^PRN^PH^^^248^8350682|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RossAIRA^CowlitzAIRA^^^^^L|MTH^Mother^HL70063|1667 Ka en Hunze St^^Bloomfield Hills^MI^48304^USA^P|^PRN^PH^^^248^8350682ORC|RE||BH30J10343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH30J10343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-889-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-889-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B74M10348^^^AIRA-TEST^MR||BarrenAIRA^ElmaAIRA^Riva^^^^L|LapeerAIRA^ElbertinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1895 Schouder Ave^^Cheboygan^MI^49721^USA^P||^PRN^PH^^^231^7105402|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarrenAIRA^LapeerAIRA^^^^^L|MTH^Mother^HL70063|1895 Schouder Ave^^Cheboygan^MI^49721^USA^P|^PRN^PH^^^231^7105402ORC|RE||BB74M10348.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB74M10348.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-889-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-890-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q83Z10359^^^AIRA-TEST^MR||ScottAIRA^JarviniaAIRA^Kerry^^^^L|RoseAIRA^SolveigAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1007 Kverbetuwe Ave^^Fostoria^MI^48435^USA^P||^PRN^PH^^^989^9764263|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ScottAIRA^RoseAIRA^^^^^L|MTH^Mother^HL70063|1007 Kverbetuwe Ave^^Fostoria^MI^48435^USA^P|^PRN^PH^^^989^9764263ORC|RE||BQ83Z10359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ83Z10359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-890-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-890-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O53S10367^^^AIRA-TEST^MR||PermanAIRA^MarianaAIRA^Gemma^^^^L|WheelerAIRA^MirrinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1105 Vrij St^^Alpha^MI^49902^USA^P||^PRN^PH^^^906^3345913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PermanAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1105 Vrij St^^Alpha^MI^49902^USA^P|^PRN^PH^^^906^3345913ORC|RE||BO53S10367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO53S10367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-890-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-891-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W77A10375^^^AIRA-TEST^MR||BreathittAIRA^ShantinaAIRA^Justice^^^^L|DanuelsonAIRA^ElinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1866 Lageningen Ave^^Detroit^MI^48223^USA^P||^PRN^PH^^^313^6174347|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BreathittAIRA^DanuelsonAIRA^^^^^L|MTH^Mother^HL70063|1866 Lageningen Ave^^Detroit^MI^48223^USA^P|^PRN^PH^^^313^6174347ORC|RE||BW77A10375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW77A10375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-891-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-891-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K09G10383^^^AIRA-TEST^MR||LetcherAIRA^SeverinaAIRA^Valborg^^^^L|HaysAIRA^WaratahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1690 Dier St^^Channing^MI^49815^USA^P||^PRN^PH^^^906^4694809|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LetcherAIRA^HaysAIRA^^^^^L|MTH^Mother^HL70063|1690 Dier St^^Channing^MI^49815^USA^P|^PRN^PH^^^906^4694809ORC|RE||BK09G10383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK09G10383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-891-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-893-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W20Y10388^^^AIRA-TEST^MR||CornelinsonAIRA^HisaAIRA^Jessie^^^^L|MuskogeeAIRA^MeiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1759 Moerdijk Ln^^Ortonville^MI^48462^USA^P||^PRN^PH^^^248^9727000|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CornelinsonAIRA^MuskogeeAIRA^^^^^L|MTH^Mother^HL70063|1759 Moerdijk Ln^^Ortonville^MI^48462^USA^P|^PRN^PH^^^248^9727000ORC|RE||BW20Y10388.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW20Y10388.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-893-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-893-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A09R10399^^^AIRA-TEST^MR||HancockAIRA^SybilAIRA^Suprabha^^^^L|MooreAIRA^ThordisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1729 Epeldoorn Cir^^Meskegon^MI^49442^USA^P||^PRN^PH^^^231^6091955|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^MooreAIRA^^^^^L|MTH^Mother^HL70063|1729 Epeldoorn Cir^^Meskegon^MI^49442^USA^P|^PRN^PH^^^231^6091955ORC|RE||BA09R10399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA09R10399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-893-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-894-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L58J10407^^^AIRA-TEST^MR||ClevelandAIRA^AdelphaAIRA^Nagihan^^^^L|DouglasAIRA^AbriendaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1248 Leel en Maas St^^Ishpeming^MI^49865^USA^P||^PRN^PH^^^906^7668747|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClevelandAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1248 Leel en Maas St^^Ishpeming^MI^49865^USA^P|^PRN^PH^^^906^7668747ORC|RE||BL58J10407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL58J10407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-894-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-894-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E02D10415^^^AIRA-TEST^MR||MontgomeryAIRA^AmenaAIRA^Zita^^^^L|OkmulgeeAIRA^DulceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1769 Ooensdrecht St^^Lennon^MI^48449^USA^P||^PRN^PH^^^989^5102988|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontgomeryAIRA^OkmulgeeAIRA^^^^^L|MTH^Mother^HL70063|1769 Ooensdrecht St^^Lennon^MI^48449^USA^P|^PRN^PH^^^989^5102988ORC|RE||BE02D10415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE02D10415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-894-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-895-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K60Q10423^^^AIRA-TEST^MR||BellAIRA^WynneAIRA^Laila^^^^L|MercerAIRA^NaiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1740 Lpsterland Cir^^Bannister^MI^48807^USA^P||^PRN^PH^^^989^2531993|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BellAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1740 Lpsterland Cir^^Bannister^MI^48807^USA^P|^PRN^PH^^^989^2531993ORC|RE||BK60Q10423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK60Q10423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-895-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-895-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P10N10428^^^AIRA-TEST^MR||SandersAIRA^MunaAIRA^Janiya^^^^L|CaseyAIRA^KatieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1249 Hoerdijk Ave^^Novi^MI^48375^USA^P||^PRN^PH^^^248^2566818|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SandersAIRA^CaseyAIRA^^^^^L|MTH^Mother^HL70063|1249 Hoerdijk Ave^^Novi^MI^48375^USA^P|^PRN^PH^^^248^2566818ORC|RE||BP10N10428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP10N10428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-895-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-896-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S81T10439^^^AIRA-TEST^MR||JeffersonAIRA^FlaviaAIRA^Somatra^^^^L|NorthumberlandAIRA^EvelinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1132 Rechtstreeks St^^Southeast^MI^48519^USA^P||^PRN^PH^^^810^5057398|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^NorthumberlandAIRA^^^^^L|MTH^Mother^HL70063|1132 Rechtstreeks St^^Southeast^MI^48519^USA^P|^PRN^PH^^^810^5057398ORC|RE||BS81T10439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS81T10439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-896-01^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-896-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B47U10447^^^AIRA-TEST^MR||ReillyAIRA^ArinyaAIRA^Lailie^^^^L|GarrardAIRA^FidelimaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1740 Jnderbanken Pl^^Painesdale^MI^49955^USA^P||^PRN^PH^^^906^3535445|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReillyAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1740 Jnderbanken Pl^^Painesdale^MI^49955^USA^P|^PRN^PH^^^906^3535445ORC|RE||BB47U10447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB47U10447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-896-11^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-898-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P74I10455^^^AIRA-TEST^MR||BaylorAIRA^BorgnyAIRA^Katelin^^^^L|BryanAIRA^SparrowAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1833 Terwerderadeel Ln^^Westwood^MI^49006^USA^P||^PRN^PH^^^269^6369655|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BaylorAIRA^BryanAIRA^^^^^L|MTH^Mother^HL70063|1833 Terwerderadeel Ln^^Westwood^MI^49006^USA^P|^PRN^PH^^^269^6369655ORC|RE||BP74I10455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP74I10455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-898-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-898-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M57P10463^^^AIRA-TEST^MR||McCullochAIRA^AnnamariaAIRA^Rachael^^^^L|CowlitzAIRA^EglantineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1083 Dden Ave^^Pleasant Ridge^MI^48069^USA^P||^PRN^PH^^^248^5101121|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCullochAIRA^CowlitzAIRA^^^^^L|MTH^Mother^HL70063|1083 Dden Ave^^Pleasant Ridge^MI^48069^USA^P|^PRN^PH^^^248^5101121ORC|RE||BM57P10463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM57P10463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-898-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-900-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L09G10468^^^AIRA-TEST^MR||RyanAIRA^IstasAIRA^Sumey^^^^L|BrooksAIRA^AnamikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1349 Den Haag Ave^^Pierport^MI^49614^USA^P||^PRN^PH^^^231^8975286|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RyanAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1349 Den Haag Ave^^Pierport^MI^49614^USA^P|^PRN^PH^^^231^8975286ORC|RE||BL09G10468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL09G10468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-900-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-900-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P51N10479^^^AIRA-TEST^MR||HarrisonAIRA^SophieAIRA^Caitrin^^^^L|FurnasAIRA^AriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1849 Voorst Pl^^Sault Sainte Marie^MI^49786^USA^P||^PRN^PH^^^906^6949997|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^FurnasAIRA^^^^^L|MTH^Mother^HL70063|1849 Voorst Pl^^Sault Sainte Marie^MI^49786^USA^P|^PRN^PH^^^906^6949997ORC|RE||BP51N10479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP51N10479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-900-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-901-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B20M10487^^^AIRA-TEST^MR||LincolnAIRA^MichelineAIRA^Leonora^^^^L|PhelpsAIRA^UlaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1199 Elektrische Pl^^Royal Oak Township^MI^48220^USA^P||^PRN^PH^^^248^8297055|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^PhelpsAIRA^^^^^L|MTH^Mother^HL70063|1199 Elektrische Pl^^Royal Oak Township^MI^48220^USA^P|^PRN^PH^^^248^8297055ORC|RE||BB20M10487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB20M10487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-901-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-901-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W75P10495^^^AIRA-TEST^MR||GrantAIRA^FabiolaAIRA^Acadia^^^^L|NewtonAIRA^GlynnisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1554 Bot Ave^^Scio^MI^48130^USA^P||^PRN^PH^^^734^3001848|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrantAIRA^NewtonAIRA^^^^^L|MTH^Mother^HL70063|1554 Bot Ave^^Scio^MI^48130^USA^P|^PRN^PH^^^734^3001848ORC|RE||BW75P10495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW75P10495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-901-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-903-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P68B10503^^^AIRA-TEST^MR||PintoAIRA^NeetaAIRA^Salimah^^^^L|SonomaAIRA^JulietAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1031 Cranendonck Cir^^Marenisco^MI^49947^USA^P||^PRN^PH^^^906^8133168|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PintoAIRA^SonomaAIRA^^^^^L|MTH^Mother^HL70063|1031 Cranendonck Cir^^Marenisco^MI^49947^USA^P|^PRN^PH^^^906^8133168ORC|RE||BP68B10503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP68B10503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-903-01^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-903-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S82S10508^^^AIRA-TEST^MR||McKinnonAIRA^JudithAIRA^Mala^^^^L|BannockAIRA^TansyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1160 Vollands Kroon Pl^^Manistee^MI^49660^USA^P||^PRN^PH^^^231^5742363|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McKinnonAIRA^BannockAIRA^^^^^L|MTH^Mother^HL70063|1160 Vollands Kroon Pl^^Manistee^MI^49660^USA^P|^PRN^PH^^^231^5742363ORC|RE||BS82S10508.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS82S10508.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-903-11^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-908-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J10L10516^^^AIRA-TEST^MR||JeffersonAIRA^TrilochanaAIRA^Alarice^^^^L|PowellAIRA^DeepikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1787 Loetinchem Pl^^Romulus^MI^48174^USA^P||^PRN^PH^^^734^2809441|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^PowellAIRA^^^^^L|MTH^Mother^HL70063|1787 Loetinchem Pl^^Romulus^MI^48174^USA^P|^PRN^PH^^^734^2809441ORC|RE||BJ10L10516.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ10L10516.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-908-41^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-908-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B53R10527^^^AIRA-TEST^MR||ErieAIRA^MaryamAIRA^Mollie^^^^L|BannerAIRA^KaiyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1307 Scht-Susteren St^^Detroit^MI^48227^USA^P||^PRN^PH^^^313^6412550|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ErieAIRA^BannerAIRA^^^^^L|MTH^Mother^HL70063|1307 Scht-Susteren St^^Detroit^MI^48227^USA^P|^PRN^PH^^^313^6412550ORC|RE||BB53R10527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB53R10527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-908-52^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-909-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A87K10535^^^AIRA-TEST^MR||GregoryAIRA^OrsolaAIRA^Caitrin^^^^L|EatonAIRA^JaelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1000 Euren Ave^^Essexville^MI^48732^USA^P||^PRN^PH^^^989^6970102|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GregoryAIRA^EatonAIRA^^^^^L|MTH^Mother^HL70063|1000 Euren Ave^^Essexville^MI^48732^USA^P|^PRN^PH^^^989^6970102ORC|RE||BA87K10535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA87K10535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-909-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-909-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C86X10543^^^AIRA-TEST^MR||MorganAIRA^KarleeAIRA^Evadine^^^^L|DixonAIRA^SavannahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1233 Pldebroek Ln^^Felch^MI^49831^USA^P||^PRN^PH^^^906^9207035|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorganAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1233 Pldebroek Ln^^Felch^MI^49831^USA^P|^PRN^PH^^^906^9207035ORC|RE||BC86X10543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC86X10543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-909-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-912-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q92B10548^^^AIRA-TEST^MR||TemplemanAIRA^GabiAIRA^Bryony^^^^L|GlasscockAIRA^ShrijaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1228 Ammen Ln^^Alpha^MI^49902^USA^P||^PRN^PH^^^906^8917060|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TemplemanAIRA^GlasscockAIRA^^^^^L|MTH^Mother^HL70063|1228 Ammen Ln^^Alpha^MI^49902^USA^P|^PRN^PH^^^906^8917060ORC|RE||BQ92B10548.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ92B10548.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-912-41^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515-912-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C94S10559^^^AIRA-TEST^MR||KearneyAIRA^DeeAIRA^Belita^^^^L|FranklinAIRA^AmaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1110 Tlagtwedde Pl^^Brampton^MI^49837^USA^P||^PRN^PH^^^906^4673807|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KearneyAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1110 Tlagtwedde Pl^^Brampton^MI^49837^USA^P|^PRN^PH^^^906^4673807ORC|RE||BC94S10559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC94S10559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515-912-52^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515084501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V22V10567^^^AIRA-TEST^MR||OwenAIRA^SmridhiAIRA^Marietta^^^^L|Des MoinesAIRA^DaniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1598 Dienen Cir^^Farmingtn Hls^MI^48332^USA^P||^PRN^PH^^^248^4774582|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwenAIRA^Des MoinesAIRA^^^^^L|MTH^Mother^HL70063|1598 Dienen Cir^^Farmingtn Hls^MI^48332^USA^P|^PRN^PH^^^248^4774582ORC|RE||BV22V10567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV22V10567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515084501^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515084511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q12I10575^^^AIRA-TEST^MR||IsabellaAIRA^LouellaAIRA^Lynna^^^^L|DurbinAIRA^GenevieveAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1401 Gevaar Ln^^Addison^MI^49220^USA^P||^PRN^PH^^^517^7617639|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IsabellaAIRA^DurbinAIRA^^^^^L|MTH^Mother^HL70063|1401 Gevaar Ln^^Addison^MI^49220^USA^P|^PRN^PH^^^517^7617639ORC|RE||BQ12I10575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ12I10575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515084511^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515085041|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N85Z10583^^^AIRA-TEST^MR||ShappeAIRA^OliveAIRA^Amber^^^^L|McCleanAIRA^VioletaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1918 Niets St^^Mc Millan^MI^49853^USA^P||^PRN^PH^^^906^7235752|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShappeAIRA^McCleanAIRA^^^^^L|MTH^Mother^HL70063|1918 Niets St^^Mc Millan^MI^49853^USA^P|^PRN^PH^^^906^7235752ORC|RE||BN85Z10583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN85Z10583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515085041^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515085052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E50X10588^^^AIRA-TEST^MR||BoydAIRA^NirvelliAIRA^Aparna^^^^L|MedinaAIRA^NoleneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1156 Mais Ln^^Leland^MI^49654^USA^P||^PRN^PH^^^231^6181787|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoydAIRA^MedinaAIRA^^^^^L|MTH^Mother^HL70063|1156 Mais Ln^^Leland^MI^49654^USA^P|^PRN^PH^^^231^6181787ORC|RE||BE50X10588.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE50X10588.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515085052^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515088902|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I15Q10599^^^AIRA-TEST^MR||ThiemerAIRA^ChanceAIRA^Sajni^^^^L|GreerAIRA^ZuzaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1682 Weinig Ln^^Crooked Lake^MI^48116^USA^P||^PRN^PH^^^810^8425225|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThiemerAIRA^GreerAIRA^^^^^L|MTH^Mother^HL70063|1682 Weinig Ln^^Crooked Lake^MI^48116^USA^P|^PRN^PH^^^810^8425225ORC|RE||BI15Q10599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI15Q10599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515088902^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515088907|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J01M10607^^^AIRA-TEST^MR||PeskenAIRA^OkalaniAIRA^Jeannette^^^^L|CambriaAIRA^ShardaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1848 Me Bilt St^^Mott Park^MI^48504^USA^P||^PRN^PH^^^810^2994210|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PeskenAIRA^CambriaAIRA^^^^^L|MTH^Mother^HL70063|1848 Me Bilt St^^Mott Park^MI^48504^USA^P|^PRN^PH^^^810^2994210ORC|RE||BJ01M10607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ01M10607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515088907^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C04A10615^^^AIRA-TEST^MR||InyoAIRA^RylanAIRA^Nellwyn^^^^L|SiouxAIRA^NaomiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1887 Loordenveld St^^Burton^MI^48519^USA^P||^PRN^PH^^^810^7405860|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|InyoAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1887 Loordenveld St^^Burton^MI^48519^USA^P|^PRN^PH^^^810^7405860ORC|RE||BC04A10615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC04A10615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089002^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089007|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X76J10623^^^AIRA-TEST^MR||CumberlandAIRA^CynthiaAIRA^Ebba^^^^L|ClearfieldAIRA^SoranoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1023 Dennep Cir^^Northville^MI^48167^USA^P||^PRN^PH^^^248^7239752|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumberlandAIRA^ClearfieldAIRA^^^^^L|MTH^Mother^HL70063|1023 Dennep Cir^^Northville^MI^48167^USA^P|^PRN^PH^^^248^7239752ORC|RE||BX76J10623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX76J10623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089007^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A45C10628^^^AIRA-TEST^MR||JonesAIRA^KaitlynnAIRA^Adeola^^^^L|GormanAIRA^CascadiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1532 Hlagtwedde St^^Lansing^MI^48910^USA^P||^PRN^PH^^^517^2322494|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JonesAIRA^GormanAIRA^^^^^L|MTH^Mother^HL70063|1532 Hlagtwedde St^^Lansing^MI^48910^USA^P|^PRN^PH^^^517^2322494ORC|RE||BA45C10628.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA45C10628.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089101^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R73U10639^^^AIRA-TEST^MR||AtokaAIRA^KajalAIRA^Azrael^^^^L|LawrenceAIRA^HineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1739 Dorger-Odoorn St^^Marshall^MI^49069^USA^P||^PRN^PH^^^269^4968879|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtokaAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1739 Dorger-Odoorn St^^Marshall^MI^49069^USA^P|^PRN^PH^^^269^4968879ORC|RE||BR73U10639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR73U10639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089111^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N22A10647^^^AIRA-TEST^MR||GlorinnAIRA^TrilbyAIRA^Kailyn^^^^L|PayneAIRA^MykalaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1739 Drnhem St^^GR^MI^49546^USA^P||^PRN^PH^^^616^8399462|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GlorinnAIRA^PayneAIRA^^^^^L|MTH^Mother^HL70063|1739 Drnhem St^^GR^MI^49546^USA^P|^PRN^PH^^^616^8399462ORC|RE||BN22A10647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN22A10647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089302^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089307|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R29B10655^^^AIRA-TEST^MR||KernAIRA^DelfinaAIRA^Haley^^^^L|IndianaAIRA^ZoleenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1476 Eorger-Odoorn Cir^^GR^MI^49528^USA^P||^PRN^PH^^^616^6262963|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KernAIRA^IndianaAIRA^^^^^L|MTH^Mother^HL70063|1476 Eorger-Odoorn Cir^^GR^MI^49528^USA^P|^PRN^PH^^^616^6262963ORC|RE||BR29B10655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR29B10655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089307^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089441|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X27G10663^^^AIRA-TEST^MR||RoachAIRA^ValimaiAIRA^Adar^^^^L|OsageAIRA^OuraniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1561 Baaksbergen St^^Hiawatha Temp Correction Fac^MI^49786^USA^P||^PRN^PH^^^906^6561080|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RoachAIRA^OsageAIRA^^^^^L|MTH^Mother^HL70063|1561 Baaksbergen St^^Hiawatha Temp Correction Fac^MI^49786^USA^P|^PRN^PH^^^906^6561080ORC|RE||BX27G10663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX27G10663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089441^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089452|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S65U10668^^^AIRA-TEST^MR||Pend OreilleAIRA^LeopoldaAIRA^Gauri^^^^L|BranchAIRA^FascienneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1159 Saaksbergen Pl^^Grosse Pointe Park^MI^48230^USA^P||^PRN^PH^^^313^2437661|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Pend OreilleAIRA^BranchAIRA^^^^^L|MTH^Mother^HL70063|1159 Saaksbergen Pl^^Grosse Pointe Park^MI^48230^USA^P|^PRN^PH^^^313^2437661ORC|RE||BS65U10668.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS65U10668.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089452^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S53B10679^^^AIRA-TEST^MR||GabrielsenAIRA^LouisaAIRA^Kaylee^^^^L|JuniataAIRA^CatavaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1379 Laren Cir^^Frenchtown^MI^48161^USA^P||^PRN^PH^^^734^8794559|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GabrielsenAIRA^JuniataAIRA^^^^^L|MTH^Mother^HL70063|1379 Laren Cir^^Frenchtown^MI^48161^USA^P|^PRN^PH^^^734^8794559ORC|RE||BS53B10679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS53B10679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089501^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H96L10687^^^AIRA-TEST^MR||HobellAIRA^BlancheAIRA^Lizzie^^^^L|PortageAIRA^ToralAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1942 Epe Pl^^Detroit^MI^48240^USA^P||^PRN^PH^^^313^5222866|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HobellAIRA^PortageAIRA^^^^^L|MTH^Mother^HL70063|1942 Epe Pl^^Detroit^MI^48240^USA^P|^PRN^PH^^^313^5222866ORC|RE||BH96L10687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH96L10687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089511^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P80K10695^^^AIRA-TEST^MR||NanceAIRA^MerriAIRA^Ayme^^^^L|HughesAIRA^JoleneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1333 Horne Ln^^Comins^MI^48619^USA^P||^PRN^PH^^^989^9732544|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NanceAIRA^HughesAIRA^^^^^L|MTH^Mother^HL70063|1333 Horne Ln^^Comins^MI^48619^USA^P|^PRN^PH^^^989^9732544ORC|RE||BP80K10695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP80K10695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089601^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C10L10703^^^AIRA-TEST^MR||LoveAIRA^ShaliniAIRA^Tiffany^^^^L|McKinnonAIRA^IgnatiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1464 Venlo Ave^^Jamestown^MI^49427^USA^P||^PRN^PH^^^616^3346350|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoveAIRA^McKinnonAIRA^^^^^L|MTH^Mother^HL70063|1464 Venlo Ave^^Jamestown^MI^49427^USA^P|^PRN^PH^^^616^3346350ORC|RE||BC10L10703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC10L10703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089611^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C63L10708^^^AIRA-TEST^MR||YubaAIRA^NettieAIRA^Lacey^^^^L|PerryAIRA^SharayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1849 Eeusden Pl^^GR^MI^49519^USA^P||^PRN^PH^^^616^2414750|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YubaAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1849 Eeusden Pl^^GR^MI^49519^USA^P|^PRN^PH^^^616^2414750ORC|RE||BC63L10708.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC63L10708.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089801^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515089811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S94D10716^^^AIRA-TEST^MR||KingAIRA^KaatjeAIRA^Gitanjali^^^^L|Walla WallaAIRA^NolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1746 Wrechterland Ave^^Howell^MI^48855^USA^P||^PRN^PH^^^517^4052633|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingAIRA^Walla WallaAIRA^^^^^L|MTH^Mother^HL70063|1746 Wrechterland Ave^^Howell^MI^48855^USA^P|^PRN^PH^^^517^4052633ORC|RE||BS94D10716.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS94D10716.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515089811^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F74P10727^^^AIRA-TEST^MR||LucasAIRA^JamesinaAIRA^Nerissa^^^^L|GustafsonAIRA^MatanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1293 Garneveld Cir^^Luce Township^MI^48118^USA^P||^PRN^PH^^^734^8960015|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LucasAIRA^GustafsonAIRA^^^^^L|MTH^Mother^HL70063|1293 Garneveld Cir^^Luce Township^MI^48118^USA^P|^PRN^PH^^^734^8960015ORC|RE||BF74P10727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF74P10727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090001^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D12D10735^^^AIRA-TEST^MR||BellAIRA^SubhadraAIRA^Mahina^^^^L|SpieccAIRA^MridulAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1103 Oestvoorne Ln^^Grandville^MI^49468^USA^P||^PRN^PH^^^616^4239156|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BellAIRA^SpieccAIRA^^^^^L|MTH^Mother^HL70063|1103 Oestvoorne Ln^^Grandville^MI^49468^USA^P|^PRN^PH^^^616^4239156ORC|RE||BD12D10735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD12D10735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090011^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H69Y10743^^^AIRA-TEST^MR||OxfordAIRA^HelgaAIRA^Melek^^^^L|PutnamAIRA^SherryAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1875 Zeventer Ln^^Clare^MI^48617^USA^P||^PRN^PH^^^989^7609741|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OxfordAIRA^PutnamAIRA^^^^^L|MTH^Mother^HL70063|1875 Zeventer Ln^^Clare^MI^48617^USA^P|^PRN^PH^^^989^7609741ORC|RE||BH69Y10743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH69Y10743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090141^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q48B10751^^^AIRA-TEST^MR||StallardAIRA^VaruniAIRA^Heloise^^^^L|MarionAIRA^KylaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1182 Staan Ln^^Commerce^MI^48382^USA^P||^PRN^PH^^^248^6459734|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StallardAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1182 Staan Ln^^Commerce^MI^48382^USA^P|^PRN^PH^^^248^6459734ORC|RE||BQ48B10751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ48B10751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090152^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J47Q10756^^^AIRA-TEST^MR||SmithAIRA^ChanahAIRA^Cherish^^^^L|PenobscotAIRA^BereniceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1124 Bchijndel Pl^^Cedar Springs^MI^49319^USA^P||^PRN^PH^^^616^6965250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SmithAIRA^PenobscotAIRA^^^^^L|MTH^Mother^HL70063|1124 Bchijndel Pl^^Cedar Springs^MI^49319^USA^P|^PRN^PH^^^616^6965250ORC|RE||BJ47Q10756.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ47Q10756.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090301^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E46O10767^^^AIRA-TEST^MR||LivingstonAIRA^DenaAIRA^Nova^^^^L|TetlowAIRA^IlanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1211 Doosendaal St^^Lenox Township^MI^48048^USA^P||^PRN^PH^^^586^2796379|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LivingstonAIRA^TetlowAIRA^^^^^L|MTH^Mother^HL70063|1211 Doosendaal St^^Lenox Township^MI^48048^USA^P|^PRN^PH^^^586^2796379ORC|RE||BE46O10767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE46O10767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090311^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090841|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K80G10775^^^AIRA-TEST^MR||ZavalaAIRA^AngelicaAIRA^Isleta^^^^L|HendersonAIRA^MimiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1090 Talkenburg aan de Geul Pl^^Grosse Pointe Park^MI^48224^USA^P||^PRN^PH^^^313^3738262|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ZavalaAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1090 Talkenburg aan de Geul Pl^^Grosse Pointe Park^MI^48224^USA^P|^PRN^PH^^^313^3738262ORC|RE||BK80G10775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK80G10775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090841^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090852|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q79X10783^^^AIRA-TEST^MR||JonesAIRA^CristyAIRA^Ylwa^^^^L|EmmetAIRA^AmorinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1958 Gissewaard Pl^^Clinton Township^MI^48035^USA^P||^PRN^PH^^^586^3910406|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JonesAIRA^EmmetAIRA^^^^^L|MTH^Mother^HL70063|1958 Gissewaard Pl^^Clinton Township^MI^48035^USA^P|^PRN^PH^^^586^3910406ORC|RE||BQ79X10783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ79X10783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090852^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090941|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H38V10791^^^AIRA-TEST^MR||LimestoneAIRA^LillianAIRA^Karlie^^^^L|LindblomAIRA^PennieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1090 Grootegast Pl^^Fargo^MI^48006^USA^P||^PRN^PH^^^810^4834736|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LimestoneAIRA^LindblomAIRA^^^^^L|MTH^Mother^HL70063|1090 Grootegast Pl^^Fargo^MI^48006^USA^P|^PRN^PH^^^810^4834736ORC|RE||BH38V10791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH38V10791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090941^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515090952|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G10M10796^^^AIRA-TEST^MR||KolarAIRA^HideAIRA^Cadence^^^^L|JoiceAIRA^DixieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1388 Toets Cir^^Lansing^MI^48912^USA^P||^PRN^PH^^^517^7660683|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KolarAIRA^JoiceAIRA^^^^^L|MTH^Mother^HL70063|1388 Toets Cir^^Lansing^MI^48912^USA^P|^PRN^PH^^^517^7660683ORC|RE||BG10M10796.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG10M10796.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515090952^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515091241|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N27Q10807^^^AIRA-TEST^MR||HooperAIRA^EmmaAIRA^Elmira^^^^L|RobertsAIRA^CynaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1143 Maalte Cir^^White Lake^MI^48383^USA^P||^PRN^PH^^^248^3643324|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HooperAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1143 Maalte Cir^^White Lake^MI^48383^USA^P|^PRN^PH^^^248^3643324ORC|RE||BN27Q10807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN27Q10807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515091241^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-19515091252|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D24R10815^^^AIRA-TEST^MR||SarpyAIRA^BelindaAIRA^Autumn^^^^L|CoconinoAIRA^NirvelliAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1497 Veel Ave^^Manitou Beach^MI^49253^USA^P||^PRN^PH^^^517^7930908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SarpyAIRA^CoconinoAIRA^^^^^L|MTH^Mother^HL70063|1497 Veel Ave^^Manitou Beach^MI^49253^USA^P|^PRN^PH^^^517^7930908ORC|RE||BD24R10815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD24R10815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||19515091252^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-21695-413-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U09F10823^^^AIRA-TEST^MR||MackinacAIRA^JaimieAIRA^Nathania^^^^L|MadisonAIRA^HelmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1139 Naarle-Nassau St^^Grand Rapids^MI^49507^USA^P||^PRN^PH^^^616^5655152|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MackinacAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1139 Naarle-Nassau St^^Grand Rapids^MI^49507^USA^P|^PRN^PH^^^616^5655152ORC|RE||BU09F10823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU09F10823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21695-413-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-21695041301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q64Q10831^^^AIRA-TEST^MR||RobinsonAIRA^KatyaAIRA^Ali^^^^L|ImperialAIRA^PragatiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1145 Mof van Twente St^^Grosse Pointe Park^MI^48215^USA^P||^PRN^PH^^^313^5627661|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobinsonAIRA^ImperialAIRA^^^^^L|MTH^Mother^HL70063|1145 Mof van Twente St^^Grosse Pointe Park^MI^48215^USA^P|^PRN^PH^^^313^5627661ORC|RE||BQ64Q10831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ64Q10831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21695041301^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-010-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U23S10836^^^AIRA-TEST^MR||RyanAIRA^CristinaAIRA^Karenza^^^^L|NapaAIRA^ChaneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1523 Eaaren Ln^^Okemos^MI^48805^USA^P||^PRN^PH^^^517^3428089|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RyanAIRA^NapaAIRA^^^^^L|MTH^Mother^HL70063|1523 Eaaren Ln^^Okemos^MI^48805^USA^P|^PRN^PH^^^517^3428089ORC|RE||BU23S10836.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU23S10836.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-010-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-013-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N98V10847^^^AIRA-TEST^MR||FarstanAIRA^UrsellAIRA^Dagna^^^^L|HancockAIRA^PennyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1973 Sergen Ln^^Bradley^MI^49311^USA^P||^PRN^PH^^^269^8173045|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FarstanAIRA^HancockAIRA^^^^^L|MTH^Mother^HL70063|1973 Sergen Ln^^Bradley^MI^49311^USA^P|^PRN^PH^^^269^8173045ORC|RE||BN98V10847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN98V10847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-013-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-013-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M24R10855^^^AIRA-TEST^MR||MalheurAIRA^AddisonAIRA^Ierne^^^^L|KinneyAIRA^AlenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1166 Toonhoogte St^^Port Sheldon^MI^49460^USA^P||^PRN^PH^^^616^5185777|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MalheurAIRA^KinneyAIRA^^^^^L|MTH^Mother^HL70063|1166 Toonhoogte St^^Port Sheldon^MI^49460^USA^P|^PRN^PH^^^616^5185777ORC|RE||BM24R10855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM24R10855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-013-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-014-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K81I10863^^^AIRA-TEST^MR||WaschingAIRA^MelanyAIRA^Kaiya^^^^L|BrazosAIRA^JesalAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1987 Laalre Ave^^Burlington^MI^49029^USA^P||^PRN^PH^^^517^6004205|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WaschingAIRA^BrazosAIRA^^^^^L|MTH^Mother^HL70063|1987 Laalre Ave^^Burlington^MI^49029^USA^P|^PRN^PH^^^517^6004205ORC|RE||BK81I10863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK81I10863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-014-01^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-014-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X27H10871^^^AIRA-TEST^MR||ButlerAIRA^PetulaAIRA^Emanuel^^^^L|CuyahogaAIRA^RochelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1647 Gaasdriel Ave^^New Troy^MI^49119^USA^P||^PRN^PH^^^269^8589968|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButlerAIRA^CuyahogaAIRA^^^^^L|MTH^Mother^HL70063|1647 Gaasdriel Ave^^New Troy^MI^49119^USA^P|^PRN^PH^^^269^8589968ORC|RE||BX27H10871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX27H10871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-014-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-015-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C35W10876^^^AIRA-TEST^MR||OlsonAIRA^ShawnnessyAIRA^Mertice^^^^L|KlebergAIRA^AnanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1576 Algemeen Ln^^Farmingtn Hls^MI^48331^USA^P||^PRN^PH^^^248^9723286|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OlsonAIRA^KlebergAIRA^^^^^L|MTH^Mother^HL70063|1576 Algemeen Ln^^Farmingtn Hls^MI^48331^USA^P|^PRN^PH^^^248^9723286ORC|RE||BC35W10876.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC35W10876.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-015-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-015-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X45C10887^^^AIRA-TEST^MR||SimmingsenAIRA^VivienneAIRA^Aspasia^^^^L|GreenleeAIRA^MayrahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1505 Groeien Pl^^Benzonia^MI^49616^USA^P||^PRN^PH^^^231^8391039|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SimmingsenAIRA^GreenleeAIRA^^^^^L|MTH^Mother^HL70063|1505 Groeien Pl^^Benzonia^MI^49616^USA^P|^PRN^PH^^^231^8391039ORC|RE||BX45C10887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX45C10887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-015-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-016-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P99F10895^^^AIRA-TEST^MR||WoodsAIRA^KaitlinAIRA^Yamileth^^^^L|ClayAIRA^DashaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1072 Harderwijk Pl^^Thompson^MI^49854^USA^P||^PRN^PH^^^906^4756724|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoodsAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1072 Harderwijk Pl^^Thompson^MI^49854^USA^P|^PRN^PH^^^906^4756724ORC|RE||BP99F10895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP99F10895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-016-01^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-016-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D31S10903^^^AIRA-TEST^MR||ThorneAIRA^HanyaAIRA^Lucie^^^^L|MartinsonAIRA^AliviaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1256 Naar beneden Cir^^Walhalla^MI^49458^USA^P||^PRN^PH^^^231^2997975|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThorneAIRA^MartinsonAIRA^^^^^L|MTH^Mother^HL70063|1256 Naar beneden Cir^^Walhalla^MI^49458^USA^P|^PRN^PH^^^231^2997975ORC|RE||BD31S10903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD31S10903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-016-02^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-017-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U51D10911^^^AIRA-TEST^MR||RyanAIRA^YoshikoAIRA^Mitsuko^^^^L|WaldoAIRA^JamilaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1631 Aeeuwarden St^^Detroit^MI^48232^USA^P||^PRN^PH^^^313^6340248|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RyanAIRA^WaldoAIRA^^^^^L|MTH^Mother^HL70063|1631 Aeeuwarden St^^Detroit^MI^48232^USA^P|^PRN^PH^^^313^6340248ORC|RE||BU51D10911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU51D10911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-017-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-017-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S60R10916^^^AIRA-TEST^MR||GreenleeAIRA^BindaAIRA^Herta^^^^L|CowleAIRA^SiddhiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1110 Vader Cir^^Grosse Pointe^MI^48215^USA^P||^PRN^PH^^^313^3500093|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenleeAIRA^CowleAIRA^^^^^L|MTH^Mother^HL70063|1110 Vader Cir^^Grosse Pointe^MI^48215^USA^P|^PRN^PH^^^313^3500093ORC|RE||BS60R10916.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS60R10916.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-017-02^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-018-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W78N10927^^^AIRA-TEST^MR||WoldAIRA^KaimiAIRA^Opal^^^^L|ValleyAIRA^JayleeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1608 Helft Ln^^Cutlerville^MI^49548^USA^P||^PRN^PH^^^616^6263824|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoldAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1608 Helft Ln^^Cutlerville^MI^49548^USA^P|^PRN^PH^^^616^6263824ORC|RE||BW78N10927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW78N10927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-018-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-018-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G18H10935^^^AIRA-TEST^MR||McLeanAIRA^WyunaAIRA^Ameerah^^^^L|GilespieAIRA^KanushiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1733 Oeerenveen St^^Gm Service Parts Operations^MI^48554^USA^P||^PRN^PH^^^810^9353224|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McLeanAIRA^GilespieAIRA^^^^^L|MTH^Mother^HL70063|1733 Oeerenveen St^^Gm Service Parts Operations^MI^48554^USA^P|^PRN^PH^^^810^9353224ORC|RE||BG18H10935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG18H10935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-018-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-110-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G60F10943^^^AIRA-TEST^MR||MidlandAIRA^LizbethAIRA^Kirima^^^^L|GlennAIRA^NgaioAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1339 Waarnemen Ave^^Russell Island^MI^48001^USA^P||^PRN^PH^^^810^4985959|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MidlandAIRA^GlennAIRA^^^^^L|MTH^Mother^HL70063|1339 Waarnemen Ave^^Russell Island^MI^48001^USA^P|^PRN^PH^^^810^4985959ORC|RE||BG60F10943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG60F10943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-110-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-113-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D58T10951^^^AIRA-TEST^MR||RoscommonAIRA^AshleyAIRA^Anahi^^^^L|Le FloreAIRA^QueenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1089 Kden St^^Secretary of State^MI^48918^USA^P||^PRN^PH^^^517^3457668|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RoscommonAIRA^Le FloreAIRA^^^^^L|MTH^Mother^HL70063|1089 Kden St^^Secretary of State^MI^48918^USA^P|^PRN^PH^^^517^3457668ORC|RE||BD58T10951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD58T10951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-113-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-113-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U04I10956^^^AIRA-TEST^MR||ShortAIRA^AideenAIRA^Nolene^^^^L|CherokeeAIRA^SerenityAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1750 Epe Ln^^Kalamazoo^MI^49048^USA^P||^PRN^PH^^^269^3686312|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShortAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1750 Epe Ln^^Kalamazoo^MI^49048^USA^P|^PRN^PH^^^269^3686312ORC|RE||BU04I10956.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU04I10956.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-113-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-114-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z54S10964^^^AIRA-TEST^MR||ValleyAIRA^TaniaAIRA^Roselani^^^^L|ChampaignAIRA^KaitlinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1835 Win Pl^^Saginaw^MI^48607^USA^P||^PRN^PH^^^989^4908995|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ValleyAIRA^ChampaignAIRA^^^^^L|MTH^Mother^HL70063|1835 Win Pl^^Saginaw^MI^48607^USA^P|^PRN^PH^^^989^4908995ORC|RE||BZ54S10964.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ54S10964.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-114-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-114-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P01J10975^^^AIRA-TEST^MR||ClermontAIRA^ShrijaniAIRA^Lillian^^^^L|Presque IsleAIRA^LeslyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1859 Booise Meren Pl^^Mio^MI^48647^USA^P||^PRN^PH^^^989^7069997|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClermontAIRA^Presque IsleAIRA^^^^^L|MTH^Mother^HL70063|1859 Booise Meren Pl^^Mio^MI^48647^USA^P|^PRN^PH^^^989^7069997ORC|RE||BP01J10975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP01J10975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-114-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-115-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M75D10983^^^AIRA-TEST^MR||DallasAIRA^PerlinaAIRA^Ashira^^^^L|ByrneAIRA^JaimieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1425 Mook en Middelaar Cir^^Grosse Pointe Farms^MI^48236^USA^P||^PRN^PH^^^313^7031451|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DallasAIRA^ByrneAIRA^^^^^L|MTH^Mother^HL70063|1425 Mook en Middelaar Cir^^Grosse Pointe Farms^MI^48236^USA^P|^PRN^PH^^^313^7031451ORC|RE||BM75D10983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM75D10983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-115-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-115-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T19U10991^^^AIRA-TEST^MR||AndroscogginAIRA^IdeliaAIRA^Mayuri^^^^L|KlamathAIRA^IantheAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1160 Wergen Cir^^Farmington Hills^MI^48331^USA^P||^PRN^PH^^^248^8821536|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndroscogginAIRA^KlamathAIRA^^^^^L|MTH^Mother^HL70063|1160 Wergen Cir^^Farmington Hills^MI^48331^USA^P|^PRN^PH^^^248^8821536ORC|RE||BT19U10991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT19U10991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-115-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-116-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V16R10999^^^AIRA-TEST^MR||HolingsonAIRA^AldaraAIRA^Jaelyn^^^^L|VenangoAIRA^InasAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1671 Grootegast Ave^^Rapid City^MI^49676^USA^P||^PRN^PH^^^231^4925419|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HolingsonAIRA^VenangoAIRA^^^^^L|MTH^Mother^HL70063|1671 Grootegast Ave^^Rapid City^MI^49676^USA^P|^PRN^PH^^^231^4925419ORC|RE||BV16R10999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV16R10999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-116-10^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-116-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T69B11007^^^AIRA-TEST^MR||FagenAIRA^CarlaAIRA^Bette^^^^L|CarbonAIRA^MariahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1975 Ge Wolden Pl^^Port Sheldon^MI^49460^USA^P||^PRN^PH^^^616^9427103|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FagenAIRA^CarbonAIRA^^^^^L|MTH^Mother^HL70063|1975 Ge Wolden Pl^^Port Sheldon^MI^49460^USA^P|^PRN^PH^^^616^9427103ORC|RE||BT69B11007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT69B11007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-116-11^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y44R11012^^^AIRA-TEST^MR||LawrenceAIRA^KamboAIRA^Tenzing^^^^L|HardingAIRA^ShrideviAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1958 Klochteren Ave^^Adrian^MI^49221^USA^P||^PRN^PH^^^517^9331436|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LawrenceAIRA^HardingAIRA^^^^^L|MTH^Mother^HL70063|1958 Klochteren Ave^^Adrian^MI^49221^USA^P|^PRN^PH^^^517^9331436ORC|RE||BY44R11012.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY44R11012.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-117-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-117-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X25F11020^^^AIRA-TEST^MR||ChristianAIRA^PosyAIRA^Luana^^^^L|MartinAIRA^KesiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1714 Weg Pl^^Elm Hall^MI^48830^USA^P||^PRN^PH^^^989^9028528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChristianAIRA^MartinAIRA^^^^^L|MTH^Mother^HL70063|1714 Weg Pl^^Elm Hall^MI^48830^USA^P|^PRN^PH^^^989^9028528ORC|RE||BX25F11020.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX25F11020.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-117-11^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-118-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L28C11031^^^AIRA-TEST^MR||ParkesAIRA^AdeolaAIRA^Lorelai^^^^L|KinnearAIRA^TimotheaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1809 Aoerdijk Cir^^Buick City^MI^48550^USA^P||^PRN^PH^^^810^5343747|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ParkesAIRA^KinnearAIRA^^^^^L|MTH^Mother^HL70063|1809 Aoerdijk Cir^^Buick City^MI^48550^USA^P|^PRN^PH^^^810^5343747ORC|RE||BL28C11031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL28C11031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-118-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-118-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q34H11039^^^AIRA-TEST^MR||HenryAIRA^NimahAIRA^Kordelia^^^^L|GreenlandAIRA^WynfledAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1607 Sundert St^^Hazel Park^MI^48030^USA^P||^PRN^PH^^^248^4066250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HenryAIRA^GreenlandAIRA^^^^^L|MTH^Mother^HL70063|1607 Sundert St^^Hazel Park^MI^48030^USA^P|^PRN^PH^^^248^4066250ORC|RE||BQ34H11039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ34H11039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-118-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-316-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M10L11047^^^AIRA-TEST^MR||WilssonAIRA^LailieAIRA^Esther^^^^L|PettersonAIRA^IshanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1383 Einsum Ln^^Belding^MI^48887^USA^P||^PRN^PH^^^616^9754991|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilssonAIRA^PettersonAIRA^^^^^L|MTH^Mother^HL70063|1383 Einsum Ln^^Belding^MI^48887^USA^P|^PRN^PH^^^616^9754991ORC|RE||BM10L11047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM10L11047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-316-01^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-316-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U05T11055^^^AIRA-TEST^MR||HitchcockAIRA^AlexaAIRA^Alejandra^^^^L|SnowAIRA^MadhulikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1856 Enschede St^^Marcellus^MI^49067^USA^P||^PRN^PH^^^269^4162704|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HitchcockAIRA^SnowAIRA^^^^^L|MTH^Mother^HL70063|1856 Enschede St^^Marcellus^MI^49067^USA^P|^PRN^PH^^^269^4162704ORC|RE||BU05T11055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU05T11055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-316-02^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-317-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M76F11063^^^AIRA-TEST^MR||CalhounAIRA^AdoniaAIRA^Morgan^^^^L|WhitmanAIRA^TakakoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1973 Nellevoetsluis Ln^^Baroda^MI^49101^USA^P||^PRN^PH^^^269^3201911|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalhounAIRA^WhitmanAIRA^^^^^L|MTH^Mother^HL70063|1973 Nellevoetsluis Ln^^Baroda^MI^49101^USA^P|^PRN^PH^^^269^3201911ORC|RE||BM76F11063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM76F11063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-317-01^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-317-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E34I11068^^^AIRA-TEST^MR||TaylorAIRA^SavanahAIRA^Juhi^^^^L|HarneyAIRA^AmenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1921 Lopen Cir^^Hermansville^MI^49847^USA^P||^PRN^PH^^^906^7364778|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^HarneyAIRA^^^^^L|MTH^Mother^HL70063|1921 Lopen Cir^^Hermansville^MI^49847^USA^P|^PRN^PH^^^906^7364778ORC|RE||BE34I11068.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE34I11068.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-317-02^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-318-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N07N11079^^^AIRA-TEST^MR||IsdalAIRA^MellieAIRA^Nurhan^^^^L|LaRueAIRA^ManhattanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1634 Lint Anthonis St^^Brownstwn Township^MI^48134^USA^P||^PRN^PH^^^734^3826042|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IsdalAIRA^LaRueAIRA^^^^^L|MTH^Mother^HL70063|1634 Lint Anthonis St^^Brownstwn Township^MI^48134^USA^P|^PRN^PH^^^734^3826042ORC|RE||BN07N11079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN07N11079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-318-01^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-318-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A29M11087^^^AIRA-TEST^MR||FremontAIRA^AverahAIRA^Parul^^^^L|CumberlandAIRA^LariAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1164 Ainsum Cir^^Gaylord^MI^49735^USA^P||^PRN^PH^^^989^7439793|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FremontAIRA^CumberlandAIRA^^^^^L|MTH^Mother^HL70063|1164 Ainsum Cir^^Gaylord^MI^49735^USA^P|^PRN^PH^^^989^7439793ORC|RE||BA29M11087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA29M11087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-318-02^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-416-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S33Y11095^^^AIRA-TEST^MR||BurlesonAIRA^KagamiAIRA^Gajendra^^^^L|HuntingdonAIRA^RosarioAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1444 Silburg Ave^^Manistique^MI^49854^USA^P||^PRN^PH^^^906^8425118|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BurlesonAIRA^HuntingdonAIRA^^^^^L|MTH^Mother^HL70063|1444 Silburg Ave^^Manistique^MI^49854^USA^P|^PRN^PH^^^906^8425118ORC|RE||BS33Y11095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS33Y11095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-416-10^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-416-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L22X11103^^^AIRA-TEST^MR||BreckinridgeAIRA^RozAIRA^Frances^^^^L|NewportAIRA^WinnieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1404 Lrechterland Ave^^Nadeau^MI^49863^USA^P||^PRN^PH^^^906^7561057|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BreckinridgeAIRA^NewportAIRA^^^^^L|MTH^Mother^HL70063|1404 Lrechterland Ave^^Nadeau^MI^49863^USA^P|^PRN^PH^^^906^7561057ORC|RE||BL22X11103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL22X11103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-416-11^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-417-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X53L11108^^^AIRA-TEST^MR||PenistonAIRA^KaliAIRA^Freyde^^^^L|WilliamsAIRA^KaiyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1696 Fe Fryske Marren St^^Cedar Springs^MI^49319^USA^P||^PRN^PH^^^616^5413980|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PenistonAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1696 Fe Fryske Marren St^^Cedar Springs^MI^49319^USA^P|^PRN^PH^^^616^5413980ORC|RE||BX53L11108.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX53L11108.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-417-10^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-417-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K63B11119^^^AIRA-TEST^MR||DawsonAIRA^MaliAIRA^Arezou^^^^L|MaloneAIRA^VanditaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1511 Kennisgeving Ln^^Sumpter Township^MI^48111^USA^P||^PRN^PH^^^734^8714130|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DawsonAIRA^MaloneAIRA^^^^^L|MTH^Mother^HL70063|1511 Kennisgeving Ln^^Sumpter Township^MI^48111^USA^P|^PRN^PH^^^734^8714130ORC|RE||BK63B11119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK63B11119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-417-11^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M58T11127^^^AIRA-TEST^MR||LakeAIRA^KeikoAIRA^Verda^^^^L|ComalAIRA^RichelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1191 Valburg Pl^^Branch^MI^49402^USA^P||^PRN^PH^^^231^4371059|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LakeAIRA^ComalAIRA^^^^^L|MTH^Mother^HL70063|1191 Valburg Pl^^Branch^MI^49402^USA^P|^PRN^PH^^^231^4371059ORC|RE||BM58T11127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM58T11127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-418-10^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-418-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I82S11135^^^AIRA-TEST^MR||PlacerAIRA^SalomeAIRA^Kaley^^^^L|HarrisonAIRA^JardenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1874 Bruin Ave^^Midland^MI^48642^USA^P||^PRN^PH^^^989^5469112|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PlacerAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1874 Bruin Ave^^Midland^MI^48642^USA^P|^PRN^PH^^^989^5469112ORC|RE||BI82S11135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI82S11135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-418-11^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-519-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W96G11143^^^AIRA-TEST^MR||LenaweeAIRA^SanyogitaAIRA^Kai^^^^L|PlacerAIRA^RenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1832 Lucht Pl^^Millington^MI^48746^USA^P||^PRN^PH^^^989^9803029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LenaweeAIRA^PlacerAIRA^^^^^L|MTH^Mother^HL70063|1832 Lucht Pl^^Millington^MI^48746^USA^P|^PRN^PH^^^989^9803029ORC|RE||BW96G11143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW96G11143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-519-01^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-519-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N40Y11148^^^AIRA-TEST^MR||JernneAIRA^AdelinaAIRA^Madalyn^^^^L|MillsAIRA^AlexandraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1009 Oooise Meren Ave^^Essexville^MI^48732^USA^P||^PRN^PH^^^989^3118901|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JernneAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1009 Oooise Meren Ave^^Essexville^MI^48732^USA^P|^PRN^PH^^^989^3118901ORC|RE||BN40Y11148.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN40Y11148.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-519-25^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332-629-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M68J11159^^^AIRA-TEST^MR||InghamAIRA^HertaAIRA^Natalya^^^^L|Van BurenAIRA^MenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1399 Pldebroek St^^Farmington Hls^MI^48331^USA^P||^PRN^PH^^^248^5223122|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|InghamAIRA^Van BurenAIRA^^^^^L|MTH^Mother^HL70063|1399 Pldebroek St^^Farmington Hls^MI^48331^USA^P|^PRN^PH^^^248^5223122ORC|RE||BM68J11159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM68J11159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332-629-10^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P65L11167^^^AIRA-TEST^MR||FloydAIRA^AntonieAIRA^Hope^^^^L|GillespieAIRA^ZeldaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1914 Biel St^^Greenbush^MI^48738^USA^P||^PRN^PH^^^989^8993702|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FloydAIRA^GillespieAIRA^^^^^L|MTH^Mother^HL70063|1914 Biel St^^Greenbush^MI^48738^USA^P|^PRN^PH^^^989^8993702ORC|RE||BP65L11167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP65L11167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001001^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q11Y11175^^^AIRA-TEST^MR||GemAIRA^BeverleyAIRA^Firaki^^^^L|AudubonAIRA^LaraineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1768 Ralfsen Cir^^Skanee^MI^49962^USA^P||^PRN^PH^^^906^8015377|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GemAIRA^AudubonAIRA^^^^^L|MTH^Mother^HL70063|1768 Ralfsen Cir^^Skanee^MI^49962^USA^P|^PRN^PH^^^906^8015377ORC|RE||BQ11Y11175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ11Y11175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001301^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R27L11183^^^AIRA-TEST^MR||WashingtonAIRA^AngeliqueAIRA^Katina^^^^L|HancockAIRA^AdelaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1838 Salkenswaard St^^Rankin^MI^48473^USA^P||^PRN^PH^^^810^4079913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^HancockAIRA^^^^^L|MTH^Mother^HL70063|1838 Salkenswaard St^^Rankin^MI^48473^USA^P|^PRN^PH^^^810^4079913ORC|RE||BR27L11183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR27L11183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001302^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B86A11188^^^AIRA-TEST^MR||SiouxAIRA^KarlyAIRA^Marcia^^^^L|ShermanAIRA^KaliAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1992 Ee Marne Pl^^Mullett Lake^MI^49761^USA^P||^PRN^PH^^^231^3882892|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiouxAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1992 Ee Marne Pl^^Mullett Lake^MI^49761^USA^P|^PRN^PH^^^231^3882892ORC|RE||BB86A11188.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB86A11188.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001401^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W49F11199^^^AIRA-TEST^MR||TetlowAIRA^AmaraAIRA^Kaleigh^^^^L|PecosAIRA^AlysonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1681 Aingewaal St^^Grayling^MI^49738^USA^P||^PRN^PH^^^989^4880698|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TetlowAIRA^PecosAIRA^^^^^L|MTH^Mother^HL70063|1681 Aingewaal St^^Grayling^MI^49738^USA^P|^PRN^PH^^^989^4880698ORC|RE||BW49F11199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW49F11199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001402^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I29Z11207^^^AIRA-TEST^MR||HeffordAIRA^SamaraAIRA^Ciar^^^^L|AnderssonAIRA^MaiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1292 Moxmeer Pl^^Walhalla^MI^49458^USA^P||^PRN^PH^^^231^2525507|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HeffordAIRA^AnderssonAIRA^^^^^L|MTH^Mother^HL70063|1292 Moxmeer Pl^^Walhalla^MI^49458^USA^P|^PRN^PH^^^231^2525507ORC|RE||BI29Z11207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI29Z11207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001501^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001502|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D57D11215^^^AIRA-TEST^MR||JessamineAIRA^AspasiaAIRA^Lillian^^^^L|CorrinAIRA^MahoganyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1654 Gedemblik Ave^^Croton^MI^49337^USA^P||^PRN^PH^^^231^5135826|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JessamineAIRA^CorrinAIRA^^^^^L|MTH^Mother^HL70063|1654 Gedemblik Ave^^Croton^MI^49337^USA^P|^PRN^PH^^^231^5135826ORC|RE||BD57D11215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD57D11215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001502^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B05H11223^^^AIRA-TEST^MR||NelsonAIRA^LorraeAIRA^Kezia^^^^L|O NeillAIRA^SnehaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1396 Kestvoorne Ln^^Detroit^MI^48275^USA^P||^PRN^PH^^^313^3196357|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NelsonAIRA^O NeillAIRA^^^^^L|MTH^Mother^HL70063|1396 Kestvoorne Ln^^Detroit^MI^48275^USA^P|^PRN^PH^^^313^3196357ORC|RE||BB05H11223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB05H11223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001601^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K78Q11228^^^AIRA-TEST^MR||BrikkeAIRA^BashaAIRA^Mathea^^^^L|San BernardinoAIRA^RomaineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1179 Dwenterand Cir^^Northville^MI^48168^USA^P||^PRN^PH^^^248^4532213|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrikkeAIRA^San BernardinoAIRA^^^^^L|MTH^Mother^HL70063|1179 Dwenterand Cir^^Northville^MI^48168^USA^P|^PRN^PH^^^248^4532213ORC|RE||BK78Q11228.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK78Q11228.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001602^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I61P11239^^^AIRA-TEST^MR||OtterstromAIRA^VashtiAIRA^Lowan^^^^L|OlsonAIRA^CarinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1248 Aollumerland en Nieuwkruisland Ave^^Bay City^MI^48707^USA^P||^PRN^PH^^^989^5273491|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OtterstromAIRA^OlsonAIRA^^^^^L|MTH^Mother^HL70063|1248 Aollumerland en Nieuwkruisland Ave^^Bay City^MI^48707^USA^P|^PRN^PH^^^989^5273491ORC|RE||BI61P11239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI61P11239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001701^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F15O11247^^^AIRA-TEST^MR||DodgeAIRA^CherAIRA^Danniell^^^^L|Santa CruzAIRA^KatyayaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1394 Vwenterand Cir^^East China Township^MI^48054^USA^P||^PRN^PH^^^810^7642319|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DodgeAIRA^Santa CruzAIRA^^^^^L|MTH^Mother^HL70063|1394 Vwenterand Cir^^East China Township^MI^48054^USA^P|^PRN^PH^^^810^7642319ORC|RE||BF15O11247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF15O11247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001702^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S15F11255^^^AIRA-TEST^MR||CochiseAIRA^PamelaAIRA^Valentina^^^^L|DavisAIRA^DamarisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1235 Eenzame Ln^^Port Sanilac^MI^48469^USA^P||^PRN^PH^^^810^4762930|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CochiseAIRA^DavisAIRA^^^^^L|MTH^Mother^HL70063|1235 Eenzame Ln^^Port Sanilac^MI^48469^USA^P|^PRN^PH^^^810^4762930ORC|RE||BS15F11255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS15F11255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001801^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332001802|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z62G11263^^^AIRA-TEST^MR||JauppiAIRA^AbagailAIRA^Olesia^^^^L|ChampaignAIRA^OrioleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1609 Bijfheerenlanden Pl^^Canton^MI^48188^USA^P||^PRN^PH^^^734^9089131|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JauppiAIRA^ChampaignAIRA^^^^^L|MTH^Mother^HL70063|1609 Bijfheerenlanden Pl^^Canton^MI^48188^USA^P|^PRN^PH^^^734^9089131ORC|RE||BZ62G11263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ62G11263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332001802^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H23H11268^^^AIRA-TEST^MR||CoosAIRA^FidelaAIRA^Zahra^^^^L|HardinAIRA^DakotaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1308 Dorsele Pl^^Mi Department of Revenue^MI^48929^USA^P||^PRN^PH^^^517^2608412|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoosAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1308 Dorsele Pl^^Mi Department of Revenue^MI^48929^USA^P|^PRN^PH^^^517^2608412ORC|RE||BH23H11268.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH23H11268.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011010^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N01R11279^^^AIRA-TEST^MR||GeaugaAIRA^LinneaAIRA^Hadiya^^^^L|ClintonAIRA^AmesAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1458 Beldrop St^^Howell^MI^48863^USA^P||^PRN^PH^^^517^2264646|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GeaugaAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1458 Beldrop St^^Howell^MI^48863^USA^P|^PRN^PH^^^517^2264646ORC|RE||BN01R11279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN01R11279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011310^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K82W11287^^^AIRA-TEST^MR||GilliamAIRA^RosalynAIRA^Devorah^^^^L|CreaserAIRA^KoorineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1942 Eerder Pl^^Plymouth^MI^48170^USA^P||^PRN^PH^^^734^7083264|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GilliamAIRA^CreaserAIRA^^^^^L|MTH^Mother^HL70063|1942 Eerder Pl^^Plymouth^MI^48170^USA^P|^PRN^PH^^^734^7083264ORC|RE||BK82W11287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK82W11287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011311^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U22I11295^^^AIRA-TEST^MR||NewaygoAIRA^WendiAIRA^Ainsley^^^^L|FultonAIRA^HilzarieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1375 Weeuwarden Cir^^Meskegon^MI^49441^USA^P||^PRN^PH^^^231^3718105|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NewaygoAIRA^FultonAIRA^^^^^L|MTH^Mother^HL70063|1375 Weeuwarden Cir^^Meskegon^MI^49441^USA^P|^PRN^PH^^^231^3718105ORC|RE||BU22I11295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU22I11295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011410^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011411|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N94K11303^^^AIRA-TEST^MR||LohmannAIRA^GregoriaAIRA^Sun^^^^L|MalaAIRA^NoniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1378 Regelen Ave^^Goodison^MI^48306^USA^P||^PRN^PH^^^248^2167289|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LohmannAIRA^MalaAIRA^^^^^L|MTH^Mother^HL70063|1378 Regelen Ave^^Goodison^MI^48306^USA^P|^PRN^PH^^^248^2167289ORC|RE||BN94K11303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN94K11303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011411^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V02R11308^^^AIRA-TEST^MR||PerryAIRA^GundaAIRA^Elianna^^^^L|SaloAIRA^GlenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1844 Gollands Kroon Pl^^Paw Paw^MI^49079^USA^P||^PRN^PH^^^269^4581022|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PerryAIRA^SaloAIRA^^^^^L|MTH^Mother^HL70063|1844 Gollands Kroon Pl^^Paw Paw^MI^49079^USA^P|^PRN^PH^^^269^4581022ORC|RE||BV02R11308.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV02R11308.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011510^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T20W11319^^^AIRA-TEST^MR||ShelbyAIRA^AlanaAIRA^Deepika^^^^L|PocahontasAIRA^KerryAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1470 Rlphen aan den Rijn Cir^^Grand Rapids^MI^49510^USA^P||^PRN^PH^^^616^8248378|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShelbyAIRA^PocahontasAIRA^^^^^L|MTH^Mother^HL70063|1470 Rlphen aan den Rijn Cir^^Grand Rapids^MI^49510^USA^P|^PRN^PH^^^616^8248378ORC|RE||BT20W11319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT20W11319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011511^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P43Y11327^^^AIRA-TEST^MR||OfvermarkAIRA^AnaAIRA^Nori^^^^L|ChickasawAIRA^BlaineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1526 Licht Cir^^Rapid River^MI^49878^USA^P||^PRN^PH^^^906^6007190|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OfvermarkAIRA^ChickasawAIRA^^^^^L|MTH^Mother^HL70063|1526 Licht Cir^^Rapid River^MI^49878^USA^P|^PRN^PH^^^906^6007190ORC|RE||BP43Y11327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP43Y11327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011610^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B30J11335^^^AIRA-TEST^MR||GarzaAIRA^VarvaraAIRA^Sunee^^^^L|BeecherAIRA^IngeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1053 Tudewater St^^Grand Rapids^MI^49528^USA^P||^PRN^PH^^^616^7421852|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarzaAIRA^BeecherAIRA^^^^^L|MTH^Mother^HL70063|1053 Tudewater St^^Grand Rapids^MI^49528^USA^P|^PRN^PH^^^616^7421852ORC|RE||BB30J11335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB30J11335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011611^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C06T11343^^^AIRA-TEST^MR||NewtonAIRA^AmiraAIRA^Consuela^^^^L|AdairAIRA^SorilbranAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1241 Wit St^^Lake Linden^MI^49945^USA^P||^PRN^PH^^^906^9953507|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NewtonAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1241 Wit St^^Lake Linden^MI^49945^USA^P|^PRN^PH^^^906^9953507ORC|RE||BC06T11343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC06T11343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011710^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011711|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G76N11348^^^AIRA-TEST^MR||ArmstrongAIRA^KatinaAIRA^Rai^^^^L|JohnsonAIRA^YasminAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1195 Bodem Cir^^Superior Township^MI^48198^USA^P||^PRN^PH^^^734^3854548|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ArmstrongAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1195 Bodem Cir^^Superior Township^MI^48198^USA^P|^PRN^PH^^^734^3854548ORC|RE||BG76N11348.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG76N11348.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011711^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U21D11359^^^AIRA-TEST^MR||KinneyAIRA^MahaliaAIRA^Brunhilde^^^^L|DodgeAIRA^MayukoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1531 Kalsmeer Ave^^Iron Mountain^MI^49802^USA^P||^PRN^PH^^^906^3554540|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KinneyAIRA^DodgeAIRA^^^^^L|MTH^Mother^HL70063|1531 Kalsmeer Ave^^Iron Mountain^MI^49802^USA^P|^PRN^PH^^^906^3554540ORC|RE||BU21D11359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU21D11359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011810^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332011811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G09K11367^^^AIRA-TEST^MR||HolmesAIRA^EstrellaAIRA^Orseline^^^^L|TillmanAIRA^DarcieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1344 Olst-Wijhe St^^South Manitou^MI^49654^USA^P||^PRN^PH^^^231^7045268|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HolmesAIRA^TillmanAIRA^^^^^L|MTH^Mother^HL70063|1344 Olst-Wijhe St^^South Manitou^MI^49654^USA^P|^PRN^PH^^^231^7045268ORC|RE||BG09K11367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG09K11367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332011811^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332031601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y62L11375^^^AIRA-TEST^MR||DelawareAIRA^LuzAIRA^Preita^^^^L|ClaytonAIRA^EndaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1855 Middelburg Ave^^Laingsburg^MI^48848^USA^P||^PRN^PH^^^517^8798360|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^ClaytonAIRA^^^^^L|MTH^Mother^HL70063|1855 Middelburg Ave^^Laingsburg^MI^48848^USA^P|^PRN^PH^^^517^8798360ORC|RE||BY62L11375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY62L11375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332031601^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332031602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S62Y11383^^^AIRA-TEST^MR||CopelandAIRA^DemelzaAIRA^Courtney^^^^L|GunnersonAIRA^KerziAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1858 Uoggenland Ln^^Detroit^MI^48218^USA^P||^PRN^PH^^^313^2589504|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CopelandAIRA^GunnersonAIRA^^^^^L|MTH^Mother^HL70063|1858 Uoggenland Ln^^Detroit^MI^48218^USA^P|^PRN^PH^^^313^2589504ORC|RE||BS62Y11383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS62Y11383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332031602^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332031701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S87J11388^^^AIRA-TEST^MR||JofrayAIRA^OrpahAIRA^Gypsy^^^^L|LaceyAIRA^LitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1033 Dergelijke St^^Flat Rock^MI^48134^USA^P||^PRN^PH^^^734^7859042|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JofrayAIRA^LaceyAIRA^^^^^L|MTH^Mother^HL70063|1033 Dergelijke St^^Flat Rock^MI^48134^USA^P|^PRN^PH^^^734^7859042ORC|RE||BS87J11388.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS87J11388.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332031701^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332031702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N05J11399^^^AIRA-TEST^MR||KarlssonAIRA^SuchitraAIRA^Menaka^^^^L|NewtonAIRA^DavinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1484 Hardenberg Ln^^Grosse Pointe Shores^MI^48236^USA^P||^PRN^PH^^^313^4461358|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KarlssonAIRA^NewtonAIRA^^^^^L|MTH^Mother^HL70063|1484 Hardenberg Ln^^Grosse Pointe Shores^MI^48236^USA^P|^PRN^PH^^^313^4461358ORC|RE||BN05J11399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN05J11399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332031702^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332031801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L58Q11407^^^AIRA-TEST^MR||InghamAIRA^ZuzanaAIRA^Tertia^^^^L|KittitasAIRA^RaekaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1344 Bracht Pl^^Washington^MI^48094^USA^P||^PRN^PH^^^586^7017604|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|InghamAIRA^KittitasAIRA^^^^^L|MTH^Mother^HL70063|1344 Bracht Pl^^Washington^MI^48094^USA^P|^PRN^PH^^^586^7017604ORC|RE||BL58Q11407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL58Q11407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332031801^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332031802|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V97E11415^^^AIRA-TEST^MR||LynchAIRA^KenyaAIRA^Pantxike^^^^L|HubbardAIRA^CorabelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1076 Vennep Pl^^Frankfort^MI^49635^USA^P||^PRN^PH^^^231^2786744|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LynchAIRA^HubbardAIRA^^^^^L|MTH^Mother^HL70063|1076 Vennep Pl^^Frankfort^MI^49635^USA^P|^PRN^PH^^^231^2786744ORC|RE||BV97E11415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV97E11415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332031802^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332041610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I26P11423^^^AIRA-TEST^MR||CassAIRA^ShelbyAIRA^Joslin^^^^L|RiversideAIRA^MilanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1465 Ducphen Ln^^Brockway Township^MI^48097^USA^P||^PRN^PH^^^810^6808008|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^RiversideAIRA^^^^^L|MTH^Mother^HL70063|1465 Ducphen Ln^^Brockway Township^MI^48097^USA^P|^PRN^PH^^^810^6808008ORC|RE||BI26P11423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI26P11423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332041610^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332041611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y68P11428^^^AIRA-TEST^MR||CrawfordAIRA^SushmitaAIRA^Misako^^^^L|TurnerAIRA^ArianeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1618 Hen Boer Pl^^Calumet^MI^49942^USA^P||^PRN^PH^^^906^9114582|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CrawfordAIRA^TurnerAIRA^^^^^L|MTH^Mother^HL70063|1618 Hen Boer Pl^^Calumet^MI^49942^USA^P|^PRN^PH^^^906^9114582ORC|RE||BY68P11428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY68P11428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332041611^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332041710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B24X11439^^^AIRA-TEST^MR||IronAIRA^AlaysiaAIRA^Ashrita^^^^L|BrownAIRA^AugustaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1128 Eerkrade Ln^^Canton Township^MI^48188^USA^P||^PRN^PH^^^734^3147960|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IronAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1128 Eerkrade Ln^^Canton Township^MI^48188^USA^P|^PRN^PH^^^734^3147960ORC|RE||BB24X11439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB24X11439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332041710^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332041711|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q47H11447^^^AIRA-TEST^MR||LewisAIRA^AchaziaAIRA^Sondra^^^^L|MasonAIRA^ZakiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1532 Eenswoude Cir^^Seney^MI^49883^USA^P||^PRN^PH^^^906^3998850|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LewisAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1532 Eenswoude Cir^^Seney^MI^49883^USA^P|^PRN^PH^^^906^3998850ORC|RE||BQ47H11447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ47H11447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332041711^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332041810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J69U11455^^^AIRA-TEST^MR||SomersetAIRA^MagnoliaAIRA^Lydia^^^^L|AudubonAIRA^JazlynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1136 Kaart Ave^^Pontiac^MI^48342^USA^P||^PRN^PH^^^248^3620049|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SomersetAIRA^AudubonAIRA^^^^^L|MTH^Mother^HL70063|1136 Kaart Ave^^Pontiac^MI^48342^USA^P|^PRN^PH^^^248^3620049ORC|RE||BJ69U11455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ69U11455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332041810^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332041811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A73N11463^^^AIRA-TEST^MR||HarmonAIRA^RubyAIRA^Sancia^^^^L|OtterstromAIRA^KlaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1079 Terug Ave^^Muskegon^MI^49443^USA^P||^PRN^PH^^^231^6584110|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarmonAIRA^OtterstromAIRA^^^^^L|MTH^Mother^HL70063|1079 Terug Ave^^Muskegon^MI^49443^USA^P|^PRN^PH^^^231^6584110ORC|RE||BA73N11463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA73N11463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332041811^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332051901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q21A11468^^^AIRA-TEST^MR||MifflinAIRA^WenonahAIRA^Rishona^^^^L|SwisherAIRA^OonaghAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1153 Sinds Pl^^Ashley^MI^48806^USA^P||^PRN^PH^^^989^4480030|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MifflinAIRA^SwisherAIRA^^^^^L|MTH^Mother^HL70063|1153 Sinds Pl^^Ashley^MI^48806^USA^P|^PRN^PH^^^989^4480030ORC|RE||BQ21A11468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ21A11468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332051901^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332051925|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N10E11479^^^AIRA-TEST^MR||ClackamasAIRA^AutumnAIRA^Turquoise^^^^L|CrawfordAIRA^RachaelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1210 Drmelo St^^Chassell^MI^49916^USA^P||^PRN^PH^^^906^4263929|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClackamasAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1210 Drmelo St^^Chassell^MI^49916^USA^P|^PRN^PH^^^906^4263929ORC|RE||BN10E11479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN10E11479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332051925^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-33332062910|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D25L11487^^^AIRA-TEST^MR||SusasAIRA^SwetaAIRA^Elmas^^^^L|MartinsonAIRA^ConsuelaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1398 Begon Ave^^Caspian^MI^49915^USA^P||^PRN^PH^^^906^9541978|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SusasAIRA^MartinsonAIRA^^^^^L|MTH^Mother^HL70063|1398 Begon Ave^^Caspian^MI^49915^USA^P|^PRN^PH^^^906^9541978ORC|RE||BD25L11487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD25L11487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||33332062910^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515-001-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U87E11495^^^AIRA-TEST^MR||LueatosAIRA^JosephineAIRA^Ambra^^^^L|KaneAIRA^CharuAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1234 Bundert Ave^^Pentwater^MI^49449^USA^P||^PRN^PH^^^231^2281036|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LueatosAIRA^KaneAIRA^^^^^L|MTH^Mother^HL70063|1234 Bundert Ave^^Pentwater^MI^49449^USA^P|^PRN^PH^^^231^2281036ORC|RE||BU87E11495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU87E11495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515-001-00^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515-001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V53P11503^^^AIRA-TEST^MR||BlaineAIRA^DanicaAIRA^Modestus^^^^L|LucasAIRA^RosenwynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1467 Winschoten Ave^^GR^MI^49519^USA^P||^PRN^PH^^^616^8426660|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlaineAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1467 Winschoten Ave^^GR^MI^49519^USA^P|^PRN^PH^^^616^8426660ORC|RE||BV53P11503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV53P11503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515-001-01^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515-002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y06Y11508^^^AIRA-TEST^MR||CumingAIRA^BeckyAIRA^Jillian^^^^L|JessenAIRA^TeaganAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1546 Doordwijk Ln^^Grand Marais^MI^49839^USA^P||^PRN^PH^^^906^4797684|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumingAIRA^JessenAIRA^^^^^L|MTH^Mother^HL70063|1546 Doordwijk Ln^^Grand Marais^MI^49839^USA^P|^PRN^PH^^^906^4797684ORC|RE||BY06Y11508.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY06Y11508.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515-002-01^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515000100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B82E11519^^^AIRA-TEST^MR||HernandezAIRA^ZuriAIRA^Kyrenia^^^^L|FoxAIRA^KismetAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1387 Lost Gelre Ln^^Conklin^MI^49403^USA^P||^PRN^PH^^^616^8599072|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HernandezAIRA^FoxAIRA^^^^^L|MTH^Mother^HL70063|1387 Lost Gelre Ln^^Conklin^MI^49403^USA^P|^PRN^PH^^^616^8599072ORC|RE||BB82E11519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB82E11519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515000100^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515000101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T56L11527^^^AIRA-TEST^MR||KossuthAIRA^RobbinAIRA^Shanata^^^^L|LyonAIRA^LailieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1599 Dassenaar St^^Lyons^MI^48851^USA^P||^PRN^PH^^^989^4733650|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KossuthAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1599 Dassenaar St^^Lyons^MI^48851^USA^P|^PRN^PH^^^989^4733650ORC|RE||BT56L11527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT56L11527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515000101^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42515000201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C79L11535^^^AIRA-TEST^MR||HampsonAIRA^FatimaAIRA^Poppy^^^^L|OtsegoAIRA^PosyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1388 Roerden Pl^^Paris^MI^49338^USA^P||^PRN^PH^^^231^8095475|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HampsonAIRA^OtsegoAIRA^^^^^L|MTH^Mother^HL70063|1388 Roerden Pl^^Paris^MI^49338^USA^P|^PRN^PH^^^231^8095475ORC|RE||BC79L11535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC79L11535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42515000201^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-012-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R79V11543^^^AIRA-TEST^MR||OlsonAIRA^BrooklynAIRA^Lalo^^^^L|GuthrieAIRA^CameoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1154 Meemster St^^Lake City^MI^49651^USA^P||^PRN^PH^^^231^9698886|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OlsonAIRA^GuthrieAIRA^^^^^L|MTH^Mother^HL70063|1154 Meemster St^^Lake City^MI^49651^USA^P|^PRN^PH^^^231^9698886ORC|RE||BR79V11543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR79V11543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-012-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-012-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O45O11548^^^AIRA-TEST^MR||AnderssonAIRA^TemperanceAIRA^Azariah^^^^L|FrioAIRA^BedeliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1447 Hmersfoort Ave^^Christian Reformed Church^MI^49560^USA^P||^PRN^PH^^^616^3592163|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AnderssonAIRA^FrioAIRA^^^^^L|MTH^Mother^HL70063|1447 Hmersfoort Ave^^Christian Reformed Church^MI^49560^USA^P|^PRN^PH^^^616^3592163ORC|RE||BO45O11548.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO45O11548.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-012-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-013-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z96M11559^^^AIRA-TEST^MR||TuscolaAIRA^MargaritaAIRA^Tabitha^^^^L|HaskellAIRA^KeziaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1902 Hinterswijk Pl^^Winn^MI^48896^USA^P||^PRN^PH^^^989^6470538|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TuscolaAIRA^HaskellAIRA^^^^^L|MTH^Mother^HL70063|1902 Hinterswijk Pl^^Winn^MI^48896^USA^P|^PRN^PH^^^989^6470538ORC|RE||BZ96M11559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ96M11559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-013-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-013-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H18V11567^^^AIRA-TEST^MR||TurvoAIRA^VanditaAIRA^Melody^^^^L|LueatosAIRA^CharityAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1505 Sedum Ave^^Dearborn^MI^48126^USA^P||^PRN^PH^^^313^4433343|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TurvoAIRA^LueatosAIRA^^^^^L|MTH^Mother^HL70063|1505 Sedum Ave^^Dearborn^MI^48126^USA^P|^PRN^PH^^^313^4433343ORC|RE||BH18V11567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH18V11567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-013-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-014-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H99G11575^^^AIRA-TEST^MR||MonroeAIRA^SolanaAIRA^Riba^^^^L|AtokaAIRA^GryffynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1353 Natie Pl^^Onondaga^MI^49264^USA^P||^PRN^PH^^^517^4725049|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MonroeAIRA^AtokaAIRA^^^^^L|MTH^Mother^HL70063|1353 Natie Pl^^Onondaga^MI^49264^USA^P|^PRN^PH^^^517^4725049ORC|RE||BH99G11575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH99G11575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-014-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-014-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P07O11583^^^AIRA-TEST^MR||NelsonAIRA^AracelyAIRA^Marianna^^^^L|GuadalupeAIRA^YarrahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1213 Ridderkerk Cir^^Grand Rapids^MI^49505^USA^P||^PRN^PH^^^616^3532198|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NelsonAIRA^GuadalupeAIRA^^^^^L|MTH^Mother^HL70063|1213 Ridderkerk Cir^^Grand Rapids^MI^49505^USA^P|^PRN^PH^^^616^3532198ORC|RE||BP07O11583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP07O11583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-014-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-015-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F78N11588^^^AIRA-TEST^MR||HopkinsAIRA^MarmaraAIRA^Piyali^^^^L|HubbardAIRA^KajaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1205 Vuijk Pl^^Sagola^MI^49881^USA^P||^PRN^PH^^^906^9312989|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HopkinsAIRA^HubbardAIRA^^^^^L|MTH^Mother^HL70063|1205 Vuijk Pl^^Sagola^MI^49881^USA^P|^PRN^PH^^^906^9312989ORC|RE||BF78N11588.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF78N11588.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-015-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-015-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G79I11599^^^AIRA-TEST^MR||UlsethAIRA^RosaAIRA^Sita^^^^L|GustafsonAIRA^KylieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1809 Westervoort Ln^^Bloomfield^MI^48302^USA^P||^PRN^PH^^^248^6433125|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UlsethAIRA^GustafsonAIRA^^^^^L|MTH^Mother^HL70063|1809 Westervoort Ln^^Bloomfield^MI^48302^USA^P|^PRN^PH^^^248^6433125ORC|RE||BG79I11599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG79I11599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-015-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-016-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E75H11607^^^AIRA-TEST^MR||WalcottAIRA^MikkiAIRA^Cynara^^^^L|ClintonAIRA^MelanieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1180 Poevorden Ln^^Lansing^MI^48919^USA^P||^PRN^PH^^^517^3509557|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WalcottAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1180 Poevorden Ln^^Lansing^MI^48919^USA^P|^PRN^PH^^^517^3509557ORC|RE||BE75H11607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE75H11607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-016-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-016-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P76R11615^^^AIRA-TEST^MR||MetcalfeAIRA^LondonAIRA^Mychau^^^^L|CochiseAIRA^EudoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1818 Serschelling Cir^^Detroit^MI^48260^USA^P||^PRN^PH^^^313^9072392|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MetcalfeAIRA^CochiseAIRA^^^^^L|MTH^Mother^HL70063|1818 Serschelling Cir^^Detroit^MI^48260^USA^P|^PRN^PH^^^313^9072392ORC|RE||BP76R11615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP76R11615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-016-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-017-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U09G11623^^^AIRA-TEST^MR||IsdalAIRA^OrselineAIRA^Donelle^^^^L|ShastaAIRA^GelasiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1694 Oeylingen Ln^^Pontiac^MI^48340^USA^P||^PRN^PH^^^248^8423008|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IsdalAIRA^ShastaAIRA^^^^^L|MTH^Mother^HL70063|1694 Oeylingen Ln^^Pontiac^MI^48340^USA^P|^PRN^PH^^^248^8423008ORC|RE||BU09G11623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU09G11623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-017-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-017-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R47F11628^^^AIRA-TEST^MR||EnnisAIRA^AirliaAIRA^Zagir^^^^L|RomsvigAIRA^AzizaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1933 Dad Ln^^Saint Clair Shores^MI^48081^USA^P||^PRN^PH^^^586^8488013|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EnnisAIRA^RomsvigAIRA^^^^^L|MTH^Mother^HL70063|1933 Dad Ln^^Saint Clair Shores^MI^48081^USA^P|^PRN^PH^^^586^8488013ORC|RE||BR47F11628.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR47F11628.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-017-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-116-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M88A11639^^^AIRA-TEST^MR||OldhamAIRA^ChilaliAIRA^Ciannait^^^^L|KalkaskaAIRA^EloueraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1570 Pick Ln^^Grandville^MI^49418^USA^P||^PRN^PH^^^616^2308146|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OldhamAIRA^KalkaskaAIRA^^^^^L|MTH^Mother^HL70063|1570 Pick Ln^^Grandville^MI^49418^USA^P|^PRN^PH^^^616^2308146ORC|RE||BM88A11639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM88A11639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-116-01^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-117-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T82C11647^^^AIRA-TEST^MR||MasonAIRA^IllonaAIRA^Kora^^^^L|VargasAIRA^NiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1023 Loxmeer St^^Fife Lake^MI^49633^USA^P||^PRN^PH^^^231^2450943|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^VargasAIRA^^^^^L|MTH^Mother^HL70063|1023 Loxmeer St^^Fife Lake^MI^49633^USA^P|^PRN^PH^^^231^2450943ORC|RE||BT82C11647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT82C11647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-117-01^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874-117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P96W11655^^^AIRA-TEST^MR||OlssenAIRA^GenjiAIRA^Nuray^^^^L|OlssenAIRA^RebaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1081 Harneveld St^^Bay View^MI^49770^USA^P||^PRN^PH^^^231^7713018|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OlssenAIRA^OlssenAIRA^^^^^L|MTH^Mother^HL70063|1081 Harneveld St^^Bay View^MI^49770^USA^P|^PRN^PH^^^231^7713018ORC|RE||BP96W11655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP96W11655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874-117-10^FLUBLOK, QUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F01S11663^^^AIRA-TEST^MR||CalhounAIRA^ArgentaAIRA^Lizette^^^^L|WagonerAIRA^PauletteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1557 Nellendoorn Ave^^Standale^MI^49504^USA^P||^PRN^PH^^^616^6584947|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalhounAIRA^WagonerAIRA^^^^^L|MTH^Mother^HL70063|1557 Nellendoorn Ave^^Standale^MI^49504^USA^P|^PRN^PH^^^616^6584947ORC|RE||BF01S11663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF01S11663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001201^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R79V11668^^^AIRA-TEST^MR||AllamakeeAIRA^TirzaAIRA^Karlie^^^^L|AurumAIRA^HavanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1160 Stadskanaal Ln^^Gm Truck and Bus^MI^48553^USA^P||^PRN^PH^^^810^4964128|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllamakeeAIRA^AurumAIRA^^^^^L|MTH^Mother^HL70063|1160 Stadskanaal Ln^^Gm Truck and Bus^MI^48553^USA^P|^PRN^PH^^^810^4964128ORC|RE||BR79V11668.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR79V11668.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001210^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O62P11676^^^AIRA-TEST^MR||MorreyAIRA^HerthaAIRA^Valerie^^^^L|WatmoughAIRA^KajaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1303 Gooien Ln^^Oakville^MI^48160^USA^P||^PRN^PH^^^734^9270846|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorreyAIRA^WatmoughAIRA^^^^^L|MTH^Mother^HL70063|1303 Gooien Ln^^Oakville^MI^48160^USA^P|^PRN^PH^^^734^9270846ORC|RE||BO62P11676.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO62P11676.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001301^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S87J11687^^^AIRA-TEST^MR||IversenAIRA^AnnamariaAIRA^Annabel^^^^L|DavisAIRA^AnahidAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1655 Mitgeest Cir^^Marcellus^MI^49067^USA^P||^PRN^PH^^^269^9079785|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IversenAIRA^DavisAIRA^^^^^L|MTH^Mother^HL70063|1655 Mitgeest Cir^^Marcellus^MI^49067^USA^P|^PRN^PH^^^269^9079785ORC|RE||BS87J11687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS87J11687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001310^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K83M11695^^^AIRA-TEST^MR||WhatcomAIRA^KiaraAIRA^Allegra^^^^L|HarmonAIRA^KerstinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1070 Laarle-Nassau St^^GR^MI^49546^USA^P||^PRN^PH^^^616^6733116|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WhatcomAIRA^HarmonAIRA^^^^^L|MTH^Mother^HL70063|1070 Laarle-Nassau St^^GR^MI^49546^USA^P|^PRN^PH^^^616^6733116ORC|RE||BK83M11695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK83M11695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001401^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D02K11703^^^AIRA-TEST^MR||DeWittAIRA^SefikaAIRA^Grace^^^^L|WolfeAIRA^TaleenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1260 Auth Ave^^Presque Isle^MI^49777^USA^P||^PRN^PH^^^989^5230495|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DeWittAIRA^WolfeAIRA^^^^^L|MTH^Mother^HL70063|1260 Auth Ave^^Presque Isle^MI^49777^USA^P|^PRN^PH^^^989^5230495ORC|RE||BD02K11703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD02K11703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001410^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N10Z11711^^^AIRA-TEST^MR||OrangeAIRA^IkuAIRA^Zara^^^^L|Presque IsleAIRA^JaydaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1949 Mirschot Pl^^GR^MI^49548^USA^P||^PRN^PH^^^616^3092011|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OrangeAIRA^Presque IsleAIRA^^^^^L|MTH^Mother^HL70063|1949 Mirschot Pl^^GR^MI^49548^USA^P|^PRN^PH^^^616^3092011ORC|RE||BN10Z11711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN10Z11711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001501^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H56Q11719^^^AIRA-TEST^MR||CochranAIRA^ZoeyAIRA^Chanah^^^^L|JacksonAIRA^DikiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1628 Hundert Ave^^Flint^MI^48555^USA^P||^PRN^PH^^^810^4741313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CochranAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1628 Hundert Ave^^Flint^MI^48555^USA^P|^PRN^PH^^^810^4741313ORC|RE||BH56Q11719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH56Q11719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001510^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A83P11724^^^AIRA-TEST^MR||HoodAIRA^ArianaAIRA^Lurlene^^^^L|JohnsonAIRA^TamathaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1409 Lnschede Cir^^Belding^MI^48887^USA^P||^PRN^PH^^^616^2967971|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoodAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1409 Lnschede Cir^^Belding^MI^48887^USA^P|^PRN^PH^^^616^2967971ORC|RE||BA83P11724.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA83P11724.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001601^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G56M11735^^^AIRA-TEST^MR||MerwikAIRA^KatelynAIRA^Janina^^^^L|CreghanAIRA^DestinyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1194 Vud-Beijerland Cir^^Bloomfield^MI^48304^USA^P||^PRN^PH^^^248^9768207|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MerwikAIRA^CreghanAIRA^^^^^L|MTH^Mother^HL70063|1194 Vud-Beijerland Cir^^Bloomfield^MI^48304^USA^P|^PRN^PH^^^248^9768207ORC|RE||BG56M11735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG56M11735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001610^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E52D11743^^^AIRA-TEST^MR||BayAIRA^ZofeyaAIRA^Clarissa^^^^L|BlaineAIRA^AmelieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1446 Spoor St^^Manitou Beach^MI^49253^USA^P||^PRN^PH^^^517^2390066|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BayAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1446 Spoor St^^Manitou Beach^MI^49253^USA^P|^PRN^PH^^^517^2390066ORC|RE||BE52D11743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE52D11743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001701^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874001710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y88W11751^^^AIRA-TEST^MR||MontgomeryAIRA^LiaAIRA^Jocelyn^^^^L|CarrollAIRA^AryannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1372 We Wolden Ave^^Springport^MI^49284^USA^P||^PRN^PH^^^517^2215564|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontgomeryAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1372 We Wolden Ave^^Springport^MI^49284^USA^P|^PRN^PH^^^517^2215564ORC|RE||BY88W11751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY88W11751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874001710^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874011601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N41Z11759^^^AIRA-TEST^MR||OttawaAIRA^YarrahAIRA^Doreen^^^^L|PageAIRA^FeliciteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1730 Pand St^^Huntington Wd^MI^48070^USA^P||^PRN^PH^^^248^9930503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OttawaAIRA^PageAIRA^^^^^L|MTH^Mother^HL70063|1730 Pand St^^Huntington Wd^MI^48070^USA^P|^PRN^PH^^^248^9930503ORC|RE||BN41Z11759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN41Z11759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874011601^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874011701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H55S11764^^^AIRA-TEST^MR||AsotinAIRA^LilianaAIRA^Ademia^^^^L|CedarAIRA^DelythAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1866 Veeze-Leende Ln^^Bingham Farms^MI^48025^USA^P||^PRN^PH^^^248^3981876|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AsotinAIRA^CedarAIRA^^^^^L|MTH^Mother^HL70063|1866 Veeze-Leende Ln^^Bingham Farms^MI^48025^USA^P|^PRN^PH^^^248^3981876ORC|RE||BH55S11764.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH55S11764.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874011701^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-42874011710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S09M11775^^^AIRA-TEST^MR||JeffersonAIRA^TanujaAIRA^Mila^^^^L|AshtabulaAIRA^RivkaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1593 Dat Pl^^Wolverine Lake^MI^48390^USA^P||^PRN^PH^^^248^4032304|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^AshtabulaAIRA^^^^^L|MTH^Mother^HL70063|1593 Dat Pl^^Wolverine Lake^MI^48390^USA^P|^PRN^PH^^^248^4032304ORC|RE||BS09M11775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS09M11775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||42874011710^FLUBLOK, QUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528-002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N93O11783^^^AIRA-TEST^MR||BelmontAIRA^KesiaAIRA^Patricia^^^^L|WebsterAIRA^ArdaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1116 Woudrichem Cir^^Wixom^MI^48393^USA^P||^PRN^PH^^^248^2925081|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BelmontAIRA^WebsterAIRA^^^^^L|MTH^Mother^HL70063|1116 Woudrichem Cir^^Wixom^MI^48393^USA^P|^PRN^PH^^^248^2925081ORC|RE||BN93O11783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN93O11783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528-002-01^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528-002-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N15C11791^^^AIRA-TEST^MR||CampAIRA^DannellAIRA^Prisha^^^^L|ClareAIRA^MajellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1916 Zitje Ln^^Kingsley^MI^49649^USA^P||^PRN^PH^^^231^5601096|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CampAIRA^ClareAIRA^^^^^L|MTH^Mother^HL70063|1916 Zitje Ln^^Kingsley^MI^49649^USA^P|^PRN^PH^^^231^5601096ORC|RE||BN15C11791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN15C11791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528-002-05^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528-003-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F38R11799^^^AIRA-TEST^MR||NanceAIRA^HestiaAIRA^Lisbet^^^^L|MalaAIRA^TaniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1935 Suijk Ave^^Mount Pleasant^MI^48858^USA^P||^PRN^PH^^^989^8546151|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NanceAIRA^MalaAIRA^^^^^L|MTH^Mother^HL70063|1935 Suijk Ave^^Mount Pleasant^MI^48858^USA^P|^PRN^PH^^^989^8546151ORC|RE||BF38R11799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF38R11799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528-003-01^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528-003-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R56W11804^^^AIRA-TEST^MR||EsceibreAIRA^AvaraAIRA^Sammie^^^^L|KnowlesAIRA^MistyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1755 Zeil St^^Homer^MI^49245^USA^P||^PRN^PH^^^517^6715575|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EsceibreAIRA^KnowlesAIRA^^^^^L|MTH^Mother^HL70063|1755 Zeil St^^Homer^MI^49245^USA^P|^PRN^PH^^^517^6715575ORC|RE||BR56W11804.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR56W11804.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528-003-05^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528000201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C99B11815^^^AIRA-TEST^MR||UvaldeAIRA^KarenaAIRA^Ora^^^^L|Twin FallsAIRA^FabrianneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1284 Ae Ronde Venen Cir^^Sodus^MI^49126^USA^P||^PRN^PH^^^269^2965170|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UvaldeAIRA^Twin FallsAIRA^^^^^L|MTH^Mother^HL70063|1284 Ae Ronde Venen Cir^^Sodus^MI^49126^USA^P|^PRN^PH^^^269^2965170ORC|RE||BC99B11815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC99B11815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528000201^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528000205|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F44C11823^^^AIRA-TEST^MR||PikeAIRA^AmbriaAIRA^Aimee^^^^L|O'BrienAIRA^TaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1961 Sijk bij Duurstede Pl^^Cornell^MI^49819^USA^P||^PRN^PH^^^906^2513146|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PikeAIRA^O'BrienAIRA^^^^^L|MTH^Mother^HL70063|1961 Sijk bij Duurstede Pl^^Cornell^MI^49819^USA^P|^PRN^PH^^^906^2513146ORC|RE||BF44C11823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF44C11823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528000205^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528000301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D55K11831^^^AIRA-TEST^MR||TurnerAIRA^CarmenAIRA^Raimy^^^^L|WheelerAIRA^CyndiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1636 Alagtwedde Ln^^Orion Township^MI^48360^USA^P||^PRN^PH^^^248^3530526|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TurnerAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1636 Alagtwedde Ln^^Orion Township^MI^48360^USA^P|^PRN^PH^^^248^3530526ORC|RE||BD55K11831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD55K11831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528000301^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-43528000305|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B78E11839^^^AIRA-TEST^MR||KnightAIRA^ChaitraAIRA^Heli^^^^L|PolkAIRA^PurnimaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1080 Laatste Cir^^Sparta^MI^49345^USA^P||^PRN^PH^^^616^8985015|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnightAIRA^PolkAIRA^^^^^L|MTH^Mother^HL70063|1080 Laatste Cir^^Sparta^MI^49345^USA^P|^PRN^PH^^^616^8985015ORC|RE||BB78E11839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB78E11839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||43528000305^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-114-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B65O11844^^^AIRA-TEST^MR||ChambersAIRA^MickieAIRA^Vanja^^^^L|WilsonAIRA^MaggieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1130 Laaksbergen Ave^^Ellsworth^MI^49729^USA^P||^PRN^PH^^^231^8713558|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChambersAIRA^WilsonAIRA^^^^^L|MTH^Mother^HL70063|1130 Laaksbergen Ave^^Ellsworth^MI^49729^USA^P|^PRN^PH^^^231^8713558ORC|RE||BB65O11844.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB65O11844.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028-114-01^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-114-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R40A11855^^^AIRA-TEST^MR||CottleAIRA^SydneeAIRA^Christian^^^^L|WhitmanAIRA^PandoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1100 Huiven Cir^^Lansing^MI^48950^USA^P||^PRN^PH^^^517^6363907|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CottleAIRA^WhitmanAIRA^^^^^L|MTH^Mother^HL70063|1100 Huiven Cir^^Lansing^MI^48950^USA^P|^PRN^PH^^^517^6363907ORC|RE||BR40A11855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR40A11855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028-114-02^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-114-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K84A11863^^^AIRA-TEST^MR||OatesAIRA^MiriamAIRA^Rana^^^^L|LivingstonAIRA^VerdaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1125 Mirschot St^^Schaffer^MI^49807^USA^P||^PRN^PH^^^906^4188057|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OatesAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1125 Mirschot St^^Schaffer^MI^49807^USA^P|^PRN^PH^^^906^4188057ORC|RE||BK84A11863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK84A11863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028-114-11^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-208-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R78R11871^^^AIRA-TEST^MR||EdwardsAIRA^GiannaAIRA^Filipina^^^^L|TamaAIRA^LyricAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1788 Hingewaard St^^Yankee Springs^MI^49333^USA^P||^PRN^PH^^^269^6496871|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EdwardsAIRA^TamaAIRA^^^^^L|MTH^Mother^HL70063|1788 Hingewaard St^^Yankee Springs^MI^49333^USA^P|^PRN^PH^^^269^6496871ORC|RE||BR78R11871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR78R11871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028-208-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-218-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z33P11879^^^AIRA-TEST^MR||FanninAIRA^BirgitAIRA^Valerie^^^^L|HughesAIRA^AllaynaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1648 Mrimmelen Pl^^Detroit^MI^48231^USA^P||^PRN^PH^^^313^7327976|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FanninAIRA^HughesAIRA^^^^^L|MTH^Mother^HL70063|1648 Mrimmelen Pl^^Detroit^MI^48231^USA^P|^PRN^PH^^^313^7327976ORC|RE||BZ33P11879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ33P11879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028-218-11^Meningococcal (Groups A) CRM197 Oligosaccharide Co^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028-219-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y00Q11884^^^AIRA-TEST^MR||SwanwickAIRA^KinetaAIRA^Hathor^^^^L|HarmonAIRA^OonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1160 Verhuizing St^^Greenwood^MI^48006^USA^P||^PRN^PH^^^810^4710740|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SwanwickAIRA^HarmonAIRA^^^^^L|MTH^Mother^HL70063|1160 Verhuizing St^^Greenwood^MI^48006^USA^P|^PRN^PH^^^810^4710740ORC|RE||BY00Q11884.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY00Q11884.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028-219-11^Meningococcal (Groups C, Y, W-135) CRM197 Oligosac^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028011401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z93L11895^^^AIRA-TEST^MR||HarneyAIRA^WhoopiAIRA^Gai^^^^L|MackeyAIRA^DoreAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1567 Ee Marne Cir^^Gladstone^MI^49837^USA^P||^PRN^PH^^^906^5906856|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarneyAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1567 Ee Marne Cir^^Gladstone^MI^49837^USA^P|^PRN^PH^^^906^5906856ORC|RE||BZ93L11895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ93L11895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028011401^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028011402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y19S11903^^^AIRA-TEST^MR||ToaleAIRA^KimoraAIRA^Temira^^^^L|DawsonAIRA^PenneyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1794 Leventer Cir^^Turner^MI^48765^USA^P||^PRN^PH^^^989^7235828|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ToaleAIRA^DawsonAIRA^^^^^L|MTH^Mother^HL70063|1794 Leventer Cir^^Turner^MI^48765^USA^P|^PRN^PH^^^989^7235828ORC|RE||BY19S11903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY19S11903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028011402^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028011411|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C48Z11911^^^AIRA-TEST^MR||WiseAIRA^ManhattanAIRA^Alicia^^^^L|HartAIRA^SagaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1968 Mittenseradiel Cir^^Podunk^MI^48158^USA^P||^PRN^PH^^^734^9361104|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WiseAIRA^HartAIRA^^^^^L|MTH^Mother^HL70063|1968 Mittenseradiel Cir^^Podunk^MI^48158^USA^P|^PRN^PH^^^734^9361104ORC|RE||BC48Z11911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC48Z11911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028011411^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028020801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U47P11919^^^AIRA-TEST^MR||KendallAIRA^VilhelminaAIRA^Terra^^^^L|RossAIRA^AvantiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1923 Sergen op Zoom Pl^^Saint Heights^MI^48310^USA^P||^PRN^PH^^^586^3330426|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KendallAIRA^RossAIRA^^^^^L|MTH^Mother^HL70063|1923 Sergen op Zoom Pl^^Saint Heights^MI^48310^USA^P|^PRN^PH^^^586^3330426ORC|RE||BU47P11919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU47P11919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028020801^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028021811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W33C11924^^^AIRA-TEST^MR||SimmingsenAIRA^ShantahAIRA^Madelynn^^^^L|BourbonAIRA^CharleneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1533 Nuth Cir^^Warren^MI^48089^USA^P||^PRN^PH^^^586^7827418|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SimmingsenAIRA^BourbonAIRA^^^^^L|MTH^Mother^HL70063|1533 Nuth Cir^^Warren^MI^48089^USA^P|^PRN^PH^^^586^7827418ORC|RE||BW33C11924.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW33C11924.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028021811^Meningococcal (Groups A) CRM197 Oligosaccharide Co^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-46028021911|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B24K11935^^^AIRA-TEST^MR||O'BrianAIRA^HarrietAIRA^Kiyoko^^^^L|IdahoAIRA^AlonsaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1506 Begon Pl^^Hiawatha Temp Correction Fac^MI^49786^USA^P||^PRN^PH^^^906^7408967|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O'BrianAIRA^IdahoAIRA^^^^^L|MTH^Mother^HL70063|1506 Begon Pl^^Hiawatha Temp Correction Fac^MI^49786^USA^P|^PRN^PH^^^906^7408967ORC|RE||BB24K11935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB24K11935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||46028021911^Meningococcal (Groups C, Y, W-135) CRM197 Oligosac^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-010-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A60I11943^^^AIRA-TEST^MR||MeeAIRA^HadyaAIRA^Alejandra^^^^L|ManisteeAIRA^IrelandAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1477 Smmen Cir^^Woodhaven^MI^48183^USA^P||^PRN^PH^^^734^7153014|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeeAIRA^ManisteeAIRA^^^^^L|MTH^Mother^HL70063|1477 Smmen Cir^^Woodhaven^MI^48183^USA^P|^PRN^PH^^^734^7153014ORC|RE||BA60I11943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA60I11943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-010-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-010-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q56M11951^^^AIRA-TEST^MR||HutchinsonAIRA^DeidraAIRA^Minnie^^^^L|PolkAIRA^CairineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1805 Onder Ave^^Oxford^MI^48370^USA^P||^PRN^PH^^^248^6611396|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HutchinsonAIRA^PolkAIRA^^^^^L|MTH^Mother^HL70063|1805 Onder Ave^^Oxford^MI^48370^USA^P|^PRN^PH^^^248^6611396ORC|RE||BQ56M11951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ56M11951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-010-25^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-010-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I04Y11959^^^AIRA-TEST^MR||CentreAIRA^JanthineAIRA^Zeeba^^^^L|AndroscogginAIRA^RaiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1631 Faren Pl^^Saginaw^MI^48638^USA^P||^PRN^PH^^^989^4159282|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CentreAIRA^AndroscogginAIRA^^^^^L|MTH^Mother^HL70063|1631 Faren Pl^^Saginaw^MI^48638^USA^P|^PRN^PH^^^989^4159282ORC|RE||BI04Y11959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI04Y11959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-010-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-011-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M49O11964^^^AIRA-TEST^MR||AtascosaAIRA^AnnamariaAIRA^Persephone^^^^L|ColemanAIRA^XylonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1642 Sormerland Ln^^Oscoda^MI^48750^USA^P||^PRN^PH^^^989^7581296|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtascosaAIRA^ColemanAIRA^^^^^L|MTH^Mother^HL70063|1642 Sormerland Ln^^Oscoda^MI^48750^USA^P|^PRN^PH^^^989^7581296ORC|RE||BM49O11964.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM49O11964.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-011-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-011-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O95C11975^^^AIRA-TEST^MR||ClackamasAIRA^PrimroseAIRA^Cambria^^^^L|TylerAIRA^PippaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1409 Rmsterdam Ln^^Caseville^MI^48725^USA^P||^PRN^PH^^^989^8898941|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClackamasAIRA^TylerAIRA^^^^^L|MTH^Mother^HL70063|1409 Rmsterdam Ln^^Caseville^MI^48725^USA^P|^PRN^PH^^^989^8898941ORC|RE||BO95C11975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO95C11975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-011-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-012-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J68L11983^^^AIRA-TEST^MR||HaleAIRA^RangiAIRA^Anastasia^^^^L|TemplemanAIRA^CheyanneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1325 Eoudrichem Ln^^Chase Bank^MI^48278^USA^P||^PRN^PH^^^313^7374359|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaleAIRA^TemplemanAIRA^^^^^L|MTH^Mother^HL70063|1325 Eoudrichem Ln^^Chase Bank^MI^48278^USA^P|^PRN^PH^^^313^7374359ORC|RE||BJ68L11983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ68L11983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-012-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-012-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O19Z11991^^^AIRA-TEST^MR||LyonAIRA^GonerilAIRA^Thurid^^^^L|MackeyAIRA^TeganAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1480 Gorinchem Cir^^Fort Gratiot^MI^48059^USA^P||^PRN^PH^^^810^8643077|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LyonAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1480 Gorinchem Cir^^Fort Gratiot^MI^48059^USA^P|^PRN^PH^^^810^8643077ORC|RE||BO19Z11991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO19Z11991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-012-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-013-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U17F11999^^^AIRA-TEST^MR||McQuadeAIRA^VivienneAIRA^Sesha^^^^L|SheridanAIRA^OlyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1662 Lernheze Pl^^Flint^MI^48555^USA^P||^PRN^PH^^^810^8875148|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McQuadeAIRA^SheridanAIRA^^^^^L|MTH^Mother^HL70063|1662 Lernheze Pl^^Flint^MI^48555^USA^P|^PRN^PH^^^810^8875148ORC|RE||BU17F11999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU17F11999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-013-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-013-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M59B12004^^^AIRA-TEST^MR||ThiemerAIRA^LatishaAIRA^Royale^^^^L|WapelloAIRA^TustiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1696 Uesterveld Ln^^Holt^MI^48842^USA^P||^PRN^PH^^^517^9650554|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThiemerAIRA^WapelloAIRA^^^^^L|MTH^Mother^HL70063|1696 Uesterveld Ln^^Holt^MI^48842^USA^P|^PRN^PH^^^517^9650554ORC|RE||BM59B12004.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM59B12004.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-013-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-013-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W44K12015^^^AIRA-TEST^MR||HockleyAIRA^AnaliaAIRA^Ashleigh^^^^L|EricksonAIRA^CarleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1660 Waarnemen Pl^^Harbor Springs^MI^49737^USA^P||^PRN^PH^^^616^2748917|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HockleyAIRA^EricksonAIRA^^^^^L|MTH^Mother^HL70063|1660 Waarnemen Pl^^Harbor Springs^MI^49737^USA^P|^PRN^PH^^^616^2748917ORC|RE||BW44K12015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW44K12015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-013-58^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-013-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U03K12023^^^AIRA-TEST^MR||MiamiAIRA^AloysiaAIRA^Margaret^^^^L|BucksAIRA^ValerieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1896 Leren Cir^^Burton^MI^48529^USA^P||^PRN^PH^^^810^5309415|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MiamiAIRA^BucksAIRA^^^^^L|MTH^Mother^HL70063|1896 Leren Cir^^Burton^MI^48529^USA^P|^PRN^PH^^^810^5309415ORC|RE||BU03K12023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU03K12023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-013-88^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-014-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I13L12031^^^AIRA-TEST^MR||LycomingAIRA^AbagailAIRA^Aisha^^^^L|Des MoinesAIRA^LodemaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1485 Te Wolden Ave^^Pontiac^MI^48340^USA^P||^PRN^PH^^^248^8790053|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LycomingAIRA^Des MoinesAIRA^^^^^L|MTH^Mother^HL70063|1485 Te Wolden Ave^^Pontiac^MI^48340^USA^P|^PRN^PH^^^248^8790053ORC|RE||BI13L12031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI13L12031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-014-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-014-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X88U12039^^^AIRA-TEST^MR||ElliottAIRA^EsperanceAIRA^Ritsuko^^^^L|PimaAIRA^SanjulaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1458 Leldermalsen Ln^^Kimball^MI^48074^USA^P||^PRN^PH^^^810^9522079|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ElliottAIRA^PimaAIRA^^^^^L|MTH^Mother^HL70063|1458 Leldermalsen Ln^^Kimball^MI^48074^USA^P|^PRN^PH^^^810^9522079ORC|RE||BX88U12039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX88U12039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-014-88^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-111-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M36K12044^^^AIRA-TEST^MR||CavilAIRA^NiobeAIRA^Sherry^^^^L|PainterAIRA^FifiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1529 Goeree-Overflakkee St^^Detroit^MI^48204^USA^P||^PRN^PH^^^313^8844063|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CavilAIRA^PainterAIRA^^^^^L|MTH^Mother^HL70063|1529 Goeree-Overflakkee St^^Detroit^MI^48204^USA^P|^PRN^PH^^^313^8844063ORC|RE||BM36K12044.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM36K12044.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-111-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-112-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O28O12055^^^AIRA-TEST^MR||UvaldeAIRA^HanyaAIRA^Yori^^^^L|MenifeeAIRA^CandraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1183 Mcherpenzeel Ln^^Loretto^MI^49852^USA^P||^PRN^PH^^^906^5298691|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UvaldeAIRA^MenifeeAIRA^^^^^L|MTH^Mother^HL70063|1183 Mcherpenzeel Ln^^Loretto^MI^49852^USA^P|^PRN^PH^^^906^5298691ORC|RE||BO28O12055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO28O12055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-112-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-113-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z36N12063^^^AIRA-TEST^MR||SivertsenAIRA^NickiAIRA^Shivani^^^^L|WayneAIRA^CrescentAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1904 Wittenseradeel Pl^^Oak Grove^MI^48863^USA^P||^PRN^PH^^^517^4131868|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SivertsenAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1904 Wittenseradeel Pl^^Oak Grove^MI^48863^USA^P|^PRN^PH^^^517^4131868ORC|RE||BZ36N12063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ36N12063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-113-00^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-113-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U24U12071^^^AIRA-TEST^MR||LindstromAIRA^DooriyaAIRA^Susan^^^^L|PickawayAIRA^MackenzieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1608 Controleren Pl^^Leroy^MI^49655^USA^P||^PRN^PH^^^231^4078629|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LindstromAIRA^PickawayAIRA^^^^^L|MTH^Mother^HL70063|1608 Controleren Pl^^Leroy^MI^49655^USA^P|^PRN^PH^^^231^4078629ORC|RE||BU24U12071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU24U12071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-113-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-215-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K75Y12079^^^AIRA-TEST^MR||MeaghanAIRA^BalbinaAIRA^Deja^^^^L|KirklandAIRA^YnesAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1326 Straat Ave^^Holton^MI^49425^USA^P||^PRN^PH^^^231^8328528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeaghanAIRA^KirklandAIRA^^^^^L|MTH^Mother^HL70063|1326 Straat Ave^^Holton^MI^49425^USA^P|^PRN^PH^^^231^8328528ORC|RE||BK75Y12079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK75Y12079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-215-10^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-215-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M54Z12084^^^AIRA-TEST^MR||WashingtonAIRA^RandaAIRA^Shian^^^^L|HardinAIRA^NoelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1400 Sroningen St^^Saint Clair Shrs^MI^48080^USA^P||^PRN^PH^^^586^9157982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1400 Sroningen St^^Saint Clair Shrs^MI^48080^USA^P|^PRN^PH^^^586^9157982ORC|RE||BM54Z12084.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM54Z12084.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-215-15^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-215-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O63C12095^^^AIRA-TEST^MR||GarfieldAIRA^LucieAIRA^Alex^^^^L|GustafsonAIRA^EfiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1329 Base Ln^^Fulton^MI^49052^USA^P||^PRN^PH^^^269^9169797|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarfieldAIRA^GustafsonAIRA^^^^^L|MTH^Mother^HL70063|1329 Base Ln^^Fulton^MI^49052^USA^P|^PRN^PH^^^269^9169797ORC|RE||BO63C12095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO63C12095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-215-58^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-215-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K36L12103^^^AIRA-TEST^MR||ClevelandAIRA^AudoraAIRA^Huberta^^^^L|GravesAIRA^AmayaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1325 Vrouwen Pl^^Troy^MI^48083^USA^P||^PRN^PH^^^248^3521926|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClevelandAIRA^GravesAIRA^^^^^L|MTH^Mother^HL70063|1325 Vrouwen Pl^^Troy^MI^48083^USA^P|^PRN^PH^^^248^3521926ORC|RE||BK36L12103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK36L12103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-215-88^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-225-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N98J12111^^^AIRA-TEST^MR||CannavinAIRA^AlonaAIRA^Jardena^^^^L|BrackenAIRA^BrodieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1513 Rente Cir^^Flint^MI^48552^USA^P||^PRN^PH^^^810^4143678|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CannavinAIRA^BrackenAIRA^^^^^L|MTH^Mother^HL70063|1513 Rente Cir^^Flint^MI^48552^USA^P|^PRN^PH^^^810^4143678ORC|RE||BN98J12111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN98J12111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-225-10^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-225-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B38N12119^^^AIRA-TEST^MR||OsageAIRA^ArunaAIRA^Hayleigh^^^^L|SwindellsAIRA^AvivaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1887 Rindhoven St^^Detroit^MI^48236^USA^P||^PRN^PH^^^313^6724661|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OsageAIRA^SwindellsAIRA^^^^^L|MTH^Mother^HL70063|1887 Rindhoven St^^Detroit^MI^48236^USA^P|^PRN^PH^^^313^6724661ORC|RE||BB38N12119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB38N12119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-225-58^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-248-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A22X12124^^^AIRA-TEST^MR||BucksAIRA^SabrinaAIRA^Rachel^^^^L|GuthrieAIRA^MeganAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1736 Womeren Ln^^Felch^MI^49831^USA^P||^PRN^PH^^^906^3739116|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BucksAIRA^GuthrieAIRA^^^^^L|MTH^Mother^HL70063|1736 Womeren Ln^^Felch^MI^49831^USA^P|^PRN^PH^^^906^3739116ORC|RE||BA22X12124.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA22X12124.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-248-58^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-250-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R20Y12135^^^AIRA-TEST^MR||AinslieAIRA^EkalaAIRA^Lynda^^^^L|ThomasAIRA^FleurAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1374 Mapendrecht Cir^^Engadine^MI^49827^USA^P||^PRN^PH^^^906^9287106|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AinslieAIRA^ThomasAIRA^^^^^L|MTH^Mother^HL70063|1374 Mapendrecht Cir^^Engadine^MI^49827^USA^P|^PRN^PH^^^906^9287106ORC|RE||BR20Y12135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR20Y12135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-250-51^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-278-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q03P12143^^^AIRA-TEST^MR||MagriAIRA^CarmitaAIRA^Lora^^^^L|GrayAIRA^TrishAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1554 Creeren Ln^^National City^MI^48748^USA^P||^PRN^PH^^^989^9982464|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MagriAIRA^GrayAIRA^^^^^L|MTH^Mother^HL70063|1554 Creeren Ln^^National City^MI^48748^USA^P|^PRN^PH^^^989^9982464ORC|RE||BQ03P12143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ03P12143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-278-10^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-286-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A95H12151^^^AIRA-TEST^MR||OsbornAIRA^TakiyahAIRA^Prachi^^^^L|CartonAIRA^CleopatraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1926 Appel Ave^^Ann Arbor^MI^48108^USA^P||^PRN^PH^^^734^3451424|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OsbornAIRA^CartonAIRA^^^^^L|MTH^Mother^HL70063|1926 Appel Ave^^Ann Arbor^MI^48108^USA^P|^PRN^PH^^^734^3451424ORC|RE||BA95H12151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA95H12151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-286-01^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-286-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F93A12159^^^AIRA-TEST^MR||WashingtonAIRA^MyronAIRA^Isabelle^^^^L|CherryAIRA^SaheliAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1007 Vrouw Ln^^Eastmanville^MI^49404^USA^P||^PRN^PH^^^616^4309380|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^CherryAIRA^^^^^L|MTH^Mother^HL70063|1007 Vrouw Ln^^Eastmanville^MI^49404^USA^P|^PRN^PH^^^616^4309380ORC|RE||BF93A12159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF93A12159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-286-05^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-286-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I92I12164^^^AIRA-TEST^MR||LewisAIRA^MiginaAIRA^Jerrica^^^^L|StephensAIRA^CheriseAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1614 Wierden Pl^^White Pine^MI^49971^USA^P||^PRN^PH^^^906^3617207|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LewisAIRA^StephensAIRA^^^^^L|MTH^Mother^HL70063|1614 Wierden Pl^^White Pine^MI^49971^USA^P|^PRN^PH^^^906^3617207ORC|RE||BI92I12164.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI92I12164.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-286-10^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-286-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S05S12175^^^AIRA-TEST^MR||DelawareAIRA^PeytonAIRA^Reine^^^^L|EllisAIRA^LiliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1855 Gereedschap Ln^^Ripley^MI^49930^USA^P||^PRN^PH^^^906^2621463|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^EllisAIRA^^^^^L|MTH^Mother^HL70063|1855 Gereedschap Ln^^Ripley^MI^49930^USA^P|^PRN^PH^^^906^2621463ORC|RE||BS05S12175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS05S12175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-286-58^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-291-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K71R12183^^^AIRA-TEST^MR||AlleghenyAIRA^VasantaAIRA^Neeta^^^^L|LenaweeAIRA^KairosAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1463 Kergen op Zoom Ave^^Gregory^MI^48137^USA^P||^PRN^PH^^^734^5493172|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlleghenyAIRA^LenaweeAIRA^^^^^L|MTH^Mother^HL70063|1463 Kergen op Zoom Ave^^Gregory^MI^48137^USA^P|^PRN^PH^^^734^5493172ORC|RE||BK71R12183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK71R12183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-291-10^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-291-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F63G12191^^^AIRA-TEST^MR||RogersAIRA^FantasiaAIRA^Cybill^^^^L|MonroeAIRA^BayleeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1392 Saaksbergen St^^Lenox^MI^48050^USA^P||^PRN^PH^^^586^3180655|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RogersAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1392 Saaksbergen St^^Lenox^MI^48050^USA^P|^PRN^PH^^^586^3180655ORC|RE||BF63G12191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF63G12191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-291-83^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-298-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A37R12199^^^AIRA-TEST^MR||CooperAIRA^LaraineAIRA^Mireya^^^^L|LeonardAIRA^UtinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1789 Loeree-Overflakkee St^^Minden City^MI^48456^USA^P||^PRN^PH^^^989^9387581|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CooperAIRA^LeonardAIRA^^^^^L|MTH^Mother^HL70063|1789 Loeree-Overflakkee St^^Minden City^MI^48456^USA^P|^PRN^PH^^^989^9387581ORC|RE||BA37R12199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA37R12199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-298-10^TRIPEDIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-386-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L17A12204^^^AIRA-TEST^MR||CulbersonAIRA^JerardaAIRA^Chloris^^^^L|MarionAIRA^ArieneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1537 Hmsterdam Cir^^Wyoming^MI^49418^USA^P||^PRN^PH^^^616^9988745|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CulbersonAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1537 Hmsterdam Cir^^Wyoming^MI^49418^USA^P|^PRN^PH^^^616^9988745ORC|RE||BL17A12204.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL17A12204.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-386-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-387-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I49B12215^^^AIRA-TEST^MR||GrantAIRA^TaliyahAIRA^Ryan^^^^L|Olsen LeeAIRA^ShobhanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1032 Oa en Hunze Pl^^Clarkston^MI^48346^USA^P||^PRN^PH^^^248^3814145|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrantAIRA^Olsen LeeAIRA^^^^^L|MTH^Mother^HL70063|1032 Oa en Hunze Pl^^Clarkston^MI^48346^USA^P|^PRN^PH^^^248^3814145ORC|RE||BI49B12215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI49B12215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-387-65^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-388-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G85Z12223^^^AIRA-TEST^MR||SweeneyAIRA^QuorraAIRA^Elizabeth^^^^L|HoeyAIRA^BryanneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1416 Wiel St^^White Lake^MI^48386^USA^P||^PRN^PH^^^248^4915340|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SweeneyAIRA^HoeyAIRA^^^^^L|MTH^Mother^HL70063|1416 Wiel St^^White Lake^MI^48386^USA^P|^PRN^PH^^^248^4915340ORC|RE||BG85Z12223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG85Z12223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-388-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-389-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q35P12231^^^AIRA-TEST^MR||McGannAIRA^SapphiraAIRA^Cynere^^^^L|EdwardsAIRA^RimaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1951 Ledemblik St^^La Salle^MI^48145^USA^P||^PRN^PH^^^734^9871505|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McGannAIRA^EdwardsAIRA^^^^^L|MTH^Mother^HL70063|1951 Ledemblik St^^La Salle^MI^48145^USA^P|^PRN^PH^^^734^9871505ORC|RE||BQ35P12231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ35P12231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-389-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-390-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q94B12239^^^AIRA-TEST^MR||ToddAIRA^RainbowAIRA^Stephenie^^^^L|ShappeAIRA^CandyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1716 Rinterswijk Pl^^China^MI^48054^USA^P||^PRN^PH^^^810^6441020|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ToddAIRA^ShappeAIRA^^^^^L|MTH^Mother^HL70063|1716 Rinterswijk Pl^^China^MI^48054^USA^P|^PRN^PH^^^810^6441020ORC|RE||BQ94B12239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ94B12239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-390-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-391-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P62B12244^^^AIRA-TEST^MR||KolarAIRA^SydneyAIRA^Alondra^^^^L|AndersonAIRA^HyeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1430 Aontferland Pl^^Detroit^MI^48239^USA^P||^PRN^PH^^^734^9896085|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KolarAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1430 Aontferland Pl^^Detroit^MI^48239^USA^P|^PRN^PH^^^734^9896085ORC|RE||BP62B12244.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP62B12244.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-391-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-392-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H57W12255^^^AIRA-TEST^MR||El DoradoAIRA^VanniAIRA^Shivaun^^^^L|McEntegartAIRA^MarsalaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1690 Aerneuzen Cir^^Frenchtown^MI^48161^USA^P||^PRN^PH^^^734^7357899|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|El DoradoAIRA^McEntegartAIRA^^^^^L|MTH^Mother^HL70063|1690 Aerneuzen Cir^^Frenchtown^MI^48161^USA^P|^PRN^PH^^^734^7357899ORC|RE||BH57W12255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH57W12255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-392-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-392-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H76R12263^^^AIRA-TEST^MR||PrebleAIRA^LinaAIRA^Edme^^^^L|EastlandAIRA^ManjulaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1593 Neel en Maas Ave^^Cannonsburg^MI^49317^USA^P||^PRN^PH^^^616^7676247|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PrebleAIRA^EastlandAIRA^^^^^L|MTH^Mother^HL70063|1593 Neel en Maas Ave^^Cannonsburg^MI^49317^USA^P|^PRN^PH^^^616^7676247ORC|RE||BH76R12263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH76R12263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-392-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-393-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I50C12271^^^AIRA-TEST^MR||ArcherAIRA^OdileAIRA^Audora^^^^L|BeecherAIRA^MitsukoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1958 Lezen Cir^^Otisville^MI^48463^USA^P||^PRN^PH^^^810^2691472|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ArcherAIRA^BeecherAIRA^^^^^L|MTH^Mother^HL70063|1958 Lezen Cir^^Otisville^MI^48463^USA^P|^PRN^PH^^^810^2691472ORC|RE||BI50C12271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI50C12271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-393-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-393-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I70Q12279^^^AIRA-TEST^MR||GilaAIRA^ZinaidaAIRA^Arva^^^^L|CottleAIRA^PaulineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1728 Heerijnen Ave^^Niles^MI^49120^USA^P||^PRN^PH^^^269^8700460|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GilaAIRA^CottleAIRA^^^^^L|MTH^Mother^HL70063|1728 Heerijnen Ave^^Niles^MI^49120^USA^P|^PRN^PH^^^269^8700460ORC|RE||BI70Q12279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI70Q12279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-393-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-394-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P83A12284^^^AIRA-TEST^MR||BenzieAIRA^CorabelleAIRA^Eartha^^^^L|HubbardAIRA^MomokoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1458 Kudwest-Fryslan Ln^^Jerome^MI^49249^USA^P||^PRN^PH^^^517^6910506|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BenzieAIRA^HubbardAIRA^^^^^L|MTH^Mother^HL70063|1458 Kudwest-Fryslan Ln^^Jerome^MI^49249^USA^P|^PRN^PH^^^517^6910506ORC|RE||BP83A12284.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP83A12284.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-394-15^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-394-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U69R12295^^^AIRA-TEST^MR||GreeneAIRA^AmataAIRA^Rhiannon^^^^L|JohnsonAIRA^JardenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1876 Varieren St^^Muskegon^MI^49441^USA^P||^PRN^PH^^^231^5191792|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreeneAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1876 Varieren St^^Muskegon^MI^49441^USA^P|^PRN^PH^^^231^5191792ORC|RE||BU69R12295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU69R12295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-394-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-395-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q55Z12303^^^AIRA-TEST^MR||LambAIRA^NadineAIRA^Jean^^^^L|KentAIRA^IonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1977 Kaart Pl^^Carleton^MI^48117^USA^P||^PRN^PH^^^734^6596150|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LambAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1977 Kaart Pl^^Carleton^MI^48117^USA^P|^PRN^PH^^^734^6596150ORC|RE||BQ55Z12303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ55Z12303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-395-65^FLUZONE HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-395-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B42Y12311^^^AIRA-TEST^MR||PottawatomieAIRA^MargaretAIRA^Neola^^^^L|BergenAIRA^ElspethAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1767 Schreeuw Pl^^Hartland^MI^48353^USA^P||^PRN^PH^^^810^8199281|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PottawatomieAIRA^BergenAIRA^^^^^L|MTH^Mother^HL70063|1767 Schreeuw Pl^^Hartland^MI^48353^USA^P|^PRN^PH^^^810^8199281ORC|RE||BB42Y12311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB42Y12311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-395-88^Fluzone HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-396-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W20K12319^^^AIRA-TEST^MR||HuronAIRA^NeridaAIRA^Quinta^^^^L|NorthamptonAIRA^IdolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1189 Houten Cir^^Chesterfield Township^MI^48051^USA^P||^PRN^PH^^^586^3382667|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HuronAIRA^NorthamptonAIRA^^^^^L|MTH^Mother^HL70063|1189 Houten Cir^^Chesterfield Township^MI^48051^USA^P|^PRN^PH^^^586^3382667ORC|RE||BW20K12319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW20K12319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-396-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-396-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B51W12324^^^AIRA-TEST^MR||ThiemerAIRA^SelaAIRA^Emogene^^^^L|DickinsonAIRA^QuellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1920 Ouder Ln^^Brighton^MI^48116^USA^P||^PRN^PH^^^810^9790982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThiemerAIRA^DickinsonAIRA^^^^^L|MTH^Mother^HL70063|1920 Ouder Ln^^Brighton^MI^48116^USA^P|^PRN^PH^^^810^9790982ORC|RE||BB51W12324.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB51W12324.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-396-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-397-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R27J12335^^^AIRA-TEST^MR||RichlandAIRA^BananAIRA^Carlen^^^^L|CusterAIRA^MakaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1725 Kaart Ln^^Bloomfield Township^MI^48304^USA^P||^PRN^PH^^^248^8906515|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichlandAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1725 Kaart Ln^^Bloomfield Township^MI^48304^USA^P|^PRN^PH^^^248^8906515ORC|RE||BR27J12335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR27J12335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-397-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-397-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q76I12343^^^AIRA-TEST^MR||BooneAIRA^UjjwalaAIRA^Anca^^^^L|FerryAIRA^DagnyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1082 Voedsel St^^Walker^MI^49544^USA^P||^PRN^PH^^^616^5945335|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BooneAIRA^FerryAIRA^^^^^L|MTH^Mother^HL70063|1082 Voedsel St^^Walker^MI^49544^USA^P|^PRN^PH^^^616^5945335ORC|RE||BQ76I12343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ76I12343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-397-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-399-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P40K12351^^^AIRA-TEST^MR||MuhlenbergAIRA^LychorindaAIRA^Kathy^^^^L|LarsonAIRA^JazminAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1629 Norsele Ave^^Gilford^MI^48736^USA^P||^PRN^PH^^^989^7828808|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MuhlenbergAIRA^LarsonAIRA^^^^^L|MTH^Mother^HL70063|1629 Norsele Ave^^Gilford^MI^48736^USA^P|^PRN^PH^^^989^7828808ORC|RE||BP40K12351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP40K12351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-399-65^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-399-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H37T12359^^^AIRA-TEST^MR||ScottAIRA^MareAIRA^Emersyn^^^^L|CaseyAIRA^CyzarineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1889 Heldhoven Cir^^Berkley^MI^48072^USA^P||^PRN^PH^^^248^7629205|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ScottAIRA^CaseyAIRA^^^^^L|MTH^Mother^HL70063|1889 Heldhoven Cir^^Berkley^MI^48072^USA^P|^PRN^PH^^^248^7629205ORC|RE||BH37T12359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH37T12359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-399-88^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-400-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X37N12364^^^AIRA-TEST^MR||TansbergAIRA^SerenityAIRA^Hope^^^^L|NightingaleAIRA^LaylahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1901 Bmstelveen St^^Bay City^MI^48708^USA^P||^PRN^PH^^^989^5964805|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TansbergAIRA^NightingaleAIRA^^^^^L|MTH^Mother^HL70063|1901 Bmstelveen St^^Bay City^MI^48708^USA^P|^PRN^PH^^^989^5964805ORC|RE||BX37N12364.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX37N12364.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-400-05^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-400-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E24I12375^^^AIRA-TEST^MR||HumboldtAIRA^JoellianeAIRA^Oralie^^^^L|AndersonAIRA^MadalynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1249 Hoxtel Pl^^Burt^MI^48417^USA^P||^PRN^PH^^^989^2291096|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HumboldtAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1249 Hoxtel Pl^^Burt^MI^48417^USA^P|^PRN^PH^^^989^2291096ORC|RE||BE24I12375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE24I12375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-400-10^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-400-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V56Q12383^^^AIRA-TEST^MR||BrownfieldAIRA^BirgetAIRA^Laina^^^^L|WayneAIRA^CorineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1913 Randgraaf Cir^^Saginaw^MI^48604^USA^P||^PRN^PH^^^989^9991669|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownfieldAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1913 Randgraaf Cir^^Saginaw^MI^48604^USA^P|^PRN^PH^^^989^9991669ORC|RE||BV56Q12383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV56Q12383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-400-15^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-400-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M88U12391^^^AIRA-TEST^MR||MeeAIRA^DeviAIRA^Sydney^^^^L|Santa BarbaraAIRA^EerinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1061 Doerden Ave^^Corunna^MI^48817^USA^P||^PRN^PH^^^989^3162199|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeeAIRA^Santa BarbaraAIRA^^^^^L|MTH^Mother^HL70063|1061 Doerden Ave^^Corunna^MI^48817^USA^P|^PRN^PH^^^989^3162199ORC|RE||BM88U12391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM88U12391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-400-20^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-400-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J79V12399^^^AIRA-TEST^MR||SweeneyAIRA^LibbyAIRA^Arinya^^^^L|JeffersonAIRA^MarvelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1658 Dier Ave^^Scotts^MI^49088^USA^P||^PRN^PH^^^269^9243117|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SweeneyAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1658 Dier Ave^^Scotts^MI^49088^USA^P|^PRN^PH^^^269^9243117ORC|RE||BJ79V12399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ79V12399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-400-58^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-400-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A76Y12404^^^AIRA-TEST^MR||CameronAIRA^FelciaAIRA^Madra^^^^L|NobleAIRA^ErwinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1954 Oedemblik Ln^^Galesburg^MI^49053^USA^P||^PRN^PH^^^269^6723451|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CameronAIRA^NobleAIRA^^^^^L|MTH^Mother^HL70063|1954 Oedemblik Ln^^Galesburg^MI^49053^USA^P|^PRN^PH^^^269^6723451ORC|RE||BA76Y12404.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA76Y12404.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-400-88^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-400-89|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O23J12415^^^AIRA-TEST^MR||VargasAIRA^ElieAIRA^Hika^^^^L|BrooksAIRA^KiriAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1304 Kijdemeren Pl^^Schaffer^MI^49807^USA^P||^PRN^PH^^^906^8216743|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VargasAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1304 Kijdemeren Pl^^Schaffer^MI^49807^USA^P|^PRN^PH^^^906^8216743ORC|RE||BO23J12415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO23J12415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-400-89^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-401-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O93Q12423^^^AIRA-TEST^MR||CrawfordAIRA^DionyzaAIRA^Indaliai^^^^L|EmmetAIRA^JoellianeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1284 Aeusden Ave^^Troy^MI^48084^USA^P||^PRN^PH^^^248^4674063|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CrawfordAIRA^EmmetAIRA^^^^^L|MTH^Mother^HL70063|1284 Aeusden Ave^^Troy^MI^48084^USA^P|^PRN^PH^^^248^4674063ORC|RE||BO93Q12423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO93Q12423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-401-65^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-401-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X01R12431^^^AIRA-TEST^MR||DimmitAIRA^LeiaAIRA^Ayse^^^^L|UvaldeAIRA^EskarneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1984 Douten Ln^^Independence^MI^48348^USA^P||^PRN^PH^^^248^4619881|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DimmitAIRA^UvaldeAIRA^^^^^L|MTH^Mother^HL70063|1984 Douten Ln^^Independence^MI^48348^USA^P|^PRN^PH^^^248^4619881ORC|RE||BX01R12431.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX01R12431.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-401-88^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-403-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E07O12439^^^AIRA-TEST^MR||IdaAIRA^QuintaAIRA^Giulietta^^^^L|HeffordAIRA^TegenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1482 Eluis Ave^^Saint Joe^MI^49085^USA^P||^PRN^PH^^^269^3609436|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IdaAIRA^HeffordAIRA^^^^^L|MTH^Mother^HL70063|1482 Eluis Ave^^Saint Joe^MI^49085^USA^P|^PRN^PH^^^269^3609436ORC|RE||BE07O12439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE07O12439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-403-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-403-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V63Z12444^^^AIRA-TEST^MR||BielaAIRA^AkritiAIRA^Guan-yin^^^^L|DixonAIRA^KatieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1121 Nieuwkoop Cir^^Mackinaw City^MI^49701^USA^P||^PRN^PH^^^231^6037413|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BielaAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1121 Nieuwkoop Cir^^Mackinaw City^MI^49701^USA^P|^PRN^PH^^^231^6037413ORC|RE||BV63Z12444.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV63Z12444.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-403-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-413-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E27W12455^^^AIRA-TEST^MR||YakimaAIRA^SienaAIRA^Odea^^^^L|HenryAIRA^AparaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1862 Beerlen St^^Mi Department of Revenue^MI^48922^USA^P||^PRN^PH^^^517^3516971|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YakimaAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1862 Beerlen St^^Mi Department of Revenue^MI^48922^USA^P|^PRN^PH^^^517^3516971ORC|RE||BE27W12455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE27W12455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-413-10^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-413-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K90S12463^^^AIRA-TEST^MR||HardinAIRA^PalomaAIRA^Naida^^^^L|WashingtonAIRA^AsellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1377 Koppersum Pl^^Waterford Township^MI^48327^USA^P||^PRN^PH^^^248^2044151|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1377 Koppersum Pl^^Waterford Township^MI^48327^USA^P|^PRN^PH^^^248^2044151ORC|RE||BK90S12463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK90S12463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-413-50^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-413-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S46U12471^^^AIRA-TEST^MR||LundgrenAIRA^EnyeAIRA^Yvonne^^^^L|MontgomeryAIRA^CarissaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1730 Soort Cir^^Benton Harbor^MI^49022^USA^P||^PRN^PH^^^269^3775428|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LundgrenAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1730 Soort Cir^^Benton Harbor^MI^49022^USA^P|^PRN^PH^^^269^3775428ORC|RE||BS46U12471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS46U12471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-413-58^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-413-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B73T12479^^^AIRA-TEST^MR||ColonAIRA^CaraAIRA^Eleanor^^^^L|StrubleAIRA^MedhaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1211 Tint Anthonis Ln^^Shelby Township^MI^48317^USA^P||^PRN^PH^^^586^6762213|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColonAIRA^StrubleAIRA^^^^^L|MTH^Mother^HL70063|1211 Tint Anthonis Ln^^Shelby Township^MI^48317^USA^P|^PRN^PH^^^586^6762213ORC|RE||BB73T12479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB73T12479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-413-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-414-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T56A12484^^^AIRA-TEST^MR||GagleAIRA^AzraAIRA^Marina^^^^L|JasperAIRA^EmaliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1884 Leudal Cir^^Benton Harbor^MI^49022^USA^P||^PRN^PH^^^269^5722387|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GagleAIRA^JasperAIRA^^^^^L|MTH^Mother^HL70063|1884 Leudal Cir^^Benton Harbor^MI^49022^USA^P|^PRN^PH^^^269^5722387ORC|RE||BT56A12484.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT56A12484.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-414-10^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-414-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L08O12495^^^AIRA-TEST^MR||DeschutesAIRA^KylahAIRA^Dionne^^^^L|HarmonAIRA^LilliannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1014 Toets Cir^^Breedsville^MI^49027^USA^P||^PRN^PH^^^269^7372036|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DeschutesAIRA^HarmonAIRA^^^^^L|MTH^Mother^HL70063|1014 Toets Cir^^Breedsville^MI^49027^USA^P|^PRN^PH^^^269^7372036ORC|RE||BL08O12495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL08O12495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-414-50^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-414-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M00L12503^^^AIRA-TEST^MR||OwyheeAIRA^NavdeepAIRA^Carlina^^^^L|WayrynenAIRA^OmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1572 Zeldhoven Cir^^Iron Mountain^MI^49801^USA^P||^PRN^PH^^^906^9822911|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwyheeAIRA^WayrynenAIRA^^^^^L|MTH^Mother^HL70063|1572 Zeldhoven Cir^^Iron Mountain^MI^49801^USA^P|^PRN^PH^^^906^9822911ORC|RE||BM00L12503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM00L12503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-414-58^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-414-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q31C12511^^^AIRA-TEST^MR||WilliamsonAIRA^MaiaAIRA^Malila^^^^L|PowerAIRA^RochelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1538 Wlst-Wijhe Ln^^Blaney Park^MI^49836^USA^P||^PRN^PH^^^906^5513559|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilliamsonAIRA^PowerAIRA^^^^^L|MTH^Mother^HL70063|1538 Wlst-Wijhe Ln^^Blaney Park^MI^49836^USA^P|^PRN^PH^^^906^5513559ORC|RE||BQ31C12511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ31C12511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-414-88^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-415-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F75J12519^^^AIRA-TEST^MR||LewisAIRA^AdonciaAIRA^Yuriko^^^^L|LakeAIRA^DrinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1898 Van St^^Saranac^MI^48881^USA^P||^PRN^PH^^^616^9469363|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LewisAIRA^LakeAIRA^^^^^L|MTH^Mother^HL70063|1898 Van St^^Saranac^MI^48881^USA^P|^PRN^PH^^^616^9469363ORC|RE||BF75J12519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF75J12519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-415-10^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-415-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U34Q12524^^^AIRA-TEST^MR||RuskAIRA^JuneAIRA^Siroun^^^^L|GrantAIRA^MariashaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1988 Ooerendaal Ave^^Tower^MI^49792^USA^P||^PRN^PH^^^989^4871368|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RuskAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1988 Ooerendaal Ave^^Tower^MI^49792^USA^P|^PRN^PH^^^989^4871368ORC|RE||BU34Q12524.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU34Q12524.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-415-58^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-415-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E66J12535^^^AIRA-TEST^MR||RussellAIRA^ArdathAIRA^Ester^^^^L|GarrardAIRA^LovedayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1939 Wierden Ln^^Brownstown Township^MI^48174^USA^P||^PRN^PH^^^734^7275667|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RussellAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1939 Wierden Ln^^Brownstown Township^MI^48174^USA^P|^PRN^PH^^^734^7275667ORC|RE||BE66J12535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE66J12535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-415-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-416-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S42K12543^^^AIRA-TEST^MR||BaylorAIRA^DuenaAIRA^Darcie^^^^L|McErlaneAIRA^AmissaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1382 Nldebroek Cir^^GR^MI^49525^USA^P||^PRN^PH^^^616^4526887|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BaylorAIRA^McErlaneAIRA^^^^^L|MTH^Mother^HL70063|1382 Nldebroek Cir^^GR^MI^49525^USA^P|^PRN^PH^^^616^4526887ORC|RE||BS42K12543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS42K12543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-416-10^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-416-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X50T12551^^^AIRA-TEST^MR||SanilacAIRA^MaitryiAIRA^Taryn^^^^L|BryanAIRA^RiannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1431 Eenswoude Pl^^Benton Harbor^MI^49022^USA^P||^PRN^PH^^^269^3135599|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SanilacAIRA^BryanAIRA^^^^^L|MTH^Mother^HL70063|1431 Eenswoude Pl^^Benton Harbor^MI^49022^USA^P|^PRN^PH^^^269^3135599ORC|RE||BX50T12551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX50T12551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-416-50^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-416-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q48J12559^^^AIRA-TEST^MR||MackinacAIRA^LisbethAIRA^Sabah^^^^L|MackinacAIRA^SunAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1409 Nellevoetsluis Cir^^Grand Rapids^MI^49528^USA^P||^PRN^PH^^^616^5929629|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MackinacAIRA^MackinacAIRA^^^^^L|MTH^Mother^HL70063|1409 Nellevoetsluis Cir^^Grand Rapids^MI^49528^USA^P|^PRN^PH^^^616^5929629ORC|RE||BQ48J12559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ48J12559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-416-58^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-416-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G08I12564^^^AIRA-TEST^MR||ThompsenAIRA^ImanAIRA^Carlin^^^^L|DouglasAIRA^HannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1739 Baalte St^^Gerber Products Inc^MI^49413^USA^P||^PRN^PH^^^231^3070159|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThompsenAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1739 Baalte St^^Gerber Products Inc^MI^49413^USA^P|^PRN^PH^^^231^3070159ORC|RE||BG08I12564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG08I12564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-416-88^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-417-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q98X12575^^^AIRA-TEST^MR||GrundyAIRA^LaverneAIRA^Akaisha^^^^L|EatonAIRA^ParveenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1890 Rchouwen-Duiveland Ln^^Shelbyville^MI^49344^USA^P||^PRN^PH^^^269^8996013|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrundyAIRA^EatonAIRA^^^^^L|MTH^Mother^HL70063|1890 Rchouwen-Duiveland Ln^^Shelbyville^MI^49344^USA^P|^PRN^PH^^^269^8996013ORC|RE||BQ98X12575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ98X12575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-417-10^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-417-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S48S12583^^^AIRA-TEST^MR||Hood RiverAIRA^HeatherAIRA^Shirin^^^^L|MartinsonAIRA^CarolineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1964 Sijsden-Margraten St^^Clay Township^MI^48001^USA^P||^PRN^PH^^^810^5538207|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Hood RiverAIRA^MartinsonAIRA^^^^^L|MTH^Mother^HL70063|1964 Sijsden-Margraten St^^Clay Township^MI^48001^USA^P|^PRN^PH^^^810^5538207ORC|RE||BS48S12583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS48S12583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-417-50^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-417-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K72Q12591^^^AIRA-TEST^MR||BentonAIRA^NadineAIRA^Jetta^^^^L|HendersonAIRA^CoryAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1405 Wmmen Ln^^Shelby Township^MI^48315^USA^P||^PRN^PH^^^586^6386736|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BentonAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1405 Wmmen Ln^^Shelby Township^MI^48315^USA^P|^PRN^PH^^^586^6386736ORC|RE||BK72Q12591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK72Q12591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-417-58^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-417-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M59I12599^^^AIRA-TEST^MR||AllenAIRA^VendelaAIRA^Kelley^^^^L|GreeneAIRA^LychorindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1510 Morst aan de Maas Ave^^White Cloud^MI^49349^USA^P||^PRN^PH^^^231^2250074|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllenAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1510 Morst aan de Maas Ave^^White Cloud^MI^49349^USA^P|^PRN^PH^^^231^2250074ORC|RE||BM59I12599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM59I12599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-417-88^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D39Z12604^^^AIRA-TEST^MR||RockcastleAIRA^DamalisAIRA^Isabel^^^^L|StarrAIRA^JewellAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1636 Lijn Cir^^Dearborn^MI^48121^USA^P||^PRN^PH^^^313^7611925|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RockcastleAIRA^StarrAIRA^^^^^L|MTH^Mother^HL70063|1636 Lijn Cir^^Dearborn^MI^48121^USA^P|^PRN^PH^^^313^7611925ORC|RE||BD39Z12604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD39Z12604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-418-10^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-418-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G10S12615^^^AIRA-TEST^MR||TaylorAIRA^MariamAIRA^Jazlyn^^^^L|AdsgaardAIRA^VigiliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1709 Veurne Pl^^Cascade^MI^49506^USA^P||^PRN^PH^^^616^3887908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TaylorAIRA^AdsgaardAIRA^^^^^L|MTH^Mother^HL70063|1709 Veurne Pl^^Cascade^MI^49506^USA^P|^PRN^PH^^^616^3887908ORC|RE||BG10S12615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG10S12615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-418-50^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-418-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z99A12623^^^AIRA-TEST^MR||BucklesAIRA^KaliAIRA^Vonni^^^^L|FarstanAIRA^GertrudeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1756 Gelijk Ave^^GR^MI^49514^USA^P||^PRN^PH^^^616^8750063|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BucklesAIRA^FarstanAIRA^^^^^L|MTH^Mother^HL70063|1756 Gelijk Ave^^GR^MI^49514^USA^P|^PRN^PH^^^616^8750063ORC|RE||BZ99A12623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ99A12623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-418-58^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-418-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B47B12631^^^AIRA-TEST^MR||San MateoAIRA^NahokoAIRA^Akanksha^^^^L|FloydAIRA^SheetalAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1685 Lden Cir^^North Lakeport^MI^48059^USA^P||^PRN^PH^^^810^9866965|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San MateoAIRA^FloydAIRA^^^^^L|MTH^Mother^HL70063|1685 Lden Cir^^North Lakeport^MI^48059^USA^P|^PRN^PH^^^810^9866965ORC|RE||BB47B12631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB47B12631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-418-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-487-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L34Y12639^^^AIRA-TEST^MR||HowarthAIRA^CarlieAIRA^Charlie^^^^L|KirklandAIRA^CristinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1988 Mteenwijkerland Ln^^Oldsmobile^MI^48921^USA^P||^PRN^PH^^^517^6915214|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowarthAIRA^KirklandAIRA^^^^^L|MTH^Mother^HL70063|1988 Mteenwijkerland Ln^^Oldsmobile^MI^48921^USA^P|^PRN^PH^^^517^6915214ORC|RE||BL34Y12639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL34Y12639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-487-58^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-488-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E09H12644^^^AIRA-TEST^MR||SylteAIRA^SandraAIRA^Talitha^^^^L|LucasAIRA^VanjanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1062 Helfzijl Ln^^Homer^MI^49245^USA^P||^PRN^PH^^^517^9546170|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SylteAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1062 Helfzijl Ln^^Homer^MI^49245^USA^P|^PRN^PH^^^517^9546170ORC|RE||BE09H12644.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE09H12644.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-488-78^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-489-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W13E12655^^^AIRA-TEST^MR||CassiaAIRA^ShantelleAIRA^Adorabelle^^^^L|ToddAIRA^KimberleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1078 Meer Ln^^Saint Clr Shrs^MI^48081^USA^P||^PRN^PH^^^586^4313560|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassiaAIRA^ToddAIRA^^^^^L|MTH^Mother^HL70063|1078 Meer Ln^^Saint Clr Shrs^MI^48081^USA^P|^PRN^PH^^^586^4313560ORC|RE||BW13E12655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW13E12655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-489-01^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-489-91|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M23O12663^^^AIRA-TEST^MR||SalterAIRA^YamilethAIRA^Ena^^^^L|HallAIRA^PortiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1336 Bongeradeel Pl^^Rockwood^MI^48173^USA^P||^PRN^PH^^^734^4286001|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SalterAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1336 Bongeradeel Pl^^Rockwood^MI^48173^USA^P|^PRN^PH^^^734^4286001ORC|RE||BM23O12663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM23O12663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-489-91^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-510-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L24F12671^^^AIRA-TEST^MR||DavisAIRA^SydneyAIRA^Leola^^^^L|TerrellAIRA^SelahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1386 Vude IJsselstreek Ln^^Bath^MI^48808^USA^P||^PRN^PH^^^517^6873549|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DavisAIRA^TerrellAIRA^^^^^L|MTH^Mother^HL70063|1386 Vude IJsselstreek Ln^^Bath^MI^48808^USA^P|^PRN^PH^^^517^6873549ORC|RE||BL24F12671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL24F12671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-510-05^PENTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-513-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S64I12679^^^AIRA-TEST^MR||HarneyAIRA^PhyllisAIRA^Angel^^^^L|CookeAIRA^NerhimAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1823 Wluis Ln^^Milford Township^MI^48381^USA^P||^PRN^PH^^^248^3168928|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarneyAIRA^CookeAIRA^^^^^L|MTH^Mother^HL70063|1823 Wluis Ln^^Milford Township^MI^48381^USA^P|^PRN^PH^^^248^3168928ORC|RE||BS64I12679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS64I12679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-513-00^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-513-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H98V12684^^^AIRA-TEST^MR||SomersetAIRA^AmbraAIRA^Addie^^^^L|PsconenAIRA^VanjaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1101 Gunst Pl^^Roos^MI^48756^USA^P||^PRN^PH^^^989^4882913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SomersetAIRA^PsconenAIRA^^^^^L|MTH^Mother^HL70063|1101 Gunst Pl^^Roos^MI^48756^USA^P|^PRN^PH^^^989^4882913ORC|RE||BH98V12684.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH98V12684.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-513-25^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-514-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S46Y12695^^^AIRA-TEST^MR||KeokukAIRA^LeannaAIRA^Julie^^^^L|BelmontAIRA^AlissaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1765 Pudwest-Fryslan Pl^^Southgate^MI^48195^USA^P||^PRN^PH^^^734^7870492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KeokukAIRA^BelmontAIRA^^^^^L|MTH^Mother^HL70063|1765 Pudwest-Fryslan Pl^^Southgate^MI^48195^USA^P|^PRN^PH^^^734^7870492ORC|RE||BS46Y12695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS46Y12695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-514-00^Fluzone Quadrivalent, Peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-514-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G79L12703^^^AIRA-TEST^MR||TrimbleAIRA^MyahAIRA^Melinda^^^^L|LatimerAIRA^EleniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1126 Derde Ave^^Harbor Point^MI^49740^USA^P||^PRN^PH^^^616^4085503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TrimbleAIRA^LatimerAIRA^^^^^L|MTH^Mother^HL70063|1126 Derde Ave^^Harbor Point^MI^49740^USA^P|^PRN^PH^^^616^4085503ORC|RE||BG79L12703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG79L12703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-514-25^Fluzone Quadrivalent, peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-516-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z96G12711^^^AIRA-TEST^MR||FurnasAIRA^AlazneAIRA^Riley^^^^L|RainsAIRA^NirvanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1643 Reimerswaal St^^Williamston^MI^48895^USA^P||^PRN^PH^^^517^3752195|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FurnasAIRA^RainsAIRA^^^^^L|MTH^Mother^HL70063|1643 Reimerswaal St^^Williamston^MI^48895^USA^P|^PRN^PH^^^517^3752195ORC|RE||BZ96G12711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ96G12711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-516-00^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-516-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q64A12719^^^AIRA-TEST^MR||JulinAIRA^StefaniaAIRA^Aldora^^^^L|MillsAIRA^AnyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1134 Begin Pl^^Imlay City^MI^48444^USA^P||^PRN^PH^^^810^4574214|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JulinAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1134 Begin Pl^^Imlay City^MI^48444^USA^P|^PRN^PH^^^810^4574214ORC|RE||BQ64A12719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ64A12719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-516-25^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-517-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X85U12724^^^AIRA-TEST^MR||CornelinsonAIRA^YasminAIRA^Christabel^^^^L|DixonAIRA^SynaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1591 Belsen Pl^^Almont Township^MI^48003^USA^P||^PRN^PH^^^810^3366455|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CornelinsonAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1591 Belsen Pl^^Almont Township^MI^48003^USA^P|^PRN^PH^^^810^3366455ORC|RE||BX85U12724.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX85U12724.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-517-00^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-517-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H35X12735^^^AIRA-TEST^MR||CalhounAIRA^NordicaAIRA^Laila^^^^L|LyonAIRA^KynaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1265 Hestervoort St^^Vassar^MI^48769^USA^P||^PRN^PH^^^989^8955239|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalhounAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1265 Hestervoort St^^Vassar^MI^48769^USA^P|^PRN^PH^^^989^8955239ORC|RE||BH35X12735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH35X12735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-517-25^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-518-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T15H12743^^^AIRA-TEST^MR||AlfalfaAIRA^VanjaAIRA^Kara^^^^L|HumboldtAIRA^MedilionAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1876 Stoom Ln^^Mullett Lake^MI^49761^USA^P||^PRN^PH^^^231^2050760|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlfalfaAIRA^HumboldtAIRA^^^^^L|MTH^Mother^HL70063|1876 Stoom Ln^^Mullett Lake^MI^49761^USA^P|^PRN^PH^^^231^2050760ORC|RE||BT15H12743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT15H12743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-518-00^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-518-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J03W12751^^^AIRA-TEST^MR||GraysonAIRA^SharnieAIRA^Shawna^^^^L|BinghamAIRA^StormyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1625 Oulst Ave^^Richland^MI^49083^USA^P||^PRN^PH^^^269^8313059|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GraysonAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1625 Oulst Ave^^Richland^MI^49083^USA^P|^PRN^PH^^^269^8313059ORC|RE||BJ03W12751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ03W12751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-518-25^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-545-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T88Z12759^^^AIRA-TEST^MR||AlpineAIRA^AlekaAIRA^Riannon^^^^L|LarssenAIRA^MadelynnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1330 Regio Ln^^Applegate^MI^48401^USA^P||^PRN^PH^^^810^6032711|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlpineAIRA^LarssenAIRA^^^^^L|MTH^Mother^HL70063|1330 Regio Ln^^Applegate^MI^48401^USA^P|^PRN^PH^^^810^6032711ORC|RE||BT88Z12759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT88Z12759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-545-03^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-545-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O43C12764^^^AIRA-TEST^MR||ClearfieldAIRA^LinaAIRA^Jessie^^^^L|HalsallAIRA^CelenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1405 Zal niet Ave^^Ada^MI^49355^USA^P||^PRN^PH^^^616^6668242|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClearfieldAIRA^HalsallAIRA^^^^^L|MTH^Mother^HL70063|1405 Zal niet Ave^^Ada^MI^49355^USA^P|^PRN^PH^^^616^6668242ORC|RE||BO43C12764.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO43C12764.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-545-05^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-545-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U61X12775^^^AIRA-TEST^MR||NolanAIRA^IolanaAIRA^Idola^^^^L|WerstadAIRA^LivAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1234 Perg en Dal Ln^^Lenox^MI^48050^USA^P||^PRN^PH^^^586^2083257|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NolanAIRA^WerstadAIRA^^^^^L|MTH^Mother^HL70063|1234 Perg en Dal Ln^^Lenox^MI^48050^USA^P|^PRN^PH^^^586^2083257ORC|RE||BU61X12775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU61X12775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-545-15^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-547-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B06W12783^^^AIRA-TEST^MR||StevensAIRA^ChanahAIRA^Olethea^^^^L|EigumAIRA^TejiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1509 Doggenland Ave^^Grosse Pointe Farms^MI^48230^USA^P||^PRN^PH^^^313^7884382|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StevensAIRA^EigumAIRA^^^^^L|MTH^Mother^HL70063|1509 Doggenland Ave^^Grosse Pointe Farms^MI^48230^USA^P|^PRN^PH^^^313^7884382ORC|RE||BB06W12783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB06W12783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-547-58^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-560-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A75C12791^^^AIRA-TEST^MR||KitsapAIRA^ClodaghAIRA^Kira^^^^L|JackAIRA^DesireeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1381 Poensdrecht Ave^^Seney^MI^49883^USA^P||^PRN^PH^^^906^2724182|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KitsapAIRA^JackAIRA^^^^^L|MTH^Mother^HL70063|1381 Poensdrecht Ave^^Seney^MI^49883^USA^P|^PRN^PH^^^906^2724182ORC|RE||BA75C12791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA75C12791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-560-05^DTAP-IPV^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-562-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D02N12799^^^AIRA-TEST^MR||GreerAIRA^MariaAIRA^Zion^^^^L|StallardAIRA^HannahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1113 Aijkerk Cir^^Hazel Park^MI^48030^USA^P||^PRN^PH^^^248^3310896|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreerAIRA^StallardAIRA^^^^^L|MTH^Mother^HL70063|1113 Aijkerk Cir^^Hazel Park^MI^48030^USA^P|^PRN^PH^^^248^3310896ORC|RE||BD02N12799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD02N12799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-562-10^Quadracel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-562-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D17P12804^^^AIRA-TEST^MR||MasonAIRA^ArianaAIRA^Quinn^^^^L|SuthernsAIRA^WaratahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1192 Flst-Wijhe Cir^^Warren^MI^48091^USA^P||^PRN^PH^^^586^7127437|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^SuthernsAIRA^^^^^L|MTH^Mother^HL70063|1192 Flst-Wijhe Cir^^Warren^MI^48091^USA^P|^PRN^PH^^^586^7127437ORC|RE||BD17P12804.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD17P12804.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-562-58^QUADRACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-589-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G59R12815^^^AIRA-TEST^MR||NobleAIRA^HelenaAIRA^Nicole^^^^L|KnoxAIRA^ZiselAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1278 Angst Pl^^Macomb^MI^48044^USA^P||^PRN^PH^^^586^3851465|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NobleAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1278 Angst Pl^^Macomb^MI^48044^USA^P|^PRN^PH^^^586^3851465ORC|RE||BG59R12815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG59R12815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-589-05^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-589-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M10N12823^^^AIRA-TEST^MR||MultnomahAIRA^AnAIRA^Onawa^^^^L|LokkenAIRA^CaralynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1255 Kaarle-Nassau Cir^^West Bloomfield^MI^48324^USA^P||^PRN^PH^^^248^9471965|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MultnomahAIRA^LokkenAIRA^^^^^L|MTH^Mother^HL70063|1255 Kaarle-Nassau Cir^^West Bloomfield^MI^48324^USA^P|^PRN^PH^^^248^9471965ORC|RE||BM10N12823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM10N12823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-589-58^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-621-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A22L12831^^^AIRA-TEST^MR||RobertsonAIRA^TalasiAIRA^Aline^^^^L|FarstanAIRA^ShifraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1640 Beiderland Pl^^Brooklyn^MI^49230^USA^P||^PRN^PH^^^517^2063346|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobertsonAIRA^FarstanAIRA^^^^^L|MTH^Mother^HL70063|1640 Beiderland Pl^^Brooklyn^MI^49230^USA^P|^PRN^PH^^^517^2063346ORC|RE||BA22L12831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA22L12831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-621-15^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-621-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G82V12839^^^AIRA-TEST^MR||CliveAIRA^QueenaAIRA^Tobit^^^^L|McDonaldAIRA^MargaritaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1959 Frootegast Ln^^Lake Angelus^MI^48326^USA^P||^PRN^PH^^^248^4995721|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CliveAIRA^McDonaldAIRA^^^^^L|MTH^Mother^HL70063|1959 Frootegast Ln^^Lake Angelus^MI^48326^USA^P|^PRN^PH^^^248^4995721ORC|RE||BG82V12839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG82V12839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-621-78^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-625-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B00I12844^^^AIRA-TEST^MR||SusquehannaAIRA^ArmillaAIRA^Orlanda^^^^L|NelsonAIRA^KritiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1258 Kteenbergen Cir^^Troy^MI^48084^USA^P||^PRN^PH^^^248^5094704|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SusquehannaAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1258 Kteenbergen Cir^^Troy^MI^48084^USA^P|^PRN^PH^^^248^5094704ORC|RE||BB00I12844.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB00I12844.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-625-15^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-625-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N94A12855^^^AIRA-TEST^MR||DundyAIRA^AnataAIRA^Fantasia^^^^L|KildahlAIRA^ElziraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1084 Nieuwe St^^Lake Odessa^MI^48849^USA^P||^PRN^PH^^^616^9254841|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DundyAIRA^KildahlAIRA^^^^^L|MTH^Mother^HL70063|1084 Nieuwe St^^Lake Odessa^MI^48849^USA^P|^PRN^PH^^^616^9254841ORC|RE||BN94A12855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN94A12855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-625-78^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-627-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U20E12863^^^AIRA-TEST^MR||NewaygoAIRA^SuellenAIRA^Emilee^^^^L|ClevelandAIRA^LilliannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1796 Eochem St^^Woodland Park^MI^49309^USA^P||^PRN^PH^^^231^3748024|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NewaygoAIRA^ClevelandAIRA^^^^^L|MTH^Mother^HL70063|1796 Eochem St^^Woodland Park^MI^49309^USA^P|^PRN^PH^^^231^3748024ORC|RE||BU20E12863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU20E12863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-627-15^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-627-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D58X12871^^^AIRA-TEST^MR||MonroeAIRA^CatarinaAIRA^Dotty^^^^L|JohnsonAIRA^GymeaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1289 Mcheemda St^^GR^MI^49525^USA^P||^PRN^PH^^^616^6094034|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MonroeAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1289 Mcheemda St^^GR^MI^49525^USA^P|^PRN^PH^^^616^6094034ORC|RE||BD58X12871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD58X12871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-627-78^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-629-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L23L12879^^^AIRA-TEST^MR||LuceAIRA^RosAIRA^Laurel^^^^L|McErlaineAIRA^NataneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1697 Gilvarenbeek St^^Riverside^MI^49084^USA^P||^PRN^PH^^^269^6486013|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LuceAIRA^McErlaineAIRA^^^^^L|MTH^Mother^HL70063|1697 Gilvarenbeek St^^Riverside^MI^49084^USA^P|^PRN^PH^^^269^6486013ORC|RE||BL23L12879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL23L12879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-629-15^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-629-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B27D12884^^^AIRA-TEST^MR||MeredithAIRA^FaineAIRA^Dionyza^^^^L|AransasAIRA^KrupaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1316 Oeiloo Pl^^Kendall^MI^49062^USA^P||^PRN^PH^^^269^7386121|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeredithAIRA^AransasAIRA^^^^^L|MTH^Mother^HL70063|1316 Oeiloo Pl^^Kendall^MI^49062^USA^P|^PRN^PH^^^269^7386121ORC|RE||BB27D12884.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB27D12884.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-629-78^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-640-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B55F12895^^^AIRA-TEST^MR||JohnsonAIRA^AnastasiaAIRA^Adela^^^^L|PasoAIRA^EloiseAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1242 Gwartewaterland St^^Bridgewater^MI^48115^USA^P||^PRN^PH^^^734^4667993|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JohnsonAIRA^PasoAIRA^^^^^L|MTH^Mother^HL70063|1242 Gwartewaterland St^^Bridgewater^MI^48115^USA^P|^PRN^PH^^^734^4667993ORC|RE||BB55F12895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB55F12895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-640-15^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-650-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q83C12903^^^AIRA-TEST^MR||RyanAIRA^GillianAIRA^Glenys^^^^L|HemphillAIRA^CalendreAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1499 Wijfheerenlanden Ave^^Muskegon^MI^49443^USA^P||^PRN^PH^^^231^5242736|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RyanAIRA^HemphillAIRA^^^^^L|MTH^Mother^HL70063|1499 Wijfheerenlanden Ave^^Muskegon^MI^49443^USA^P|^PRN^PH^^^231^5242736ORC|RE||BQ83C12903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ83C12903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-650-10^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-650-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L37T12911^^^AIRA-TEST^MR||StallardAIRA^ChandaniAIRA^Lida^^^^L|TownAIRA^HoldaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1908 Len Boer Cir^^Detroit^MI^48221^USA^P||^PRN^PH^^^313^4108763|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StallardAIRA^TownAIRA^^^^^L|MTH^Mother^HL70063|1908 Len Boer Cir^^Detroit^MI^48221^USA^P|^PRN^PH^^^313^4108763ORC|RE||BL37T12911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL37T12911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-650-25^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-650-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O04I12919^^^AIRA-TEST^MR||EdmonsonAIRA^RozellaAIRA^Lassie^^^^L|CoosAIRA^NornaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1712 Medeklinker Pl^^Traverse City^MI^49686^USA^P||^PRN^PH^^^231^7364314|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EdmonsonAIRA^CoosAIRA^^^^^L|MTH^Mother^HL70063|1712 Medeklinker Pl^^Traverse City^MI^49686^USA^P|^PRN^PH^^^231^7364314ORC|RE||BO04I12919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO04I12919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-650-50^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-650-70|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D38L12924^^^AIRA-TEST^MR||UpshurAIRA^LianaAIRA^Bates^^^^L|LaenAIRA^SimbaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1827 Luidhorn Cir^^Livonia^MI^48152^USA^P||^PRN^PH^^^734^5205157|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UpshurAIRA^LaenAIRA^^^^^L|MTH^Mother^HL70063|1827 Luidhorn Cir^^Livonia^MI^48152^USA^P|^PRN^PH^^^734^5205157ORC|RE||BD38L12924.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD38L12924.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-650-70^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-650-90|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F77K12935^^^AIRA-TEST^MR||AllenAIRA^MavisAIRA^Padma^^^^L|BeaverAIRA^IdehAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1172 Zierden Ave^^Riley^MI^48041^USA^P||^PRN^PH^^^810^2766102|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllenAIRA^BeaverAIRA^^^^^L|MTH^Mother^HL70063|1172 Zierden Ave^^Riley^MI^48041^USA^P|^PRN^PH^^^810^2766102ORC|RE||BF77K12935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF77K12935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-650-90^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-703-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O05S12943^^^AIRA-TEST^MR||AudubonAIRA^DaphneAIRA^Bryleigh^^^^L|SnohomishAIRA^OdetteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1416 Zssen Cir^^Filer City^MI^49634^USA^P||^PRN^PH^^^231^5501023|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AudubonAIRA^SnohomishAIRA^^^^^L|MTH^Mother^HL70063|1416 Zssen Cir^^Filer City^MI^49634^USA^P|^PRN^PH^^^231^5501023ORC|RE||BO05S12943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO05S12943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-703-55^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-705-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X85P12951^^^AIRA-TEST^MR||CameronAIRA^ValborgAIRA^Thaddea^^^^L|WebsterAIRA^JulinkaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1331 Btadskanaal Ave^^Michigan Center^MI^49254^USA^P||^PRN^PH^^^517^4223621|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CameronAIRA^WebsterAIRA^^^^^L|MTH^Mother^HL70063|1331 Btadskanaal Ave^^Michigan Center^MI^49254^USA^P|^PRN^PH^^^517^4223621ORC|RE||BX85P12951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX85P12951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-705-55^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-707-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G70F12959^^^AIRA-TEST^MR||ClintonAIRA^KlaraAIRA^Zigana^^^^L|MariposaAIRA^JaperaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1230 Tluis Ln^^Berville^MI^48002^USA^P||^PRN^PH^^^810^3362862|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClintonAIRA^MariposaAIRA^^^^^L|MTH^Mother^HL70063|1230 Tluis Ln^^Berville^MI^48002^USA^P|^PRN^PH^^^810^3362862ORC|RE||BG70F12959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG70F12959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-707-48^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-707-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z68A12964^^^AIRA-TEST^MR||CassAIRA^HerthaAIRA^Christy^^^^L|MarionAIRA^SakukoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1663 Nieuwe Pl^^Shelby Township^MI^48316^USA^P||^PRN^PH^^^586^8978729|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1663 Nieuwe Pl^^Shelby Township^MI^48316^USA^P|^PRN^PH^^^586^8978729ORC|RE||BZ68A12964.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ68A12964.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-707-55^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-708-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J64H12975^^^AIRA-TEST^MR||ShawAIRA^GaliAIRA^Kassandra^^^^L|StarkAIRA^My-DuyenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1649 Laarbeek Ln^^Cannonsburg^MI^49317^USA^P||^PRN^PH^^^616^7541761|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShawAIRA^StarkAIRA^^^^^L|MTH^Mother^HL70063|1649 Laarbeek Ln^^Cannonsburg^MI^49317^USA^P|^PRN^PH^^^616^7541761ORC|RE||BJ64H12975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ64H12975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-708-40^Fluzone Intradermal Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-708-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C98F12983^^^AIRA-TEST^MR||ScottAIRA^DeetaAIRA^Makenzie^^^^L|OwenAIRA^UrsulaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1946 Aitgeest Ln^^Kentwood Brch^MI^49528^USA^P||^PRN^PH^^^616^3228231|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ScottAIRA^OwenAIRA^^^^^L|MTH^Mother^HL70063|1946 Aitgeest Ln^^Kentwood Brch^MI^49528^USA^P|^PRN^PH^^^616^3228231ORC|RE||BC98F12983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC98F12983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-708-48^FLUZONE INTRADERMAL QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-709-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C63T12991^^^AIRA-TEST^MR||CalhounAIRA^BakanaAIRA^Modestus^^^^L|PresidioAIRA^CathleneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1248 Drunssum St^^Flat Rock^MI^48134^USA^P||^PRN^PH^^^734^9942690|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalhounAIRA^PresidioAIRA^^^^^L|MTH^Mother^HL70063|1248 Drunssum St^^Flat Rock^MI^48134^USA^P|^PRN^PH^^^734^9942690ORC|RE||BC63T12991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC63T12991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-709-48^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-709-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N19B12999^^^AIRA-TEST^MR||HaagenAIRA^GwynAIRA^Effie^^^^L|MathiesenAIRA^HadiyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1352 Neus Cir^^Warren^MI^48092^USA^P||^PRN^PH^^^586^6150798|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaagenAIRA^MathiesenAIRA^^^^^L|MTH^Mother^HL70063|1352 Neus Cir^^Warren^MI^48092^USA^P|^PRN^PH^^^586^6150798ORC|RE||BN19B12999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN19B12999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-709-55^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-710-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B21V13004^^^AIRA-TEST^MR||KentAIRA^SolanaAIRA^Coreen^^^^L|ArthurAIRA^ShaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1073 Ee Wolden St^^Quincy^MI^49082^USA^P||^PRN^PH^^^517^5779271|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KentAIRA^ArthurAIRA^^^^^L|MTH^Mother^HL70063|1073 Ee Wolden St^^Quincy^MI^49082^USA^P|^PRN^PH^^^517^5779271ORC|RE||BB21V13004.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB21V13004.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-710-40^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-710-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V11O13015^^^AIRA-TEST^MR||CedarAIRA^MerisAIRA^Japera^^^^L|MorrosAIRA^MaataAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1331 Horne St^^Port Huron Township^MI^48060^USA^P||^PRN^PH^^^810^9210214|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CedarAIRA^MorrosAIRA^^^^^L|MTH^Mother^HL70063|1331 Horne St^^Port Huron Township^MI^48060^USA^P|^PRN^PH^^^810^9210214ORC|RE||BV11O13015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV11O13015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-710-48^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-712-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U51R13023^^^AIRA-TEST^MR||Hood RiverAIRA^LeylaAIRA^Katie^^^^L|PainterAIRA^NeveahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1797 Bchijndel Ln^^Deerfield^MI^49238^USA^P||^PRN^PH^^^517^2012787|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Hood RiverAIRA^PainterAIRA^^^^^L|MTH^Mother^HL70063|1797 Bchijndel Ln^^Deerfield^MI^49238^USA^P|^PRN^PH^^^517^2012787ORC|RE||BU51R13023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU51R13023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-712-40^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-712-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C02O13031^^^AIRA-TEST^MR||BucklesAIRA^JoyceAIRA^Davida^^^^L|Keya PahaAIRA^VinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1937 Hotterdam St^^Detroit^MI^48203^USA^P||^PRN^PH^^^313^3546578|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BucklesAIRA^Keya PahaAIRA^^^^^L|MTH^Mother^HL70063|1937 Hotterdam St^^Detroit^MI^48203^USA^P|^PRN^PH^^^313^3546578ORC|RE||BC02O13031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC02O13031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-712-48^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-718-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B70Y13039^^^AIRA-TEST^MR||GelfryAIRA^IsokeAIRA^Ulla^^^^L|BinghamAIRA^MorganaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1247 Kergen Pl^^Central Michigan University^MI^48859^USA^P||^PRN^PH^^^989^5963243|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GelfryAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1247 Kergen Pl^^Central Michigan University^MI^48859^USA^P|^PRN^PH^^^989^5963243ORC|RE||BB70Y13039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB70Y13039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-718-10^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-718-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O86R13044^^^AIRA-TEST^MR||BuffaloAIRA^SavarnaAIRA^Ambrosine^^^^L|DalyAIRA^AbileneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1995 Kde Ln^^Harrisville^MI^48740^USA^P||^PRN^PH^^^989^9242856|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BuffaloAIRA^DalyAIRA^^^^^L|MTH^Mother^HL70063|1995 Kde Ln^^Harrisville^MI^48740^USA^P|^PRN^PH^^^989^9242856ORC|RE||BO86R13044.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO86R13044.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-718-88^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-790-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E27S13055^^^AIRA-TEST^MR||ButlerAIRA^MollieAIRA^Cilla^^^^L|GartenlaubAIRA^ChristianAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1643 Meppel Ln^^Marlette^MI^48453^USA^P||^PRN^PH^^^989^8314894|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButlerAIRA^GartenlaubAIRA^^^^^L|MTH^Mother^HL70063|1643 Meppel Ln^^Marlette^MI^48453^USA^P|^PRN^PH^^^989^8314894ORC|RE||BE27S13055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE27S13055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-790-20^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-790-38|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D19X13063^^^AIRA-TEST^MR||SonomaAIRA^NancyAIRA^Kiona^^^^L|ShoshoneAIRA^NilganAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1273 Woerendaal Ave^^Hubbell^MI^49934^USA^P||^PRN^PH^^^906^3892239|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SonomaAIRA^ShoshoneAIRA^^^^^L|MTH^Mother^HL70063|1273 Woerendaal Ave^^Hubbell^MI^49934^USA^P|^PRN^PH^^^906^3892239ORC|RE||BD19X13063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD19X13063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-790-38^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-790-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A16T13071^^^AIRA-TEST^MR||WilliamsAIRA^IrihapetiAIRA^Chaya^^^^L|FagenAIRA^SkylarAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1750 Levenaar Ln^^Breedsville^MI^49027^USA^P||^PRN^PH^^^269^7790851|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilliamsAIRA^FagenAIRA^^^^^L|MTH^Mother^HL70063|1750 Levenaar Ln^^Breedsville^MI^49027^USA^P|^PRN^PH^^^269^7790851ORC|RE||BA16T13071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA16T13071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-790-51^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-790-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R82W13079^^^AIRA-TEST^MR||KalkaskaAIRA^ButtercupAIRA^Magnolia^^^^L|ComancheAIRA^AlateaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1413 Loppersum Pl^^Ypsilanti^MI^48198^USA^P||^PRN^PH^^^734^9475679|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KalkaskaAIRA^ComancheAIRA^^^^^L|MTH^Mother^HL70063|1413 Loppersum Pl^^Ypsilanti^MI^48198^USA^P|^PRN^PH^^^734^9475679ORC|RE||BR82W13079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR82W13079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-790-88^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-800-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y19C13084^^^AIRA-TEST^MR||MarionAIRA^AnnamariaAIRA^Maggie^^^^L|OaklandAIRA^KynthiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1354 Koggenland Ln^^New Baltimore^MI^48047^USA^P||^PRN^PH^^^586^2271451|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarionAIRA^OaklandAIRA^^^^^L|MTH^Mother^HL70063|1354 Koggenland Ln^^New Baltimore^MI^48047^USA^P|^PRN^PH^^^586^2271451ORC|RE||BY19C13084.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY19C13084.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-800-83^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-820-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L06I13095^^^AIRA-TEST^MR||GagleAIRA^KatinaAIRA^Cairine^^^^L|FayetteAIRA^NatashaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1005 Hijchen Pl^^Harper Woods^MI^48225^USA^P||^PRN^PH^^^313^4092974|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GagleAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1005 Hijchen Pl^^Harper Woods^MI^48225^USA^P|^PRN^PH^^^313^4092974ORC|RE||BL06I13095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL06I13095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-820-10^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-860-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R32D13103^^^AIRA-TEST^MR||SchleicherAIRA^GlenysAIRA^Laura^^^^L|BergenAIRA^XiomaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1172 Raaren Ave^^Waterford Township^MI^48328^USA^P||^PRN^PH^^^248^7587365|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SchleicherAIRA^BergenAIRA^^^^^L|MTH^Mother^HL70063|1172 Raaren Ave^^Waterford Township^MI^48328^USA^P|^PRN^PH^^^248^7587365ORC|RE||BR32D13103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR32D13103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-860-10^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-860-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A60O13111^^^AIRA-TEST^MR||TylerAIRA^GabrielleAIRA^Danna^^^^L|GannonAIRA^ViennaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1866 Loordenveld Pl^^Grand Jct^MI^49056^USA^P||^PRN^PH^^^269^2321292|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TylerAIRA^GannonAIRA^^^^^L|MTH^Mother^HL70063|1866 Loordenveld Pl^^Grand Jct^MI^49056^USA^P|^PRN^PH^^^269^2321292ORC|RE||BA60O13111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA60O13111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-860-55^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-860-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R09G13119^^^AIRA-TEST^MR||BlancoAIRA^ZelindaAIRA^Xuxa^^^^L|SimpsonAIRA^JendyoseAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1969 Worne Ln^^Gaylord^MI^49734^USA^P||^PRN^PH^^^989^3810296|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlancoAIRA^SimpsonAIRA^^^^^L|MTH^Mother^HL70063|1969 Worne Ln^^Gaylord^MI^49734^USA^P|^PRN^PH^^^989^3810296ORC|RE||BR09G13119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR09G13119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-860-78^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-860-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B33A13124^^^AIRA-TEST^MR||MarshallAIRA^ChitraAIRA^Etain^^^^L|BreckinridgeAIRA^OriannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1245 Oa en Hunze Cir^^Croswell^MI^48422^USA^P||^PRN^PH^^^810^2095487|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarshallAIRA^BreckinridgeAIRA^^^^^L|MTH^Mother^HL70063|1245 Oa en Hunze Cir^^Croswell^MI^48422^USA^P|^PRN^PH^^^810^2095487ORC|RE||BB33A13124.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB33A13124.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-860-88^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-913-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A46M13135^^^AIRA-TEST^MR||SmithAIRA^RileyAIRA^Asenette^^^^L|ShelbyAIRA^VivianAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1259 Henlo Pl^^Troy^MI^48084^USA^P||^PRN^PH^^^248^5766104|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SmithAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1259 Henlo Pl^^Troy^MI^48084^USA^P|^PRN^PH^^^248^5766104ORC|RE||BA46M13135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA46M13135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-913-01^STAMARIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-915-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O49N13143^^^AIRA-TEST^MR||MidlandAIRA^EmilyAIRA^Eirene^^^^L|MahoningAIRA^CandideAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1442 Warneveld Pl^^Grosse Pointe^MI^48215^USA^P||^PRN^PH^^^313^8071526|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MidlandAIRA^MahoningAIRA^^^^^L|MTH^Mother^HL70063|1442 Warneveld Pl^^Grosse Pointe^MI^48215^USA^P|^PRN^PH^^^313^8071526ORC|RE||BO49N13143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO49N13143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-915-01^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-915-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T56X13151^^^AIRA-TEST^MR||WynneAIRA^KaiyaAIRA^Jayde^^^^L|HaagenAIRA^NuAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1847 Oinsum Ln^^Saint Heights^MI^48314^USA^P||^PRN^PH^^^586^7859732|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WynneAIRA^HaagenAIRA^^^^^L|MTH^Mother^HL70063|1847 Oinsum Ln^^Saint Heights^MI^48314^USA^P|^PRN^PH^^^586^7859732ORC|RE||BT56X13151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT56X13151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-915-05^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-915-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L84J13159^^^AIRA-TEST^MR||MillsAIRA^ShikhaAIRA^Mikayla^^^^L|PlymouthAIRA^AliyahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1418 Hudewater Ave^^Chassell^MI^49916^USA^P||^PRN^PH^^^906^9121927|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MillsAIRA^PlymouthAIRA^^^^^L|MTH^Mother^HL70063|1418 Hudewater Ave^^Chassell^MI^49916^USA^P|^PRN^PH^^^906^9121927ORC|RE||BL84J13159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL84J13159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-915-58^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281-915-68|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J18M13164^^^AIRA-TEST^MR||CornelinsonAIRA^BlossomAIRA^Raven^^^^L|WheelerAIRA^ArtemisiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1356 Jeeuwarden Cir^^Iron River^MI^49935^USA^P||^PRN^PH^^^906^7841610|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CornelinsonAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1356 Jeeuwarden Cir^^Iron River^MI^49935^USA^P|^PRN^PH^^^906^7841610ORC|RE||BJ18M13164.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ18M13164.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281-915-68^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V28Y13175^^^AIRA-TEST^MR||TehamaAIRA^GretteAIRA^Ronda^^^^L|CraneAIRA^YonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1650 Dolenwaard Ave^^Northeast^MI^48509^USA^P||^PRN^PH^^^810^3138914|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TehamaAIRA^CraneAIRA^^^^^L|MTH^Mother^HL70063|1650 Dolenwaard Ave^^Northeast^MI^48509^USA^P|^PRN^PH^^^810^3138914ORC|RE||BV28Y13175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV28Y13175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001010^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001025|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P57V13183^^^AIRA-TEST^MR||MasonAIRA^KrystalAIRA^Alexia^^^^L|StoryAIRA^GaliAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1131 Dmmen St^^DTE Energy Brm^MI^48269^USA^P||^PRN^PH^^^313^6225185|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^StoryAIRA^^^^^L|MTH^Mother^HL70063|1131 Dmmen St^^DTE Energy Brm^MI^48269^USA^P|^PRN^PH^^^313^6225185ORC|RE||BP57V13183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP57V13183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001025^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001050|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A21H13191^^^AIRA-TEST^MR||BoyleAIRA^DaralisAIRA^Vanjan^^^^L|LucasAIRA^IphigeniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1577 Crummen Ave^^Laurium^MI^49913^USA^P||^PRN^PH^^^906^3166445|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoyleAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1577 Crummen Ave^^Laurium^MI^49913^USA^P|^PRN^PH^^^906^3166445ORC|RE||BA21H13191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA21H13191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001050^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R29R13199^^^AIRA-TEST^MR||GogebicAIRA^ElyshiaAIRA^Sacha^^^^L|MontgomeryAIRA^OpalineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1326 Oestland St^^Oakland Township^MI^48363^USA^P||^PRN^PH^^^248^4519203|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GogebicAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1326 Oestland St^^Oakland Township^MI^48363^USA^P|^PRN^PH^^^248^4519203ORC|RE||BR29R13199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR29R13199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001110^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001150|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T15Q13204^^^AIRA-TEST^MR||PetersonAIRA^ChyouAIRA^Hadassah^^^^L|BrikkeAIRA^KeikoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1884 Be Ronde Venen Ave^^West Bloomfield^MI^48323^USA^P||^PRN^PH^^^248^2940420|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PetersonAIRA^BrikkeAIRA^^^^^L|MTH^Mother^HL70063|1884 Be Ronde Venen Ave^^West Bloomfield^MI^48323^USA^P|^PRN^PH^^^248^2940420ORC|RE||BT15Q13204.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT15Q13204.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001150^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V39U13215^^^AIRA-TEST^MR||MorrowAIRA^GilbertaAIRA^Ashima^^^^L|SeminoleAIRA^VilhelminaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1985 Wontferland St^^Sidnaw^MI^49961^USA^P||^PRN^PH^^^906^8568987|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorrowAIRA^SeminoleAIRA^^^^^L|MTH^Mother^HL70063|1985 Wontferland St^^Sidnaw^MI^49961^USA^P|^PRN^PH^^^906^8568987ORC|RE||BV39U13215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV39U13215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001210^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001250|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q83H13223^^^AIRA-TEST^MR||ApacheAIRA^JanessaAIRA^Caydence^^^^L|ClackamasAIRA^LuiseAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1519 Gijfheerenlanden Pl^^Comerica Incorporated^MI^48264^USA^P||^PRN^PH^^^313^8643172|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ApacheAIRA^ClackamasAIRA^^^^^L|MTH^Mother^HL70063|1519 Gijfheerenlanden Pl^^Comerica Incorporated^MI^48264^USA^P|^PRN^PH^^^313^8643172ORC|RE||BQ83H13223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ83H13223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001250^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N27M13231^^^AIRA-TEST^MR||AdamsAIRA^TonyaAIRA^Jessica^^^^L|ShermanAIRA^AlmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1553 Wierden Pl^^Big Bay^MI^49808^USA^P||^PRN^PH^^^906^5442092|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdamsAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1553 Wierden Pl^^Big Bay^MI^49808^USA^P|^PRN^PH^^^906^5442092ORC|RE||BN27M13231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN27M13231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001310^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001350|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y99L13239^^^AIRA-TEST^MR||LaRueAIRA^TiponyaAIRA^Elaine^^^^L|ArmstrongAIRA^WendyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1095 Soggenland Ln^^Saint Heights^MI^48313^USA^P||^PRN^PH^^^586^8064723|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LaRueAIRA^ArmstrongAIRA^^^^^L|MTH^Mother^HL70063|1095 Soggenland Ln^^Saint Heights^MI^48313^USA^P|^PRN^PH^^^586^8064723ORC|RE||BY99L13239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY99L13239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001350^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001358|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V68D13244^^^AIRA-TEST^MR||HancockAIRA^RomanaAIRA^Holly^^^^L|CroweAIRA^TalonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1678 Cchagen Cir^^Southfield^MI^48033^USA^P||^PRN^PH^^^248^4162428|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^CroweAIRA^^^^^L|MTH^Mother^HL70063|1678 Cchagen Cir^^Southfield^MI^48033^USA^P|^PRN^PH^^^248^4162428ORC|RE||BV68D13244.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV68D13244.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001358^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001388|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U11R13255^^^AIRA-TEST^MR||LyonAIRA^MelancthaAIRA^Tessie^^^^L|BeckhamAIRA^FenellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1839 Bijmegen Cir^^Olivet^MI^49076^USA^P||^PRN^PH^^^269^9822015|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LyonAIRA^BeckhamAIRA^^^^^L|MTH^Mother^HL70063|1839 Bijmegen Cir^^Olivet^MI^49076^USA^P|^PRN^PH^^^269^9822015ORC|RE||BU11R13255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU11R13255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001388^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001450|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y75A13263^^^AIRA-TEST^MR||BuckshornAIRA^RhondaAIRA^Micheline^^^^L|YubaAIRA^AlexandraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1819 Oundert Pl^^Georgetown Tp^MI^49428^USA^P||^PRN^PH^^^616^7787393|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BuckshornAIRA^YubaAIRA^^^^^L|MTH^Mother^HL70063|1819 Oundert Pl^^Georgetown Tp^MI^49428^USA^P|^PRN^PH^^^616^7787393ORC|RE||BY75A13263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY75A13263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001450^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281001488|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S86B13271^^^AIRA-TEST^MR||CimarronAIRA^GiorgioAIRA^Ricarda^^^^L|WarrenAIRA^JaninaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1633 Aergen Pl^^Northville^MI^48168^USA^P||^PRN^PH^^^248^9946508|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CimarronAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1633 Aergen Pl^^Northville^MI^48168^USA^P|^PRN^PH^^^248^9946508ORC|RE||BS86B13271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS86B13271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281001488^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281011125|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z66A13279^^^AIRA-TEST^MR||LivingstonAIRA^TonyaAIRA^Maria^^^^L|LlanoAIRA^AnnabelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1813 Aennep Cir^^Amway Corp^MI^49356^USA^P||^PRN^PH^^^616^9540062|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LivingstonAIRA^LlanoAIRA^^^^^L|MTH^Mother^HL70063|1813 Aennep Cir^^Amway Corp^MI^49356^USA^P|^PRN^PH^^^616^9540062ORC|RE||BZ66A13279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ66A13279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281011125^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281011225|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J67D13284^^^AIRA-TEST^MR||HawkeAIRA^CatavaAIRA^Nazirah^^^^L|CrawfordAIRA^NoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1322 Granendonck St^^Beaverton^MI^48612^USA^P||^PRN^PH^^^989^7621046|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HawkeAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1322 Granendonck St^^Beaverton^MI^48612^USA^P|^PRN^PH^^^989^7621046ORC|RE||BJ67D13284.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ67D13284.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281011225^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281011300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M38K13295^^^AIRA-TEST^MR||SwindellsAIRA^UnaizaAIRA^Rochelle^^^^L|OtterstromAIRA^CelieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1417 Ahenen Cir^^Farmington^MI^48332^USA^P||^PRN^PH^^^248^9632546|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SwindellsAIRA^OtterstromAIRA^^^^^L|MTH^Mother^HL70063|1417 Ahenen Cir^^Farmington^MI^48332^USA^P|^PRN^PH^^^248^9632546ORC|RE||BM38K13295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM38K13295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281011300^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281011325|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E04K13303^^^AIRA-TEST^MR||LancasterAIRA^AdahAIRA^Desta^^^^L|RoachAIRA^PaulinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1072 Haalte Ln^^Vandalia^MI^49095^USA^P||^PRN^PH^^^269^9965100|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LancasterAIRA^RoachAIRA^^^^^L|MTH^Mother^HL70063|1072 Haalte Ln^^Vandalia^MI^49095^USA^P|^PRN^PH^^^269^9965100ORC|RE||BE04K13303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE04K13303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281011325^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281021510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V46U13311^^^AIRA-TEST^MR||BeaverAIRA^ThereseAIRA^Nevada^^^^L|AdsonAIRA^CariAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1956 Dill en Sint Hubert Pl^^Millington^MI^48746^USA^P||^PRN^PH^^^989^2564336|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BeaverAIRA^AdsonAIRA^^^^^L|MTH^Mother^HL70063|1956 Dill en Sint Hubert Pl^^Millington^MI^48746^USA^P|^PRN^PH^^^989^2564336ORC|RE||BV46U13311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV46U13311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281021510^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281021515|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H83A13319^^^AIRA-TEST^MR||FayetteAIRA^LodemaAIRA^Dionyza^^^^L|YavapaiAIRA^AdelynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1381 Hith St^^Marshall^MI^49069^USA^P||^PRN^PH^^^269^3542918|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FayetteAIRA^YavapaiAIRA^^^^^L|MTH^Mother^HL70063|1381 Hith St^^Marshall^MI^49069^USA^P|^PRN^PH^^^269^3542918ORC|RE||BH83A13319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH83A13319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281021515^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281021558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W72H13324^^^AIRA-TEST^MR||DickinsonAIRA^AdelinaAIRA^Thalassa^^^^L|HoreAIRA^DarayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1175 Boot Cir^^Saline^MI^48176^USA^P||^PRN^PH^^^734^3094073|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickinsonAIRA^HoreAIRA^^^^^L|MTH^Mother^HL70063|1175 Boot Cir^^Saline^MI^48176^USA^P|^PRN^PH^^^734^3094073ORC|RE||BW72H13324.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW72H13324.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281021558^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281021588|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P24D13335^^^AIRA-TEST^MR||SuthernsAIRA^EsmeAIRA^Bohdana^^^^L|SolanoAIRA^SigridAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1913 Smsterdam Pl^^Saint Clair Township^MI^48079^USA^P||^PRN^PH^^^810^8916003|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SuthernsAIRA^SolanoAIRA^^^^^L|MTH^Mother^HL70063|1913 Smsterdam Pl^^Saint Clair Township^MI^48079^USA^P|^PRN^PH^^^810^8916003ORC|RE||BP24D13335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP24D13335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281021588^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281022510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q63Z13343^^^AIRA-TEST^MR||WashingtonAIRA^NooraAIRA^Melinda^^^^L|JacksonAIRA^FaynaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1390 Sestervoort Ln^^Ida^MI^48140^USA^P||^PRN^PH^^^734^6037567|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1390 Sestervoort Ln^^Ida^MI^48140^USA^P|^PRN^PH^^^734^6037567ORC|RE||BQ63Z13343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ63Z13343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281022510^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281022558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D75G13351^^^AIRA-TEST^MR||BurkeAIRA^LiliAIRA^Uriana^^^^L|OlsonAIRA^StefanieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1223 Dengelo Ln^^Sturgis^MI^49091^USA^P||^PRN^PH^^^269^5894978|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BurkeAIRA^OlsonAIRA^^^^^L|MTH^Mother^HL70063|1223 Dengelo Ln^^Sturgis^MI^49091^USA^P|^PRN^PH^^^269^5894978ORC|RE||BD75G13351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD75G13351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281022558^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281024858|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P22B13359^^^AIRA-TEST^MR||PerryAIRA^MadhuAIRA^Lisette^^^^L|WintermanAIRA^TacincalaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1465 Earneveld Cir^^Berlin Township^MI^48002^USA^P||^PRN^PH^^^810^7418033|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PerryAIRA^WintermanAIRA^^^^^L|MTH^Mother^HL70063|1465 Earneveld Cir^^Berlin Township^MI^48002^USA^P|^PRN^PH^^^810^7418033ORC|RE||BP22B13359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP22B13359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281024858^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281025051|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U82P13364^^^AIRA-TEST^MR||JuniataAIRA^SileAIRA^Devika^^^^L|MercedAIRA^YaffahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1952 Haastricht Cir^^Brownstown^MI^48174^USA^P||^PRN^PH^^^734^7335495|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JuniataAIRA^MercedAIRA^^^^^L|MTH^Mother^HL70063|1952 Haastricht Cir^^Brownstown^MI^48174^USA^P|^PRN^PH^^^734^7335495ORC|RE||BU82P13364.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU82P13364.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281025051^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281027810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M89X13375^^^AIRA-TEST^MR||WilssonAIRA^EmmaleeAIRA^Delbin^^^^L|HoodAIRA^KonstanzeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1731 Bruin Ln^^Bad Axe^MI^48413^USA^P||^PRN^PH^^^989^8004136|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilssonAIRA^HoodAIRA^^^^^L|MTH^Mother^HL70063|1731 Bruin Ln^^Bad Axe^MI^48413^USA^P|^PRN^PH^^^989^8004136ORC|RE||BM89X13375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM89X13375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281027810^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281028601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T69Y13383^^^AIRA-TEST^MR||LimestoneAIRA^ChantelAIRA^Averi^^^^L|OttawaAIRA^MaleahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1375 Voorzijde Ln^^Midland^MI^48670^USA^P||^PRN^PH^^^989^2459036|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LimestoneAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1375 Voorzijde Ln^^Midland^MI^48670^USA^P|^PRN^PH^^^989^2459036ORC|RE||BT69Y13383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT69Y13383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281028601^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281028605|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G02B13391^^^AIRA-TEST^MR||HygensAIRA^TuhinaAIRA^Quinn^^^^L|LucasAIRA^ClorisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1257 Dedemblik Pl^^Jamestown^MI^49427^USA^P||^PRN^PH^^^616^3491669|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HygensAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1257 Dedemblik Pl^^Jamestown^MI^49427^USA^P|^PRN^PH^^^616^3491669ORC|RE||BG02B13391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG02B13391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281028605^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281028610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q31R13399^^^AIRA-TEST^MR||GuadalupeAIRA^AnnaAIRA^Lauren^^^^L|LeeAIRA^WillowAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1624 Fwolle Cir^^Calumet^MI^49918^USA^P||^PRN^PH^^^906^2515490|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GuadalupeAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1624 Fwolle Cir^^Calumet^MI^49918^USA^P|^PRN^PH^^^906^2515490ORC|RE||BQ31R13399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ31R13399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281028610^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281028658|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P14J13404^^^AIRA-TEST^MR||MercerAIRA^MutsukoAIRA^Danae^^^^L|MahoodAIRA^AmbraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1470 Rreda St^^Germfask^MI^49836^USA^P||^PRN^PH^^^906^4818738|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MercerAIRA^MahoodAIRA^^^^^L|MTH^Mother^HL70063|1470 Rreda St^^Germfask^MI^49836^USA^P|^PRN^PH^^^906^4818738ORC|RE||BP14J13404.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP14J13404.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281028658^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281029110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F87V13415^^^AIRA-TEST^MR||HaskellAIRA^ShubhaAIRA^Gili^^^^L|ValleyAIRA^ValerieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1221 Kapitein Pl^^Grosse Pointe^MI^48230^USA^P||^PRN^PH^^^313^2049844|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaskellAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1221 Kapitein Pl^^Grosse Pointe^MI^48230^USA^P|^PRN^PH^^^313^2049844ORC|RE||BF87V13415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF87V13415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281029110^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281029183|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H90E13423^^^AIRA-TEST^MR||Mc VeetyAIRA^BrittanyAIRA^Anastasia^^^^L|WayneAIRA^RoshanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1463 Wijfheerenlanden Ave^^Lansing^MI^48919^USA^P||^PRN^PH^^^517^9419370|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Mc VeetyAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1463 Wijfheerenlanden Ave^^Lansing^MI^48919^USA^P|^PRN^PH^^^517^9419370ORC|RE||BH90E13423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH90E13423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281029183^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281029810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A26L13431^^^AIRA-TEST^MR||MickelAIRA^ChristianaAIRA^Chelsa^^^^L|ClarkAIRA^SalmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1513 Beerssen Cir^^Milford Township^MI^48380^USA^P||^PRN^PH^^^248^4580208|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MickelAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1513 Beerssen Cir^^Milford Township^MI^48380^USA^P|^PRN^PH^^^248^4580208ORC|RE||BA26L13431.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA26L13431.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281029810^TRIPEDIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281038615|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z30X13439^^^AIRA-TEST^MR||BeckhamAIRA^SakinahAIRA^Presley^^^^L|HammarAIRA^SynaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1046 Podegraven-Reeuwijk St^^Unionville^MI^48767^USA^P||^PRN^PH^^^989^2403336|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BeckhamAIRA^HammarAIRA^^^^^L|MTH^Mother^HL70063|1046 Podegraven-Reeuwijk St^^Unionville^MI^48767^USA^P|^PRN^PH^^^989^2403336ORC|RE||BZ30X13439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ30X13439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281038615^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281038765|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E44G13444^^^AIRA-TEST^MR||WaldoAIRA^AramintaAIRA^Eirian^^^^L|WallowaAIRA^KatyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1969 Stroom Cir^^Gm Service Parts Operations^MI^48554^USA^P||^PRN^PH^^^810^4053843|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WaldoAIRA^WallowaAIRA^^^^^L|MTH^Mother^HL70063|1969 Stroom Cir^^Gm Service Parts Operations^MI^48554^USA^P|^PRN^PH^^^810^4053843ORC|RE||BE44G13444.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE44G13444.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281038765^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281038815|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M00Z13455^^^AIRA-TEST^MR||RinggoldAIRA^KenyaAIRA^Phebe^^^^L|StrubleAIRA^FlaviaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1330 Mcherpenzeel Cir^^Waterford^MI^48329^USA^P||^PRN^PH^^^248^8107118|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RinggoldAIRA^StrubleAIRA^^^^^L|MTH^Mother^HL70063|1330 Mcherpenzeel Cir^^Waterford^MI^48329^USA^P|^PRN^PH^^^248^8107118ORC|RE||BM00Z13455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM00Z13455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281038815^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281038965|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L76M13463^^^AIRA-TEST^MR||PageAIRA^LizzieAIRA^Paloma^^^^L|BurtAIRA^ValAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1701 Aeventer Ave^^Northwest^MI^48531^USA^P||^PRN^PH^^^810^6422018|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PageAIRA^BurtAIRA^^^^^L|MTH^Mother^HL70063|1701 Aeventer Ave^^Northwest^MI^48531^USA^P|^PRN^PH^^^810^6422018ORC|RE||BL76M13463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL76M13463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281038965^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039015|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B03X13471^^^AIRA-TEST^MR||BaylorAIRA^SajiliAIRA^Sage^^^^L|DickinsonAIRA^VanoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1671 Den Haag St^^Lapeer^MI^48446^USA^P||^PRN^PH^^^810^5369348|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BaylorAIRA^DickinsonAIRA^^^^^L|MTH^Mother^HL70063|1671 Den Haag St^^Lapeer^MI^48446^USA^P|^PRN^PH^^^810^5369348ORC|RE||BB03X13471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB03X13471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039015^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039165|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M97E13479^^^AIRA-TEST^MR||DawsonAIRA^NuAIRA^Louisa^^^^L|SwisherAIRA^AleshaneeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1717 Heusel-De Mierden Pl^^Swartz Creek^MI^48473^USA^P||^PRN^PH^^^810^7486984|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DawsonAIRA^SwisherAIRA^^^^^L|MTH^Mother^HL70063|1717 Heusel-De Mierden Pl^^Swartz Creek^MI^48473^USA^P|^PRN^PH^^^810^7486984ORC|RE||BM97E13479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM97E13479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039165^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039215|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F86V13484^^^AIRA-TEST^MR||WellsAIRA^BirkitaAIRA^Loris^^^^L|HarrisonAIRA^SalimahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1832 Nijsden-Margraten Pl^^Oakley^MI^48649^USA^P||^PRN^PH^^^989^9523711|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WellsAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1832 Nijsden-Margraten Pl^^Oakley^MI^48649^USA^P|^PRN^PH^^^989^9523711ORC|RE||BF86V13484.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF86V13484.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039215^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039278|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R21K13495^^^AIRA-TEST^MR||BrazosAIRA^DemiAIRA^Vidonia^^^^L|ConnorAIRA^HedeaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1164 Kopie St^^Mulliken^MI^48861^USA^P||^PRN^PH^^^517^4123146|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrazosAIRA^ConnorAIRA^^^^^L|MTH^Mother^HL70063|1164 Kopie St^^Mulliken^MI^48861^USA^P|^PRN^PH^^^517^4123146ORC|RE||BR21K13495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR21K13495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039278^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039365|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J83Y13503^^^AIRA-TEST^MR||OrangeAIRA^FantineAIRA^Neva^^^^L|WayneAIRA^LindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1349 Praktijk St^^Blissfield^MI^49228^USA^P||^PRN^PH^^^517^6310299|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OrangeAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1349 Praktijk St^^Blissfield^MI^49228^USA^P|^PRN^PH^^^517^6310299ORC|RE||BJ83Y13503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ83Y13503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039365^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039388|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X45L13511^^^AIRA-TEST^MR||BrotAIRA^PunitaAIRA^Riane^^^^L|BenewahAIRA^MaritzaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1430 Zmersfoort Ln^^Atlas^MI^48411^USA^P||^PRN^PH^^^810^3327540|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrotAIRA^BenewahAIRA^^^^^L|MTH^Mother^HL70063|1430 Zmersfoort Ln^^Atlas^MI^48411^USA^P|^PRN^PH^^^810^3327540ORC|RE||BX45L13511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX45L13511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039388^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039415|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q81V13519^^^AIRA-TEST^MR||RobertsAIRA^LaineAIRA^Luise^^^^L|McEntegartAIRA^AnninkaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1815 Aaanstad Cir^^Maybee^MI^48159^USA^P||^PRN^PH^^^734^6392161|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobertsAIRA^McEntegartAIRA^^^^^L|MTH^Mother^HL70063|1815 Aaanstad Cir^^Maybee^MI^48159^USA^P|^PRN^PH^^^734^6392161ORC|RE||BQ81V13519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ81V13519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039415^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039478|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P47Q13524^^^AIRA-TEST^MR||FultonAIRA^TheraAIRA^Aspen^^^^L|AlleghenyAIRA^EngelbertaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1880 Rij Cir^^Dryden^MI^48428^USA^P||^PRN^PH^^^810^5916333|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FultonAIRA^AlleghenyAIRA^^^^^L|MTH^Mother^HL70063|1880 Rij Cir^^Dryden^MI^48428^USA^P|^PRN^PH^^^810^5916333ORC|RE||BP47Q13524.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP47Q13524.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039478^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039565|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K72W13535^^^AIRA-TEST^MR||LemhiAIRA^SashaAIRA^Hathor^^^^L|OcarioAIRA^PrabhatiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1721 Verrassing Cir^^Melvin^MI^48454^USA^P||^PRN^PH^^^810^9794659|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LemhiAIRA^OcarioAIRA^^^^^L|MTH^Mother^HL70063|1721 Verrassing Cir^^Melvin^MI^48454^USA^P|^PRN^PH^^^810^9794659ORC|RE||BK72W13535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK72W13535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039565^FLUZONE HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039588|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D34B13543^^^AIRA-TEST^MR||PowerAIRA^RosyAIRA^Roshan^^^^L|ManningAIRA^AbigailAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1810 Woppersum Pl^^Detroit^MI^48288^USA^P||^PRN^PH^^^313^9003540|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PowerAIRA^ManningAIRA^^^^^L|MTH^Mother^HL70063|1810 Woppersum Pl^^Detroit^MI^48288^USA^P|^PRN^PH^^^313^9003540ORC|RE||BD34B13543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD34B13543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039588^Fluzone HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039615|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N04W13551^^^AIRA-TEST^MR||ClearwaterAIRA^FinvarraAIRA^Barbara^^^^L|NemahaAIRA^NichelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1564 Oarneveld Ave^^Dexter^MI^48130^USA^P||^PRN^PH^^^734^4930901|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClearwaterAIRA^NemahaAIRA^^^^^L|MTH^Mother^HL70063|1564 Oarneveld Ave^^Dexter^MI^48130^USA^P|^PRN^PH^^^734^4930901ORC|RE||BN04W13551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN04W13551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039615^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039678|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A41W13559^^^AIRA-TEST^MR||RyanAIRA^CristionaAIRA^Mayako^^^^L|FresnoAIRA^MartaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1397 Vergen op Zoom Cir^^Evart^MI^49631^USA^P||^PRN^PH^^^231^9030471|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RyanAIRA^FresnoAIRA^^^^^L|MTH^Mother^HL70063|1397 Vergen op Zoom Cir^^Evart^MI^49631^USA^P|^PRN^PH^^^231^9030471ORC|RE||BA41W13559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA41W13559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039678^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039765|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S00F13564^^^AIRA-TEST^MR||BucklesAIRA^DannellAIRA^Kineta^^^^L|ArenacAIRA^MidoriAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1038 Westland St^^Pittsford^MI^49271^USA^P||^PRN^PH^^^517^4531785|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BucklesAIRA^ArenacAIRA^^^^^L|MTH^Mother^HL70063|1038 Westland St^^Pittsford^MI^49271^USA^P|^PRN^PH^^^517^4531785ORC|RE||BS00F13564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS00F13564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039765^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039788|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U86J13575^^^AIRA-TEST^MR||CowlitzAIRA^GaliaAIRA^Liberty^^^^L|San MateoAIRA^PallaviAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1588 Nlphen-Chaam St^^Walhalla^MI^49458^USA^P||^PRN^PH^^^231^4515216|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CowlitzAIRA^San MateoAIRA^^^^^L|MTH^Mother^HL70063|1588 Nlphen-Chaam St^^Walhalla^MI^49458^USA^P|^PRN^PH^^^231^4515216ORC|RE||BU86J13575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU86J13575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039788^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039965|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E61E13583^^^AIRA-TEST^MR||HaskellAIRA^ReeseAIRA^Neroli^^^^L|MarinAIRA^TourmalineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1611 Dilversum St^^Sodus^MI^49126^USA^P||^PRN^PH^^^269^8904378|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaskellAIRA^MarinAIRA^^^^^L|MTH^Mother^HL70063|1611 Dilversum St^^Sodus^MI^49126^USA^P|^PRN^PH^^^269^8904378ORC|RE||BE61E13583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE61E13583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039965^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281039988|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H17N13591^^^AIRA-TEST^MR||DarkeAIRA^KismetAIRA^Brier^^^^L|BentonAIRA^PallaviAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1612 Rcht-Susteren Pl^^East Grand Ra^MI^49506^USA^P||^PRN^PH^^^616^3160765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DarkeAIRA^BentonAIRA^^^^^L|MTH^Mother^HL70063|1612 Rcht-Susteren Pl^^East Grand Ra^MI^49506^USA^P|^PRN^PH^^^616^3160765ORC|RE||BH17N13591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH17N13591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281039988^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P86G13599^^^AIRA-TEST^MR||Los AngelesAIRA^JaneAIRA^Muna^^^^L|CulbersonAIRA^ChristaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1923 Rotterdam Cir^^Flint^MI^48532^USA^P||^PRN^PH^^^810^4950272|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Los AngelesAIRA^CulbersonAIRA^^^^^L|MTH^Mother^HL70063|1923 Rotterdam Cir^^Flint^MI^48532^USA^P|^PRN^PH^^^810^4950272ORC|RE||BP86G13599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP86G13599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040005^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P55R13604^^^AIRA-TEST^MR||CharlevoixAIRA^AbhilashaAIRA^Salwa^^^^L|BedfordAIRA^CathieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1890 Ocharsterland Ln^^Allegan^MI^49010^USA^P||^PRN^PH^^^269^2298743|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CharlevoixAIRA^BedfordAIRA^^^^^L|MTH^Mother^HL70063|1890 Ocharsterland Ln^^Allegan^MI^49010^USA^P|^PRN^PH^^^269^2298743ORC|RE||BP55R13604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP55R13604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040010^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040015|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R64P13615^^^AIRA-TEST^MR||MontgomeryAIRA^CarinAIRA^Sorrel^^^^L|WhartonAIRA^AlumaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1082 Bunnik Pl^^McBrides^MI^48852^USA^P||^PRN^PH^^^989^8908970|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontgomeryAIRA^WhartonAIRA^^^^^L|MTH^Mother^HL70063|1082 Bunnik Pl^^McBrides^MI^48852^USA^P|^PRN^PH^^^989^8908970ORC|RE||BR64P13615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR64P13615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040015^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040020|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q38J13623^^^AIRA-TEST^MR||DarkeAIRA^LoganAIRA^Sydney^^^^L|WilliamsAIRA^KesiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1444 Ledemblik Pl^^Crystal^MI^48818^USA^P||^PRN^PH^^^989^2263430|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DarkeAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1444 Ledemblik Pl^^Crystal^MI^48818^USA^P|^PRN^PH^^^989^2263430ORC|RE||BQ38J13623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ38J13623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040020^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040058|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q73L13631^^^AIRA-TEST^MR||AntrimAIRA^MatildaAIRA^Apollonia^^^^L|SmithAIRA^FloramariaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1988 Eeldermalsen Ave^^Applegate^MI^48401^USA^P||^PRN^PH^^^810^6213314|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AntrimAIRA^SmithAIRA^^^^^L|MTH^Mother^HL70063|1988 Eeldermalsen Ave^^Applegate^MI^48401^USA^P|^PRN^PH^^^810^6213314ORC|RE||BQ73L13631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ73L13631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040058^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040088|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N53J13639^^^AIRA-TEST^MR||PsconenAIRA^CaileyAIRA^Antonia^^^^L|VenturaAIRA^LucyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1834 Voedsel Ave^^Gm Truck and Bus^MI^48551^USA^P||^PRN^PH^^^810^9274056|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PsconenAIRA^VenturaAIRA^^^^^L|MTH^Mother^HL70063|1834 Voedsel Ave^^Gm Truck and Bus^MI^48551^USA^P|^PRN^PH^^^810^9274056ORC|RE||BN53J13639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN53J13639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040088^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040089|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D80R13644^^^AIRA-TEST^MR||EllisAIRA^XenobiaAIRA^Wallis^^^^L|TulsaAIRA^IrihapetiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1780 Bijefurd St^^Eastlake^MI^49626^USA^P||^PRN^PH^^^231^7739532|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EllisAIRA^TulsaAIRA^^^^^L|MTH^Mother^HL70063|1780 Bijefurd St^^Eastlake^MI^49626^USA^P|^PRN^PH^^^231^7739532ORC|RE||BD80R13644.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD80R13644.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040089^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040165|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H84L13655^^^AIRA-TEST^MR||OwyheeAIRA^ClaraAIRA^Gajendra^^^^L|PerryAIRA^SawyerAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1373 Sersel Ln^^Detroit^MI^48275^USA^P||^PRN^PH^^^313^2835017|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwyheeAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1373 Sersel Ln^^Detroit^MI^48275^USA^P|^PRN^PH^^^313^2835017ORC|RE||BH84L13655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH84L13655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040165^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040188|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q58I13663^^^AIRA-TEST^MR||KingAIRA^DianeAIRA^Timandra^^^^L|SiouxAIRA^ChanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1597 Mmallingerland Cir^^Flint^MI^48532^USA^P||^PRN^PH^^^810^9406101|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1597 Mmallingerland Cir^^Flint^MI^48532^USA^P|^PRN^PH^^^810^9406101ORC|RE||BQ58I13663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ58I13663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040188^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040365|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V60K13671^^^AIRA-TEST^MR||HutchinsonAIRA^TamahAIRA^Rebecca^^^^L|ClarkeAIRA^EnolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1498 Hldebroek St^^Tower^MI^49792^USA^P||^PRN^PH^^^989^4393969|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HutchinsonAIRA^ClarkeAIRA^^^^^L|MTH^Mother^HL70063|1498 Hldebroek St^^Tower^MI^49792^USA^P|^PRN^PH^^^989^4393969ORC|RE||BV60K13671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV60K13671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040365^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281040388|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J83C13679^^^AIRA-TEST^MR||WyomingAIRA^NualaAIRA^Kaer^^^^L|MurphyAIRA^ColumbineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1760 Materiaal Ave^^Cheboygan^MI^49721^USA^P||^PRN^PH^^^231^5993391|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WyomingAIRA^MurphyAIRA^^^^^L|MTH^Mother^HL70063|1760 Materiaal Ave^^Cheboygan^MI^49721^USA^P|^PRN^PH^^^231^5993391ORC|RE||BJ83C13679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ83C13679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281040388^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E58N13684^^^AIRA-TEST^MR||PowerAIRA^ZethelAIRA^Ramya^^^^L|SarpyAIRA^AntonieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1078 Bontfoort Pl^^Montgomery^MI^49255^USA^P||^PRN^PH^^^517^5200407|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PowerAIRA^SarpyAIRA^^^^^L|MTH^Mother^HL70063|1078 Bontfoort Pl^^Montgomery^MI^49255^USA^P|^PRN^PH^^^517^5200407ORC|RE||BE58N13684.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE58N13684.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041310^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041350|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L93N13695^^^AIRA-TEST^MR||FayetteAIRA^LucianAIRA^Olivia^^^^L|FremontAIRA^LeilahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1402 Zaanstad St^^Oakville^MI^48160^USA^P||^PRN^PH^^^734^6768490|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FayetteAIRA^FremontAIRA^^^^^L|MTH^Mother^HL70063|1402 Zaanstad St^^Oakville^MI^48160^USA^P|^PRN^PH^^^734^6768490ORC|RE||BL93N13695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL93N13695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041350^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041358|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W10U13703^^^AIRA-TEST^MR||WillacyAIRA^RupalAIRA^Rosevear^^^^L|BucksAIRA^GenistaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1714 Dierden Cir^^Bham^MI^48012^USA^P||^PRN^PH^^^248^3226975|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WillacyAIRA^BucksAIRA^^^^^L|MTH^Mother^HL70063|1714 Dierden Cir^^Bham^MI^48012^USA^P|^PRN^PH^^^248^3226975ORC|RE||BW10U13703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW10U13703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041358^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041388|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E59H13711^^^AIRA-TEST^MR||HillsdaleAIRA^FadilaAIRA^Ginny^^^^L|YumaAIRA^ValarieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1750 Kardenberg St^^Manton^MI^49663^USA^P||^PRN^PH^^^231^2797415|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HillsdaleAIRA^YumaAIRA^^^^^L|MTH^Mother^HL70063|1750 Kardenberg St^^Manton^MI^49663^USA^P|^PRN^PH^^^231^2797415ORC|RE||BE59H13711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE59H13711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041388^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D37N13719^^^AIRA-TEST^MR||IndianaAIRA^NovyannaAIRA^Mindel^^^^L|PerkinsAIRA^BrileyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1534 Vooral St^^GR^MI^49523^USA^P||^PRN^PH^^^616^9718841|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IndianaAIRA^PerkinsAIRA^^^^^L|MTH^Mother^HL70063|1534 Vooral St^^GR^MI^49523^USA^P|^PRN^PH^^^616^9718841ORC|RE||BD37N13719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD37N13719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041410^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041450|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K68L13724^^^AIRA-TEST^MR||MartinAIRA^SveaAIRA^Yamuna^^^^L|O'ConnellAIRA^KeldaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1475 Marum Cir^^Rea^MI^48131^USA^P||^PRN^PH^^^734^7783713|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MartinAIRA^O'ConnellAIRA^^^^^L|MTH^Mother^HL70063|1475 Marum Cir^^Rea^MI^48131^USA^P|^PRN^PH^^^734^7783713ORC|RE||BK68L13724.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK68L13724.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041450^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041458|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S43M13735^^^AIRA-TEST^MR||HancockAIRA^GalinaAIRA^Siri^^^^L|PlatteAIRA^LexiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1486 Nss Pl^^Saranac^MI^48881^USA^P||^PRN^PH^^^616^8600557|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^PlatteAIRA^^^^^L|MTH^Mother^HL70063|1486 Nss Pl^^Saranac^MI^48881^USA^P|^PRN^PH^^^616^8600557ORC|RE||BS43M13735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS43M13735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041458^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041488|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U58E13743^^^AIRA-TEST^MR||UnionAIRA^AmeerahAIRA^Nalini^^^^L|ValleyAIRA^KeshiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1209 Nmstelveen Pl^^Saint Clair Shrs^MI^48082^USA^P||^PRN^PH^^^586^9798870|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UnionAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1209 Nmstelveen Pl^^Saint Clair Shrs^MI^48082^USA^P|^PRN^PH^^^586^9798870ORC|RE||BU58E13743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU58E13743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041488^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z68D13751^^^AIRA-TEST^MR||SharplesAIRA^DohnaAIRA^Branka^^^^L|AppanooseAIRA^NerinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1646 Instrument St^^Muskegon^MI^49444^USA^P||^PRN^PH^^^231^4743731|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SharplesAIRA^AppanooseAIRA^^^^^L|MTH^Mother^HL70063|1646 Instrument St^^Muskegon^MI^49444^USA^P|^PRN^PH^^^231^4743731ORC|RE||BZ68D13751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ68D13751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041510^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S63M13759^^^AIRA-TEST^MR||McFernanAIRA^CamilaAIRA^Clare^^^^L|KiernanAIRA^RhiamonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1210 Borsele Cir^^Clyde Township^MI^48049^USA^P||^PRN^PH^^^810^9988891|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McFernanAIRA^KiernanAIRA^^^^^L|MTH^Mother^HL70063|1210 Borsele Cir^^Clyde Township^MI^48049^USA^P|^PRN^PH^^^810^9988891ORC|RE||BS63M13759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS63M13759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041558^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041588|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B79U13764^^^AIRA-TEST^MR||EliasonAIRA^NamikoAIRA^Arti^^^^L|MackinacAIRA^MandieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1207 Verbranden St^^Bay View^MI^49770^USA^P||^PRN^PH^^^231^8140723|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EliasonAIRA^MackinacAIRA^^^^^L|MTH^Mother^HL70063|1207 Verbranden St^^Bay View^MI^49770^USA^P|^PRN^PH^^^231^8140723ORC|RE||BB79U13764.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB79U13764.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041588^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V77E13775^^^AIRA-TEST^MR||Del NorteAIRA^TamahAIRA^Amaya^^^^L|WotherspoonAIRA^MahdiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1371 Dverbetuwe Ln^^Mid Michigan Reg Med Center^MI^48670^USA^P||^PRN^PH^^^989^7715380|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Del NorteAIRA^WotherspoonAIRA^^^^^L|MTH^Mother^HL70063|1371 Dverbetuwe Ln^^Mid Michigan Reg Med Center^MI^48670^USA^P|^PRN^PH^^^989^7715380ORC|RE||BV77E13775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV77E13775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041610^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041650|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D29L13783^^^AIRA-TEST^MR||SkagitAIRA^CamilleAIRA^Nerissa^^^^L|BrownAIRA^MaddisonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1004 Jerwerderadiel Cir^^Waterford^MI^48327^USA^P||^PRN^PH^^^248^7927441|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SkagitAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1004 Jerwerderadiel Cir^^Waterford^MI^48327^USA^P|^PRN^PH^^^248^7927441ORC|RE||BD29L13783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD29L13783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041650^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041658|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X56U13791^^^AIRA-TEST^MR||MifflinAIRA^LastriAIRA^Eliza^^^^L|WorleyAIRA^HaraldaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1344 Guren Cir^^Wixom^MI^48393^USA^P||^PRN^PH^^^248^8712676|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MifflinAIRA^WorleyAIRA^^^^^L|MTH^Mother^HL70063|1344 Guren Cir^^Wixom^MI^48393^USA^P|^PRN^PH^^^248^8712676ORC|RE||BX56U13791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX56U13791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041658^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041688|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E60V13799^^^AIRA-TEST^MR||MartinAIRA^RabiAIRA^Erica^^^^L|LandbergAIRA^ThuridAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1067 Wirschot Pl^^Lansing^MI^48919^USA^P||^PRN^PH^^^517^4602409|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MartinAIRA^LandbergAIRA^^^^^L|MTH^Mother^HL70063|1067 Wirschot Pl^^Lansing^MI^48919^USA^P|^PRN^PH^^^517^4602409ORC|RE||BE60V13799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE60V13799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041688^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X56R13804^^^AIRA-TEST^MR||JonesAIRA^CarlinaAIRA^Alohi^^^^L|ReillyAIRA^MerlinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1450 Btede Broec St^^Hudsonville^MI^49426^USA^P||^PRN^PH^^^616^4712971|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JonesAIRA^ReillyAIRA^^^^^L|MTH^Mother^HL70063|1450 Btede Broec St^^Hudsonville^MI^49426^USA^P|^PRN^PH^^^616^4712971ORC|RE||BX56R13804.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX56R13804.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041710^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041750|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y16G13815^^^AIRA-TEST^MR||ThomasAIRA^ElsieAIRA^Yenene^^^^L|JauppiAIRA^AleksiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1922 Begon Ln^^Williamsburg^MI^49690^USA^P||^PRN^PH^^^231^5368577|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThomasAIRA^JauppiAIRA^^^^^L|MTH^Mother^HL70063|1922 Begon Ln^^Williamsburg^MI^49690^USA^P|^PRN^PH^^^231^5368577ORC|RE||BY16G13815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY16G13815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041750^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041758|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S35R13823^^^AIRA-TEST^MR||UptonAIRA^BonitaAIRA^Cynere^^^^L|CochiseAIRA^GuyraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1228 Htrecht Cir^^Colon^MI^49040^USA^P||^PRN^PH^^^269^8781277|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UptonAIRA^CochiseAIRA^^^^^L|MTH^Mother^HL70063|1228 Htrecht Cir^^Colon^MI^49040^USA^P|^PRN^PH^^^269^8781277ORC|RE||BS35R13823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS35R13823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041758^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041788|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y96I13831^^^AIRA-TEST^MR||MickelAIRA^BlinnAIRA^Missy^^^^L|ForestAIRA^DelvineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1811 Tijdens Ave^^Dollar Bay^MI^49922^USA^P||^PRN^PH^^^906^3211314|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MickelAIRA^ForestAIRA^^^^^L|MTH^Mother^HL70063|1811 Tijdens Ave^^Dollar Bay^MI^49922^USA^P|^PRN^PH^^^906^3211314ORC|RE||BY96I13831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY96I13831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041788^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X79S13839^^^AIRA-TEST^MR||MetcalfeAIRA^TrudyAIRA^Tess^^^^L|FultonAIRA^ItiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1765 Apeldoorn Ave^^Putnam Township^MI^48169^USA^P||^PRN^PH^^^734^9097620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MetcalfeAIRA^FultonAIRA^^^^^L|MTH^Mother^HL70063|1765 Apeldoorn Ave^^Putnam Township^MI^48169^USA^P|^PRN^PH^^^734^9097620ORC|RE||BX79S13839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX79S13839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041810^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041850|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U40I13844^^^AIRA-TEST^MR||HardinAIRA^MelinaAIRA^Frances^^^^L|WashingtonAIRA^CadrianAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1782 Fe Wolden Pl^^Roseville^MI^48066^USA^P||^PRN^PH^^^586^7832949|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1782 Fe Wolden Pl^^Roseville^MI^48066^USA^P|^PRN^PH^^^586^7832949ORC|RE||BU40I13844.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU40I13844.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041850^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041858|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O11X13855^^^AIRA-TEST^MR||MurphyAIRA^NimahAIRA^Chaya^^^^L|JohnssonAIRA^MaineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1851 Achtervoegsel Cir^^Hoxeyville^MI^49601^USA^P||^PRN^PH^^^231^3796717|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MurphyAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1851 Achtervoegsel Cir^^Hoxeyville^MI^49601^USA^P|^PRN^PH^^^231^3796717ORC|RE||BO11X13855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO11X13855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041858^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281041888|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V85O13863^^^AIRA-TEST^MR||BinghamAIRA^AdriannaAIRA^Danika^^^^L|LoganAIRA^LeonardaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1512 Hernheze Ln^^East Detroit^MI^48021^USA^P||^PRN^PH^^^586^5224099|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BinghamAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1512 Hernheze Ln^^East Detroit^MI^48021^USA^P|^PRN^PH^^^586^5224099ORC|RE||BV85O13863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV85O13863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281041888^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281048758|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A91V13871^^^AIRA-TEST^MR||AdamsAIRA^BeataAIRA^Lisbeth^^^^L|FisherAIRA^ZofeyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1427 Tittenseradeel St^^Clinton Township^MI^48035^USA^P||^PRN^PH^^^586^6412245|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdamsAIRA^FisherAIRA^^^^^L|MTH^Mother^HL70063|1427 Tittenseradeel St^^Clinton Township^MI^48035^USA^P|^PRN^PH^^^586^6412245ORC|RE||BA91V13871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA91V13871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281048758^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281048878|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z08C13879^^^AIRA-TEST^MR||HarneyAIRA^ShanataAIRA^Siham^^^^L|HarrisAIRA^QuiritaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1166 Blauw Cir^^Dow Chemical Mi Division^MI^48667^USA^P||^PRN^PH^^^989^7176230|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarneyAIRA^HarrisAIRA^^^^^L|MTH^Mother^HL70063|1166 Blauw Cir^^Dow Chemical Mi Division^MI^48667^USA^P|^PRN^PH^^^989^7176230ORC|RE||BZ08C13879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ08C13879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281048878^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281048901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I51E13884^^^AIRA-TEST^MR||WashingtonAIRA^SavannahAIRA^Lorie^^^^L|PikeAIRA^SawyerAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1200 Dchagen St^^Schoolcraft^MI^49087^USA^P||^PRN^PH^^^269^7224140|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1200 Dchagen St^^Schoolcraft^MI^49087^USA^P|^PRN^PH^^^269^7224140ORC|RE||BI51E13884.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI51E13884.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281048901^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281048991|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V65G13895^^^AIRA-TEST^MR||BergenAIRA^OfeliaAIRA^Dorothy^^^^L|NelsonAIRA^ThisbeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1220 Kint-Michielsgestel Ln^^East Jordan^MI^49727^USA^P||^PRN^PH^^^231^2331352|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BergenAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1220 Kint-Michielsgestel Ln^^East Jordan^MI^49727^USA^P|^PRN^PH^^^231^2331352ORC|RE||BV65G13895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV65G13895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281048991^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R02W13903^^^AIRA-TEST^MR||HaskellAIRA^SnehAIRA^Jina^^^^L|SivertsenAIRA^HananAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1694 Gss Ln^^Cannonsburg^MI^49317^USA^P||^PRN^PH^^^616^9980832|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HaskellAIRA^SivertsenAIRA^^^^^L|MTH^Mother^HL70063|1694 Gss Ln^^Cannonsburg^MI^49317^USA^P|^PRN^PH^^^616^9980832ORC|RE||BR02W13903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR02W13903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051005^PENTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G13X13911^^^AIRA-TEST^MR||IsaksonAIRA^AryanaAIRA^Lili^^^^L|WashingtonAIRA^AmberAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1188 Stein Ln^^Midland^MI^48667^USA^P||^PRN^PH^^^989^6898080|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IsaksonAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1188 Stein Ln^^Midland^MI^48667^USA^P|^PRN^PH^^^989^6898080ORC|RE||BG13X13911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG13X13911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051300^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051325|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A62A13919^^^AIRA-TEST^MR||HoreAIRA^GardeniaAIRA^Joy^^^^L|Red WillowAIRA^CandaceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1543 Domeren St^^Kentwood Brch^MI^49528^USA^P||^PRN^PH^^^616^9652312|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoreAIRA^Red WillowAIRA^^^^^L|MTH^Mother^HL70063|1543 Domeren St^^Kentwood Brch^MI^49528^USA^P|^PRN^PH^^^616^9652312ORC|RE||BA62A13919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA62A13919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051325^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051400|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O57U13924^^^AIRA-TEST^MR||FultonAIRA^NizanaAIRA^Hye^^^^L|KarlssonAIRA^JazlynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1969 Neerenveen St^^Orion Township^MI^48362^USA^P||^PRN^PH^^^248^7699593|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FultonAIRA^KarlssonAIRA^^^^^L|MTH^Mother^HL70063|1969 Neerenveen St^^Orion Township^MI^48362^USA^P|^PRN^PH^^^248^7699593ORC|RE||BO57U13924.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO57U13924.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051400^Fluzone Quadrivalent, Peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051425|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N19R13935^^^AIRA-TEST^MR||TillamookAIRA^AwstaAIRA^Julia^^^^L|ArcherAIRA^LeslieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1551 Hunspeet Ln^^Brownstwn Township^MI^48173^USA^P||^PRN^PH^^^734^7836725|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TillamookAIRA^ArcherAIRA^^^^^L|MTH^Mother^HL70063|1551 Hunspeet Ln^^Brownstwn Township^MI^48173^USA^P|^PRN^PH^^^734^7836725ORC|RE||BN19R13935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN19R13935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051425^Fluzone Quadrivalent, peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051600|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K85J13943^^^AIRA-TEST^MR||SalterAIRA^CayleeAIRA^Cadee^^^^L|LawrenceAIRA^ShareeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1260 Niets Ave^^Belleville^MI^48111^USA^P||^PRN^PH^^^734^7358124|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SalterAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1260 Niets Ave^^Belleville^MI^48111^USA^P|^PRN^PH^^^734^7358124ORC|RE||BK85J13943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK85J13943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051600^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051625|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G92V13951^^^AIRA-TEST^MR||WexfordAIRA^AlaquaAIRA^Filippa^^^^L|PatariAIRA^GemmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1391 Hinnenmaas Cir^^Turner^MI^48765^USA^P||^PRN^PH^^^989^7072039|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WexfordAIRA^PatariAIRA^^^^^L|MTH^Mother^HL70063|1391 Hinnenmaas Cir^^Turner^MI^48765^USA^P|^PRN^PH^^^989^7072039ORC|RE||BG92V13951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG92V13951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051625^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N79B13959^^^AIRA-TEST^MR||AlconaAIRA^LondynAIRA^Perla^^^^L|ColoradoAIRA^TryphenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1581 Aandgraaf Ln^^Washingtn Township^MI^48095^USA^P||^PRN^PH^^^586^3157547|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlconaAIRA^ColoradoAIRA^^^^^L|MTH^Mother^HL70063|1581 Aandgraaf Ln^^Washingtn Township^MI^48095^USA^P|^PRN^PH^^^586^3157547ORC|RE||BN79B13959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN79B13959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051700^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051725|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U92Y13967^^^AIRA-TEST^MR||TansbergAIRA^AyameAIRA^Stephanie^^^^L|PendletonAIRA^ImaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1998 Bestland Cir^^Boon^MI^49618^USA^P||^PRN^PH^^^231^6868148|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TansbergAIRA^PendletonAIRA^^^^^L|MTH^Mother^HL70063|1998 Bestland Cir^^Boon^MI^49618^USA^P|^PRN^PH^^^231^6868148ORC|RE||BU92Y13967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU92Y13967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051725^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051800|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N65Q13975^^^AIRA-TEST^MR||SchuylkillAIRA^NestaAIRA^Kailyn^^^^L|AdsgaardAIRA^SusannahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1704 Geel Ave^^Lansing^MI^48933^USA^P||^PRN^PH^^^517^8700268|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SchuylkillAIRA^AdsgaardAIRA^^^^^L|MTH^Mother^HL70063|1704 Geel Ave^^Lansing^MI^48933^USA^P|^PRN^PH^^^517^8700268ORC|RE||BN65Q13975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN65Q13975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051800^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281051825|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J58C13980^^^AIRA-TEST^MR||CoalAIRA^ClaireAIRA^Colleen^^^^L|JuniataAIRA^GiselleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1973 Oorlog Pl^^Dimondale^MI^48821^USA^P||^PRN^PH^^^517^3212097|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoalAIRA^JuniataAIRA^^^^^L|MTH^Mother^HL70063|1973 Oorlog Pl^^Dimondale^MI^48821^USA^P|^PRN^PH^^^517^3212097ORC|RE||BJ58C13980.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ58C13980.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281051825^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281054503|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z98N13991^^^AIRA-TEST^MR||HarrisonAIRA^HollyeAIRA^Aparna^^^^L|SacramentoAIRA^AurkeneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1121 Waddinxveen Pl^^Huron Township^MI^48164^USA^P||^PRN^PH^^^734^7907901|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisonAIRA^SacramentoAIRA^^^^^L|MTH^Mother^HL70063|1121 Waddinxveen Pl^^Huron Township^MI^48164^USA^P|^PRN^PH^^^734^7907901ORC|RE||BZ98N13991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ98N13991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281054503^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281054505|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J68Z13999^^^AIRA-TEST^MR||WashingtonAIRA^YrsaAIRA^Volante^^^^L|HickmanAIRA^PaulinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1851 Bezoek Pl^^Chesterfield Township^MI^48047^USA^P||^PRN^PH^^^586^7457615|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^HickmanAIRA^^^^^L|MTH^Mother^HL70063|1851 Bezoek Pl^^Chesterfield Township^MI^48047^USA^P|^PRN^PH^^^586^7457615ORC|RE||BJ68Z13999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ68Z13999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281054505^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281054515|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N81R14007^^^AIRA-TEST^MR||SusasAIRA^NixieAIRA^Cher^^^^L|FagenAIRA^LaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1958 Breed Pl^^Calumet^MI^49913^USA^P||^PRN^PH^^^906^9459313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SusasAIRA^FagenAIRA^^^^^L|MTH^Mother^HL70063|1958 Breed Pl^^Calumet^MI^49913^USA^P|^PRN^PH^^^906^9459313ORC|RE||BN81R14007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN81R14007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281054515^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281054758|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L22V14015^^^AIRA-TEST^MR||LarssenAIRA^ChiquitaAIRA^Sharmistha^^^^L|Twin FallsAIRA^EvonneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1696 Oijk bij Duurstede Pl^^Saginaw^MI^48602^USA^P||^PRN^PH^^^989^2842577|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LarssenAIRA^Twin FallsAIRA^^^^^L|MTH^Mother^HL70063|1696 Oijk bij Duurstede Pl^^Saginaw^MI^48602^USA^P|^PRN^PH^^^989^2842577ORC|RE||BL22V14015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL22V14015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281054758^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281056005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y45L14020^^^AIRA-TEST^MR||MorrisAIRA^PramadaAIRA^Oda^^^^L|MadisonAIRA^KayleeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1689 Westland St^^New Era^MI^49446^USA^P||^PRN^PH^^^231^4020688|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorrisAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1689 Westland St^^New Era^MI^49446^USA^P|^PRN^PH^^^231^4020688ORC|RE||BY45L14020.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY45L14020.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281056005^DTAP-IPV^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281056210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J78S14031^^^AIRA-TEST^MR||KingsAIRA^VinaAIRA^Nichelle^^^^L|OlsonAIRA^TaniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1165 Uoggenland Ln^^Detroit^MI^48279^USA^P||^PRN^PH^^^313^9494588|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingsAIRA^OlsonAIRA^^^^^L|MTH^Mother^HL70063|1165 Uoggenland Ln^^Detroit^MI^48279^USA^P|^PRN^PH^^^313^9494588ORC|RE||BJ78S14031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ78S14031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281056210^Quadracel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281056258|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R92Q14039^^^AIRA-TEST^MR||BrennanAIRA^LuvenaAIRA^Trupti^^^^L|HallAIRA^RosannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1426 Ziel Ln^^Brownstown Township^MI^48164^USA^P||^PRN^PH^^^734^7943755|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrennanAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1426 Ziel Ln^^Brownstown Township^MI^48164^USA^P|^PRN^PH^^^734^7943755ORC|RE||BR92Q14039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR92Q14039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281056258^QUADRACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281058905|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E61K14047^^^AIRA-TEST^MR||NobleAIRA^RenAIRA^Vikki^^^^L|BraceyAIRA^SivAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1528 Gebruiken Ave^^Frederic^MI^49733^USA^P||^PRN^PH^^^989^8009084|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NobleAIRA^BraceyAIRA^^^^^L|MTH^Mother^HL70063|1528 Gebruiken Ave^^Frederic^MI^49733^USA^P|^PRN^PH^^^989^8009084ORC|RE||BE61K14047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE61K14047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281058905^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281058958|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C94Q14055^^^AIRA-TEST^MR||NordholmAIRA^AlohaAIRA^Sadhana^^^^L|ShackelfordAIRA^IshitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1002 Nmsterdam Cir^^Northville Township^MI^48167^USA^P||^PRN^PH^^^248^8229924|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NordholmAIRA^ShackelfordAIRA^^^^^L|MTH^Mother^HL70063|1002 Nmsterdam Cir^^Northville Township^MI^48167^USA^P|^PRN^PH^^^248^8229924ORC|RE||BC94Q14055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC94Q14055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281058958^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281062115|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T52I14060^^^AIRA-TEST^MR||ShoshoneAIRA^MarlonAIRA^Beda^^^^L|JacksonAIRA^EnyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1628 Hekela Ave^^Rogers City^MI^49779^USA^P||^PRN^PH^^^989^6338055|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShoshoneAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1628 Hekela Ave^^Rogers City^MI^49779^USA^P|^PRN^PH^^^989^6338055ORC|RE||BT52I14060.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT52I14060.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281062115^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281062178|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F69V14071^^^AIRA-TEST^MR||NelsenAIRA^CadenceAIRA^Trisha^^^^L|BrackenAIRA^SamAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1846 Laadhoeke Cir^^Sterling Heights^MI^48313^USA^P||^PRN^PH^^^586^3851524|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NelsenAIRA^BrackenAIRA^^^^^L|MTH^Mother^HL70063|1846 Laadhoeke Cir^^Sterling Heights^MI^48313^USA^P|^PRN^PH^^^586^3851524ORC|RE||BF69V14071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF69V14071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281062178^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281062515|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B21O14079^^^AIRA-TEST^MR||FinnAIRA^IndiraAIRA^Ernestine^^^^L|LovingAIRA^ArtemisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1605 Bedden Pl^^Ray^MI^48096^USA^P||^PRN^PH^^^586^7625072|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FinnAIRA^LovingAIRA^^^^^L|MTH^Mother^HL70063|1605 Bedden Pl^^Ray^MI^48096^USA^P|^PRN^PH^^^586^7625072ORC|RE||BB21O14079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB21O14079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281062515^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281062578|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E53L14087^^^AIRA-TEST^MR||AlleganAIRA^DarraAIRA^Asmita^^^^L|RichlandAIRA^TharaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1891 Zitje Cir^^Sand Lake^MI^49343^USA^P||^PRN^PH^^^616^6855092|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlleganAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1891 Zitje Cir^^Sand Lake^MI^49343^USA^P|^PRN^PH^^^616^6855092ORC|RE||BE53L14087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE53L14087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281062578^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281062715|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R77D14095^^^AIRA-TEST^MR||JeffersonAIRA^BryleeAIRA^Cerdwin^^^^L|SamuelsonAIRA^PendaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1093 Rlbrandswaard St^^Kingston^MI^48741^USA^P||^PRN^PH^^^989^7673966|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^SamuelsonAIRA^^^^^L|MTH^Mother^HL70063|1093 Rlbrandswaard St^^Kingston^MI^48741^USA^P|^PRN^PH^^^989^7673966ORC|RE||BR77D14095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR77D14095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281062715^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281062778|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H50D14100^^^AIRA-TEST^MR||VenangoAIRA^JessicaAIRA^Maitane^^^^L|GarrardAIRA^AliyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1135 Meest Pl^^Moline^MI^49335^USA^P||^PRN^PH^^^616^7378145|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VenangoAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1135 Meest Pl^^Moline^MI^49335^USA^P|^PRN^PH^^^616^7378145ORC|RE||BH50D14100.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH50D14100.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281062778^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281062915|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K11U14111^^^AIRA-TEST^MR||JauppiAIRA^TemaAIRA^Bacia^^^^L|JofrayAIRA^YejideAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1519 Gesneden Pl^^Clarklake^MI^49234^USA^P||^PRN^PH^^^517^5735365|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JauppiAIRA^JofrayAIRA^^^^^L|MTH^Mother^HL70063|1519 Gesneden Pl^^Clarklake^MI^49234^USA^P|^PRN^PH^^^517^5735365ORC|RE||BK11U14111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK11U14111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281062915^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281062978|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O83T14119^^^AIRA-TEST^MR||ForestAIRA^TuruaAIRA^Alaine^^^^L|RileyAIRA^ManiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1145 Geleden St^^Saint James^MI^49782^USA^P||^PRN^PH^^^906^4118007|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ForestAIRA^RileyAIRA^^^^^L|MTH^Mother^HL70063|1145 Geleden St^^Saint James^MI^49782^USA^P|^PRN^PH^^^906^4118007ORC|RE||BO83T14119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO83T14119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281062978^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281064015|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G99R14127^^^AIRA-TEST^MR||FultonAIRA^SelenaAIRA^Hali^^^^L|PenistonAIRA^ShobhanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1424 Slkmaar Pl^^Kentwood^MI^49512^USA^P||^PRN^PH^^^616^9827511|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FultonAIRA^PenistonAIRA^^^^^L|MTH^Mother^HL70063|1424 Slkmaar Pl^^Kentwood^MI^49512^USA^P|^PRN^PH^^^616^9827511ORC|RE||BG99R14127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG99R14127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281064015^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281065010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E57I14135^^^AIRA-TEST^MR||AllamakeeAIRA^WinterAIRA^Edeva^^^^L|HallAIRA^AzulAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1787 Le Marne St^^Rochester^MI^48309^USA^P||^PRN^PH^^^248^5975380|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllamakeeAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1787 Le Marne St^^Rochester^MI^48309^USA^P|^PRN^PH^^^248^5975380ORC|RE||BE57I14135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE57I14135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281065010^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281065025|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R73O14140^^^AIRA-TEST^MR||LeonardAIRA^NavdeepAIRA^Liliana^^^^L|TereAIRA^ImeldaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1191 Geertruidenberg Ln^^Hessel^MI^49745^USA^P||^PRN^PH^^^906^6383293|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeonardAIRA^TereAIRA^^^^^L|MTH^Mother^HL70063|1191 Geertruidenberg Ln^^Hessel^MI^49745^USA^P|^PRN^PH^^^906^6383293ORC|RE||BR73O14140.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR73O14140.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281065025^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281065050|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X32P14151^^^AIRA-TEST^MR||IowaAIRA^EvanaAIRA^Amelie^^^^L|GilespieAIRA^BernadetteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1907 Wuth Ln^^Hickory Corners^MI^49060^USA^P||^PRN^PH^^^269^6293503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IowaAIRA^GilespieAIRA^^^^^L|MTH^Mother^HL70063|1907 Wuth Ln^^Hickory Corners^MI^49060^USA^P|^PRN^PH^^^269^6293503ORC|RE||BX32P14151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX32P14151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281065050^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281065070|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y87B14159^^^AIRA-TEST^MR||KlamathAIRA^YehudiAIRA^Hester^^^^L|FurnasAIRA^AdahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1040 Eint-Oedenrode Ave^^Lachine^MI^49753^USA^P||^PRN^PH^^^989^3497716|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KlamathAIRA^FurnasAIRA^^^^^L|MTH^Mother^HL70063|1040 Eint-Oedenrode Ave^^Lachine^MI^49753^USA^P|^PRN^PH^^^989^3497716ORC|RE||BY87B14159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY87B14159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281065070^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281065090|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F75B14167^^^AIRA-TEST^MR||BrennanAIRA^MorvaAIRA^Janiyah^^^^L|CarterAIRA^HermelindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1809 Hoogeveen Ave^^Farmingtn Hls^MI^48335^USA^P||^PRN^PH^^^248^4372753|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrennanAIRA^CarterAIRA^^^^^L|MTH^Mother^HL70063|1809 Hoogeveen Ave^^Farmingtn Hls^MI^48335^USA^P|^PRN^PH^^^248^4372753ORC|RE||BF75B14167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF75B14167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281065090^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281070355|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F93I14175^^^AIRA-TEST^MR||PayetteAIRA^MahaliaAIRA^Flos^^^^L|GrantAIRA^SuprabhaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1050 Pldebroek Ln^^Saugatuck^MI^49453^USA^P||^PRN^PH^^^269^3994647|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PayetteAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1050 Pldebroek Ln^^Saugatuck^MI^49453^USA^P|^PRN^PH^^^269^3994647ORC|RE||BF93I14175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF93I14175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281070355^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281070555|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K01B14180^^^AIRA-TEST^MR||CollingsworthAIRA^EmersonAIRA^Ivana^^^^L|DouglasAIRA^IldikoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1347 Deventer Ave^^Yankee Springs^MI^49333^USA^P||^PRN^PH^^^269^7151374|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CollingsworthAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1347 Deventer Ave^^Yankee Springs^MI^49333^USA^P|^PRN^PH^^^269^7151374ORC|RE||BK01B14180.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK01B14180.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281070555^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281070748|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V58P14191^^^AIRA-TEST^MR||TuscarawasAIRA^WhitneyAIRA^Sue^^^^L|OntonagonAIRA^AdenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1367 Beldrop St^^Caledonia^MI^49316^USA^P||^PRN^PH^^^616^3298309|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TuscarawasAIRA^OntonagonAIRA^^^^^L|MTH^Mother^HL70063|1367 Beldrop St^^Caledonia^MI^49316^USA^P|^PRN^PH^^^616^3298309ORC|RE||BV58P14191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV58P14191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281070748^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281070755|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U73K14199^^^AIRA-TEST^MR||JohnAIRA^SangmuAIRA^Modestus^^^^L|BelmontAIRA^CarnelianAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1463 Vorger-Odoorn Ln^^GR^MI^49546^USA^P||^PRN^PH^^^616^6613552|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JohnAIRA^BelmontAIRA^^^^^L|MTH^Mother^HL70063|1463 Vorger-Odoorn Ln^^GR^MI^49546^USA^P|^PRN^PH^^^616^6613552ORC|RE||BU73K14199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU73K14199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281070755^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281070840|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C63N14207^^^AIRA-TEST^MR||MontagueAIRA^CarysAIRA^Hibernia^^^^L|GrayAIRA^DulcineaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1809 Ooeree-Overflakkee Ln^^Detroit^MI^48225^USA^P||^PRN^PH^^^313^2856029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontagueAIRA^GrayAIRA^^^^^L|MTH^Mother^HL70063|1809 Ooeree-Overflakkee Ln^^Detroit^MI^48225^USA^P|^PRN^PH^^^313^2856029ORC|RE||BC63N14207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC63N14207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281070840^Fluzone Intradermal Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281070848|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B94B14215^^^AIRA-TEST^MR||RichlandAIRA^CajaAIRA^Shoshana^^^^L|DalyAIRA^CorinnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1236 Npe Ln^^Mi Department of Revenue^MI^48922^USA^P||^PRN^PH^^^517^6586568|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichlandAIRA^DalyAIRA^^^^^L|MTH^Mother^HL70063|1236 Npe Ln^^Mi Department of Revenue^MI^48922^USA^P|^PRN^PH^^^517^6586568ORC|RE||BB94B14215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB94B14215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281070848^FLUZONE INTRADERMAL QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281070948|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A90H14220^^^AIRA-TEST^MR||JacksonAIRA^ManyaAIRA^Rosaleen^^^^L|HoeyAIRA^TailynnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1392 Koord-Beveland Ln^^Coppersville^MI^49404^USA^P||^PRN^PH^^^616^6417826|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^HoeyAIRA^^^^^L|MTH^Mother^HL70063|1392 Koord-Beveland Ln^^Coppersville^MI^49404^USA^P|^PRN^PH^^^616^6417826ORC|RE||BA90H14220.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA90H14220.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281070948^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281070955|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A51C14231^^^AIRA-TEST^MR||San FranciscoAIRA^ChaviAIRA^Vitoria^^^^L|ClayAIRA^ElanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1159 Hoerendaal Cir^^GR^MI^49501^USA^P||^PRN^PH^^^616^9890636|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San FranciscoAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1159 Hoerendaal Cir^^GR^MI^49501^USA^P|^PRN^PH^^^616^9890636ORC|RE||BA51C14231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA51C14231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281070955^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281071040|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T42F14239^^^AIRA-TEST^MR||PatariAIRA^MalcaAIRA^Yukako^^^^L|ByrneAIRA^BindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1048 Zude IJsselstreek Pl^^Lake Isabella^MI^48893^USA^P||^PRN^PH^^^989^2883722|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PatariAIRA^ByrneAIRA^^^^^L|MTH^Mother^HL70063|1048 Zude IJsselstreek Pl^^Lake Isabella^MI^48893^USA^P|^PRN^PH^^^989^2883722ORC|RE||BT42F14239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT42F14239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281071040^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281071048|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y95W14247^^^AIRA-TEST^MR||EnaAIRA^KiaraAIRA^Ranee^^^^L|LaRueAIRA^DeannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1478 Yeimerswaal Pl^^Ironwood^MI^49938^USA^P||^PRN^PH^^^906^9825782|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EnaAIRA^LaRueAIRA^^^^^L|MTH^Mother^HL70063|1478 Yeimerswaal Pl^^Ironwood^MI^49938^USA^P|^PRN^PH^^^906^9825782ORC|RE||BY95W14247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY95W14247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281071048^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281071240|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W15Q14255^^^AIRA-TEST^MR||SaloAIRA^SabihaAIRA^Volumnia^^^^L|ShiawasseeAIRA^MariyahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1779 Hoensdrecht Cir^^Lakeport^MI^48059^USA^P||^PRN^PH^^^810^2055262|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SaloAIRA^ShiawasseeAIRA^^^^^L|MTH^Mother^HL70063|1779 Hoensdrecht Cir^^Lakeport^MI^48059^USA^P|^PRN^PH^^^810^2055262ORC|RE||BW15Q14255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW15Q14255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281071240^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281071248|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q52G14260^^^AIRA-TEST^MR||WilliamsAIRA^KeikoAIRA^Meckenzie^^^^L|NanceAIRA^ZeniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1343 Mverbetuwe Ave^^Treetops Vil^MI^49735^USA^P||^PRN^PH^^^989^4209424|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilliamsAIRA^NanceAIRA^^^^^L|MTH^Mother^HL70063|1343 Mverbetuwe Ave^^Treetops Vil^MI^49735^USA^P|^PRN^PH^^^989^4209424ORC|RE||BQ52G14260.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ52G14260.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281071248^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281071810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H82T14271^^^AIRA-TEST^MR||KentAIRA^LucilleAIRA^Letitia^^^^L|GustafsonAIRA^ScarlettAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1037 Jerwerderadiel Ln^^Skandia^MI^49885^USA^P||^PRN^PH^^^906^9178849|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KentAIRA^GustafsonAIRA^^^^^L|MTH^Mother^HL70063|1037 Jerwerderadiel Ln^^Skandia^MI^49885^USA^P|^PRN^PH^^^906^9178849ORC|RE||BH82T14271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH82T14271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281071810^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281071888|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I39I14279^^^AIRA-TEST^MR||AndroscogginAIRA^JahnaviAIRA^Alanna^^^^L|BlaineAIRA^EvadneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1118 Arimpenerwaard Pl^^Wakefield^MI^49968^USA^P||^PRN^PH^^^906^4118503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndroscogginAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1118 Arimpenerwaard Pl^^Wakefield^MI^49968^USA^P|^PRN^PH^^^906^4118503ORC|RE||BI39I14279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI39I14279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281071888^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281079020|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E22H14287^^^AIRA-TEST^MR||OrangeAIRA^JovitaAIRA^Nediva^^^^L|MonroeAIRA^AdelaideAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1409 Algemeen Ln^^Saginaw^MI^48609^USA^P||^PRN^PH^^^989^4269976|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OrangeAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1409 Algemeen Ln^^Saginaw^MI^48609^USA^P|^PRN^PH^^^989^4269976ORC|RE||BE22H14287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE22H14287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281079020^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281079038|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W87H14295^^^AIRA-TEST^MR||Saint JosephAIRA^AnniceAIRA^Gili^^^^L|WayneAIRA^LucindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1193 Lundert Cir^^Fraser^MI^48026^USA^P||^PRN^PH^^^586^8477507|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Saint JosephAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1193 Lundert Cir^^Fraser^MI^48026^USA^P|^PRN^PH^^^586^8477507ORC|RE||BW87H14295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW87H14295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281079038^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281079051|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L10I14300^^^AIRA-TEST^MR||BlairAIRA^DebbyAIRA^Vienna^^^^L|CaddoAIRA^AlavdaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1688 Maals Pl^^Grant^MI^49327^USA^P||^PRN^PH^^^231^4829383|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlairAIRA^CaddoAIRA^^^^^L|MTH^Mother^HL70063|1688 Maals Pl^^Grant^MI^49327^USA^P|^PRN^PH^^^231^4829383ORC|RE||BL10I14300.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL10I14300.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281079051^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281079088|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P28W14311^^^AIRA-TEST^MR||TuolumneAIRA^NiveditaAIRA^Alana^^^^L|HarmonAIRA^TutiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1939 Be Bilt Ave^^Grandville^MI^49418^USA^P||^PRN^PH^^^616^6681782|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TuolumneAIRA^HarmonAIRA^^^^^L|MTH^Mother^HL70063|1939 Be Bilt Ave^^Grandville^MI^49418^USA^P|^PRN^PH^^^616^6681782ORC|RE||BP28W14311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP28W14311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281079088^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281080083|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R09J14319^^^AIRA-TEST^MR||HardinAIRA^PhilanaAIRA^Ireland^^^^L|AndersonAIRA^JohannaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1225 Appel Cir^^Sang^MI^48045^USA^P||^PRN^PH^^^586^5572372|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1225 Appel Cir^^Sang^MI^48045^USA^P|^PRN^PH^^^586^5572372ORC|RE||BR09J14319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR09J14319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281080083^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281082010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J98E14327^^^AIRA-TEST^MR||Nez PerceAIRA^MarilynAIRA^Myrna^^^^L|WallerAIRA^BrianaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1488 Haalre Pl^^Comins^MI^48619^USA^P||^PRN^PH^^^989^4342784|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Nez PerceAIRA^WallerAIRA^^^^^L|MTH^Mother^HL70063|1488 Haalre Pl^^Comins^MI^48619^USA^P|^PRN^PH^^^989^4342784ORC|RE||BJ98E14327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ98E14327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281082010^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281086010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y77D14335^^^AIRA-TEST^MR||GravesAIRA^ApolloniaAIRA^Delaney^^^^L|Olsen LeeAIRA^SherAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1908 Ee Marne Ln^^Secretary of State^MI^48918^USA^P||^PRN^PH^^^517^7499988|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GravesAIRA^Olsen LeeAIRA^^^^^L|MTH^Mother^HL70063|1908 Ee Marne Ln^^Secretary of State^MI^48918^USA^P|^PRN^PH^^^517^7499988ORC|RE||BY77D14335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY77D14335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281086010^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281086055|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N17E14340^^^AIRA-TEST^MR||GillespieAIRA^SuprabhaAIRA^Ynes^^^^L|PutnamAIRA^BindiyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1024 Oluis Cir^^Hghtn Lk Heights^MI^48630^USA^P||^PRN^PH^^^989^8109880|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GillespieAIRA^PutnamAIRA^^^^^L|MTH^Mother^HL70063|1024 Oluis Cir^^Hghtn Lk Heights^MI^48630^USA^P|^PRN^PH^^^989^8109880ORC|RE||BN17E14340.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN17E14340.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281086055^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281086078|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J32E14351^^^AIRA-TEST^MR||GoodingAIRA^YurikoAIRA^Avara^^^^L|BraceyAIRA^EsperanzaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1310 Zutphen Ave^^Middlevle^MI^49333^USA^P||^PRN^PH^^^269^2450951|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GoodingAIRA^BraceyAIRA^^^^^L|MTH^Mother^HL70063|1310 Zutphen Ave^^Middlevle^MI^49333^USA^P|^PRN^PH^^^269^2450951ORC|RE||BJ32E14351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ32E14351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281086078^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281086088|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T74X14359^^^AIRA-TEST^MR||BurtAIRA^JadeAIRA^Skye^^^^L|TobinAIRA^HemangiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1379 Veilig St^^Houghton^MI^49931^USA^P||^PRN^PH^^^906^3143732|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BurtAIRA^TobinAIRA^^^^^L|MTH^Mother^HL70063|1379 Veilig St^^Houghton^MI^49931^USA^P|^PRN^PH^^^906^3143732ORC|RE||BT74X14359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT74X14359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281086088^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281091301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D22U14367^^^AIRA-TEST^MR||LemhiAIRA^AkilahAIRA^Emmett^^^^L|McCrackenAIRA^KayaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1304 Hladel St^^Cedar River^MI^49887^USA^P||^PRN^PH^^^906^4587587|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LemhiAIRA^McCrackenAIRA^^^^^L|MTH^Mother^HL70063|1304 Hladel St^^Cedar River^MI^49887^USA^P|^PRN^PH^^^906^4587587ORC|RE||BD22U14367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD22U14367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281091301^STAMARIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281091501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N73Y14375^^^AIRA-TEST^MR||HusseyAIRA^RudelleAIRA^Kristel^^^^L|LuceAIRA^PurvaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1421 Soevorden St^^Farmington Hls^MI^48332^USA^P||^PRN^PH^^^248^2576786|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HusseyAIRA^LuceAIRA^^^^^L|MTH^Mother^HL70063|1421 Soevorden St^^Farmington Hls^MI^48332^USA^P|^PRN^PH^^^248^2576786ORC|RE||BN73Y14375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN73Y14375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281091501^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281091505|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L29Y14380^^^AIRA-TEST^MR||MenomineeAIRA^CassidyAIRA^Evadne^^^^L|MaderaAIRA^ElexusAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1557 Normerland St^^Bridgman^MI^49106^USA^P||^PRN^PH^^^269^8014286|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MenomineeAIRA^MaderaAIRA^^^^^L|MTH^Mother^HL70063|1557 Normerland St^^Bridgman^MI^49106^USA^P|^PRN^PH^^^269^8014286ORC|RE||BL29Y14380.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL29Y14380.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281091505^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281091558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O68X14391^^^AIRA-TEST^MR||MerwikAIRA^ChikaAIRA^Aysegal^^^^L|WilliamsAIRA^HadaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1421 Be Wolden Cir^^Rockford^MI^49351^USA^P||^PRN^PH^^^616^4006106|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MerwikAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1421 Be Wolden Cir^^Rockford^MI^49351^USA^P|^PRN^PH^^^616^4006106ORC|RE||BO68X14391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO68X14391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281091558^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-49281091568|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B98L14399^^^AIRA-TEST^MR||WarrenAIRA^MichaelaAIRA^Raksha^^^^L|NorthamptonAIRA^LarissaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1654 Caals Cir^^Parma^MI^49269^USA^P||^PRN^PH^^^517^8948506|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WarrenAIRA^NorthamptonAIRA^^^^^L|MTH^Mother^HL70063|1654 Caals Cir^^Parma^MI^49269^USA^P|^PRN^PH^^^517^8948506ORC|RE||BB98L14399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB98L14399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||49281091568^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-1693-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L09O14407^^^AIRA-TEST^MR||ToddAIRA^MarciaAIRA^Mahala^^^^L|RainsAIRA^CherishAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1343 Zuiden Pl^^Cascade^MI^49506^USA^P||^PRN^PH^^^616^6813962|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ToddAIRA^RainsAIRA^^^^^L|MTH^Mother^HL70063|1343 Zuiden Pl^^Cascade^MI^49506^USA^P|^PRN^PH^^^616^6813962ORC|RE||BL09O14407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL09O14407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-1693-0^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-1693-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y71K14415^^^AIRA-TEST^MR||LowndesAIRA^ImeldaAIRA^Shanelle^^^^L|WaldoAIRA^MariAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1013 Kluis St^^Marion^MI^49665^USA^P||^PRN^PH^^^231^8544711|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LowndesAIRA^WaldoAIRA^^^^^L|MTH^Mother^HL70063|1013 Kluis St^^Marion^MI^49665^USA^P|^PRN^PH^^^231^8544711ORC|RE||BY71K14415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY71K14415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-1693-9^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-2883-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O00C14423^^^AIRA-TEST^MR||GrayAIRA^SamaraAIRA^Candra^^^^L|SnyderAIRA^MatangiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1073 Aangelegenheid Pl^^Lansing^MI^48919^USA^P||^PRN^PH^^^517^5234418|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrayAIRA^SnyderAIRA^^^^^L|MTH^Mother^HL70063|1073 Aangelegenheid Pl^^Lansing^MI^48919^USA^P|^PRN^PH^^^517^5234418ORC|RE||BO00C14423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO00C14423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-2883-0^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-2883-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A13Z14431^^^AIRA-TEST^MR||BolgenAIRA^MarshaAIRA^Shika^^^^L|KirklandAIRA^KatarinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1136 Poordenveld Cir^^Cedar River^MI^49887^USA^P||^PRN^PH^^^906^8194829|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BolgenAIRA^KirklandAIRA^^^^^L|MTH^Mother^HL70063|1136 Poordenveld Cir^^Cedar River^MI^49887^USA^P|^PRN^PH^^^906^8194829ORC|RE||BA13Z14431.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA13Z14431.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-2883-9^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-3096-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L47D14436^^^AIRA-TEST^MR||GilespieAIRA^SarasvatiAIRA^Ziazan^^^^L|PetersAIRA^SkyeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1087 Beenendaal Ln^^Trufant^MI^49347^USA^P||^PRN^PH^^^231^8271841|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GilespieAIRA^PetersAIRA^^^^^L|MTH^Mother^HL70063|1087 Beenendaal Ln^^Trufant^MI^49347^USA^P|^PRN^PH^^^231^8271841ORC|RE||BL47D14436.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL47D14436.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-3096-0^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-3469-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S99N14447^^^AIRA-TEST^MR||GanesAIRA^EsmereldaAIRA^Maeve^^^^L|TaylorAIRA^RachAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1776 Balkenburg aan de Geul Cir^^Commerce Township^MI^48390^USA^P||^PRN^PH^^^248^9183072|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GanesAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1776 Balkenburg aan de Geul Cir^^Commerce Township^MI^48390^USA^P|^PRN^PH^^^248^9183072ORC|RE||BS99N14447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS99N14447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-3469-0^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090-3469-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y04J14455^^^AIRA-TEST^MR||TemplemanAIRA^PazAIRA^Jessica^^^^L|RoscommonAIRA^JocelynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1068 Histerwijk St^^Gladwin^MI^48624^USA^P||^PRN^PH^^^989^2657285|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TemplemanAIRA^RoscommonAIRA^^^^^L|MTH^Mother^HL70063|1068 Histerwijk St^^Gladwin^MI^48624^USA^P|^PRN^PH^^^989^2657285ORC|RE||BY04J14455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY04J14455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090-3469-9^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090169300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U02V14463^^^AIRA-TEST^MR||ErathAIRA^SagaraAIRA^Beda^^^^L|WalshAIRA^MerisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1026 Mais Cir^^Sylvan Beach^MI^49463^USA^P||^PRN^PH^^^231^9151020|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ErathAIRA^WalshAIRA^^^^^L|MTH^Mother^HL70063|1026 Mais Cir^^Sylvan Beach^MI^49463^USA^P|^PRN^PH^^^231^9151020ORC|RE||BU02V14463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU02V14463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090169300^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090169309|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T31V14471^^^AIRA-TEST^MR||SiskiyouAIRA^ZiaAIRA^Breanna^^^^L|GlennAIRA^MalloryAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1955 Dollands Kroon Ave^^Kincheloe^MI^49784^USA^P||^PRN^PH^^^906^4842914|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiskiyouAIRA^GlennAIRA^^^^^L|MTH^Mother^HL70063|1955 Dollands Kroon Ave^^Kincheloe^MI^49784^USA^P|^PRN^PH^^^906^4842914ORC|RE||BT31V14471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT31V14471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090169309^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090288300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I03M14476^^^AIRA-TEST^MR||McDonaldAIRA^VesnaAIRA^Cait^^^^L|ShappeAIRA^SamanthaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1982 Elst-Wijhe St^^Greenwood Township^MI^48006^USA^P||^PRN^PH^^^810^7868925|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McDonaldAIRA^ShappeAIRA^^^^^L|MTH^Mother^HL70063|1982 Elst-Wijhe St^^Greenwood Township^MI^48006^USA^P|^PRN^PH^^^810^7868925ORC|RE||BI03M14476.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI03M14476.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090288300^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090288309|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J25F14487^^^AIRA-TEST^MR||FurnasAIRA^JohannaAIRA^Wyuna^^^^L|YavapaiAIRA^HaleighaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1742 Suggereren St^^Kalamazoo^MI^49003^USA^P||^PRN^PH^^^269^9278132|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FurnasAIRA^YavapaiAIRA^^^^^L|MTH^Mother^HL70063|1742 Suggereren St^^Kalamazoo^MI^49003^USA^P|^PRN^PH^^^269^9278132ORC|RE||BJ25F14487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ25F14487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090288309^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090309600|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y10F14495^^^AIRA-TEST^MR||FurnasAIRA^SonamAIRA^Ailsa^^^^L|CowleyAIRA^CarolynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1689 Sranendonck Ln^^Higgins Lake^MI^48627^USA^P||^PRN^PH^^^989^5871602|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FurnasAIRA^CowleyAIRA^^^^^L|MTH^Mother^HL70063|1689 Sranendonck Ln^^Higgins Lake^MI^48627^USA^P|^PRN^PH^^^989^5871602ORC|RE||BY10F14495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY10F14495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090309600^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090346900|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L65P14503^^^AIRA-TEST^MR||DawsonAIRA^BarbieAIRA^Logan^^^^L|ShelbyAIRA^AnnabelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1260 Veendam Ln^^Okemos^MI^48805^USA^P||^PRN^PH^^^517^9110659|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DawsonAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1260 Veendam Ln^^Okemos^MI^48805^USA^P|^PRN^PH^^^517^9110659ORC|RE||BL65P14503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL65P14503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090346900^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-50090346909|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K54Q14511^^^AIRA-TEST^MR||MahoningAIRA^LizzyAIRA^Freyde^^^^L|NapaAIRA^BerangerAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1721 Fudwest-Fryslan St^^Chesaning^MI^48616^USA^P||^PRN^PH^^^989^2405503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MahoningAIRA^NapaAIRA^^^^^L|MTH^Mother^HL70063|1721 Fudwest-Fryslan St^^Chesaning^MI^48616^USA^P|^PRN^PH^^^989^2405503ORC|RE||BK54Q14511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK54Q14511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||50090346909^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285-138-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J60C14516^^^AIRA-TEST^MR||ClareAIRA^BhayanaAIRA^Bernadette^^^^L|KinnearAIRA^LakshmiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1273 Dennep Pl^^Naubinway^MI^49762^USA^P||^PRN^PH^^^906^6222786|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClareAIRA^KinnearAIRA^^^^^L|MTH^Mother^HL70063|1273 Dennep Pl^^Naubinway^MI^49762^USA^P|^PRN^PH^^^906^6222786ORC|RE||BJ60C14516.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ60C14516.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285-138-50^Adenovirus Type 4 and Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285-174-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H70W14527^^^AIRA-TEST^MR||RiverAIRA^RivkaAIRA^Anahid^^^^L|HayesAIRA^DeborahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1842 Grijs Ave^^Baldwin^MI^49304^USA^P||^PRN^PH^^^231^9672275|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RiverAIRA^HayesAIRA^^^^^L|MTH^Mother^HL70063|1842 Grijs Ave^^Baldwin^MI^49304^USA^P|^PRN^PH^^^231^9672275ORC|RE||BH70W14527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH70W14527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285-174-02^Adenovirus Type 4 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285-175-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B69E14535^^^AIRA-TEST^MR||BeecherAIRA^SurabhiAIRA^Gilen^^^^L|HamiltonAIRA^LienAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1863 Voekel St^^Prescott^MI^48756^USA^P||^PRN^PH^^^989^7839968|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BeecherAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1863 Voekel St^^Prescott^MI^48756^USA^P|^PRN^PH^^^989^7839968ORC|RE||BB69E14535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB69E14535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285-175-02^Adenovirus Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285013850|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H91U14543^^^AIRA-TEST^MR||AtwellAIRA^RobinAIRA^Saskia^^^^L|BullittAIRA^CochitiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1841 Castricum Ave^^Stockbridge^MI^49285^USA^P||^PRN^PH^^^517^3959032|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtwellAIRA^BullittAIRA^^^^^L|MTH^Mother^HL70063|1841 Castricum Ave^^Stockbridge^MI^49285^USA^P|^PRN^PH^^^517^3959032ORC|RE||BH91U14543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH91U14543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285013850^Adenovirus Type 4 and Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285017402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R04J14551^^^AIRA-TEST^MR||PulaskiAIRA^SunitaAIRA^Waseme^^^^L|MartinsonAIRA^SavinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1596 Kwolle Ln^^Chase Bank^MI^48278^USA^P||^PRN^PH^^^313^9322396|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PulaskiAIRA^MartinsonAIRA^^^^^L|MTH^Mother^HL70063|1596 Kwolle Ln^^Chase Bank^MI^48278^USA^P|^PRN^PH^^^313^9322396ORC|RE||BR04J14551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR04J14551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285017402^Adenovirus Type 4 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-51285017502|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S57S14556^^^AIRA-TEST^MR||TriggAIRA^OdileAIRA^Catalonia^^^^L|JacksonAIRA^DarraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1174 Rchagen Ln^^State of Mich Dept Treasury^MI^48930^USA^P||^PRN^PH^^^517^2695600|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TriggAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1174 Rchagen Ln^^State of Mich Dept Treasury^MI^48930^USA^P|^PRN^PH^^^517^2695600ORC|RE||BS57S14556.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS57S14556.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||51285017502^Adenovirus Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-0734-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M05R14567^^^AIRA-TEST^MR||TuscolaAIRA^SnigdhaAIRA^Farrah^^^^L|JacksonAIRA^AftonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1594 Idee St^^Novi^MI^48375^USA^P||^PRN^PH^^^248^6459261|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TuscolaAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1594 Idee St^^Novi^MI^48375^USA^P|^PRN^PH^^^248^6459261ORC|RE||BM05R14567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM05R14567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-0734-0^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-0980-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S13G14575^^^AIRA-TEST^MR||HumboldtAIRA^YaraAIRA^Haldana^^^^L|ZavalaAIRA^KarlaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1622 Eenzame Ln^^Reading^MI^49274^USA^P||^PRN^PH^^^517^2223204|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HumboldtAIRA^ZavalaAIRA^^^^^L|MTH^Mother^HL70063|1622 Eenzame Ln^^Reading^MI^49274^USA^P|^PRN^PH^^^517^2223204ORC|RE||BS13G14575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS13G14575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-0980-0^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-2219-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J11T14583^^^AIRA-TEST^MR||GogebicAIRA^HopeAIRA^Alannah^^^^L|EnaAIRA^DanielaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1542 Aubbergen Ave^^Burton^MI^48529^USA^P||^PRN^PH^^^810^3620233|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GogebicAIRA^EnaAIRA^^^^^L|MTH^Mother^HL70063|1542 Aubbergen Ave^^Burton^MI^48529^USA^P|^PRN^PH^^^810^3620233ORC|RE||BJ11T14583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ11T14583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-2219-0^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-2219-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T11C14591^^^AIRA-TEST^MR||McClungAIRA^AnayaAIRA^Zennor^^^^L|SierraAIRA^AnandaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1197 Cluis Ln^^Saline^MI^48176^USA^P||^PRN^PH^^^734^4201603|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McClungAIRA^SierraAIRA^^^^^L|MTH^Mother^HL70063|1197 Cluis Ln^^Saline^MI^48176^USA^P|^PRN^PH^^^734^4201603ORC|RE||BT11C14591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT11C14591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-2219-1^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-3339-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U43Z14596^^^AIRA-TEST^MR||HardinAIRA^ParisAIRA^Nandita^^^^L|FrioAIRA^TiffanyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1391 Vlphen aan den Rijn St^^Lake Orion^MI^48360^USA^P||^PRN^PH^^^248^4308645|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^FrioAIRA^^^^^L|MTH^Mother^HL70063|1391 Vlphen aan den Rijn St^^Lake Orion^MI^48360^USA^P|^PRN^PH^^^248^4308645ORC|RE||BU43Z14596.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU43Z14596.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-3339-1^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-3339-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N31U14607^^^AIRA-TEST^MR||CheyenneAIRA^DesireeAIRA^Indaliai^^^^L|MasonAIRA^CaleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1634 Hill St^^Dow Chemical Mi Division^MI^48667^USA^P||^PRN^PH^^^989^2703406|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CheyenneAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1634 Hill St^^Dow Chemical Mi Division^MI^48667^USA^P|^PRN^PH^^^989^2703406ORC|RE||BN31U14607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN31U14607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-3339-9^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-4320-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E72M14615^^^AIRA-TEST^MR||SandersAIRA^ChristelAIRA^Lasca^^^^L|MackeyAIRA^SonalAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1210 Dergeijk Cir^^Commerce^MI^48390^USA^P||^PRN^PH^^^248^4244501|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SandersAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1210 Dergeijk Cir^^Commerce^MI^48390^USA^P|^PRN^PH^^^248^4244501ORC|RE||BE72M14615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE72M14615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-4320-0^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-4320-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y89D14623^^^AIRA-TEST^MR||AlbrechtsonAIRA^EleanorAIRA^Brittany^^^^L|RichlandAIRA^SariahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1036 De hand Pl^^Andrews University^MI^49104^USA^P||^PRN^PH^^^269^4572242|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlbrechtsonAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1036 De hand Pl^^Andrews University^MI^49104^USA^P|^PRN^PH^^^269^4572242ORC|RE||BY89D14623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY89D14623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-4320-9^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-6177-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D33H14631^^^AIRA-TEST^MR||TrinityAIRA^JoleneAIRA^Barbie^^^^L|MecostaAIRA^TottyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1269 Beek Ave^^Farmingtn Hls^MI^48333^USA^P||^PRN^PH^^^248^2654614|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TrinityAIRA^MecostaAIRA^^^^^L|MTH^Mother^HL70063|1269 Beek Ave^^Farmingtn Hls^MI^48333^USA^P|^PRN^PH^^^248^2654614ORC|RE||BD33H14631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD33H14631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-6177-0^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868-6180-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D10U14639^^^AIRA-TEST^MR||HughesAIRA^AxeliaAIRA^Beryan^^^^L|HuntingdonAIRA^SarishaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1057 Midden-Drenthe Ln^^Byron^MI^48418^USA^P||^PRN^PH^^^810^7376730|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HughesAIRA^HuntingdonAIRA^^^^^L|MTH^Mother^HL70063|1057 Midden-Drenthe Ln^^Byron^MI^48418^USA^P|^PRN^PH^^^810^7376730ORC|RE||BD10U14639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD10U14639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868-6180-0^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868073400|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H25A14647^^^AIRA-TEST^MR||JeffersonAIRA^MelinaAIRA^Nola^^^^L|O DayAIRA^AlviraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1881 Hon en Breugel St^^Engadine^MI^49827^USA^P||^PRN^PH^^^906^4525171|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^O DayAIRA^^^^^L|MTH^Mother^HL70063|1881 Hon en Breugel St^^Engadine^MI^49827^USA^P|^PRN^PH^^^906^4525171ORC|RE||BH25A14647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH25A14647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868073400^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868098000|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P52D14652^^^AIRA-TEST^MR||PowerAIRA^KionaAIRA^Bobby^^^^L|ArcherAIRA^OndineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1698 Binkelland St^^Scottville^MI^49454^USA^P||^PRN^PH^^^231^6190944|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PowerAIRA^ArcherAIRA^^^^^L|MTH^Mother^HL70063|1698 Binkelland St^^Scottville^MI^49454^USA^P|^PRN^PH^^^231^6190944ORC|RE||BP52D14652.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP52D14652.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868098000^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868221900|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F21F14663^^^AIRA-TEST^MR||HughesAIRA^HesperAIRA^Nyoko^^^^L|ClarkAIRA^NewlynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1133 Souten Cir^^Munger^MI^48747^USA^P||^PRN^PH^^^989^5786200|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HughesAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1133 Souten Cir^^Munger^MI^48747^USA^P|^PRN^PH^^^989^5786200ORC|RE||BF21F14663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF21F14663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868221900^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868221901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O54M14671^^^AIRA-TEST^MR||ClarkAIRA^TrinityAIRA^Fuensanta^^^^L|FayetteAIRA^LuanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1848 Antwoord Cir^^Center Line^MI^48015^USA^P||^PRN^PH^^^586^2388556|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClarkAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1848 Antwoord Cir^^Center Line^MI^48015^USA^P|^PRN^PH^^^586^2388556ORC|RE||BO54M14671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO54M14671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868221901^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868333901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F84E14679^^^AIRA-TEST^MR||SimmingsenAIRA^CayleeAIRA^Morgance^^^^L|JacksonAIRA^KaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1512 Schilderen Ln^^Grand Rapids^MI^49502^USA^P||^PRN^PH^^^616^4981048|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SimmingsenAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1512 Schilderen Ln^^Grand Rapids^MI^49502^USA^P|^PRN^PH^^^616^4981048ORC|RE||BF84E14679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF84E14679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868333901^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868333909|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q10A14687^^^AIRA-TEST^MR||ToaleAIRA^FayeAIRA^Lona^^^^L|BrownAIRA^SadbAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1237 Lpsterland Ln^^Fibre^MI^49780^USA^P||^PRN^PH^^^906^8054459|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ToaleAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1237 Lpsterland Ln^^Fibre^MI^49780^USA^P|^PRN^PH^^^906^8054459ORC|RE||BQ10A14687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ10A14687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868333909^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868432000|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N73C14692^^^AIRA-TEST^MR||SwanwickAIRA^BerangerAIRA^Moya^^^^L|AlleghenyAIRA^CaraleeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1122 Ginkelland Cir^^Mulliken^MI^48861^USA^P||^PRN^PH^^^517^7483244|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SwanwickAIRA^AlleghenyAIRA^^^^^L|MTH^Mother^HL70063|1122 Ginkelland Cir^^Mulliken^MI^48861^USA^P|^PRN^PH^^^517^7483244ORC|RE||BN73C14692.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN73C14692.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868432000^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868432009|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I32R14703^^^AIRA-TEST^MR||OatesAIRA^LeeAIRA^Etana^^^^L|RogersAIRA^CaledoniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1996 Bangedijk Cir^^Burnips^MI^49314^USA^P||^PRN^PH^^^616^6570068|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OatesAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1996 Bangedijk Cir^^Burnips^MI^49314^USA^P|^PRN^PH^^^616^6570068ORC|RE||BI32R14703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI32R14703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868432009^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868617700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L12L14711^^^AIRA-TEST^MR||TillamookAIRA^ErikaAIRA^Esther^^^^L|AndersonAIRA^CarleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1764 Ltrechtse Heuvelrug Ave^^Buick City^MI^48550^USA^P||^PRN^PH^^^810^2681904|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TillamookAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1764 Ltrechtse Heuvelrug Ave^^Buick City^MI^48550^USA^P|^PRN^PH^^^810^2681904ORC|RE||BL12L14711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL12L14711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868617700^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-54868618000|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X40T14719^^^AIRA-TEST^MR||CedarAIRA^LisabetAIRA^Leoma^^^^L|LebanonAIRA^BonnyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1077 Hteenbergen Pl^^Frankfort^MI^49635^USA^P||^PRN^PH^^^231^6498451|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CedarAIRA^LebanonAIRA^^^^^L|MTH^Mother^HL70063|1077 Hteenbergen Pl^^Frankfort^MI^49635^USA^P|^PRN^PH^^^231^6498451ORC|RE||BX40T14719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX40T14719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||54868618000^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-55045-3841-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N53H14727^^^AIRA-TEST^MR||ThorsenAIRA^KarensaAIRA^Wilfreda^^^^L|WilliamsonAIRA^MackenzieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1947 Vdam-Volendam Ln^^Royal Oak^MI^48073^USA^P||^PRN^PH^^^248^7528793|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThorsenAIRA^WilliamsonAIRA^^^^^L|MTH^Mother^HL70063|1947 Vdam-Volendam Ln^^Royal Oak^MI^48073^USA^P|^PRN^PH^^^248^7528793ORC|RE||BN53H14727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN53H14727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||55045-3841-1^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-55045384101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D68Q14732^^^AIRA-TEST^MR||MeeAIRA^GabriellaAIRA^Zdenka^^^^L|WashingtonAIRA^VernaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1034 Herschelling St^^Washington Township^MI^48095^USA^P||^PRN^PH^^^586^7903756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeeAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1034 Herschelling St^^Washington Township^MI^48095^USA^P|^PRN^PH^^^586^7903756ORC|RE||BD68Q14732.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD68Q14732.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||55045384101^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-801-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R20K14743^^^AIRA-TEST^MR||HoodAIRA^JonieAIRA^Lexi^^^^L|BarryAIRA^YukakoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1244 Mittard-Geleen Ave^^Kinde^MI^48445^USA^P||^PRN^PH^^^989^8467781|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoodAIRA^BarryAIRA^^^^^L|MTH^Mother^HL70063|1244 Mittard-Geleen Ave^^Kinde^MI^48445^USA^P|^PRN^PH^^^989^8467781ORC|RE||BR20K14743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR20K14743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-801-11^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-802-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z84Q14751^^^AIRA-TEST^MR||PinalAIRA^AlthedaAIRA^Devorah^^^^L|Del NorteAIRA^AlvaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1303 Lengte Ave^^Shelby Township^MI^48317^USA^P||^PRN^PH^^^586^2265383|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PinalAIRA^Del NorteAIRA^^^^^L|MTH^Mother^HL70063|1303 Lengte Ave^^Shelby Township^MI^48317^USA^P|^PRN^PH^^^586^2265383ORC|RE||BZ84Q14751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ84Q14751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-802-02^AS03 Adjuvant^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-804-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z12A14759^^^AIRA-TEST^MR||PerkinsAIRA^HerschellAIRA^Cristina^^^^L|MackeyAIRA^SushmaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1692 Iudwest Fryslan Pl^^Houghton^MI^49921^USA^P||^PRN^PH^^^906^8865740|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PerkinsAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1692 Iudwest Fryslan Pl^^Houghton^MI^49921^USA^P|^PRN^PH^^^906^8865740ORC|RE||BZ12A14759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ12A14759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-804-01^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-806-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O66M14767^^^AIRA-TEST^MR||RowanAIRA^KorneliaAIRA^Jarah^^^^L|CameronAIRA^ChelseaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1228 Dteenbergen Cir^^Alanson^MI^49706^USA^P||^PRN^PH^^^616^3559366|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RowanAIRA^CameronAIRA^^^^^L|MTH^Mother^HL70063|1228 Dteenbergen Cir^^Alanson^MI^49706^USA^P|^PRN^PH^^^616^3559366ORC|RE||BO66M14767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO66M14767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-806-01^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-806-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R53K14772^^^AIRA-TEST^MR||StallardAIRA^LailieAIRA^Micah^^^^L|ClintonAIRA^AnitraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1246 Douten Cir^^Lawrence^MI^49064^USA^P||^PRN^PH^^^269^5557639|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StallardAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1246 Douten Cir^^Lawrence^MI^49064^USA^P|^PRN^PH^^^269^5557639ORC|RE||BR53K14772.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR53K14772.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-806-05^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-808-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B87G14783^^^AIRA-TEST^MR||ClareAIRA^AhnadaAIRA^Narkeasha^^^^L|McErlaneAIRA^CorinneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1673 Zeere Ln^^Amway Corp^MI^49357^USA^P||^PRN^PH^^^616^7447317|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClareAIRA^McErlaneAIRA^^^^^L|MTH^Mother^HL70063|1673 Zeere Ln^^Amway Corp^MI^49357^USA^P|^PRN^PH^^^616^7447317ORC|RE||BB87G14783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB87G14783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-808-15^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-809-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y97Z14791^^^AIRA-TEST^MR||GogebicAIRA^JohannaAIRA^Lanaya^^^^L|KnightAIRA^NishaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1192 Kon Cir^^GR^MI^49503^USA^P||^PRN^PH^^^616^9995942|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GogebicAIRA^KnightAIRA^^^^^L|MTH^Mother^HL70063|1192 Kon Cir^^GR^MI^49503^USA^P|^PRN^PH^^^616^9995942ORC|RE||BY97Z14791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY97Z14791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-809-01^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-809-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L56X14799^^^AIRA-TEST^MR||ClevelandAIRA^SteshaAIRA^Sheridan^^^^L|WebsterAIRA^CassielAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1341 Mexel Cir^^Croswell^MI^48422^USA^P||^PRN^PH^^^810^5558547|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClevelandAIRA^WebsterAIRA^^^^^L|MTH^Mother^HL70063|1341 Mexel Cir^^Croswell^MI^48422^USA^P|^PRN^PH^^^810^5558547ORC|RE||BL56X14799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL56X14799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-809-05^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-810-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E01N14807^^^AIRA-TEST^MR||BrazoriaAIRA^EileenAIRA^Karla^^^^L|EnaAIRA^SareaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1768 Dollands Kroon Cir^^Canton Township^MI^48187^USA^P||^PRN^PH^^^734^2108845|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrazoriaAIRA^EnaAIRA^^^^^L|MTH^Mother^HL70063|1768 Dollands Kroon Cir^^Canton Township^MI^48187^USA^P|^PRN^PH^^^734^2108845ORC|RE||BE01N14807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE01N14807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-810-01^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-810-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F29B14812^^^AIRA-TEST^MR||LyonAIRA^NadiraAIRA^Briony^^^^L|CusterAIRA^SashenkaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1802 Zlphen aan den Rijn St^^Scio^MI^48130^USA^P||^PRN^PH^^^734^8880840|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LyonAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1802 Zlphen aan den Rijn St^^Scio^MI^48130^USA^P|^PRN^PH^^^734^8880840ORC|RE||BF29B14812.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF29B14812.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-810-11^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-810-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C79O14823^^^AIRA-TEST^MR||SequoyahAIRA^FinvarraAIRA^Isabelle^^^^L|SheridanAIRA^BambalinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1814 Yudwest-Fryslan Ln^^Nottawa^MI^49075^USA^P||^PRN^PH^^^269^2435972|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SequoyahAIRA^SheridanAIRA^^^^^L|MTH^Mother^HL70063|1814 Yudwest-Fryslan Ln^^Nottawa^MI^49075^USA^P|^PRN^PH^^^269^2435972ORC|RE||BC79O14823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC79O14823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-810-43^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-810-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z15O14831^^^AIRA-TEST^MR||LieAIRA^GeraldineAIRA^Ianthe^^^^L|BurnetAIRA^CorowaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1084 Nijchen Cir^^Rosebush^MI^48878^USA^P||^PRN^PH^^^989^7037266|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LieAIRA^BurnetAIRA^^^^^L|MTH^Mother^HL70063|1084 Nijchen Cir^^Rosebush^MI^48878^USA^P|^PRN^PH^^^989^7037266ORC|RE||BZ15O14831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ15O14831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-810-52^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-811-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J23O14839^^^AIRA-TEST^MR||WoldAIRA^LudmilaAIRA^Coralia^^^^L|CassAIRA^ChaitraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1051 Dellendoorn St^^Munger^MI^48747^USA^P||^PRN^PH^^^989^5221114|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoldAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1051 Dellendoorn St^^Munger^MI^48747^USA^P|^PRN^PH^^^989^5221114ORC|RE||BJ23O14839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ23O14839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-811-41^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-811-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I14K14847^^^AIRA-TEST^MR||NorthamptonAIRA^DanaAIRA^Evangeline^^^^L|ShackelfordAIRA^DyanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1872 Blijven Ln^^Nazareth^MI^49074^USA^P||^PRN^PH^^^269^6877101|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NorthamptonAIRA^ShackelfordAIRA^^^^^L|MTH^Mother^HL70063|1872 Blijven Ln^^Nazareth^MI^49074^USA^P|^PRN^PH^^^269^6877101ORC|RE||BI14K14847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI14K14847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-811-43^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-811-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A59D14852^^^AIRA-TEST^MR||BucksAIRA^YurikoAIRA^Jaslene^^^^L|WoodsAIRA^DianaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1273 Helft Ave^^Macomb Township^MI^48042^USA^P||^PRN^PH^^^586^2334738|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BucksAIRA^WoodsAIRA^^^^^L|MTH^Mother^HL70063|1273 Helft Ave^^Macomb Township^MI^48042^USA^P|^PRN^PH^^^586^2334738ORC|RE||BA59D14852.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA59D14852.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-811-51^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-811-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A06K14863^^^AIRA-TEST^MR||CameronAIRA^DietlindeAIRA^Sweta^^^^L|HarneyAIRA^KyraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1070 Katwijk Pl^^Northville^MI^48168^USA^P||^PRN^PH^^^248^7694562|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CameronAIRA^HarneyAIRA^^^^^L|MTH^Mother^HL70063|1070 Katwijk Pl^^Northville^MI^48168^USA^P|^PRN^PH^^^248^7694562ORC|RE||BA06K14863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA06K14863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-811-52^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-812-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S95Z14871^^^AIRA-TEST^MR||AshlandAIRA^SidraAIRA^Armada^^^^L|ShermanAIRA^GazelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1749 Eluis Cir^^Hesperia^MI^49421^USA^P||^PRN^PH^^^231^2347018|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AshlandAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1749 Eluis Cir^^Hesperia^MI^49421^USA^P|^PRN^PH^^^231^2347018ORC|RE||BS95Z14871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS95Z14871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-812-01^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-812-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B23H14879^^^AIRA-TEST^MR||LeelanauAIRA^MoiraAIRA^Dobrila^^^^L|GreenAIRA^WinemaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1377 Dongeradeel Ln^^Saint Clr Shores^MI^48080^USA^P||^PRN^PH^^^586^4944201|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeelanauAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1377 Dongeradeel Ln^^Saint Clr Shores^MI^48080^USA^P|^PRN^PH^^^586^4944201ORC|RE||BB23H14879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB23H14879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-812-11^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-812-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M11I14887^^^AIRA-TEST^MR||LeelanauAIRA^TatumAIRA^Cameron^^^^L|WilssonAIRA^LillianAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1124 Ijs Ln^^Sodus^MI^49126^USA^P||^PRN^PH^^^269^3296403|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeelanauAIRA^WilssonAIRA^^^^^L|MTH^Mother^HL70063|1124 Ijs Ln^^Sodus^MI^49126^USA^P|^PRN^PH^^^269^3296403ORC|RE||BM11I14887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM11I14887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-812-43^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-812-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T51X14892^^^AIRA-TEST^MR||BordenAIRA^IdonaAIRA^Carin^^^^L|BradyAIRA^CambriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1327 Cs-Hertogenbosch Pl^^Keweenaw Bay^MI^49908^USA^P||^PRN^PH^^^906^6936352|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BordenAIRA^BradyAIRA^^^^^L|MTH^Mother^HL70063|1327 Cs-Hertogenbosch Pl^^Keweenaw Bay^MI^49908^USA^P|^PRN^PH^^^906^6936352ORC|RE||BT51X14892.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT51X14892.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-812-52^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C37W14903^^^AIRA-TEST^MR||JohnstonAIRA^AmeerahAIRA^Fantasia^^^^L|BrownAIRA^EriantheAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1535 Zeeze-Leende Ave^^Bedford^MI^49020^USA^P||^PRN^PH^^^269^5021060|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JohnstonAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1535 Zeeze-Leende Ave^^Bedford^MI^49020^USA^P|^PRN^PH^^^269^5021060ORC|RE||BC37W14903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC37W14903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-01^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C19U14911^^^AIRA-TEST^MR||OttawaAIRA^KianaAIRA^Lucretia^^^^L|MendocinoAIRA^PreitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1099 Kantoor Cir^^Flint^MI^48553^USA^P||^PRN^PH^^^810^8075565|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OttawaAIRA^MendocinoAIRA^^^^^L|MTH^Mother^HL70063|1099 Kantoor Cir^^Flint^MI^48553^USA^P|^PRN^PH^^^810^8075565ORC|RE||BC19U14911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC19U14911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-05^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S44V14919^^^AIRA-TEST^MR||SacramentoAIRA^JenniferAIRA^Farah^^^^L|SandstromAIRA^AmayaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1662 Bepaalde St^^Walker^MI^49534^USA^P||^PRN^PH^^^616^2664853|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SacramentoAIRA^SandstromAIRA^^^^^L|MTH^Mother^HL70063|1662 Bepaalde St^^Walker^MI^49534^USA^P|^PRN^PH^^^616^2664853ORC|RE||BS44V14919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS44V14919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-11^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H89U14927^^^AIRA-TEST^MR||DelawareAIRA^TheclaAIRA^Annabella^^^^L|NewaygoAIRA^CampbellAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1641 Hint-Michielsgestel Pl^^Kalamazoo^MI^49004^USA^P||^PRN^PH^^^269^2050052|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^NewaygoAIRA^^^^^L|MTH^Mother^HL70063|1641 Hint-Michielsgestel Pl^^Kalamazoo^MI^49004^USA^P|^PRN^PH^^^269^2050052ORC|RE||BH89U14927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH89U14927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-34^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F42F14932^^^AIRA-TEST^MR||UnionAIRA^KestrelAIRA^Theresia^^^^L|HillsdaleAIRA^KynthiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1861 Dss Ln^^Detroit^MI^48208^USA^P||^PRN^PH^^^313^8705213|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UnionAIRA^HillsdaleAIRA^^^^^L|MTH^Mother^HL70063|1861 Dss Ln^^Detroit^MI^48208^USA^P|^PRN^PH^^^313^8705213ORC|RE||BF42F14932.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF42F14932.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-41^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P13O14940^^^AIRA-TEST^MR||LivingstonAIRA^KellyAIRA^Holly^^^^L|JacksonAIRA^ShaylaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1866 Tien Cir^^Leonard^MI^48367^USA^P||^PRN^PH^^^248^2011156|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LivingstonAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1866 Tien Cir^^Leonard^MI^48367^USA^P|^PRN^PH^^^248^2011156ORC|RE||BP13O14940.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP13O14940.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-43^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-46|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z70A14951^^^AIRA-TEST^MR||VictoriaAIRA^KaitlinAIRA^Addisyn^^^^L|GreeneAIRA^MachikoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1451 Nedum St^^Middleton^MI^48856^USA^P||^PRN^PH^^^989^7760957|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VictoriaAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1451 Nedum St^^Middleton^MI^48856^USA^P|^PRN^PH^^^989^7760957ORC|RE||BZ70A14951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ70A14951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-46^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N59Y14959^^^AIRA-TEST^MR||HoltAIRA^AlankritaAIRA^Allisson^^^^L|Van BurenAIRA^DilysAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1276 Nchouwen-Duiveland Ave^^Northville Township^MI^48167^USA^P||^PRN^PH^^^248^8911535|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoltAIRA^Van BurenAIRA^^^^^L|MTH^Mother^HL70063|1276 Nchouwen-Duiveland Ave^^Northville Township^MI^48167^USA^P|^PRN^PH^^^248^8911535ORC|RE||BN59Y14959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN59Y14959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-48^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-815-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z69J14967^^^AIRA-TEST^MR||CrawfordAIRA^SushantiAIRA^Tuhina^^^^L|FillmoreAIRA^KaileeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1762 Rijk Cir^^Marshall^MI^49068^USA^P||^PRN^PH^^^269^8070603|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CrawfordAIRA^FillmoreAIRA^^^^^L|MTH^Mother^HL70063|1762 Rijk Cir^^Marshall^MI^49068^USA^P|^PRN^PH^^^269^8070603ORC|RE||BZ69J14967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ69J14967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-815-52^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-816-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O32L14975^^^AIRA-TEST^MR||JacksonAIRA^ShaktiAIRA^Davina^^^^L|KrogAIRA^LondynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1979 Huiven Ln^^Charlotte^MI^48813^USA^P||^PRN^PH^^^517^4101348|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^KrogAIRA^^^^^L|MTH^Mother^HL70063|1979 Huiven Ln^^Charlotte^MI^48813^USA^P|^PRN^PH^^^517^4101348ORC|RE||BO32L14975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO32L14975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-816-01^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-816-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z69V14983^^^AIRA-TEST^MR||DodgeAIRA^KatrinAIRA^Tenley^^^^L|KentAIRA^MickiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1498 Yard St^^Calumet^MI^49913^USA^P||^PRN^PH^^^906^4560123|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DodgeAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1498 Yard St^^Calumet^MI^49913^USA^P|^PRN^PH^^^906^4560123ORC|RE||BZ69V14983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ69V14983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-816-05^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-818-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H52J14988^^^AIRA-TEST^MR||LarssenAIRA^AaliyahAIRA^Jacinta^^^^L|CurryAIRA^SumatiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1767 Poekel Ave^^Hancock^MI^49930^USA^P||^PRN^PH^^^906^8214526|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LarssenAIRA^CurryAIRA^^^^^L|MTH^Mother^HL70063|1767 Poekel Ave^^Hancock^MI^49930^USA^P|^PRN^PH^^^906^8214526ORC|RE||BH52J14988.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH52J14988.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-818-11^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-819-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q59L14999^^^AIRA-TEST^MR||TereAIRA^SachiAIRA^Magena^^^^L|HubbardAIRA^ManuelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1405 Niessenlanden Ave^^Flint^MI^48554^USA^P||^PRN^PH^^^810^6934342|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TereAIRA^HubbardAIRA^^^^^L|MTH^Mother^HL70063|1405 Niessenlanden Ave^^Flint^MI^48554^USA^P|^PRN^PH^^^810^6934342ORC|RE||BQ59L14999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ59L14999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-819-12^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-820-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E37V15007^^^AIRA-TEST^MR||PrebleAIRA^NasicheAIRA^Tamah^^^^L|CartonAIRA^EvelinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1164 Seist Ln^^Erie^MI^48133^USA^P||^PRN^PH^^^734^4067323|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PrebleAIRA^CartonAIRA^^^^^L|MTH^Mother^HL70063|1164 Seist Ln^^Erie^MI^48133^USA^P|^PRN^PH^^^734^4067323ORC|RE||BE37V15007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE37V15007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-820-01^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-820-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D30W15015^^^AIRA-TEST^MR||GrundyAIRA^RanaAIRA^Lurline^^^^L|ClarkeAIRA^JazmynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1179 Aontferland Cir^^Bentley^MI^48613^USA^P||^PRN^PH^^^989^7815239|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrundyAIRA^ClarkeAIRA^^^^^L|MTH^Mother^HL70063|1179 Aontferland Cir^^Bentley^MI^48613^USA^P|^PRN^PH^^^989^7815239ORC|RE||BD30W15015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD30W15015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-820-11^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-820-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K86J15023^^^AIRA-TEST^MR||LancasterAIRA^OletheaAIRA^Nichelle^^^^L|KnowlesAIRA^LaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1746 Kon en Breugel Cir^^Grand Rapids^MI^49506^USA^P||^PRN^PH^^^616^2603873|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LancasterAIRA^KnowlesAIRA^^^^^L|MTH^Mother^HL70063|1746 Kon en Breugel Cir^^Grand Rapids^MI^49506^USA^P|^PRN^PH^^^616^2603873ORC|RE||BK86J15023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK86J15023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-820-43^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-820-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O34D15028^^^AIRA-TEST^MR||WintermanAIRA^JazmynAIRA^Tuesday^^^^L|BrazoriaAIRA^KadishaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1520 Mranendonck Cir^^Morley^MI^49336^USA^P||^PRN^PH^^^231^6111015|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WintermanAIRA^BrazoriaAIRA^^^^^L|MTH^Mother^HL70063|1520 Mranendonck Cir^^Morley^MI^49336^USA^P|^PRN^PH^^^231^6111015ORC|RE||BO34D15028.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO34D15028.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-820-52^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-821-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U64M15039^^^AIRA-TEST^MR||WettilandAIRA^DoloresAIRA^Elvan^^^^L|WintermanAIRA^ShailiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1470 Naren St^^Paris^MI^49338^USA^P||^PRN^PH^^^231^4444321|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WettilandAIRA^WintermanAIRA^^^^^L|MTH^Mother^HL70063|1470 Naren St^^Paris^MI^49338^USA^P|^PRN^PH^^^231^4444321ORC|RE||BU64M15039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU64M15039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-821-01^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-821-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J51Z15047^^^AIRA-TEST^MR||GrahamAIRA^GeorginaAIRA^Gillian^^^^L|HaagenAIRA^GonerilAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1397 Bouda Ave^^Grosse Pointe Farms^MI^48236^USA^P||^PRN^PH^^^313^8913447|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrahamAIRA^HaagenAIRA^^^^^L|MTH^Mother^HL70063|1397 Bouda Ave^^Grosse Pointe Farms^MI^48236^USA^P|^PRN^PH^^^313^8913447ORC|RE||BJ51Z15047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ51Z15047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-821-05^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-821-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F20U15055^^^AIRA-TEST^MR||CheboyganAIRA^QuincyAIRA^Phuong^^^^L|GreenAIRA^PiperAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1610 Volgen Ln^^Lake Leelanau^MI^49653^USA^P||^PRN^PH^^^231^4389220|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CheboyganAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1610 Volgen Ln^^Lake Leelanau^MI^49653^USA^P|^PRN^PH^^^231^4389220ORC|RE||BF20U15055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF20U15055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-821-11^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-821-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z86J15063^^^AIRA-TEST^MR||MasonAIRA^AskiniAIRA^Candida^^^^L|LewisAIRA^RandaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1336 Wollumerland Pl^^Montrose^MI^48457^USA^P||^PRN^PH^^^810^8613781|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1336 Wollumerland Pl^^Montrose^MI^48457^USA^P|^PRN^PH^^^810^8613781ORC|RE||BZ86J15063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ86J15063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-821-34^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-821-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q29K15068^^^AIRA-TEST^MR||GrantAIRA^MarisaAIRA^Sabine^^^^L|HendersonAIRA^PeggyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1579 Vongen Ave^^Au Gres^MI^48703^USA^P||^PRN^PH^^^989^2827076|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrantAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1579 Vongen Ave^^Au Gres^MI^48703^USA^P|^PRN^PH^^^989^2827076ORC|RE||BQ29K15068.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ29K15068.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-821-43^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-821-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U60N15079^^^AIRA-TEST^MR||LucasAIRA^NylahAIRA^Iku^^^^L|NilsenAIRA^ShonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1964 Hidden-Drenthe Ave^^Milford Township^MI^48380^USA^P||^PRN^PH^^^248^6219244|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LucasAIRA^NilsenAIRA^^^^^L|MTH^Mother^HL70063|1964 Hidden-Drenthe Ave^^Milford Township^MI^48380^USA^P|^PRN^PH^^^248^6219244ORC|RE||BU60N15079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU60N15079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-821-52^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-823-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C82Z15087^^^AIRA-TEST^MR||MagriAIRA^GargiAIRA^Alani^^^^L|FremmingAIRA^LoisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1748 Rlbrandswaard Ave^^Tipton^MI^49287^USA^P||^PRN^PH^^^517^4897145|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MagriAIRA^FremmingAIRA^^^^^L|MTH^Mother^HL70063|1748 Rlbrandswaard Ave^^Tipton^MI^49287^USA^P|^PRN^PH^^^517^4897145ORC|RE||BC82Z15087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC82Z15087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-823-11^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-825-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A86K15095^^^AIRA-TEST^MR||ThornleyAIRA^TeresaAIRA^Dalia^^^^L|OntonagonAIRA^MarleeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1452 Vallen Ln^^Arcadia^MI^49613^USA^P||^PRN^PH^^^231^9398601|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThornleyAIRA^OntonagonAIRA^^^^^L|MTH^Mother^HL70063|1452 Vallen Ln^^Arcadia^MI^49613^USA^P|^PRN^PH^^^231^9398601ORC|RE||BA86K15095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA86K15095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-825-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-825-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F34R15103^^^AIRA-TEST^MR||BexarAIRA^PriyankaAIRA^Birkita^^^^L|Roger MillsAIRA^KeelyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1815 Achagen Ln^^White Pine^MI^49971^USA^P||^PRN^PH^^^906^4686605|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BexarAIRA^Roger MillsAIRA^^^^^L|MTH^Mother^HL70063|1815 Achagen Ln^^White Pine^MI^49971^USA^P|^PRN^PH^^^906^4686605ORC|RE||BF34R15103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF34R15103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-825-11^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-825-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R54H15108^^^AIRA-TEST^MR||BremerAIRA^CathieAIRA^Shevaun^^^^L|JacksonAIRA^IleanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1391 Klimmen St^^Rosebush^MI^48878^USA^P||^PRN^PH^^^989^4868729|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BremerAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1391 Klimmen St^^Rosebush^MI^48878^USA^P|^PRN^PH^^^989^4868729ORC|RE||BR54H15108.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR54H15108.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-825-43^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-825-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V07E15119^^^AIRA-TEST^MR||CusackAIRA^SunnivaAIRA^Wanika^^^^L|JolsenAIRA^OnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1769 Woorn Cir^^Grand Rapids^MI^49555^USA^P||^PRN^PH^^^616^3739881|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CusackAIRA^JolsenAIRA^^^^^L|MTH^Mother^HL70063|1769 Woorn Cir^^Grand Rapids^MI^49555^USA^P|^PRN^PH^^^616^3739881ORC|RE||BV07E15119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV07E15119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-825-52^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-826-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L71T15127^^^AIRA-TEST^MR||ColemanAIRA^PraptiAIRA^Placida^^^^L|MontagueAIRA^KatinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1728 Hijssen Ave^^Goetzville^MI^49736^USA^P||^PRN^PH^^^906^4197865|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColemanAIRA^MontagueAIRA^^^^^L|MTH^Mother^HL70063|1728 Hijssen Ave^^Goetzville^MI^49736^USA^P|^PRN^PH^^^906^4197865ORC|RE||BL71T15127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL71T15127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-826-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-826-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C09W15135^^^AIRA-TEST^MR||MahaskaAIRA^EllemaAIRA^Yachne^^^^L|MonroeAIRA^GregoriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1380 Ve Wolden Ave^^Cedar Lake^MI^48812^USA^P||^PRN^PH^^^989^4221901|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MahaskaAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1380 Ve Wolden Ave^^Cedar Lake^MI^48812^USA^P|^PRN^PH^^^989^4221901ORC|RE||BC09W15135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC09W15135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-826-05^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-826-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F67H15143^^^AIRA-TEST^MR||GarfieldAIRA^WanettaAIRA^Gabriela^^^^L|AdamsAIRA^KasmiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1127 Spoedig Ln^^Orchard Lake^MI^48323^USA^P||^PRN^PH^^^248^3926698|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarfieldAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1127 Spoedig Ln^^Orchard Lake^MI^48323^USA^P|^PRN^PH^^^248^3926698ORC|RE||BF67H15143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF67H15143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-826-11^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-826-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N91Z15148^^^AIRA-TEST^MR||DunnAIRA^UnnatiAIRA^Gulara^^^^L|TaylorAIRA^MandaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1219 Dwartewaterland St^^Elm Hall^MI^48830^USA^P||^PRN^PH^^^989^4022767|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DunnAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1219 Dwartewaterland St^^Elm Hall^MI^48830^USA^P|^PRN^PH^^^989^4022767ORC|RE||BN91Z15148.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN91Z15148.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-826-34^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-826-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I16T15159^^^AIRA-TEST^MR||JoiceAIRA^SafiaAIRA^Abira^^^^L|NowataAIRA^SaktiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1939 Stoel Pl^^Au Sable^MI^48750^USA^P||^PRN^PH^^^989^3699492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JoiceAIRA^NowataAIRA^^^^^L|MTH^Mother^HL70063|1939 Stoel Pl^^Au Sable^MI^48750^USA^P|^PRN^PH^^^989^3699492ORC|RE||BI16T15159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI16T15159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-826-43^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-826-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B78X15167^^^AIRA-TEST^MR||AndersonAIRA^LalaAIRA^Laxmi^^^^L|WashingtonAIRA^TheodoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1475 Oor Cir^^Farwell^MI^48622^USA^P||^PRN^PH^^^989^9993706|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndersonAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1475 Oor Cir^^Farwell^MI^48622^USA^P|^PRN^PH^^^989^9993706ORC|RE||BB78X15167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB78X15167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-826-52^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-828-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J61E15175^^^AIRA-TEST^MR||JeffersonAIRA^GennaAIRA^Madrona^^^^L|ClintonAIRA^ZeliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1128 Henkum St^^Cement City^MI^49233^USA^P||^PRN^PH^^^517^6471496|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1128 Henkum St^^Cement City^MI^49233^USA^P|^PRN^PH^^^517^6471496ORC|RE||BJ61E15175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ61E15175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-828-01^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-828-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O96I15183^^^AIRA-TEST^MR||ProtheroeAIRA^ReneeAIRA^Arabella^^^^L|GustafsonAIRA^PenneyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1549 Verslaan Ln^^Frankenmuth^MI^48787^USA^P||^PRN^PH^^^989^5219473|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ProtheroeAIRA^GustafsonAIRA^^^^^L|MTH^Mother^HL70063|1549 Verslaan Ln^^Frankenmuth^MI^48787^USA^P|^PRN^PH^^^989^5219473ORC|RE||BO96I15183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO96I15183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-828-03^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-830-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M96V15188^^^AIRA-TEST^MR||AllenAIRA^KeishaAIRA^Yejide^^^^L|ShortAIRA^KasmiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1555 Zaltbommel Ln^^Macatawa^MI^49434^USA^P||^PRN^PH^^^616^4802362|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllenAIRA^ShortAIRA^^^^^L|MTH^Mother^HL70063|1555 Zaltbommel Ln^^Macatawa^MI^49434^USA^P|^PRN^PH^^^616^4802362ORC|RE||BM96V15188.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM96V15188.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-830-05^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-830-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K94O15199^^^AIRA-TEST^MR||AndersenAIRA^KaruahAIRA^Devika^^^^L|GreeneAIRA^SudhaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1635 Jteenwijkerland Pl^^New Boston^MI^48164^USA^P||^PRN^PH^^^734^8434703|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndersenAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1635 Jteenwijkerland Pl^^New Boston^MI^48164^USA^P|^PRN^PH^^^734^8434703ORC|RE||BK94O15199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK94O15199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-830-34^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-830-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X88K15207^^^AIRA-TEST^MR||FarrellAIRA^DietlindeAIRA^Alazne^^^^L|PerryAIRA^MahuruAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1605 Oanderd Cir^^Hickory Corners^MI^49060^USA^P||^PRN^PH^^^269^5241378|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FarrellAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1605 Oanderd Cir^^Hickory Corners^MI^49060^USA^P|^PRN^PH^^^269^5241378ORC|RE||BX88K15207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX88K15207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-830-43^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-830-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q45H15215^^^AIRA-TEST^MR||KrogAIRA^EriantheAIRA^Iola^^^^L|HudspethAIRA^DotAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1175 Neiderland Ln^^Walled Lake^MI^48390^USA^P||^PRN^PH^^^248^4285392|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KrogAIRA^HudspethAIRA^^^^^L|MTH^Mother^HL70063|1175 Neiderland Ln^^Walled Lake^MI^48390^USA^P|^PRN^PH^^^248^4285392ORC|RE||BQ45H15215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ45H15215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-830-52^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-842-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y14A15223^^^AIRA-TEST^MR||OmssundAIRA^BerniceAIRA^Machi^^^^L|Van ZandtAIRA^CaitrinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1217 Pollands Kroon Ave^^Palo^MI^48870^USA^P||^PRN^PH^^^989^7694837|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OmssundAIRA^Van ZandtAIRA^^^^^L|MTH^Mother^HL70063|1217 Pollands Kroon Ave^^Palo^MI^48870^USA^P|^PRN^PH^^^989^7694837ORC|RE||BY14A15223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY14A15223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-842-01^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-842-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B47S15228^^^AIRA-TEST^MR||LoupAIRA^AleksandraAIRA^Samara^^^^L|KyleAIRA^NoleenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1488 Aingewaard St^^GR^MI^49501^USA^P||^PRN^PH^^^616^4075556|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoupAIRA^KyleAIRA^^^^^L|MTH^Mother^HL70063|1488 Aingewaard St^^GR^MI^49501^USA^P|^PRN^PH^^^616^4075556ORC|RE||BB47S15228.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB47S15228.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-842-05^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-842-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E35D15239^^^AIRA-TEST^MR||OcarioAIRA^ZeanesAIRA^Braelynn^^^^L|PortageAIRA^KatrinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1719 Zomeren Ln^^Galien^MI^49113^USA^P||^PRN^PH^^^269^5357043|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OcarioAIRA^PortageAIRA^^^^^L|MTH^Mother^HL70063|1719 Zomeren Ln^^Galien^MI^49113^USA^P|^PRN^PH^^^269^5357043ORC|RE||BE35D15239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE35D15239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-842-11^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-842-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z18E15247^^^AIRA-TEST^MR||OcarioAIRA^AldaraAIRA^Yejide^^^^L|WilsonAIRA^WendiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1738 Katwijk Ln^^Carsonville^MI^48419^USA^P||^PRN^PH^^^810^8930799|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OcarioAIRA^WilsonAIRA^^^^^L|MTH^Mother^HL70063|1738 Katwijk Ln^^Carsonville^MI^48419^USA^P|^PRN^PH^^^810^8930799ORC|RE||BZ18E15247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ18E15247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-842-34^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-842-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M13P15255^^^AIRA-TEST^MR||San JuanAIRA^AderesAIRA^Kyla^^^^L|HardinAIRA^CampbellAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1671 Noirle St^^Elmira^MI^49730^USA^P||^PRN^PH^^^231^3861393|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San JuanAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1671 Noirle St^^Elmira^MI^49730^USA^P|^PRN^PH^^^231^3861393ORC|RE||BM13P15255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM13P15255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-842-41^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-842-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K73L15263^^^AIRA-TEST^MR||EmmetAIRA^TenleyAIRA^Darinka^^^^L|ChambersAIRA^PaniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1031 Jochem Ave^^Bloomfield^MI^48303^USA^P||^PRN^PH^^^248^8153250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EmmetAIRA^ChambersAIRA^^^^^L|MTH^Mother^HL70063|1031 Jochem Ave^^Bloomfield^MI^48303^USA^P|^PRN^PH^^^248^8153250ORC|RE||BK73L15263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK73L15263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-842-43^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-842-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y86X15268^^^AIRA-TEST^MR||CraneAIRA^CloveAIRA^Kellan^^^^L|SowdenAIRA^PhillidaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1781 Ging Pl^^Rea^MI^48131^USA^P||^PRN^PH^^^734^6281863|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CraneAIRA^SowdenAIRA^^^^^L|MTH^Mother^HL70063|1781 Ging Pl^^Rea^MI^48131^USA^P|^PRN^PH^^^734^6281863ORC|RE||BY86X15268.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY86X15268.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-842-51^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-842-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T99S15279^^^AIRA-TEST^MR||SacAIRA^ShelaAIRA^Guan-yin^^^^L|OwyheeAIRA^FinolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1690 Aieuwkoop Cir^^Willow Run^MI^48198^USA^P||^PRN^PH^^^734^2067067|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SacAIRA^OwyheeAIRA^^^^^L|MTH^Mother^HL70063|1690 Aieuwkoop Cir^^Willow Run^MI^48198^USA^P|^PRN^PH^^^734^2067067ORC|RE||BT99S15279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT99S15279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-842-52^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-851-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F76K15287^^^AIRA-TEST^MR||MooreAIRA^ChristineAIRA^Josephine^^^^L|JulinAIRA^TarangaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1666 Gelijk Cir^^Holland^MI^49424^USA^P||^PRN^PH^^^616^8949090|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MooreAIRA^JulinAIRA^^^^^L|MTH^Mother^HL70063|1666 Gelijk Cir^^Holland^MI^49424^USA^P|^PRN^PH^^^616^8949090ORC|RE||BF76K15287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF76K15287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-851-01^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-854-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W44M15295^^^AIRA-TEST^MR||SewardAIRA^AlysonAIRA^Diarria^^^^L|PecosAIRA^EmeliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1078 Ben Cir^^Rockwood^MI^48173^USA^P||^PRN^PH^^^734^2400738|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SewardAIRA^PecosAIRA^^^^^L|MTH^Mother^HL70063|1078 Ben Cir^^Rockwood^MI^48173^USA^P|^PRN^PH^^^734^2400738ORC|RE||BW44M15295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW44M15295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-854-52^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-879-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O04E15303^^^AIRA-TEST^MR||AndersonAIRA^PazAIRA^Ailis^^^^L|SchleicherAIRA^KeverneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1726 Weerde Cir^^Somerset^MI^49281^USA^P||^PRN^PH^^^517^7813437|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndersonAIRA^SchleicherAIRA^^^^^L|MTH^Mother^HL70063|1726 Weerde Cir^^Somerset^MI^49281^USA^P|^PRN^PH^^^517^7813437ORC|RE||BO04E15303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO04E15303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-879-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-879-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P70B15308^^^AIRA-TEST^MR||CastroAIRA^SeptimaAIRA^Nikki^^^^L|GarzaAIRA^MaeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1645 Aijdemeren St^^Middleville^MI^49333^USA^P||^PRN^PH^^^269^5455362|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CastroAIRA^GarzaAIRA^^^^^L|MTH^Mother^HL70063|1645 Aijdemeren St^^Middleville^MI^49333^USA^P|^PRN^PH^^^269^5455362ORC|RE||BP70B15308.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP70B15308.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-879-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-880-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A44Z15319^^^AIRA-TEST^MR||JacintoAIRA^PramaAIRA^Dollie^^^^L|San MateoAIRA^HeidiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1626 Sosterhout Pl^^Northeast^MI^48506^USA^P||^PRN^PH^^^810^7372720|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacintoAIRA^San MateoAIRA^^^^^L|MTH^Mother^HL70063|1626 Sosterhout Pl^^Northeast^MI^48506^USA^P|^PRN^PH^^^810^7372720ORC|RE||BA44Z15319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA44Z15319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-880-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-880-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L28Q15327^^^AIRA-TEST^MR||WagonerAIRA^TionneAIRA^Leilah^^^^L|IrvingAIRA^AshlynnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1925 Normerland St^^Kimball^MI^48074^USA^P||^PRN^PH^^^810^7277384|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WagonerAIRA^IrvingAIRA^^^^^L|MTH^Mother^HL70063|1925 Normerland St^^Kimball^MI^48074^USA^P|^PRN^PH^^^810^7277384ORC|RE||BL28Q15327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL28Q15327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-880-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-881-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H88H15335^^^AIRA-TEST^MR||Del NorteAIRA^KeiraAIRA^Nisi^^^^L|UmatillaAIRA^ChlorisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1485 Positie Ln^^East Kingsford^MI^49801^USA^P||^PRN^PH^^^906^9381979|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Del NorteAIRA^UmatillaAIRA^^^^^L|MTH^Mother^HL70063|1485 Positie Ln^^East Kingsford^MI^49801^USA^P|^PRN^PH^^^906^9381979ORC|RE||BH88H15335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH88H15335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-881-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-881-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V18O15343^^^AIRA-TEST^MR||ColfaxAIRA^MiriyanAIRA^Charmian^^^^L|AnderssonAIRA^KaetheAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1368 Veld Cir^^Lansing^MI^48909^USA^P||^PRN^PH^^^517^5029511|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColfaxAIRA^AnderssonAIRA^^^^^L|MTH^Mother^HL70063|1368 Veld Cir^^Lansing^MI^48909^USA^P|^PRN^PH^^^517^5029511ORC|RE||BV18O15343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV18O15343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-881-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-883-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J36I15351^^^AIRA-TEST^MR||HowarthAIRA^SophroniaAIRA^Leslie^^^^L|WaschingAIRA^AlexinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1637 Helpen St^^Wyoming^MI^49508^USA^P||^PRN^PH^^^616^9680387|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowarthAIRA^WaschingAIRA^^^^^L|MTH^Mother^HL70063|1637 Helpen St^^Wyoming^MI^49508^USA^P|^PRN^PH^^^616^9680387ORC|RE||BJ36I15351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ36I15351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-883-41^Fluarix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-883-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T25X15359^^^AIRA-TEST^MR||MitchellAIRA^ShriAIRA^Jobey^^^^L|PsconenAIRA^JuneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1884 Achtkarspelen Cir^^Allenton^MI^48002^USA^P||^PRN^PH^^^810^7454648|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MitchellAIRA^PsconenAIRA^^^^^L|MTH^Mother^HL70063|1884 Achtkarspelen Cir^^Allenton^MI^48002^USA^P|^PRN^PH^^^810^7454648ORC|RE||BT25X15359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT25X15359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-883-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-898-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L92J15364^^^AIRA-TEST^MR||WorthAIRA^ChyouAIRA^Verena^^^^L|PimaAIRA^JasminAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1413 Wampen Cir^^Rockland^MI^49960^USA^P||^PRN^PH^^^906^4291114|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WorthAIRA^PimaAIRA^^^^^L|MTH^Mother^HL70063|1413 Wampen Cir^^Rockland^MI^49960^USA^P|^PRN^PH^^^906^4291114ORC|RE||BL92J15364.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL92J15364.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-898-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-898-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P29E15375^^^AIRA-TEST^MR||StarkAIRA^AyalaAIRA^Arlynda^^^^L|BerrienAIRA^SaraiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1403 Dlst-Wijhe Pl^^Dafter^MI^49724^USA^P||^PRN^PH^^^906^9555841|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StarkAIRA^BerrienAIRA^^^^^L|MTH^Mother^HL70063|1403 Dlst-Wijhe Pl^^Dafter^MI^49724^USA^P|^PRN^PH^^^906^9555841ORC|RE||BP29E15375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP29E15375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-898-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-900-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S06Z15383^^^AIRA-TEST^MR||JoiceAIRA^DominicaAIRA^Shanelle^^^^L|BaylorAIRA^JordanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1649 Mond Pl^^Warren^MI^48088^USA^P||^PRN^PH^^^586^9583070|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JoiceAIRA^BaylorAIRA^^^^^L|MTH^Mother^HL70063|1649 Mond Pl^^Warren^MI^48088^USA^P|^PRN^PH^^^586^9583070ORC|RE||BS06Z15383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS06Z15383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-900-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-900-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L17K15391^^^AIRA-TEST^MR||GibbonsAIRA^OliveAIRA^Deanna^^^^L|CoryellAIRA^VictoriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1102 Hoeree-Overflakkee Ave^^Brownstown^MI^48174^USA^P||^PRN^PH^^^734^9937878|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GibbonsAIRA^CoryellAIRA^^^^^L|MTH^Mother^HL70063|1102 Hoeree-Overflakkee Ave^^Brownstown^MI^48174^USA^P|^PRN^PH^^^734^9937878ORC|RE||BL17K15391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL17K15391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-900-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-901-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y29J15399^^^AIRA-TEST^MR||EdmundsAIRA^OhannaAIRA^Mabel^^^^L|BoundaryAIRA^MeiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1283 Sutten Pl^^Grand Rapids^MI^49525^USA^P||^PRN^PH^^^616^6390305|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EdmundsAIRA^BoundaryAIRA^^^^^L|MTH^Mother^HL70063|1283 Sutten Pl^^Grand Rapids^MI^49525^USA^P|^PRN^PH^^^616^6390305ORC|RE||BY29J15399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY29J15399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-901-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-901-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M32M15404^^^AIRA-TEST^MR||HodgeAIRA^NoleenAIRA^Jeremia^^^^L|CookeAIRA^MyieshaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1393 Eend Ln^^Rosebush^MI^48878^USA^P||^PRN^PH^^^989^9831235|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HodgeAIRA^CookeAIRA^^^^^L|MTH^Mother^HL70063|1393 Eend Ln^^Rosebush^MI^48878^USA^P|^PRN^PH^^^989^9831235ORC|RE||BM32M15404.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM32M15404.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-901-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-903-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M42I15415^^^AIRA-TEST^MR||HolmesAIRA^HarleyAIRA^Janine^^^^L|BoydAIRA^BrielleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1889 Besterveld Ln^^Fort Gratiot^MI^48059^USA^P||^PRN^PH^^^810^8274594|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HolmesAIRA^BoydAIRA^^^^^L|MTH^Mother^HL70063|1889 Besterveld Ln^^Fort Gratiot^MI^48059^USA^P|^PRN^PH^^^810^8274594ORC|RE||BM42I15415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM42I15415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-903-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-903-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F60O15423^^^AIRA-TEST^MR||LeonAIRA^ShonaAIRA^Yusra^^^^L|ShelbyAIRA^ArdaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1525 Oytsjerksteradiel Pl^^Kenton^MI^49967^USA^P||^PRN^PH^^^906^8446219|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeonAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1525 Oytsjerksteradiel Pl^^Kenton^MI^49967^USA^P|^PRN^PH^^^906^8446219ORC|RE||BF60O15423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF60O15423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-903-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-905-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N30P15431^^^AIRA-TEST^MR||ConnorAIRA^HuaAIRA^Aiyanna^^^^L|BenzieAIRA^RubyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1387 Natie Pl^^Mulliken^MI^48861^USA^P||^PRN^PH^^^517^5226349|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ConnorAIRA^BenzieAIRA^^^^^L|MTH^Mother^HL70063|1387 Natie Pl^^Mulliken^MI^48861^USA^P|^PRN^PH^^^517^5226349ORC|RE||BN30P15431.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN30P15431.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-905-41^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-905-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U99M15439^^^AIRA-TEST^MR||BooneAIRA^SalimahAIRA^Kirima^^^^L|CusterAIRA^ZendaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1060 Regel Cir^^Hubbell^MI^49934^USA^P||^PRN^PH^^^906^5694498|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BooneAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1060 Regel Cir^^Hubbell^MI^49934^USA^P|^PRN^PH^^^906^5694498ORC|RE||BU99M15439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU99M15439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-905-52^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-907-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J91S15444^^^AIRA-TEST^MR||DelawareAIRA^CoreyAIRA^Ashling^^^^L|PerryAIRA^ConsueloAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1091 Veek Pl^^Clayton Township^MI^49235^USA^P||^PRN^PH^^^517^5344629|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DelawareAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1091 Veek Pl^^Clayton Township^MI^49235^USA^P|^PRN^PH^^^517^5344629ORC|RE||BJ91S15444.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ91S15444.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-907-41^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-907-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q25S15455^^^AIRA-TEST^MR||WellsAIRA^VivienAIRA^Lysandra^^^^L|NolanAIRA^MikkiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1898 Zedum Ln^^Weidman^MI^48893^USA^P||^PRN^PH^^^989^2187596|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WellsAIRA^NolanAIRA^^^^^L|MTH^Mother^HL70063|1898 Zedum Ln^^Weidman^MI^48893^USA^P|^PRN^PH^^^989^2187596ORC|RE||BQ25S15455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ25S15455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-907-52^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-955-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S25Z15463^^^AIRA-TEST^MR||HodgeAIRA^CarolineAIRA^Kanya^^^^L|EriksonAIRA^RishonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1968 Luid St^^Pierport^MI^49614^USA^P||^PRN^PH^^^231^4366466|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HodgeAIRA^EriksonAIRA^^^^^L|MTH^Mother^HL70063|1968 Luid St^^Pierport^MI^49614^USA^P|^PRN^PH^^^231^4366466ORC|RE||BS25Z15463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS25Z15463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-955-09^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-958-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P11J15471^^^AIRA-TEST^MR||MarinAIRA^AmayaAIRA^Dyan^^^^L|BordenAIRA^PelagiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1939 Moerdijk Cir^^Northeast^MI^48506^USA^P||^PRN^PH^^^810^2832245|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarinAIRA^BordenAIRA^^^^^L|MTH^Mother^HL70063|1939 Moerdijk Cir^^Northeast^MI^48506^USA^P|^PRN^PH^^^810^2832245ORC|RE||BP11J15471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP11J15471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-958-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-959-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M59T15479^^^AIRA-TEST^MR||DefianceAIRA^KimatraAIRA^Erline^^^^L|CheyenneAIRA^HadassahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1161 Euren Ln^^Reading^MI^49274^USA^P||^PRN^PH^^^517^8926747|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DefianceAIRA^CheyenneAIRA^^^^^L|MTH^Mother^HL70063|1161 Euren Ln^^Reading^MI^49274^USA^P|^PRN^PH^^^517^8926747ORC|RE||BM59T15479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM59T15479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-959-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-964-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W77W15484^^^AIRA-TEST^MR||BrownAIRA^HjordisAIRA^Lakota^^^^L|MadisonAIRA^DavinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1633 Doen St^^GR^MI^49506^USA^P||^PRN^PH^^^616^3761329|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1633 Doen St^^GR^MI^49506^USA^P|^PRN^PH^^^616^3761329ORC|RE||BW77W15484.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW77W15484.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-964-12^RABAVERT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-966-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K59T15495^^^AIRA-TEST^MR||NicholasAIRA^StormyAIRA^Chika^^^^L|OntonagonAIRA^RainaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1492 Poest Cir^^Beverly Hills^MI^48025^USA^P||^PRN^PH^^^248^4825145|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NicholasAIRA^OntonagonAIRA^^^^^L|MTH^Mother^HL70063|1492 Poest Cir^^Beverly Hills^MI^48025^USA^P|^PRN^PH^^^248^4825145ORC|RE||BK59T15495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK59T15495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-966-01^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-966-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A78X15503^^^AIRA-TEST^MR||HowathAIRA^FabienneAIRA^Idola^^^^L|CalhounAIRA^TaylarAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1541 Seventer St^^White Lake^MI^48383^USA^P||^PRN^PH^^^248^6039426|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowathAIRA^CalhounAIRA^^^^^L|MTH^Mother^HL70063|1541 Seventer St^^White Lake^MI^48383^USA^P|^PRN^PH^^^248^6039426ORC|RE||BA78X15503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA78X15503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-966-12^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-976-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S19D15511^^^AIRA-TEST^MR||HuronAIRA^FaincheAIRA^Maliah^^^^L|SylteAIRA^ZuleikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1404 Haasdonk Cir^^Rogers City^MI^49779^USA^P||^PRN^PH^^^989^7305294|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HuronAIRA^SylteAIRA^^^^^L|MTH^Mother^HL70063|1404 Haasdonk Cir^^Rogers City^MI^49779^USA^P|^PRN^PH^^^989^7305294ORC|RE||BS19D15511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS19D15511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-976-02^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-976-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W34G15519^^^AIRA-TEST^MR||HarmonAIRA^AuraAIRA^Reba^^^^L|DuvalAIRA^MyraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1985 Sergen op Zoom Cir^^Grant^MI^49327^USA^P||^PRN^PH^^^231^5899764|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarmonAIRA^DuvalAIRA^^^^^L|MTH^Mother^HL70063|1985 Sergen op Zoom Cir^^Grant^MI^49327^USA^P|^PRN^PH^^^231^5899764ORC|RE||BW34G15519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW34G15519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-976-06^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160-976-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S41W15524^^^AIRA-TEST^MR||AlofsonAIRA^ChrysillaAIRA^Sanjula^^^^L|PerkinsAIRA^OanezAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1049 Coord-Beveland Pl^^Emmett Township^MI^48022^USA^P||^PRN^PH^^^810^5685458|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlofsonAIRA^PerkinsAIRA^^^^^L|MTH^Mother^HL70063|1049 Coord-Beveland Pl^^Emmett Township^MI^48022^USA^P|^PRN^PH^^^810^5685458ORC|RE||BS41W15524.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS41W15524.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160-976-20^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160080111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H74Z15535^^^AIRA-TEST^MR||PlacerAIRA^AudrinaAIRA^Winter^^^^L|BooneAIRA^GanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1331 Lenlo Pl^^Harrietta^MI^49638^USA^P||^PRN^PH^^^231^9591586|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PlacerAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1331 Lenlo Pl^^Harrietta^MI^49638^USA^P|^PRN^PH^^^231^9591586ORC|RE||BH74Z15535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH74Z15535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160080111^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160080202|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D14Q15543^^^AIRA-TEST^MR||PlymouthAIRA^CoraliaAIRA^Marguerite^^^^L|GregoryAIRA^MayaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1753 Horne Pl^^Saint Clair Shores^MI^48080^USA^P||^PRN^PH^^^586^9891223|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PlymouthAIRA^GregoryAIRA^^^^^L|MTH^Mother^HL70063|1753 Horne Pl^^Saint Clair Shores^MI^48080^USA^P|^PRN^PH^^^586^9891223ORC|RE||BD14Q15543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD14Q15543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160080202^AS03 Adjuvant^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160080401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I48L15551^^^AIRA-TEST^MR||MahoneyAIRA^DalilaAIRA^Pazia^^^^L|SmithAIRA^ClarissaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1183 Glimlach Pl^^Stony Creek^MI^48160^USA^P||^PRN^PH^^^734^5328331|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MahoneyAIRA^SmithAIRA^^^^^L|MTH^Mother^HL70063|1183 Glimlach Pl^^Stony Creek^MI^48160^USA^P|^PRN^PH^^^734^5328331ORC|RE||BI48L15551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI48L15551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160080401^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160080601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N81A15559^^^AIRA-TEST^MR||Del NorteAIRA^PerlaAIRA^Paulomi^^^^L|FurnasAIRA^ShulamitAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1020 Rekenen Cir^^Delton^MI^49046^USA^P||^PRN^PH^^^269^5492194|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Del NorteAIRA^FurnasAIRA^^^^^L|MTH^Mother^HL70063|1020 Rekenen Cir^^Delton^MI^49046^USA^P|^PRN^PH^^^269^5492194ORC|RE||BN81A15559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN81A15559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160080601^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160080605|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O96X15564^^^AIRA-TEST^MR||MickelAIRA^LeslyAIRA^Bona^^^^L|DickAIRA^OmakaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1860 Stuk Pl^^Clarkston^MI^48348^USA^P||^PRN^PH^^^248^9053529|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MickelAIRA^DickAIRA^^^^^L|MTH^Mother^HL70063|1860 Stuk Pl^^Clarkston^MI^48348^USA^P|^PRN^PH^^^248^9053529ORC|RE||BO96X15564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO96X15564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160080605^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160080815|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D18S15575^^^AIRA-TEST^MR||RoseAIRA^CayleighAIRA^Sangmu^^^^L|OatesAIRA^DevorahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1590 Zoorn Cir^^Kingsley^MI^49649^USA^P||^PRN^PH^^^231^2268526|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RoseAIRA^OatesAIRA^^^^^L|MTH^Mother^HL70063|1590 Zoorn Cir^^Kingsley^MI^49649^USA^P|^PRN^PH^^^231^2268526ORC|RE||BD18S15575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD18S15575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160080815^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160080901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L19D15583^^^AIRA-TEST^MR||DeweyAIRA^MayakoAIRA^Jewell^^^^L|TexasAIRA^RomildaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1143 Verleden Cir^^Gm Vehicle Development Center^MI^48557^USA^P||^PRN^PH^^^810^5927648|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DeweyAIRA^TexasAIRA^^^^^L|MTH^Mother^HL70063|1143 Verleden Cir^^Gm Vehicle Development Center^MI^48557^USA^P|^PRN^PH^^^810^5927648ORC|RE||BL19D15583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL19D15583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160080901^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160080905|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C03Q15591^^^AIRA-TEST^MR||SkamaniaAIRA^DeborahAIRA^Erma^^^^L|MasonAIRA^WynonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1200 Beweging Pl^^Battle Creek^MI^49015^USA^P||^PRN^PH^^^269^6677365|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SkamaniaAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1200 Beweging Pl^^Battle Creek^MI^49015^USA^P|^PRN^PH^^^269^6677365ORC|RE||BC03Q15591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC03Q15591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160080905^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y47D15599^^^AIRA-TEST^MR||RonningAIRA^ElieAIRA^Idola^^^^L|LebanonAIRA^EglantineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1315 Geleden Cir^^Ludington^MI^49431^USA^P||^PRN^PH^^^231^9264704|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RonningAIRA^LebanonAIRA^^^^^L|MTH^Mother^HL70063|1315 Geleden Cir^^Ludington^MI^49431^USA^P|^PRN^PH^^^231^9264704ORC|RE||BY47D15599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY47D15599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081001^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V58P15604^^^AIRA-TEST^MR||VanceAIRA^CarlenAIRA^Agatha^^^^L|JonesAIRA^KarkaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1441 Rde St^^Keego Harbor^MI^48320^USA^P||^PRN^PH^^^248^4794449|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|VanceAIRA^JonesAIRA^^^^^L|MTH^Mother^HL70063|1441 Rde St^^Keego Harbor^MI^48320^USA^P|^PRN^PH^^^248^4794449ORC|RE||BV58P15604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV58P15604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081011^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081043|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W15V15615^^^AIRA-TEST^MR||AndrewsAIRA^SondraAIRA^Eilis^^^^L|CherokeeAIRA^SonamAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1262 Nexel Ln^^Minden^MI^48456^USA^P||^PRN^PH^^^989^4764178|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndrewsAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1262 Nexel Ln^^Minden^MI^48456^USA^P|^PRN^PH^^^989^4764178ORC|RE||BW15V15615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW15V15615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081043^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P23Z15623^^^AIRA-TEST^MR||CamasAIRA^JustineAIRA^Ghislaine^^^^L|BerreenAIRA^MansiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1114 Kaart Ave^^Burtchville^MI^48059^USA^P||^PRN^PH^^^810^3589711|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CamasAIRA^BerreenAIRA^^^^^L|MTH^Mother^HL70063|1114 Kaart Ave^^Burtchville^MI^48059^USA^P|^PRN^PH^^^810^3589711ORC|RE||BP23Z15623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP23Z15623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081052^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S50S15631^^^AIRA-TEST^MR||OakAIRA^EttieAIRA^Rhodanthe^^^^L|WashitaAIRA^TatianaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1096 Amstelveen Pl^^Lachine^MI^49753^USA^P||^PRN^PH^^^989^8107558|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OakAIRA^WashitaAIRA^^^^^L|MTH^Mother^HL70063|1096 Amstelveen Pl^^Lachine^MI^49753^USA^P|^PRN^PH^^^989^8107558ORC|RE||BS50S15631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS50S15631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081141^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081143|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M68C15639^^^AIRA-TEST^MR||ClintonAIRA^DixieAIRA^Eloise^^^^L|PedersenAIRA^OrendaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1511 Haarbeek Pl^^Brighton^MI^48116^USA^P||^PRN^PH^^^810^8520844|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClintonAIRA^PedersenAIRA^^^^^L|MTH^Mother^HL70063|1511 Haarbeek Pl^^Brighton^MI^48116^USA^P|^PRN^PH^^^810^8520844ORC|RE||BM68C15639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM68C15639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081143^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081151|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L57F15644^^^AIRA-TEST^MR||OsbornAIRA^GayleAIRA^Ceres^^^^L|KenedyAIRA^DarleneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1904 Roxmeer St^^Carland^MI^48831^USA^P||^PRN^PH^^^989^8447815|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OsbornAIRA^KenedyAIRA^^^^^L|MTH^Mother^HL70063|1904 Roxmeer St^^Carland^MI^48831^USA^P|^PRN^PH^^^989^8447815ORC|RE||BL57F15644.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL57F15644.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081151^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A91B15655^^^AIRA-TEST^MR||KirklandAIRA^IlaAIRA^Raegan^^^^L|ShortAIRA^HildeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1485 Land Pl^^Brownstown Township^MI^48173^USA^P||^PRN^PH^^^734^2442807|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KirklandAIRA^ShortAIRA^^^^^L|MTH^Mother^HL70063|1485 Land Pl^^Brownstown Township^MI^48173^USA^P|^PRN^PH^^^734^2442807ORC|RE||BA91B15655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA91B15655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081152^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V71D15663^^^AIRA-TEST^MR||DauphinAIRA^PhutikaAIRA^Christine^^^^L|HillAIRA^LeuraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1891 Reudal Ave^^Birmingham^MI^48012^USA^P||^PRN^PH^^^248^5871399|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DauphinAIRA^HillAIRA^^^^^L|MTH^Mother^HL70063|1891 Reudal Ave^^Birmingham^MI^48012^USA^P|^PRN^PH^^^248^5871399ORC|RE||BV71D15663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV71D15663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081201^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081211|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A82G15671^^^AIRA-TEST^MR||DuvalAIRA^AbijahAIRA^Adele^^^^L|DeltaAIRA^IdehAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1267 Kat Cir^^Detroit^MI^48222^USA^P||^PRN^PH^^^313^7192496|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DuvalAIRA^DeltaAIRA^^^^^L|MTH^Mother^HL70063|1267 Kat Cir^^Detroit^MI^48222^USA^P|^PRN^PH^^^313^7192496ORC|RE||BA82G15671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA82G15671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081211^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081243|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S66P15679^^^AIRA-TEST^MR||CoconinoAIRA^ArtemisiaAIRA^Hadara^^^^L|ErathAIRA^IsabellAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1171 Denray St^^Fairview^MI^48621^USA^P||^PRN^PH^^^989^4131358|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoconinoAIRA^ErathAIRA^^^^^L|MTH^Mother^HL70063|1171 Denray St^^Fairview^MI^48621^USA^P|^PRN^PH^^^989^4131358ORC|RE||BS66P15679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS66P15679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081243^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081252|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B06G15684^^^AIRA-TEST^MR||HarneyAIRA^AlaineAIRA^Birdie^^^^L|CottonAIRA^TeanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1661 Reizen Ln^^Oscoda^MI^48750^USA^P||^PRN^PH^^^989^5484279|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarneyAIRA^CottonAIRA^^^^^L|MTH^Mother^HL70063|1661 Reizen Ln^^Oscoda^MI^48750^USA^P|^PRN^PH^^^989^5484279ORC|RE||BB06G15684.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB06G15684.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081252^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S54F15695^^^AIRA-TEST^MR||MorreyAIRA^MerryAIRA^Nimue^^^^L|JakobsenAIRA^TessAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1904 Boerderij Ave^^Ypsilanti^MI^48198^USA^P||^PRN^PH^^^734^5381118|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorreyAIRA^JakobsenAIRA^^^^^L|MTH^Mother^HL70063|1904 Boerderij Ave^^Ypsilanti^MI^48198^USA^P|^PRN^PH^^^734^5381118ORC|RE||BS54F15695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS54F15695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081501^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081505|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D73I15703^^^AIRA-TEST^MR||AlpineAIRA^JaniyahAIRA^Gisselle^^^^L|ArmstrongAIRA^DeeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1936 Voosendaal Cir^^Custer^MI^49405^USA^P||^PRN^PH^^^231^9162806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlpineAIRA^ArmstrongAIRA^^^^^L|MTH^Mother^HL70063|1936 Voosendaal Cir^^Custer^MI^49405^USA^P|^PRN^PH^^^231^9162806ORC|RE||BD73I15703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD73I15703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081505^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C28V15711^^^AIRA-TEST^MR||CrosbieAIRA^KionaAIRA^Davine^^^^L|StarrAIRA^AideenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1425 Gas St^^Brighton Township^MI^48114^USA^P||^PRN^PH^^^810^7660344|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CrosbieAIRA^StarrAIRA^^^^^L|MTH^Mother^HL70063|1425 Gas St^^Brighton Township^MI^48114^USA^P|^PRN^PH^^^810^7660344ORC|RE||BC28V15711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC28V15711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081511^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081534|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C65R15719^^^AIRA-TEST^MR||MahaskaAIRA^RubyAIRA^Lilia^^^^L|DentonAIRA^DahliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1229 Lladel Cir^^Selfridge^MI^48045^USA^P||^PRN^PH^^^586^2052029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MahaskaAIRA^DentonAIRA^^^^^L|MTH^Mother^HL70063|1229 Lladel Cir^^Selfridge^MI^48045^USA^P|^PRN^PH^^^586^2052029ORC|RE||BC65R15719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC65R15719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081534^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081541|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S91E15724^^^AIRA-TEST^MR||CulbersonAIRA^AchenAIRA^Falda^^^^L|FitzpatrickAIRA^MaiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1815 Dengelo Cir^^Kent City^MI^49330^USA^P||^PRN^PH^^^616^9343938|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CulbersonAIRA^FitzpatrickAIRA^^^^^L|MTH^Mother^HL70063|1815 Dengelo Cir^^Kent City^MI^49330^USA^P|^PRN^PH^^^616^9343938ORC|RE||BS91E15724.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS91E15724.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081541^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081543|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S65Q15735^^^AIRA-TEST^MR||WrigleyAIRA^KarissaAIRA^Rhoda^^^^L|LouisaAIRA^AnnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1493 Elk Cir^^Raisinville Township^MI^48161^USA^P||^PRN^PH^^^734^4109996|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WrigleyAIRA^LouisaAIRA^^^^^L|MTH^Mother^HL70063|1493 Elk Cir^^Raisinville Township^MI^48161^USA^P|^PRN^PH^^^734^4109996ORC|RE||BS65Q15735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS65Q15735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081543^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081546|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P68L15743^^^AIRA-TEST^MR||StarkAIRA^JoannAIRA^Judith^^^^L|MeredithAIRA^RoselleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1749 Merschelling Ave^^Novi^MI^48377^USA^P||^PRN^PH^^^248^7424900|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StarkAIRA^MeredithAIRA^^^^^L|MTH^Mother^HL70063|1749 Merschelling Ave^^Novi^MI^48377^USA^P|^PRN^PH^^^248^7424900ORC|RE||BP68L15743.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP68L15743.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081546^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081548|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T49O15751^^^AIRA-TEST^MR||CarrollAIRA^MadeiraAIRA^Casilda^^^^L|HudspethAIRA^HermiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1092 Kantoor Pl^^Riverside^MI^49084^USA^P||^PRN^PH^^^269^6945695|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarrollAIRA^HudspethAIRA^^^^^L|MTH^Mother^HL70063|1092 Kantoor Pl^^Riverside^MI^49084^USA^P|^PRN^PH^^^269^6945695ORC|RE||BT49O15751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT49O15751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081548^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081552|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O00P15759^^^AIRA-TEST^MR||SeminoleAIRA^BranwenAIRA^Grace^^^^L|OldhamAIRA^LevinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1454 Kerneuzen Ln^^Au Gres^MI^48703^USA^P||^PRN^PH^^^989^7080133|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SeminoleAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1454 Kerneuzen Ln^^Au Gres^MI^48703^USA^P|^PRN^PH^^^989^7080133ORC|RE||BO00P15759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO00P15759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081552^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V41R15764^^^AIRA-TEST^MR||SheridanAIRA^LarissaAIRA^Amira^^^^L|KingAIRA^HadiyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1882 Vernheze Cir^^Comerica Incorporated^MI^48264^USA^P||^PRN^PH^^^313^2078529|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SheridanAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1882 Vernheze Cir^^Comerica Incorporated^MI^48264^USA^P|^PRN^PH^^^313^2078529ORC|RE||BV41R15764.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV41R15764.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081601^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081605|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G27M15775^^^AIRA-TEST^MR||JanttiAIRA^EndoraAIRA^Cory^^^^L|OldhamAIRA^AdivaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1938 Symbool St^^Midland^MI^48686^USA^P||^PRN^PH^^^989^6265607|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JanttiAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1938 Symbool St^^Midland^MI^48686^USA^P|^PRN^PH^^^989^6265607ORC|RE||BG27M15775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG27M15775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081605^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P64U15783^^^AIRA-TEST^MR||HumboldtAIRA^AlexinaAIRA^Anninka^^^^L|OhioAIRA^CallistaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1080 Trek Cir^^Bessemer^MI^49911^USA^P||^PRN^PH^^^906^7188216|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HumboldtAIRA^OhioAIRA^^^^^L|MTH^Mother^HL70063|1080 Trek Cir^^Bessemer^MI^49911^USA^P|^PRN^PH^^^906^7188216ORC|RE||BP64U15783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP64U15783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081811^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160081912|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V14B15791^^^AIRA-TEST^MR||BrotAIRA^ShanataAIRA^Valisa^^^^L|KohlmeisterAIRA^LynetteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1479 Eoorst Ln^^Warren^MI^48089^USA^P||^PRN^PH^^^586^8223801|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrotAIRA^KohlmeisterAIRA^^^^^L|MTH^Mother^HL70063|1479 Eoorst Ln^^Warren^MI^48089^USA^P|^PRN^PH^^^586^8223801ORC|RE||BV14B15791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV14B15791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160081912^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K69P15799^^^AIRA-TEST^MR||SutterAIRA^PearlAIRA^Adelinda^^^^L|BreckinridgeAIRA^SammaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1542 Leel en Maas Pl^^Washington^MI^48094^USA^P||^PRN^PH^^^586^7987922|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SutterAIRA^BreckinridgeAIRA^^^^^L|MTH^Mother^HL70063|1542 Leel en Maas Pl^^Washington^MI^48094^USA^P|^PRN^PH^^^586^7987922ORC|RE||BK69P15799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK69P15799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082001^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D05C15804^^^AIRA-TEST^MR||AransasAIRA^KarenAIRA^Kristen^^^^L|IrwinAIRA^CarineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1459 Wssen Pl^^Stalwart^MI^49736^USA^P||^PRN^PH^^^906^4703656|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AransasAIRA^IrwinAIRA^^^^^L|MTH^Mother^HL70063|1459 Wssen Pl^^Stalwart^MI^49736^USA^P|^PRN^PH^^^906^4703656ORC|RE||BD05C15804.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD05C15804.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082011^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082043|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G52M15815^^^AIRA-TEST^MR||DickAIRA^TirzaAIRA^Jaina^^^^L|JeromeAIRA^EmmalynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1964 Naaren Ave^^Flint^MI^48550^USA^P||^PRN^PH^^^810^3942935|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickAIRA^JeromeAIRA^^^^^L|MTH^Mother^HL70063|1964 Naaren Ave^^Flint^MI^48550^USA^P|^PRN^PH^^^810^3942935ORC|RE||BG52M15815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG52M15815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082043^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V98H15823^^^AIRA-TEST^MR||LibertyAIRA^GraceAIRA^Marley^^^^L|Mc VeetyAIRA^IphigeniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1359 Lijfheerenlanden Ave^^Covington^MI^49919^USA^P||^PRN^PH^^^906^4910874|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LibertyAIRA^Mc VeetyAIRA^^^^^L|MTH^Mother^HL70063|1359 Lijfheerenlanden Ave^^Covington^MI^49919^USA^P|^PRN^PH^^^906^4910874ORC|RE||BV98H15823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV98H15823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082052^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T45Z15831^^^AIRA-TEST^MR||LancasterAIRA^PerryAIRA^Madelyn^^^^L|GranholmAIRA^UdayaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1788 Widden-Drenthe Ave^^Wequetonsing^MI^49740^USA^P||^PRN^PH^^^616^2960192|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LancasterAIRA^GranholmAIRA^^^^^L|MTH^Mother^HL70063|1788 Widden-Drenthe Ave^^Wequetonsing^MI^49740^USA^P|^PRN^PH^^^616^2960192ORC|RE||BT45Z15831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT45Z15831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082101^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F05L15839^^^AIRA-TEST^MR||San SabaAIRA^ReidunAIRA^Ryba^^^^L|McQuadeAIRA^ImaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1166 Laatste St^^Rumely^MI^49826^USA^P||^PRN^PH^^^906^5925250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San SabaAIRA^McQuadeAIRA^^^^^L|MTH^Mother^HL70063|1166 Laatste St^^Rumely^MI^49826^USA^P|^PRN^PH^^^906^5925250ORC|RE||BF05L15839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF05L15839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082105^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G56Y15844^^^AIRA-TEST^MR||McClainAIRA^NaraAIRA^Aparna^^^^L|CuyahogaAIRA^UlrikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1479 Zingen Ave^^Point Elizabeth^MI^48725^USA^P||^PRN^PH^^^989^6840512|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McClainAIRA^CuyahogaAIRA^^^^^L|MTH^Mother^HL70063|1479 Zingen Ave^^Point Elizabeth^MI^48725^USA^P|^PRN^PH^^^989^6840512ORC|RE||BG56Y15844.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG56Y15844.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082111^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082134|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U16A15855^^^AIRA-TEST^MR||AndrewsAIRA^NizanaAIRA^Soleil^^^^L|ClayAIRA^AinhoaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1676 Eirschot Ave^^Onaway^MI^49765^USA^P||^PRN^PH^^^989^3436002|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndrewsAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1676 Eirschot Ave^^Onaway^MI^49765^USA^P|^PRN^PH^^^989^3436002ORC|RE||BU16A15855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU16A15855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082134^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082143|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O34R15863^^^AIRA-TEST^MR||MagriAIRA^EloiseAIRA^Lisette^^^^L|MarionAIRA^AthelaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1707 Heerijnen Pl^^Weidman^MI^48893^USA^P||^PRN^PH^^^989^4233911|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MagriAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1707 Heerijnen Pl^^Weidman^MI^48893^USA^P|^PRN^PH^^^989^4233911ORC|RE||BO34R15863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO34R15863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082143^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M53D15871^^^AIRA-TEST^MR||PlumasAIRA^CalixteAIRA^Ada^^^^L|JepsenAIRA^ShelbyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1585 Deusel-De Mierden Pl^^Millbrook^MI^49310^USA^P||^PRN^PH^^^989^4353835|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PlumasAIRA^JepsenAIRA^^^^^L|MTH^Mother^HL70063|1585 Deusel-De Mierden Pl^^Millbrook^MI^49310^USA^P|^PRN^PH^^^989^4353835ORC|RE||BM53D15871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM53D15871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082152^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H97N15879^^^AIRA-TEST^MR||OhioAIRA^HayleeAIRA^Gytha^^^^L|DelawareAIRA^CarlinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1709 Maarbeek Pl^^Naubinway^MI^49762^USA^P||^PRN^PH^^^906^3562811|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OhioAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1709 Maarbeek Pl^^Naubinway^MI^49762^USA^P|^PRN^PH^^^906^3562811ORC|RE||BH97N15879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH97N15879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082311^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E85M15887^^^AIRA-TEST^MR||BrooksAIRA^HadiyaAIRA^Abrienda^^^^L|AshtabulaAIRA^HeloiseAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1490 Oeimerswaal St^^Troy^MI^48098^USA^P||^PRN^PH^^^248^9390369|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrooksAIRA^AshtabulaAIRA^^^^^L|MTH^Mother^HL70063|1490 Oeimerswaal St^^Troy^MI^48098^USA^P|^PRN^PH^^^248^9390369ORC|RE||BE85M15887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE85M15887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082501^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W91G15895^^^AIRA-TEST^MR||GuthrieAIRA^DebraAIRA^Marliss^^^^L|BeaverAIRA^GlennisAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1007 Kchagen Pl^^Perrinton^MI^48871^USA^P||^PRN^PH^^^989^2000388|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GuthrieAIRA^BeaverAIRA^^^^^L|MTH^Mother^HL70063|1007 Kchagen Pl^^Perrinton^MI^48871^USA^P|^PRN^PH^^^989^2000388ORC|RE||BW91G15895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW91G15895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082511^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082543|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W59V15900^^^AIRA-TEST^MR||MiljkeimAIRA^EvanaAIRA^Faustine^^^^L|MenomineeAIRA^TydfillAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1958 Noordwijk St^^Elm Hall^MI^48830^USA^P||^PRN^PH^^^989^2149813|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MiljkeimAIRA^MenomineeAIRA^^^^^L|MTH^Mother^HL70063|1958 Noordwijk St^^Elm Hall^MI^48830^USA^P|^PRN^PH^^^989^2149813ORC|RE||BW59V15900.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW59V15900.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082543^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082552|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S76Q15911^^^AIRA-TEST^MR||FlemingAIRA^AlejandraAIRA^Alia^^^^L|DickinsonAIRA^TalullaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1610 Huis St^^Casco Township^MI^48064^USA^P||^PRN^PH^^^810^5096267|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FlemingAIRA^DickinsonAIRA^^^^^L|MTH^Mother^HL70063|1610 Huis St^^Casco Township^MI^48064^USA^P|^PRN^PH^^^810^5096267ORC|RE||BS76Q15911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS76Q15911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082552^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E90O15919^^^AIRA-TEST^MR||WhatcomAIRA^JodieAIRA^Engracia^^^^L|GarfieldAIRA^NeerjaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1491 Wijkerk Ln^^Paradise^MI^49768^USA^P||^PRN^PH^^^906^7487756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WhatcomAIRA^GarfieldAIRA^^^^^L|MTH^Mother^HL70063|1491 Wijkerk Ln^^Paradise^MI^49768^USA^P|^PRN^PH^^^906^7487756ORC|RE||BE90O15919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE90O15919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082601^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082605|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H81H15927^^^AIRA-TEST^MR||Twin FallsAIRA^LilacAIRA^Ames^^^^L|San MateoAIRA^TomikoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1507 Ducphen St^^Treetops Village^MI^49735^USA^P||^PRN^PH^^^989^4252896|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Twin FallsAIRA^San MateoAIRA^^^^^L|MTH^Mother^HL70063|1507 Ducphen St^^Treetops Village^MI^49735^USA^P|^PRN^PH^^^989^4252896ORC|RE||BH81H15927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH81H15927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082605^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W13K15935^^^AIRA-TEST^MR||McClainAIRA^AlalaAIRA^Sripada^^^^L|ProvidenceAIRA^SophiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1400 Diepe St^^Richmond Township^MI^48062^USA^P||^PRN^PH^^^586^3745434|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McClainAIRA^ProvidenceAIRA^^^^^L|MTH^Mother^HL70063|1400 Diepe St^^Richmond Township^MI^48062^USA^P|^PRN^PH^^^586^3745434ORC|RE||BW13K15935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW13K15935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082611^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082634|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A05F15940^^^AIRA-TEST^MR||ViergesAIRA^HaraldaAIRA^Imogene^^^^L|LuceAIRA^AdeleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1580 Wittenseradeel Cir^^Midland Hospital Center^MI^48670^USA^P||^PRN^PH^^^989^9035572|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ViergesAIRA^LuceAIRA^^^^^L|MTH^Mother^HL70063|1580 Wittenseradeel Cir^^Midland Hospital Center^MI^48670^USA^P|^PRN^PH^^^989^9035572ORC|RE||BA05F15940.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA05F15940.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082634^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082643|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N69A15951^^^AIRA-TEST^MR||GemAIRA^ShysieAIRA^Morgen^^^^L|JonesAIRA^AmiahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1543 Bopik Ave^^Ramsay^MI^49959^USA^P||^PRN^PH^^^906^2717019|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GemAIRA^JonesAIRA^^^^^L|MTH^Mother^HL70063|1543 Bopik Ave^^Ramsay^MI^49959^USA^P|^PRN^PH^^^906^2717019ORC|RE||BN69A15951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN69A15951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082643^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082652|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J42R15959^^^AIRA-TEST^MR||ClallamAIRA^ArezouAIRA^Delaney^^^^L|ShermanAIRA^SydneyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1048 Deusel-De Mierden Cir^^Independence Township^MI^48346^USA^P||^PRN^PH^^^248^3498414|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClallamAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1048 Deusel-De Mierden Cir^^Independence Township^MI^48346^USA^P|^PRN^PH^^^248^3498414ORC|RE||BJ42R15959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ42R15959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082652^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M70U15967^^^AIRA-TEST^MR||SilowAIRA^BessieAIRA^Tilda^^^^L|KarlssonAIRA^AndrasAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1324 Het Ln^^Riverview^MI^48192^USA^P||^PRN^PH^^^734^3959147|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SilowAIRA^KarlssonAIRA^^^^^L|MTH^Mother^HL70063|1324 Het Ln^^Riverview^MI^48192^USA^P|^PRN^PH^^^734^3959147ORC|RE||BM70U15967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM70U15967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082801^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160082803|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K42Z15975^^^AIRA-TEST^MR||OkanoganAIRA^JenniferAIRA^Phaedra^^^^L|SaloAIRA^NoorAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1793 Nijmegen Ave^^Eastport^MI^49627^USA^P||^PRN^PH^^^231^9620608|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OkanoganAIRA^SaloAIRA^^^^^L|MTH^Mother^HL70063|1793 Nijmegen Ave^^Eastport^MI^49627^USA^P|^PRN^PH^^^231^9620608ORC|RE||BK42Z15975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK42Z15975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160082803^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160083005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F47W15983^^^AIRA-TEST^MR||JeffersonAIRA^MahinaAIRA^Tammi^^^^L|ClintonAIRA^RaekaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1791 Hteenwijkerland Ln^^Iron Mountain^MI^49831^USA^P||^PRN^PH^^^906^6723304|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1791 Hteenwijkerland Ln^^Iron Mountain^MI^49831^USA^P|^PRN^PH^^^906^6723304ORC|RE||BF47W15983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF47W15983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160083005^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160083034|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E56G15991^^^AIRA-TEST^MR||LincolnAIRA^InesAIRA^Gypsy^^^^L|BrooksAIRA^AzaleaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1018 Buenen Ave^^Rochester^MI^48309^USA^P||^PRN^PH^^^248^5940475|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LincolnAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1018 Buenen Ave^^Rochester^MI^48309^USA^P|^PRN^PH^^^248^5940475ORC|RE||BE56G15991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE56G15991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160083034^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160083043|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z83C15996^^^AIRA-TEST^MR||FarrellAIRA^AlishaAIRA^Maliah^^^^L|OntonagonAIRA^GeraldineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1489 Marneveld Pl^^Brunswick^MI^49425^USA^P||^PRN^PH^^^231^5693127|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FarrellAIRA^OntonagonAIRA^^^^^L|MTH^Mother^HL70063|1489 Marneveld Pl^^Brunswick^MI^49425^USA^P|^PRN^PH^^^231^5693127ORC|RE||BZ83C15996.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ83C15996.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160083043^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160083052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F90A16007^^^AIRA-TEST^MR||LaenAIRA^LeodaAIRA^Subhuja^^^^L|WalshAIRA^FaricaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1231 Oiddelburg St^^Michigan Bankard^MI^48950^USA^P||^PRN^PH^^^517^5635102|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LaenAIRA^WalshAIRA^^^^^L|MTH^Mother^HL70063|1231 Oiddelburg St^^Michigan Bankard^MI^48950^USA^P|^PRN^PH^^^517^5635102ORC|RE||BF90A16007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF90A16007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160083052^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160084201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X48C16015^^^AIRA-TEST^MR||SulitAIRA^AddisonAIRA^Sun^^^^L|EnaAIRA^AlcinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1447 Bereiken Ave^^Snover^MI^48472^USA^P||^PRN^PH^^^810^6277519|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SulitAIRA^EnaAIRA^^^^^L|MTH^Mother^HL70063|1447 Bereiken Ave^^Snover^MI^48472^USA^P|^PRN^PH^^^810^6277519ORC|RE||BX48C16015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX48C16015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160084201^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160084205|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A00I16023^^^AIRA-TEST^MR||LorainAIRA^NyssaAIRA^Violenta^^^^L|OcarioAIRA^ChristmasAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1458 Woermond Ln^^Superior Township^MI^48105^USA^P||^PRN^PH^^^734^6996953|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LorainAIRA^OcarioAIRA^^^^^L|MTH^Mother^HL70063|1458 Woermond Ln^^Superior Township^MI^48105^USA^P|^PRN^PH^^^734^6996953ORC|RE||BA00I16023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA00I16023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160084205^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160084211|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P74X16031^^^AIRA-TEST^MR||CumingAIRA^GotzoneAIRA^Moya^^^^L|CarterAIRA^ShielaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1349 Zesterveld Ln^^Ashley^MI^48806^USA^P||^PRN^PH^^^989^2194334|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumingAIRA^CarterAIRA^^^^^L|MTH^Mother^HL70063|1349 Zesterveld Ln^^Ashley^MI^48806^USA^P|^PRN^PH^^^989^2194334ORC|RE||BP74X16031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP74X16031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160084211^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160084234|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C84Z16036^^^AIRA-TEST^MR||HuntingdonAIRA^AbbieAIRA^Paola^^^^L|ThiemerAIRA^LaliAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1898 Tranendonck Ave^^South Manitou^MI^49654^USA^P||^PRN^PH^^^231^6517594|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HuntingdonAIRA^ThiemerAIRA^^^^^L|MTH^Mother^HL70063|1898 Tranendonck Ave^^South Manitou^MI^49654^USA^P|^PRN^PH^^^231^6517594ORC|RE||BC84Z16036.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC84Z16036.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160084234^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160084241|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B79E16047^^^AIRA-TEST^MR||O'BrienAIRA^RosenwynAIRA^Lili^^^^L|FloydAIRA^SonnenscheinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1003 Kollands Kroon Cir^^GR^MI^49505^USA^P||^PRN^PH^^^616^5871829|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O'BrienAIRA^FloydAIRA^^^^^L|MTH^Mother^HL70063|1003 Kollands Kroon Cir^^GR^MI^49505^USA^P|^PRN^PH^^^616^5871829ORC|RE||BB79E16047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB79E16047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160084241^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160084243|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V31J16055^^^AIRA-TEST^MR||SullivanAIRA^MyraAIRA^Suvrata^^^^L|San JuanAIRA^MargaretAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1108 Me Marne Ln^^Bay Shore^MI^49711^USA^P||^PRN^PH^^^231^5742077|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SullivanAIRA^San JuanAIRA^^^^^L|MTH^Mother^HL70063|1108 Me Marne Ln^^Bay Shore^MI^49711^USA^P|^PRN^PH^^^231^5742077ORC|RE||BV31J16055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV31J16055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160084243^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160084251|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y87Z16063^^^AIRA-TEST^MR||KenedyAIRA^RenukaAIRA^Philida^^^^L|ErieAIRA^ParnellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1503 Bedden Cir^^Midland^MI^48674^USA^P||^PRN^PH^^^989^5003547|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KenedyAIRA^ErieAIRA^^^^^L|MTH^Mother^HL70063|1503 Bedden Cir^^Midland^MI^48674^USA^P|^PRN^PH^^^989^5003547ORC|RE||BY87Z16063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY87Z16063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160084251^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160084252|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J03J16071^^^AIRA-TEST^MR||RiverAIRA^PalomiAIRA^Clare^^^^L|StarrAIRA^TerhiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1225 Heerhugowaard St^^Pontiac^MI^48343^USA^P||^PRN^PH^^^248^3260672|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RiverAIRA^StarrAIRA^^^^^L|MTH^Mother^HL70063|1225 Heerhugowaard St^^Pontiac^MI^48343^USA^P|^PRN^PH^^^248^3260672ORC|RE||BJ03J16071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ03J16071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160084252^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160085101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y11S16076^^^AIRA-TEST^MR||WoodburyAIRA^RenAIRA^Raizel^^^^L|StevensAIRA^KanthaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1079 Oromstrijen Ln^^Weston^MI^49289^USA^P||^PRN^PH^^^517^3105572|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoodburyAIRA^StevensAIRA^^^^^L|MTH^Mother^HL70063|1079 Oromstrijen Ln^^Weston^MI^49289^USA^P|^PRN^PH^^^517^3105572ORC|RE||BY11S16076.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY11S16076.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160085101^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160085452|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I13W16087^^^AIRA-TEST^MR||LegresleyAIRA^ZofeyaAIRA^Christiana^^^^L|GarrardAIRA^AretaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1130 Dergeijk Ln^^Stanton^MI^48888^USA^P||^PRN^PH^^^989^4641670|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LegresleyAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1130 Dergeijk Ln^^Stanton^MI^48888^USA^P|^PRN^PH^^^989^4641670ORC|RE||BI13W16087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI13W16087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160085452^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160087941|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R40I16095^^^AIRA-TEST^MR||FrontierAIRA^GalateaAIRA^Madhuri^^^^L|MontcalmAIRA^MariahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1830 Kaarbeek Cir^^Corunna^MI^48817^USA^P||^PRN^PH^^^989^6242400|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FrontierAIRA^MontcalmAIRA^^^^^L|MTH^Mother^HL70063|1830 Kaarbeek Cir^^Corunna^MI^48817^USA^P|^PRN^PH^^^989^6242400ORC|RE||BR40I16095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR40I16095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160087941^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160087952|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z62Z16103^^^AIRA-TEST^MR||CollingsworthAIRA^SharonAIRA^Miley^^^^L|PolkAIRA^AlgerineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1902 Hekela Ln^^Detroit^MI^48235^USA^P||^PRN^PH^^^313^7731316|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CollingsworthAIRA^PolkAIRA^^^^^L|MTH^Mother^HL70063|1902 Hekela Ln^^Detroit^MI^48235^USA^P|^PRN^PH^^^313^7731316ORC|RE||BZ62Z16103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ62Z16103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160087952^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160088041|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M26Z16111^^^AIRA-TEST^MR||WheelerAIRA^KieraAIRA^Emilia^^^^L|HemphillAIRA^ArzikiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1929 Deerenveen Cir^^Pointe Aux Pins^MI^49775^USA^P||^PRN^PH^^^231^6527546|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WheelerAIRA^HemphillAIRA^^^^^L|MTH^Mother^HL70063|1929 Deerenveen Cir^^Pointe Aux Pins^MI^49775^USA^P|^PRN^PH^^^231^6527546ORC|RE||BM26Z16111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM26Z16111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160088041^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160088052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D34Q16116^^^AIRA-TEST^MR||NelsenAIRA^NashaAIRA^Raja^^^^L|MarshallAIRA^SandraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1771 Sranendonck Ave^^Grosse Pointe Woods^MI^48236^USA^P||^PRN^PH^^^313^6637352|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NelsenAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1771 Sranendonck Ave^^Grosse Pointe Woods^MI^48236^USA^P|^PRN^PH^^^313^6637352ORC|RE||BD34Q16116.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD34Q16116.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160088052^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160088141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A52R16127^^^AIRA-TEST^MR||ClevelandAIRA^EmmetAIRA^Verrin^^^^L|MonroeAIRA^ArlyndaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1537 Lomeren Ln^^Centennial Heights^MI^49913^USA^P||^PRN^PH^^^906^7086375|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClevelandAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1537 Lomeren Ln^^Centennial Heights^MI^49913^USA^P|^PRN^PH^^^906^7086375ORC|RE||BA52R16127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA52R16127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160088141^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160088152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z65E16135^^^AIRA-TEST^MR||FultonAIRA^ColensoAIRA^Helen^^^^L|SuthernsAIRA^OrindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1456 Happy Pl^^Cement City^MI^49281^USA^P||^PRN^PH^^^517^6952449|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FultonAIRA^SuthernsAIRA^^^^^L|MTH^Mother^HL70063|1456 Happy Pl^^Cement City^MI^49281^USA^P|^PRN^PH^^^517^6952449ORC|RE||BZ65E16135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ65E16135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160088152^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160088341|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R02Q16143^^^AIRA-TEST^MR||BlaineAIRA^KeelinAIRA^Sachi^^^^L|RomsvigAIRA^AlumitAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1165 Lilburg Cir^^Grand Rapids^MI^49512^USA^P||^PRN^PH^^^616^2555286|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BlaineAIRA^RomsvigAIRA^^^^^L|MTH^Mother^HL70063|1165 Lilburg Cir^^Grand Rapids^MI^49512^USA^P|^PRN^PH^^^616^2555286ORC|RE||BR02Q16143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR02Q16143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160088341^Fluarix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160088352|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P28Q16151^^^AIRA-TEST^MR||ClayAIRA^AvrilAIRA^Birgitta^^^^L|YorkAIRA^ShayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1324 Aoststellingwerf Ln^^Holland^MI^49422^USA^P||^PRN^PH^^^616^5596421|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClayAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1324 Aoststellingwerf Ln^^Holland^MI^49422^USA^P|^PRN^PH^^^616^5596421ORC|RE||BP28Q16151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP28Q16151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160088352^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160089841|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O06I16159^^^AIRA-TEST^MR||WashingtonAIRA^ArmorelAIRA^Kara^^^^L|SundeAIRA^AnielaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1581 Vude IJsselstreek Pl^^East Lansing^MI^48825^USA^P||^PRN^PH^^^517^9816588|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^SundeAIRA^^^^^L|MTH^Mother^HL70063|1581 Vude IJsselstreek Pl^^East Lansing^MI^48825^USA^P|^PRN^PH^^^517^9816588ORC|RE||BO06I16159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO06I16159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160089841^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160089852|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V44F16164^^^AIRA-TEST^MR||TrimbleAIRA^OphiraAIRA^Savitri^^^^L|KarleAIRA^IllonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1252 Gijfheerenlanden Cir^^Canadian Lakes^MI^49346^USA^P||^PRN^PH^^^231^3449772|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TrimbleAIRA^KarleAIRA^^^^^L|MTH^Mother^HL70063|1252 Gijfheerenlanden Cir^^Canadian Lakes^MI^49346^USA^P|^PRN^PH^^^231^3449772ORC|RE||BV44F16164.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV44F16164.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160089852^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090041|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S39B16175^^^AIRA-TEST^MR||UvaldeAIRA^RajaAIRA^Joscelin^^^^L|Pend OreilleAIRA^DelveneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1828 Weerde Ave^^Eckerman^MI^49728^USA^P||^PRN^PH^^^906^6373569|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|UvaldeAIRA^Pend OreilleAIRA^^^^^L|MTH^Mother^HL70063|1828 Weerde Ave^^Eckerman^MI^49728^USA^P|^PRN^PH^^^906^6373569ORC|RE||BS39B16175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS39B16175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090041^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U68W16183^^^AIRA-TEST^MR||WellsAIRA^SafiyaAIRA^Delanna^^^^L|MontereyAIRA^RevelationAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1607 Bith Ave^^Pellston^MI^49769^USA^P||^PRN^PH^^^616^3260712|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WellsAIRA^MontereyAIRA^^^^^L|MTH^Mother^HL70063|1607 Bith Ave^^Pellston^MI^49769^USA^P|^PRN^PH^^^616^3260712ORC|RE||BU68W16183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU68W16183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090052^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B34D16191^^^AIRA-TEST^MR||BrowneAIRA^HirokoAIRA^Maysa^^^^L|JacintoAIRA^SamanthaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1678 Toxtel St^^GR^MI^49506^USA^P||^PRN^PH^^^616^4017800|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrowneAIRA^JacintoAIRA^^^^^L|MTH^Mother^HL70063|1678 Toxtel St^^GR^MI^49506^USA^P|^PRN^PH^^^616^4017800ORC|RE||BB34D16191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB34D16191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090141^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B75F16199^^^AIRA-TEST^MR||HawkeAIRA^RickenaAIRA^Altair^^^^L|WashingtonAIRA^SarasvatiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1723 Dolenwaard Cir^^Boardwalk^MI^48638^USA^P||^PRN^PH^^^989^4729518|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HawkeAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1723 Dolenwaard Cir^^Boardwalk^MI^48638^USA^P|^PRN^PH^^^989^4729518ORC|RE||BB75F16199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB75F16199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090152^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090341|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y46D16207^^^AIRA-TEST^MR||GeneseeAIRA^AilsaAIRA^Kiana^^^^L|RandallAIRA^VandanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1580 Eunschoten Ave^^Seney^MI^49883^USA^P||^PRN^PH^^^906^2641488|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GeneseeAIRA^RandallAIRA^^^^^L|MTH^Mother^HL70063|1580 Eunschoten Ave^^Seney^MI^49883^USA^P|^PRN^PH^^^906^2641488ORC|RE||BY46D16207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY46D16207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090341^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090352|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X13P16212^^^AIRA-TEST^MR||NobleAIRA^KaylaAIRA^Britney^^^^L|EdmundsAIRA^AyashaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1333 Geeuwarden Ave^^Oakley^MI^48649^USA^P||^PRN^PH^^^989^5101144|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NobleAIRA^EdmundsAIRA^^^^^L|MTH^Mother^HL70063|1333 Geeuwarden Ave^^Oakley^MI^48649^USA^P|^PRN^PH^^^989^5101144ORC|RE||BX13P16212.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX13P16212.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090352^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090541|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C54R16223^^^AIRA-TEST^MR||WebsterAIRA^LeighAIRA^Morgana^^^^L|CooperAIRA^ShaunnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1856 Guidhorn Ln^^East Kingsford^MI^49801^USA^P||^PRN^PH^^^906^6077220|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WebsterAIRA^CooperAIRA^^^^^L|MTH^Mother^HL70063|1856 Guidhorn Ln^^East Kingsford^MI^49801^USA^P|^PRN^PH^^^906^6077220ORC|RE||BC54R16223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC54R16223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090541^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090552|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D23W16231^^^AIRA-TEST^MR||AllamakeeAIRA^SunnyAIRA^Ronnie^^^^L|CraneAIRA^Joo-EunAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1630 Rustig Ln^^Romulus^MI^48174^USA^P||^PRN^PH^^^734^6097528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllamakeeAIRA^CraneAIRA^^^^^L|MTH^Mother^HL70063|1630 Rustig Ln^^Romulus^MI^48174^USA^P|^PRN^PH^^^734^6097528ORC|RE||BD23W16231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD23W16231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090552^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090741|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q18Y16239^^^AIRA-TEST^MR||PendletonAIRA^SuzanneAIRA^Eudocie^^^^L|MonroeAIRA^DulceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1724 Herkelland Cir^^Hersey^MI^49639^USA^P||^PRN^PH^^^231^4601447|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PendletonAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1724 Herkelland Cir^^Hersey^MI^49639^USA^P|^PRN^PH^^^231^4601447ORC|RE||BQ18Y16239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ18Y16239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090741^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160090752|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R89T16247^^^AIRA-TEST^MR||GageAIRA^CarenzaAIRA^Madison^^^^L|LincolnAIRA^KarlieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1632 Buis Cir^^GR^MI^49508^USA^P||^PRN^PH^^^616^7368512|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GageAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1632 Buis Cir^^GR^MI^49508^USA^P|^PRN^PH^^^616^7368512ORC|RE||BR89T16247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR89T16247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160090752^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160095509|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z69V16255^^^AIRA-TEST^MR||ClallamAIRA^OksanaAIRA^Riya^^^^L|BuchananAIRA^ZoeyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1389 Bytsjerksteradiel Pl^^Detroit^MI^48207^USA^P||^PRN^PH^^^313^7295568|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClallamAIRA^BuchananAIRA^^^^^L|MTH^Mother^HL70063|1389 Bytsjerksteradiel Pl^^Detroit^MI^48207^USA^P|^PRN^PH^^^313^7295568ORC|RE||BZ69V16255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ69V16255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160095509^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160095801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M62I16260^^^AIRA-TEST^MR||GarfieldAIRA^HadyaAIRA^Achal^^^^L|BremerAIRA^WillaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1243 Moeilijk Cir^^De Tour Vlle^MI^49725^USA^P||^PRN^PH^^^906^6047676|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarfieldAIRA^BremerAIRA^^^^^L|MTH^Mother^HL70063|1243 Moeilijk Cir^^De Tour Vlle^MI^49725^USA^P|^PRN^PH^^^906^6047676ORC|RE||BM62I16260.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM62I16260.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160095801^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160095901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S92K16271^^^AIRA-TEST^MR||PendletonAIRA^AlayahAIRA^Sharlene^^^^L|WashingtonAIRA^LaloAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1890 Voorjaar Cir^^Waterford^MI^48330^USA^P||^PRN^PH^^^248^8169344|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PendletonAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1890 Voorjaar Cir^^Waterford^MI^48330^USA^P|^PRN^PH^^^248^8169344ORC|RE||BS92K16271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS92K16271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160095901^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160096412|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B64R16279^^^AIRA-TEST^MR||NilsenAIRA^MarvelAIRA^Lyndal^^^^L|HowarthAIRA^DeanneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1772 Ge Fryske Marren St^^Comins^MI^48619^USA^P||^PRN^PH^^^989^9740816|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NilsenAIRA^HowarthAIRA^^^^^L|MTH^Mother^HL70063|1772 Ge Fryske Marren St^^Comins^MI^48619^USA^P|^PRN^PH^^^989^9740816ORC|RE||BB64R16279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB64R16279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160096412^RABAVERT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160096601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T12I16287^^^AIRA-TEST^MR||OaklandAIRA^LiviaAIRA^Ragnhild^^^^L|McQuadeAIRA^CaseyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1655 Montfoort St^^Washington Township^MI^48094^USA^P||^PRN^PH^^^586^7604603|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OaklandAIRA^McQuadeAIRA^^^^^L|MTH^Mother^HL70063|1655 Montfoort St^^Washington Township^MI^48094^USA^P|^PRN^PH^^^586^7604603ORC|RE||BT12I16287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT12I16287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160096601^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160096612|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J32L16295^^^AIRA-TEST^MR||MarionAIRA^BrooklynnAIRA^Miki^^^^L|TaylorAIRA^LoreleiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1963 Roes Ln^^Flint^MI^48519^USA^P||^PRN^PH^^^810^8237077|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MarionAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1963 Roes Ln^^Flint^MI^48519^USA^P|^PRN^PH^^^810^8237077ORC|RE||BJ32L16295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ32L16295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160096612^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160097602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I78K16303^^^AIRA-TEST^MR||BreckinridgeAIRA^GillianAIRA^Mariposa^^^^L|SylteAIRA^LalimaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1625 Hooise Meren St^^Lake Orion^MI^48360^USA^P||^PRN^PH^^^248^4125795|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BreckinridgeAIRA^SylteAIRA^^^^^L|MTH^Mother^HL70063|1625 Hooise Meren St^^Lake Orion^MI^48360^USA^P|^PRN^PH^^^248^4125795ORC|RE||BI78K16303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI78K16303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160097602^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160097606|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V02Q16311^^^AIRA-TEST^MR||BernstrainAIRA^AmethystAIRA^Anya^^^^L|EatonAIRA^DarrelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1671 Mden Ln^^Redford^MI^48239^USA^P||^PRN^PH^^^734^5448779|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BernstrainAIRA^EatonAIRA^^^^^L|MTH^Mother^HL70063|1671 Mden Ln^^Redford^MI^48239^USA^P|^PRN^PH^^^734^5448779ORC|RE||BV02Q16311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV02Q16311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160097606^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-58160097620|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U12M16316^^^AIRA-TEST^MR||ChampaignAIRA^PaigeAIRA^Alena^^^^L|RockAIRA^JainaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1458 Borst aan de Maas St^^Union Lake^MI^48387^USA^P||^PRN^PH^^^248^2946448|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChampaignAIRA^RockAIRA^^^^^L|MTH^Mother^HL70063|1458 Borst aan de Maas St^^Union Lake^MI^48387^USA^P|^PRN^PH^^^248^2946448ORC|RE||BU12M16316.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU12M16316.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||58160097620^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62195-051-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T33P16327^^^AIRA-TEST^MR||JeffersonAIRA^EarthaAIRA^Araceli^^^^L|AndersonAIRA^LailieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1021 Lreda Ave^^Clinton Township^MI^48036^USA^P||^PRN^PH^^^586^6312361|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1021 Lreda Ave^^Clinton Township^MI^48036^USA^P|^PRN^PH^^^586^6312361ORC|RE||BT33P16327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT33P16327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62195-051-01^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62195-051-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H64N16335^^^AIRA-TEST^MR||AlbrechtsonAIRA^FlannaAIRA^Bevin^^^^L|ArthurAIRA^ArdineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1829 Fittenseradeel Ln^^Springfld Township^MI^48350^USA^P||^PRN^PH^^^248^5127012|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlbrechtsonAIRA^ArthurAIRA^^^^^L|MTH^Mother^HL70063|1829 Fittenseradeel Ln^^Springfld Township^MI^48350^USA^P|^PRN^PH^^^248^5127012ORC|RE||BH64N16335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH64N16335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62195-051-10^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62195005101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M06N16343^^^AIRA-TEST^MR||AtascosaAIRA^CorabelleAIRA^Akira^^^^L|LincolnAIRA^AshlynnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1270 Verschillen Cir^^Cadillac^MI^49601^USA^P||^PRN^PH^^^231^9617767|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AtascosaAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1270 Verschillen Cir^^Cadillac^MI^49601^USA^P|^PRN^PH^^^231^9617767ORC|RE||BM06N16343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM06N16343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62195005101^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62195005110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B63E16351^^^AIRA-TEST^MR||JeffersonAIRA^ClaireAIRA^Kasey^^^^L|LarsonAIRA^NoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1115 Gulst Ave^^Brockway^MI^48097^USA^P||^PRN^PH^^^810^8834848|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^LarsonAIRA^^^^^L|MTH^Mother^HL70063|1115 Gulst Ave^^Brockway^MI^48097^USA^P|^PRN^PH^^^810^8834848ORC|RE||BB63E16351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB63E16351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62195005110^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577-613-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J47T16359^^^AIRA-TEST^MR||AntrimAIRA^MahinaAIRA^Chloe^^^^L|HoltAIRA^AimeeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1716 Koxtel Cir^^Kalamazoo^MI^49048^USA^P||^PRN^PH^^^269^3154246|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AntrimAIRA^HoltAIRA^^^^^L|MTH^Mother^HL70063|1716 Koxtel Cir^^Kalamazoo^MI^49048^USA^P|^PRN^PH^^^269^3154246ORC|RE||BJ47T16359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ47T16359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62577-613-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577-613-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F29F16367^^^AIRA-TEST^MR||ClarkAIRA^SilviaAIRA^Vilhelmina^^^^L|KarleAIRA^PrimroseAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1710 Melmond Ave^^Harvey^MI^49855^USA^P||^PRN^PH^^^906^3067245|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClarkAIRA^KarleAIRA^^^^^L|MTH^Mother^HL70063|1710 Melmond Ave^^Harvey^MI^49855^USA^P|^PRN^PH^^^906^3067245ORC|RE||BF29F16367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF29F16367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62577-613-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577-614-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G94X16372^^^AIRA-TEST^MR||SacAIRA^EdenAIRA^Wallis^^^^L|LickingAIRA^PunitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1760 Tude IJsselstreek Pl^^Flint^MI^48550^USA^P||^PRN^PH^^^810^7576103|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SacAIRA^LickingAIRA^^^^^L|MTH^Mother^HL70063|1760 Tude IJsselstreek Pl^^Flint^MI^48550^USA^P|^PRN^PH^^^810^7576103ORC|RE||BG94X16372.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG94X16372.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62577-614-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577-614-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O69B16383^^^AIRA-TEST^MR||ReillyAIRA^PrabhatiAIRA^Zigana^^^^L|BelmontAIRA^AmritaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1869 Sissewaard Pl^^Eau Claire^MI^49111^USA^P||^PRN^PH^^^269^4971493|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReillyAIRA^BelmontAIRA^^^^^L|MTH^Mother^HL70063|1869 Sissewaard Pl^^Eau Claire^MI^49111^USA^P|^PRN^PH^^^269^4971493ORC|RE||BO69B16383.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO69B16383.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62577-614-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577061301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S76I16391^^^AIRA-TEST^MR||PayetteAIRA^LondonAIRA^Anahi^^^^L|CaribouAIRA^SashaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1498 Slecht Cir^^Kentwood Brch^MI^49528^USA^P||^PRN^PH^^^616^3190051|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PayetteAIRA^CaribouAIRA^^^^^L|MTH^Mother^HL70063|1498 Slecht Cir^^Kentwood Brch^MI^49528^USA^P|^PRN^PH^^^616^3190051ORC|RE||BS76I16391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS76I16391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62577061301^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577061311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B97A16399^^^AIRA-TEST^MR||HallAIRA^DellaAIRA^Madalyn^^^^L|SheridanAIRA^DarrelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1441 Buidhorn St^^Ellsworth^MI^49729^USA^P||^PRN^PH^^^231^6783721|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HallAIRA^SheridanAIRA^^^^^L|MTH^Mother^HL70063|1441 Buidhorn St^^Ellsworth^MI^49729^USA^P|^PRN^PH^^^231^6783721ORC|RE||BB97A16399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB97A16399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62577061311^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577061401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I11B16407^^^AIRA-TEST^MR||HarrisAIRA^JourneeAIRA^Toni^^^^L|MenomineeAIRA^DonnaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1011 Dekela Ave^^White Lake^MI^48383^USA^P||^PRN^PH^^^248^2959895|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarrisAIRA^MenomineeAIRA^^^^^L|MTH^Mother^HL70063|1011 Dekela Ave^^White Lake^MI^48383^USA^P|^PRN^PH^^^248^2959895ORC|RE||BI11B16407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI11B16407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62577061401^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-62577061411|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N09B16415^^^AIRA-TEST^MR||IoniaAIRA^MirabelleAIRA^Dianthe^^^^L|FoxAIRA^ZulaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1478 Nerneuzen Pl^^Troy^MI^48084^USA^P||^PRN^PH^^^248^3806261|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IoniaAIRA^FoxAIRA^^^^^L|MTH^Mother^HL70063|1478 Nerneuzen Pl^^Troy^MI^48084^USA^P|^PRN^PH^^^248^3806261ORC|RE||BN09B16415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN09B16415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||62577061411^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63361-245-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L57X16423^^^AIRA-TEST^MR||HowathAIRA^LystraAIRA^Rona^^^^L|ColumbiaAIRA^LorenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1442 Oa en Hunze Pl^^L Anse^MI^49946^USA^P||^PRN^PH^^^906^6534037|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowathAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1442 Oa en Hunze Pl^^L Anse^MI^49946^USA^P|^PRN^PH^^^906^6534037ORC|RE||BL57X16423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL57X16423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63361-245-10^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63361-245-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M33Q16428^^^AIRA-TEST^MR||MasonAIRA^RossaAIRA^Carrigan^^^^L|LoganAIRA^ElinorAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1158 Volenwaard Ave^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^5997536|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1158 Volenwaard Ave^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^5997536ORC|RE||BM33Q16428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM33Q16428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63361-245-58^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63361024510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V89J16439^^^AIRA-TEST^MR||LamarAIRA^LowanAIRA^Shantina^^^^L|WinneshiekAIRA^KaraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1536 Vost Gelre Pl^^Lincoln Park^MI^48146^USA^P||^PRN^PH^^^313^9819108|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LamarAIRA^WinneshiekAIRA^^^^^L|MTH^Mother^HL70063|1536 Vost Gelre Pl^^Lincoln Park^MI^48146^USA^P|^PRN^PH^^^313^9819108ORC|RE||BV89J16439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV89J16439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63361024510^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63361024558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J80K16447^^^AIRA-TEST^MR||Los AngelesAIRA^AshleighAIRA^Shridevi^^^^L|AthensAIRA^JoelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1358 Bollumerland en Nieuwkruisland Ave^^Sault Sainte Marie^MI^49788^USA^P||^PRN^PH^^^906^3810251|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Los AngelesAIRA^AthensAIRA^^^^^L|MTH^Mother^HL70063|1358 Bollumerland en Nieuwkruisland Ave^^Sault Sainte Marie^MI^49788^USA^P|^PRN^PH^^^906^3810251ORC|RE||BJ80K16447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ80K16447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63361024558^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-501-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L85M16455^^^AIRA-TEST^MR||AllottAIRA^KalareAIRA^Chelsea^^^^L|ShelbyAIRA^OnyxAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1560 Vwenterand St^^Grand Rapids^MI^49512^USA^P||^PRN^PH^^^616^6267007|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllottAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1560 Vwenterand St^^Grand Rapids^MI^49512^USA^P|^PRN^PH^^^616^6267007ORC|RE||BL85M16455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL85M16455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-501-01^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-501-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U14U16463^^^AIRA-TEST^MR||IndianaAIRA^EllenAIRA^Chantal^^^^L|PhelpsAIRA^ProsperaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1072 Wit Ave^^Northville Tw^MI^48167^USA^P||^PRN^PH^^^248^2946835|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IndianaAIRA^PhelpsAIRA^^^^^L|MTH^Mother^HL70063|1072 Wit Ave^^Northville Tw^MI^48167^USA^P|^PRN^PH^^^248^2946835ORC|RE||BU14U16463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU14U16463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-501-02^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-511-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L24O16468^^^AIRA-TEST^MR||BakerAIRA^IolantheAIRA^Mayoko^^^^L|MartinsonAIRA^AlakeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1520 Pchinnen St^^China Township^MI^48054^USA^P||^PRN^PH^^^810^6604868|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BakerAIRA^MartinsonAIRA^^^^^L|MTH^Mother^HL70063|1520 Pchinnen St^^China Township^MI^48054^USA^P|^PRN^PH^^^810^6604868ORC|RE||BL24O16468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL24O16468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-511-11^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-612-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D29G16479^^^AIRA-TEST^MR||WettilandAIRA^KaileyAIRA^Teal^^^^L|ButlerAIRA^OlesiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1503 Zundert St^^GR^MI^49503^USA^P||^PRN^PH^^^616^6856250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WettilandAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1503 Zundert St^^GR^MI^49503^USA^P|^PRN^PH^^^616^6856250ORC|RE||BD29G16479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD29G16479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-612-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-612-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z60E16487^^^AIRA-TEST^MR||EliasonAIRA^BrittanyAIRA^Aubine^^^^L|MeeAIRA^RohanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1867 Bolenwaard Cir^^Orion^MI^48362^USA^P||^PRN^PH^^^248^2127490|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EliasonAIRA^MeeAIRA^^^^^L|MTH^Mother^HL70063|1867 Bolenwaard Cir^^Orion^MI^48362^USA^P|^PRN^PH^^^248^2127490ORC|RE||BZ60E16487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ60E16487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-612-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-613-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G05T16495^^^AIRA-TEST^MR||CusackAIRA^CoreyAIRA^Jin^^^^L|BucklesAIRA^SariaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1529 Dansingerland Ave^^Hudsonville^MI^49426^USA^P||^PRN^PH^^^616^3765643|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CusackAIRA^BucklesAIRA^^^^^L|MTH^Mother^HL70063|1529 Dansingerland Ave^^Hudsonville^MI^49426^USA^P|^PRN^PH^^^616^3765643ORC|RE||BG05T16495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG05T16495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-613-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851-613-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M07S16503^^^AIRA-TEST^MR||HernandezAIRA^TillyAIRA^Aleigha^^^^L|YoakumAIRA^YonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1008 Wollumerland en Nieuwkruisland Pl^^Saint Clair Shores^MI^48080^USA^P||^PRN^PH^^^586^3210847|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HernandezAIRA^YoakumAIRA^^^^^L|MTH^Mother^HL70063|1008 Wollumerland en Nieuwkruisland Pl^^Saint Clair Shores^MI^48080^USA^P|^PRN^PH^^^586^3210847ORC|RE||BM07S16503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM07S16503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851-613-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851050101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C38M16508^^^AIRA-TEST^MR||ThornleyAIRA^RuriAIRA^Leba^^^^L|ErikssonAIRA^TeanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1506 Oudwest-Fryslan Ave^^Marquette^MI^49855^USA^P||^PRN^PH^^^906^5602391|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThornleyAIRA^ErikssonAIRA^^^^^L|MTH^Mother^HL70063|1506 Oudwest-Fryslan Ave^^Marquette^MI^49855^USA^P|^PRN^PH^^^906^5602391ORC|RE||BC38M16508.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC38M16508.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851050101^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851050102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q61K16519^^^AIRA-TEST^MR||GratiotAIRA^AchenAIRA^Ruperta^^^^L|StonewallAIRA^JamieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1163 Uoerendaal Ave^^Richland^MI^49083^USA^P||^PRN^PH^^^269^2943035|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GratiotAIRA^StonewallAIRA^^^^^L|MTH^Mother^HL70063|1163 Uoerendaal Ave^^Richland^MI^49083^USA^P|^PRN^PH^^^269^2943035ORC|RE||BQ61K16519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ61K16519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851050102^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851051111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A52E16527^^^AIRA-TEST^MR||KingfisherAIRA^KatelynnAIRA^Tarana^^^^L|BrackenAIRA^MalvaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1206 View St^^Point Elizabeth^MI^48725^USA^P||^PRN^PH^^^989^6806366|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingfisherAIRA^BrackenAIRA^^^^^L|MTH^Mother^HL70063|1206 View St^^Point Elizabeth^MI^48725^USA^P|^PRN^PH^^^989^6806366ORC|RE||BA52E16527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA52E16527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851051111^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851061201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H13L16535^^^AIRA-TEST^MR||SaundersAIRA^AstaAIRA^Quirita^^^^L|ClintonAIRA^KlavdiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1207 Pand Ln^^Grand Rapids^MI^49503^USA^P||^PRN^PH^^^616^9937868|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SaundersAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1207 Pand Ln^^Grand Rapids^MI^49503^USA^P|^PRN^PH^^^616^9937868ORC|RE||BH13L16535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH13L16535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851061201^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851061211|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T87W16543^^^AIRA-TEST^MR||WrightAIRA^LynnAIRA^Clarabelle^^^^L|PulaskiAIRA^AnnetteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1734 Mergeijk Ln^^Muskegon^MI^49441^USA^P||^PRN^PH^^^231^6767873|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WrightAIRA^PulaskiAIRA^^^^^L|MTH^Mother^HL70063|1734 Mergeijk Ln^^Muskegon^MI^49441^USA^P|^PRN^PH^^^231^6767873ORC|RE||BT87W16543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT87W16543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851061211^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851061301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N69H16551^^^AIRA-TEST^MR||SagadahocAIRA^ElianeAIRA^Galiena^^^^L|McFernanAIRA^RashidaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1223 Hotterdam St^^Ewen^MI^49925^USA^P||^PRN^PH^^^906^7691751|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SagadahocAIRA^McFernanAIRA^^^^^L|MTH^Mother^HL70063|1223 Hotterdam St^^Ewen^MI^49925^USA^P|^PRN^PH^^^906^7691751ORC|RE||BN69H16551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN69H16551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851061301^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-63851061311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J14I16559^^^AIRA-TEST^MR||FisherAIRA^WalburgaAIRA^Mare^^^^L|CarrollAIRA^AtlantaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1424 Vleermuis Ave^^Southeast^MI^48529^USA^P||^PRN^PH^^^810^7531674|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FisherAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1424 Vleermuis Ave^^Southeast^MI^48529^USA^P|^PRN^PH^^^810^7531674ORC|RE||BJ14I16559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ14I16559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||63851061311^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-64678-211-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O17T16564^^^AIRA-TEST^MR||WashingtonAIRA^MadraAIRA^Nora^^^^L|NelsonAIRA^HesterAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1531 Gaarbeek Ln^^Hamburg Township^MI^48189^USA^P||^PRN^PH^^^734^3376407|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1531 Gaarbeek Ln^^Hamburg Township^MI^48189^USA^P|^PRN^PH^^^734^3376407ORC|RE||BO17T16564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO17T16564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||64678-211-01^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-64678-211-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X55W16575^^^AIRA-TEST^MR||KernAIRA^VegaAIRA^Tyler^^^^L|DavisAIRA^AristaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1645 Teerijnen Ave^^Wyoming^MI^49519^USA^P||^PRN^PH^^^616^7491263|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KernAIRA^DavisAIRA^^^^^L|MTH^Mother^HL70063|1645 Teerijnen Ave^^Wyoming^MI^49519^USA^P|^PRN^PH^^^616^7491263ORC|RE||BX55W16575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX55W16575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||64678-211-05^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-64678021101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z17A16583^^^AIRA-TEST^MR||HumboldtAIRA^HeddaAIRA^Meredith^^^^L|BendAIRA^UjjwalaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1026 Eend Ave^^Detroit^MI^48244^USA^P||^PRN^PH^^^313^3635579|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HumboldtAIRA^BendAIRA^^^^^L|MTH^Mother^HL70063|1026 Eend Ave^^Detroit^MI^48244^USA^P|^PRN^PH^^^313^3635579ORC|RE||BZ17A16583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ17A16583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||64678021101^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-64678021105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K14A16591^^^AIRA-TEST^MR||O DayAIRA^AdoniaAIRA^Kris^^^^L|HendersonAIRA^VeronaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1614 Lucphen Ln^^Oakland^MI^48306^USA^P||^PRN^PH^^^248^3334628|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O DayAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1614 Lucphen Ln^^Oakland^MI^48306^USA^P|^PRN^PH^^^248^3334628ORC|RE||BK14A16591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK14A16591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||64678021105^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-107-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F34B16599^^^AIRA-TEST^MR||DubuqueAIRA^ShianAIRA^Nitika^^^^L|LarssenAIRA^VolanteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1742 Gijnwaarden Cir^^Allen^MI^49227^USA^P||^PRN^PH^^^517^5215139|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DubuqueAIRA^LarssenAIRA^^^^^L|MTH^Mother^HL70063|1742 Gijnwaarden Cir^^Allen^MI^49227^USA^P|^PRN^PH^^^517^5215139ORC|RE||BF34B16599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF34B16599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-107-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-108-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P64Z16604^^^AIRA-TEST^MR||KimbleAIRA^MeritAIRA^Benita^^^^L|AsotinAIRA^MoriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1450 Afvragen St^^Walkerville^MI^49459^USA^P||^PRN^PH^^^231^8900492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KimbleAIRA^AsotinAIRA^^^^^L|MTH^Mother^HL70063|1450 Afvragen St^^Walkerville^MI^49459^USA^P|^PRN^PH^^^231^8900492ORC|RE||BP64Z16604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP64Z16604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-108-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-108-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M65D16615^^^AIRA-TEST^MR||BayAIRA^QuobaAIRA^Eris^^^^L|CokeAIRA^SanciaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1075 Euenen Ave^^Grand Marais^MI^49839^USA^P||^PRN^PH^^^906^2389364|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BayAIRA^CokeAIRA^^^^^L|MTH^Mother^HL70063|1075 Euenen Ave^^Grand Marais^MI^49839^USA^P|^PRN^PH^^^906^2389364ORC|RE||BM65D16615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM65D16615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-108-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-109-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C10C16623^^^AIRA-TEST^MR||PauldingAIRA^MuniraAIRA^Camilla^^^^L|VictoriaAIRA^CelinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1143 Nellendoorn Pl^^Twining^MI^48766^USA^P||^PRN^PH^^^989^8852099|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PauldingAIRA^VictoriaAIRA^^^^^L|MTH^Mother^HL70063|1143 Nellendoorn Pl^^Twining^MI^48766^USA^P|^PRN^PH^^^989^8852099ORC|RE||BC10C16623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC10C16623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-109-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-109-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U30C16631^^^AIRA-TEST^MR||TereAIRA^PriyaAIRA^June^^^^L|DuncanAIRA^BenitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1621 View Ave^^Herron^MI^49744^USA^P||^PRN^PH^^^989^5411490|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TereAIRA^DuncanAIRA^^^^^L|MTH^Mother^HL70063|1621 View Ave^^Herron^MI^49744^USA^P|^PRN^PH^^^989^5411490ORC|RE||BU30C16631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU30C16631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-109-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-110-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H87J16639^^^AIRA-TEST^MR||HarperAIRA^BarbaraAIRA^Kavindra^^^^L|OxfordAIRA^AxeliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1267 Dosser Ln^^Gay^MI^49945^USA^P||^PRN^PH^^^906^7700942|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarperAIRA^OxfordAIRA^^^^^L|MTH^Mother^HL70063|1267 Dosser Ln^^Gay^MI^49945^USA^P|^PRN^PH^^^906^7700942ORC|RE||BH87J16639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH87J16639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-110-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-110-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D17M16644^^^AIRA-TEST^MR||CaseyAIRA^LeilahAIRA^Ximena^^^^L|HockleyAIRA^KaiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1572 Moerdijk St^^Mussey^MI^48014^USA^P||^PRN^PH^^^810^2986204|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CaseyAIRA^HockleyAIRA^^^^^L|MTH^Mother^HL70063|1572 Moerdijk St^^Mussey^MI^48014^USA^P|^PRN^PH^^^810^2986204ORC|RE||BD17M16644.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD17M16644.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-110-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-200-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y28O16652^^^AIRA-TEST^MR||DillAIRA^TrifineAIRA^Giselle^^^^L|OkanoganAIRA^MimiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1910 Teldhoven Ln^^Lansing State Journal^MI^48919^USA^P||^PRN^PH^^^517^9299703|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DillAIRA^OkanoganAIRA^^^^^L|MTH^Mother^HL70063|1910 Teldhoven Ln^^Lansing State Journal^MI^48919^USA^P|^PRN^PH^^^517^9299703ORC|RE||BY28O16652.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY28O16652.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-200-01^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-200-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q80M16663^^^AIRA-TEST^MR||HuronAIRA^NeveahAIRA^Joslyn^^^^L|SantiagoAIRA^AudoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1595 Temert-Bakel Ln^^Barryton^MI^49305^USA^P||^PRN^PH^^^989^5572123|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HuronAIRA^SantiagoAIRA^^^^^L|MTH^Mother^HL70063|1595 Temert-Bakel Ln^^Barryton^MI^49305^USA^P|^PRN^PH^^^989^5572123ORC|RE||BQ80M16663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ80M16663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-200-10^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-300-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T74P16671^^^AIRA-TEST^MR||AllenAIRA^PebblesAIRA^Asta^^^^L|CharlevoixAIRA^MalakAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1730 Moes Cir^^Independence Township^MI^48346^USA^P||^PRN^PH^^^248^5780700|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AllenAIRA^CharlevoixAIRA^^^^^L|MTH^Mother^HL70063|1730 Moes Cir^^Independence Township^MI^48346^USA^P|^PRN^PH^^^248^5780700ORC|RE||BT74P16671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT74P16671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-300-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-300-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B82H16679^^^AIRA-TEST^MR||LakeAIRA^SuchiAIRA^Anca^^^^L|CarrollAIRA^MridulAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1176 Achtervoegsel St^^Flint^MI^48506^USA^P||^PRN^PH^^^810^2545919|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LakeAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1176 Achtervoegsel St^^Flint^MI^48506^USA^P|^PRN^PH^^^810^2545919ORC|RE||BB82H16679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB82H16679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-300-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-301-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T95K16687^^^AIRA-TEST^MR||LarssenAIRA^TemaAIRA^Momoko^^^^L|GogebicAIRA^PendaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1081 Wist Ave^^Flint^MI^48502^USA^P||^PRN^PH^^^810^6014844|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LarssenAIRA^GogebicAIRA^^^^^L|MTH^Mother^HL70063|1081 Wist Ave^^Flint^MI^48502^USA^P|^PRN^PH^^^810^6014844ORC|RE||BT95K16687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT95K16687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-301-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-301-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B46B16695^^^AIRA-TEST^MR||JuniataAIRA^CindyAIRA^Zaria^^^^L|CarlsonAIRA^EvaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1206 Yard Cir^^Detroit^MI^48242^USA^P||^PRN^PH^^^313^8800698|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JuniataAIRA^CarlsonAIRA^^^^^L|MTH^Mother^HL70063|1206 Yard Cir^^Detroit^MI^48242^USA^P|^PRN^PH^^^313^8800698ORC|RE||BB46B16695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB46B16695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-301-10^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-302-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z38K16700^^^AIRA-TEST^MR||HenryAIRA^KoraAIRA^Hiroko^^^^L|McLennanAIRA^SamanthaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1641 Nongeradeel Ln^^Detroit^MI^48221^USA^P||^PRN^PH^^^313^5535032|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HenryAIRA^McLennanAIRA^^^^^L|MTH^Mother^HL70063|1641 Nongeradeel Ln^^Detroit^MI^48221^USA^P|^PRN^PH^^^313^5535032ORC|RE||BZ38K16700.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ38K16700.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-302-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-302-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T98F16711^^^AIRA-TEST^MR||BrownfieldAIRA^LucineAIRA^Alva^^^^L|HenryAIRA^CelandineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1393 Boeree-Overflakkee Cir^^Chesterfield^MI^48047^USA^P||^PRN^PH^^^586^9743713|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownfieldAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1393 Boeree-Overflakkee Cir^^Chesterfield^MI^48047^USA^P|^PRN^PH^^^586^9743713ORC|RE||BT98F16711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT98F16711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-302-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-303-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F04C16719^^^AIRA-TEST^MR||YuurAIRA^CelesteAIRA^Alpha^^^^L|LoganAIRA^ZenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1185 Delmond St^^Michigamme^MI^49861^USA^P||^PRN^PH^^^906^3294384|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YuurAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1185 Delmond St^^Michigamme^MI^49861^USA^P|^PRN^PH^^^906^3294384ORC|RE||BF04C16719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF04C16719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-303-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-303-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R61Z16727^^^AIRA-TEST^MR||HoggAIRA^TanashaAIRA^Nyree^^^^L|AdsgaardAIRA^AbirAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1502 Ztten-Leur Ln^^Lowell^MI^49331^USA^P||^PRN^PH^^^616^4103714|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoggAIRA^AdsgaardAIRA^^^^^L|MTH^Mother^HL70063|1502 Ztten-Leur Ln^^Lowell^MI^49331^USA^P|^PRN^PH^^^616^4103714ORC|RE||BR61Z16727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR61Z16727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-303-10^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-304-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K25I16735^^^AIRA-TEST^MR||WashitaAIRA^RosAIRA^Nisi^^^^L|MonroeAIRA^EkalaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1792 Deze Ave^^Ewen^MI^49925^USA^P||^PRN^PH^^^906^5384780|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashitaAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1792 Deze Ave^^Ewen^MI^49925^USA^P|^PRN^PH^^^906^5384780ORC|RE||BK25I16735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK25I16735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-304-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-304-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V08R16740^^^AIRA-TEST^MR||ZavalaAIRA^CecilyAIRA^Haldana^^^^L|JohnsonAIRA^AilsaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1785 Oidden-Drenthe Ave^^Interlochen^MI^49643^USA^P||^PRN^PH^^^231^6541322|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ZavalaAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1785 Oidden-Drenthe Ave^^Interlochen^MI^49643^USA^P|^PRN^PH^^^231^6541322ORC|RE||BV08R16740.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV08R16740.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-304-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-305-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R86L16751^^^AIRA-TEST^MR||LawrenceAIRA^GalyaAIRA^Marita^^^^L|KeokukAIRA^SissyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1293 Hilvarenbeek Ln^^Brownstwn Township^MI^48183^USA^P||^PRN^PH^^^734^7482449|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LawrenceAIRA^KeokukAIRA^^^^^L|MTH^Mother^HL70063|1293 Hilvarenbeek Ln^^Brownstwn Township^MI^48183^USA^P|^PRN^PH^^^734^7482449ORC|RE||BR86L16751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR86L16751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-305-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019-305-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P30H16759^^^AIRA-TEST^MR||StevensAIRA^SevillaAIRA^Allison^^^^L|DavisAIRA^AylaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1793 Derde Ave^^Ripley^MI^49930^USA^P||^PRN^PH^^^906^8592056|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StevensAIRA^DavisAIRA^^^^^L|MTH^Mother^HL70063|1793 Derde Ave^^Ripley^MI^49930^USA^P|^PRN^PH^^^906^8592056ORC|RE||BP30H16759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP30H16759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019-305-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019010701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H28O16767^^^AIRA-TEST^MR||OwyheeAIRA^CaronAIRA^Meredith^^^^L|AdaAIRA^ZuleikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1607 Hoekel St^^Grand Rapids^MI^49516^USA^P||^PRN^PH^^^616^9301518|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OwyheeAIRA^AdaAIRA^^^^^L|MTH^Mother^HL70063|1607 Hoekel St^^Grand Rapids^MI^49516^USA^P|^PRN^PH^^^616^9301518ORC|RE||BH28O16767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH28O16767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019010701^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019010801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H46I16775^^^AIRA-TEST^MR||KendallAIRA^ReaganAIRA^Savanna^^^^L|MonroeAIRA^DiellaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1199 Hucphen Cir^^Clarkston^MI^48348^USA^P||^PRN^PH^^^248^6657985|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KendallAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1199 Hucphen Cir^^Clarkston^MI^48348^USA^P|^PRN^PH^^^248^6657985ORC|RE||BH46I16775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH46I16775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019010801^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019010810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T22D16780^^^AIRA-TEST^MR||PayneAIRA^MitsukoAIRA^Cait^^^^L|HendersonAIRA^GevaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1395 Capelle aan den IJssel Ave^^Brownstown^MI^48174^USA^P||^PRN^PH^^^734^3711222|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PayneAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1395 Capelle aan den IJssel Ave^^Brownstown^MI^48174^USA^P|^PRN^PH^^^734^3711222ORC|RE||BT22D16780.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT22D16780.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019010810^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019010901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T98T16791^^^AIRA-TEST^MR||GuadalupeAIRA^ArianeAIRA^Elaine^^^^L|CummingsAIRA^ShivaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1223 Deed Cir^^Kincheloe^MI^49784^USA^P||^PRN^PH^^^906^4600590|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GuadalupeAIRA^CummingsAIRA^^^^^L|MTH^Mother^HL70063|1223 Deed Cir^^Kincheloe^MI^49784^USA^P|^PRN^PH^^^906^4600590ORC|RE||BT98T16791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT98T16791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019010901^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019010910|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V64W16799^^^AIRA-TEST^MR||PierceAIRA^KallieAIRA^Arya^^^^L|MorrowAIRA^JenayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1131 Noogeveen Ave^^Pentwater^MI^49449^USA^P||^PRN^PH^^^231^4807101|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PierceAIRA^MorrowAIRA^^^^^L|MTH^Mother^HL70063|1131 Noogeveen Ave^^Pentwater^MI^49449^USA^P|^PRN^PH^^^231^4807101ORC|RE||BV64W16799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV64W16799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019010910^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019011001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B47S16807^^^AIRA-TEST^MR||MercerAIRA^CorlissAIRA^Henka^^^^L|CampAIRA^GiacintaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1462 Vouw Ave^^Ithaca^MI^48847^USA^P||^PRN^PH^^^989^6412570|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MercerAIRA^CampAIRA^^^^^L|MTH^Mother^HL70063|1462 Vouw Ave^^Ithaca^MI^48847^USA^P|^PRN^PH^^^989^6412570ORC|RE||BB47S16807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB47S16807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019011001^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019011010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y10Z16815^^^AIRA-TEST^MR||LarsenAIRA^EudociaAIRA^Armelle^^^^L|LimestoneAIRA^GalayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1958 Onkhuizen Pl^^Borculo^MI^49464^USA^P||^PRN^PH^^^616^2388416|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LarsenAIRA^LimestoneAIRA^^^^^L|MTH^Mother^HL70063|1958 Onkhuizen Pl^^Borculo^MI^49464^USA^P|^PRN^PH^^^616^2388416ORC|RE||BY10Z16815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY10Z16815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019011010^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019020001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B48K16820^^^AIRA-TEST^MR||HoltAIRA^InasAIRA^Tracy^^^^L|HenryAIRA^PemaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1971 Keiderland Ln^^Woodland^MI^48897^USA^P||^PRN^PH^^^269^3182008|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HoltAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1971 Keiderland Ln^^Woodland^MI^48897^USA^P|^PRN^PH^^^269^3182008ORC|RE||BB48K16820.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB48K16820.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019020001^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019020010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A75V16831^^^AIRA-TEST^MR||RockwallAIRA^StinaAIRA^Pacifica^^^^L|LaneAIRA^VikritiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1136 Oederweert Ave^^Cedar River^MI^49887^USA^P||^PRN^PH^^^906^5064617|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RockwallAIRA^LaneAIRA^^^^^L|MTH^Mother^HL70063|1136 Oederweert Ave^^Cedar River^MI^49887^USA^P|^PRN^PH^^^906^5064617ORC|RE||BA75V16831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA75V16831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019020010^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U24L16839^^^AIRA-TEST^MR||Buena VistaAIRA^AquariaAIRA^Kiele^^^^L|Santa ClaraAIRA^TarshaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1264 Plagtwedde Ave^^Seney^MI^49883^USA^P||^PRN^PH^^^906^4446084|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Buena VistaAIRA^Santa ClaraAIRA^^^^^L|MTH^Mother^HL70063|1264 Plagtwedde Ave^^Seney^MI^49883^USA^P|^PRN^PH^^^906^4446084ORC|RE||BU24L16839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU24L16839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030001^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E29T16847^^^AIRA-TEST^MR||RobertsAIRA^LenoreAIRA^Julianne^^^^L|YoakumAIRA^BenedictaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1474 Drimmelen Cir^^Allenton^MI^48002^USA^P||^PRN^PH^^^810^5619726|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobertsAIRA^YoakumAIRA^^^^^L|MTH^Mother^HL70063|1474 Drimmelen Cir^^Allenton^MI^48002^USA^P|^PRN^PH^^^810^5619726ORC|RE||BE29T16847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE29T16847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030010^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C53Z16855^^^AIRA-TEST^MR||GibbonsAIRA^NimaAIRA^Riddhi^^^^L|GrantAIRA^AmiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1350 Slip Cir^^Saint James^MI^49782^USA^P||^PRN^PH^^^906^7796948|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GibbonsAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1350 Slip Cir^^Saint James^MI^49782^USA^P|^PRN^PH^^^906^7796948ORC|RE||BC53Z16855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC53Z16855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030101^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B72S16860^^^AIRA-TEST^MR||ToaleAIRA^HeroAIRA^Sevilla^^^^L|InghamAIRA^CatrionaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1883 Loetinchem Ave^^Charlevoix^MI^49720^USA^P||^PRN^PH^^^231^6223240|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ToaleAIRA^InghamAIRA^^^^^L|MTH^Mother^HL70063|1883 Loetinchem Ave^^Charlevoix^MI^49720^USA^P|^PRN^PH^^^231^6223240ORC|RE||BB72S16860.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB72S16860.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030110^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G16C16871^^^AIRA-TEST^MR||Black HawkAIRA^MareldaAIRA^Shavonne^^^^L|NordholmAIRA^NevadaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1089 Beststellingwerf Ave^^Union City^MI^49094^USA^P||^PRN^PH^^^517^4480714|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Black HawkAIRA^NordholmAIRA^^^^^L|MTH^Mother^HL70063|1089 Beststellingwerf Ave^^Union City^MI^49094^USA^P|^PRN^PH^^^517^4480714ORC|RE||BG16C16871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG16C16871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030201^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R99Y16879^^^AIRA-TEST^MR||ShelbyAIRA^KatherineAIRA^Jewell^^^^L|MarionAIRA^FarrahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1003 Pijkerk Pl^^Keego Harbor^MI^48320^USA^P||^PRN^PH^^^248^9947967|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShelbyAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1003 Pijkerk Pl^^Keego Harbor^MI^48320^USA^P|^PRN^PH^^^248^9947967ORC|RE||BR99Y16879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR99Y16879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030210^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L33J16887^^^AIRA-TEST^MR||KarleAIRA^TaptiAIRA^Abbey^^^^L|SkamaniaAIRA^JaniyahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1226 Beist Pl^^Orion^MI^48362^USA^P||^PRN^PH^^^248^4589684|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KarleAIRA^SkamaniaAIRA^^^^^L|MTH^Mother^HL70063|1226 Beist Pl^^Orion^MI^48362^USA^P|^PRN^PH^^^248^4589684ORC|RE||BL33J16887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL33J16887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030301^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T27A16895^^^AIRA-TEST^MR||HardinAIRA^CharisseAIRA^Celene^^^^L|ChambersAIRA^YarallaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1393 Ba en Hunze St^^Lawrence^MI^49064^USA^P||^PRN^PH^^^269^4743855|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardinAIRA^ChambersAIRA^^^^^L|MTH^Mother^HL70063|1393 Ba en Hunze St^^Lawrence^MI^49064^USA^P|^PRN^PH^^^269^4743855ORC|RE||BT27A16895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT27A16895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030310^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T59D16903^^^AIRA-TEST^MR||WolfeAIRA^MalaAIRA^Ayla^^^^L|SacramentoAIRA^GitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1948 Weuningen St^^Lima Township^MI^48118^USA^P||^PRN^PH^^^734^7279150|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WolfeAIRA^SacramentoAIRA^^^^^L|MTH^Mother^HL70063|1948 Weuningen St^^Lima Township^MI^48118^USA^P|^PRN^PH^^^734^7279150ORC|RE||BT59D16903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT59D16903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030401^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y62I16911^^^AIRA-TEST^MR||HartAIRA^EiddwenAIRA^Sibyl^^^^L|PutnamAIRA^IsobelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1938 Creeren St^^Lansing^MI^48908^USA^P||^PRN^PH^^^517^7891243|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HartAIRA^PutnamAIRA^^^^^L|MTH^Mother^HL70063|1938 Creeren St^^Lansing^MI^48908^USA^P|^PRN^PH^^^517^7891243ORC|RE||BY62I16911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY62I16911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030410^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A22D16916^^^AIRA-TEST^MR||WaldoAIRA^KakraAIRA^Shivani^^^^L|AdairAIRA^AgnesAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1516 Bint Anthonis St^^Laurium^MI^49913^USA^P||^PRN^PH^^^906^3995599|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WaldoAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1516 Bint Anthonis St^^Laurium^MI^49913^USA^P|^PRN^PH^^^906^3995599ORC|RE||BA22D16916.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA22D16916.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030501^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66019030510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E76A16927^^^AIRA-TEST^MR||GanronAIRA^SydneeAIRA^Dai^^^^L|GilespieAIRA^RebelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1497 Dampen Pl^^Kent City^MI^49330^USA^P||^PRN^PH^^^616^8502879|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GanronAIRA^GilespieAIRA^^^^^L|MTH^Mother^HL70063|1497 Dampen Pl^^Kent City^MI^49330^USA^P|^PRN^PH^^^616^8502879ORC|RE||BE76A16927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE76A16927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66019030510^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-000-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C81K16935^^^AIRA-TEST^MR||BooneAIRA^DerrythAIRA^Meghan^^^^L|MercerAIRA^ElishaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1289 Echouwen-Duiveland Cir^^Loretto^MI^49852^USA^P||^PRN^PH^^^906^9395684|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BooneAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1289 Echouwen-Duiveland Cir^^Loretto^MI^49852^USA^P|^PRN^PH^^^906^9395684ORC|RE||BC81K16935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC81K16935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-000-01^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-000-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H21U16943^^^AIRA-TEST^MR||HallAIRA^AllysonAIRA^Roxanne^^^^L|ClaytonAIRA^XuxaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1511 Goxmeer Cir^^Blanchard^MI^49310^USA^P||^PRN^PH^^^989^7978106|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HallAIRA^ClaytonAIRA^^^^^L|MTH^Mother^HL70063|1511 Goxmeer Cir^^Blanchard^MI^49310^USA^P|^PRN^PH^^^989^7978106ORC|RE||BH21U16943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH21U16943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-000-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-112-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R84Y16951^^^AIRA-TEST^MR||CarbonAIRA^SusanAIRA^Jigisha^^^^L|CalhounAIRA^AzariaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1855 Verneuzen Ave^^Pearl Beach^MI^48001^USA^P||^PRN^PH^^^810^7060671|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarbonAIRA^CalhounAIRA^^^^^L|MTH^Mother^HL70063|1855 Verneuzen Ave^^Pearl Beach^MI^48001^USA^P|^PRN^PH^^^810^7060671ORC|RE||BR84Y16951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR84Y16951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-112-02^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-112-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X73G16956^^^AIRA-TEST^MR||PresidioAIRA^KynleeAIRA^Alisa^^^^L|Mc VeetyAIRA^AylaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1105 Produceren Cir^^Luther^MI^49656^USA^P||^PRN^PH^^^231^9934902|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PresidioAIRA^Mc VeetyAIRA^^^^^L|MTH^Mother^HL70063|1105 Produceren Cir^^Luther^MI^49656^USA^P|^PRN^PH^^^231^9934902ORC|RE||BX73G16956.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX73G16956.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-112-10^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-113-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G14S16967^^^AIRA-TEST^MR||BoundaryAIRA^AymeAIRA^Flanna^^^^L|KitsapAIRA^CherishAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1595 Keimerswaal Ave^^Pickford^MI^49774^USA^P||^PRN^PH^^^906^2675432|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoundaryAIRA^KitsapAIRA^^^^^L|MTH^Mother^HL70063|1595 Keimerswaal Ave^^Pickford^MI^49774^USA^P|^PRN^PH^^^906^2675432ORC|RE||BG14S16967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG14S16967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-113-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-113-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G85F16975^^^AIRA-TEST^MR||McCurtainAIRA^CarenzaAIRA^Luana^^^^L|GogebicAIRA^TrinityAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1311 Sint-Oedenrode St^^Detroit^MI^48227^USA^P||^PRN^PH^^^313^2799332|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCurtainAIRA^GogebicAIRA^^^^^L|MTH^Mother^HL70063|1311 Sint-Oedenrode St^^Detroit^MI^48227^USA^P|^PRN^PH^^^313^2799332ORC|RE||BG85F16975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG85F16975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-113-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-114-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A20D16983^^^AIRA-TEST^MR||CreaserAIRA^CarmenAIRA^Lorelai^^^^L|PenistonAIRA^HeliceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1858 Hopen St^^Rosebush^MI^48878^USA^P||^PRN^PH^^^989^3359208|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CreaserAIRA^PenistonAIRA^^^^^L|MTH^Mother^HL70063|1858 Hopen St^^Rosebush^MI^48878^USA^P|^PRN^PH^^^989^3359208ORC|RE||BA20D16983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA20D16983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-114-02^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-114-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M18Y16991^^^AIRA-TEST^MR||PetersAIRA^CarynAIRA^Lotty^^^^L|GageAIRA^BrigitAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1842 Saasdriel Ln^^Sault S Marie^MI^49788^USA^P||^PRN^PH^^^906^5759632|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PetersAIRA^GageAIRA^^^^^L|MTH^Mother^HL70063|1842 Saasdriel Ln^^Sault S Marie^MI^49788^USA^P|^PRN^PH^^^906^5759632ORC|RE||BM18Y16991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM18Y16991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-114-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-115-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H67N16996^^^AIRA-TEST^MR||BeaverAIRA^KyrenaAIRA^Ronnie^^^^L|NobleAIRA^AwusiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1414 Vloeistof Ave^^Mount Morris^MI^48458^USA^P||^PRN^PH^^^810^3929415|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BeaverAIRA^NobleAIRA^^^^^L|MTH^Mother^HL70063|1414 Vloeistof Ave^^Mount Morris^MI^48458^USA^P|^PRN^PH^^^810^3929415ORC|RE||BH67N16996.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH67N16996.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-115-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-115-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P82U17007^^^AIRA-TEST^MR||ElliottAIRA^NathalieAIRA^Sophie^^^^L|AnderssonAIRA^AlbaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1320 Roggenland St^^Utica^MI^48318^USA^P||^PRN^PH^^^586^8056082|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ElliottAIRA^AnderssonAIRA^^^^^L|MTH^Mother^HL70063|1320 Roggenland St^^Utica^MI^48318^USA^P|^PRN^PH^^^586^8056082ORC|RE||BP82U17007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP82U17007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-115-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-116-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P28R17015^^^AIRA-TEST^MR||DaviessAIRA^VeenaAIRA^Keira^^^^L|WrightAIRA^AnnAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1440 Zopik Ln^^Frankenmuth^MI^48734^USA^P||^PRN^PH^^^989^5069551|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DaviessAIRA^WrightAIRA^^^^^L|MTH^Mother^HL70063|1440 Zopik Ln^^Frankenmuth^MI^48734^USA^P|^PRN^PH^^^989^5069551ORC|RE||BP28R17015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP28R17015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-116-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-116-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E89E17023^^^AIRA-TEST^MR||FranklinAIRA^GarnetAIRA^Akanksha^^^^L|WarrenAIRA^NovaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1450 Noststellingwerf Ln^^Farmingtn Hls^MI^48332^USA^P||^PRN^PH^^^248^5164673|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1450 Noststellingwerf Ln^^Farmingtn Hls^MI^48332^USA^P|^PRN^PH^^^248^5164673ORC|RE||BE89E17023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE89E17023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-116-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-116-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y49M17031^^^AIRA-TEST^MR||BrennanAIRA^CatalinaAIRA^Hallie^^^^L|TaylorAIRA^SebastianneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1122 Doetinchem Pl^^Lum^MI^48412^USA^P||^PRN^PH^^^810^2223420|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrennanAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1122 Doetinchem Pl^^Lum^MI^48412^USA^P|^PRN^PH^^^810^2223420ORC|RE||BY49M17031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY49M17031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-116-11^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-116-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P55U17039^^^AIRA-TEST^MR||JeffersonAIRA^KebiraAIRA^Vashti^^^^L|WashingtonAIRA^SidneyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1536 Venster Ln^^MI Metro^MI^48340^USA^P||^PRN^PH^^^248^6624986|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1536 Venster Ln^^MI Metro^MI^48340^USA^P|^PRN^PH^^^248^6624986ORC|RE||BP55U17039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP55U17039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-116-12^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-117-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V10O17047^^^AIRA-TEST^MR||ChippewaAIRA^TanujaAIRA^Mallika^^^^L|KnoxAIRA^BeatriceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1262 Hen Boer Ave^^Clinton Township^MI^48038^USA^P||^PRN^PH^^^586^7981125|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChippewaAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1262 Hen Boer Ave^^Clinton Township^MI^48038^USA^P|^PRN^PH^^^586^7981125ORC|RE||BV10O17047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV10O17047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-117-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I90P17052^^^AIRA-TEST^MR||ChickasawAIRA^HayleighAIRA^Kamala^^^^L|SylteAIRA^YonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1329 Toststellingwerf Pl^^Ameritech^MI^48663^USA^P||^PRN^PH^^^989^2686721|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChickasawAIRA^SylteAIRA^^^^^L|MTH^Mother^HL70063|1329 Toststellingwerf Pl^^Ameritech^MI^48663^USA^P|^PRN^PH^^^989^2686721ORC|RE||BI90P17052.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI90P17052.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-117-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-117-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I15K17063^^^AIRA-TEST^MR||PolkAIRA^ReeseAIRA^Eleanor^^^^L|OtoeAIRA^NaysaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1305 Boirle St^^Brunswick^MI^49425^USA^P||^PRN^PH^^^231^2459524|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PolkAIRA^OtoeAIRA^^^^^L|MTH^Mother^HL70063|1305 Boirle St^^Brunswick^MI^49425^USA^P|^PRN^PH^^^231^2459524ORC|RE||BI15K17063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI15K17063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-117-11^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-117-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y34H17071^^^AIRA-TEST^MR||BallAIRA^KirstenAIRA^Taryn^^^^L|PottawattamieAIRA^NaysaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1979 Bandgraaf Cir^^Iron Mountain^MI^49802^USA^P||^PRN^PH^^^906^6128531|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BallAIRA^PottawattamieAIRA^^^^^L|MTH^Mother^HL70063|1979 Bandgraaf Cir^^Iron Mountain^MI^49802^USA^P|^PRN^PH^^^906^6128531ORC|RE||BY34H17071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY34H17071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-117-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-118-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I03Y17079^^^AIRA-TEST^MR||ColonAIRA^SitaAIRA^Cora^^^^L|ClarksonAIRA^AlayahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1482 Leren St^^Bessemer^MI^49911^USA^P||^PRN^PH^^^906^7769317|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColonAIRA^ClarksonAIRA^^^^^L|MTH^Mother^HL70063|1482 Leren St^^Bessemer^MI^49911^USA^P|^PRN^PH^^^906^7769317ORC|RE||BI03Y17079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI03Y17079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-118-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-118-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A31O17087^^^AIRA-TEST^MR||WolfeAIRA^OliveAIRA^Akanksha^^^^L|WestmorelandAIRA^ZinniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1106 Judwest-Fryslan Ave^^Farmington^MI^48333^USA^P||^PRN^PH^^^248^5967147|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WolfeAIRA^WestmorelandAIRA^^^^^L|MTH^Mother^HL70063|1106 Judwest-Fryslan Ave^^Farmington^MI^48333^USA^P|^PRN^PH^^^248^5967147ORC|RE||BA31O17087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA31O17087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-118-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-118-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E02G17092^^^AIRA-TEST^MR||BonnerAIRA^GillianAIRA^Kelsey^^^^L|WashingtonAIRA^ArlyndaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1735 Zaaren Ln^^Minden City^MI^48456^USA^P||^PRN^PH^^^989^7840013|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BonnerAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1735 Zaaren Ln^^Minden City^MI^48456^USA^P|^PRN^PH^^^989^7840013ORC|RE||BE02G17092.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE02G17092.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-118-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-118-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D10H17103^^^AIRA-TEST^MR||BarrettAIRA^TanushiAIRA^Kiera^^^^L|HamiltonAIRA^MadeleineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1903 Dengelo Ave^^Glendora^MI^49107^USA^P||^PRN^PH^^^269^6904053|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarrettAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1903 Dengelo Ave^^Glendora^MI^49107^USA^P|^PRN^PH^^^269^6904053ORC|RE||BD10H17103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD10H17103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-118-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-200-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S49W17111^^^AIRA-TEST^MR||TriggAIRA^MelekAIRA^Manjusha^^^^L|UnionAIRA^AddysonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1220 Bereiken Cir^^Leland^MI^49654^USA^P||^PRN^PH^^^231^5621838|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TriggAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1220 Bereiken Cir^^Leland^MI^49654^USA^P|^PRN^PH^^^231^5621838ORC|RE||BS49W17111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS49W17111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-200-02^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521-200-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q22J17119^^^AIRA-TEST^MR||DanielsonAIRA^DavineAIRA^Emilia^^^^L|BrennanAIRA^VaIdaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1940 Aeudal Pl^^Michiana^MI^49117^USA^P||^PRN^PH^^^269^9691483|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DanielsonAIRA^BrennanAIRA^^^^^L|MTH^Mother^HL70063|1940 Aeudal Pl^^Michiana^MI^49117^USA^P|^PRN^PH^^^269^9691483ORC|RE||BQ22J17119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ22J17119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521-200-10^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521000001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W94O17127^^^AIRA-TEST^MR||NordholmAIRA^AlbaAIRA^Dayla^^^^L|JeromeAIRA^AlonzaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1227 Poosendaal Ave^^Farmington Hills^MI^48334^USA^P||^PRN^PH^^^248^4364400|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NordholmAIRA^JeromeAIRA^^^^^L|MTH^Mother^HL70063|1227 Poosendaal Ave^^Farmington Hills^MI^48334^USA^P|^PRN^PH^^^248^4364400ORC|RE||BW94O17127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW94O17127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521000001^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521000011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O69S17132^^^AIRA-TEST^MR||Keya PahaAIRA^FosettaAIRA^Mairin^^^^L|ChristensonAIRA^SubhadraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1194 Luid Cir^^Pullman^MI^49450^USA^P||^PRN^PH^^^269^7736748|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Keya PahaAIRA^ChristensonAIRA^^^^^L|MTH^Mother^HL70063|1194 Luid Cir^^Pullman^MI^49450^USA^P|^PRN^PH^^^269^7736748ORC|RE||BO69S17132.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO69S17132.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521000011^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011202|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F35A17143^^^AIRA-TEST^MR||ShortAIRA^RoseAIRA^Maata^^^^L|ShelbyAIRA^MiriamAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1955 Oongeradeel Ln^^Canton Township^MI^48187^USA^P||^PRN^PH^^^734^2347057|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShortAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1955 Oongeradeel Ln^^Canton Township^MI^48187^USA^P|^PRN^PH^^^734^2347057ORC|RE||BF35A17143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF35A17143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011202^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F52X17151^^^AIRA-TEST^MR||MalaAIRA^RawnieAIRA^Ananda^^^^L|JonesAIRA^FreydeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1527 Karlingen Pl^^Merriweather^MI^49947^USA^P||^PRN^PH^^^906^2714930|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MalaAIRA^JonesAIRA^^^^^L|MTH^Mother^HL70063|1527 Karlingen Pl^^Merriweather^MI^49947^USA^P|^PRN^PH^^^906^2714930ORC|RE||BF52X17151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF52X17151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011210^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N78D17159^^^AIRA-TEST^MR||HockingAIRA^NishaAIRA^Lyla^^^^L|TillamookAIRA^ColumbaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1927 Tint Anthonis Ave^^Port Huron^MI^48061^USA^P||^PRN^PH^^^810^9336029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HockingAIRA^TillamookAIRA^^^^^L|MTH^Mother^HL70063|1927 Tint Anthonis Ave^^Port Huron^MI^48061^USA^P|^PRN^PH^^^810^9336029ORC|RE||BN78D17159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN78D17159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011302^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W23Z17167^^^AIRA-TEST^MR||IversenAIRA^SerenaAIRA^Abbey^^^^L|HamiltonAIRA^HesperAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1690 Llissingen Ave^^Brighton^MI^48116^USA^P||^PRN^PH^^^810^9154233|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IversenAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1690 Llissingen Ave^^Brighton^MI^48116^USA^P|^PRN^PH^^^810^9154233ORC|RE||BW23Z17167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW23Z17167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011310^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z80D17175^^^AIRA-TEST^MR||LucasAIRA^BethanyAIRA^Veleda^^^^L|LibertyAIRA^MelekAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1890 Oederweert Ln^^Royal Oak Township^MI^48220^USA^P||^PRN^PH^^^248^9885029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LucasAIRA^LibertyAIRA^^^^^L|MTH^Mother^HL70063|1890 Oederweert Ln^^Royal Oak Township^MI^48220^USA^P|^PRN^PH^^^248^9885029ORC|RE||BZ80D17175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ80D17175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011402^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L53N17180^^^AIRA-TEST^MR||WashingtonAIRA^BethanyAIRA^Sheela^^^^L|SusasAIRA^TrilochanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1644 Scht-Susteren St^^Copper City^MI^49917^USA^P||^PRN^PH^^^906^8551806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^SusasAIRA^^^^^L|MTH^Mother^HL70063|1644 Scht-Susteren St^^Copper City^MI^49917^USA^P|^PRN^PH^^^906^8551806ORC|RE||BL53N17180.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL53N17180.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011410^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011502|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V37U17191^^^AIRA-TEST^MR||ClintonAIRA^AriannaAIRA^Emma^^^^L|UlsethAIRA^MayaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1053 Linkelland St^^Lansing^MI^48933^USA^P||^PRN^PH^^^517^5482583|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClintonAIRA^UlsethAIRA^^^^^L|MTH^Mother^HL70063|1053 Linkelland St^^Lansing^MI^48933^USA^P|^PRN^PH^^^517^5482583ORC|RE||BV37U17191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV37U17191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011502^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H37G17199^^^AIRA-TEST^MR||MohaveAIRA^BronwenAIRA^Pamela^^^^L|GrantAIRA^JonesyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1894 Aalfsen Cir^^Edwardsburg^MI^49130^USA^P||^PRN^PH^^^269^4476811|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MohaveAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1894 Aalfsen Cir^^Edwardsburg^MI^49130^USA^P|^PRN^PH^^^269^4476811ORC|RE||BH37G17199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH37G17199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011510^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M60A17207^^^AIRA-TEST^MR||NavarroAIRA^CharleighAIRA^Japera^^^^L|O'ConnellAIRA^KajolAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1068 Wensen Pl^^Clarklake^MI^49234^USA^P||^PRN^PH^^^517^3671057|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NavarroAIRA^O'ConnellAIRA^^^^^L|MTH^Mother^HL70063|1068 Wensen Pl^^Clarklake^MI^49234^USA^P|^PRN^PH^^^517^3671057ORC|RE||BM60A17207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM60A17207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011602^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T02B17215^^^AIRA-TEST^MR||CamasAIRA^MarleyAIRA^Hanan^^^^L|KrogAIRA^AnielaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1982 Woosendaal Cir^^North Manitou^MI^49654^USA^P||^PRN^PH^^^231^8582695|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CamasAIRA^KrogAIRA^^^^^L|MTH^Mother^HL70063|1982 Woosendaal Cir^^North Manitou^MI^49654^USA^P|^PRN^PH^^^231^8582695ORC|RE||BT02B17215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT02B17215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011610^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L71L17223^^^AIRA-TEST^MR||AntelopeAIRA^HortenseAIRA^Kayley^^^^L|ParmerAIRA^KelseyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1599 Eeuningen Ave^^GR^MI^49504^USA^P||^PRN^PH^^^616^8183707|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AntelopeAIRA^ParmerAIRA^^^^^L|MTH^Mother^HL70063|1599 Eeuningen Ave^^GR^MI^49504^USA^P|^PRN^PH^^^616^8183707ORC|RE||BL71L17223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL71L17223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011611^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011612|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L66L17228^^^AIRA-TEST^MR||PurolaAIRA^HathorAIRA^Dawa^^^^L|NemahaAIRA^FrederikaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1456 Uilburg Ave^^Barton City^MI^48705^USA^P||^PRN^PH^^^989^5219185|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PurolaAIRA^NemahaAIRA^^^^^L|MTH^Mother^HL70063|1456 Uilburg Ave^^Barton City^MI^48705^USA^P|^PRN^PH^^^989^5219185ORC|RE||BL66L17228.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL66L17228.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011612^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U98Z17239^^^AIRA-TEST^MR||JepsenAIRA^RoselleAIRA^Africa^^^^L|San JoaquinAIRA^ShaliniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1407 Sirschot Pl^^Pleasant Lake^MI^49272^USA^P||^PRN^PH^^^517^6404821|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JepsenAIRA^San JoaquinAIRA^^^^^L|MTH^Mother^HL70063|1407 Sirschot Pl^^Pleasant Lake^MI^49272^USA^P|^PRN^PH^^^517^6404821ORC|RE||BU98Z17239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU98Z17239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011702^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V30U17247^^^AIRA-TEST^MR||MultnomahAIRA^LylaAIRA^Edda^^^^L|CrosbieAIRA^DoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1779 Oesterveld Pl^^Chippewa Reg Correction Fac^MI^49784^USA^P||^PRN^PH^^^906^8883978|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MultnomahAIRA^CrosbieAIRA^^^^^L|MTH^Mother^HL70063|1779 Oesterveld Pl^^Chippewa Reg Correction Fac^MI^49784^USA^P|^PRN^PH^^^906^8883978ORC|RE||BV30U17247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV30U17247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011710^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011711|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E16F17255^^^AIRA-TEST^MR||RichardsonAIRA^CadenceAIRA^Radella^^^^L|GibbonsAIRA^GloraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1730 Tteenwijkerland Ave^^Mayfield^MI^49666^USA^P||^PRN^PH^^^231^9687754|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichardsonAIRA^GibbonsAIRA^^^^^L|MTH^Mother^HL70063|1730 Tteenwijkerland Ave^^Mayfield^MI^49666^USA^P|^PRN^PH^^^231^9687754ORC|RE||BE16F17255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE16F17255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011711^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011712|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H94M17263^^^AIRA-TEST^MR||ToddAIRA^AmishaAIRA^Kyoko^^^^L|ErikssonAIRA^MajondraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1524 Vesterveld Cir^^Borculo^MI^49464^USA^P||^PRN^PH^^^616^5790825|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ToddAIRA^ErikssonAIRA^^^^^L|MTH^Mother^HL70063|1524 Vesterveld Cir^^Borculo^MI^49464^USA^P|^PRN^PH^^^616^5790825ORC|RE||BH94M17263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH94M17263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011712^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011802|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z74M17271^^^AIRA-TEST^MR||DickAIRA^FannyAIRA^Autumn^^^^L|HarlanAIRA^ShakuntalaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1569 Groep Ave^^Northeast^MI^48509^USA^P||^PRN^PH^^^810^9756914|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickAIRA^HarlanAIRA^^^^^L|MTH^Mother^HL70063|1569 Groep Ave^^Northeast^MI^48509^USA^P|^PRN^PH^^^810^9756914ORC|RE||BZ74M17271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ74M17271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011802^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q71X17276^^^AIRA-TEST^MR||FitzpatrickAIRA^AmataAIRA^Sashi^^^^L|StonewallAIRA^PratimaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1580 Roermond Ln^^Mottville^MI^49099^USA^P||^PRN^PH^^^269^7596298|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FitzpatrickAIRA^StonewallAIRA^^^^^L|MTH^Mother^HL70063|1580 Roermond Ln^^Mottville^MI^49099^USA^P|^PRN^PH^^^269^7596298ORC|RE||BQ71X17276.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ71X17276.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011810^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J97E17287^^^AIRA-TEST^MR||McFernanAIRA^JewellAIRA^Hiroko^^^^L|LegresleyAIRA^RihanaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1574 Hoed Ln^^Walloon Lake^MI^49796^USA^P||^PRN^PH^^^231^8890478|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McFernanAIRA^LegresleyAIRA^^^^^L|MTH^Mother^HL70063|1574 Hoed Ln^^Walloon Lake^MI^49796^USA^P|^PRN^PH^^^231^8890478ORC|RE||BJ97E17287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ97E17287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011811^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521011812|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V64Y17295^^^AIRA-TEST^MR||WynneAIRA^OrioleAIRA^Piyali^^^^L|HowathAIRA^AmberAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1971 Schelp Pl^^Rockwood^MI^48173^USA^P||^PRN^PH^^^734^2330408|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WynneAIRA^HowathAIRA^^^^^L|MTH^Mother^HL70063|1971 Schelp Pl^^Rockwood^MI^48173^USA^P|^PRN^PH^^^734^2330408ORC|RE||BV64Y17295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV64Y17295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521011812^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521020002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A95V17303^^^AIRA-TEST^MR||AndersenAIRA^BryherAIRA^Juliet^^^^L|WaschingAIRA^MargoAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1467 Wekela Cir^^Gm Vehicle Development Center^MI^48557^USA^P||^PRN^PH^^^810^6139269|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AndersenAIRA^WaschingAIRA^^^^^L|MTH^Mother^HL70063|1467 Wekela Cir^^Gm Vehicle Development Center^MI^48557^USA^P|^PRN^PH^^^810^6139269ORC|RE||BA95V17303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA95V17303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521020002^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-66521020010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C15V17311^^^AIRA-TEST^MR||CastroAIRA^JeannetteAIRA^Teji^^^^L|LassenAIRA^AnkareedaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1381 Tudewater Cir^^Detroit^MI^48269^USA^P||^PRN^PH^^^313^9897992|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CastroAIRA^LassenAIRA^^^^^L|MTH^Mother^HL70063|1381 Tudewater Cir^^Detroit^MI^48269^USA^P|^PRN^PH^^^313^9897992ORC|RE||BC15V17311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC15V17311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||66521020010^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-69401-000-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E94X17319^^^AIRA-TEST^MR||WayneAIRA^AlmiraAIRA^Kora^^^^L|SheridanAIRA^AracelyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1643 Elagtwedde Cir^^West Bloomfield^MI^48323^USA^P||^PRN^PH^^^248^9167587|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WayneAIRA^SheridanAIRA^^^^^L|MTH^Mother^HL70063|1643 Elagtwedde Cir^^West Bloomfield^MI^48323^USA^P|^PRN^PH^^^248^9167587ORC|RE||BE94X17319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE94X17319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||69401-000-01^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-69401-000-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G96C17324^^^AIRA-TEST^MR||MaloneAIRA^IndrinaAIRA^Surabhi^^^^L|SilowAIRA^SylviaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1702 Leiderdorp Pl^^Brownstwn Township^MI^48134^USA^P||^PRN^PH^^^734^7132156|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MaloneAIRA^SilowAIRA^^^^^L|MTH^Mother^HL70063|1702 Leiderdorp Pl^^Brownstwn Township^MI^48134^USA^P|^PRN^PH^^^734^7132156ORC|RE||BG96C17324.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG96C17324.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||69401-000-02^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-69401000001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M90S17335^^^AIRA-TEST^MR||FranklinAIRA^JewellAIRA^Alankrita^^^^L|DahlAIRA^VandaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1843 Minuscuul Ln^^Rea^MI^48131^USA^P||^PRN^PH^^^734^7929170|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FranklinAIRA^DahlAIRA^^^^^L|MTH^Mother^HL70063|1843 Minuscuul Ln^^Rea^MI^48131^USA^P|^PRN^PH^^^734^7929170ORC|RE||BM90S17335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM90S17335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||69401000001^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-69401000002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V69X17343^^^AIRA-TEST^MR||ClareAIRA^DeeAIRA^Gayatri^^^^L|KingAIRA^SukutaiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1237 Valburg Ave^^Bloomfield Hills^MI^48304^USA^P||^PRN^PH^^^248^5733993|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClareAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1237 Valburg Ave^^Bloomfield Hills^MI^48304^USA^P|^PRN^PH^^^248^5733993ORC|RE||BV69X17343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV69X17343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||69401000002^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460-001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F72R17351^^^AIRA-TEST^MR||KayAIRA^SariahAIRA^Theresa^^^^L|SaloAIRA^DottyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1920 Htrecht Cir^^Constantine^MI^49042^USA^P||^PRN^PH^^^269^7374823|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KayAIRA^SaloAIRA^^^^^L|MTH^Mother^HL70063|1920 Htrecht Cir^^Constantine^MI^49042^USA^P|^PRN^PH^^^269^7374823ORC|RE||BF72R17351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF72R17351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70460-001-01^Vaxchora^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460-002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L32X17359^^^AIRA-TEST^MR||CorrinAIRA^CeliaAIRA^Ofilia^^^^L|ManisteeAIRA^LotteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1589 Me Wolden Ave^^Ash Township^MI^48117^USA^P||^PRN^PH^^^734^4667212|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CorrinAIRA^ManisteeAIRA^^^^^L|MTH^Mother^HL70063|1589 Me Wolden Ave^^Ash Township^MI^48117^USA^P|^PRN^PH^^^734^4667212ORC|RE||BL32X17359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL32X17359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70460-002-01^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460-002-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H32I17367^^^AIRA-TEST^MR||BenewahAIRA^KordeliaAIRA^Hanna^^^^L|ShermanAIRA^BonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1252 Oollands Kroon Ln^^Holland^MI^49424^USA^P||^PRN^PH^^^616^3957681|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BenewahAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1252 Oollands Kroon Ln^^Holland^MI^49424^USA^P|^PRN^PH^^^616^3957681ORC|RE||BH32I17367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH32I17367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70460-002-02^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460000101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P12W17375^^^AIRA-TEST^MR||KingsAIRA^KaylynnAIRA^Phyliss^^^^L|JacintoAIRA^EulaliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1269 Binsum Ln^^Cross Village^MI^49723^USA^P||^PRN^PH^^^616^2778549|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KingsAIRA^JacintoAIRA^^^^^L|MTH^Mother^HL70063|1269 Binsum Ln^^Cross Village^MI^49723^USA^P|^PRN^PH^^^616^2778549ORC|RE||BP12W17375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP12W17375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70460000101^Vaxchora^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460000201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T70X17380^^^AIRA-TEST^MR||GreenupAIRA^AmalaAIRA^Zalia^^^^L|VanceAIRA^MaximeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1831 Lontfoort St^^Cloverdale^MI^49035^USA^P||^PRN^PH^^^269^3028728|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenupAIRA^VanceAIRA^^^^^L|MTH^Mother^HL70063|1831 Lontfoort St^^Cloverdale^MI^49035^USA^P|^PRN^PH^^^269^3028728ORC|RE||BT70X17380.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT70X17380.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70460000201^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70460000202|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K23M17391^^^AIRA-TEST^MR||PerryAIRA^ShayleeAIRA^Ruchira^^^^L|CassAIRA^AvantiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1318 Koggenland Ave^^Fulton^MI^49052^USA^P||^PRN^PH^^^269^3484039|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PerryAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1318 Koggenland Ave^^Fulton^MI^49052^USA^P|^PRN^PH^^^269^3484039ORC|RE||BK23M17391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK23M17391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70460000202^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J33H17399^^^AIRA-TEST^MR||San DiegoAIRA^BelladonnaAIRA^Simran^^^^L|RogersAIRA^ShayAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1691 Dinsum Cir^^Norvell^MI^49263^USA^P||^PRN^PH^^^517^6706549|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San DiegoAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1691 Dinsum Cir^^Norvell^MI^49263^USA^P|^PRN^PH^^^517^6706549ORC|RE||BJ33H17399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ33H17399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-001-01^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-001-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J71Q17407^^^AIRA-TEST^MR||MickelAIRA^ColumbaAIRA^Saroja^^^^L|FoxAIRA^SirounAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1720 Lilvarenbeek St^^Edwardsburg^MI^49130^USA^P||^PRN^PH^^^269^9472767|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MickelAIRA^FoxAIRA^^^^^L|MTH^Mother^HL70063|1720 Lilvarenbeek St^^Edwardsburg^MI^49130^USA^P|^PRN^PH^^^269^9472767ORC|RE||BJ71Q17407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ71Q17407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-001-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E23T17415^^^AIRA-TEST^MR||CookeAIRA^BetteAIRA^Lyndel^^^^L|JanttiAIRA^YoginiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1443 Vuenen St^^Millbrook^MI^49310^USA^P||^PRN^PH^^^989^6388583|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CookeAIRA^JanttiAIRA^^^^^L|MTH^Mother^HL70063|1443 Vuenen St^^Millbrook^MI^49310^USA^P|^PRN^PH^^^989^6388583ORC|RE||BE23T17415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE23T17415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-002-01^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-002-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X23E17423^^^AIRA-TEST^MR||DixonAIRA^BirgittaAIRA^Majesta^^^^L|UpshurAIRA^KamrynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1697 Varneveld Ln^^Business Reply Mail^MI^49502^USA^P||^PRN^PH^^^616^6267963|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DixonAIRA^UpshurAIRA^^^^^L|MTH^Mother^HL70063|1697 Varneveld Ln^^Business Reply Mail^MI^49502^USA^P|^PRN^PH^^^616^6267963ORC|RE||BX23E17423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX23E17423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-002-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-018-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K39E17428^^^AIRA-TEST^MR||ClarksonAIRA^TrishnaAIRA^Savanah^^^^L|MonroeAIRA^YamiletAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1060 Calsmeer Pl^^Detroit^MI^48278^USA^P||^PRN^PH^^^313^2827719|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClarksonAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1060 Calsmeer Pl^^Detroit^MI^48278^USA^P|^PRN^PH^^^313^2827719ORC|RE||BK39E17428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK39E17428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-018-03^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-018-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q11C17439^^^AIRA-TEST^MR||ShoshoneAIRA^AmadisAIRA^Evadne^^^^L|PiscataquisAIRA^ZaneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1450 Geststellingwerf Ln^^Good Hart^MI^49737^USA^P||^PRN^PH^^^616^6458411|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShoshoneAIRA^PiscataquisAIRA^^^^^L|MTH^Mother^HL70063|1450 Geststellingwerf Ln^^Good Hart^MI^49737^USA^P|^PRN^PH^^^616^6458411ORC|RE||BQ11C17439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ11C17439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-018-04^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-119-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E79X17447^^^AIRA-TEST^MR||PasoAIRA^AquaAIRA^Mahina^^^^L|MarshallAIRA^DelfinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1218 Aankomen Ln^^Brownstown Township^MI^48134^USA^P||^PRN^PH^^^734^4699020|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PasoAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1218 Aankomen Ln^^Brownstown Township^MI^48134^USA^P|^PRN^PH^^^734^4699020ORC|RE||BE79X17447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE79X17447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-119-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-119-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q30R17455^^^AIRA-TEST^MR||SusasAIRA^DaraAIRA^Clematis^^^^L|OldhamAIRA^JulianaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1976 Kint-Michielsgestel Pl^^Rives Jct^MI^49277^USA^P||^PRN^PH^^^517^8970544|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SusasAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1976 Kint-Michielsgestel Pl^^Rives Jct^MI^49277^USA^P|^PRN^PH^^^517^8970544ORC|RE||BQ30R17455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ30R17455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-119-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-119-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L51E17463^^^AIRA-TEST^MR||WayrynenAIRA^AyianaAIRA^Reka^^^^L|McKinnonAIRA^CarriganAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1642 Soes Ave^^Grosse Pointe^MI^48224^USA^P||^PRN^PH^^^313^4747877|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WayrynenAIRA^McKinnonAIRA^^^^^L|MTH^Mother^HL70063|1642 Soes Ave^^Grosse Pointe^MI^48224^USA^P|^PRN^PH^^^313^4747877ORC|RE||BL51E17463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL51E17463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-119-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-119-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X41J17468^^^AIRA-TEST^MR||LehighAIRA^PerouzeAIRA^Adyson^^^^L|Palo AltoAIRA^LorelaiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1361 Aldebroek Cir^^Detroit^MI^48205^USA^P||^PRN^PH^^^313^5800111|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LehighAIRA^Palo AltoAIRA^^^^^L|MTH^Mother^HL70063|1361 Aldebroek Cir^^Detroit^MI^48205^USA^P|^PRN^PH^^^313^5800111ORC|RE||BX41J17468.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX41J17468.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-119-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-120-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F50A17479^^^AIRA-TEST^MR||PawneeAIRA^OderaAIRA^Akili^^^^L|MooreAIRA^RuthAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1770 Dint-Michielsgestel Pl^^Brethren^MI^49619^USA^P||^PRN^PH^^^231^5300537|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PawneeAIRA^MooreAIRA^^^^^L|MTH^Mother^HL70063|1770 Dint-Michielsgestel Pl^^Brethren^MI^49619^USA^P|^PRN^PH^^^231^5300537ORC|RE||BF50A17479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF50A17479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-120-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-120-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K03R17487^^^AIRA-TEST^MR||ButlerAIRA^KianaAIRA^Reena^^^^L|FranklinAIRA^EllaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1243 Ledemblik Ave^^Farmington Hills^MI^48331^USA^P||^PRN^PH^^^248^6885872|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButlerAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1243 Ledemblik Ave^^Farmington Hills^MI^48331^USA^P|^PRN^PH^^^248^6885872ORC|RE||BK03R17487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK03R17487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-120-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-120-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H69M17495^^^AIRA-TEST^MR||ButteAIRA^AerynAIRA^Ellin^^^^L|SilsethAIRA^CecilyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1819 Oeendam Ave^^Grand Ledge^MI^48837^USA^P||^PRN^PH^^^517^5071781|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButteAIRA^SilsethAIRA^^^^^L|MTH^Mother^HL70063|1819 Oeendam Ave^^Grand Ledge^MI^48837^USA^P|^PRN^PH^^^517^5071781ORC|RE||BH69M17495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH69M17495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-120-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-120-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P86J17503^^^AIRA-TEST^MR||MonroeAIRA^IvyAIRA^Batyah^^^^L|MohaveAIRA^LisaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1844 Tudwest-Fryslan Pl^^Sterling Heights^MI^48313^USA^P||^PRN^PH^^^586^5297308|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MonroeAIRA^MohaveAIRA^^^^^L|MTH^Mother^HL70063|1844 Tudwest-Fryslan Pl^^Sterling Heights^MI^48313^USA^P|^PRN^PH^^^586^5297308ORC|RE||BP86J17503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP86J17503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-120-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-200-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q65Q17508^^^AIRA-TEST^MR||TylerAIRA^AmissaAIRA^Alena^^^^L|AnderssonAIRA^SuchitraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1622 Ge Wolden Ln^^Eagle River^MI^49950^USA^P||^PRN^PH^^^906^5829480|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TylerAIRA^AnderssonAIRA^^^^^L|MTH^Mother^HL70063|1622 Ge Wolden Ln^^Eagle River^MI^49950^USA^P|^PRN^PH^^^906^5829480ORC|RE||BQ65Q17508.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ65Q17508.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-200-01^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-200-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F81Z17519^^^AIRA-TEST^MR||TehamaAIRA^RenukaAIRA^Lindsay^^^^L|WiseAIRA^LeonaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1419 Lutphen Ln^^South Manitou^MI^49654^USA^P||^PRN^PH^^^231^5799387|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TehamaAIRA^WiseAIRA^^^^^L|MTH^Mother^HL70063|1419 Lutphen Ln^^South Manitou^MI^49654^USA^P|^PRN^PH^^^231^5799387ORC|RE||BF81Z17519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF81Z17519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-200-02^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-200-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S98E17527^^^AIRA-TEST^MR||BarkerAIRA^FloramariaAIRA^Poonam^^^^L|WolfeAIRA^JarviniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1221 Kalderberge St^^Oakland Township^MI^48363^USA^P||^PRN^PH^^^248^6789328|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarkerAIRA^WolfeAIRA^^^^^L|MTH^Mother^HL70063|1221 Kalderberge St^^Oakland Township^MI^48363^USA^P|^PRN^PH^^^248^6789328ORC|RE||BS98E17527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS98E17527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-200-11^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-200-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F47C17535^^^AIRA-TEST^MR||GreenleeAIRA^EmersonAIRA^Aasia^^^^L|ThompsenAIRA^KrupaliAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1625 Aest Maas en Waal Ln^^Charlevoix^MI^49711^USA^P||^PRN^PH^^^231^2170305|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenleeAIRA^ThompsenAIRA^^^^^L|MTH^Mother^HL70063|1625 Aest Maas en Waal Ln^^Charlevoix^MI^49711^USA^P|^PRN^PH^^^231^2170305ORC|RE||BF47C17535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF47C17535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-200-12^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-201-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T98V17543^^^AIRA-TEST^MR||AlbrechtsonAIRA^JamieAIRA^Tama^^^^L|GraysonAIRA^AmyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1315 Zout Ln^^Grosse Pointe^MI^48236^USA^P||^PRN^PH^^^313^3325185|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AlbrechtsonAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1315 Zout Ln^^Grosse Pointe^MI^48236^USA^P|^PRN^PH^^^313^3325185ORC|RE||BT98V17543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT98V17543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-201-01^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-201-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N16A17548^^^AIRA-TEST^MR||FremmingAIRA^NardaAIRA^Valentina^^^^L|OttawaAIRA^MarleeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1090 Langzaam Ave^^Prattville^MI^49271^USA^P||^PRN^PH^^^517^8433674|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FremmingAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1090 Langzaam Ave^^Prattville^MI^49271^USA^P|^PRN^PH^^^517^8433674ORC|RE||BN16A17548.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN16A17548.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-201-11^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-301-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M59N17559^^^AIRA-TEST^MR||LycomingAIRA^BenildaAIRA^Emmanuelle^^^^L|LewisAIRA^ShantinaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1656 Hrimpenerwaard Cir^^Grand Rapids^MI^49508^USA^P||^PRN^PH^^^616^7441921|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LycomingAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1656 Hrimpenerwaard Cir^^Grand Rapids^MI^49508^USA^P|^PRN^PH^^^616^7441921ORC|RE||BM59N17559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM59N17559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-301-10^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-301-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E96B17567^^^AIRA-TEST^MR||CalhounAIRA^AthelaAIRA^Michal^^^^L|BakeyAIRA^RaymaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1159 Reertruidenberg St^^Taylor^MI^48180^USA^P||^PRN^PH^^^313^9832959|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CalhounAIRA^BakeyAIRA^^^^^L|MTH^Mother^HL70063|1159 Reertruidenberg St^^Taylor^MI^48180^USA^P|^PRN^PH^^^313^9832959ORC|RE||BE96B17567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE96B17567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-301-12^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-318-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S06Q17575^^^AIRA-TEST^MR||ClareAIRA^YareliAIRA^Gwenhyvar^^^^L|BonnevilleAIRA^LindonAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1415 Maals Pl^^Whittaker^MI^48190^USA^P||^PRN^PH^^^734^2766025|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClareAIRA^BonnevilleAIRA^^^^^L|MTH^Mother^HL70063|1415 Maals Pl^^Whittaker^MI^48190^USA^P|^PRN^PH^^^734^2766025ORC|RE||BS06Q17575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS06Q17575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-318-03^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-318-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S58F17583^^^AIRA-TEST^MR||YumaAIRA^OrsolaAIRA^Jiba^^^^L|OaklandAIRA^RudraniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1670 Mwenterand Pl^^Westland^MI^48186^USA^P||^PRN^PH^^^734^3733225|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YumaAIRA^OaklandAIRA^^^^^L|MTH^Mother^HL70063|1670 Mwenterand Pl^^Westland^MI^48186^USA^P|^PRN^PH^^^734^3733225ORC|RE||BS58F17583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS58F17583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-318-04^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H73U17591^^^AIRA-TEST^MR||FrioAIRA^NealaAIRA^Cherie^^^^L|WeilAIRA^MiahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1599 Synaarlo Ln^^Grand Marais^MI^49839^USA^P||^PRN^PH^^^906^2782672|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FrioAIRA^WeilAIRA^^^^^L|MTH^Mother^HL70063|1599 Synaarlo Ln^^Grand Marais^MI^49839^USA^P|^PRN^PH^^^906^2782672ORC|RE||BH73U17591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH73U17591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-418-10^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-418-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q45S17599^^^AIRA-TEST^MR||MickelAIRA^JosephineAIRA^Alzena^^^^L|LaneAIRA^MaliAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1797 Bopik Pl^^Midland^MI^48686^USA^P||^PRN^PH^^^989^6458846|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MickelAIRA^LaneAIRA^^^^^L|MTH^Mother^HL70063|1797 Bopik Pl^^Midland^MI^48686^USA^P|^PRN^PH^^^989^6458846ORC|RE||BQ45S17599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ45S17599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-418-11^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-614-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X21U17604^^^AIRA-TEST^MR||HubbardAIRA^JazlynnAIRA^Gizane^^^^L|WashingtonAIRA^DextraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1616 Zoggenland Ln^^Farmington^MI^48334^USA^P||^PRN^PH^^^248^9705912|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HubbardAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1616 Zoggenland Ln^^Farmington^MI^48334^USA^P|^PRN^PH^^^248^9705912ORC|RE||BX21U17604.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX21U17604.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-614-01^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461-614-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D92P17615^^^AIRA-TEST^MR||LewisAIRA^AliaAIRA^Judy^^^^L|NordholmAIRA^SheenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1889 Sorendijk Ave^^Ottawa Lake^MI^49267^USA^P||^PRN^PH^^^734^7728047|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LewisAIRA^NordholmAIRA^^^^^L|MTH^Mother^HL70063|1889 Sorendijk Ave^^Ottawa Lake^MI^49267^USA^P|^PRN^PH^^^734^7728047ORC|RE||BD92P17615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD92P17615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461-614-11^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461000101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C30R17623^^^AIRA-TEST^MR||HardingAIRA^MarvelaAIRA^Zita^^^^L|FranklinAIRA^MaximeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1421 Heeuwarden Cir^^Sunfield^MI^48890^USA^P||^PRN^PH^^^517^7394426|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HardingAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1421 Heeuwarden Cir^^Sunfield^MI^48890^USA^P|^PRN^PH^^^517^7394426ORC|RE||BC30R17623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC30R17623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461000101^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461000111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S33K17631^^^AIRA-TEST^MR||MorrinAIRA^KamrynAIRA^Vera^^^^L|IsaksonAIRA^MercedesAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1216 Bsten Cir^^Amway Corp^MI^49357^USA^P||^PRN^PH^^^616^7795696|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorrinAIRA^IsaksonAIRA^^^^^L|MTH^Mother^HL70063|1216 Bsten Cir^^Amway Corp^MI^49357^USA^P|^PRN^PH^^^616^7795696ORC|RE||BS33K17631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS33K17631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461000111^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461000201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G76T17639^^^AIRA-TEST^MR||LeknesAIRA^DelfinaAIRA^Orissa^^^^L|SchuylkillAIRA^ZoeAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1122 Dijnacker-Nootdorp Cir^^Crystal^MI^48818^USA^P||^PRN^PH^^^989^5636144|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LeknesAIRA^SchuylkillAIRA^^^^^L|MTH^Mother^HL70063|1122 Dijnacker-Nootdorp Cir^^Crystal^MI^48818^USA^P|^PRN^PH^^^989^5636144ORC|RE||BG76T17639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG76T17639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461000201^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461000211|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O22N17644^^^AIRA-TEST^MR||ClarksonAIRA^SadieAIRA^Ekala^^^^L|GibbonsAIRA^AccaliaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1428 Rustig Ln^^Hagar Shores^MI^49039^USA^P||^PRN^PH^^^269^4114677|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClarksonAIRA^GibbonsAIRA^^^^^L|MTH^Mother^HL70063|1428 Rustig Ln^^Hagar Shores^MI^49039^USA^P|^PRN^PH^^^269^4114677ORC|RE||BO22N17644.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO22N17644.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461000211^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461001803|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O24I17655^^^AIRA-TEST^MR||WashitaAIRA^LlvAIRA^Eliora^^^^L|HarneyAIRA^MellissaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1389 Vrnhem Cir^^Caledonia^MI^49316^USA^P||^PRN^PH^^^616^4310564|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashitaAIRA^HarneyAIRA^^^^^L|MTH^Mother^HL70063|1389 Vrnhem Cir^^Caledonia^MI^49316^USA^P|^PRN^PH^^^616^4310564ORC|RE||BO24I17655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO24I17655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461001803^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461001804|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B01Q17663^^^AIRA-TEST^MR||McCullochAIRA^BriellaAIRA^Rosaline^^^^L|KnoxAIRA^OkalaniAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1822 Euijk Cir^^Maybee^MI^48159^USA^P||^PRN^PH^^^734^2657258|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCullochAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1822 Euijk Cir^^Maybee^MI^48159^USA^P|^PRN^PH^^^734^2657258ORC|RE||BB01Q17663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB01Q17663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461001804^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461011902|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A13W17671^^^AIRA-TEST^MR||GabrielsenAIRA^SusiAIRA^Idola^^^^L|AlexanderAIRA^DaisyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1113 Caals Pl^^Westwood^MI^49009^USA^P||^PRN^PH^^^269^6998857|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GabrielsenAIRA^AlexanderAIRA^^^^^L|MTH^Mother^HL70063|1113 Caals Pl^^Westwood^MI^49009^USA^P|^PRN^PH^^^269^6998857ORC|RE||BA13W17671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA13W17671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461011902^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461011910|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H88U17679^^^AIRA-TEST^MR||MorrinAIRA^BlinnAIRA^Amadora^^^^L|CummingsAIRA^JanthineAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1597 Trummen St^^Southfield^MI^48086^USA^P||^PRN^PH^^^248^3769552|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorrinAIRA^CummingsAIRA^^^^^L|MTH^Mother^HL70063|1597 Trummen St^^Southfield^MI^48086^USA^P|^PRN^PH^^^248^3769552ORC|RE||BH88U17679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH88U17679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461011910^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461011911|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P25S17687^^^AIRA-TEST^MR||CottonAIRA^GotzoneAIRA^Jazmin^^^^L|CowleAIRA^VonnyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1078 Se Wolden St^^Detroit^MI^48205^USA^P||^PRN^PH^^^313^2724312|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CottonAIRA^CowleAIRA^^^^^L|MTH^Mother^HL70063|1078 Se Wolden St^^Detroit^MI^48205^USA^P|^PRN^PH^^^313^2724312ORC|RE||BP25S17687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP25S17687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461011911^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461011912|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P67Y17695^^^AIRA-TEST^MR||AdsgaardAIRA^ShevaunAIRA^Saraid^^^^L|GarfieldAIRA^LolaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1745 Serneuzen St^^Keweenaw Bay^MI^49908^USA^P||^PRN^PH^^^906^3821832|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AdsgaardAIRA^GarfieldAIRA^^^^^L|MTH^Mother^HL70063|1745 Serneuzen St^^Keweenaw Bay^MI^49908^USA^P|^PRN^PH^^^906^3821832ORC|RE||BP67Y17695.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP67Y17695.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461011912^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461012002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z02B17700^^^AIRA-TEST^MR||ChelanAIRA^StormAIRA^Fidela^^^^L|CanadianAIRA^UshaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1344 Lellingwedde St^^Livonia^MI^48153^USA^P||^PRN^PH^^^734^3247372|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChelanAIRA^CanadianAIRA^^^^^L|MTH^Mother^HL70063|1344 Lellingwedde St^^Livonia^MI^48153^USA^P|^PRN^PH^^^734^3247372ORC|RE||BZ02B17700.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ02B17700.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461012002^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461012010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K30Q17711^^^AIRA-TEST^MR||RichardsonAIRA^KamalaAIRA^Temira^^^^L|RobertsAIRA^AnsleyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1286 Vinkelland Ave^^Gilford^MI^48736^USA^P||^PRN^PH^^^989^4802990|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichardsonAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1286 Vinkelland Ave^^Gilford^MI^48736^USA^P|^PRN^PH^^^989^4802990ORC|RE||BK30Q17711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK30Q17711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461012010^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461012011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W92K17719^^^AIRA-TEST^MR||KaufmanAIRA^TawnieAIRA^Tryne^^^^L|CroweAIRA^CelesteAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1430 Hchagen Pl^^Newport^MI^48166^USA^P||^PRN^PH^^^734^7004171|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KaufmanAIRA^CroweAIRA^^^^^L|MTH^Mother^HL70063|1430 Hchagen Pl^^Newport^MI^48166^USA^P|^PRN^PH^^^734^7004171ORC|RE||BW92K17719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW92K17719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461012011^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461012012|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z27K17727^^^AIRA-TEST^MR||SterlingAIRA^ImaAIRA^Reka^^^^L|TrumbullAIRA^WasimaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1181 Demsmond Pl^^Houghton^MI^49931^USA^P||^PRN^PH^^^906^2009195|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SterlingAIRA^TrumbullAIRA^^^^^L|MTH^Mother^HL70063|1181 Demsmond Pl^^Houghton^MI^49931^USA^P|^PRN^PH^^^906^2009195ORC|RE||BZ27K17727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ27K17727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461012012^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461020001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E49M17735^^^AIRA-TEST^MR||CoosAIRA^RayelleAIRA^Halima^^^^L|PacificAIRA^ClianthaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1441 Flat Cir^^Pointe Aux Barques^MI^48467^USA^P||^PRN^PH^^^989^2977756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoosAIRA^PacificAIRA^^^^^L|MTH^Mother^HL70063|1441 Flat Cir^^Pointe Aux Barques^MI^48467^USA^P|^PRN^PH^^^989^2977756ORC|RE||BE49M17735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE49M17735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461020001^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461020002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N98K17740^^^AIRA-TEST^MR||MontgomeryAIRA^SelenaAIRA^Stacy^^^^L|LucasAIRA^PythiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1970 Wude IJsselstreek St^^Amway Corp^MI^49355^USA^P||^PRN^PH^^^616^2142928|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontgomeryAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1970 Wude IJsselstreek St^^Amway Corp^MI^49355^USA^P|^PRN^PH^^^616^2142928ORC|RE||BN98K17740.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN98K17740.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461020002^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461020011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L79J17751^^^AIRA-TEST^MR||StoryAIRA^EbereAIRA^Kalare^^^^L|HendersonAIRA^EndaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1760 Koogeveen Pl^^Hersey^MI^49639^USA^P||^PRN^PH^^^231^3634736|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StoryAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1760 Koogeveen Pl^^Hersey^MI^49639^USA^P|^PRN^PH^^^231^3634736ORC|RE||BL79J17751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL79J17751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461020011^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461020012|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O85F17759^^^AIRA-TEST^MR||IslandAIRA^AncillaAIRA^Kavindra^^^^L|ShiawasseeAIRA^PranatiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1460 Te Wolden Pl^^Southfield^MI^48034^USA^P||^PRN^PH^^^248^9266653|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IslandAIRA^ShiawasseeAIRA^^^^^L|MTH^Mother^HL70063|1460 Te Wolden Pl^^Southfield^MI^48034^USA^P|^PRN^PH^^^248^9266653ORC|RE||BO85F17759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO85F17759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461020012^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461020101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L31Z17767^^^AIRA-TEST^MR||LorainAIRA^SrishtiAIRA^Lida^^^^L|UnionAIRA^SanyogitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1758 Miss Ln^^Mott Park^MI^48504^USA^P||^PRN^PH^^^810^3237134|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LorainAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1758 Miss Ln^^Mott Park^MI^48504^USA^P|^PRN^PH^^^810^3237134ORC|RE||BL31Z17767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL31Z17767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461020101^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461020111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F39Z17775^^^AIRA-TEST^MR||WheelerAIRA^AlcinaAIRA^Mara^^^^L|MooreAIRA^QuenbyAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1172 Geluidsoverlast Pl^^Flat Rock^MI^48134^USA^P||^PRN^PH^^^734^2787508|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WheelerAIRA^MooreAIRA^^^^^L|MTH^Mother^HL70063|1172 Geluidsoverlast Pl^^Flat Rock^MI^48134^USA^P|^PRN^PH^^^734^2787508ORC|RE||BF39Z17775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF39Z17775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461020111^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461030110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C35F17783^^^AIRA-TEST^MR||RogersAIRA^AddisynAIRA^Aiyana^^^^L|WatersAIRA^LaviniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1716 Sestervoort Ave^^Detroit^MI^48205^USA^P||^PRN^PH^^^313^4417379|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RogersAIRA^WatersAIRA^^^^^L|MTH^Mother^HL70063|1716 Sestervoort Ave^^Detroit^MI^48205^USA^P|^PRN^PH^^^313^4417379ORC|RE||BC35F17783.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC35F17783.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461030110^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461030112|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A84P17791^^^AIRA-TEST^MR||GrundyAIRA^PearlieAIRA^Lilia^^^^L|HopkinsAIRA^ShobhaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1378 Audwest-Fryslan St^^Hickory Isle^MI^48138^USA^P||^PRN^PH^^^734^9201692|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrundyAIRA^HopkinsAIRA^^^^^L|MTH^Mother^HL70063|1378 Audwest-Fryslan St^^Hickory Isle^MI^48138^USA^P|^PRN^PH^^^734^9201692ORC|RE||BA84P17791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA84P17791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461030112^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461031803|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E07J17796^^^AIRA-TEST^MR||McQuadeAIRA^ArnaldaAIRA^Audriana^^^^L|LawrenceAIRA^LailieAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1580 Zwartewaterland Pl^^Elk Rapids^MI^49629^USA^P||^PRN^PH^^^231^8952902|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McQuadeAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1580 Zwartewaterland Pl^^Elk Rapids^MI^49629^USA^P|^PRN^PH^^^231^8952902ORC|RE||BE07J17796.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE07J17796.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461031803^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461031804|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B81G17807^^^AIRA-TEST^MR||PayneAIRA^KleaAIRA^Mine^^^^L|SusquehannaAIRA^LindaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1511 Taarle-Nassau Cir^^Berrien Sprgs^MI^49103^USA^P||^PRN^PH^^^269^9569139|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PayneAIRA^SusquehannaAIRA^^^^^L|MTH^Mother^HL70063|1511 Taarle-Nassau Cir^^Berrien Sprgs^MI^49103^USA^P|^PRN^PH^^^269^9569139ORC|RE||BB81G17807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB81G17807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461031804^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461041810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B59J17815^^^AIRA-TEST^MR||AslsenAIRA^AmorinaAIRA^Hinda^^^^L|MorrosAIRA^ShiraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1611 Gelijkaardige Ln^^Michigamme^MI^49861^USA^P||^PRN^PH^^^906^3525220|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AslsenAIRA^MorrosAIRA^^^^^L|MTH^Mother^HL70063|1611 Gelijkaardige Ln^^Michigamme^MI^49861^USA^P|^PRN^PH^^^906^3525220ORC|RE||BB59J17815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB59J17815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461041810^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461041811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R68N17823^^^AIRA-TEST^MR||IsdalAIRA^ThisbeAIRA^Lucy^^^^L|KentAIRA^SalomaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1471 Bcheemda Cir^^Hamilton^MI^49419^USA^P||^PRN^PH^^^269^2433817|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IsdalAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1471 Bcheemda Cir^^Hamilton^MI^49419^USA^P|^PRN^PH^^^269^2433817ORC|RE||BR68N17823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR68N17823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461041811^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461061401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V00W17831^^^AIRA-TEST^MR||TerrellAIRA^MalikaAIRA^Natasha^^^^L|MeeAIRA^AdrienneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1746 Wchouwen-Duiveland Ln^^Houghton Lake^MI^48629^USA^P||^PRN^PH^^^989^4867081|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TerrellAIRA^MeeAIRA^^^^^L|MTH^Mother^HL70063|1746 Wchouwen-Duiveland Ln^^Houghton Lake^MI^48629^USA^P|^PRN^PH^^^989^4867081ORC|RE||BV00W17831.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV00W17831.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461061401^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-70461061411|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S78W17836^^^AIRA-TEST^MR||MeigsAIRA^CybeleAIRA^Geranium^^^^L|OtterstromAIRA^SushmitaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1328 Rinterswijk Cir^^Big Bay^MI^49808^USA^P||^PRN^PH^^^906^3903908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MeigsAIRA^OtterstromAIRA^^^^^L|MTH^Mother^HL70063|1328 Rinterswijk Cir^^Big Bay^MI^49808^USA^P|^PRN^PH^^^906^3903908ORC|RE||BS78W17836.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS78W17836.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||70461061411^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420-470-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G05O17847^^^AIRA-TEST^MR||KlickitatAIRA^ToriAIRA^Danica^^^^L|ClintonAIRA^ShulamitAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1816 Wpe Pl^^Elsie^MI^48831^USA^P||^PRN^PH^^^989^4134423|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KlickitatAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1816 Wpe Pl^^Elsie^MI^48831^USA^P|^PRN^PH^^^989^4134423ORC|RE||BG05O17847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG05O17847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||76420-470-10^Physicians EZ Use Flu Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420-471-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F72E17855^^^AIRA-TEST^MR||BorthroydAIRA^MorgandyAIRA^Kanushi^^^^L|McClungAIRA^ToniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1415 Dilburg St^^Selfridge Angb^MI^48045^USA^P||^PRN^PH^^^586^8983433|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BorthroydAIRA^McClungAIRA^^^^^L|MTH^Mother^HL70063|1415 Dilburg St^^Selfridge Angb^MI^48045^USA^P|^PRN^PH^^^586^8983433ORC|RE||BF72E17855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF72E17855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||76420-471-01^Medical Provider Single Use EZ Flu Shot Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420-482-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W20A17863^^^AIRA-TEST^MR||JonesAIRA^KaniyaAIRA^Fala^^^^L|BurkeAIRA^LorrettaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1899 Dulst Cir^^Detroit^MI^48268^USA^P||^PRN^PH^^^313^8833355|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JonesAIRA^BurkeAIRA^^^^^L|MTH^Mother^HL70063|1899 Dulst Cir^^Detroit^MI^48268^USA^P|^PRN^PH^^^313^8833355ORC|RE||BW20A17863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW20A17863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||76420-482-01^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420-483-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O27W17871^^^AIRA-TEST^MR||HutchinsonAIRA^EvelynAIRA^Jaya^^^^L|HarneyAIRA^MandaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1293 Larum Cir^^Conklin^MI^49403^USA^P||^PRN^PH^^^616^7844913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HutchinsonAIRA^HarneyAIRA^^^^^L|MTH^Mother^HL70063|1293 Larum Cir^^Conklin^MI^49403^USA^P|^PRN^PH^^^616^7844913ORC|RE||BO27W17871.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO27W17871.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||76420-483-01^Medical Provider Single Use EZ Flu Shot 2013-2014^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420047010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T82Z17879^^^AIRA-TEST^MR||SundeAIRA^SoledadAIRA^Marisol^^^^L|HarrisonAIRA^SonyaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1200 Succes St^^Cedarville^MI^49719^USA^P||^PRN^PH^^^906^3862689|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SundeAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1200 Succes St^^Cedarville^MI^49719^USA^P|^PRN^PH^^^906^3862689ORC|RE||BT82Z17879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT82Z17879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||76420047010^Physicians EZ Use Flu Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420047101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K12Q17884^^^AIRA-TEST^MR||LevyAIRA^VanessaAIRA^Alinga^^^^L|CheyenneAIRA^MiriyanAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1289 Ae Bilt Cir^^Amway Corp^MI^49355^USA^P||^PRN^PH^^^616^5456660|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LevyAIRA^CheyenneAIRA^^^^^L|MTH^Mother^HL70063|1289 Ae Bilt Cir^^Amway Corp^MI^49355^USA^P|^PRN^PH^^^616^5456660ORC|RE||BK12Q17884.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK12Q17884.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||76420047101^Medical Provider Single Use EZ Flu Shot Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420048201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W71U17895^^^AIRA-TEST^MR||PeskenAIRA^MalvaAIRA^Artemisia^^^^L|OlsenAIRA^KaiaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1824 Lolenwaard Cir^^Dearborn Heights^MI^48125^USA^P||^PRN^PH^^^313^4012678|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PeskenAIRA^OlsenAIRA^^^^^L|MTH^Mother^HL70063|1824 Lolenwaard Cir^^Dearborn Heights^MI^48125^USA^P|^PRN^PH^^^313^4012678ORC|RE||BW71U17895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW71U17895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||76420048201^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-NDC-76420048301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J31M17903^^^AIRA-TEST^MR||OtsegoAIRA^BraelynnAIRA^Kebira^^^^L|CreekAIRA^HaraldaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1882 Lijst St^^Freeland^MI^48623^USA^P||^PRN^PH^^^989^2547227|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OtsegoAIRA^CreekAIRA^^^^^L|MTH^Mother^HL70063|1882 Lijst St^^Freeland^MI^48623^USA^P|^PRN^PH^^^989^2547227ORC|RE||BJ31M17903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ31M17903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||76420048301^Medical Provider Single Use EZ Flu Shot 2013-2014^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-MIA04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S19Z17911^^^AIRA-TEST^MR||CarsonAIRA^PatienceAIRA^Gizane^^^^L|PerryAIRA^OhannaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1065 Bittenseradeel Ln^^Orleans^MI^48865^USA^P||^PRN^PH^^^616^9621196|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarsonAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1065 Bittenseradeel Ln^^Orleans^MI^48865^USA^P|^PRN^PH^^^616^9621196ORC|RE||BS19Z17911.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS19Z17911.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA04^Public vaccine - MI-VRP (Michigan Vaccine Replacement Program)^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-MIA05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K98K17919^^^AIRA-TEST^MR||TereAIRA^LatifaAIRA^Deepti^^^^L|RaumaAIRA^LatishaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1622 Kaarlemmermeer Pl^^Iron Mountain^MI^49801^USA^P||^PRN^PH^^^906^7396438|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TereAIRA^RaumaAIRA^^^^^L|MTH^Mother^HL70063|1622 Kaarlemmermeer Pl^^Iron Mountain^MI^49801^USA^P|^PRN^PH^^^906^7396438ORC|RE||BK98K17919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK98K17919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA05^Medicare (parts A, B and D)^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-MIA08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G91K17924^^^AIRA-TEST^MR||WilliamsAIRA^LylaAIRA^Fantine^^^^L|LoganAIRA^JimenaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1886 Teek Pl^^Dearborn^MI^48126^USA^P||^PRN^PH^^^313^4034597|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilliamsAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1886 Teek Pl^^Dearborn^MI^48126^USA^P|^PRN^PH^^^313^4034597ORC|RE||BG91K17924.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG91K17924.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA08^Private Stock Vaccine -Other Public Purchase^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-MIA10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H70D17932^^^AIRA-TEST^MR||BentonAIRA^BayleeAIRA^Nairne^^^^L|WilliamsAIRA^ArlyndaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1907 Insecten Ln^^Onondaga^MI^49264^USA^P||^PRN^PH^^^517^6804928|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BentonAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1907 Insecten Ln^^Onondaga^MI^49264^USA^P|^PRN^PH^^^517^6804928ORC|RE||BH70D17932.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH70D17932.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA10^All Hazard eligible -Public Purchase^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-MIA14|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N19F17943^^^AIRA-TEST^MR||TravisAIRA^KhloeAIRA^Arva^^^^L|WoldAIRA^JocundaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1742 Lulst Ave^^Wolverine^MI^49799^USA^P||^PRN^PH^^^231^9844953|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TravisAIRA^WoldAIRA^^^^^L|MTH^Mother^HL70063|1742 Lulst Ave^^Wolverine^MI^49799^USA^P|^PRN^PH^^^231^9844953ORC|RE||BN19F17943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN19F17943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA14^Medicaid-Non VFC^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-OR01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P57W17951^^^AIRA-TEST^MR||RunnelsAIRA^VenetiaAIRA^Mariyah^^^^L|JacksonAIRA^AlakeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1024 Lenlo Ave^^Detroit^MI^48218^USA^P||^PRN^PH^^^313^5234456|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RunnelsAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1024 Lenlo Ave^^Detroit^MI^48218^USA^P|^PRN^PH^^^313^5234456ORC|RE||BP57W17951.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP57W17951.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|OR01^S - Special Projects^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B74X17959^^^AIRA-TEST^MR||BenewahAIRA^JoelleAIRA^Deiene^^^^L|GuthrieAIRA^PetuniaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1455 Olagtwedde Ave^^Wheeler^MI^48662^USA^P||^PRN^PH^^^989^5670545|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BenewahAIRA^GuthrieAIRA^^^^^L|MTH^Mother^HL70063|1455 Olagtwedde Ave^^Wheeler^MI^48662^USA^P|^PRN^PH^^^989^5670545ORC|RE||BB74X17959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB74X17959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V00^VFC eligibility unknown^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B99D17967^^^AIRA-TEST^MR||HayesAIRA^AryanaAIRA^Adelina^^^^L|PetersenAIRA^LemanaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1012 Aevenaar Ave^^Saginaw^MI^48608^USA^P||^PRN^PH^^^989^4117573|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HayesAIRA^PetersenAIRA^^^^^L|MTH^Mother^HL70063|1012 Aevenaar Ave^^Saginaw^MI^48608^USA^P|^PRN^PH^^^989^4117573ORC|RE||BB99D17967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB99D17967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H80D17975^^^AIRA-TEST^MR||AntelopeAIRA^JoannaAIRA^Cheyanne^^^^L|HaagenAIRA^SumeyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1621 Terkrade Ave^^Grand Rapids^MI^49548^USA^P||^PRN^PH^^^616^5421414|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AntelopeAIRA^HaagenAIRA^^^^^L|MTH^Mother^HL70063|1621 Terkrade Ave^^Grand Rapids^MI^49548^USA^P|^PRN^PH^^^616^5421414ORC|RE||BH80D17975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH80D17975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible-Medicaid/Medicaid managed care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X25B17980^^^AIRA-TEST^MR||RogersAIRA^PankhudiAIRA^Ashlynn^^^^L|PetersonAIRA^NorahAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1368 Daalre St^^Tower^MI^49792^USA^P||^PRN^PH^^^989^5120492|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RogersAIRA^PetersonAIRA^^^^^L|MTH^Mother^HL70063|1368 Daalre St^^Tower^MI^49792^USA^P|^PRN^PH^^^989^5120492ORC|RE||BX25B17980.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX25B17980.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible-Uninsured^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R33I17991^^^AIRA-TEST^MR||OatesAIRA^GisselleAIRA^Sanako^^^^L|MarshallAIRA^TemaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1038 Tint Anthonis Ln^^Kinross^MI^49752^USA^P||^PRN^PH^^^906^4030749|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OatesAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1038 Tint Anthonis Ln^^Kinross^MI^49752^USA^P|^PRN^PH^^^906^4030749ORC|RE||BR33I17991.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR33I17991.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible- American Indian/Alaskan Native^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B62E17999^^^AIRA-TEST^MR||WebsterAIRA^MaximeAIRA^Diane^^^^L|MasonAIRA^MinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1689 Den Haag Pl^^Silver Lake^MI^49436^USA^P||^PRN^PH^^^231^2111254|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WebsterAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1689 Den Haag Pl^^Silver Lake^MI^49436^USA^P|^PRN^PH^^^231^2111254ORC|RE||BB62E17999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB62E17999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible-Federally Qualified Health Center Patient^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M83M18007^^^AIRA-TEST^MR||MasonAIRA^DitaAIRA^Ione^^^^L|SilsethAIRA^KeyannaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1456 Naam Pl^^Detroit^MI^48231^USA^P||^PRN^PH^^^313^3206022|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MasonAIRA^SilsethAIRA^^^^^L|MTH^Mother^HL70063|1456 Naam Pl^^Detroit^MI^48231^USA^P|^PRN^PH^^^313^3206022ORC|RE||BM83M18007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM83M18007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V06^VFC eligible- State specific eligibility (e.g. S-CHIP plan)^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H55Y18015^^^AIRA-TEST^MR||BranchAIRA^SonyaAIRA^Caitlin^^^^L|StonewallAIRA^BeliciaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1136 Oampen Pl^^Ontonagon^MI^49953^USA^P||^PRN^PH^^^906^4017112|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BranchAIRA^StonewallAIRA^^^^^L|MTH^Mother^HL70063|1136 Oampen Pl^^Ontonagon^MI^49953^USA^P|^PRN^PH^^^906^4017112ORC|RE||BH55Y18015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH55Y18015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V07^VFC eligibility- Local-specific eligibility^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L84W18023^^^AIRA-TEST^MR||NapaAIRA^JadaAIRA^Canace^^^^L|IsdalAIRA^BatyahAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1467 Echouwen-Duiveland Pl^^Orion^MI^48359^USA^P||^PRN^PH^^^248^4580727|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NapaAIRA^IsdalAIRA^^^^^L|MTH^Mother^HL70063|1467 Echouwen-Duiveland Pl^^Orion^MI^48359^USA^P|^PRN^PH^^^248^4580727ORC|RE||BL84W18023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL84W18023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V08^Not VFC eligible-Under-insured^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V22|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D43B18028^^^AIRA-TEST^MR||McClainAIRA^GiovannaAIRA^Jayleen^^^^L|LyonAIRA^HelvetiaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1880 We Bilt Ln^^Detroit^MI^48215^USA^P||^PRN^PH^^^313^5191860|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McClainAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1880 We Bilt Ln^^Detroit^MI^48215^USA^P|^PRN^PH^^^313^5191860ORC|RE||BD43B18028.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD43B18028.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V22^CHIP^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V23|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D05Y18039^^^AIRA-TEST^MR||CarrollAIRA^AveryAIRA^Harmony^^^^L|BakeyAIRA^RenukaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1032 Breed St^^Athens^MI^49011^USA^P||^PRN^PH^^^269^7516383|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarrollAIRA^BakeyAIRA^^^^^L|MTH^Mother^HL70063|1032 Breed St^^Athens^MI^49011^USA^P|^PRN^PH^^^269^7516383ORC|RE||BD05Y18039.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD05Y18039.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V23^317^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V24|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z56O18047^^^AIRA-TEST^MR||HeffordAIRA^LeanneAIRA^Gregoria^^^^L|KeokukAIRA^JagratiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1107 Lopen Ln^^Bath^MI^48808^USA^P||^PRN^PH^^^517^8916046|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HeffordAIRA^KeokukAIRA^^^^^L|MTH^Mother^HL70063|1107 Lopen Ln^^Bath^MI^48808^USA^P|^PRN^PH^^^517^8916046ORC|RE||BZ56O18047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ56O18047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V24^Medicare^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-VFC-V25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F38A18055^^^AIRA-TEST^MR||HarlanAIRA^EvelynnAIRA^Perlina^^^^L|YavapaiAIRA^RuchiraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1887 Schijndel Pl^^Long Lake^MI^48743^USA^P||^PRN^PH^^^989^2712441|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarlanAIRA^YavapaiAIRA^^^^^L|MTH^Mother^HL70063|1887 Schijndel Pl^^Long Lake^MI^48743^USA^P|^PRN^PH^^^989^2712441ORC|RE||BF38A18055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF38A18055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V25^Sate program eligibility^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-B|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B86X18063^^^AIRA-TEST^MR||SiskiyouAIRA^DoreenAIRA^Tivona^^^^L|ColumbiaAIRA^AraxieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1827 Rersel Cir^^Hudsonville^MI^49426^USA^B||^PRN^PH^^^616^2227205|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiskiyouAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1827 Rersel Cir^^Hudsonville^MI^49426^USA^P|^PRN^PH^^^616^2227205ORC|RE||BB86X18063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB86X18063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-BA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T05C18068^^^AIRA-TEST^MR||KentonAIRA^GiorgiaAIRA^Rajni^^^^L|DauphinAIRA^NitzanaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1659 Norger-Odoorn Pl^^Rudyard^MI^49780^USA^BA||^PRN^PH^^^906^5174360|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KentonAIRA^DauphinAIRA^^^^^L|MTH^Mother^HL70063|1659 Norger-Odoorn Pl^^Rudyard^MI^49780^USA^P|^PRN^PH^^^906^5174360ORC|RE||BT05C18068.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT05C18068.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-BDL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D03P18079^^^AIRA-TEST^MR||OxfordAIRA^PebblesAIRA^Astrid^^^^L|NemahaAIRA^ArianeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1668 Woestijn Pl^^Richmond^MI^48062^USA^BDL||^PRN^PH^^^586^5182159|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OxfordAIRA^NemahaAIRA^^^^^L|MTH^Mother^HL70063|1668 Woestijn Pl^^Richmond^MI^48062^USA^P|^PRN^PH^^^586^5182159ORC|RE||BD03P18079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD03P18079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-BR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C03S18087^^^AIRA-TEST^MR||SimpsonAIRA^CosimaAIRA^Magdalena^^^^L|WayneAIRA^HestiaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1536 Familie St^^Riley^MI^48041^USA^BR||^PRN^PH^^^810^9336360|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SimpsonAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1536 Familie St^^Riley^MI^48041^USA^P|^PRN^PH^^^810^9336360ORC|RE||BC03S18087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC03S18087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-C|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K58J18095^^^AIRA-TEST^MR||PenistonAIRA^LaniAIRA^Rona^^^^L|GratiotAIRA^MindaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1151 Hengelo St^^Sault S Marie^MI^49786^USA^C||^PRN^PH^^^906^8541763|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PenistonAIRA^GratiotAIRA^^^^^L|MTH^Mother^HL70063|1151 Hengelo St^^Sault S Marie^MI^49786^USA^P|^PRN^PH^^^906^8541763ORC|RE||BK58J18095.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK58J18095.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-F|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N29C18103^^^AIRA-TEST^MR||GarzaAIRA^LeopoldaAIRA^Ivana^^^^L|CuyahogaAIRA^AnabelleAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1116 Pergen Cir^^Portage^MI^49002^USA^F||^PRN^PH^^^269^3946230|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarzaAIRA^CuyahogaAIRA^^^^^L|MTH^Mother^HL70063|1116 Pergen Cir^^Portage^MI^49002^USA^P|^PRN^PH^^^269^3946230ORC|RE||BN29C18103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN29C18103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-H|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y79L18111^^^AIRA-TEST^MR||MartinAIRA^KamalaAIRA^Kamakshi^^^^L|GreeneAIRA^CandaceAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1353 Ontmoeten Cir^^Crystal Falls^MI^49920^USA^H||^PRN^PH^^^906^8343491|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MartinAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1353 Ontmoeten Cir^^Crystal Falls^MI^49920^USA^P|^PRN^PH^^^906^8343491ORC|RE||BY79L18111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY79L18111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-L|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B81X18119^^^AIRA-TEST^MR||McErlaneAIRA^BessAIRA^Haldana^^^^L|HighlandAIRA^VasilikiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1452 Lingewaard St^^Kent City^MI^49330^USA^L||^PRN^PH^^^616^2886617|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McErlaneAIRA^HighlandAIRA^^^^^L|MTH^Mother^HL70063|1452 Lingewaard St^^Kent City^MI^49330^USA^P|^PRN^PH^^^616^2886617ORC|RE||BB81X18119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB81X18119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-M|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B23T18124^^^AIRA-TEST^MR||BellAIRA^ZuzannaAIRA^Gauri^^^^L|WatmoughAIRA^BridgetAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1167 Rmallingerland Cir^^Lake Orion^MI^48362^USA^M||^PRN^PH^^^248^4562829|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BellAIRA^WatmoughAIRA^^^^^L|MTH^Mother^HL70063|1167 Rmallingerland Cir^^Lake Orion^MI^48362^USA^P|^PRN^PH^^^248^4562829ORC|RE||BB23T18124.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB23T18124.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-N|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L04Y18135^^^AIRA-TEST^MR||WashingtonAIRA^IdoniaAIRA^Zee^^^^L|RichlandAIRA^MorillaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1531 Square Ave^^Point Aux Pin^MI^49775^USA^N||^PRN^PH^^^231^7095177|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1531 Square Ave^^Point Aux Pin^MI^49775^USA^P|^PRN^PH^^^231^7095177ORC|RE||BL04Y18135.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL04Y18135.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-O|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O07W18143^^^AIRA-TEST^MR||McIntoshAIRA^KatrinAIRA^Mykala^^^^L|KenedyAIRA^DovaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1886 Bantumadiel St^^Seney^MI^49883^USA^O||^PRN^PH^^^906^7592922|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McIntoshAIRA^KenedyAIRA^^^^^L|MTH^Mother^HL70063|1886 Bantumadiel St^^Seney^MI^49883^USA^P|^PRN^PH^^^906^7592922ORC|RE||BO07W18143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO07W18143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-P|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V03G18151^^^AIRA-TEST^MR||LoganAIRA^RuellaAIRA^Jonina^^^^L|SanduskyAIRA^ThaliaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1916 Miessenlanden Cir^^De Tour Vlle^MI^49725^USA^P||^PRN^PH^^^906^3003593|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoganAIRA^SanduskyAIRA^^^^^L|MTH^Mother^HL70063|1916 Miessenlanden Cir^^De Tour Vlle^MI^49725^USA^P|^PRN^PH^^^906^3003593ORC|RE||BV03G18151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV03G18151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-ADR-TYPE1-RH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R93O18159^^^AIRA-TEST^MR||NordholmAIRA^FrancesAIRA^Isabella^^^^L|SnohomishAIRA^LourdesAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1399 Doesburg Pl^^Bessemer^MI^49911^USA^RH||^PRN^PH^^^906^5411008|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NordholmAIRA^SnohomishAIRA^^^^^L|MTH^Mother^HL70063|1399 Doesburg Pl^^Bessemer^MI^49911^USA^P|^PRN^PH^^^906^5411008ORC|RE||BR93O18159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR93O18159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90281|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H83B18167^^^AIRA-TEST^MR||HubbardAIRA^EllieAIRA^Phillida^^^^L|TuolumneAIRA^RivaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1725 Slaap St^^Reese^MI^48757^USA^P||^PRN^PH^^^989^9427831|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HubbardAIRA^TuolumneAIRA^^^^^L|MTH^Mother^HL70063|1725 Slaap St^^Reese^MI^48757^USA^P|^PRN^PH^^^989^9427831ORC|RE||BH83B18167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90281^IG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH83B18167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90283|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G43D18175^^^AIRA-TEST^MR||SewardAIRA^TerhiAIRA^Revelation^^^^L|UnionAIRA^SulaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1308 Blij Ln^^Croswell^MI^48422^USA^P||^PRN^PH^^^810^2078876|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SewardAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1308 Blij Ln^^Croswell^MI^48422^USA^P|^PRN^PH^^^810^2078876ORC|RE||BG43D18175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90283^IGIV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG43D18175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90287|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H95E18180^^^AIRA-TEST^MR||SeminoleAIRA^PenganaAIRA^Candide^^^^L|ThompsenAIRA^ElizabethAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1617 Halburg Cir^^Comstock Park^MI^49321^USA^P||^PRN^PH^^^616^8147129|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SeminoleAIRA^ThompsenAIRA^^^^^L|MTH^Mother^HL70063|1617 Halburg Cir^^Comstock Park^MI^49321^USA^P|^PRN^PH^^^616^8147129ORC|RE||BH95E18180.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90287^botulinum antitoxin^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH95E18180.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90291|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z35K18191^^^AIRA-TEST^MR||ReillyAIRA^SharmilaAIRA^Baylee^^^^L|ArmstrongAIRA^CandaceAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1928 Hmmen St^^Augusta Township^MI^48160^USA^P||^PRN^PH^^^734^2086211|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReillyAIRA^ArmstrongAIRA^^^^^L|MTH^Mother^HL70063|1928 Hmmen St^^Augusta Township^MI^48160^USA^P|^PRN^PH^^^734^2086211ORC|RE||BZ35K18191.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90291^CMVIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ35K18191.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90296|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S78C18199^^^AIRA-TEST^MR||LuceAIRA^JerricaAIRA^Jean^^^^L|PiscataquisAIRA^TyneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1364 Toogeveen Pl^^Simplicity Pattern^MI^49121^USA^P||^PRN^PH^^^269^9057556|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LuceAIRA^PiscataquisAIRA^^^^^L|MTH^Mother^HL70063|1364 Toogeveen Pl^^Simplicity Pattern^MI^49121^USA^P|^PRN^PH^^^269^9057556ORC|RE||BS78C18199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90296^diphtheria antitoxin^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS78C18199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90371|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M99D18207^^^AIRA-TEST^MR||JonsonAIRA^LilaAIRA^Sonal^^^^L|ValleyAIRA^EdaleneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1842 Hoxmeer Ave^^Novi^MI^48376^USA^P||^PRN^PH^^^248^6882525|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JonsonAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1842 Hoxmeer Ave^^Novi^MI^48376^USA^P|^PRN^PH^^^248^6882525ORC|RE||BM99D18207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90371^HBIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM99D18207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90375|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z45B18215^^^AIRA-TEST^MR||LyastromAIRA^ApirkaAIRA^Jayde^^^^L|CroweAIRA^SushantiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1105 Bandgraaf Cir^^Lansing^MI^48912^USA^P||^PRN^PH^^^517^6352230|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LyastromAIRA^CroweAIRA^^^^^L|MTH^Mother^HL70063|1105 Bandgraaf Cir^^Lansing^MI^48912^USA^P|^PRN^PH^^^517^6352230ORC|RE||BZ45B18215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90375^RIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ45B18215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90376|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y76J18223^^^AIRA-TEST^MR||DecaturAIRA^NiobeAIRA^Rosetta^^^^L|GalvestonAIRA^NanakoAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1886 Natuurlijke St^^Dansville^MI^48819^USA^P||^PRN^PH^^^517^5383449|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DecaturAIRA^GalvestonAIRA^^^^^L|MTH^Mother^HL70063|1886 Natuurlijke St^^Dansville^MI^48819^USA^P|^PRN^PH^^^517^5383449ORC|RE||BY76J18223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90376^RIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY76J18223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90378|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I92F18228^^^AIRA-TEST^MR||LemhiAIRA^FloraAIRA^Ciannait^^^^L|TillamookAIRA^EmileeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1071 In de richting van Ave^^Washington^MI^48094^USA^P||^PRN^PH^^^586^6531033|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LemhiAIRA^TillamookAIRA^^^^^L|MTH^Mother^HL70063|1071 In de richting van Ave^^Washington^MI^48094^USA^P|^PRN^PH^^^586^6531033ORC|RE||BI92F18228.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90378^RSV-MAb^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI92F18228.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90379|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z34G18239^^^AIRA-TEST^MR||HancockAIRA^QuintessaAIRA^Callia^^^^L|KenedyAIRA^ViolentaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1830 Seere Ln^^Northville^MI^48167^USA^P||^PRN^PH^^^248^6556390|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^KenedyAIRA^^^^^L|MTH^Mother^HL70063|1830 Seere Ln^^Northville^MI^48167^USA^P|^PRN^PH^^^248^6556390ORC|RE||BZ34G18239.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90379^RSV-IGIV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ34G18239.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90389|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N90Z18247^^^AIRA-TEST^MR||CumberlandAIRA^SaheliAIRA^Catalina^^^^L|JohnstonAIRA^AbijahAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1111 Fractie Pl^^Muskegon Heights^MI^49444^USA^P||^PRN^PH^^^231^9970115|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumberlandAIRA^JohnstonAIRA^^^^^L|MTH^Mother^HL70063|1111 Fractie Pl^^Muskegon Heights^MI^49444^USA^P|^PRN^PH^^^231^9970115ORC|RE||BN90Z18247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90389^TIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN90Z18247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90393|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C67K18255^^^AIRA-TEST^MR||MontgomeryAIRA^EllaAIRA^Melissa^^^^L|AthensAIRA^PoonamAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1727 Auidhorn Pl^^Goodison^MI^48306^USA^P||^PRN^PH^^^248^8876627|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontgomeryAIRA^AthensAIRA^^^^^L|MTH^Mother^HL70063|1727 Auidhorn Pl^^Goodison^MI^48306^USA^P|^PRN^PH^^^248^8876627ORC|RE||BC67K18255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90393^vaccinia immune globulin^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC67K18255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90396|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D16M18263^^^AIRA-TEST^MR||SimmingsenAIRA^BerangerAIRA^Bonny^^^^L|LoganAIRA^AveryAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1306 Mellendoorn Cir^^MI Metro^MI^48340^USA^P||^PRN^PH^^^248^6221923|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SimmingsenAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1306 Mellendoorn Cir^^MI Metro^MI^48340^USA^P|^PRN^PH^^^248^6221923ORC|RE||BD16M18263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90396^VZIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD16M18263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90470|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J77O18271^^^AIRA-TEST^MR||SenecaAIRA^YamunaAIRA^Jesse^^^^L|KentAIRA^KennedyAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1308 Wodegraven-Reeuwijk Pl^^Metamora^MI^48455^USA^P||^PRN^PH^^^810^6123242|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SenecaAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1308 Wodegraven-Reeuwijk Pl^^Metamora^MI^48455^USA^P|^PRN^PH^^^810^6123242ORC|RE||BJ77O18271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90470^Novel Influenza-H1N1-09, all formulations^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ77O18271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90476|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W00T18276^^^AIRA-TEST^MR||HowarthAIRA^NitaraAIRA^Ildiko^^^^L|RobertsAIRA^AldaraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1471 Won en Breugel Ave^^Cascade Township^MI^49546^USA^P||^PRN^PH^^^616^9345517|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowarthAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1471 Won en Breugel Ave^^Cascade Township^MI^49546^USA^P|^PRN^PH^^^616^9345517ORC|RE||BW00T18276.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90476^adenovirus, type 4^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW00T18276.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90477|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U09R18287^^^AIRA-TEST^MR||MurrayAIRA^HappyAIRA^Lorna^^^^L|ProtheroeAIRA^DeidraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1956 Laalre Ave^^Stony Creek^MI^48160^USA^P||^PRN^PH^^^734^7378325|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MurrayAIRA^ProtheroeAIRA^^^^^L|MTH^Mother^HL70063|1956 Laalre Ave^^Stony Creek^MI^48160^USA^P|^PRN^PH^^^734^7378325ORC|RE||BU09R18287.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90477^adenovirus, type 7^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU09R18287.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90581|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P09M18295^^^AIRA-TEST^MR||RandallAIRA^RosamondAIRA^Anne^^^^L|CaseyAIRA^JaimieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1959 Rint-Michielsgestel Cir^^New Baltimore^MI^48047^USA^P||^PRN^PH^^^586^3884007|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RandallAIRA^CaseyAIRA^^^^^L|MTH^Mother^HL70063|1959 Rint-Michielsgestel Cir^^New Baltimore^MI^48047^USA^P|^PRN^PH^^^586^3884007ORC|RE||BP09M18295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90581^anthrax^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP09M18295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90585|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H87O18303^^^AIRA-TEST^MR||HofflundAIRA^EnoraAIRA^Ethelda^^^^L|BendAIRA^NandiniAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1700 Hpeldoorn Ave^^Southfield Township^MI^48025^USA^P||^PRN^PH^^^248^2375057|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HofflundAIRA^BendAIRA^^^^^L|MTH^Mother^HL70063|1700 Hpeldoorn Ave^^Southfield Township^MI^48025^USA^P|^PRN^PH^^^248^2375057ORC|RE||BH87O18303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90585^BCG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH87O18303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90620|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I38T18311^^^AIRA-TEST^MR||EnnisAIRA^AnnaAIRA^Kylie^^^^L|SaundersAIRA^ShakoAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1248 Doesburg Ln^^Colon^MI^49040^USA^P||^PRN^PH^^^269^9316592|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EnnisAIRA^SaundersAIRA^^^^^L|MTH^Mother^HL70063|1248 Doesburg Ln^^Colon^MI^49040^USA^P|^PRN^PH^^^269^9316592ORC|RE||BI38T18311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90620^Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B, 2 dose schedule, for intramuscular^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI38T18311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90621|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B57D18319^^^AIRA-TEST^MR||CherokeeAIRA^AfricaAIRA^Amarante^^^^L|RunnelsAIRA^LaraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1746 Hlkmaar Ave^^Grand Rapids^MI^49588^USA^P||^PRN^PH^^^616^2175854|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CherokeeAIRA^RunnelsAIRA^^^^^L|MTH^Mother^HL70063|1746 Hlkmaar Ave^^Grand Rapids^MI^49588^USA^P|^PRN^PH^^^616^2175854ORC|RE||BB57D18319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90621^Meningococcal recombinant lipoprotein vaccine, serogroup B, 3 dose schedule, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB57D18319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90625|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J19Z18324^^^AIRA-TEST^MR||BarryAIRA^QadiraAIRA^Zdenka^^^^L|SummitAIRA^GotzoneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1193 Wierden Cir^^Woodland^MI^48897^USA^P||^PRN^PH^^^269^4637052|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarryAIRA^SummitAIRA^^^^^L|MTH^Mother^HL70063|1193 Wierden Cir^^Woodland^MI^48897^USA^P|^PRN^PH^^^269^4637052ORC|RE||BJ19Z18324.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90625^Cholera vaccine live, adult dosage, 1 dose schedule, for oral use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ19Z18324.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90630|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E60H18335^^^AIRA-TEST^MR||WoodAIRA^QuintaAIRA^Majida^^^^L|AlgerAIRA^TerrylynAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1522 Poerdijk Cir^^Lake Ann^MI^49650^USA^P||^PRN^PH^^^231^4616024|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WoodAIRA^AlgerAIRA^^^^^L|MTH^Mother^HL70063|1522 Poerdijk Cir^^Lake Ann^MI^49650^USA^P|^PRN^PH^^^231^4616024ORC|RE||BE60H18335.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90630^Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE60H18335.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90632|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G94Z18343^^^AIRA-TEST^MR||ThurstonAIRA^CordeliaAIRA^Ireland^^^^L|DouglasAIRA^AmaraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1501 Vilt St^^Duck Lake^MI^49284^USA^P||^PRN^PH^^^517^8292418|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ThurstonAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1501 Vilt St^^Duck Lake^MI^49284^USA^P|^PRN^PH^^^517^8292418ORC|RE||BG94Z18343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90632^Hep A, adult^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG94Z18343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90633|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I94M18351^^^AIRA-TEST^MR||KaneAIRA^OletheaAIRA^Xaviera^^^^L|SiouxAIRA^KirstenAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1645 Reerssen St^^Detroit^MI^48229^USA^P||^PRN^PH^^^313^6571781|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KaneAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1645 Reerssen St^^Detroit^MI^48229^USA^P|^PRN^PH^^^313^6571781ORC|RE||BI94M18351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90633^Hep A, ped/adol, 2 dose^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI94M18351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90634|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O46D18359^^^AIRA-TEST^MR||LoupAIRA^SraddhaAIRA^Marinka^^^^L|ErikssonAIRA^ParulAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1192 Bepalen Ln^^Vermontville^MI^49096^USA^P||^PRN^PH^^^517^8464987|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoupAIRA^ErikssonAIRA^^^^^L|MTH^Mother^HL70063|1192 Bepalen Ln^^Vermontville^MI^49096^USA^P|^PRN^PH^^^517^8464987ORC|RE||BO46D18359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90634^Hep A, ped/adol, 3 dose^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO46D18359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90636|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y42I18367^^^AIRA-TEST^MR||LegresleyAIRA^GudduAIRA^Eglantine^^^^L|BorthroydAIRA^MelosaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1720 Drimmelen Ave^^Rose City^MI^48654^USA^P||^PRN^PH^^^989^2493232|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LegresleyAIRA^BorthroydAIRA^^^^^L|MTH^Mother^HL70063|1720 Drimmelen Ave^^Rose City^MI^48654^USA^P|^PRN^PH^^^989^2493232ORC|RE||BY42I18367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90636^Hep A-Hep B^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY42I18367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90644|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N40M18375^^^AIRA-TEST^MR||GanronAIRA^EllieAIRA^Tineka Jawana^^^^L|LampasasAIRA^EugeniaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1227 Eollands Kroon Ave^^Osseo^MI^49266^USA^P||^PRN^PH^^^517^2942622|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GanronAIRA^LampasasAIRA^^^^^L|MTH^Mother^HL70063|1227 Eollands Kroon Ave^^Osseo^MI^49266^USA^P|^PRN^PH^^^517^2942622ORC|RE||BN40M18375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90644^Meningococcal C/Y-HIB PRP^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN40M18375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90645|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L73J18380^^^AIRA-TEST^MR||ButlerAIRA^RosieAIRA^Kali^^^^L|LivingstonAIRA^JennyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1546 Me Fryske Marren St^^Rumely^MI^49826^USA^P||^PRN^PH^^^906^8924984|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ButlerAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1546 Me Fryske Marren St^^Rumely^MI^49826^USA^P|^PRN^PH^^^906^8924984ORC|RE||BL73J18380.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90645^Hib (HbOC)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL73J18380.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90646|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D66T18391^^^AIRA-TEST^MR||ShermanAIRA^IrinaAIRA^Angel^^^^L|OlsenAIRA^ThedaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1810 Rijswijk Pl^^DTE^MI^48260^USA^P||^PRN^PH^^^313^7440433|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShermanAIRA^OlsenAIRA^^^^^L|MTH^Mother^HL70063|1810 Rijswijk Pl^^DTE^MI^48260^USA^P|^PRN^PH^^^313^7440433ORC|RE||BD66T18391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90646^Hib (PRP-D)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD66T18391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90647|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M39Y18399^^^AIRA-TEST^MR||MerrickAIRA^MahdiAIRA^Misako^^^^L|ComancheAIRA^JaidenAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1895 Bmmen Ave^^Farmingtn Hls^MI^48336^USA^P||^PRN^PH^^^248^2099196|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MerrickAIRA^ComancheAIRA^^^^^L|MTH^Mother^HL70063|1895 Bmmen Ave^^Farmingtn Hls^MI^48336^USA^P|^PRN^PH^^^248^2099196ORC|RE||BM39Y18399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90647^Hib (PRP-OMP)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM39Y18399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90648|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M36H18407^^^AIRA-TEST^MR||LoganAIRA^RubyAIRA^Jemma^^^^L|WarrenAIRA^ManuellaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1688 Pchinnen Ln^^Port Sheldon^MI^49460^USA^P||^PRN^PH^^^616^3573489|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoganAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1688 Pchinnen Ln^^Port Sheldon^MI^49460^USA^P|^PRN^PH^^^616^3573489ORC|RE||BM36H18407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90648^Hib (PRP-T)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM36H18407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90649|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W14Z18415^^^AIRA-TEST^MR||PeskenAIRA^DervlaAIRA^Thaisa^^^^L|JeffersonAIRA^ClotildaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1756 Ce Fryske Marren St^^Omena^MI^49674^USA^P||^PRN^PH^^^231^5984570|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PeskenAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1756 Ce Fryske Marren St^^Omena^MI^49674^USA^P|^PRN^PH^^^231^5984570ORC|RE||BW14Z18415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90649^HPV, quadrivalent^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW14Z18415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90650|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V53J18423^^^AIRA-TEST^MR||ClevelandAIRA^KaydenceAIRA^Maliha^^^^L|MartinAIRA^NardaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1222 Happy Cir^^Detroit River Station^MI^48222^USA^P||^PRN^PH^^^313^5485019|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClevelandAIRA^MartinAIRA^^^^^L|MTH^Mother^HL70063|1222 Happy Cir^^Detroit River Station^MI^48222^USA^P|^PRN^PH^^^313^5485019ORC|RE||BV53J18423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90650^HPV, bivalent^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV53J18423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90651|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I18Z18428^^^AIRA-TEST^MR||ReynoldsAIRA^EstefaniaAIRA^Zofia^^^^L|WashingtonAIRA^AthelaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1523 Toonhoogte Ln^^Grosse Pointe^MI^48230^USA^P||^PRN^PH^^^313^3783058|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReynoldsAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1523 Toonhoogte Ln^^Grosse Pointe^MI^48230^USA^P|^PRN^PH^^^313^3783058ORC|RE||BI18Z18428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90651^Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (HPV)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI18Z18428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90653|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V84H18439^^^AIRA-TEST^MR||ColemanAIRA^KileyAIRA^Herta^^^^L|MartinAIRA^CaseyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1482 Achtkarspelen Cir^^Meskegon^MI^49444^USA^P||^PRN^PH^^^231^5745198|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ColemanAIRA^MartinAIRA^^^^^L|MTH^Mother^HL70063|1482 Achtkarspelen Cir^^Meskegon^MI^49444^USA^P|^PRN^PH^^^231^5745198ORC|RE||BV84H18439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90653^Influenza virus vaccine, inactivated, subunit, adjuvanted for IM us^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV84H18439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90654|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F22E18447^^^AIRA-TEST^MR||CoryellAIRA^AxelleAIRA^Vandita^^^^L|SnyderAIRA^SavitaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1009 Ooensdrecht Ln^^Blissfield^MI^49228^USA^P||^PRN^PH^^^517^2835197|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CoryellAIRA^SnyderAIRA^^^^^L|MTH^Mother^HL70063|1009 Ooensdrecht Ln^^Blissfield^MI^49228^USA^P|^PRN^PH^^^517^2835197ORC|RE||BF22E18447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90654^Influenza, seasonal, injectable, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF22E18447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90655|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F99E18455^^^AIRA-TEST^MR||MontcalmAIRA^ZonaAIRA^Vandana^^^^L|CartonAIRA^TahneeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1225 Kamp Pl^^Milford^MI^48380^USA^P||^PRN^PH^^^248^2431589|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontcalmAIRA^CartonAIRA^^^^^L|MTH^Mother^HL70063|1225 Kamp Pl^^Milford^MI^48380^USA^P|^PRN^PH^^^248^2431589ORC|RE||BF99E18455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90655^Influenza, seasonal, injectable, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF99E18455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90656|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F17G18463^^^AIRA-TEST^MR||Santa BarbaraAIRA^ShaunnaAIRA^Arashel^^^^L|MasonAIRA^ImamAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1530 Heek St^^Grant Township^MI^48032^USA^P||^PRN^PH^^^810^3184061|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Santa BarbaraAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1530 Heek St^^Grant Township^MI^48032^USA^P|^PRN^PH^^^810^3184061ORC|RE||BF17G18463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90656^Influenza, seasonal, injectable, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF17G18463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90657|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K61A18471^^^AIRA-TEST^MR||PawneeAIRA^QuiritaAIRA^Yasmeen^^^^L|SacramentoAIRA^AvaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1594 Linkelland Ln^^Hartford^MI^49057^USA^P||^PRN^PH^^^269^4026124|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PawneeAIRA^SacramentoAIRA^^^^^L|MTH^Mother^HL70063|1594 Linkelland Ln^^Hartford^MI^49057^USA^P|^PRN^PH^^^269^4026124ORC|RE||BK61A18471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90657^Influenza, seasonal, injectable^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK61A18471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90658|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T66K18476^^^AIRA-TEST^MR||BedfordAIRA^ZakiaAIRA^Lorrae^^^^L|HughesAIRA^AinsleyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1636 Woststellingwerf Ln^^Plainwell^MI^49080^USA^P||^PRN^PH^^^269^7419745|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BedfordAIRA^HughesAIRA^^^^^L|MTH^Mother^HL70063|1636 Woststellingwerf Ln^^Plainwell^MI^49080^USA^P|^PRN^PH^^^269^7419745ORC|RE||BT66K18476.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90658^Influenza, seasonal, injectable^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT66K18476.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90659|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U47E18487^^^AIRA-TEST^MR||ReevesAIRA^ReneeAIRA^Charline^^^^L|WardleAIRA^RoannaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1327 Darderwijk Ln^^Boardwalk^MI^48638^USA^P||^PRN^PH^^^989^6713214|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ReevesAIRA^WardleAIRA^^^^^L|MTH^Mother^HL70063|1327 Darderwijk Ln^^Boardwalk^MI^48638^USA^P|^PRN^PH^^^989^6713214ORC|RE||BU47E18487.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90659^influenza, whole^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU47E18487.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90660|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J24P18495^^^AIRA-TEST^MR||WashingtonAIRA^AnnetteAIRA^Ashira^^^^L|MasonAIRA^KarlieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1484 Wmmen Ln^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^5351628|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1484 Wmmen Ln^^New Buffalo^MI^49117^USA^P|^PRN^PH^^^269^5351628ORC|RE||BJ24P18495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90660^influenza, live, intranasal^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ24P18495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90661|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T83F18503^^^AIRA-TEST^MR||PortageAIRA^IerneAIRA^Questa^^^^L|San JoaquinAIRA^CatavaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1592 Zijn Ln^^Novi^MI^48377^USA^P||^PRN^PH^^^248^5377054|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PortageAIRA^San JoaquinAIRA^^^^^L|MTH^Mother^HL70063|1592 Zijn Ln^^Novi^MI^48377^USA^P|^PRN^PH^^^248^5377054ORC|RE||BT83F18503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90661^Influenza, injectable, MDCK, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT83F18503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90662|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N16E18511^^^AIRA-TEST^MR||OntonagonAIRA^AryannaAIRA^Ayita^^^^L|MasonAIRA^KetziaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1666 Overbetuwe Ave^^Hickory Corners^MI^49060^USA^P||^PRN^PH^^^269^5353512|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OntonagonAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1666 Overbetuwe Ave^^Hickory Corners^MI^49060^USA^P|^PRN^PH^^^269^5353512ORC|RE||BN16E18511.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90662^Influenza, high dose seasonal^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN16E18511.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90663|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G65Y18519^^^AIRA-TEST^MR||TownAIRA^ElodieAIRA^Indaliai^^^^L|RobinsonAIRA^NishaAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1971 Alle Pl^^Detroit^MI^48233^USA^P||^PRN^PH^^^313^6549190|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TownAIRA^RobinsonAIRA^^^^^L|MTH^Mother^HL70063|1971 Alle Pl^^Detroit^MI^48233^USA^P|^PRN^PH^^^313^6549190ORC|RE||BG65Y18519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90663^Novel Influenza-H1N1-09, all formulations^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG65Y18519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90664|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z37S18527^^^AIRA-TEST^MR||McCurtainAIRA^FelipaAIRA^Vaishali^^^^L|OldhamAIRA^CapriceAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1480 Hpsterland Pl^^Dansville^MI^48819^USA^P||^PRN^PH^^^517^8350956|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McCurtainAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1480 Hpsterland Pl^^Dansville^MI^48819^USA^P|^PRN^PH^^^517^8350956ORC|RE||BZ37S18527.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90664^Novel Influenza-H1N1-09, nasal^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ37S18527.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90665|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G49L18532^^^AIRA-TEST^MR||PlumasAIRA^GhislaineAIRA^Leauna^^^^L|ClarkAIRA^JacintaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1438 Rongeradeel Ln^^Oak Park^MI^48237^USA^P||^PRN^PH^^^248^7369064|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PlumasAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1438 Rongeradeel Ln^^Oak Park^MI^48237^USA^P|^PRN^PH^^^248^7369064ORC|RE||BG49L18532.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90665^Lyme disease^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG49L18532.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90666|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D55X18543^^^AIRA-TEST^MR||LambAIRA^AmbriaAIRA^Namazzi^^^^L|IsabellaAIRA^SasthiAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1235 Kdam-Volendam St^^Sherwood^MI^49089^USA^P||^PRN^PH^^^517^4073438|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LambAIRA^IsabellaAIRA^^^^^L|MTH^Mother^HL70063|1235 Kdam-Volendam St^^Sherwood^MI^49089^USA^P|^PRN^PH^^^517^4073438ORC|RE||BD55X18543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90666^Novel influenza-H1N1-09, preservative-free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD55X18543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90668|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K26U18551^^^AIRA-TEST^MR||AuglaizeAIRA^FredaAIRA^Rupali^^^^L|DuncanAIRA^RudelleAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1525 Hoevorden Pl^^Meskegon^MI^49441^USA^P||^PRN^PH^^^231^7225642|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AuglaizeAIRA^DuncanAIRA^^^^^L|MTH^Mother^HL70063|1525 Hoevorden Pl^^Meskegon^MI^49441^USA^P|^PRN^PH^^^231^7225642ORC|RE||BK26U18551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90668^Novel influenza-H1N1-09^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK26U18551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90669|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I71U18559^^^AIRA-TEST^MR||BrownAIRA^OrselineAIRA^Tirion^^^^L|MontmorencyMuskegonAIRA^AmandaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1295 Biel Ln^^Chassell^MI^49916^USA^P||^PRN^PH^^^906^2171208|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrownAIRA^MontmorencyMuskegonAIRA^^^^^L|MTH^Mother^HL70063|1295 Biel Ln^^Chassell^MI^49916^USA^P|^PRN^PH^^^906^2171208ORC|RE||BI71U18559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90669^pneumococcal conjugate PCV 7^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI71U18559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90670|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S01J18567^^^AIRA-TEST^MR||AntrimAIRA^AsteraAIRA^Belda^^^^L|PikeAIRA^EucleaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1055 Weghel Cir^^Sault S Marie^MI^49784^USA^P||^PRN^PH^^^906^3338187|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AntrimAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1055 Weghel Cir^^Sault S Marie^MI^49784^USA^P|^PRN^PH^^^906^3338187ORC|RE||BS01J18567.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90670^Pneumococcal conjugate PCV 13^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS01J18567.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90672|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D46M18575^^^AIRA-TEST^MR||IslandAIRA^CharisseAIRA^Laurel^^^^L|CrookAIRA^ClareAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1196 Waalwijk St^^Sault S Marie^MI^49785^USA^P||^PRN^PH^^^906^6333917|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IslandAIRA^CrookAIRA^^^^^L|MTH^Mother^HL70063|1196 Waalwijk St^^Sault S Marie^MI^49785^USA^P|^PRN^PH^^^906^6333917ORC|RE||BD46M18575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90672^Influenza virus vaccine, quadrivalent, live, for intranasal use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD46M18575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90673|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B08W18583^^^AIRA-TEST^MR||DixonAIRA^TanakaAIRA^Prama^^^^L|KingAIRA^ValentinaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1160 Kerg en Dal Cir^^Grosse Pointe Farms^MI^48236^USA^P||^PRN^PH^^^313^6350865|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DixonAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1160 Kerg en Dal Cir^^Grosse Pointe Farms^MI^48236^USA^P|^PRN^PH^^^313^6350865ORC|RE||BB08W18583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90673^Influenza, recombinant, injectable, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB08W18583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90674|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R00R18588^^^AIRA-TEST^MR||LaneAIRA^GloriaAIRA^Kajol^^^^L|HenryAIRA^ZivaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1708 Vijfheerenlanden Cir^^Sault Sainte Marie^MI^49788^USA^P||^PRN^PH^^^906^6837144|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LaneAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1708 Vijfheerenlanden Cir^^Sault Sainte Marie^MI^49788^USA^P|^PRN^PH^^^906^6837144ORC|RE||BR00R18588.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90674^Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR00R18588.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90675|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y31Z18599^^^AIRA-TEST^MR||DillAIRA^CoreyAIRA^Cora^^^^L|GlorinnAIRA^AdysonAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1572 Ede Pl^^Frenchtown^MI^48161^USA^P||^PRN^PH^^^734^7532295|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DillAIRA^GlorinnAIRA^^^^^L|MTH^Mother^HL70063|1572 Ede Pl^^Frenchtown^MI^48161^USA^P|^PRN^PH^^^734^7532295ORC|RE||BY31Z18599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90675^rabies, intramuscular injection^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY31Z18599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90676|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E49B18607^^^AIRA-TEST^MR||DickAIRA^PallasAIRA^Meenakshi^^^^L|MadisonAIRA^KaleighAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1148 Vedemblik Pl^^Frederic^MI^49733^USA^P||^PRN^PH^^^989^6158269|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1148 Vedemblik Pl^^Frederic^MI^49733^USA^P|^PRN^PH^^^989^6158269ORC|RE||BE49B18607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90676^rabies, intradermal injection^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE49B18607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90680|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V04G18615^^^AIRA-TEST^MR||NolanAIRA^LeaunaAIRA^Rudelle^^^^L|BlaineAIRA^CeriseAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1648 Werneuzen Ln^^Farmington Hills^MI^48334^USA^P||^PRN^PH^^^248^3725582|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NolanAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1648 Werneuzen Ln^^Farmington Hills^MI^48334^USA^P|^PRN^PH^^^248^3725582ORC|RE||BV04G18615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90680^rotavirus, pentavalent^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV04G18615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90681|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y33W18623^^^AIRA-TEST^MR||HawkeAIRA^PapillonAIRA^Janiyah^^^^L|PetersAIRA^YaraviAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1809 Dood Pl^^Southfield^MI^48076^USA^P||^PRN^PH^^^248^9772680|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HawkeAIRA^PetersAIRA^^^^^L|MTH^Mother^HL70063|1809 Dood Pl^^Southfield^MI^48076^USA^P|^PRN^PH^^^248^9772680ORC|RE||BY33W18623.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90681^rotavirus, monovalent^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY33W18623.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90682|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O82Z18631^^^AIRA-TEST^MR||IoniaAIRA^HisaAIRA^Sylvia^^^^L|HodgeAIRA^ReineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1129 Bantumadiel Ln^^Grand Rapids^MI^49528^USA^P||^PRN^PH^^^616^6805298|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IoniaAIRA^HodgeAIRA^^^^^L|MTH^Mother^HL70063|1129 Bantumadiel Ln^^Grand Rapids^MI^49528^USA^P|^PRN^PH^^^616^6805298ORC|RE||BO82Z18631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90682^Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO82Z18631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90685|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M29Y18636^^^AIRA-TEST^MR||LampasasAIRA^TionneAIRA^Pakuna^^^^L|DickinsonAIRA^MeganAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1446 Herneuzen Pl^^Nazareth^MI^49074^USA^P||^PRN^PH^^^269^3732122|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LampasasAIRA^DickinsonAIRA^^^^^L|MTH^Mother^HL70063|1446 Herneuzen Pl^^Nazareth^MI^49074^USA^P|^PRN^PH^^^269^3732122ORC|RE||BM29Y18636.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90685^Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to children 6-35 months of age, for intramuscular us^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM29Y18636.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90686|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J95S18647^^^AIRA-TEST^MR||BeckhamAIRA^VeraAIRA^Leighton^^^^L|BlancoAIRA^LenoraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1428 Zalkenswaard Pl^^Harbor Beach^MI^48441^USA^P||^PRN^PH^^^989^3302911|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BeckhamAIRA^BlancoAIRA^^^^^L|MTH^Mother^HL70063|1428 Zalkenswaard Pl^^Harbor Beach^MI^48441^USA^P|^PRN^PH^^^989^3302911ORC|RE||BJ95S18647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90686^Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to individuals 3 years of age and older, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ95S18647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90687|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W68W18655^^^AIRA-TEST^MR||DuvalAIRA^VendelaAIRA^Sudevi^^^^L|HenryAIRA^JuliaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1541 Wrootegast Ave^^Lakeview^MI^48850^USA^P||^PRN^PH^^^989^4359792|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DuvalAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1541 Wrootegast Ave^^Lakeview^MI^48850^USA^P|^PRN^PH^^^989^4359792ORC|RE||BW68W18655.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90687^Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW68W18655.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90688|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K77N18663^^^AIRA-TEST^MR||FloydAIRA^DanielleAIRA^Lysandra^^^^L|FremmingAIRA^LeiaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1813 Reimerswaal Cir^^Chase Bank^MI^48278^USA^P||^PRN^PH^^^313^2504204|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FloydAIRA^FremmingAIRA^^^^^L|MTH^Mother^HL70063|1813 Reimerswaal Cir^^Chase Bank^MI^48278^USA^P|^PRN^PH^^^313^2504204ORC|RE||BK77N18663.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90688^Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK77N18663.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90689|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S41C18671^^^AIRA-TEST^MR||DeuelAIRA^DamarisAIRA^Payton^^^^L|SnowAIRA^JayleneAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1678 Otrijen Pl^^China Township^MI^48054^USA^P||^PRN^PH^^^810^2012139|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DeuelAIRA^SnowAIRA^^^^^L|MTH^Mother^HL70063|1678 Otrijen Pl^^China Township^MI^48054^USA^P|^PRN^PH^^^810^2012139ORC|RE||BS41C18671.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90689^Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS41C18671.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90690|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A62K18679^^^AIRA-TEST^MR||JacksonAIRA^AureliaAIRA^Lea^^^^L|WhartonAIRA^LariAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1984 Eunspeet Pl^^Lakeland^MI^48143^USA^P||^PRN^PH^^^810^2645584|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^WhartonAIRA^^^^^L|MTH^Mother^HL70063|1984 Eunspeet Pl^^Lakeland^MI^48143^USA^P|^PRN^PH^^^810^2645584ORC|RE||BA62K18679.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90690^typhoid, oral^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA62K18679.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90691|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A31B18687^^^AIRA-TEST^MR||McKinnonAIRA^HeddaAIRA^Dobrila^^^^L|OkmulgeeAIRA^ConncettaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1263 Aantumadiel Ln^^Hickory Crnrs^MI^49060^USA^P||^PRN^PH^^^269^9254077|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McKinnonAIRA^OkmulgeeAIRA^^^^^L|MTH^Mother^HL70063|1263 Aantumadiel Ln^^Hickory Crnrs^MI^49060^USA^P|^PRN^PH^^^269^9254077ORC|RE||BA31B18687.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90691^typhoid, ViCPs^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA31B18687.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90692|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M97X18692^^^AIRA-TEST^MR||HernandezAIRA^RomyAIRA^Karolina^^^^L|MasonAIRA^KaniyaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1118 Rittenseradeel St^^Yankee Springs^MI^49333^USA^P||^PRN^PH^^^269^5716170|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HernandezAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1118 Rittenseradeel St^^Yankee Springs^MI^49333^USA^P|^PRN^PH^^^269^5716170ORC|RE||BM97X18692.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90692^typhoid, parenteral^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM97X18692.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90693|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y63A18703^^^AIRA-TEST^MR||SiskiyouAIRA^KaylenAIRA^Gwendolen^^^^L|OklahomaAIRA^RonnyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1259 Soest Pl^^Port Sheldon^MI^49460^USA^P||^PRN^PH^^^616^2105263|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiskiyouAIRA^OklahomaAIRA^^^^^L|MTH^Mother^HL70063|1259 Soest Pl^^Port Sheldon^MI^49460^USA^P|^PRN^PH^^^616^2105263ORC|RE||BY63A18703.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90693^typhoid, parenteral, AKD (U.S. military)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY63A18703.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90696|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T99B18711^^^AIRA-TEST^MR||CarterAIRA^MamtaAIRA^Win^^^^L|DixonAIRA^HildegardAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1410 Krootegast St^^Grand Rapids^MI^49588^USA^P||^PRN^PH^^^616^3340913|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CarterAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1410 Krootegast St^^Grand Rapids^MI^49588^USA^P|^PRN^PH^^^616^3340913ORC|RE||BT99B18711.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90696^DTaP-IPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT99B18711.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90697|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E68N18719^^^AIRA-TEST^MR||MackinacAIRA^CordeliaAIRA^Takara^^^^L|ColumbiaAIRA^AtalantaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1993 Daanstad St^^Wellston^MI^49689^USA^P||^PRN^PH^^^231^9130080|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MackinacAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1993 Daanstad St^^Wellston^MI^49689^USA^P|^PRN^PH^^^231^9130080ORC|RE||BE68N18719.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90697^Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE68N18719.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90698|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V35B18727^^^AIRA-TEST^MR||StarkAIRA^WyanetAIRA^Ria^^^^L|SummitAIRA^SindyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1063 Mwenterand Cir^^Copemish^MI^49625^USA^P||^PRN^PH^^^231^7301907|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StarkAIRA^SummitAIRA^^^^^L|MTH^Mother^HL70063|1063 Mwenterand Cir^^Copemish^MI^49625^USA^P|^PRN^PH^^^231^7301907ORC|RE||BV35B18727.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90698^DTaP-Hib-IPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV35B18727.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T38N18735^^^AIRA-TEST^MR||GarfieldAIRA^AbbieAIRA^Portia^^^^L|LampasasAIRA^LottaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1118 Gerkrade Cir^^Deckerville^MI^48427^USA^P||^PRN^PH^^^810^4578227|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarfieldAIRA^LampasasAIRA^^^^^L|MTH^Mother^HL70063|1118 Gerkrade Cir^^Deckerville^MI^48427^USA^P|^PRN^PH^^^810^4578227ORC|RE||BT38N18735.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90700^DTaP, 5 pertussis antigens^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT38N18735.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A76L18740^^^AIRA-TEST^MR||LamarAIRA^AroraAIRA^Niley^^^^L|Cerro GordoAIRA^LeolaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1020 Kaag en Braassem Cir^^Williamsburg^MI^49690^USA^P||^PRN^PH^^^231^7383913|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LamarAIRA^Cerro GordoAIRA^^^^^L|MTH^Mother^HL70063|1020 Kaag en Braassem Cir^^Williamsburg^MI^49690^USA^P|^PRN^PH^^^231^7383913ORC|RE||BA76L18740.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90701^DTP^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA76L18740.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V94A18751^^^AIRA-TEST^MR||PetersAIRA^MyleeAIRA^Amaranth^^^^L|AllenAIRA^RuchiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1690 Tchagen Cir^^Michigan Center^MI^49254^USA^P||^PRN^PH^^^517^8769442|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PetersAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1690 Tchagen Cir^^Michigan Center^MI^49254^USA^P|^PRN^PH^^^517^8769442ORC|RE||BV94A18751.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90702^DT (pediatric)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV94A18751.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90703|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B20F18759^^^AIRA-TEST^MR||GillespieAIRA^HokuAIRA^Ileana^^^^L|FayetteAIRA^KianaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1085 Kinkelland St^^Burlington^MI^49029^USA^P||^PRN^PH^^^517^3399593|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GillespieAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1085 Kinkelland St^^Burlington^MI^49029^USA^P|^PRN^PH^^^517^3399593ORC|RE||BB20F18759.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90703^tetanus toxoid, adsorbed^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB20F18759.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90704|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q23T18767^^^AIRA-TEST^MR||StevensAIRA^YamiletAIRA^Bryanne^^^^L|LibertyAIRA^CynthiaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1035 Jmmen Ln^^Midland^MI^48641^USA^P||^PRN^PH^^^989^4148163|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|StevensAIRA^LibertyAIRA^^^^^L|MTH^Mother^HL70063|1035 Jmmen Ln^^Midland^MI^48641^USA^P|^PRN^PH^^^989^4148163ORC|RE||BQ23T18767.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90704^mumps^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ23T18767.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90705|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L93A18775^^^AIRA-TEST^MR||SweeneyAIRA^BirgittaAIRA^Harper^^^^L|JohnAIRA^AzariahAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1166 Heerenveen Cir^^Whittaker^MI^48190^USA^P||^PRN^PH^^^734^2275859|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SweeneyAIRA^JohnAIRA^^^^^L|MTH^Mother^HL70063|1166 Heerenveen Cir^^Whittaker^MI^48190^USA^P|^PRN^PH^^^734^2275859ORC|RE||BL93A18775.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90705^measles^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL93A18775.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90706|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R60U18780^^^AIRA-TEST^MR||CartonAIRA^YumikoAIRA^Summer^^^^L|AsotinAIRA^MariashaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1851 Eheden St^^Htn Lk Hghts^MI^48630^USA^P||^PRN^PH^^^989^5475258|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CartonAIRA^AsotinAIRA^^^^^L|MTH^Mother^HL70063|1851 Eheden St^^Htn Lk Hghts^MI^48630^USA^P|^PRN^PH^^^989^5475258ORC|RE||BR60U18780.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90706^rubella^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR60U18780.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90707|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D73S18791^^^AIRA-TEST^MR||JeffersonAIRA^DakotaAIRA^Viveka^^^^L|DauphinAIRA^ZohraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1110 Srimmelen Pl^^Royal Oak^MI^48067^USA^P||^PRN^PH^^^248^8460641|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JeffersonAIRA^DauphinAIRA^^^^^L|MTH^Mother^HL70063|1110 Srimmelen Pl^^Royal Oak^MI^48067^USA^P|^PRN^PH^^^248^8460641ORC|RE||BD73S18791.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90707^MMR^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD73S18791.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90708|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H65P18799^^^AIRA-TEST^MR||FremontAIRA^MarissaAIRA^Charlee^^^^L|ThiemerAIRA^TotieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1544 Veidschendam-Voorburg St^^Stalwart^MI^49736^USA^P||^PRN^PH^^^906^7934447|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FremontAIRA^ThiemerAIRA^^^^^L|MTH^Mother^HL70063|1544 Veidschendam-Voorburg St^^Stalwart^MI^49736^USA^P|^PRN^PH^^^906^7934447ORC|RE||BH65P18799.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90708^M/R^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH65P18799.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B81O18807^^^AIRA-TEST^MR||HowardAIRA^TonieAIRA^Rhonda^^^^L|PatricioAIRA^NivertaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1627 Dsten Ave^^Hartford^MI^49057^USA^P||^PRN^PH^^^269^2833314|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HowardAIRA^PatricioAIRA^^^^^L|MTH^Mother^HL70063|1627 Dsten Ave^^Hartford^MI^49057^USA^P|^PRN^PH^^^269^2833314ORC|RE||BB81O18807.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90710^MMRV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB81O18807.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90712|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K57Q18815^^^AIRA-TEST^MR||SiouxAIRA^AdelynAIRA^Ohanna^^^^L|HamiltonAIRA^RylieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1911 Kordrecht St^^Coppersville^MI^49404^USA^P||^PRN^PH^^^616^3705873|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiouxAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1911 Kordrecht St^^Coppersville^MI^49404^USA^P|^PRN^PH^^^616^3705873ORC|RE||BK57Q18815.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90712^OPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK57Q18815.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90713|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H89U18823^^^AIRA-TEST^MR||YubaAIRA^KirtiAIRA^Johanna^^^^L|RainsAIRA^AllieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1072 Bezoek Ave^^Grosse Pointe Farms^MI^48236^USA^P||^PRN^PH^^^313^4056866|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YubaAIRA^RainsAIRA^^^^^L|MTH^Mother^HL70063|1072 Bezoek Ave^^Grosse Pointe Farms^MI^48236^USA^P|^PRN^PH^^^313^4056866ORC|RE||BH89U18823.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90713^IPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH89U18823.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90714|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A04H18828^^^AIRA-TEST^MR||NorthamptonAIRA^CiannaitAIRA^Rubi^^^^L|ColumbiaAIRA^AndieAIRA^^^^^M|20040831|F||2106-3^White^CDCREC|1976 Taadhoeke Ln^^Cascade^MI^49546^USA^P||^PRN^PH^^^616^6414958|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NorthamptonAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1976 Taadhoeke Ln^^Cascade^MI^49546^USA^P|^PRN^PH^^^616^6414958ORC|RE||BA04H18828.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20041031||90714^typhoid, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA04H18828.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20041231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20041231||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90715|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C78Q18839^^^AIRA-TEST^MR||GrantAIRA^SysheAIRA^Jolie^^^^L|JeffersonAIRA^AlekaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1539 Ze Wolden St^^Saginaw^MI^48603^USA^P||^PRN^PH^^^989^8590667|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrantAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1539 Ze Wolden St^^Saginaw^MI^48603^USA^P|^PRN^PH^^^989^8590667ORC|RE||BC78Q18839.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90715^Tdap^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC78Q18839.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90716|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T47O18847^^^AIRA-TEST^MR||ClarionAIRA^KyraAIRA^Everild^^^^L|LoweAIRA^AlizaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1629 Loekel St^^Cedar River^MI^49887^USA^P||^PRN^PH^^^906^3037587|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClarionAIRA^LoweAIRA^^^^^L|MTH^Mother^HL70063|1629 Loekel St^^Cedar River^MI^49887^USA^P|^PRN^PH^^^906^3037587ORC|RE||BT47O18847.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90716^varicella^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT47O18847.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90717|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O73P18855^^^AIRA-TEST^MR||HancockAIRA^JonesyAIRA^Marielle^^^^L|MercerAIRA^TianaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1585 Alburg St^^Rodney^MI^49342^USA^P||^PRN^PH^^^231^8825020|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1585 Alburg St^^Rodney^MI^49342^USA^P|^PRN^PH^^^231^8825020ORC|RE||BO73P18855.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90717^yellow fever^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO73P18855.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90718|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B14D18863^^^AIRA-TEST^MR||McPhersonAIRA^FlowerAIRA^Giana^^^^L|ElkAIRA^LuciaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1114 Beschrijven Cir^^Flint^MI^48503^USA^P||^PRN^PH^^^810^4078441|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|McPhersonAIRA^ElkAIRA^^^^^L|MTH^Mother^HL70063|1114 Beschrijven Cir^^Flint^MI^48503^USA^P|^PRN^PH^^^810^4078441ORC|RE||BB14D18863.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90718^Td (adult), adsorbed^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB14D18863.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90720|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J33N18868^^^AIRA-TEST^MR||BonnevilleAIRA^CherylAIRA^Honey^^^^L|BraceyAIRA^MckenzieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1041 Longeradeel Ave^^Battle Creek^MI^49014^USA^P||^PRN^PH^^^269^4108759|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BonnevilleAIRA^BraceyAIRA^^^^^L|MTH^Mother^HL70063|1041 Longeradeel Ave^^Battle Creek^MI^49014^USA^P|^PRN^PH^^^269^4108759ORC|RE||BJ33N18868.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90720^DTP-Hib^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ33N18868.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90721|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G50M18879^^^AIRA-TEST^MR||Cerro GordoAIRA^ChikaAIRA^Marlene^^^^L|MasonAIRA^MarjaniAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1646 Ee Wolden Cir^^Mendon^MI^49072^USA^P||^PRN^PH^^^269^8640417|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Cerro GordoAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1646 Ee Wolden Cir^^Mendon^MI^49072^USA^P|^PRN^PH^^^269^8640417ORC|RE||BG50M18879.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90721^DTaP-Hib^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG50M18879.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90723|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V73E18887^^^AIRA-TEST^MR||GreenAIRA^LeticiaAIRA^Nadia^^^^L|LarssenAIRA^AysegalAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1761 Verwerderadeel Ave^^Brockway^MI^48097^USA^P||^PRN^PH^^^810^3196548|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenAIRA^LarssenAIRA^^^^^L|MTH^Mother^HL70063|1761 Verwerderadeel Ave^^Brockway^MI^48097^USA^P|^PRN^PH^^^810^3196548ORC|RE||BV73E18887.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90723^DTaP-Hep B-IPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV73E18887.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90724|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A65R18895^^^AIRA-TEST^MR||BoyleAIRA^RomanaAIRA^Siroun^^^^L|McKiernanAIRA^VigiliaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1795 Zmsterdam Pl^^Painesdale^MI^49955^USA^P||^PRN^PH^^^906^7562257|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BoyleAIRA^McKiernanAIRA^^^^^L|MTH^Mother^HL70063|1795 Zmsterdam Pl^^Painesdale^MI^49955^USA^P|^PRN^PH^^^906^7562257ORC|RE||BA65R18895.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90724^influenza, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA65R18895.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90725|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D62F18903^^^AIRA-TEST^MR||San BernardinoAIRA^MardiAIRA^Nina^^^^L|BrownAIRA^ChruseAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1303 Oeerijnen Ln^^Roscommon^MI^48653^USA^P||^PRN^PH^^^989^7849493|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San BernardinoAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1303 Oeerijnen Ln^^Roscommon^MI^48653^USA^P|^PRN^PH^^^989^7849493ORC|RE||BD62F18903.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90725^cholera^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD62F18903.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90726|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U25E18908^^^AIRA-TEST^MR||DomoAIRA^LuceAIRA^Katherine^^^^L|EstillAIRA^CaimileAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1363 Buenen St^^Selfridge Air National Guard^MI^48045^USA^P||^PRN^PH^^^586^8876698|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DomoAIRA^EstillAIRA^^^^^L|MTH^Mother^HL70063|1363 Buenen St^^Selfridge Air National Guard^MI^48045^USA^P|^PRN^PH^^^586^8876698ORC|RE||BU25E18908.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90726^rabies, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU25E18908.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90727|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P24T18919^^^AIRA-TEST^MR||MadisonAIRA^BhavyaAIRA^Melli^^^^L|SutterAIRA^DionyzaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1960 Bissewaard Ave^^Byron Township^MI^49315^USA^P||^PRN^PH^^^616^5050853|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MadisonAIRA^SutterAIRA^^^^^L|MTH^Mother^HL70063|1960 Bissewaard Ave^^Byron Township^MI^49315^USA^P|^PRN^PH^^^616^5050853ORC|RE||BP24T18919.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90727^plague^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP24T18919.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90728|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U53J18927^^^AIRA-TEST^MR||HancockAIRA^EvaAIRA^Angie^^^^L|JakobsenAIRA^NoelleAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1998 Dpe Ln^^Northwest^MI^48504^USA^P||^PRN^PH^^^810^5985990|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HancockAIRA^JakobsenAIRA^^^^^L|MTH^Mother^HL70063|1998 Dpe Ln^^Northwest^MI^48504^USA^P|^PRN^PH^^^810^5985990ORC|RE||BU53J18927.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90728^BCG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU53J18927.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90730|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G42K18935^^^AIRA-TEST^MR||Hood RiverAIRA^OnyxAIRA^Angwen^^^^L|San Luis ObispoAIRA^GabbyAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1665 Salkenburg aan de Geul Ln^^Brownstown Township^MI^48174^USA^P||^PRN^PH^^^734^2161943|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Hood RiverAIRA^San Luis ObispoAIRA^^^^^L|MTH^Mother^HL70063|1665 Salkenburg aan de Geul Ln^^Brownstown Township^MI^48174^USA^P|^PRN^PH^^^734^2161943ORC|RE||BG42K18935.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90730^Hep A, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG42K18935.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90731|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V73V18943^^^AIRA-TEST^MR||BremerAIRA^TierraAIRA^Birgit^^^^L|ClearfieldAIRA^UltreiaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1314 Geerssen Pl^^Detroit^MI^48219^USA^P||^PRN^PH^^^313^8421540|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BremerAIRA^ClearfieldAIRA^^^^^L|MTH^Mother^HL70063|1314 Geerssen Pl^^Detroit^MI^48219^USA^P|^PRN^PH^^^313^8421540ORC|RE||BV73V18943.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90731^Hep B, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV73V18943.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90732|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U28Y18948^^^AIRA-TEST^MR||BarkerAIRA^NadezdaAIRA^Isabel^^^^L|YumaAIRA^DagnaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1969 Groep Ln^^Tower^MI^49792^USA^P||^PRN^PH^^^989^4382937|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BarkerAIRA^YumaAIRA^^^^^L|MTH^Mother^HL70063|1969 Groep Ln^^Tower^MI^49792^USA^P|^PRN^PH^^^989^4382937ORC|RE||BU28Y18948.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90732^pneumococcal polysaccharide PPV23^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU28Y18948.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90733|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B52A18959^^^AIRA-TEST^MR||BuschAIRA^ChristeaAIRA^Rylie^^^^L|ClayAIRA^FaithAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1093 Pond St^^Berlin Township^MI^48002^USA^P||^PRN^PH^^^810^2510935|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BuschAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1093 Pond St^^Berlin Township^MI^48002^USA^P|^PRN^PH^^^810^2510935ORC|RE||BB52A18959.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90733^meningococcal MPSV4^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB52A18959.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90734|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W34B18967^^^AIRA-TEST^MR||PolkAIRA^AlannaAIRA^Alexis^^^^L|AndersenAIRA^RebelAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1462 Bergeijk Ave^^Brownstown Township^MI^48193^USA^P||^PRN^PH^^^734^6918964|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PolkAIRA^AndersenAIRA^^^^^L|MTH^Mother^HL70063|1462 Bergeijk Ave^^Brownstown Township^MI^48193^USA^P|^PRN^PH^^^734^6918964ORC|RE||BW34B18967.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90734^meningococcal MCV4P^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW34B18967.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90735|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J44L18975^^^AIRA-TEST^MR||NormanAIRA^CyrillaAIRA^Emelia^^^^L|GrahamAIRA^VanniAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1854 Blokkeren Ln^^Flint^MI^48506^USA^P||^PRN^PH^^^810^2558620|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NormanAIRA^GrahamAIRA^^^^^L|MTH^Mother^HL70063|1854 Blokkeren Ln^^Flint^MI^48506^USA^P|^PRN^PH^^^810^2558620ORC|RE||BJ44L18975.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90735^Japanese encephalitis SC^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ44L18975.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90736|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J34U18983^^^AIRA-TEST^MR||DickAIRA^BehiraAIRA^Valerie^^^^L|VictoriaAIRA^TrinityAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1114 Voorbeeld Cir^^De Tour Vlle^MI^49725^USA^P||^PRN^PH^^^906^9359137|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickAIRA^VictoriaAIRA^^^^^L|MTH^Mother^HL70063|1114 Voorbeeld Cir^^De Tour Vlle^MI^49725^USA^P|^PRN^PH^^^906^9359137ORC|RE||BJ34U18983.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90736^zoster^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ34U18983.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90737|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P71F18988^^^AIRA-TEST^MR||ShermanAIRA^AmiAIRA^Goldie^^^^L|MillsAIRA^MarleneAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1981 Kanderd Ln^^Good Hart^MI^49737^USA^P||^PRN^PH^^^616^6612854|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShermanAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1981 Kanderd Ln^^Good Hart^MI^49737^USA^P|^PRN^PH^^^616^6612854ORC|RE||BP71F18988.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90737^Hib, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP71F18988.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90738|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B78J18999^^^AIRA-TEST^MR||JacksonAIRA^DaeAIRA^Garland^^^^L|JasperAIRA^BrookeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1561 Enkelvoudige St^^Oak Park^MI^48237^USA^P||^PRN^PH^^^248^7412758|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|JacksonAIRA^JasperAIRA^^^^^L|MTH^Mother^HL70063|1561 Enkelvoudige St^^Oak Park^MI^48237^USA^P|^PRN^PH^^^248^7412758ORC|RE||BB78J18999.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90738^Japanese Encephalitis IM^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB78J18999.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90739|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I80I19007^^^AIRA-TEST^MR||PageAIRA^RunaAIRA^Adriana^^^^L|BolgenAIRA^ShelbyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1202 Kreeg St^^North Street^MI^48049^USA^P||^PRN^PH^^^810^5347956|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PageAIRA^BolgenAIRA^^^^^L|MTH^Mother^HL70063|1202 Kreeg St^^North Street^MI^48049^USA^P|^PRN^PH^^^810^5347956ORC|RE||BI80I19007.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90739^Hepatitis B, adult dosage (2 dose schedule), for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI80I19007.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90740|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G54W19015^^^AIRA-TEST^MR||WashingtonAIRA^GraceAIRA^Takara^^^^L|KittitasAIRA^MaryAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1451 Lengte Ln^^Brownstwn Township^MI^48183^USA^P||^PRN^PH^^^734^2368581|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WashingtonAIRA^KittitasAIRA^^^^^L|MTH^Mother^HL70063|1451 Lengte Ln^^Brownstwn Township^MI^48183^USA^P|^PRN^PH^^^734^2368581ORC|RE||BG54W19015.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90740^Hep B, dialysis^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG54W19015.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90741|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F91B19023^^^AIRA-TEST^MR||GeneseeAIRA^FaymeAIRA^Phaedra^^^^L|Van BurenAIRA^HisaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1773 Haastricht Pl^^Lum^MI^48412^USA^P||^PRN^PH^^^810^9009474|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GeneseeAIRA^Van BurenAIRA^^^^^L|MTH^Mother^HL70063|1773 Haastricht Pl^^Lum^MI^48412^USA^P|^PRN^PH^^^810^9009474ORC|RE||BF91B19023.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90741^IG, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF91B19023.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90743|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N52S19031^^^AIRA-TEST^MR||MendocinoAIRA^HayleeAIRA^Elbertine^^^^L|HockleyAIRA^RionaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1341 Persoon Pl^^Sterling Heights^MI^48313^USA^P||^PRN^PH^^^586^7156927|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MendocinoAIRA^HockleyAIRA^^^^^L|MTH^Mother^HL70063|1341 Persoon Pl^^Sterling Heights^MI^48313^USA^P|^PRN^PH^^^586^7156927ORC|RE||BN52S19031.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90743^Hep B, adult^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN52S19031.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90744|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A35I19036^^^AIRA-TEST^MR||HighlandAIRA^EliannaAIRA^Iphigenia^^^^L|LieAIRA^ElbertineAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1111 Lwenterand Pl^^Blanchard^MI^49310^USA^P||^PRN^PH^^^989^3861224|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HighlandAIRA^LieAIRA^^^^^L|MTH^Mother^HL70063|1111 Lwenterand Pl^^Blanchard^MI^49310^USA^P|^PRN^PH^^^989^3861224ORC|RE||BA35I19036.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90744^Hep B, adolescent or pediatric^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA35I19036.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90745|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F32M19047^^^AIRA-TEST^MR||GregoryAIRA^PrunellaAIRA^Lotty^^^^L|SalineAIRA^YdelAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1785 Deze Ave^^Comins^MI^48619^USA^P||^PRN^PH^^^989^4513053|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GregoryAIRA^SalineAIRA^^^^^L|MTH^Mother^HL70063|1785 Deze Ave^^Comins^MI^48619^USA^P|^PRN^PH^^^989^4513053ORC|RE||BF32M19047.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90745^Hep B, adolescent/high risk infant^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF32M19047.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90746|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V71W19055^^^AIRA-TEST^MR||WilsonAIRA^AliciaAIRA^Annora^^^^L|MadisonAIRA^MaduraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1064 Roermond Cir^^Macomb^MI^48042^USA^P||^PRN^PH^^^586^9227448|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilsonAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1064 Roermond Cir^^Macomb^MI^48042^USA^P|^PRN^PH^^^586^9227448ORC|RE||BV71W19055.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90746^Hep B, adult^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV71W19055.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90747|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z42N19063^^^AIRA-TEST^MR||NorthumberlandAIRA^LilianaAIRA^Kamilia^^^^L|HobellAIRA^CampbellAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1381 Oinschoten St^^White Lake^MI^48383^USA^P||^PRN^PH^^^248^3670772|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NorthumberlandAIRA^HobellAIRA^^^^^L|MTH^Mother^HL70063|1381 Oinschoten St^^White Lake^MI^48383^USA^P|^PRN^PH^^^248^3670772ORC|RE||BZ42N19063.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90747^Hep B, dialysis^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ42N19063.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90748|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H12A19071^^^AIRA-TEST^MR||PittsburgAIRA^VidaAIRA^Diki^^^^L|ClayAIRA^WaltraudAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1892 Woeterwoude St^^Orion Township^MI^48360^USA^P||^PRN^PH^^^248^2626705|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PittsburgAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1892 Woeterwoude St^^Orion Township^MI^48360^USA^P|^PRN^PH^^^248^2626705ORC|RE||BH12A19071.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90748^Hib-Hep B^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH12A19071.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90750|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X99I19079^^^AIRA-TEST^MR||Presque IsleAIRA^UraniaAIRA^Yoshiko^^^^L|ChoctawAIRA^SatokoAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1737 Vertegenwoordigen Cir^^Litchfield^MI^49252^USA^P||^PRN^PH^^^517^4787562|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Presque IsleAIRA^ChoctawAIRA^^^^^L|MTH^Mother^HL70063|1737 Vertegenwoordigen Cir^^Litchfield^MI^49252^USA^P|^PRN^PH^^^517^4787562ORC|RE||BX99I19079.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90750^Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX99I19079.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CPT-90756|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H66F19087^^^AIRA-TEST^MR||YorkAIRA^JaydaAIRA^Mrinalini^^^^L|MontgomeryAIRA^NeetaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1757 Zissewaard Pl^^Flint^MI^48555^USA^P||^PRN^PH^^^810^6306155|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|YorkAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1757 Zissewaard Pl^^Flint^MI^48555^USA^P|^PRN^PH^^^810^6306155ORC|RE||BH66F19087.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||90756^Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH66F19087.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-117|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F10X19092^^^AIRA-TEST^MR||Pend OreilleAIRA^HelimaAIRA^Cara^^^^L|ClintonAIRA^IsadoraAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1507 Hoek Ave^^Highland Township^MI^48356^USA^P||^PRN^PH^^^248^2661608|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Pend OreilleAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1507 Hoek Ave^^Highland Township^MI^48356^USA^P|^PRN^PH^^^248^2661608ORC|RE||BF10X19092.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||117^VZIG (IND)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF10X19092.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y15Q19103^^^AIRA-TEST^MR||AinslieAIRA^TerriAIRA^Clare^^^^L|WhitakerAIRA^ToniaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1883 Slechte Pl^^Monroe^MI^48110^USA^P||^PRN^PH^^^734^8106164|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|AinslieAIRA^WhitakerAIRA^^^^^L|MTH^Mother^HL70063|1883 Slechte Pl^^Monroe^MI^48110^USA^P|^PRN^PH^^^734^8106164ORC|RE||BY15Q19103.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||12^diphtheria antitoxin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY15Q19103.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-123|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I86E19111^^^AIRA-TEST^MR||RileyAIRA^KessieAIRA^Juliet^^^^L|McDonaldAIRA^MarkettaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1503 Afdekking Cir^^Onekama^MI^49675^USA^P||^PRN^PH^^^231^5390529|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RileyAIRA^McDonaldAIRA^^^^^L|MTH^Mother^HL70063|1503 Afdekking Cir^^Onekama^MI^49675^USA^P|^PRN^PH^^^231^5390529ORC|RE||BI86E19111.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||123^influenza, H5N1-1203^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI86E19111.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-13|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L14J19119^^^AIRA-TEST^MR||CaddoAIRA^MickieAIRA^Belladonna^^^^L|KnoxAIRA^EmmanuelAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1057 Geval Pl^^White Lake^MI^48386^USA^P||^PRN^PH^^^248^7805465|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CaddoAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1057 Geval Pl^^White Lake^MI^48386^USA^P|^PRN^PH^^^248^7805465ORC|RE||BL14J19119.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||13^TIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL14J19119.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-145|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B92V19127^^^AIRA-TEST^MR||GrantAIRA^AcadiaAIRA^Caragh^^^^L|TuscarawasAIRA^ValeskaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1166 Doden Ave^^Kalamazoo^MI^49002^USA^P||^PRN^PH^^^269^7391103|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrantAIRA^TuscarawasAIRA^^^^^L|MTH^Mother^HL70063|1166 Doden Ave^^Kalamazoo^MI^49002^USA^P|^PRN^PH^^^269^7391103ORC|RE||BB92V19127.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||145^RSV-Mab (new)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB92V19127.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-146|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D72O19132^^^AIRA-TEST^MR||MontereyAIRA^ThoraAIRA^Thomasina^^^^L|GormanAIRA^LoganAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1906 Keylingen Pl^^Conklin^MI^49403^USA^P||^PRN^PH^^^616^6308243|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontereyAIRA^GormanAIRA^^^^^L|MTH^Mother^HL70063|1906 Keylingen Pl^^Conklin^MI^49403^USA^P|^PRN^PH^^^616^6308243ORC|RE||BD72O19132.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||146^DTaP,IPV,Hib,HepB^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD72O19132.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-154|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E73O19143^^^AIRA-TEST^MR||FerryAIRA^YachiAIRA^Ann-Margret^^^^L|DelawareAIRA^IleneAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1800 Le Ronde Venen St^^Ewen^MI^49925^USA^P||^PRN^PH^^^906^6574470|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|FerryAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1800 Le Ronde Venen St^^Ewen^MI^49925^USA^P|^PRN^PH^^^906^6574470ORC|RE||BE73O19143.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||154^Hepatitis A immune globulin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE73O19143.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-156|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y92V19151^^^AIRA-TEST^MR||SaloAIRA^RoseanneAIRA^Clare^^^^L|MeigsAIRA^NamazziAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1640 We Marne Cir^^East Lansing^MI^48824^USA^P||^PRN^PH^^^517^4598160|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SaloAIRA^MeigsAIRA^^^^^L|MTH^Mother^HL70063|1640 We Marne Cir^^East Lansing^MI^48824^USA^P|^PRN^PH^^^517^4598160ORC|RE||BY92V19151.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||156^Rho(D)-IG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY92V19151.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-157|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y84K19159^^^AIRA-TEST^MR||KnoxAIRA^SharmanAIRA^Caydence^^^^L|BeckhamAIRA^MaciAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1308 Vuijk Pl^^Bloomfield^MI^48301^USA^P||^PRN^PH^^^248^3572559|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnoxAIRA^BeckhamAIRA^^^^^L|MTH^Mother^HL70063|1308 Vuijk Pl^^Bloomfield^MI^48301^USA^P|^PRN^PH^^^248^3572559ORC|RE||BY84K19159.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||157^Rho(D) -IG IM^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY84K19159.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-159|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B27P19167^^^AIRA-TEST^MR||BrennanAIRA^LuceAIRA^Caren^^^^L|OxfordAIRA^AdornaAIRA^^^^^M|20120704|F||2106-3^White^CDCREC|1269 Doggenland Cir^^Otisville^MI^48463^USA^P||^PRN^PH^^^810^4747000|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BrennanAIRA^OxfordAIRA^^^^^L|MTH^Mother^HL70063|1269 Doggenland Cir^^Otisville^MI^48463^USA^P|^PRN^PH^^^810^4747000ORC|RE||BB27P19167.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130704||159^Rho(D) Unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB27P19167.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130904||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130904||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-23|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O48X19175^^^AIRA-TEST^MR||MorrellAIRA^SoniaAIRA^Haley^^^^L|KitsapAIRA^ColleenAIRA^^^^^M|20180116|F||2106-3^White^CDCREC|1197 Veere Pl^^Benton Harbor^MI^49023^USA^P||^PRN^PH^^^269^9189496|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MorrellAIRA^KitsapAIRA^^^^^L|MTH^Mother^HL70063|1197 Veere Pl^^Benton Harbor^MI^49023^USA^P|^PRN^PH^^^269^9189496ORC|RE||BO48X19175.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180316||23^plague^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO48X19175.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180516||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180516||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-27|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K99S19183^^^AIRA-TEST^MR||GreenleeAIRA^MarisaAIRA^Hailee^^^^L|HenryAIRA^ChanceAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1631 Moeder Ln^^Traverse City^MI^49696^USA^P||^PRN^PH^^^231^5528903|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreenleeAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1631 Moeder Ln^^Traverse City^MI^49696^USA^P|^PRN^PH^^^231^5528903ORC|RE||BK99S19183.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||27^botulinum antitoxin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK99S19183.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-29|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W17O19188^^^AIRA-TEST^MR||KohlmeisterAIRA^DellAIRA^Alondra^^^^L|RichlandAIRA^OliveAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1124 Douten Pl^^Flint^MI^48553^USA^P||^PRN^PH^^^810^6396107|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KohlmeisterAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1124 Douten Pl^^Flint^MI^48553^USA^P|^PRN^PH^^^810^6396107ORC|RE||BW17O19188.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||29^CMVIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW17O19188.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-30|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V88O19199^^^AIRA-TEST^MR||MontcalmAIRA^BirgetAIRA^Annabella^^^^L|Contra CostaAIRA^CarynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1690 Buth Pl^^Marysville^MI^48040^USA^P||^PRN^PH^^^810^9572047|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MontcalmAIRA^Contra CostaAIRA^^^^^L|MTH^Mother^HL70063|1690 Buth Pl^^Marysville^MI^48040^USA^P|^PRN^PH^^^810^9572047ORC|RE||BV88O19199.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||30^HBIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV88O19199.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-36|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K46O19207^^^AIRA-TEST^MR||GraysonAIRA^ShannahAIRA^Asisa^^^^L|MariposaAIRA^CamAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1249 Bynaarlo St^^Carland^MI^48831^USA^P||^PRN^PH^^^989^3705305|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GraysonAIRA^MariposaAIRA^^^^^L|MTH^Mother^HL70063|1249 Bynaarlo St^^Carland^MI^48831^USA^P|^PRN^PH^^^989^3705305ORC|RE||BK46O19207.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||36^VZIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK46O19207.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-56|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E90B19215^^^AIRA-TEST^MR||WiseAIRA^ZionaAIRA^Minna^^^^L|KnightAIRA^AnnaliseAIRA^^^^^M|19690831|F||2106-3^White^CDCREC|1562 Sodegraven-Reeuwijk St^^Portage^MI^49081^USA^P||^PRN^PH^^^269^4371195|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WiseAIRA^KnightAIRA^^^^^L|MTH^Mother^HL70063|1562 Sodegraven-Reeuwijk St^^Portage^MI^49081^USA^P|^PRN^PH^^^269^4371195ORC|RE||BE90B19215.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19691031||56^dengue fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE90B19215.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19691231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19691231||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-57|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R29S19223^^^AIRA-TEST^MR||San BernardinoAIRA^YachiAIRA^Kismet^^^^L|MonoAIRA^DikiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1610 Dmallingerland Ave^^Cascade^MI^49546^USA^P||^PRN^PH^^^616^4762563|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|San BernardinoAIRA^MonoAIRA^^^^^L|MTH^Mother^HL70063|1610 Dmallingerland Ave^^Cascade^MI^49546^USA^P|^PRN^PH^^^616^4762563ORC|RE||BR29S19223.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||57^hantavirus^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR29S19223.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P19H19231^^^AIRA-TEST^MR||BeckhamAIRA^ElizabethAIRA^Swati^^^^L|ShelbyAIRA^CoraAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1135 Derneuzen Pl^^Rochester Hls^MI^48309^USA^P||^PRN^PH^^^248^2727580|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BeckhamAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1135 Derneuzen Pl^^Rochester Hls^MI^48309^USA^P|^PRN^PH^^^248^2727580ORC|RE||BP19H19231.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||58^Hep C^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP19H19231.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-59|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G37A19236^^^AIRA-TEST^MR||SolanoAIRA^DivyaAIRA^Pomona^^^^L|JohnsonAIRA^CambriaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1235 Iude IJsselstreek St^^Luzerne^MI^48636^USA^P||^PRN^PH^^^989^9228208|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SolanoAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1235 Iude IJsselstreek St^^Luzerne^MI^48636^USA^P|^PRN^PH^^^989^9228208ORC|RE||BG37A19236.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||59^Hep E^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG37A19236.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-60|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q40E19247^^^AIRA-TEST^MR||KentAIRA^OfrahAIRA^Antionette^^^^L|GradyAIRA^MaliseAIRA^^^^^M|19690831|F||2106-3^White^CDCREC|1288 Kanderd Pl^^Novi^MI^48376^USA^P||^PRN^PH^^^248^8301973|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KentAIRA^GradyAIRA^^^^^L|MTH^Mother^HL70063|1288 Kanderd Pl^^Novi^MI^48376^USA^P|^PRN^PH^^^248^8301973ORC|RE||BQ40E19247.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19691031||60^herpes simplex 2^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ40E19247.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19691231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19691231||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-61|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N51D19255^^^AIRA-TEST^MR||MurphyAIRA^BabetteAIRA^Haylee^^^^L|CopelandAIRA^AysegalAIRA^^^^^M|19690831|F||2106-3^White^CDCREC|1119 Weerijnen Ave^^Kentwood^MI^49508^USA^P||^PRN^PH^^^616^3288677|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MurphyAIRA^CopelandAIRA^^^^^L|MTH^Mother^HL70063|1119 Weerijnen Ave^^Kentwood^MI^49508^USA^P|^PRN^PH^^^616^3288677ORC|RE||BN51D19255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19691031||61^HIV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN51D19255.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19691231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19691231||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-63|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S96R19263^^^AIRA-TEST^MR||SutterAIRA^JardenaAIRA^Ruth^^^^L|SilowAIRA^LizbethAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1996 Proberen Ln^^Burr Oak^MI^49030^USA^P||^PRN^PH^^^269^9362166|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SutterAIRA^SilowAIRA^^^^^L|MTH^Mother^HL70063|1996 Proberen Ln^^Burr Oak^MI^49030^USA^P|^PRN^PH^^^269^9362166ORC|RE||BS96R19263.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||63^Junin virus^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS96R19263.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-64|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A07F19271^^^AIRA-TEST^MR||DawesAIRA^MarneAIRA^Eartha^^^^L|AurumAIRA^RachAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1656 Aontfoort Cir^^Thompsonville^MI^49683^USA^P||^PRN^PH^^^231^7159186|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DawesAIRA^AurumAIRA^^^^^L|MTH^Mother^HL70063|1656 Aontfoort Cir^^Thompsonville^MI^49683^USA^P|^PRN^PH^^^231^7159186ORC|RE||BA07F19271.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||64^leishmaniasis^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA07F19271.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z57Y19279^^^AIRA-TEST^MR||LoganAIRA^ToveAIRA^Galya^^^^L|LawrenceAIRA^AniyahAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1321 Scht-Susteren Ln^^Harbert^MI^49115^USA^P||^PRN^PH^^^269^2727804|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|LoganAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1321 Scht-Susteren Ln^^Harbert^MI^49115^USA^P|^PRN^PH^^^269^2727804ORC|RE||BZ57Y19279.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||65^leprosy^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ57Y19279.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-67|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G15J19284^^^AIRA-TEST^MR||ClatsopAIRA^KarlaAIRA^Melina^^^^L|HolmfAIRA^NeelamAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1060 Oittard-Geleen Ave^^Russell Island^MI^48001^USA^P||^PRN^PH^^^810^2752460|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ClatsopAIRA^HolmfAIRA^^^^^L|MTH^Mother^HL70063|1060 Oittard-Geleen Ave^^Russell Island^MI^48001^USA^P|^PRN^PH^^^810^2752460ORC|RE||BG15J19284.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||67^malaria^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG15J19284.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-68|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S38D19295^^^AIRA-TEST^MR||GarzaAIRA^KaridaAIRA^Kleopatra^^^^L|AndersonAIRA^EsmereldaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1752 Hrimmelen Ave^^Ortonville^MI^48462^USA^P||^PRN^PH^^^248^7969577|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GarzaAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1752 Hrimmelen Ave^^Ortonville^MI^48462^USA^P|^PRN^PH^^^248^7969577ORC|RE||BS38D19295.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||68^melanoma^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS38D19295.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-70|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H57Z19303^^^AIRA-TEST^MR||EsceibreAIRA^RupertaAIRA^Maisie^^^^L|JeffersonAIRA^TheresaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1935 Ginnenmaas Ln^^Fremont^MI^49413^USA^P||^PRN^PH^^^231^2087802|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EsceibreAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1935 Ginnenmaas Ln^^Fremont^MI^49413^USA^P|^PRN^PH^^^231^2087802ORC|RE||BH57Z19303.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||70^Q fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH57Z19303.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-71|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W47E19311^^^AIRA-TEST^MR||IarrestadAIRA^HortenseAIRA^Tyler^^^^L|WintermanAIRA^CorabelleAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1951 Goppersum St^^Detroit^MI^48216^USA^P||^PRN^PH^^^313^8506312|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|IarrestadAIRA^WintermanAIRA^^^^^L|MTH^Mother^HL70063|1951 Goppersum St^^Detroit^MI^48216^USA^P|^PRN^PH^^^313^8506312ORC|RE||BW47E19311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||71^RSV-IGIV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW47E19311.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-72|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G11G19319^^^AIRA-TEST^MR||ArmstrongAIRA^LexyAIRA^Zion^^^^L|JensenAIRA^KaylenAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1259 Eaaren Ln^^Shelbyville^MI^49344^USA^P||^PRN^PH^^^269^9625628|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ArmstrongAIRA^JensenAIRA^^^^^L|MTH^Mother^HL70063|1259 Eaaren Ln^^Shelbyville^MI^49344^USA^P|^PRN^PH^^^269^9625628ORC|RE||BG11G19319.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||72^rheumatic fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG11G19319.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-73|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B83Y19327^^^AIRA-TEST^MR||SiouxAIRA^ChitrangdaAIRA^Siddhi^^^^L|WheelerAIRA^WillowAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1008 Me Bilt Pl^^Minden^MI^48456^USA^P||^PRN^PH^^^989^9783800|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SiouxAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1008 Me Bilt Pl^^Minden^MI^48456^USA^P|^PRN^PH^^^989^9783800ORC|RE||BB83Y19327.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||73^Rift Valley fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB83Y19327.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-79|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q69I19332^^^AIRA-TEST^MR||DanuelsonAIRA^QueridaAIRA^Seirian^^^^L|FitzpatrickAIRA^MalatiAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1162 Krootegast Pl^^East Grand Rapids^MI^49546^USA^P||^PRN^PH^^^616^2610858|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DanuelsonAIRA^FitzpatrickAIRA^^^^^L|MTH^Mother^HL70063|1162 Krootegast Pl^^East Grand Rapids^MI^49546^USA^P|^PRN^PH^^^616^2610858ORC|RE||BQ69I19332.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||79^vaccinia immune globulin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ69I19332.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-86|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M14W19343^^^AIRA-TEST^MR||BeecherAIRA^DamitaAIRA^Idola^^^^L|KrogAIRA^FranAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1258 Evenement Ln^^Brownstown Township^MI^48193^USA^P||^PRN^PH^^^734^4381984|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BeecherAIRA^KrogAIRA^^^^^L|MTH^Mother^HL70063|1258 Evenement Ln^^Brownstown Township^MI^48193^USA^P|^PRN^PH^^^734^4381984ORC|RE||BM14W19343.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||86^IG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM14W19343.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-87|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C65E19351^^^AIRA-TEST^MR||WallowaAIRA^BlytheAIRA^Adelaide^^^^L|McKinnonAIRA^DakinAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1070 Lint Anthonis Pl^^Central Lake^MI^49622^USA^P||^PRN^PH^^^231^2004987|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WallowaAIRA^McKinnonAIRA^^^^^L|MTH^Mother^HL70063|1070 Lint Anthonis Pl^^Central Lake^MI^49622^USA^P|^PRN^PH^^^231^2004987ORC|RE||BC65E19351.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||87^IGIV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC65E19351.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-93|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J79I19359^^^AIRA-TEST^MR||KinneyAIRA^GudaAIRA^Miyoko^^^^L|PerkinsAIRA^QueenaAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1828 Stichtse Vecht Ln^^Edwardsburg^MI^49112^USA^P||^PRN^PH^^^269^6088361|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KinneyAIRA^PerkinsAIRA^^^^^L|MTH^Mother^HL70063|1828 Stichtse Vecht Ln^^Edwardsburg^MI^49112^USA^P|^PRN^PH^^^269^6088361ORC|RE||BJ79I19359.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||93^RSV-MAb^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ79I19359.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-95|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S47U19367^^^AIRA-TEST^MR||GagleAIRA^RandieAIRA^Aleta^^^^L|SummresgillAIRA^BathshebaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1794 Zeven St^^Mc Millan^MI^49853^USA^P||^PRN^PH^^^906^9782541|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GagleAIRA^SummresgillAIRA^^^^^L|MTH^Mother^HL70063|1794 Zeven St^^Mc Millan^MI^49853^USA^P|^PRN^PH^^^906^9782541ORC|RE||BS47U19367.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||95^TST-OT tine test^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS47U19367.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-96|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J61V19375^^^AIRA-TEST^MR||BucksAIRA^AlanaAIRA^Peace^^^^L|OatesAIRA^JanisaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1812 Rotterdam St^^Skandia^MI^49885^USA^P||^PRN^PH^^^906^2335741|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BucksAIRA^OatesAIRA^^^^^L|MTH^Mother^HL70063|1812 Rotterdam St^^Skandia^MI^49885^USA^P|^PRN^PH^^^906^2335741ORC|RE||BJ61V19375.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||96^TST-PPD intradermal^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ61V19375.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-97|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C70C19380^^^AIRA-TEST^MR||BergenAIRA^TrishnaAIRA^Rosa^^^^L|AshtabulaAIRA^ElanoraAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1937 Rerkelland Ave^^Hickory Corners^MI^49060^USA^P||^PRN^PH^^^269^8234322|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BergenAIRA^AshtabulaAIRA^^^^^L|MTH^Mother^HL70063|1937 Rerkelland Ave^^Hickory Corners^MI^49060^USA^P|^PRN^PH^^^269^8234322ORC|RE||BC70C19380.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||97^TST-PPD tine test^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC70C19380.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-98|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P23G19391^^^AIRA-TEST^MR||GreeneAIRA^CorentineAIRA^Kiara^^^^L|IndianaAIRA^AveriAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1848 Geiderland Ave^^Mio^MI^48647^USA^P||^PRN^PH^^^989^4618989|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GreeneAIRA^IndianaAIRA^^^^^L|MTH^Mother^HL70063|1848 Geiderland Ave^^Mio^MI^48647^USA^P|^PRN^PH^^^989^4618989ORC|RE||BP23G19391.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||98^TST, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP23G19391.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-99|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D55J19399^^^AIRA-TEST^MR||CassAIRA^JuliaAIRA^Leewana^^^^L|MeadeAIRA^TrudiAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1136 Uit St^^Grosse Pointe Park^MI^48215^USA^P||^PRN^PH^^^313^9960459|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CassAIRA^MeadeAIRA^^^^^L|MTH^Mother^HL70063|1136 Uit St^^Grosse Pointe Park^MI^48215^USA^P|^PRN^PH^^^313^9960459ORC|RE||BD55J19399.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||99^RESERVED - do not use^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD55J19399.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-998|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F56Q19407^^^AIRA-TEST^MR||GladwinAIRA^MaiaAIRA^Cyrena^^^^L|ShelbyAIRA^StephanyAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1627 Reghel Cir^^Midland^MI^48670^USA^P||^PRN^PH^^^989^2752298|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GladwinAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1627 Reghel Cir^^Midland^MI^48670^USA^P|^PRN^PH^^^989^2752298ORC|RE||BF56Q19407.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||998^no vaccine administered^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF56Q19407.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2TQk-CV-CVX-999|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D56X19415^^^AIRA-TEST^MR||Palo AltoAIRA^PattyAIRA^Shakira^^^^L|La PazAIRA^NaiaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1908 Wollumerland en Nieuwkruisland Ln^^McMillan^MI^49853^USA^P||^PRN^PH^^^906^9515671|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|Palo AltoAIRA^La PazAIRA^^^^^L|MTH^Mother^HL70063|1908 Wollumerland en Nieuwkruisland Ln^^McMillan^MI^49853^USA^P|^PRN^PH^^^906^9515671ORC|RE||BD56X19415.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||999^unknown^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD56X19415.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3xcX-DE.01.01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S63U19745^^^AIRA-TEST^MR||ChambersAIRA^KerstinAIRA^Dianne^^^^L|HoughtonAIRA^HelgaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1258 Laarbeek St^^Hamtramck^MI^48212^USA^P||^PRN^PH^^^313^5059333|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChambersAIRA^HoughtonAIRA^^^^^L|MTH^Mother^HL70063|1258 Laarbeek St^^Hamtramck^MI^48212^USA^P|^PRN^PH^^^313^5059333ORC|RE||BS63U19745.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3xcX-DE.01.02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S63U19745^^^AIRA-TEST^MR||ChambersAIRA^KerstinAIRA^Dianne^^^^L|HoughtonAIRA^HelgaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1258 Laarbeek St^^Hamtramck^MI^48212^USA^P||^PRN^PH^^^313^5059333|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ChambersAIRA^HoughtonAIRA^^^^^L|MTH^Mother^HL70063|1258 Laarbeek St^^Hamtramck^MI^48212^USA^P|^PRN^PH^^^313^5059333ORC|RE||BS63U19745.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AMSH|^~\&|||||20200307144805-0700||VXU^V04^VXU_V04|2Sor-DQMQE0115|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M54X159.F9^^^AIRA-TEST^MR||LyonAIRA^KomalAIRA^Karensa^^^^L|NeorinAIRA^PhillidaAIRA^^^^^M|20210307|F||2106-3^White^CDCREC|1347 Helsen Ave^^Redford Township^MI^48239^USA^P||^PRN^PH^^^734^6489548|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LyonAIRA^PhillidaAIRA^^^^^L|MTH^Mother^HL70063|1347 Helsen Ave^^Redford Township^MI^48239^USA^P|^PRN^PH^^^734^6489548|ORC|RE||Y82Y579.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144805-0700||VXU^V04^VXU_V04|2Sor-DQMQE0116|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||O60W161.Fe^^^AIRA-TEST^MR||CottonAIRA^GlennaAIRA^Sebastiana^^^^L|ThorsenAIRA^EkaterinaAIRA^^^^^M|20210307|F||2106-3^White^CDCREC|1277 Ontwikkelen Pl^^Grosse Pointe Park^MI^48236^USA^P||^PRN^PH^^^313^8346300|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LoupAIRA^EkaterinaAIRA^^^^^L|MTH^Mother^HL70063|1277 Ontwikkelen Pl^^Grosse Pointe Park^MI^48236^USA^P|^PRN^PH^^^313^8346300|ORC|RE||U43H585.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144805-0700||VXU^V04^VXU_V04|2Sor-DQMQE0117|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J33O163.Fj^^^AIRA-TEST^MR||WrigleyAIRA^RaulAIRA^Leandro^^^^L|ThayerAIRA^AintzaneAIRA^^^^^M|DOB|M||2054-5^Black or African-American^CDCREC|1428 Goes St^^Seneca^MI^49256^USA^P||^PRN^PH^^^517^6353944|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|ThayerAIRA^AintzaneAIRA^^^^^L|MTH^Mother^HL70063|1428 Goes St^^Seneca^MI^49256^USA^P|^PRN^PH^^^517^6353944|ORC|RE||S77C589.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0118|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||V24C165.Fn^^^AIRA-TEST^MR||McIntoshAIRA^NoelAIRA^^^^^L|HobellAIRA^RosevearAIRA^^^^^M||M||2054-5^Black or African-American^CDCREC|1461 Warmte Ln^^Burton^MI^48519^USA^P||^PRN^PH^^^810^9942576|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|McIntoshAIRA^RosevearAIRA^^^^^L|MTH^Mother^HL70063|1461 Warmte Ln^^Burton^MI^48519^USA^P|^PRN^PH^^^810^9942576|ORC|RE||X35O594.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0120|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G53V169.Fw^^^AIRA-TEST^MR||TarrantAIRA^EdAIRA^C^^^^L|MestaAIRA^NatalieAIRA^^^^^M|18950115|M||2131-1^Other Race^CDCREC|1192 Nellendoorn St^^Escanaba^MI^49829^USA^P||^PRN^PH^^^906^9588402|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MestaAIRA^NatalieAIRA^^^^^L|MTH^Mother^HL70063|1192 Nellendoorn St^^Escanaba^MI^49829^USA^P|^PRN^PH^^^906^9588402|ORC|RE||U71B599.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0129|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U46E197.GD^^^AIRA-TEST^MR||VenangoAIRA^BananAIRA^Phoebe^^^^L|JolsenAIRA^ShayleeAIRA^^^^^M|20160316|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1919 Oroningen St^^Goodrich^MI^48438^USA^P||^PRN^PH^^^810^5228145|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||19500101|Y|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|VenangoAIRA^ShayleeAIRA^^^^^L|MTH^Mother^HL70063|1919 Oroningen St^^Goodrich^MI^48438^USA^P|^PRN^PH^^^810^5228145|ORC|RE||V46G604.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0130|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D35Z199.GI^^^AIRA-TEST^MR||JepsenAIRA^BodenAIRA^M^^^^L|JepsenAIRA^LucianaAIRA^^^^^M|20160307|M||2054-5^Black or African-American^CDCREC|1244 Beenendaal Ln^^Howard City^MI^49329^USA^P||^PRN^PH^^^231^8542761|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20210307|Y|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|GalliaAIRA^LucianaAIRA^^^^^L|MTH^Mother^HL70063|1244 Beenendaal Ln^^Howard City^MI^49329^USA^P|^PRN^PH^^^231^8542761|ORC|RE||Z74I610.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0131|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X40U201.GN^^^AIRA-TEST^MR||BerreenAIRA^DiamondAIRA^Abbott^^^^L|TownAIRA^ZelahAIRA^^^^^M|20160320|M||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1234 Benlo Ln^^Hartland Township^MI^48114^USA^P||^PRN^PH^^^810^3035043|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||Y|Y|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BerreenAIRA^ZelahAIRA^^^^^L|MTH^Mother^HL70063|1234 Benlo Ln^^Hartland Township^MI^48114^USA^P|^PRN^PH^^^810^3035043|ORC|RE||F65E615.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0133|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||F53L205.GX^^^AIRA-TEST^MR||MartinAIRA^CasondraAIRA^R^^^^L|OceanaAIRA^IstasAIRA^^^^^M|20160228|F||2054-5^Black or African-American^CDCREC|1079 Rudewater Cir^^Elm Hall^MI^48830^USA^P||^PRN^PH^^^989^5435244|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20200307|N|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|OceanaAIRA^IstasAIRA^^^^^L|MTH^Mother^HL70063|1079 Rudewater Cir^^Elm Hall^MI^48830^USA^P|^PRN^PH^^^989^5435244|ORC|RE||Q12K619.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0139|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S74P217.Hs^^^AIRA-TEST^MR||CastroAIRA^GauravAIRA^A^^^^L|Van BurenAIRA^SebastianaAIRA^^^^^M|20160303|M||2054-5^Black or African-American^CDCREC|1873 Quart Ln^^Fennville^MI^49408^USA^P||^PRN^PH^^^269^8206358|||||||||105 E Market St^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CastroAIRA^SebastianaAIRA^^^^^L|MTH^Mother^HL70063|1873 Quart Ln^^Fennville^MI^49408^USA^P|^PRN^PH^^^269^8206358|ORC|RE||F89A625.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0140|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||H94H275.JF^^^AIRA-TEST^MR||ClevelandAIRA^Apt #5^Akana^^^^L|San Luis ObispoAIRA^RosAIRA^^^^^M|20160303|F||2106-3^White^CDCREC|1022 Warneveld Ln^^Muskegon^MI^49442^USA^P||^PRN^PH^^^231^9512109|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|San Luis ObispoAIRA^RosAIRA^^^^^L|MTH^Mother^HL70063|1022 Warneveld Ln^^Muskegon^MI^49442^USA^P|^PRN^PH^^^231^9512109|ORC|RE||D41B628.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||P48F277.JK^^^AIRA-TEST^MR||LinnAIRA^^H^^^^L|BourbonAIRA^ArabelleAIRA^^^^^M|20160304|M||2106-3^White^CDCREC|1471 Veldhoven Ln^^Clarksville^MI^48815^USA^P||^PRN^PH^^^616^5543877|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LinnAIRA^ArabelleAIRA^^^^^L|MTH^Mother^HL70063|1471 Veldhoven Ln^^Clarksville^MI^48815^USA^P|^PRN^PH^^^616^5543877|ORC|RE||G67U632.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0146|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Z52G225.HJ^^^AIRA-TEST^MR||NolanAIRA^NarrahAIRA^Matt^^^^L|ParasariAIRA^IrvetteAIRA^^^^^M|20160226|||2106-3^White^CDCREC|1920 Dmersfoort Ave^^Grand Rapids^MI^49525^USA^P||^PRN^PH^^^616^5468868|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|NolanAIRA^IrvetteAIRA^^^^^L|MTH^Mother^HL70063|1920 Dmersfoort Ave^^Grand Rapids^MI^49525^USA^P|^PRN^PH^^^616^5468868|ORC|RE||L38T637.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0147|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0147^^^AIRA-TEST^MR||BoyleAIRA^AyianaAIRA^Ivana^^^^L|AlfalfaAIRA^LastriAIRA^^^^^M|20160228|A||1002-5^American Indian or Alaska Native^CDCREC|1658 Daalte Cir^^York Township^MI^48160^USA^P||^PRN^PH^^^734^5252768|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BoyleAIRA^LastriAIRA^^^^^L|MTH^Mother^HL70063|1658 Daalte Cir^^York Township^MI^48160^USA^P|^PRN^PH^^^734^5252768|ORC|RE||R66E641.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0165|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W31G281.JV^^^AIRA-TEST^MR||Apt #5^DeieneAIRA^^^^^L|FremontAIRA^UnaAIRA^^^^^M|20160307|F||2028-9^Asian^CDCREC|1597 Umallingerland Ln^^Brownstown Township^MI^48164^USA^P||^PRN^PH^^^734^5553611|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|KimballAIRA^UnaAIRA^^^^^L|MTH^Mother^HL70063|1597 Umallingerland Ln^^Brownstown Township^MI^48164^USA^P|^PRN^PH^^^734^5553611|ORC|RE||D66H644.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0166|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Q04A283.K0^^^AIRA-TEST^MR||^ClancyAIRA^B^^^^L|PocahontasAIRA^NabelungAIRA^^^^^M|20160305|M||2106-3^White^CDCREC|1209 Gijnwaarden Ln^^Bellaire^MI^49615^USA^P||^PRN^PH^^^231^8499112|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LindstromAIRA^NabelungAIRA^^^^^L|MTH^Mother^HL70063|1209 Gijnwaarden Ln^^Bellaire^MI^49615^USA^P|^PRN^PH^^^231^8499112|ORC|RE||C55M651.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0200|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J04J371.Nn^^^AIRA-TEST^MR||HubbardAIRA^AneiraAIRA^Kathie^^^^L|HubbardAIRA^MalayaAIRA^^^^^M|20160311|F||2054-5^Black or African-American^CDCREC|1664 Heerlen Ave^^Gay^MI^49945^USA^P||^PRN^PH^^^906^5018803|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|Y|20160311|||A|20200307|20200307|NK1|1|OsceolaAIRA^MalayaAIRA^^^^^L|MTH^Mother^HL70063|1664 Heerlen Ave^^Gay^MI^49945^USA^P|^PRN^PH^^^906^5018803|ORC|RE||X81A657.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0220|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||^^^^||BinghamAIRA^JarredAIRA^Sabre^^^^L|BrikkeAIRA^AbhilashaAIRA^^^^^M|20160229|M||2106-3^White^CDCREC|1960 Zof van Twente Pl^^Orion Township^MI^48362^USA^P||^PRN^PH^^^248^6546623|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BinghamAIRA^AbhilashaAIRA^^^^^L|MTH^Mother^HL70063|1960 Zof van Twente Pl^^Orion Township^MI^48362^USA^P|^PRN^PH^^^248^6546623|ORC|RE||I13F664.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0244|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W67K473.Rp^^^AIRA-TEST^MR||SmithAIRA^BentonAIRA^Ilhan^^^^L|HabberstadAIRA^DrewAIRA^^^^^M|20160313|M||2106-3^White^CDCREC|1623 Leusel-De Mierden St^^Bloomingdale^MI^49026^USA^P||^PRN^PH^^^269^8262825|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|SmithAIRA^DrewAIRA^^^^^L|MTH^Mother^HL70063|1623 Leusel-De Mierden St^^Bloomingdale^MI^49026^USA^P|^PRN^PH^^^269^8262825|ORC|RE||L43R670.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0247|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R20T481.RH^^^AIRA-TEST^MR||LoveAIRA^BehiraAIRA^Bettina^^^^L|HansonAIRA^GiuliettaAIRA^^^^^M|20160224|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1840 Oloemendaal Pl^^Lambertville^MI^48144^USA^P||^PRN^PH^^^734^8203257|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HansonAIRA^GiuliettaAIRA^^^^^L|MTH^Mother^HL70063|1840 Oloemendaal Pl^^Lambertville^MI^48144^USA^P|^PRN^PH^^^734^8203257|ORC|RE||P26B675.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||PCV^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0252|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T94A495.Sd^^^AIRA-TEST^MR||LincolnAIRA^KenanAIRA^Z^^^^L|LamarAIRA^MaireadAIRA^^^^^M|20160226|M||1002-5^American Indian or Alaska Native^CDCREC|1443 Moes Cir^^Moran^MI^49760^USA^P||^PRN^PH^^^906^8087639|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HutchinsonAIRA^MaireadAIRA^^^^^L|MTH^Mother^HL70063|1443 Moes Cir^^Moran^MI^49760^USA^P|^PRN^PH^^^906^8087639|ORC|RE||H69P681.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20210307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0253|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X42O497.Sh^^^AIRA-TEST^MR||HowathAIRA^DaneAIRA^C^^^^L|PiscataquisAIRA^ElbertineAIRA^^^^^M|20160324|M||2054-5^Black or African-American^CDCREC|1125 Lift Ln^^GR^MI^49548^USA^P||^PRN^PH^^^616^5929517|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20160324|Y|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HowathAIRA^ElbertineAIRA^^^^^L|MTH^Mother^HL70063|1125 Lift Ln^^GR^MI^49548^USA^P|^PRN^PH^^^616^5929517|ORC|RE||K13H687.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144806-0700||VXU^V04^VXU_V04|2Sor-DQMQE0255|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||B61W501.Sq^^^AIRA-TEST^MR||KolarAIRA^AlikaAIRA^Karsa^^^^L|SulitAIRA^LeonaAIRA^^^^^M|20160320|M||2054-5^Black or African-American^CDCREC|1220 Perkendam Ave^^Kalamazoo^MI^49005^USA^P||^PRN^PH^^^269^3013805|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|SulitAIRA^LeonaAIRA^^^^^L|MTH^Mother^HL70063|1220 Perkendam Ave^^Kalamazoo^MI^49005^USA^P|^PRN^PH^^^269^3013805|ORC|RE||A38J693.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|19700101||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0257|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W32P505.SA^^^AIRA-TEST^MR||JensenAIRA^RaiAIRA^Briella^^^^L|CedarAIRA^TeresaAIRA^^^^^M|20160316|F||2106-3^White^CDCREC|1994 Soord-Beveland St^^Lansing^MI^48919^USA^P||^PRN^PH^^^517^2771245|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|JensenAIRA^TeresaAIRA^^^^^L|MTH^Mother^HL70063|1994 Soord-Beveland St^^Lansing^MI^48919^USA^P|^PRN^PH^^^517^2771245|ORC|RE||Q16H700.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||01^DTP^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0260|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M88P511.SS^^^AIRA-TEST^MR||HammarAIRA^NormAIRA^^^^^L|JohnsonAIRA^SariahAIRA^^^^^M|20160308|M||2106-3^White^CDCREC|1963 Nerwerderadeel Cir^^Newaygo^MI^49337^USA^P||^PRN^PH^^^231^7140486|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|JohnsonAIRA^SariahAIRA^^^^^L|MTH^Mother^HL70063|1963 Nerwerderadeel Cir^^Newaygo^MI^49337^USA^P|^PRN^PH^^^231^7140486|ORC|RE||C83L707.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|MMR||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0261|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R28X513.SX^^^AIRA-TEST^MR||TereAIRA^JordynAIRA^D^^^^L|JonesAIRA^GiuliaAIRA^^^^^M|20160313|M||2054-5^Black or African-American^CDCREC|1350 Plannen Ln^^Sidney^MI^48885^USA^P||^PRN^PH^^^989^4232362|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|TereAIRA^GiuliaAIRA^^^^^L|MTH^Mother^HL70063|1350 Plannen Ln^^Sidney^MI^48885^USA^P|^PRN^PH^^^989^4232362|ORC|RE||X00H710.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0289|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J69F577.Vw^^^AIRA-TEST^MR||StanislausAIRA^KlimentAIRA^Zowie^^^^L|OtsegoAIRA^SagaraAIRA^^^^^M|20160306|M||2028-9^Asian^CDCREC|1401 Begeleiden St^^Leslie^MI^49251^USA^P||^PRN^PH^^^517^4657023|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|OtsegoAIRA^SagaraAIRA^^^^^L|MTH^Mother^HL70063|1401 Begeleiden St^^Leslie^MI^49251^USA^P|^PRN^PH^^^517^4657023|ORC|RE||W63K713.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||MMR|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0308|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S70D621.XE^^^AIRA-TEST^MR||BayAIRA^BalderAIRA^^^^^L|CooperAIRA^AzariaAIRA^^^^^M|20160228|M||2106-3^White^CDCREC|1194 Molecuul Cir^^Drummond Island^MI^49726^USA^P||^PRN^PH^^^906^6963788|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BayAIRA^AzariaAIRA^^^^^L|MTH^Mother^HL70063|1194 Molecuul Cir^^Drummond Island^MI^49726^USA^P|^PRN^PH^^^906^6963788|ORC|RE||K76G718.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0310^^^AIRA-TEST^MR||MarionAIRA^CherAIRA^Shashi^^^^L|NorthumberlandAIRA^NathalieAIRA^^^^^M|20160226|F||1002-5^American Indian or Alaska Native^CDCREC|1031 Lijst Pl^^Manitou Beach^MI^49253^USA^P||^PRN^PH^^^517^5641461|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MarionAIRA^NathalieAIRA^^^^^L|MTH^Mother^HL70063|1031 Lijst Pl^^Manitou Beach^MI^49253^USA^P|^PRN^PH^^^517^5641461|ORC|RE||U71N724.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX^90744^HepB^C4|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0314|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G28E635.Yp^^^AIRA-TEST^MR||SomersetAIRA^ImogenAIRA^Ragnhild^^^^L|BurnetAIRA^AvaraAIRA^^^^^M|20160301|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1072 Zucphen St^^Detroit^MI^48264^USA^P||^PRN^PH^^^313^9206844|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BurnetAIRA^AvaraAIRA^^^^^L|MTH^Mother^HL70063|1072 Zucphen St^^Detroit^MI^48264^USA^P|^PRN^PH^^^313^9206844|ORC|RE||E22C732.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0332|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G93C691.11h^^^AIRA-TEST^MR||ChambersAIRA^BodAIRA^Pisanio^^^^L|HarrisonAIRA^ThaliaAIRA^^^^^M|20160228|M||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1958 Aanbod Ave^^Rogers City^MI^49779^USA^P||^PRN^PH^^^989^5602923|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CokeAIRA^ThaliaAIRA^^^^^L|MTH^Mother^HL70063|1958 Aanbod Ave^^Rogers City^MI^49779^USA^P|^PRN^PH^^^989^5602923|ORC|RE||Q29O739.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0333|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0333^^^AIRA-TEST^MR||RoscommonAIRA^BurchardAIRA^Rimon^^^^L|YavapaiAIRA^OpalineAIRA^^^^^M|20160313|M||2106-3^White^CDCREC|1688 Zuidplas Pl^^De Witt^MI^48820^USA^P||^PRN^PH^^^517^3622270|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BurlesonAIRA^OpalineAIRA^^^^^L|MTH^Mother^HL70063|1688 Zuidplas Pl^^De Witt^MI^48820^USA^P|^PRN^PH^^^517^3622270|ORC|RE||G98V745.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||LA^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0359|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0359^^^AIRA-TEST^MR||LucasAIRA^JennyAIRA^Senta^^^^L|McLennanAIRA^MikaelaAIRA^^^^^M|20160302|F||2106-3^White^CDCREC|1075 Caarlemmermeer Cir^^DTE^MI^48260^USA^P||^PRN^PH^^^313^8865198|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|ChesterAIRA^MikaelaAIRA^^^^^L|MTH^Mother^HL70063|1075 Caarlemmermeer Cir^^DTE^MI^48260^USA^P|^PRN^PH^^^313^8865198|ORC|RE||G82I751.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|00^Parental Decision||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0366|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||H21Y803.16n^^^AIRA-TEST^MR||BonnevilleAIRA^PindarusAIRA^Ballard^^^^L|CampAIRA^DayaAIRA^^^^^M|20160306|M||2106-3^White^CDCREC|1105 Lundert Cir^^Whittaker^MI^48190^USA^P||^PRN^PH^^^734^9848398|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CampAIRA^DayaAIRA^^^^^L|MTH^Mother^HL70063|1105 Lundert Cir^^Whittaker^MI^48190^USA^P|^PRN^PH^^^734^9848398|ORC|RE||A56F758.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|Harvey|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0467|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R47H655.Zy^^^AIRA-TEST^MR||ColusaAIRA^TristessaAIRA^^^^^L|HowardAIRA^BrankaAIRA^^^^^M|20160309|F||2106-3^White^CDCREC|1075 Todegraven-Reeuwijk Cir^^Seney^MI^49883^USA^P||^PRN^PH^^^906^2699919|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|ColusaAIRA^BrankaAIRA^^^^^L|MTH^Mother^HL70063|1075 Todegraven-Reeuwijk Cir^^Seney^MI^49883^USA^P|^PRN^PH^^^906^2699919|ORC|RE||O17A765.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V00^VFC eligibility unknown^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0468|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||B17L657.ZF^^^AIRA-TEST^MR||MeadeAIRA^VladilenAIRA^Naresh^^^^L|HardinAIRA^RoseAIRA^^^^^M|20160228|M||1002-5^American Indian or Alaska Native^CDCREC|1673 Rudewater Ln^^Flint^MI^48531^USA^P||^PRN^PH^^^810^5693665|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HardinAIRA^RoseAIRA^^^^^L|MTH^Mother^HL70063|1673 Rudewater Ln^^Flint^MI^48531^USA^P|^PRN^PH^^^810^5693665|ORC|RE||F79T769.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|^^||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0469|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C67P659.ZM^^^AIRA-TEST^MR||HawkeAIRA^HaldanaAIRA^Callisto^^^^L|BaragaAIRA^WillaAIRA^^^^^M|20160313|F||2106-3^White^CDCREC|1042 Tarneveld St^^Mason^MI^48854^USA^P||^PRN^PH^^^517^2395423|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BaragaAIRA^WillaAIRA^^^^^L|MTH^Mother^HL70063|1042 Tarneveld St^^Mason^MI^48854^USA^P|^PRN^PH^^^517^2395423|ORC|RE||P65A775.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|ZZZ01^VFC Eligible^||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0491|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M25G471.Rl^^^AIRA-TEST^MR||WrightAIRA^StoddardAIRA^Putnam^^^^L|GladwinAIRA^DalilaAIRA^^^^^M|20160311|M||2106-3^White^CDCREC|1766 Dpmeer Ln^^Benton Harbor^MI^49023^USA^P||^PRN^PH^^^269^4926017|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|WrightAIRA^DalilaAIRA^^^^^L|MTH^Mother^HL70063|1766 Dpmeer Ln^^Benton Harbor^MI^49023^USA^P|^PRN^PH^^^269^4926017|ORC|RE||H98Z781.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||01^DTP^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0493|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X66Y771.152^^^AIRA-TEST^MR||FranklinAIRA^BryantAIRA^G^^^^L|AlconaAIRA^JamyaAIRA^^^^^M|20160308|M||2106-3^White^CDCREC|1908 He Fryske Marren Ave^^Fountain^MI^49410^USA^P||^PRN^PH^^^231^9944391|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|AlconaAIRA^JamyaAIRA^^^^^L|MTH^Mother^HL70063|1908 He Fryske Marren Ave^^Fountain^MI^49410^USA^P|^PRN^PH^^^231^9944391|ORC|RE||D17E787.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||02^OPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||WAL^Wyeth^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0058|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C64I5.v1^^^AIRA-TEST^MR||BlancoAIRA^SolveigAIRA^P^^^^L|WallerAIRA^BedaAIRA^^^^^M|20160319|F||2131-1^Other Race^CDCREC|1973 Neurne Pl^^Fenwick^MI^48834^USA^P||^PRN^PH^^^989^7699024|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|WallerAIRA^BedaAIRA^^^^^L|MTH^Mother^HL70063|1973 Neurne Pl^^ANYTOWN^MI^48834^USA^P|^PRN^PH^^^989^7699024|ORC|RE||U99Y793.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0064|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J61Y17.w7^^^AIRA-TEST^MR||LarssenAIRA^VevetteAIRA^S^^^^L|IdaAIRA^SabaAIRA^^^^^M|20160306|F||2054-5^Black or African-American^CDCREC|1345 Hoed Pl^^Cloverdale^MI^49035^USA^P||^PRN^PH^^^269^8416810|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|ClayAIRA^SabaAIRA^^^^^L|MTH^Mother^HL70063|1345 Hoed Pl^^Cloverdale^MI^49035^SOMETHING^P|^PRN^PH^^^269^8416810|ORC|RE||N97S799.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0074|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Z62I37.y7^^^AIRA-TEST^MR||NewtonAIRA^MalakAIRA^^^^^L|LincolnAIRA^MeghaAIRA^^^^^M|20160309|F||2054-5^Black or African-American^CDCREC|1620 Hen Pl^^Wolverine Lake^MI^48390^USA^P||^PRN^PH^^^248^9731556|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|NewtonAIRA^MeghaAIRA^^^^^L|MTH^Mother^HL70063|1620 Hen Pl^^Wolverine Lake^Mass^48390^USA^P|^PRN^PH^^^248^9731556|ORC|RE||B89L805.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0077|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X84L55.z2^^^AIRA-TEST^MR||HofflundAIRA^AramintaAIRA^Rane^^^^L|PettersonAIRA^ElyseAIRA^^^^^M|20160319|F||2054-5^Black or African-American^CDCREC|1525 Wlissingen Pl^^Eben Junction^MI^49825^USA^P||^PRN^PH^^^906^4835705|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HofflundAIRA^ElyseAIRA^^^^^L|MTH^Mother^HL70063|1525 Wlissingen Pl^^Eben Junction^MI^9o21o^USA^P|^PRN^PH^^^906^4835705|ORC|RE||X63N810.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0079|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S25P59.zk^^^AIRA-TEST^MR||MahoningAIRA^MarielleAIRA^Z^^^^L|WerstadAIRA^AlleneAIRA^^^^^M|20160304|F||2054-5^Black or African-American^CDCREC|1371 Werelddeel St^^Wolverine Lake^MI^48390^USA^P||^PRN^PH^^^248^3714382|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|^^^^^^L|MTH^Mother^HL70063|1371 Werelddeel St^^Wolverine Lake^MI^48390^USA^P|^PRN^PH^^^248^3714382|ORC|RE||V71B816.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0080|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D98X61.zr^^^AIRA-TEST^MR||HarlanAIRA^BertAIRA^Abi^^^^L|CaribouAIRA^RinzenAIRA^^^^^M|20160307|M||2106-3^White^CDCREC|1247 Nardenberg St^^Grayling^MI^49738^USA^P||^PRN^PH^^^989^2685988|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CaribouAIRA^^^^^^L|MTH^Mother^HL70063|1247 Nardenberg St^^Grayling^MI^49738^USA^P|^PRN^PH^^^989^2685988|ORC|RE||C81Z824.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0081|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T90Z63.zy^^^AIRA-TEST^MR||GreeleyAIRA^SheetalAIRA^Adelina^^^^L|StarrAIRA^KrupaliAIRA^^^^^M|20160318|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1877 Zarum Pl^^Shelby Township^MI^48316^USA^P||^PRN^PH^^^586^8607350|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|^KrupaliAIRA^^^^^L|MTH^Mother^HL70063|1877 Zarum Pl^^Shelby Township^MI^48316^USA^P|^PRN^PH^^^586^8607350|ORC|RE||W84W831.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0082|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D04T65.zE^^^AIRA-TEST^MR||EmmetAIRA^HelouseAIRA^^^^^L|WolfeAIRA^YumakoAIRA^^^^^M|20160315|F||2106-3^White^CDCREC|1360 Hoeree-Overflakkee Cir^^Essexville^MI^48732^USA^P||^PRN^PH^^^989^7339057|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|EmmetAIRA^YumakoAIRA^^^^^L|MTH^Mother^HL70063|1360 Hoeree-Overflakkee Cir^^Essexville^MI^48732^USA^P|^PRN^PH^^^^7339057|ORC|RE||B24U837.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0083|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y92P67.zM^^^AIRA-TEST^MR||KalamazooAIRA^AsztrikAIRA^Gamaliel^^^^L|McErlaineAIRA^IphigeniaAIRA^^^^^M|20160301|M||1002-5^American Indian or Alaska Native^CDCREC|1462 Harderwijk Pl^^Deerton^MI^49822^USA^P||^PRN^PH^^^906^2551956|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|NanceAIRA^IphigeniaAIRA^^^^^L|MTH^Mother^HL70063|1462 Harderwijk Pl^^Deerton^MI^49822^USA^P|^PRN^PH^^^APPLE GATE^2551956|ORC|RE||H67S842.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144807-0700||VXU^V04^VXU_V04|2Sor-DQMQE0088|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C89F77.Ak^^^AIRA-TEST^MR||MenifeeAIRA^VolettaAIRA^Brenna^^^^L|FremstadAIRA^MirabelAIRA^^^^^M|20160311|F||2106-3^White^CDCREC|1326 Meek St^^Dexter^MI^48130^USA^P||^PRN^PH^^^734^6455055|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|FremstadAIRA^MirabelAIRA^^^^^L|^^|1326 Meek St^^Dexter^MI^48130^USA^P|^PRN^PH^^^734^6455055|ORC|RE||Q53K848.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0090|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M29F83.AE^^^AIRA-TEST^MR||MadisonAIRA^MaliahAIRA^J^^^^L|PikeAIRA^AriadneAIRA^^^^^M|20160315|F||2054-5^Black or African-American^CDCREC|1402 Beumen Pl^^Oakland^MI^48363^USA^P||^PRN^PH^^^248^6295733|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HamiltonAIRA^AriadneAIRA^^^^^L|DS^Dog Sitter^HL70063|1402 Beumen Pl^^Oakland^MI^48363^USA^P|^PRN^PH^^^248^6295733|ORC|RE||W17G855.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0099|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W11G115.CT^^^AIRA-TEST^MR||HartAIRA^ZorroAIRA^Joziah^^^^L|ModocAIRA^SnehaAIRA^^^^^M|20160301|M||2106-3^White^CDCREC|1556 Hexel Pl^^Hamtramck^MI^48212^US of A^P||^PRN^PH^^^313^9389872|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CallowayAIRA^SnehaAIRA^^^^^L|MTH^Mother^HL70063|1556 Hexel Pl^^Hamtramck^MI^48212^USA^P|^PRN^PH^^^313^9389872|ORC|RE||B52A861.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0112|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X09C153.EW^^^AIRA-TEST^MR||PerkinsAIRA^KaliyahAIRA^Tekla^^^^L|ClarkAIRA^LizzieAIRA^^^^^M|20160309|F||2106-3^White^CDCREC|1373 Bill en Sint Hubert St^^Niles^MI^50^USA^P||^PRN^PH^^^269^5730090|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|PerkinsAIRA^LizzieAIRA^^^^^L|MTH^Mother^HL70063|1373 Bill en Sint Hubert St^^Niles^MI^49120^USA^P|^PRN^PH^^^269^5730090|ORC|RE||G04B867.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0121|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W66F171.FB^^^AIRA-TEST^MR||O NeillAIRA^SeligAIRA^Somerset^^^^L|BellAIRA^LenoraAIRA^^^^^M|20160307|M||2106-3^White^CDCREC|1326 Bruin Pl^^Moran^MI^49760^USA^P||^PRN^PH^^^906^3827284|||||||||2186-5^not Hispanic or Latino^CDCREC||X|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|O NeillAIRA^LenoraAIRA^^^^^L|MTH^Mother^HL70063|1326 Bruin Pl^^Moran^MI^49760^USA^P|^PRN^PH^^^906^3827284|ORC|RE||O61H871.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0123|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A54U175.FO^^^AIRA-TEST^MR||HaskellAIRA^BryonyAIRA^^^^^L|HughesAIRA^GuidaAIRA^^^^^M|20160313|F||2106-3^White^CDCREC|1350 Raaren Pl^^Mason^MI^48854^USA^P||^PRN^PH^^^517^7128445|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|Twin|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HaskellAIRA^GuidaAIRA^^^^^L|MTH^Mother^HL70063|1350 Raaren Pl^^Mason^MI^48854^USA^P|^PRN^PH^^^517^7128445|ORC|RE||H96R875.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0135|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||L49O209.H6^^^AIRA-TEST^MR||LatahAIRA^MariashaAIRA^^^^^L|JonesAIRA^RayneAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1377 Neemskerk Pl^^Ironwood^MI^49938^USA^P||^PRN^PH^^^906^8921692|||||||||H^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LatahAIRA^RayneAIRA^^^^^L|MTH^Mother^HL70063|1377 Neemskerk Pl^^Ironwood^MI^49938^USA^P|^PRN^PH^^^906^8921692|ORC|RE||C67C878.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0153|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||F53F243.Im^^^AIRA-TEST^MR||HardinAIRA^PenroseAIRA^A^^^^L|OscodaAIRA^VesperaAIRA^^^^^M|20160305|M||2054-5^Black or African-American^CDCREC|1758 Gerneuzen Pl^^Hamburg^MI^48139^USA^P||^PRN^PH^^^810^7397498|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HardinAIRA^^^^^^L|MTH^Mother^HL70063|1758 Gerneuzen Pl^^Hamburg^MI^48139^USA^P|^PRN^PH^^^810^7397498|ORC|RE||P63M882.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0154|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C99V245.Iq^^^AIRA-TEST^MR||LieAIRA^CassandraAIRA^T^^^^L|PolkAIRA^SonnenscheinAIRA^^^^^M|20160302|F||2106-3^White^CDCREC|1699 Veilig Cir^^Onsted^MI^49265^USA^P||^PRN^PH^^^517^7632210|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|^SonnenscheinAIRA^^^^^L|MTH^Mother^HL70063|1699 Veilig Cir^^Onsted^MI^49265^USA^P|^PRN^PH^^^517^7632210|ORC|RE||H04W887.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0155|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X72T239.Id^^^AIRA-TEST^MR||MonroeAIRA^HeaAIRA^Fruma^^^^L|MonroeAIRA^TemiraAIRA^^^^^M|20160321|F||2054-5^Black or African-American^CDCREC|1176 Spoor Ln^^Bradley^MI^49311^USA^P||^PRN^PH^^^269^9360686|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|^^^^^^L|MTH^Mother^HL70063|1176 Spoor Ln^^Bradley^MI^49311^USA^P|^PRN^PH^^^269^9360686|ORC|RE||T54Z891.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0157|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A57X247.Iv^^^AIRA-TEST^MR||TaylorAIRA^TamaraAIRA^L^^^^L|GageAIRA^KarlaAIRA^^^^^M|20160227|F||2106-3^White^CDCREC|1884 Heurne Ave^^Alma^MI^48802^USA^P||^PRN^PH^^^989^5921067|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|TaylorAIRA^KarlaAIRA^^^^^L|MTH^Mother^HL70063|1884 Heurne Ave^^Alma^MI^48802^USA^P|^PRN^PH^^^989^5921067|ORC|RE||I50H895.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0159|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y46Y251.ID^^^AIRA-TEST^MR||AdamsAIRA^WidAIRA^Tarang^^^^L|DubuqueAIRA^RaquelleAIRA^^^^^M|20160314|M||2028-9^Asian^CDCREC|1338 Aubbergen St^^Walker^MI^49534^USA^P||^PRN^PH^^^616^9914345|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|TkrenAIRA^RaquelleAIRA^^^^^L|^Mother^HL70063|1338 Aubbergen St^^Walker^MI^49534^USA^P|^PRN^PH^^^616^9914345|ORC|RE||D69P899.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0164|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||N38N261.J3^^^AIRA-TEST^MR||TuolumneAIRA^GaynorAIRA^Sonnenschein^^^^L|MinidokaAIRA^LucinaAIRA^^^^^M|20160312|F||2106-3^White^CDCREC|1601 Ke Ronde Venen Pl^^Dearborn^MI^48126^USA^P||^PRN^PH^^^313^5757470|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||MMR|20200307|20200307|NK1|1|TuolumneAIRA^LucinaAIRA^^^^^L|MTH^Mother^HL70063|1601 Ke Ronde Venen Pl^^Dearborn^MI^48126^USA^P|^PRN^PH^^^313^5757470|ORC|RE||X39T903.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0174|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M74A299.KG^^^AIRA-TEST^MR||CusackAIRA^TamoraAIRA^Tonya^^^^L|HardinAIRA^XaquelinaAIRA^^^^^M|20160301|F||2106-3^White^CDCREC|1807 Zoerdijk Pl^^Grosse Pointe Farms^MI^48236^USA^P||4139179^PRN^PH^^^^4139179|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HardinAIRA^XaquelinaAIRA^^^^^L|MTH^Mother^HL70063|1807 Zoerdijk Pl^^Grosse Pointe Farms^MI^48236^USA^P|^PRN^PH^^^313^4139179|ORC|RE||J92T906.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0175|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S95I301.KK^^^AIRA-TEST^MR||WellsAIRA^DavisAIRA^Jayant^^^^L|FayetteAIRA^CairistionaAIRA^^^^^M|20160229|M||2106-3^White^CDCREC|1716 Brak Cir^^Jackson^MI^49203^USA^P||104 E Market St^^Allegany^^^MI^04599|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|WellsAIRA^CairistionaAIRA^^^^^L|MTH^Mother^HL70063|1716 Brak Cir^^Jackson^MI^49203^USA^P|^PRN^PH^^^517^2874520|ORC|RE||A70T911.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0198|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C60J367.Ne^^^AIRA-TEST^MR||FitzpatrickAIRA^ChetAIRA^Raphael^^^^L|SimmingsenAIRA^TarshaAIRA^^^^^M|20160304|M||2106-3^White^CDCREC|1006 Weumen Pl^^Edmore^MI^48829^USA^P||^PRN^PH^^^989^3995199|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|(555)555-1234||||A|20200307|20200307|NK1|1|FitzpatrickAIRA^TarshaAIRA^^^^^L|MTH^Mother^HL70063|1006 Weumen Pl^^Edmore^MI^48829^USA^P|^PRN^PH^^^989^3995199|ORC|RE||C15Z915.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0205|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||N37Z381.NP^^^AIRA-TEST^MR||KitsapAIRA^MayraAIRA^^^^^L|SwindellsAIRA^EfterpiAIRA^^^^^M|20160316|F||2106-3^White^CDCREC|1907 Leugen Ave^^Perry^MI^48872^USA^P||^PRN^PH^^^517^7906045|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||(505)555-1234^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|KitsapAIRA^EfterpiAIRA^^^^^L|MTH^Mother^HL70063|1907 Leugen Ave^^Perry^MI^48872^USA^P|^PRN^PH^^^517^7906045|ORC|RE||G15Q919.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0206|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R88M383.NU^^^AIRA-TEST^MR||CarrollAIRA^ZuzanaAIRA^G^^^^L|LyonAIRA^BalaAIRA^^^^^M|20160319|F||I^White^CDCREC|1018 Geven Ave^^Augusta^MI^49012^USA^P||^PRN^PH^^^269^3731000|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CarrollAIRA^BalaAIRA^^^^^L|MTH^Mother^HL70063|1018 Geven Ave^^Augusta^MI^49012^USA^P|^PRN^PH^^^269^3731000|ORC|RE||K98Z923.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X47C391.Oc^^^AIRA-TEST^MR||LaneAIRA^LadomarAIRA^Rudy^^^^L|MarquetteAIRA^AyushiAIRA^^^^^M|20160323|M||108 N Main St^White^CDCREC|1681 Teventer Ln^^Rochester Hls^MI^48307^USA^P||^PRN^PH^^^248^3725927|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MasonAIRA^AyushiAIRA^^^^^L|MTH^Mother^HL70063|1681 Teventer Ln^^Rochester Hls^MI^48307^USA^P|^PRN^PH^^^248^3725927|ORC|RE||V66H927.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0217|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S19M405.OK^^^AIRA-TEST^MR||ErikssonAIRA^BiondelloAIRA^A^^^^L|CannavinAIRA^CeanaAIRA^^^^^M|20160318|M||2106-3^White^CDCREC|1030 Castricum Ln^^Coleman^MI^48618^USA^P||^PRN^PH^^^989^2658455|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||Immu-compromised|20200307|20200307|NK1|1|ErikssonAIRA^CeanaAIRA^^^^^L|MTH^Mother^HL70063|1030 Castricum Ln^^Coleman^MI^48618^USA^P|^PRN^PH^^^989^2658455|ORC|RE||W12Q931.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0218|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C30O407.OO^^^AIRA-TEST^MR~123456789^^^USA^SS||KentAIRA^SaundersAIRA^O^^^^L|MaderaAIRA^JosslynAIRA^^^^^M|20160229|M||2106-3^White^CDCREC|1948 Woppersum Ln^^Brethren^MI^49619^USA^P||^PRN^PH^^^231^8968180|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|KentAIRA^JosslynAIRA^^^^^L|MTH^Mother^HL70063|1948 Woppersum Ln^^Brethren^MI^49619^USA^P|^PRN^PH^^^231^8968180|ORC|RE||N58F935.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0236|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||K59O455.QH^^^AIRA-TEST^MR||FayetteAIRA^WinsomeAIRA^^^^^L|HardingAIRA^SnigdhaAIRA^^^^^M|20160306|F||2054-5^Black or African-American^CDCREC|1964 Reertruidenberg Cir^^Southfield^MI^48034^USA^P||^PRN^PH^^^248^2869875|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HardingAIRA^SnigdhaAIRA^^^^^L|MTH^Mother^HL70063|1964 Reertruidenberg Cir^^Southfield^MI^48034^USA^P|^PRN^PH^^^248^2869875|ORC|RE||A67A939.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|P|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0245|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Z58K475.Ru^^^AIRA-TEST^MR||JohnsonAIRA^ConstanceAIRA^Meckenzie^^^^L|RobertsonAIRA^ToralAIRA^^^^^M|20160308|F||2106-3^White^CDCREC|1348 Vtichtse Vecht Ln^^Kentwood^MI^49518^USA^P||^PRN^PH^^^616^2615259|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|JohnsonAIRA^ToralAIRA^^^^^L|MTH^Mother^HL70063|1348 Vtichtse Vecht Ln^^Kentwood^MI^49518^USA^P|^PRN^PH^^^616^2615259|ORC|RE||I48Q943.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||45^Hep B, unspecified formulation^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144808-0700||VXU^V04^VXU_V04|2Sor-DQMQE0249|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G86J485.RQ^^^AIRA-TEST^MR||AshtabulaAIRA^OtisAIRA^A^^^^L|WoodsAIRA^ZerlinaAIRA^^^^^M|20160309|M||2106-3^White^CDCREC|1141 Graad Ave^^Farmingtn Hls^MI^48336^USA^P||^PRN^PH^^^248^2325378|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MuskingumAIRA^ZerlinaAIRA^^^^^L|MTH^Mother^HL70063|1141 Graad Ave^^Farmingtn Hls^MI^48336^USA^P|^PRN^PH^^^248^2325378|ORC|RE||K38N947.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||999^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0251|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M31I493.S8^^^AIRA-TEST^MR||MathiesenAIRA^StellaAIRA^Thana^^^^L|HopkinsAIRA^AcediaAIRA^^^^^M|20160306|F||2054-5^Black or African-American^CDCREC|1605 Rernheze Ave^^Oak Park^MI^48237^USA^P||^PRN^PH^^^248^4937914|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HopkinsAIRA^AcediaAIRA^^^^^L|MTH^Mother^HL70063|1605 Rernheze Ave^^Oak Park^MI^48237^USA^P|^PRN^PH^^^248^4937914|ORC|RE||P82P951.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP|20160306|MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0256|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U19F503.Sv^^^AIRA-TEST^MR||AudubonAIRA^MaureenAIRA^Malavika^^^^L|RomsvigAIRA^KeishaAIRA^^^^^M|20011010|F||2054-5^Black or African-American^CDCREC|1088 Plaats Pl^^Treetops Vil^MI^49735^USA^P||^PRN^PH^^^989^9780105|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|AudubonAIRA^KeishaAIRA^^^^^L|MTH^Mother^HL70063|1088 Plaats Pl^^Treetops Vil^MI^49735^USA^P|^PRN^PH^^^989^9780105|ORC|RE||K96A955.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20100301||100^pneumococcal conjugate PCV 7^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0258|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A18N507.SI^^^AIRA-TEST^MR||AldridgeAIRA^ErnestineAIRA^Allayna^^^^L|TexasAIRA^ChaneAIRA^^^^^M|20160316|F||2106-3^White^CDCREC|1482 Neesp Ln^^Imlay City^MI^48444^USA^P||^PRN^PH^^^810^8690648|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|TexasAIRA^ChaneAIRA^^^^^L|MTH^Mother^HL70063|1482 Neesp Ln^^Imlay City^MI^48444^USA^P|^PRN^PH^^^810^8690648|ORC|RE||X12Q959.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||118^HPV, bivalent^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0273|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T69G545.Ud^^^AIRA-TEST^MR||MerrickAIRA^MiriamAIRA^Shaunna^^^^L|AshtabulaAIRA^DayaAIRA^^^^^M|20160310|F||2106-3^White^CDCREC|1562 Rlochteren St^^Sharon Hollow^MI^48158^USA^P||^PRN^PH^^^734^6101110|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MerrickAIRA^DayaAIRA^^^^^L|MTH^Mother^HL70063|1562 Rlochteren St^^Sharon Hollow^MI^48158^USA^P|^PRN^PH^^^734^6101110|ORC|RE||P18W963.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|IN^Intranasal^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0278|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J52W555.UE^^^AIRA-TEST^MR||RobertsAIRA^SukutaiAIRA^V^^^^L|HancockAIRA^KatrenAIRA^^^^^M|20160311|F||2054-5^Black or African-American^CDCREC|1330 Oidderkerk Pl^^Saint Clr Shrs^MI^48080^USA^P||^PRN^PH^^^586^5239135|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CedarAIRA^KatrenAIRA^^^^^L|MTH^Mother^HL70063|1330 Oidderkerk Pl^^Saint Clr Shrs^MI^48080^USA^P|^PRN^PH^^^586^5239135|ORC|RE||J56K967.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|MMR^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0284|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S82Q567.V8^^^AIRA-TEST^MR||PittsburgAIRA^ValgerdrAIRA^Solosolo^^^^L|KearneyAIRA^KatyaAIRA^^^^^M|20160314|F||2106-3^White^CDCREC|1030 Honderd Cir^^Swartz Creek^MI^48473^USA^P||^PRN^PH^^^810^9770150|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|PittsburgAIRA^KatyaAIRA^^^^^L|MTH^Mother^HL70063|1030 Honderd Cir^^Swartz Creek^MI^48473^USA^P|^PRN^PH^^^810^9770150|ORC|RE||G98Q971.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|Jones Clinic^^|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0327|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S84C681.10O^^^AIRA-TEST^MR||SullivanAIRA^ElanaAIRA^J^^^^L|HoeyAIRA^MignonetteAIRA^^^^^M|20160305|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1829 Eeuningen Cir^^Jeddo^MI^48032^USA^P||^PRN^PH^^^810^8795399|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|SullivanAIRA^MignonetteAIRA^^^^^L|MTH^Mother^HL70063|1829 Eeuningen Cir^^Jeddo^MI^48032^USA^P|^PRN^PH^^^810^8795399|ORC|RE||U40V975.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|999|||00^New immunization record^NIP001|||||||||||CP|A|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0329|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||L41P685.10Y^^^AIRA-TEST^MR||BreckinridgeAIRA^MackenzieAIRA^Penda^^^^L|MontgomeryAIRA^CosimaAIRA^^^^^M|20160222|F||2106-3^White^CDCREC|1298 Belangrijkste Ln^^Highland^MI^48357^USA^P||^PRN^PH^^^248^6545610|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HarneyAIRA^CosimaAIRA^^^^^L|MTH^Mother^HL70063|1298 Belangrijkste Ln^^Highland^MI^48357^USA^P|^PRN^PH^^^248^6545610|ORC|RE||Y33H979.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||01^Historical information - source unspecified^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0336|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R63K703.12o^^^AIRA-TEST^MR||DurbinAIRA^CoraAIRA^Carlina^^^^L|BendAIRA^TasmineAIRA^^^^^M|20160323|F||2106-3^White^CDCREC|1776 Leek Cir^^Grosse Pointe Woods^MI^48230^USA^P||^PRN^PH^^^313^5154872|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|EvansAIRA^TasmineAIRA^^^^^L|MTH^Mother^HL70063|1776 Leek Cir^^Grosse Pointe Woods^MI^48230^USA^P|^PRN^PH^^^313^5154872|ORC|RE||J86B983.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH|Never|MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0338|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D13O707.12x^^^AIRA-TEST^MR||CumingAIRA^DonAIRA^Ralph^^^^L|ClarkeAIRA^AnsleyAIRA^^^^^M|20160318|M||2106-3^White^CDCREC|1881 Geval Pl^^Pinconning^MI^48650^USA^P||^PRN^PH^^^989^9729826|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|ClarkeAIRA^AnsleyAIRA^^^^^L|MTH^Mother^HL70063|1881 Geval Pl^^Pinconning^MI^48650^USA^P|^PRN^PH^^^989^9729826|ORC|RE||Z56B987.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Lot||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0339|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G55Y709.12C^^^AIRA-TEST^MR||Van WertAIRA^MairinAIRA^^^^^L|PasoAIRA^AlbinaAIRA^^^^^M|20160303|F||1002-5^American Indian or Alaska Native^CDCREC|1370 Ledemblik St^^Rochester Hls^MI^48309^USA^P||^PRN^PH^^^248^3333473|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|Van WertAIRA^AlbinaAIRA^^^^^L|MTH^Mother^HL70063|1370 Ledemblik St^^Rochester Hls^MI^48309^USA^P|^PRN^PH^^^248^3333473|ORC|RE||T21M991.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0343|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X17I719.12Z^^^AIRA-TEST^MR||KrogAIRA^AmonAIRA^^^^^L|AdamsAIRA^PaulinaAIRA^^^^^M|20160223|M||2106-3^White^CDCREC|1104 Wit Cir^^Bailey^MI^49303^USA^P||^PRN^PH^^^231^9916569|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|KrogAIRA^PaulinaAIRA^^^^^L|MTH^Mother^HL70063|1104 Wit Cir^^Bailey^MI^49303^USA^P|^PRN^PH^^^231^9916569|ORC|RE||G55T995.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ|||||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0344|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0344^^^AIRA-TEST^MR||BerrienAIRA^CinderellaAIRA^Amelia^^^^L|LimestoneAIRA^AvocaAIRA^^^^^M|20160302|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1119 Gergen Pl^^Prescott^MI^48756^USA^P||^PRN^PH^^^989^4707270|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LimestoneAIRA^AvocaAIRA^^^^^L|MTH^Mother^HL70063|1119 Gergen Pl^^Prescott^MI^48756^USA^P|^PRN^PH^^^989^4707270|ORC|RE||W46I999.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||ZZZ^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0370|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||I95P729.13n^^^AIRA-TEST^MR||MontagueAIRA^PsycheAIRA^Deion^^^^L|KimballAIRA^MarinelAIRA^^^^^M|20160301|F||2106-3^White^CDCREC|1386 Zijfheerenlanden Ln^^Coldwater^MI^49036^USA^P||^PRN^PH^^^517^2733445|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|O NeillAIRA^MarinelAIRA^^^^^L|MTH^Mother^HL70063|1386 Zijfheerenlanden Ln^^Coldwater^MI^49036^USA^P|^PRN^PH^^^517^2733445|ORC|20110506||P94U1003.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0372|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U13D733.13A^^^AIRA-TEST^MR||Olsen LeeAIRA^AleshaneeAIRA^R^^^^L|GreenAIRA^Joo-EunAIRA^^^^^M|20160308|F||2028-9^Asian^CDCREC|1131 Oissewaard Ave^^La Salle^MI^48145^USA^P||^PRN^PH^^^734^6662094|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|Olsen LeeAIRA^Joo-EunAIRA^^^^^L|MTH^Mother^HL70063|1131 Oissewaard Ave^^La Salle^MI^48145^USA^P|^PRN^PH^^^734^6662094|ORC|UR||Y53A1006.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0393|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||K86T413.P3^^^^MR||StanislausAIRA^JamesinaAIRA^Castalia^^^^L|CumberlandAIRA^DivaAIRA^^^^^M|20160302|F||1002-5^American Indian or Alaska Native^CDCREC|1538 Woppersum Ave^^GR^MI^49507^USA^P||^PRN^PH^^^616^8498742|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|StanislausAIRA^DivaAIRA^^^^^L|MTH^Mother^HL70063|1538 Woppersum Ave^^GR^MI^49507^USA^P|^PRN^PH^^^616^8498742|ORC|RE||K81J1011.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0394|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G53V415.P7^^^AIRA-TEST^||ParkAIRA^RidgleyAIRA^Mukul^^^^L|HutchinsonAIRA^YolandaAIRA^^^^^M|20160308|M||2106-3^White^CDCREC|1668 Krechterland Ave^^Sharon^MI^48158^USA^P||^PRN^PH^^^734^4585717|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|ParkAIRA^YolandaAIRA^^^^^L|MTH^Mother^HL70063|1668 Krechterland Ave^^Sharon^MI^48158^USA^P|^PRN^PH^^^734^4585717|ORC|RE||N98S1015.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0399|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T14T51.yP^^^AIRA-TEST^MR||TitusAIRA^PritaAIRA^Arianna^^^^L|LakeAIRA^BrieAIRA^^^^^M|20160226|F||1002-5^American Indian or Alaska Native^CDCREC|1036 Lernheze St^^Northville Township^MI^48167^USA^P||^PRN^PH^^^248^5766032|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|StanislausAIRA^BrieAIRA^^^^^L|MTH^Mother^HL70063|1036 Lernheze St^^Northville Township^MI^48167^USA^PRIMARY|^PRN^PH^^^248^5766032|ORC|RE||G13C1019.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0409|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D63R295.Kw^^^AIRA-TEST^MR||AdamsAIRA^AilenAIRA^^^^^Samuel|CalhounAIRA^MariselaAIRA^^^^^M|20160312|M||2106-3^White^CDCREC|1886 Buijk St^^DTE Energy^MI^48268^USA^P||^PRN^PH^^^313^5076213|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CalhounAIRA^MariselaAIRA^^^^^L|MTH^Mother^HL70063|1886 Buijk St^^DTE Energy^MI^48268^USA^P|^PRN^PH^^^313^5076213|ORC|RE||Z59L1023.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0450|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||K82K543.U8^^^AIRA-TEST^MR||LoweAIRA^UlprusAIRA^Kerwin^^^^L|AdamsAIRA^JusticeAIRA^^^^^M|20160229|M||2028-9^Asian^CDCREC|1862 Brand Ave^^Frenchtown^MI^48161^USA^P||^PRN^PH^^^734^4745708|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LoweAIRA^JusticeAIRA^^^^^L|MTH^Mother^HL70063|1862 Brand Ave^^Frenchtown^MI^48161^USA^P|^PRN^PH^^^734^4745708|ORC|RE||G03V1027.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|CM^milliliters^ISO+||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0451|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A10N141.Er^^^AIRA-TEST^MR||ShelbyAIRA^DelroyAIRA^Andrew^^^^L|RoscommonAIRA^KoraAIRA^^^^^M|20160319|M||1002-5^American Indian or Alaska Native^CDCREC|1246 Steenbergen Cir^^Lake Isabella^MI^48893^USA^||^PRN^PH^^^989^3103672|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|ShelbyAIRA^KoraAIRA^^^^^L|MTH^Mother^HL70063|1246 Steenbergen Cir^^Lake Isabella^MI^48893^USA^P|^PRN^PH^^^989^3103672|ORC|RE||N40Y1031.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144809-0700||VXU^V04^VXU_V04|2Sor-DQMQE0457|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||H65R313.Lb^^^AIRA-TEST^MR||CarsonAIRA^WenAIRA^Cristofer^^^^L|PottawattamieAIRA^ChiaraAIRA^^^^^M|20160312|M||2131-1^Other Race^CDCREC|1712 Ganderd Cir^^Brockway^MI^48097^USA^P||(810)6578384^Apt B^PH^^^810^6578384|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|PottawattamieAIRA^ChiaraAIRA^^^^^L|MTH^Mother^HL70063|1712 Ganderd Cir^^Brockway^MI^48097^USA^P|^PRN^PH^^^810^6578384|ORC|RE||B94T1035.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0462|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||I94N323.Ly^^^AIRA-TEST^MR||HolmesAIRA^MaxeyAIRA^Santiago^^^^L|CreghanAIRA^MarisolAIRA^^^^^M|20160226|M||2106-3^White^CDCREC|1450 Disse Ave^^Sylvan Beach^MI^49461^USA^P||(231)5588735^PRN^BAD^^^231^5588735|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HolmesAIRA^MarisolAIRA^^^^^L|MTH^Mother^HL70063|1450 Disse Ave^^Sylvan Beach^MI^49461^USA^P|^PRN^PH^^^231^5588735|ORC|RE||J14S1039.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0473|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||B74Q93.Be^^^AIRA-TEST^MR||MooreAIRA^ShmuelAIRA^Gaylord^^^^L|MahoningAIRA^GaleAIRA^^^^^M|20160302|M||2106-3^White^CDCREC|1835 Brunssum Pl^^Columbus^MI^48063^USA^P||^PRN^PH^^^810^5970889|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MooreAIRA^GaleAIRA^^^^^L|MTH^Mother^HL70063|1835 Brunssum Pl^^Columbus^MI^48063^USA^P|^PRN^PH^^^810^5970889|ORC|RE||E19O1043.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1||64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0474|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y98Y95.Bp^^^AIRA-TEST^MR||BayAIRA^BurdetteAIRA^^^^^L|CambriaAIRA^FeliciaAIRA^^^^^M|20160308|F||2054-5^Black or African-American^CDCREC|1583 Gebruiken St^^Warren^MI^48397^USA^P||^PRN^PH^^^586^4656574|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BayAIRA^FeliciaAIRA^^^^^L|MTH^Mother^HL70063|1583 Gebruiken St^^Warren^MI^48397^USA^P|^PRN^PH^^^586^4656574|ORC|RE||G15F1047.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CODED VALUE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0483|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T04M487.RV^^^AIRA-TEST^MR||CambriaAIRA^BrigitteAIRA^Amaris^^^^L|LilleyAIRA^SyriaAIRA^^^^^M|20160228|F||2106-3^White^CDCREC|1996 Pchinnen Cir^^Houghton Lake^MI^48629^USA^P||^PRN^PH^^^989^9731290|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CambriaAIRA^SyriaAIRA^^^^^L|MTH^Mother^HL70063|1996 Pchinnen Cir^^Houghton Lake^MI^48629^USA^P|^PRN^PH^^^989^9731290|ORC|RE||C31A1051.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0484|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y53J489.RZ^^^AIRA-TEST^MR||GuthrieAIRA^KuraAIRA^S^^^^L|GuthrieAIRA^AhnadaAIRA^^^^^M|20160228|F||2106-3^White^CDCREC|1569 Rerkelland St^^Grand Blanc^MI^48480^USA^P||^PRN^PH^^^810^8295942|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|DubuqueAIRA^AhnadaAIRA^^^^^L|MTH^Mother^HL70063|1569 Rerkelland St^^Grand Blanc^MI^48480^USA^P|^PRN^PH^^^810^8295942|ORC|RE||C17B1055.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX CODE|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0485|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||F89X81.Ay^^^AIRA-TEST^MR||EglandAIRA^SaraiAIRA^A^^^^L|JessenAIRA^SilverAIRA^^^^^M|20160305|F||1002-5^American Indian or Alaska Native^CDCREC|1286 Eytsjerksteradiel St^^Kimball^MI^48074^USA^P||^PRN^PH^^^810^2390194|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MasonAIRA^SilverAIRA^^^^^L|CHD^Child^HL70063|1286 Eytsjerksteradiel St^^Kimball^MI^48074^USA^P|^PRN^PH^^^810^2390194|ORC|RE||L69X1059.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0490|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||P77J479.RD^^^AIRA-TEST^MR||GosperAIRA^ChrissyAIRA^S^^^^L|NightingaleAIRA^JuttaAIRA^^^^^M|20011010|F||2054-5^Black or African-American^CDCREC|1176 Goed Cir^^Strongs^MI^49790^USA^P||^PRN^PH^^^906^3207120|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BedfordAIRA^JuttaAIRA^^^^^L|MTH^Mother^HL70063|1176 Goed Cir^^Strongs^MI^49790^USA^P|^PRN^PH^^^906^3207120|ORC|RE||D75G1063.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20100301||100^pneumococcal conjugate PCV 7^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0516|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||V38N297.KB^^^AIRA-TEST^MR||Saint JosephAIRA^InnocentiaAIRA^Irma^^^^A|CharlevoixAIRA^LyrisAIRA^^^^^M|20160307|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1852 Bolenwaard Ln^^Roosevelt Park^MI^49441^USA^P||^PRN^PH^^^231^2578156|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|Saint JosephAIRA^LyrisAIRA^^^^^L|MTH^Mother^HL70063|1852 Bolenwaard Ln^^Roosevelt Park^MI^49441^USA^P|^PRN^PH^^^231^2578156|ORC|RE||X20D1067.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0520|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C99N149.EN^^^AIRA-TEST^MR||TaylorAIRA^LlewellynAIRA^A^^^^L|MarionAIRA^AkelaAIRA^^^^^M|20160307|M||2106-3^White^CDCREC|1484 Meester Pl^^Whitehall^MI^49463^USA^PRIMARY||^PRN^PH^^^231^5100780|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MarionAIRA^AkelaAIRA^^^^^L|MTH^Mother^HL70063|1484 Meester Pl^^Whitehall^MI^49463^USA^P|^PRN^PH^^^231^5100780|ORC|RE||O38Q1071.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0555|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||L25W527.Tw^^^AIRA-TEST^MR||DimmitAIRA^MimiAIRA^Kendra^^^^L|WatersAIRA^JaimeAIRA^^^^^M|20160311|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1024 Ve Wolden Ln^^Kalkaska^MI^49646^USA^P||^PRN^PH^^^231^4791250|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|WatersAIRA^JaimeAIRA^^^^^L|MTH^Mother^HL70063|1024 Ve Wolden Ln^^Kalkaska^MI^49646^USA^P|^PRN^PH^^^231^4791250|ORC|RE||V07P1075.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|MMR|mL^mililiters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0060|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||L07Z9.vm^^^AIRA-TEST^MR||WotherspoonAIRA^GhadaAIRA^^^^^L|CarsonAIRA^SemineAIRA^^^^^M|20160227|F||2106-3^White^CDCREC|1845 Vtrecht Ln^^Gregory^MI^48137^USA^P||^PRN^PH^^^734^3223257|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MorrellAIRA^SemineAIRA^^^^^L|MTH^Mother^HL70063|1845 Vtrecht Ln^^Gregory^MI^48137^US^P|^PRN^PH^^^734^3223257|ORC|RE||B36W1079.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0095|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y43F107.Cn^^^AIRA-TEST^MR||CedarAIRA^BentleyAIRA^Greyson^^^^L|ShermanAIRA^LanetteAIRA^^^^^M|20160223|M||2131-1^Other Race^CDCREC|1766 Lpsterland Pl^^Arnold^MI^49819^US^P||^PRN^PH^^^906^5311464|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|CedarAIRA^LanetteAIRA^^^^^L|MTH^Mother^HL70063|1766 Lpsterland Pl^^Arnold^MI^49819^USA^P|^PRN^PH^^^906^5311464|ORC|RE||G06Z1083.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0180|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||H31J331.LQ^^^AIRA-TEST^MR||AdamsAIRA^ItzelAIRA^Jacinthe^^^^L|HougenAIRA^GymeaAIRA^^^^^M|20160309|F||2106-3^White^CDCREC|1660 Lezen Ln^^Grand Rapids^MI^49523^USA^P||^PRN^PH^^^616^3696110|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|AdamsAIRA^GymeaAIRA^^^^^L|MTH^Mother^HL70063|1660 Lezen Ln^^Grand Rapids^MI^49523^USA^P|^PRN^PH^^^616^3696110|ORC|RE||P11X1086.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0235|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||E89W453.QC^^^AIRA-TEST^MR||WallinAIRA^RaymonAIRA^P^^^^L|HancockAIRA^TempestAIRA^^^^^M|20160224|M||2106-3^White^CDCREC|1000 Hirschot Pl^^Grand Rapids^MI^49501^USA^P||^PRN^PH^^^616^2202151|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|StevensAIRA^TempestAIRA^^^^^L|MTH^Mother^HL70063|1000 Hirschot Pl^^Grand Rapids^MI^49501^USA^P|^PRN^PH^^^616^2202151|ORC|RE||X69F1091.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP||RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0248|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0248^^^AIRA-TEST^MR||ClarkAIRA^NinoAIRA^Sterling^^^^L|BranchAIRA^ShaylaAIRA^^^^^M|20160301|M||2054-5^Black or African-American^CDCREC|1538 Dilversum Pl^^Comerica Incorporated^MI^48264^USA^P||^PRN^PH^^^313^2528625|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BranchAIRA^ShaylaAIRA^^^^^L|MTH^Mother^HL70063|1538 Dilversum Pl^^Comerica Incorporated^MI^48264^USA^P|^PRN^PH^^^313^2528625|ORC|RE||Z06H1095.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||998^No Vaccine Administered^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0259|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Z18Y509.SN^^^AIRA-TEST^MR||HayesAIRA^LeticiaAIRA^Dominica^^^^L|FanninAIRA^KimoraAIRA^^^^^M|20160311|F||2106-3^White^CDCREC|1411 Nardinxveld-Giessendam St^^Gould City^MI^49838^USA^P||^PRN^PH^^^906^6002605|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HayesAIRA^KimoraAIRA^^^^^L|MTH^Mother^HL70063|1411 Nardinxveld-Giessendam St^^Gould City^MI^49838^USA^P|^PRN^PH^^^906^6002605|ORC|RE||K64O1098.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||118^HPV, bivalent^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0271|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||V56M533.TL^^^AIRA-TEST^MR||BernstrainAIRA^PeytonAIRA^A^^^^L|BrownAIRA^HadassahAIRA^^^^^M|20160307|M||2106-3^White^CDCREC|1982 Noordwijkerhout Ave^^Bloomfld Township^MI^48303^USA^P||^PRN^PH^^^248^5268409|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|BernstrainAIRA^HadassahAIRA^^^^^L|MTH^Mother^HL70063|1982 Noordwijkerhout Ave^^Bloomfld Township^MI^48303^USA^P|^PRN^PH^^^248^5268409|ORC|RE||H58N1102.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|999|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0272|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||K21M541.U4^^^AIRA-TEST^MR||KnoxAIRA^StanleyAIRA^Weston^^^^L|MontgomeryAIRA^TammiAIRA^^^^^M|20160321|M||2106-3^White^CDCREC|1345 Aieuwkoop Cir^^Sterling Heights^MI^48314^USA^P||^PRN^PH^^^586^3854773|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|KnoxAIRA^TammiAIRA^^^^^L|MTH^Mother^HL70063|1345 Aieuwkoop Cir^^Sterling Heights^MI^48314^USA^P|^PRN^PH^^^586^3854773|ORC|RE||H58S1107.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0277|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U86Q553.UA^^^AIRA-TEST^MR||MeigsAIRA^AncelAIRA^Meredith^^^^L|OkfuskeeAIRA^AmiAIRA^^^^^M|20160316|M||2106-3^White^CDCREC|1432 Klaar Cir^^Morrice^MI^48857^USA^P||^PRN^PH^^^517^3646992|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|MahoneyAIRA^AmiAIRA^^^^^L|MTH^Mother^HL70063|1432 Klaar Cir^^Morrice^MI^48857^USA^P|^PRN^PH^^^517^3646992|ORC|RE||S65Y1111.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0322|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U25A671.10p^^^AIRA-TEST^MR||HusseyAIRA^BhaveshAIRA^Ehner^^^^L|HusseyAIRA^SanyogitaAIRA^^^^^M|20160304|M||2106-3^White^CDCREC|1611 Vertegenwoordigen Ave^^New Boston^MI^48164^USA^P||^PRN^PH^^^734^3002350|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|WayneAIRA^SanyogitaAIRA^^^^^L|MTH^Mother^HL70063|1611 Vertegenwoordigen Ave^^New Boston^MI^48164^USA^P|^PRN^PH^^^734^3002350|ORC|RE||^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0325|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0325^^^AIRA-TEST^MR||FranklinAIRA^SandiAIRA^Berry^^^^L|WilliamsAIRA^KimberlyAIRA^^^^^M|20160313|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1068 Lijken St^^Brownstwn Township^MI^48183^USA^P||^PRN^PH^^^734^6656636|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|FranklinAIRA^KimberlyAIRA^^^^^L|MTH^Mother^HL70063|1068 Lijken St^^Brownstwn Township^MI^48183^USA^P|^PRN^PH^^^734^6656636|ORC|RE||^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0340|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S38F711.12G^^^AIRA-TEST^MR||HardingAIRA^DanutaAIRA^^^^^L|QuinlaAIRA^BethanAIRA^^^^^M|20160314|F||2106-3^White^CDCREC|1539 Voeren St^^Ovid^MI^48866^USA^P||^PRN^PH^^^989^9680249|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HardingAIRA^BethanAIRA^^^^^L|MTH^Mother^HL70063|1539 Voeren St^^Ovid^MI^48866^USA^P|^PRN^PH^^^989^9680249|ORC|RE||K98M1122.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||BA^Baxter^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0363|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||B60X797.168^^^AIRA-TEST^MR||JeffersonAIRA^ZelahAIRA^P^^^^L|HolmfAIRA^IslaAIRA^^^^^M|20160308|F||1002-5^American Indian or Alaska Native^CDCREC|1742 Rerneuzen Ave^^Sang^MI^48045^USA^P||^PRN^PH^^^586^5086584|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|JeffersonAIRA^IslaAIRA^^^^^L|MTH^Mother^HL70063|1742 Rerneuzen Ave^^Sang^MI^48045^USA^P|^PRN^PH^^^586^5086584|ORC|RE||X34M1127.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||RE|A|MSH|^~\&|||||20200307144810-0700||VXU^V04^VXU_V04|2Sor-DQMQE0371|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J35C731.13s^^^AIRA-TEST^MR||JohnsonAIRA^UshnishaAIRA^Rufus^^^^L|FisherAIRA^PeridotAIRA^^^^^M|20160315|M||2054-5^Black or African-American^CDCREC|1799 Hrechterland Pl^^Vulcan^MI^49892^USA^P||^PRN^PH^^^906^3025502|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|JohnsonAIRA^PeridotAIRA^^^^^L|MTH^Mother^HL70063|1799 Hrechterland Pl^^Vulcan^MI^49892^USA^P|^PRN^PH^^^906^3025502|ORC|||R81E1131.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144811-0700||VXU^V04^VXU_V04|2Sor-DQMQE0382|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C73P647.Z7^^^AIRA-TEST^MR||WalshAIRA^AbraAIRA^Donelle^^^^L|RichardsonAIRA^TerrylynAIRA^^^^^M|20160302|F||2054-5^Black or African-American^CDCREC|1168 Foppersum Ln^^Dewitt^MI^48820^USA^P||^PRN^PH^^^517^3117937|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|RichardsonAIRA^TerrylynAIRA^^^^^L|MTH^Mother^HL70063|1168 Foppersum Ln^^Dewitt^MI^48820^USA^P|^PRN^PH^^^517^3117937|ORC|RE||^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144811-0700||VXU^V04^VXU_V04|2Sor-DQMQE0398|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C89N49.yJ^^^AIRA-TEST^MR||JoiceAIRA^KerAIRA^Curio^^^^L|JoiceAIRA^ModestyAIRA^^^^^M|20160319|M||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1036 Tak Pl^^Saint Joe^MI^49085^USA^P||^PRN^PH^^^269^2268893|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LancasterAIRA^ModestyAIRA^^^^^L|MTH^Mother^HL70063|1036 Tak Pl^^Saint Joe^MI^49085^USA^|^PRN^PH^^^269^2268893|ORC|RE||N11Z1139.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144811-0700||VXU^V04^VXU_V04|2Sor-DQMQE0408|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A66K293.Ks^^^AIRA-TEST^MR||AlofsonAIRA^YungaraAIRA^Jolan^^^^|HancockAIRA^BeritAIRA^^^^^M|20160307|F||2028-9^Asian^CDCREC|1353 Raarlemmermeer St^^Mason^MI^48854^USA^P||^PRN^PH^^^517^8657220|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|HancockAIRA^BeritAIRA^^^^^L|MTH^Mother^HL70063|1353 Raarlemmermeer St^^Mason^MI^48854^USA^P|^PRN^PH^^^517^8657220|ORC|RE||N03J1143.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144811-0700||VXU^V04^VXU_V04|2Sor-DQMQE0447|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G48W535.TP^^^AIRA-TEST^MR||SciotoAIRA^RiordanAIRA^Branch^^^^L|KentAIRA^DylanAIRA^^^^^M|20160321|M||2106-3^White^CDCREC|1156 Woeterwoude St^^Northville Tw^MI^48167^USA^P||^PRN^PH^^^248^5162609|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|KlebergAIRA^DylanAIRA^^^^^L|MTH^Mother^HL70063|1156 Woeterwoude St^^Northville Tw^MI^48167^USA^P|^PRN^PH^^^248^5162609|ORC|RE||A41D1147.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX|1|dose^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144811-0700||VXU^V04^VXU_V04|2Sor-DQMQE0456|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||P88Z311.L7^^^AIRA-TEST^MR||GrantAIRA^UlfredAIRA^Sudeva^^^^L|SeminoleAIRA^RahelAIRA^^^^^M|20160301|M||2106-3^White^CDCREC|1426 Hoog Ln^^Newport^MI^48166^USA^P||(734)3101669^^PH^^^734^3101669|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|GrantAIRA^RahelAIRA^^^^^L|MTH^Mother^HL70063|1426 Hoog Ln^^Newport^MI^48166^USA^P|^PRN^PH^^^734^3101669|ORC|RE||Z37J1151.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200307144811-0700||VXU^V04^VXU_V04|2Sor-DQMQE0554|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M75Z529.TB^^^AIRA-TEST^MR||HopkinsAIRA^LuluAIRA^Agneta^^^^L|LarssenAIRA^KonstanzeAIRA^^^^^M|20160315|F||1002-5^American Indian or Alaska Native^CDCREC|1198 Slphen aan den Rijn St^^South Manitou^MI^49654^USA^P||^PRN^PH^^^231^2276777|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307|NK1|1|LarssenAIRA^KonstanzeAIRA^^^^^L|MTH^Mother^HL70063|1198 Slphen aan den Rijn St^^South Manitou^MI^49654^USA^P|^PRN^PH^^^231^2276777|ORC|RE||I05X1155.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200307||94^MMRV^CVX||mL^mililiters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200307|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200307||||||F|MSH|^~\&|||||20200306073733.994-0500||VXU^V04^VXU_V04|2RwT-GM-1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F02H5^^^NIST-MPI-1^MR||CanadianAIRA^TemaniAIRA^Kartikeya^^^^L|SundeAIRA^^^^^^M|20191227|M||1002-5^American Indian or Alaska Native^CDCREC|1429 Vrouw Ln^^Rives Jct^MI^49277^USA^P||^PRN^PH^^^517^9209059|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200306|||A|20191227|20200306NK1|1|CanadianAIRA^SundeAIRA^Elizabeth^^^^L|MTH^Mother^HL70063|1429 Vrouw Ln^^Rives Jct^MI^49277^USA^P|^PRN^PH^^^517^9209059NK1|2|CanadianAIRA^MeaghanAIRA^William^^^^L|FTH^Father^HL70063|1429 Vrouw Ln^^Rives Jct^MI^49277^USA^P|^PRN^CP^^^517^9209059ORC|RE|AF02H5.1^NIST-AA-IZ-2|BF02H5.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MDRXA|0|1|20200306||49281-0560-05^Pentacel^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||526434|20200403|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300017211160720^Polio VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306OBX|5|CE|69764-9^Document Type^LN|4|253088698300006611150402^Haemophilus Influenzae type b VIS^cdcgs1vis||||||F|||20200306OBX|6|DT|29769-7^Date Vis Presented^LN|4|20200306||||||F|||20200306OBX|7|CE|69764-9^Document Type^LN|5|253088698300003511070517^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F|||20200306OBX|8|DT|29769-7^Date Vis Presented^LN|5|20200306||||||F|||20200306ORC|RE|AF02H5.2^NIST-AA-IZ-2|BF02H5.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||00006-4047-20^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||297961|20200529|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300019611150415^Rotavirus VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AF02H5.3^NIST-AA-IZ-2|BF02H5.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MDRXA|0|1|20200306||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||353480|20200410|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300015811151105^Pneumococcal Conjugate (PCV13) VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE||BF02H5.4^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRNRXA|0|1|20191228||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AORC|RE||BF02H5.5^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRNRXA|0|1|20200126||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AMSH|^~\&|||||20200306084727.655-0500||VXU^V04^VXU_V04|2RwT-GM-1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y35J10^^^NIST-MPI-1^MR||TrimbleAIRA^HueAIRA^^^^^L||19880226|F||2028-9^Asian^CDCREC|1183 Gssen St^^East Lansing^MI^48826^USA^P||^PRN^PH^^^517^9598725~^NET^^Elise.Wong@isp.com|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200306|||A|19880226|20200306ORC|RE|AY35J10.1^NIST-AA-IZ-2|BY35J10.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MDRXA|0|1|20200306||49281-0215-88^TENIVAC^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||315841|20200828|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300028811170411^Tetanus/Diphtheria (Td) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE||BY35J10.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRNRXA|0|1|20190625||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AORC|RE||BY35J10.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRNRXA|0|1|20180726||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AMSH|^~\&|||||20200306093847.808-0500||VXU^V04^VXU_V04|2RwT-GM-1.3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R28E17^^^NIST-MPI-1^MR||HardinAIRA^YuleAIRA^Vencel^^^^L||20190213|M||2106-3^White^CDCREC|1959 Anders Pl^^Lum^MI^48412^USA^P||^PRN^PH^^^810^3791224|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||NPD1|||||||||||08^Reminder/recall - to provider^HL70215|N|20200306|||A|20090213|20200306NK1|1|HardinAIRA^HusseyAIRA^Leonard^^^^L|FTH^Father^HL70063|1959 Anders Pl^^Lum^MI^48412^USA^P|^PRN^PH^^^810^3791224ORC|RE|AR28E17.1^NIST-AA-IZ-2|BR28E17.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MDRXA|0|1|20200306||00006-4095-01^VAQTA^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||208490|20201002|MSD^Merck and Co., Inc.^MVX|||CP|URXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RwT-GM-2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A58D26^^^AIRA^MR||HamiltonAIRA^TamiaAIRA^Allayna^^^^L|AndersonAIRA^XimenaAIRA^^^^^M|20190223|F||2106-3^White^CDCREC|1916 Verhogen St^^Linwood^MI^48634^USA^P||^PRN^PH^^^989^7900266|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|HamiltonAIRA^AndersonAIRA^Marion^^^^L|MTH^Mother^HL70063|1916 Verhogen St^^Linwood^MI^48634^USA^P|^PRN^PH^^^989^7900266ORC|RE|AA58D26.1^AIRA|BA58D26.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRNRXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411100521^Measles Mumps Rubella Varicella VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RwT-GM-2.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X65A33^^^AIRA^MR||GrantAIRA^TalasiAIRA^Ren^^^^L|MariposaAIRA^EurwenAIRA^^^^^M|20040224|F||2106-3^White^CDCREC|1426 Waanstad Pl^^Middlevle^MI^49333^USA^P||^PRN^PH^^^269^7846108|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|GrantAIRA^MariposaAIRA^Marion^^^^L|MTH^Mother^HL70063|1426 Waanstad Pl^^Middlevle^MI^49333^USA^P|^PRN^PH^^^269^7846108ORC|RE||BX65A33.1^AIRARXA|0|1|20080306||03^MMR^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RwT-GM-2.3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I08G40^^^AIRA^MR||KeokukAIRA^BehiraAIRA^Fayre^^^^L|MathiesenAIRA^OndineAIRA^^^^^M|20181124|F||2106-3^White^CDCREC|1752 Bittard-Geleen Ln^^Oldsmobile^MI^48921^USA^P||^PRN^PH^^^517^6615643|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|KeokukAIRA^MathiesenAIRA^Marion^^^^L|MTH^Mother^HL70063|1752 Bittard-Geleen Ln^^Oldsmobile^MI^48921^USA^P|^PRN^PH^^^517^6615643ORC|RE||BI08G40.1^AIRARXA|0|1|20181124||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.2^AIRARXA|0|1|20190124||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.3^AIRARXA|0|1|20190124||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.4^AIRARXA|0|1|20190124||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.5^AIRARXA|0|1|20190124||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.6^AIRARXA|0|1|20190124||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.7^AIRARXA|0|1|20190124||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.8^AIRARXA|0|1|20190326||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.9^AIRARXA|0|1|20190326||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.10^AIRARXA|0|1|20190326||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.11^AIRARXA|0|1|20190326||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.12^AIRARXA|0|1|20190326||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.13^AIRARXA|0|1|20190526||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.14^AIRARXA|0|1|20190526||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.15^AIRARXA|0|1|20190526||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.16^AIRARXA|0|1|20190526||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BI08G40.17^AIRARXA|0|1|20190526||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AI08G40.18^AIRA|BI08G40.18^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||120^DTaP-Hib-IPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||983BG|20201129|PMC^Sanofi^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AI08G40.19^AIRA|BI08G40.19^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||133^PCV13^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A1345C|20201129|PFR^Pfizer^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AI08G40.20^AIRA|BI08G40.20^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411100521^Measles Mumps Rubella Varicella VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AI08G40.21^AIRA|BI08G40.21^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||83^Hep A peds^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||825AR23|20201129|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RwT-GM-2.4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R59E47^^^AIRA^MR||ThompsenAIRA^DahliaAIRA^^^^^L||20160224|FORC|RE||BR59E47.1^AIRARXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||AOBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||FOBX|2|CE|69764-9^Document Type^LN|2|253088698300013411100521^Measles Mumps Rubella Varicella VIS^cdcgs1vis||||||FOBX|3|DT|29769-7^Date Vis Presented^LN|2|20200306||||||FMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RwT-GM-2.5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I28M54^^^AIRA^MR||Van BurenAIRA^AwusiAIRA^^^^^L||20160224|FORC|RE||BI28M54.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AMSH|^~\&|||||20200306082215-0400||VXU^V04^VXU_V04|2ROP-A.01.01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G22X157^^^MAA^MR||AtwellAIRA^SevitaAIRA^Miley^^^^L|OsceolaAIRA^CyndiAIRA^^^^^M|20180316|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|1536 Kan St^^Lake Angelus^MI^48326^USA^L||^PRN^PH^^^248^5300759|||||||||2186-5^non Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200120|20200120NK1|1|AtwellAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1536 Kan St^^Lake Angelus^MI^48326^USA^L|^PRN^PH^^^248^5300759ORC|RE||BG22X157.1^NDA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||140^Influenza^CVX|0.25|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001|7832-1^Lemon^Mike^A^^^^^NIST-AA-1|^^^B31||||J6702KP|20200706|PMC^sanofi pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LA^Left Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200304|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306082215-0500||VXU^V04^VXU_V04|2ROP-A.01.02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F81H162^^^MAA^MR~184-25-4562^^^MAA^SS||FayetteAIRA^BeathanAIRA^^^^^L||19490201|M|||||^~^NET^^Eisig@hotmail.comORC|RE||BF81H162.1^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20200306||115^Tdap^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||^^^0||||Z79YG|20200706|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200304|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|139^Td(adult) unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20130509||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306082215-0500||VXU^V04^VXU_V04|2ROP-A.01.03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R73S169^^^MAA^MR||GarfieldAIRA^AksanaAIRA^^^^^L||20090506|FORC|RE||BR73S169.1^NDARXA|0|1|20181021||83^Hep A^CVX|999|||01^Historical information - source unspecified^NIP001MSH|^~\&|||||20200306082215-0500||VXU^V04^VXU_V04|2ROP-A.01.04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O93G176^^^MAA^MR||HammarAIRA^MileyAIRA^^^^^L||20090418|FPD1||||||||||||N|20200306ORC|RE||BO93G176.1^NDARXA|0|1|20181020||118^HPV^CVX|999|||01^Historical information - source unspecified^NIP001MSH|^~\&|||||20200306082215-0500||VXU^V04^VXU_V04|2ROP-A.01.05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R96A183^^^MAA^MR||OttawaAIRA^ParkAIRA^^^^^L||20180329|MORC|RE||BR96A183.1^CDCRXA|0|1|20200306||03^MMR^CVX|999||||||||||||00^Parental Refusal^NIP002||REMSH|^~\&|||||20200306082215-0500||VXU^V04^VXU_V04|2ROP-A.01.06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W60B190^^^NIST MPI^MR||AmmensAIRA^WalidaAIRA^^^^^L||20090504|FORC|RE||BW60B190.1^CDCRXA|0|1|20181021||998^No vaccine administered^CVX|999||||||||||||||NAOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella infection^SCT||||||FMSH|^~\&|||||20200306082215-0500||VXU^V04^VXU_V04|2ROP-A.01.07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P17I197^^^MAA^MR||JohnsonAIRA^SeyedAIRA^Mosi^^^^L||20170311|MORC|RE||BP17I197.1^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20200306||140^Influenza^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||W1356FE|20200706|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200122|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FORC|RE||BP17I197.2^NDARXA|0|1|20180906||133^PCV 13^CVX|999|||01^Historical information - source unspecified^NIP001ORC|RE||BP17I197.3^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20200306||110^DTaP-Hep B-IPV^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||78HH34I|20200706|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LA^Left Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200122|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|107^DTaP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20070517||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FOBX|5|CE|30956-7^vaccine type^LN|3|89^Polio^CVX||||||FOBX|6|TS|29768-9^Date vaccine information statement published^LN|3|20111108||||||FOBX|7|TS|29769-7^Date vaccine information statement presented^LN|3|20200306||||||FOBX|8|CE|30956-7^vaccine type^LN|4|45^Hep B, unspecified formulation^CVX||||||FOBX|9|TS|29768-9^Date vaccine information statement published^LN|4|20120202||||||FOBX|10|TS|29769-7^Date vaccine information statement presented^LN|4|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2ROP-A0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S92J200^^^AIRA-TEST^MR||CumberlandAIRA^CaelynAIRA^Diantha^^^^L|ClarkAIRA^AditiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1920 Otrijen Pl^^London Township^MI^48160^USA^P||^PRN^PH^^^734^8266416|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumberlandAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1920 Otrijen Pl^^London Township^MI^48160^USA^P|^PRN^PH^^^734^8266416ORC|RE||BS92J200.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS92J200.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306073733.994-0500||VXU^V04^VXU_V04|2RSW-L.IZ-AD-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y80I214^^^NIST-MPI-1^MR||AlexandersonAIRA^LawrenceAIRA^Bemus^^^^L|LeknesAIRA^^^^^^M|20191227|M||1002-5^American Indian or Alaska Native^CDCREC|1575 Meventer St^^Kentwood^MI^49508^USA^P||^PRN^PH^^^616^4932505|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200306|||A|20191227|20200306NK1|1|AlexandersonAIRA^LeknesAIRA^Elizabeth^^^^L|MTH^Mother^HL70063|1575 Meventer St^^Kentwood^MI^49508^USA^P|^PRN^PH^^^616^4932505NK1|2|AlexandersonAIRA^OldhamAIRA^William^^^^L|FTH^Father^HL70063|1575 Meventer St^^Kentwood^MI^49508^USA^P|^PRN^CP^^^616^4932505ORC|RE|AY80I214.1^NIST-AA-IZ-2|BY80I214.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||49281-0560-05^Pentacel^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||526434|20200403|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300017211160720^Polio VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306OBX|5|CE|69764-9^Document Type^LN|4|253088698300006611150402^Haemophilus Influenzae type b VIS^cdcgs1vis||||||F|||20200306OBX|6|DT|29769-7^Date Vis Presented^LN|4|20200306||||||F|||20200306OBX|7|CE|69764-9^Document Type^LN|5|253088698300003511070517^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F|||20200306OBX|8|DT|29769-7^Date Vis Presented^LN|5|20200306||||||F|||20200306ORC|RE|AY80I214.2^NIST-AA-IZ-2|BY80I214.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||00006-4047-20^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||297961|20200529|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300019611150415^Rotavirus VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AY80I214.3^NIST-AA-IZ-2|BY80I214.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||353480|20200410|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300015811151105^Pneumococcal Conjugate (PCV13) VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE||BY80I214.4^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20191228||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AORC|RE||BY80I214.5^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200126||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AMSH|^~\&|||||20200306084727.655-0500||VXU^V04^VXU_V04|2RSW-L.IZ-AD-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X12X220^^^NIST-MPI-1^MR||MidlandAIRA^NatalaAIRA^^^^^L||19880226|F||2028-9^Asian^CDCREC|1106 Huenen Cir^^Belleville^MI^48112^USA^P||^PRN^PH^^^734^6762795~^NET^^Elise.Wong@isp.com|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200306|||A|19880226|20200306ORC|RE|AX12X220.1^NIST-AA-IZ-2|BX12X220.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||49281-0215-88^TENIVAC^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||315841|20200828|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300028811170411^Tetanus/Diphtheria (Td) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE||BX12X220.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20190625||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AORC|RE||BX12X220.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20180726||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AMSH|^~\&|||||20200306093847.804-0500||VXU^V04^VXU_V04|2RSW-L.IZ-AD-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V99E225^^^NIST-MPI-1^MR||RowanAIRA^ClaraAIRA^Ita^^^^L|CassAIRA^^^^^^M|20080902|F||2106-3^White^CDCREC|1199 Vriend Cir^^Oden^MI^49764^USA^P||^PRN^PH^^^616^7836043|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||01^No reminder/recall^HL70215|Y|20200306|||A|20080902|20200306NK1|1|RowanAIRA^CassAIRA^Michelle^^^^L|MTH^Mother^HL70063|1199 Vriend Cir^^Oden^MI^49764^USA^P|^PRN^PH^^^616^7836043ORC|RE|AV99E225.1^NIST-AA-IZ-2|BV99E225.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||00006-4119-01^GARDASIL 9^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||795441|20200904|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V05^VFC Eligible - Underinsured^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300029511161202^HPV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306093847.804-0500||VXU^V04^VXU_V04|2RSW-L.IZ-AD-4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H72I232^^^NIST-MPI-1^MR||HenryAIRA^MadeleineAIRA^Isabella^^^^L|AurumAIRA^^^^^^M|20080902|F||2106-3^White^CDCREC|1699 Oollumerland en Nieuwkruisland Ln^^Big Bay^MI^49808^USA^P||^PRN^PH^^^906^8255309|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||01^No reminder/recall^HL70215|Y|20200306|||A|20080902|20200306NK1|1|HenryAIRA^AurumAIRA^Michelle^^^^L|MTH^Mother^HL70063|1699 Oollumerland en Nieuwkruisland Ln^^Big Bay^MI^49808^USA^P|^PRN^PH^^^906^8255309ORC|RE|AH72I232.1^NIST-AA-IZ-2|BH72I232.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||00006-4119-01^GARDASIL 9^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||795441|20200904|MSD^Merck and Co., Inc.^MVX|||CP|DRXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V05^VFC Eligible - Underinsured^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300029511161202^HPV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306093847.808-0500||VXU^V04^VXU_V04|2RSW-L.IZ-AD-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O40T239^^^NIST-MPI-1^MR||StevensAIRA^NawangAIRA^Theobold^^^^L||20190213|M||2106-3^White^CDCREC|1492 Saaren Cir^^Grass Lake^MI^49240^USA^P||^PRN^PH^^^517^7279885|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||NPD1|||||||||||08^Reminder/recall - to provider^HL70215|N|20200306|||A|20090213|20200306NK1|1|StevensAIRA^PolkAIRA^Leonard^^^^L|FTH^Father^HL70063|1492 Saaren Cir^^Grass Lake^MI^49240^USA^P|^PRN^PH^^^517^7279885ORC|RE|AO40T239.1^NIST-AA-IZ-2|BO40T239.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||58160-0806-01^HIBERIX^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||328734|20200605|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AO40T239.2^NIST-AA-IZ-2|BO40T239.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||00006-4095-01^VAQTA^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||208940|20201002|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AO40T239.3^NIST-AA-IZ-2|BO40T239.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||00006-4681-01^M-M-R II^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||134301|20200710|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300012711120420^Measles/Mumps/Rubella VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE||BO40T239.4^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200306093847.808-0500||VXU^V04^VXU_V04|2RSW-L.IZ-AD-6|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O06Q248^^^NIST-MPI-1^MR||YoakumAIRA^AmiensAIRA^Sterne^^^^L||20190213|M||2106-3^White^CDCREC|1072 Kuidplas St^^Simplicity Pattern^MI^49121^USA^P||^PRN^PH^^^269^8676944|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||NPD1|||||||||||08^Reminder/recall - to provider^HL70215|N|20200306|||A|20090213|20200306NK1|1|YoakumAIRA^MifflinAIRA^Leonard^^^^L|FTH^Father^HL70063|1072 Kuidplas St^^Simplicity Pattern^MI^49121^USA^P|^PRN^PH^^^269^8676944ORC|RE|AO06Q248.1^NIST-AA-IZ-2|BO06Q248.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200306||00006-4095-01^VAQTA^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||208490|20201002|MSD^Merck and Co., Inc.^MVX|||CP|URXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3xfW-P.1.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J58R19757^^^AIRA-TEST^MR||BerntsenAIRA^CathleenAIRA^Thorberta^^^^L|HughesAIRA^ZuzannaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1874 Woxmeer St^^Flint^MI^48531^USA^P||^PRN^PH^^^810^4837895|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|BerntsenAIRA^HughesAIRA^^^^^L|MTH^Mother^HL70063|1874 Woxmeer St^^Flint^MI^48531^USA^P|^PRN^PH^^^810^4837895ORC|RE||BJ58R19757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wQe-Q15.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C38F19647^^^AIRA-TEST^MR||MuskingumAIRA^AllegraAIRA^Fawn^^^^L|CassAIRA^MaceyAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1083 Kchouwen-Duiveland Pl^^Greenland^MI^49929^USA^P||^PRN^PH^^^906^8541218|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MuskingumAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1083 Kchouwen-Duiveland Pl^^Greenland^MI^49929^USA^P|^PRN^PH^^^906^8541218ORC|RE||BC38F19647.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC38F19647.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wQe-Q15.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G28V19657^^^AIRA-TEST^MR||MurphyAIRA^KarlyAIRA^Rylan^^^^L|UptonAIRA^RobalynAIRA^^^^^M|20191105|F||2106-3^White^CDCREC|1572 Tranekeradeel Pl^^Southeast^MI^48519^USA^P||^PRN^PH^^^810^8687426|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MurphyAIRA^UptonAIRA^^^^^L|MTH^Mother^HL70063|1572 Tranekeradeel Pl^^Southeast^MI^48519^USA^P|^PRN^PH^^^810^8687426ORC|RE||BG28V19657.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG28V19657.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|3wW7-QA.1.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T77C19673^^^AIRA^MR||MuscatineAIRA^RhiannonAIRA^Francesca^^^^L|PerryAIRA^NeriaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1489 Bornwirdhuizen St^^Hastings^MI^49058^USA^P||^PRN^PH^^^269^7342472|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MuscatineAIRA^PerryAIRA^Marion^^^^L|MTH^Mother^HL70063|1489 Bornwirdhuizen St^^Hastings^MI^49058^USA^P|^PRN^PH^^^269^7342472ORC|RE|AT77C19673.1^AIRA|BT77C19673.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AT77C19673.2^AIRA|BT77C19673.2^AIRARXA|0|1|20190306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|3wW7-QA.2.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W90Q19681^^^AIRA^MR||PowerAIRA^ShaneAIRA^Raquel^^^^L|OttawaAIRA^KenyattaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1662 Celmond Cir^^Orion^MI^48362^USA^P||^PRN^PH^^^248^6138968|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|PowerAIRA^OttawaAIRA^Marion^^^^L|MTH^Mother^HL70063|1662 Celmond Cir^^Orion^MI^48362^USA^P|^PRN^PH^^^248^6138968ORC|RE|AW90Q19681.1^AIRA|BW90Q19681.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AW90Q19681.2^AIRA|BW90Q19681.2^AIRARXA|0|1|20190306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|3wW7-QA.3.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S60B19689^^^AIRA^MR||WexfordAIRA^PerditaAIRA^Aparna^^^^L|LarssenAIRA^ShevaunAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1911 Eenmaal Pl^^Saranac^MI^48881^USA^P||^PRN^PH^^^616^6967387|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|WexfordAIRA^LarssenAIRA^Marion^^^^L|MTH^Mother^HL70063|1911 Eenmaal Pl^^Saranac^MI^48881^USA^P|^PRN^PH^^^616^6967387ORC|RE|AS60B19689.1^AIRA|BS60B19689.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AS60B19689.2^AIRA|BS60B19689.2^AIRARXA|0|1|20190306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|3wW7-QA.3.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P43B19696^^^AIRA^MR||AmadorAIRA^NimmiAIRA^Vonni^^^^L|TravisAIRA^JanetAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1103 Nardinxveld-Giessendam Ln^^Point Aux Pin^MI^49775^USA^P||^PRN^PH^^^231^6473910|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|AmadorAIRA^TravisAIRA^Marion^^^^L|MTH^Mother^HL70063|1103 Nardinxveld-Giessendam Ln^^Point Aux Pin^MI^49775^USA^P|^PRN^PH^^^231^6473910ORC|RE|AP43B19696.1^AIRA|BP43B19696.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AP43B19696.2^AIRA|BP43B19696.2^AIRARXA|0|1|20190306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|3wW7-QA.5.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W95C19705^^^AIRA^MR||ClareAIRA^AstridAIRA^Vicki^^^^L|AlconaAIRA^EmaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1762 Birschot St^^Saint Heights^MI^48314^USA^P||^PRN^PH^^^586^8469190|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|1|||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ClareAIRA^AlconaAIRA^Marion^^^^L|MTH^Mother^HL70063|1762 Birschot St^^Saint Heights^MI^48314^USA^P|^PRN^PH^^^586^8469190ORC|RE|AW95C19705.1^AIRA|BW95C19705.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AW95C19705.2^AIRA|BW95C19705.2^AIRARXA|0|1|20190306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|3wW7-QA.5.1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O80G19714^^^AIRA^MR||ClareAIRA^AstridAIRA^Aiden^^^^L|AlconaAIRA^EmaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1762 Birschot St^^Saint Heights^MI^48314^USA^P||^PRN^PH^^^586^8469190|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|2|||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ClareAIRA^AlconaAIRA^Marion^^^^L|MTH^Mother^HL70063|1762 Birschot St^^Saint Heights^MI^48314^USA^P|^PRN^PH^^^586^8469190ORC|RE|AW95C19705.1^AIRA|BW95C19705.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AW95C19705.2^AIRA|BW95C19705.2^AIRARXA|0|1|20190306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|3wW7-QA.7.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P75B19736^^^AIRA^MR||PowellAIRA^WalburgaAIRA^Kiera^^^^L|QuinlaAIRA^HermosaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1999 Zidden-Delfland Pl^^Springport^MI^49284^USA^P||^PRN^PH^^^517^7223695|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|PowellAIRA^QuinlaAIRA^Marion^^^^L|MTH^Mother^HL70063|1999 Zidden-Delfland Pl^^Springport^MI^49284^USA^P|^PRN^PH^^^517^7223695ORC|RE||BP75B19736.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BP75B19736.2^AIRARXA|0|1|20170306||83^Hep A peds^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.1.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J51G255^^^AIRA^MR||WashingtonAIRA^JazlynAIRA^Kaili^^^^L|ColusaAIRA^LenoraAIRA^^^^^M|20190223|F||2106-3^White^CDCREC|1592 Echagen Ave^^Fair Haven^MI^48023^USA^P||^PRN^PH^^^810^8446235|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|WashingtonAIRA^ColusaAIRA^Marion^^^^L|MTH^Mother^HL70063|1592 Echagen Ave^^Fair Haven^MI^48023^USA^P|^PRN^PH^^^810^8446235ORC|RE|AJ51G255.1^AIRA|BJ51G255.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.1.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J55Q257^^^AIRA^MR||BelmontAIRA^FotiniAIRA^Elrica^^^^L|UlsethAIRA^AdolfinaAIRA^^^^^M|20190223|F||2106-3^White^CDCREC|1172 Iellevoetsluis Ave^^Oxford^MI^48371^USA^P||^PRN^PH^^^248^8809640|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|BelmontAIRA^UlsethAIRA^Marion^^^^L|MTH^Mother^HL70063|1172 Iellevoetsluis Ave^^Oxford^MI^48371^USA^P|^PRN^PH^^^248^8809640ORC|RE|AJ55Q257.1^AIRA|BJ55Q257.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z02T263^^^AIRA^MR||O NeillAIRA^RinzenAIRA^^^^^L||20160224|FORC|RE||BZ02T263.1^AIRARXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||AOBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||FOBX|2|CE|69764-9^Document Type^LN|2|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||FOBX|3|DT|29769-7^Date Vis Presented^LN|2|20200306||||||FMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W35P265^^^AIRA^MR||JuniataAIRA^NadiraAIRA^^^^^L||20160224|FORC|RE||BW35P265.1^AIRARXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||AOBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||FOBX|2|CE|69764-9^Document Type^LN|2|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||FOBX|3|DT|29769-7^Date Vis Presented^LN|2|20200306||||||FMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P75U271^^^AIRA^MR||HillAIRA^SwetaAIRA^^^^^L||20160224|FORC|RE||BP75U271.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V63W273^^^AIRA^MR||GreggAIRA^PaulinaAIRA^^^^^L||20160224|FORC|RE||BV63W273.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.3.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O41Z281^^^AIRA^MR||JohnstonAIRA^ValoraAIRA^^^^^L||20160224|FORC|RE||9999^AIRA|RXA|0|1|20200306||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.3.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D65Y283^^^AIRA^MR||DawsonAIRA^ParveenAIRA^^^^^L||20160224|FORC|RE||9999^AIRA|RXA|0|1|20200306||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.4.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B87B291^^^AIRA^MR||GrantAIRA^EuphrosyneAIRA^^^^^L||20160224|FORC|RE||BB87B291.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AORC|RE||9999^AIRA|RXA|0|1|20170306||998^No Vaccine Administered^CVX|999|||||||||||||||AOBX|1|CE|31044-1^Reaction^LN|1|39579001^Anaphylaxis^SCT||||||FMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.4.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L35T293^^^AIRA^MR||MarionAIRA^EuphemiaAIRA^^^^^L||20160224|FORC|RE||BL35T293.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AORC|RE||9999^AIRA|RXA|0|1|20170306||998^No Vaccine Administered^CVX|999|||||||||||||||AOBX|1|CE|31044-1^Reaction^LN|1|39579001^Anaphylaxis^SCT||||||FMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.5.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W44B301^^^AIRA^MR||CassAIRA^BryanneAIRA^^^^^L||20160224|FORC|RE||BW44B301.1^AIRARXA|0|1|20170306||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||AORC|RE||9999^AIRA|RXA|0|1|20170306||998^No Vaccine Administered^CVX|999|||||||||||||||AOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^History of Varicella infection^SCT||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.10.5.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G43E303^^^AIRA^MR||OfvermarkAIRA^AbiraAIRA^^^^^L||20160224|FORC|RE||BG43E303.1^AIRARXA|0|1|20170306||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||AORC|RE||9999^AIRA|RXA|0|1|20170306||998^No Vaccine Administered^CVX|999|||||||||||||||AOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^History of Varicella infection^SCT||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.11.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N87Z311^^^AIRA^MR||LilleyAIRA^YsabelAIRA^Terena^^^^L|MeredithAIRA^AlankritaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1556 Sreda St^^Selfridge Angb^MI^48045^USA^P||^PRN^PH^^^586^6234459|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|LilleyAIRA^MeredithAIRA^Marion^^^^L|MTH^Mother^HL70063|1556 Sreda St^^Selfridge Angb^MI^48045^USA^P|^PRN^PH^^^586^6234459ORC|RE|AN87Z311.1^AIRA|BN87Z311.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||PA|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.11.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z78X313^^^AIRA^MR||OscodaAIRA^TarshaAIRA^Gardenia^^^^L|SykesAIRA^FionavarAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1293 Hutten Ln^^Woodhaven^MI^48183^USA^P||^PRN^PH^^^734^2505806|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|OscodaAIRA^SykesAIRA^Marion^^^^L|MTH^Mother^HL70063|1293 Hutten Ln^^Woodhaven^MI^48183^USA^P|^PRN^PH^^^734^2505806ORC|RE|AZ78X313.1^AIRA|BZ78X313.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||PA|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.11.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R68U321^^^AIRA^MR||SusquehannaAIRA^NeaAIRA^Richelle^^^^L|PlymouthAIRA^LeaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1346 Eittard-Geleen Ln^^Waterford^MI^48328^USA^P||^PRN^PH^^^248^7123579|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|SusquehannaAIRA^PlymouthAIRA^Marion^^^^L|MTH^Mother^HL70063|1346 Eittard-Geleen Ln^^Waterford^MI^48328^USA^P|^PRN^PH^^^248^7123579ORC|RE|AR68U321.1^AIRA|BR68U321.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||PA|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.11.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U31W323^^^AIRA^MR||JohnssonAIRA^OuraniaAIRA^Aura^^^^L|CameronAIRA^InnocentiaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1409 Klap Cir^^Dearborn^MI^48124^USA^P||^PRN^PH^^^313^8984487|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|JohnssonAIRA^CameronAIRA^Marion^^^^L|MTH^Mother^HL70063|1409 Klap Cir^^Dearborn^MI^48124^USA^P|^PRN^PH^^^313^8984487ORC|RE|AU31W323.1^AIRA|BU31W323.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||PA|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.12.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R37N331^^^AIRA^MR||SilowAIRA^VivienAIRA^Akshita^^^^L|SwisherAIRA^VincentiaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1878 Heerijnen Ln^^Chesterfield^MI^48051^USA^P||^PRN^PH^^^586^8099457|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|SilowAIRA^SwisherAIRA^Marion^^^^L|MTH^Mother^HL70063|1878 Heerijnen Ln^^Chesterfield^MI^48051^USA^P|^PRN^PH^^^586^8099457ORC|RE|AR37N331.1^AIRA|BR37N331.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.13.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A40T338^^^AIRA^MR||StrubleAIRA^MaliahAIRA^Ema^^^^L|BielaAIRA^RachelAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1520 Oergen Ln^^Rose City^MI^48654^USA^P||^PRN^PH^^^989^8203930|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|StrubleAIRA^BielaAIRA^Marion^^^^L|MTH^Mother^HL70063|1520 Oergen Ln^^Rose City^MI^48654^USA^P|^PRN^PH^^^989^8203930ORC|RE|AA40T338.1^AIRA|BA40T338.1^AIRARXA|0|1|20150223||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.13.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K93K345^^^AIRA^MR||JohnsonAIRA^SalalAIRA^Subhadra^^^^L|CroweAIRA^BakarneAIRA^^^^^M||F||2106-3^White^CDCREC|1302 Verloren Ave^^Saranac^MI^48881^USA^P||^PRN^PH^^^616^8607468|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|JohnsonAIRA^CroweAIRA^Marion^^^^L|MTH^Mother^HL70063|1302 Verloren Ave^^Saranac^MI^48881^USA^P|^PRN^PH^^^616^8607468ORC|RE|AK93K345.1^AIRA|BK93K345.1^AIRARXA|0|1|20200306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.15.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G83R352^^^AIRA^MR||ClarkeAIRA^YsabelAIRA^Shanessa^^^^L|Los AngelesAIRA^VerityAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1333 Drechterland Ln^^Delray^MI^48217^USA^P||^PRN^PH^^^313^6827504|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ClarkeAIRA^Los AngelesAIRA^Marion^^^^L|MTH^Mother^HL70063|1333 Drechterland Ln^^Delray^MI^48217^USA^P|^PRN^PH^^^313^6827504ORC|RE|AG83R352.1^AIRA|BG83R352.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00005-1971-04^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AG83R352.2^AIRA|BG83R352.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00006-4047-41^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AG83R352.3^AIRA|BG83R352.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281-0860-10^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.15.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N59B354^^^AIRA^MR||CowleAIRA^JanaeAIRA^Wenona^^^^L|TrumbullAIRA^ArdenAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1392 Nandgraaf Ave^^Warren^MI^48092^USA^P||^PRN^PH^^^586^6235971|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|CowleAIRA^TrumbullAIRA^Marion^^^^L|MTH^Mother^HL70063|1392 Nandgraaf Ave^^Warren^MI^48092^USA^P|^PRN^PH^^^586^6235971ORC|RE|AN59B354.1^AIRA|BN59B354.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00005-1971-04^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AN59B354.2^AIRA|BN59B354.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00006-4047-41^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AN59B354.3^AIRA|BN59B354.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281-0860-10^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.15.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O90H362^^^AIRA^MR||BonnevilleAIRA^YdelAIRA^Brook^^^^L|DixonAIRA^DanielleAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1642 Woermond Pl^^Saint Heights^MI^48311^USA^P||^PRN^PH^^^586^3356097|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|BonnevilleAIRA^DixonAIRA^Marion^^^^L|MTH^Mother^HL70063|1642 Woermond Pl^^Saint Heights^MI^48311^USA^P|^PRN^PH^^^586^3356097ORC|RE|AO90H362.1^AIRA|BO90H362.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AO90H362.2^AIRA|BO90H362.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00006-4047-01^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AO90H362.3^AIRA|BO90H362.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281-0860-78^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.15.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U48B364^^^AIRA^MR||Box ButteAIRA^KumariAIRA^Arora^^^^L|McEntegartAIRA^TokikoAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1321 Bernheze Pl^^Marcellus^MI^49067^USA^P||^PRN^PH^^^269^6166847|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|Box ButteAIRA^McEntegartAIRA^Marion^^^^L|MTH^Mother^HL70063|1321 Bernheze Pl^^Marcellus^MI^49067^USA^P|^PRN^PH^^^269^6166847ORC|RE|AU48B364.1^AIRA|BU48B364.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AU48B364.2^AIRA|BU48B364.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00006-4047-01^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AU48B364.3^AIRA|BU48B364.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281-0860-78^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.16.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X12H372^^^AIRA^MR||ComalAIRA^MenaAIRA^Lenis^^^^L|OlsenAIRA^RaneAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1581 Gaasdriel Ave^^Brownstown^MI^48183^USA^P||^PRN^PH^^^734^8540380|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ComalAIRA^OlsenAIRA^Marion^^^^L|MTH^Mother^HL70063|1581 Gaasdriel Ave^^Brownstown^MI^48183^USA^P|^PRN^PH^^^734^8540380ORC|RE|AX12H372.1^AIRA|BX12H372.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00005197104^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AX12H372.2^AIRA|BX12H372.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00006404741^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AX12H372.3^AIRA|BX12H372.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281086010^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.16.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A56C374^^^AIRA^MR||ChristensenAIRA^BerthildaAIRA^Kamali^^^^L|MonroeAIRA^AsterAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1898 Roetermeer Pl^^Barbeau^MI^49710^USA^P||^PRN^PH^^^906^4891760|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ChristensenAIRA^MonroeAIRA^Marion^^^^L|MTH^Mother^HL70063|1898 Roetermeer Pl^^Barbeau^MI^49710^USA^P|^PRN^PH^^^906^4891760ORC|RE|AA56C374.1^AIRA|BA56C374.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00005197104^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AA56C374.2^AIRA|BA56C374.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00006404741^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AA56C374.3^AIRA|BA56C374.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281086010^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.16.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A33S382^^^AIRA^MR||LawrenceAIRA^GalayAIRA^Yoshi^^^^L|CoshoctonAIRA^BaraAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1921 Eytsjerksteradiel Ln^^Farmington^MI^48333^USA^P||^PRN^PH^^^248^6584188|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|LawrenceAIRA^CoshoctonAIRA^Marion^^^^L|MTH^Mother^HL70063|1921 Eytsjerksteradiel Ln^^Farmington^MI^48333^USA^P|^PRN^PH^^^248^6584188ORC|RE|AA33S382.1^AIRA|BA33S382.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00005197101^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AA33S382.2^AIRA|BA33S382.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00006404701^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AA33S382.3^AIRA|BA33S382.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281086078^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.16.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E38F384^^^AIRA^MR||HoughtonAIRA^LexyAIRA^Yrsa^^^^L|BuffaloAIRA^NeetaAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1958 Erootegast Ave^^Lansing^MI^48924^USA^P||^PRN^PH^^^517^2273075|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|HoughtonAIRA^BuffaloAIRA^Marion^^^^L|MTH^Mother^HL70063|1958 Erootegast Ave^^Lansing^MI^48924^USA^P|^PRN^PH^^^517^2273075ORC|RE|AE38F384.1^AIRA|BE38F384.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00005197101^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AE38F384.2^AIRA|BE38F384.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||00006404701^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AE38F384.3^AIRA|BE38F384.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281086078^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.16.3.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M09J392^^^AIRA^MR||MarionAIRA^NettieAIRA^Kora^^^^L|HenryAIRA^NualaAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1830 Aoggenland Pl^^Mott Park^MI^48504^USA^P||^PRN^PH^^^810^5114717|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MarionAIRA^HenryAIRA^Marion^^^^L|MTH^Mother^HL70063|1830 Aoggenland Pl^^Mott Park^MI^48504^USA^P|^PRN^PH^^^810^5114717ORC|RE|AM09J392.1^AIRA|BM09J392.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||0005-1971-04^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AM09J392.2^AIRA|BM09J392.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||0006-4047-41^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AM09J392.3^AIRA|BM09J392.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281-860-10^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.16.3.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U36S394^^^AIRA^MR||DawsonAIRA^EvaAIRA^Quinn^^^^L|AlleghenyAIRA^GirijaAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1013 Ne Fryske Marren St^^Farmington Hills^MI^48336^USA^P||^PRN^PH^^^248^2662472|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|DawsonAIRA^AlleghenyAIRA^Marion^^^^L|MTH^Mother^HL70063|1013 Ne Fryske Marren St^^Farmington Hills^MI^48336^USA^P|^PRN^PH^^^248^2662472ORC|RE|AU36S394.1^AIRA|BU36S394.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||0005-1971-04^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AU36S394.2^AIRA|BU36S394.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||0006-4047-41^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AU36S394.3^AIRA|BU36S394.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281-860-10^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.16.4.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G36O402^^^AIRA^MR||ValleyAIRA^DietlindeAIRA^Lokelani^^^^L|MiamiAIRA^HillaryAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1161 Hinsum Ln^^Hamtramck^MI^48212^USA^P||^PRN^PH^^^313^7573615|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ValleyAIRA^MiamiAIRA^Marion^^^^L|MTH^Mother^HL70063|1161 Hinsum Ln^^Hamtramck^MI^48212^USA^P|^PRN^PH^^^313^7573615ORC|RE|AG36O402.1^AIRA|BG36O402.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||0005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AG36O402.2^AIRA|BG36O402.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||0006-4047-01^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AG36O402.3^AIRA|BG36O402.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281-860-78^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|2RXb-SA.16.4.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I97W404^^^AIRA^MR||BoyleAIRA^AnielaAIRA^Honour^^^^L|LivingstonAIRA^IratzeAIRA^^^^^M|20200105|F||2106-3^White^CDCREC|1546 Wilze en Rijen Ave^^Stephenson^MI^49887^USA^P||^PRN^PH^^^906^2020188|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|BoyleAIRA^LivingstonAIRA^Marion^^^^L|MTH^Mother^HL70063|1546 Wilze en Rijen Ave^^Stephenson^MI^49887^USA^P|^PRN^PH^^^906^2020188ORC|RE|AI97W404.1^AIRA|BI97W404.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||0005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250102|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AI97W404.2^AIRA|BI97W404.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||0006-4047-01^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250220|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306ORC|RE|AI97W404.3^AIRA|BI97W404.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||49281-860-78^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241226|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151128||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.2.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B02C412^^^AIRA^MR||DallamAIRA^GloriaAIRA^Pratima^^^^L|ViergesAIRA^SirishaAIRA^^^^^M|20040224|F||2106-3^White^CDCREC|1620 Gesterveld Cir^^Hardwood^MI^49807^USA^P||^PRN^PH^^^906^8026610|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|DallamAIRA^ViergesAIRA^Marion^^^^L|MTH^Mother^HL70063|1620 Gesterveld Cir^^Hardwood^MI^49807^USA^P|^PRN^PH^^^906^8026610ORC|RE||BB02C412.1^AIRARXA|0|1|20080306||03^MMR^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.2.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z47P414^^^AIRA^MR||AshlandAIRA^AyleenAIRA^Destiny^^^^L|MahoodAIRA^IlenaAIRA^^^^^M|20040224|F||2106-3^White^CDCREC|1539 Gijnwaarden St^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^6596005|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|AshlandAIRA^MahoodAIRA^Marion^^^^L|MTH^Mother^HL70063|1539 Gijnwaarden St^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^6596005ORC|RE||BZ47P414.1^AIRARXA|0|1|20080306||03^MMR^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.3.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B76Z422^^^AIRA^MR||MercerAIRA^MariyahAIRA^Chloe^^^^L|PayneAIRA^MedeaAIRA^^^^^M|20181124|F||2106-3^White^CDCREC|1466 Echt-Susteren Ln^^Ishpeming^MI^49865^USA^P||^PRN^PH^^^906^5896796|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MercerAIRA^PayneAIRA^Marion^^^^L|MTH^Mother^HL70063|1466 Echt-Susteren Ln^^Ishpeming^MI^49865^USA^P|^PRN^PH^^^906^5896796ORC|RE||BB76Z422.1^AIRARXA|0|1|20181124||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.2^AIRARXA|0|1|20190124||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.3^AIRARXA|0|1|20190124||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.4^AIRARXA|0|1|20190124||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.5^AIRARXA|0|1|20190124||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.6^AIRARXA|0|1|20190124||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.7^AIRARXA|0|1|20190124||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.8^AIRARXA|0|1|20190326||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.9^AIRARXA|0|1|20190326||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.10^AIRARXA|0|1|20190326||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.11^AIRARXA|0|1|20190326||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.12^AIRARXA|0|1|20190326||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.13^AIRARXA|0|1|20190526||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.14^AIRARXA|0|1|20190526||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.15^AIRARXA|0|1|20190526||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.16^AIRARXA|0|1|20190526||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BB76Z422.17^AIRARXA|0|1|20190526||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AB76Z422.18^AIRA|BB76Z422.18^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||120^DTaP-Hib-IPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||983BG|20201129|PMC^Sanofi^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AB76Z422.19^AIRA|BB76Z422.19^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||133^PCV13^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A1345C|20201129|PFR^Pfizer^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AB76Z422.20^AIRA|BB76Z422.20^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AB76Z422.21^AIRA|BB76Z422.21^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||83^Hep A peds^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||825AR23|20201129|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.3.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z24O424^^^AIRA^MR||HawkeAIRA^IlannaAIRA^Vivienne^^^^L|UpshurAIRA^DeliciaAIRA^^^^^M|20181124|F||2106-3^White^CDCREC|1508 Oytsjerksteradiel St^^Marenisco^MI^49947^USA^P||^PRN^PH^^^906^7571811|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|HawkeAIRA^UpshurAIRA^Marion^^^^L|MTH^Mother^HL70063|1508 Oytsjerksteradiel St^^Marenisco^MI^49947^USA^P|^PRN^PH^^^906^7571811ORC|RE||BZ24O424.1^AIRARXA|0|1|20181124||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.2^AIRARXA|0|1|20190124||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.3^AIRARXA|0|1|20190124||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.4^AIRARXA|0|1|20190124||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.5^AIRARXA|0|1|20190124||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.6^AIRARXA|0|1|20190124||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.7^AIRARXA|0|1|20190124||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.8^AIRARXA|0|1|20190326||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.9^AIRARXA|0|1|20190326||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.10^AIRARXA|0|1|20190326||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.11^AIRARXA|0|1|20190326||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.12^AIRARXA|0|1|20190326||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.13^AIRARXA|0|1|20190526||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.14^AIRARXA|0|1|20190526||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.15^AIRARXA|0|1|20190526||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.16^AIRARXA|0|1|20190526||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BZ24O424.17^AIRARXA|0|1|20190526||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AZ24O424.18^AIRA|BZ24O424.18^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||120^DTaP-Hib-IPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||983BG|20201129|PMC^Sanofi^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AZ24O424.19^AIRA|BZ24O424.19^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||133^PCV13^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A1345C|20201129|PFR^Pfizer^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AZ24O424.20^AIRA|BZ24O424.20^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AZ24O424.21^AIRA|BZ24O424.21^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||83^Hep A peds^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||825AR23|20201129|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F90O432^^^AIRA^MR||ThompsenAIRA^HuyanaAIRA^Erline^^^^L|BonnerAIRA^JamariAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1883 Wrijven Ln^^Garden City^MI^48136^USA^P||^PRN^PH^^^734^7967238|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ThompsenAIRA^BonnerAIRA^Marion^^^^L|MTH^Mother^HL70063|1883 Wrijven Ln^^Garden City^MI^48136^USA^P|^PRN^PH^^^734^7967238ORC|RE|AF90O432.1^AIRA|BF90O432.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N25I434^^^AIRA^MR||MartinAIRA^DarraAIRA^Bronte^^^^L|LevyAIRA^VaisakhiAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1409 Woordenveld Ave^^Grosse Pointe Shores^MI^48230^USA^P||^PRN^PH^^^313^4376316|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MartinAIRA^LevyAIRA^Marion^^^^L|MTH^Mother^HL70063|1409 Woordenveld Ave^^Grosse Pointe Shores^MI^48230^USA^P|^PRN^PH^^^313^4376316ORC|RE|AN25I434.1^AIRA|BN25I434.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F90O432^^^AIRA^MR||ThompsenAIRA^HuyanaAIRA^Erline^^^^L|BonnerAIRA^JamariAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1883 Wrijven Ln^^Garden City^MI^48136^USA^P||^PRN^PH^^^734^7967238|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ThompsenAIRA^BonnerAIRA^Marion^^^^L|MTH^Mother^HL70063|1883 Wrijven Ln^^Garden City^MI^48136^USA^P|^PRN^PH^^^734^7967238ORC|RE|AF90O432.1^AIRA|BF90O432.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200304||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|U|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.1.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N25I434^^^AIRA^MR||MartinAIRA^DarraAIRA^Bronte^^^^L|LevyAIRA^VaisakhiAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1409 Woordenveld Ave^^Grosse Pointe Shores^MI^48230^USA^P||^PRN^PH^^^313^4376316|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MartinAIRA^LevyAIRA^Marion^^^^L|MTH^Mother^HL70063|1409 Woordenveld Ave^^Grosse Pointe Shores^MI^48230^USA^P|^PRN^PH^^^313^4376316ORC|RE|AN25I434.1^AIRA|BN25I434.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200304||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|U|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X16N453^^^AIRA^MR||ParkerAIRA^OfraAIRA^Yogita^^^^L|ThomasAIRA^MilenaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1622 Versel Pl^^Ortonville^MI^48462^USA^P||^PRN^PH^^^248^4342429|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ParkerAIRA^ThomasAIRA^Marion^^^^L|MTH^Mother^HL70063|1622 Versel Pl^^Ortonville^MI^48462^USA^P|^PRN^PH^^^248^4342429ORC|RE|AX16N453.1^AIRA|BX16N453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||08^HepB adolescent or pediatric^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201129|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300005911190815^Hepatitis B Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E88O455^^^AIRA^MR||MuskogeeAIRA^TirzaAIRA^Emmuna^^^^L|McClungAIRA^AdornaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1600 Gnschede Ln^^De Tour Village^MI^49725^USA^P||^PRN^PH^^^906^7381218|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MuskogeeAIRA^McClungAIRA^Marion^^^^L|MTH^Mother^HL70063|1600 Gnschede Ln^^De Tour Village^MI^49725^USA^P|^PRN^PH^^^906^7381218ORC|RE|AE88O455.1^AIRA|BE88O455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||08^HepB adolescent or pediatric^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201129|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300005911190815^Hepatitis B Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.2.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X16N453^^^AIRA^MR||ParkerAIRA^OfraAIRA^Yogita^^^^L|ThomasAIRA^MilenaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1622 Versel Pl^^Ortonville^MI^48462^USA^P||^PRN^PH^^^248^4342429|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|ParkerAIRA^ThomasAIRA^Marion^^^^L|MTH^Mother^HL70063|1622 Versel Pl^^Ortonville^MI^48462^USA^P|^PRN^PH^^^248^4342429ORC|RE|AX16N453.1^AIRA|BX16N453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201129|SKB^GlaxoSmithKline^MVX|||CP|U|RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300005911190815^Hepatitis A Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.2.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E88O455^^^AIRA^MR||MuskogeeAIRA^TirzaAIRA^Emmuna^^^^L|McClungAIRA^AdornaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1600 Gnschede Ln^^De Tour Village^MI^49725^USA^P||^PRN^PH^^^906^7381218|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MuskogeeAIRA^McClungAIRA^Marion^^^^L|MTH^Mother^HL70063|1600 Gnschede Ln^^De Tour Village^MI^49725^USA^P|^PRN^PH^^^906^7381218ORC|RE|AE88O455.1^AIRA|BE88O455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201129|SKB^GlaxoSmithKline^MVX|||CP|U|RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300005911190815^Hepatitis A Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.3.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M69J470^^^AIRA^MR||MarlinAIRA^RosevearAIRA^Anne^^^^L|PsconenAIRA^TiponyaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1582 Remert-Bakel Ave^^Lansing^MI^48908^USA^P||^PRN^PH^^^517^5732014|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MarlinAIRA^PsconenAIRA^Marion^^^^L|MTH^Mother^HL70063|1582 Remert-Bakel Ave^^Lansing^MI^48908^USA^P|^PRN^PH^^^517^5732014ORC|RE|AM69J470.1^AIRA|BM69J470.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.3.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N74X472^^^AIRA^MR||GogebicAIRA^EveAIRA^Paloma^^^^L|IslandAIRA^KasmiraAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1429 Mensen Cir^^Flint^MI^48556^USA^P||^PRN^PH^^^810^9418424|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|GogebicAIRA^IslandAIRA^Marion^^^^L|MTH^Mother^HL70063|1429 Mensen Cir^^Flint^MI^48556^USA^P|^PRN^PH^^^810^9418424ORC|RE|AN74X472.1^AIRA|BN74X472.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.3.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M69J470^^^AIRA^MR||MarlinAIRA^RosevearAIRA^Anne^^^^L|PsconenAIRA^TiponyaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1582 Remert-Bakel Ave^^Lansing^MI^48908^USA^P||^PRN^PH^^^517^5732014|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MarlinAIRA^PsconenAIRA^Marion^^^^L|MTH^Mother^HL70063|1582 Remert-Bakel Ave^^Lansing^MI^48908^USA^P|^PRN^PH^^^517^5732014ORC|RE|AM69J470.1^AIRA|X44W480.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200304||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|U|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.4.3.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N74X472^^^AIRA^MR||GogebicAIRA^EveAIRA^Paloma^^^^L|IslandAIRA^KasmiraAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1429 Mensen Cir^^Flint^MI^48556^USA^P||^PRN^PH^^^810^9418424|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|GogebicAIRA^IslandAIRA^Marion^^^^L|MTH^Mother^HL70063|1429 Mensen Cir^^Flint^MI^48556^USA^P|^PRN^PH^^^810^9418424ORC|RE|AN74X472.1^AIRA|J53A481.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200304||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|U|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.5.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R08A489^^^AIRA^MR||BonnerAIRA^RaeganAIRA^Talia^^^^L|ThrockmortonAIRA^NettyAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1568 Peidschendam-Voorburg St^^Hamtramck^MI^48211^USA^P||^PRN^PH^^^313^3615161|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|BonnerAIRA^ThrockmortonAIRA^Marion^^^^L|MTH^Mother^HL70063|1568 Peidschendam-Voorburg St^^Hamtramck^MI^48211^USA^P|^PRN^PH^^^313^3615161ORC|RE|AR08A489.1^AIRA|BR08A489.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AR08A489.2^AIRA|BR08A489.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201129|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.5.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S35J491^^^AIRA^MR||LancasterAIRA^ShivaunAIRA^Jarka^^^^L|SutterAIRA^StaceyAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1721 Motor Cir^^Hart^MI^49420^USA^P||^PRN^PH^^^231^9948868|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|LancasterAIRA^SutterAIRA^Marion^^^^L|MTH^Mother^HL70063|1721 Motor Cir^^Hart^MI^49420^USA^P|^PRN^PH^^^231^9948868ORC|RE|AS35J491.1^AIRA|BS35J491.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306ORC|RE|AS35J491.2^AIRA|BS35J491.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201129|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.5.1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R08A489^^^AIRA^MR||BonnerAIRA^RaeganAIRA^Talia^^^^L|ThrockmortonAIRA^NettyAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1568 Peidschendam-Voorburg St^^Hamtramck^MI^48211^USA^P||^PRN^PH^^^313^3615161|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|BonnerAIRA^ThrockmortonAIRA^Marion^^^^L|MTH^Mother^HL70063|1568 Peidschendam-Voorburg St^^Hamtramck^MI^48211^USA^P|^PRN^PH^^^313^3615161ORC|RE|AR08A489.1^AIRA|BR08A489.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|D|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.5.1.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S35J491^^^AIRA^MR||LancasterAIRA^ShivaunAIRA^Jarka^^^^L|SutterAIRA^StaceyAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1721 Motor Cir^^Hart^MI^49420^USA^P||^PRN^PH^^^231^9948868|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|LancasterAIRA^SutterAIRA^Marion^^^^L|MTH^Mother^HL70063|1721 Motor Cir^^Hart^MI^49420^USA^P|^PRN^PH^^^231^9948868ORC|RE|AS35J491.1^AIRA|BS35J491.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201129|MSD^Merck and Co^MVX|||CP|D|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200306OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200306|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200306OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200306||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.6.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B55L506^^^AIRA^MR||MarionAIRA^GwendolynAIRA^Brooklyn^^^^L|GarvinAIRA^SaritaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1100 Dontferland Ave^^South Haven^MI^49090^USA^P||^PRN^PH^^^269^3989269|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|Y|20200306|||A|20200306|20200306NK1|1|MarionAIRA^GarvinAIRA^Marion^^^^L|MTH^Mother^HL70063|1100 Dontferland Ave^^South Haven^MI^49090^USA^P|^PRN^PH^^^269^3989269ORC|RE|AB55L506.1^AIRA|BB55L506.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.6.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X61B508^^^AIRA^MR||CruzAIRA^RibaAIRA^Jayden^^^^L|MorrowAIRA^LuciaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1807 Pmallingerland St^^Fairgrove^MI^48733^USA^P||^PRN^PH^^^989^8710812|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|Y|20200306|||A|20200306|20200306NK1|1|CruzAIRA^MorrowAIRA^Marion^^^^L|MTH^Mother^HL70063|1807 Pmallingerland St^^Fairgrove^MI^48733^USA^P|^PRN^PH^^^989^8710812ORC|RE|AX61B508.1^AIRA|BX61B508.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.6.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L28B516^^^AIRA^MR||WynneAIRA^GriseldaAIRA^Zera^^^^L|CoryellAIRA^TatumAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1098 Meiderland Ave^^Forest Hills^MI^49506^USA^P||^PRN^PH^^^616^6047742|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|WynneAIRA^CoryellAIRA^Marion^^^^L|MTH^Mother^HL70063|1098 Meiderland Ave^^Forest Hills^MI^49506^USA^P|^PRN^PH^^^616^6047742ORC|RE|AL28B516.1^AIRA|BL28B516.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.6.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H28A518^^^AIRA^MR||JacksonAIRA^NonaAIRA^Aviva^^^^L|JeromeAIRA^MedaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1284 Wormerland St^^Harrison^MI^48625^USA^P||^PRN^PH^^^989^5108779|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|JacksonAIRA^JeromeAIRA^Marion^^^^L|MTH^Mother^HL70063|1284 Wormerland St^^Harrison^MI^48625^USA^P|^PRN^PH^^^989^5108779ORC|RE|AH28A518.1^AIRA|BH28A518.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.7.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q60P524^^^AIRA^MR||HammarAIRA^GayAIRA^Clover^^^^L|KaufmanAIRA^ReaganAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1609 Bieden St^^Beaver Island^MI^49782^USA^P||^PRN^PH^^^906^5202266|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|HammarAIRA^KaufmanAIRA^Marion^^^^L|MTH^Mother^HL70063|1609 Bieden St^^Beaver Island^MI^49782^USA^P|^PRN^PH^^^906^5202266ORC|RE||9999^AIRA|RXA|0|1|20200306||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.7.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B00A526^^^AIRA^MR||WrigleyAIRA^MarikoAIRA^Dore^^^^L|TemplemanAIRA^MayukoAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1497 Synaarlo Ln^^Eau Claire^MI^49111^USA^P||^PRN^PH^^^269^4466216|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|WrigleyAIRA^TemplemanAIRA^Marion^^^^L|MTH^Mother^HL70063|1497 Synaarlo Ln^^Eau Claire^MI^49111^USA^P|^PRN^PH^^^269^4466216ORC|RE||9999^AIRA|RXA|0|1|20200306||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.8.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q95V534^^^AIRA^MR||MarionAIRA^BinaAIRA^Gretel^^^^L|LeeAIRA^JasleneAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1221 Suidhorn Ave^^Horton^MI^49246^USA^P||^PRN^PH^^^517^5974408|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MarionAIRA^LeeAIRA^Marion^^^^L|MTH^Mother^HL70063|1221 Suidhorn Ave^^Horton^MI^49246^USA^P|^PRN^PH^^^517^5974408ORC|RE|AQ95V534.1^AIRA|BQ95V534.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.8.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S22X536^^^AIRA^MR||Cerro GordoAIRA^DevikaAIRA^Regan^^^^L|LycomingAIRA^RicardaAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1194 Tundert Ave^^Cooks^MI^49817^USA^P||^PRN^PH^^^906^9635686|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|Cerro GordoAIRA^LycomingAIRA^Marion^^^^L|MTH^Mother^HL70063|1194 Tundert Ave^^Cooks^MI^49817^USA^P|^PRN^PH^^^906^9635686ORC|RE|AS22X536.1^AIRA|BS22X536.1^AIRARXA|0|1|20170306||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.8.1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q95V534^^^AIRA^MR||MarionAIRA^BinaAIRA^Gretel^^^^L|LeeAIRA^JasleneAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1221 Suidhorn Ave^^Horton^MI^49246^USA^P||^PRN^PH^^^517^5974408|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MarionAIRA^LeeAIRA^Marion^^^^L|MTH^Mother^HL70063|1221 Suidhorn Ave^^Horton^MI^49246^USA^P|^PRN^PH^^^517^5974408ORC|RE||9999^AIRA|RXA|0|1|20170306||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|31044-1^Reaction^LN|1|39579001^Anaphylaxis^SCT||||||F|||20170306|MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.8.1.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q95V534^^^AIRA^MR||MarionAIRA^BinaAIRA^Gretel^^^^L|LeeAIRA^JasleneAIRA^^^^^M|20160224|F||2106-3^White^CDCREC|1221 Suidhorn Ave^^Horton^MI^49246^USA^P||^PRN^PH^^^517^5974408|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MarionAIRA^LeeAIRA^Marion^^^^L|MTH^Mother^HL70063|1221 Suidhorn Ave^^Horton^MI^49246^USA^P|^PRN^PH^^^517^5974408ORC|RE||9999^AIRA|RXA|0|1|20170306||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|31044-1^Reaction^LN|1|39579001^Anaphylaxis^SCT||||||F|||20170306|MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.9.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X69Q551^^^AIRA^MR||LokkenAIRA^HaydenAIRA^Zaza^^^^L|McCrackenAIRA^SveaAIRA^^^^^M|19940223|F||2106-3^White^CDCREC|1894 Saasdriel Ave^^Johannesburg^MI^49751^USA^P||^PRN^PH^^^989^4358199|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|LokkenAIRA^McCrackenAIRA^Marion^^^^L|MTH^Mother^HL70063|1894 Saasdriel Ave^^Johannesburg^MI^49751^USA^P|^PRN^PH^^^989^4358199ORC|RE||9999^AIRA|RXA|0|1|20200306||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|30945-0^Vaccination contraindication^LN|1|77386006^Patient Currently Pregnant^SCT||||||F|||20200306OBX|2|DT|30946-8^Vaccination contraindication effective date^LN|1|20160605||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.9.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C78S553^^^AIRA^MR||NevadaAIRA^KaydenAIRA^Estelle^^^^L|FreestoneAIRA^YoshiAIRA^^^^^M|19940223|F||2106-3^White^CDCREC|1167 Methode St^^Sidney^MI^48885^USA^P||^PRN^PH^^^989^4674531|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|NevadaAIRA^FreestoneAIRA^Marion^^^^L|MTH^Mother^HL70063|1167 Methode St^^Sidney^MI^48885^USA^P|^PRN^PH^^^989^4674531ORC|RE||9999^AIRA|RXA|0|1|20200306||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|30945-0^Vaccination contraindication^LN|1|77386006^Patient Currently Pregnant^SCT||||||F|||20200306OBX|2|DT|30946-8^Vaccination contraindication effective date^LN|1|20160605||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.9.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E96Y563^^^AIRA^MR||HuronAIRA^KidenAIRA^Qamra^^^^L|Santa ClaraAIRA^ZambdaAIRA^^^^^M|20190223|F||2106-3^White^CDCREC|1617 Noetinchem Cir^^Brownstown^MI^48193^USA^P||^PRN^PH^^^734^7931658|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|HuronAIRA^Santa ClaraAIRA^Marion^^^^L|MTH^Mother^HL70063|1617 Noetinchem Cir^^Brownstown^MI^48193^USA^P|^PRN^PH^^^734^7931658ORC|RE||9999^AIRA|RXA|0|1|20200306||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^History of Varicella infection^SCT||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.9.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N34M565^^^AIRA^MR||AdairAIRA^CorinnaAIRA^Quirita^^^^L|LindstromAIRA^SultanaAIRA^^^^^M|20190223|F||2106-3^White^CDCREC|1817 Oelfzijl Ave^^Ocqueoc^MI^49759^USA^P||^PRN^PH^^^989^7368825|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|AdairAIRA^LindstromAIRA^Marion^^^^L|MTH^Mother^HL70063|1817 Oelfzijl Ave^^Ocqueoc^MI^49759^USA^P|^PRN^PH^^^989^7368825ORC|RE||9999^AIRA|RXA|0|1|20200306||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^History of Varicella infection^SCT||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.9.3.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K42B571^^^AIRA^MR||LatahAIRA^ShikhaAIRA^Naretha^^^^L|MenomineeAIRA^TorieAIRA^^^^^M|20190223|F||2106-3^White^CDCREC|1719 Lill en Sint Hubert Pl^^Flint^MI^48529^USA^P||^PRN^PH^^^810^4364031|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|LatahAIRA^MenomineeAIRA^Marion^^^^L|MTH^Mother^HL70063|1719 Lill en Sint Hubert Pl^^Flint^MI^48529^USA^P|^PRN^PH^^^810^4364031ORC|RE||9999^AIRA|RXA|0|1|20200306||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|75505-8^Disease with serological evidence of immunity^LN|1|271511000^Serology confirmed Hepatitis B^SCT||||||F|||20200306MSH|^~\&|||||20200306102500-0600||VXU^V04^VXU_V04|2RXb-SA.9.3.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H51X573^^^AIRA^MR||MenomineeAIRA^TarshaAIRA^Fayina^^^^L|LilleyAIRA^RhiannonAIRA^^^^^M|20190223|F||2106-3^White^CDCREC|1675 Jaar Pl^^Grosse Pointe Park^MI^48224^USA^P||^PRN^PH^^^313^6599516|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200306|||A|20200306|20200306NK1|1|MenomineeAIRA^LilleyAIRA^Marion^^^^L|MTH^Mother^HL70063|1675 Jaar Pl^^Grosse Pointe Park^MI^48224^USA^P|^PRN^PH^^^313^6599516ORC|RE||9999^AIRA|RXA|0|1|20200306||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|75505-8^Disease with serological evidence of immunity^LN|1|271511000^Serology confirmed Hepatitis B^SCT||||||F|||20200306MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C22W19423^^^AIRA-TEST^MR||RefugioAIRA^EudocieAIRA^Camellia^^^^L|GrantAIRA^QuentinAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1091 Ieder-Betuwe Ave^^Detroit^MI^48265^USA^P||^PRN^PH^^^313^3442878|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RefugioAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1091 Ieder-Betuwe Ave^^Detroit^MI^48265^USA^P|^PRN^PH^^^313^3442878ORC|RE||BC22W19423.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC22W19423.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||PID|1||J27S19428^^^AIRA-TEST^MR||KnoxAIRA^PragyaAIRA^Journey^^^^L|BaylorAIRA^ClareAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1864 Eijssen Cir^^Sault S Marie^MI^49783^USA^P||^PRN^PH^^^906^8521559|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KnoxAIRA^BaylorAIRA^^^^^L|MTH^Mother^HL70063|1864 Eijssen Cir^^Sault S Marie^MI^49783^USA^P|^PRN^PH^^^906^8521559ORC|RE||BJ27S19428.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ27S19428.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.103|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1|PID|1||K68F19439^^^AIRA-TEST^MR||KananenAIRA^DarbyAIRA^Lalima^^^^L|TaylorAIRA^SabiraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1143 Ooxmeer Ln^^Prattville^MI^49271^USA^P||^PRN^PH^^^517^7521111|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|KananenAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1143 Ooxmeer Ln^^Prattville^MI^49271^USA^P|^PRN^PH^^^517^7521111ORC|RE||BK68F19439.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK68F19439.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.104|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T15S19447^^^0150213078758545063923627551051491551309522531961813775465660544151359463423961785519077061002329538304335083417576758883245593515366797956994553074861722186495615122557516057512303953281108735246094086930050554922031951679769^MR||GrantAIRA^SandyaAIRA^Erica^^^^L|HopkinsAIRA^CarnationAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1120 Ceeuwarden Ln^^Brampton^MI^49837^USA^P||^PRN^PH^^^906^9777778|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GrantAIRA^HopkinsAIRA^^^^^L|MTH^Mother^HL70063|1120 Ceeuwarden Ln^^Brampton^MI^49837^USA^P|^PRN^PH^^^906^9777778ORC|RE||BT15S19447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT15S19447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D85X19455^^^AIRA-TEST^PI||RiverAIRA^BrooklynAIRA^Randa^^^^L|LyonAIRA^MaudeAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1541 Dtrecht St^^Lakeside^MI^49116^USA^P||^PRN^PH^^^269^2319955|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RiverAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1541 Dtrecht St^^Lakeside^MI^49116^USA^P|^PRN^PH^^^269^2319955ORC|RE||BD85X19455.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD85X19455.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.106|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A50V19463^^^AIRA-TEST^MR||CheboyganAIRA^LizzyAIRA^Zenda^^^^L|CochranAIRA^AnaAIRA^^^^^M|20131003113759-0700|F||2106-3^White^CDCREC|1839 Hampen Ln^^Glendora^MI^49107^USA^P||^PRN^PH^^^269^3026236|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CheboyganAIRA^CochranAIRA^^^^^L|MTH^Mother^HL70063|1839 Hampen Ln^^Glendora^MI^49107^USA^P|^PRN^PH^^^269^3026236ORC|RE||BA50V19463.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA50V19463.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.107|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H33H19471^^^AIRA-TEST^MR||RobertsonAIRA^DalilaAIRA^Dana^^^^L|BordenAIRA^LydiaAIRA^^^^^M|20160105|F||KLINGON^Klingon^CDCREC|1212 Wortel St^^Novi^MI^48375^USA^P||^PRN^PH^^^248^2466009|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RobertsonAIRA^BordenAIRA^^^^^L|MTH^Mother^HL70063|1212 Wortel St^^Novi^MI^48375^USA^P|^PRN^PH^^^248^2466009ORC|RE||BH33H19471.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH33H19471.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.108|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H82X19479^^^AIRA-TEST^MR||OneidaAIRA^TarynAIRA^Jaqueline^^^^L|GraysonAIRA^EllinAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1434 Korsele Ln^^Hickory Isle^MI^48138^USA^P||^PRN^PH^^^734^9584984|||||||||KLINGON^Klingon^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|OneidaAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1434 Korsele Ln^^Hickory Isle^MI^48138^USA^P|^PRN^PH^^^734^9584984ORC|RE||BH82X19479.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH82X19479.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.109|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H82S19484^^^AIRA-TEST^MR||ShermanAIRA^AkilaAIRA^Mali^^^^L|CreaserAIRA^RachelAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1842 Saarlemmermeer Ave^^Armada^MI^48005^USA^P||^PRN^PH^^^586^3533985|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ShermanAIRA^CreaserAIRA^^^^^L|MTH^Mother^HL70063|1842 Saarlemmermeer Ave^^Armada^MI^48005^USA^P|^PRN^PH^^^586^3533985ORC|RE||BH82S19484.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH82S19484.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P83S19495^^^AIRA-TEST^MR||DickinsonAIRA^ClymeneAIRA^Ventura^^^^L|JacksonAIRA^LysandraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1483 Mais Cir^^Wyoming^MI^49508^USA^P||^PRN^PH^^^616^4167693|||||||||2186-5^not Hispanic or Latino^CDCREC||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DickinsonAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1483 Mais Cir^^Wyoming^MI^49508^USA^P|^PRN^PH^^^616^4167693ORC|RE||BP83S19495.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP83S19495.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N08O19503^^^AIRA-TEST^MR||DunnAIRA^CameronAIRA^Mimi^^^^L|RowanAIRA^SaraAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1453 Luenen St^^Imlay City^MI^48444^USA^P||^PRN^PH^^^810^4983357|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|DunnAIRA^RowanAIRA^^^^^L|MTH^Mother^HL70063|1453 Luenen St^^Imlay City^MI^48444^USA^P|^PRN^PH^^^810^4983357ORC|RE||BN08O19503.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN08O19503.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.112|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W34Y19511^^^AIRA-TEST^MR||WinneshiekAIRA^GiselleAIRA^Asenette^^^^L|CopelandAIRA^PaolaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1963 Uerg en Dal Ln^^Carleton^MI^48117^USA^P||^PRN^PH^^^734^6891243|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WinneshiekAIRA^CopelandAIRA^^^^^L|MTH^Mother^HL70063|1963 Uerg en Dal Ln^^Carleton^MI^48117^USA^P|^PRN^PH^^^734^6891243MSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.113|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P77M19519^^^AIRA-TEST^MR||TemplemanAIRA^MarnyAIRA^Zsa-Zsa^^^^L|CusterAIRA^NgaireAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1021 Verschillen Pl^^Elk Rapids^MI^49629^USA^P||^PRN^PH^^^231^4431917|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|TemplemanAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1021 Verschillen Pl^^Elk Rapids^MI^49629^USA^P|^PRN^PH^^^231^4431917ORC|RE||BP77M19519.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200307145039-0700||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP77M19519.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.114|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R73H19524^^^AIRA-TEST^MR||RichardsonAIRA^AnamikaAIRA^Dacia^^^^L|WyomingAIRA^DonelleAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1135 Sinkelland Ln^^Iron Mountain^MI^49831^USA^P||^PRN^PH^^^906^9034968|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|RichardsonAIRA^WyomingAIRA^^^^^L|MTH^Mother^HL70063|1135 Sinkelland Ln^^Iron Mountain^MI^49831^USA^P|^PRN^PH^^^906^9034968ORC|RE||BR73H19524.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR73H19524.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.115|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B88M19535^^^AIRA-TEST^MR||SmithAIRA^JirraAIRA^Aditi^^^^L|TiogaAIRA^ZulemaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1944 Woststellingwerf Cir^^South Haven^MI^49090^USA^P||^PRN^PH^^^269^9274141|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|SmithAIRA^TiogaAIRA^^^^^L|MTH^Mother^HL70063|1944 Woststellingwerf Cir^^South Haven^MI^49090^USA^P|^PRN^PH^^^269^9274141ORC|RE||BB88M19535.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^This \F\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB88M19535.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.116|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C39A19543^^^AIRA-TEST^MR||CumingAIRA^KalleAIRA^Florence^^^^L|FayetteAIRA^CadrianAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1652 Waasdriel Ln^^Bessemer^MI^49911^USA^P||^PRN^PH^^^906^3054611|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CumingAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1652 Waasdriel Ln^^Bessemer^MI^49911^USA^P|^PRN^PH^^^906^3054611ORC|RE||BC39A19543.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^This \S\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC39A19543.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.117|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E96Y19551^^^AIRA-TEST^MR||NavajoAIRA^AveolelaAIRA^Lucetta^^^^L|FultonAIRA^AllysonAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1330 Ware Ln^^Kaleva^MI^49645^USA^P||^PRN^PH^^^231^8633457|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|NavajoAIRA^FultonAIRA^^^^^L|MTH^Mother^HL70063|1330 Ware Ln^^Kaleva^MI^49645^USA^P|^PRN^PH^^^231^8633457ORC|RE||BE96Y19551.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^This \T\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE96Y19551.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.118|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O94F19559^^^AIRA-TEST^MR||O'BrienAIRA^GaleAIRA^Presley^^^^L|HardemanAIRA^AnnunziataAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1842 Wedum Ave^^Harbor Beach^MI^48441^USA^P||^PRN^PH^^^989^6194480|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|O'BrienAIRA^HardemanAIRA^^^^^L|MTH^Mother^HL70063|1842 Wedum Ave^^Harbor Beach^MI^48441^USA^P|^PRN^PH^^^989^6194480ORC|RE||BO94F19559.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^This \R\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO94F19559.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.119|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C80K19564^^^AIRA-TEST^MR||PolkAIRA^CayleeAIRA^Sarita^^^^L|HayesAIRA^ShantiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1977 Probleem Ave^^Flint^MI^48507^USA^P||^PRN^PH^^^810^8097495|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|PolkAIRA^HayesAIRA^^^^^L|MTH^Mother^HL70063|1977 Probleem Ave^^Flint^MI^48507^USA^P|^PRN^PH^^^810^8097495ORC|RE||BC80K19564.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^This \E\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC80K19564.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.120|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y13Q19575^^^AIRA-TEST^MR||ProtheroeAIRA^SharayAIRA^Lotty^^^^L|KingAIRA^BonnieAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1230 Aelfzijl St^^Commerce Township^MI^48390^USA^P||^PRN^PH^^^248^8826211|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|ProtheroeAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1230 Aelfzijl St^^Commerce Township^MI^48390^USA^P|^PRN^PH^^^248^8826211ORC|RE||BY13Q19575.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^This \ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY13Q19575.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.121|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V52J19583^^^AIRA-TEST^MR||CowleAIRA^YamiletAIRA^Sharmistha^^^^L|MontcalmAIRA^SujataAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1938 Muur Ln^^Atlas^MI^48411^USA^P||^PRN^PH^^^810^6977654|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CowleAIRA^MontcalmAIRA^^^^^L|MTH^Mother^HL70063|1938 Muur Ln^^Atlas^MI^48411^USA^P|^PRN^PH^^^810^6977654ORC|RE||BV52J19583.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^This is a very long description for a vaccine, that normally you shouldn't expect to see, but since this field should not be read by the receiver it should be accepted, HL7 allows up to 199 chars.^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV52J19583.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.122|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O66Z19591^^^AIRA-TEST^MR||MonroeAIRA^DorotheaAIRA^Nan^^^^L|ColumbiaAIRA^EstaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1556 Veldrop Ave^^Romulus^MI^48174^USA^P||^PRN^PH^^^734^7842200|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|MonroeAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1556 Veldrop Ave^^Romulus^MI^48174^USA^P|^PRN^PH^^^734^7842200ORC|RE||BO66Z19591.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001||||||||^This is a very long description for a manufac, that normally you shouldn't expect to see, but since this field should not be read by the receiver it should be accepted, HL7 allows up to 199 chars.|||CP|AORC|RE||BO66Z19591.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.123|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q14I19599^^^AIRA-TEST^MR||HarperAIRA^MerlynAIRA^Aleena^^^^L|DelawareAIRA^NoemiAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1187 Tiel St^^Consumers Energy^MI^48937^USA^P||^PRN^PH^^^517^7495269|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarperAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1187 Tiel St^^Consumers Energy^MI^48937^USA^P|^PRN^PH^^^517^7495269ORC|RE||BQ14I19599.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001||||||||^Merk & Co|||CP|AORC|RE||BQ14I19599.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.124|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E23O19607^^^AIRA-TEST^MR||HarperAIRA^VonnieAIRA^Vasudhara^^^^L|WallinAIRA^CeanaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1529 Hedum Pl^^Delphi West^MI^48555^USA^P||^PRN^PH^^^810^5415796|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|HarperAIRA^WallinAIRA^^^^^L|MTH^Mother^HL70063|1529 Hedum Pl^^Delphi West^MI^48555^USA^P|^PRN^PH^^^810^5415796ORC|RE||BE23O19607.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|A||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||ORC|RE||BE23O19607.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.125|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z88A19615^^^AIRA-TEST^MR||WilsonAIRA^AlbaAIRA^Grania^^^^L|McCuskerAIRA^Guan-yinAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1125 Loon op Zand Cir^^Richmond Township^MI^48062^USA^P||^PRN^PH^^^586^6838108|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|WilsonAIRA^McCuskerAIRA^^^^^L|MTH^Mother^HL70063|1125 Loon op Zand Cir^^Richmond Township^MI^48062^USA^P|^PRN^PH^^^586^6838108ORC|RE||BZ88A19615.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|A|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1|ORC|RE||BZ88A19615.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.126|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y11I19620^^^AIRA-TEST^MR||CottonAIRA^OksanaAIRA^Myrtle^^^^L|FoxAIRA^AnvitaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1846 Deere Pl^^Comerica^MI^48255^USA^P||^PRN^PH^^^313^5028729|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|CottonAIRA^FoxAIRA^^^^^L|MTH^Mother^HL70063|1846 Deere Pl^^Comerica^MI^48255^USA^P|^PRN^PH^^^313^5028729ORC|RE||BY11I19620.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY11I19620.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.127|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M81I19631^^^AIRA-TEST^MR||GallatinAIRA^CrescentAIRA^Dee^^^^L|McCrackenAIRA^MarissaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1637 Beerlen Ave^^Hopkins^MI^49328^USA^P||^PRN^PH^^^269^6630223|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|GallatinAIRA^McCrackenAIRA^^^^^L|MTH^Mother^HL70063|1637 Beerlen Ave^^Hopkins^MI^49328^USA^P|^PRN^PH^^^269^6630223ORC|RE||BM81I19631.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM81I19631.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||FMSH|^~\&|||||20200306140619-0400||VXU^V04^VXU_V04|3wcI-D.01.135|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q99K19639^^^AIRA-TEST^MR||None^NeomaAIRA^Agnes^^^^L|KrogAIRA^JarkaAIRA^^^^^M|20160105|F||2106-3^White^CDCREC|1176 Vochem Pl^^Strongs^MI^49790^USA^P||^PRN^PH^^^906^2458644|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200306|20200306NK1|1|EigumAIRA^KrogAIRA^^^^^L|MTH^Mother^HL70063|1176 Vochem Pl^^Strongs^MI^49790^USA^P|^PRN^PH^^^906^2458644ORC|RE||BQ99K19639.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200105||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ99K19639.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200306||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200306||||||F